#BioGRID Chemical Interaction ID	BioGRID Gene ID	Entrez Gene ID	Systematic Name	Official Symbol	Synonyms	Organism ID	Organism	Action	Interaction Type	Author	Pubmed ID	BioGRID Publication ID	BioGRID Chemical ID	Chemical Name	Chemical Synonyms	Chemical Brands	Chemical Source	Chemical Source ID	Molecular Formula	Chemical Type	ATC Codes	CAS Number	Curated By	Method	Method Description	Related BioGRID Gene ID	Related Entrez Gene ID	Related Systematic Name	Related Official Symbol	Related Synonyms	Related Organism ID	Related Organism	Related Type	Notes	InChIKey
552	108499	2205	RP11-550P17.3	FCER1A	FCE1A|FcERI	9606	Homo sapiens	unknown	target	Mirkina I (2007)	17368811	172013	42	Omalizumab	Ig gamma-1 chain C region	xolair	DRUGBANK	DB00043	C6450H9916N1714O2023S38	biologic	R03DX05	242138-07-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
553	108499	2205	RP11-550P17.3	FCER1A	FCE1A|FcERI	9606	Homo sapiens	unknown	target	Beck LA (2004)	15356552	172012	42	Omalizumab	Ig gamma-1 chain C region	xolair	DRUGBANK	DB00043	C6450H9916N1714O2023S38	biologic	R03DX05	242138-07-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
561	112952	7097	-	TLR2	CD282|TIL4	9606	Homo sapiens	unknown	target	Welty DM (2003)	14617145	172016	44	OspA lipoprotein	Outer surface protein A precursor	-	DRUGBANK	DB00045	C1198H2012N322O422S2	biologic	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1287	111060	5020	-	OXT	OT|OT-NPI|OXT-NPI	9606	Homo sapiens	binder	target	Imming P (2006)	17016423	171742	102	Oxytocin	Syntocinon|Pitocin	oxytocin injection|oxytocin|pi	DRUGBANK	DB00107	C43H66N12O12S2	biologic	H01BB02|G02AC01	50-56-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1288	111060	5020	-	OXT	OT|OT-NPI|OXT-NPI	9606	Homo sapiens	binder	target	Land H (1983)	6687626	172427	102	Oxytocin	Syntocinon|Pitocin	oxytocin injection|oxytocin|pi	DRUGBANK	DB00107	C43H66N12O12S2	biologic	H01BB02|G02AC01	50-56-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
1289	111060	5020	-	OXT	OT|OT-NPI|OXT-NPI	9606	Homo sapiens	binder	target	Rao VV (1992)	1486803	172428	102	Oxytocin	Syntocinon|Pitocin	oxytocin injection|oxytocin|pi	DRUGBANK	DB00107	C43H66N12O12S2	biologic	H01BB02|G02AC01	50-56-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
2142	110180	3992	-	FADS1	D5D|FADS6|FADSD5|LLCDL1|TU12	9606	Homo sapiens	ligand	target	Mohan IK (2000)	10765977	173065	126	Alpha-Linolenic Acid	9,12,15-Octadecatrienoic acid|all-cis-9,12,15-Octadecatrienoic acid|alpha-Linolenic acid|(9Z,12Z,15Z)-Octadecatrienoic acid|9-cis,12-cis,15-cis-octadecatrienoic acid|-linolenic acid|(9,12,15)-linolenic acid|ALA|(Z,Z,Z)-9,12,15-octadecatrienoic acid|cis-delta(9,12,15)-Octadecatrienoic acid|Linolenic acid|cis,cis,cis-9,12,15-Octadecatrienoic acid	folcaps omega-3|ultimatecare o	DRUGBANK	DB00132	C18H30O2	small molecule	-	463-40-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTOSIQBPPRVQHS-PDBXOOCHSA-N
2143	110180	3992	-	FADS1	D5D|FADS6|FADSD5|LLCDL1|TU12	9606	Homo sapiens	ligand	target	Maniongui C (1993)	8487621	173064	126	Alpha-Linolenic Acid	9,12,15-Octadecatrienoic acid|all-cis-9,12,15-Octadecatrienoic acid|alpha-Linolenic acid|(9Z,12Z,15Z)-Octadecatrienoic acid|9-cis,12-cis,15-cis-octadecatrienoic acid|-linolenic acid|(9,12,15)-linolenic acid|ALA|(Z,Z,Z)-9,12,15-octadecatrienoic acid|cis-delta(9,12,15)-Octadecatrienoic acid|Linolenic acid|cis,cis,cis-9,12,15-Octadecatrienoic acid	folcaps omega-3|ultimatecare o	DRUGBANK	DB00132	C18H30O2	small molecule	-	463-40-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTOSIQBPPRVQHS-PDBXOOCHSA-N
2144	110180	3992	-	FADS1	D5D|FADS6|FADSD5|LLCDL1|TU12	9606	Homo sapiens	ligand	target	Xiang M (2006)	16988497	173067	126	Alpha-Linolenic Acid	9,12,15-Octadecatrienoic acid|all-cis-9,12,15-Octadecatrienoic acid|alpha-Linolenic acid|(9Z,12Z,15Z)-Octadecatrienoic acid|9-cis,12-cis,15-cis-octadecatrienoic acid|-linolenic acid|(9,12,15)-linolenic acid|ALA|(Z,Z,Z)-9,12,15-octadecatrienoic acid|cis-delta(9,12,15)-Octadecatrienoic acid|Linolenic acid|cis,cis,cis-9,12,15-Octadecatrienoic acid	folcaps omega-3|ultimatecare o	DRUGBANK	DB00132	C18H30O2	small molecule	-	463-40-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTOSIQBPPRVQHS-PDBXOOCHSA-N
2145	110180	3992	-	FADS1	D5D|FADS6|FADSD5|LLCDL1|TU12	9606	Homo sapiens	ligand	target	Descomps B (1995)	8673626	173066	126	Alpha-Linolenic Acid	9,12,15-Octadecatrienoic acid|all-cis-9,12,15-Octadecatrienoic acid|alpha-Linolenic acid|(9Z,12Z,15Z)-Octadecatrienoic acid|9-cis,12-cis,15-cis-octadecatrienoic acid|-linolenic acid|(9,12,15)-linolenic acid|ALA|(Z,Z,Z)-9,12,15-octadecatrienoic acid|cis-delta(9,12,15)-Octadecatrienoic acid|Linolenic acid|cis,cis,cis-9,12,15-Octadecatrienoic acid	folcaps omega-3|ultimatecare o	DRUGBANK	DB00132	C18H30O2	small molecule	-	463-40-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTOSIQBPPRVQHS-PDBXOOCHSA-N
2146	110180	3992	-	FADS1	D5D|FADS6|FADSD5|LLCDL1|TU12	9606	Homo sapiens	ligand	target	Hoffman DR (2001)	11518758	173063	126	Alpha-Linolenic Acid	9,12,15-Octadecatrienoic acid|all-cis-9,12,15-Octadecatrienoic acid|alpha-Linolenic acid|(9Z,12Z,15Z)-Octadecatrienoic acid|9-cis,12-cis,15-cis-octadecatrienoic acid|-linolenic acid|(9,12,15)-linolenic acid|ALA|(Z,Z,Z)-9,12,15-octadecatrienoic acid|cis-delta(9,12,15)-Octadecatrienoic acid|Linolenic acid|cis,cis,cis-9,12,15-Octadecatrienoic acid	folcaps omega-3|ultimatecare o	DRUGBANK	DB00132	C18H30O2	small molecule	-	463-40-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTOSIQBPPRVQHS-PDBXOOCHSA-N
2147	114810	9415	-	FADS2	D6D|DES6|FADSD6|LLCDL2|SLL0262|TU13	9606	Homo sapiens	ligand	target	Xiang M (2006)	16988497	173067	126	Alpha-Linolenic Acid	9,12,15-Octadecatrienoic acid|all-cis-9,12,15-Octadecatrienoic acid|alpha-Linolenic acid|(9Z,12Z,15Z)-Octadecatrienoic acid|9-cis,12-cis,15-cis-octadecatrienoic acid|-linolenic acid|(9,12,15)-linolenic acid|ALA|(Z,Z,Z)-9,12,15-octadecatrienoic acid|cis-delta(9,12,15)-Octadecatrienoic acid|Linolenic acid|cis,cis,cis-9,12,15-Octadecatrienoic acid	folcaps omega-3|ultimatecare o	DRUGBANK	DB00132	C18H30O2	small molecule	-	463-40-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTOSIQBPPRVQHS-PDBXOOCHSA-N
2148	114810	9415	-	FADS2	D6D|DES6|FADSD6|LLCDL2|SLL0262|TU13	9606	Homo sapiens	ligand	target	Baylin A (2007)	17284757	158289	126	Alpha-Linolenic Acid	9,12,15-Octadecatrienoic acid|all-cis-9,12,15-Octadecatrienoic acid|alpha-Linolenic acid|(9Z,12Z,15Z)-Octadecatrienoic acid|9-cis,12-cis,15-cis-octadecatrienoic acid|-linolenic acid|(9,12,15)-linolenic acid|ALA|(Z,Z,Z)-9,12,15-octadecatrienoic acid|cis-delta(9,12,15)-Octadecatrienoic acid|Linolenic acid|cis,cis,cis-9,12,15-Octadecatrienoic acid	folcaps omega-3|ultimatecare o	DRUGBANK	DB00132	C18H30O2	small molecule	-	463-40-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTOSIQBPPRVQHS-PDBXOOCHSA-N
2149	114810	9415	-	FADS2	D6D|DES6|FADSD6|LLCDL2|SLL0262|TU13	9606	Homo sapiens	ligand	target	Li MC (2004)	15481543	173069	126	Alpha-Linolenic Acid	9,12,15-Octadecatrienoic acid|all-cis-9,12,15-Octadecatrienoic acid|alpha-Linolenic acid|(9Z,12Z,15Z)-Octadecatrienoic acid|9-cis,12-cis,15-cis-octadecatrienoic acid|-linolenic acid|(9,12,15)-linolenic acid|ALA|(Z,Z,Z)-9,12,15-octadecatrienoic acid|cis-delta(9,12,15)-Octadecatrienoic acid|Linolenic acid|cis,cis,cis-9,12,15-Octadecatrienoic acid	folcaps omega-3|ultimatecare o	DRUGBANK	DB00132	C18H30O2	small molecule	-	463-40-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTOSIQBPPRVQHS-PDBXOOCHSA-N
2150	114810	9415	-	FADS2	D6D|DES6|FADSD6|LLCDL2|SLL0262|TU13	9606	Homo sapiens	ligand	target	Portolesi R (2007)	17409318	173068	126	Alpha-Linolenic Acid	9,12,15-Octadecatrienoic acid|all-cis-9,12,15-Octadecatrienoic acid|alpha-Linolenic acid|(9Z,12Z,15Z)-Octadecatrienoic acid|9-cis,12-cis,15-cis-octadecatrienoic acid|-linolenic acid|(9,12,15)-linolenic acid|ALA|(Z,Z,Z)-9,12,15-octadecatrienoic acid|cis-delta(9,12,15)-Octadecatrienoic acid|Linolenic acid|cis,cis,cis-9,12,15-Octadecatrienoic acid	folcaps omega-3|ultimatecare o	DRUGBANK	DB00132	C18H30O2	small molecule	-	463-40-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTOSIQBPPRVQHS-PDBXOOCHSA-N
2151	114810	9415	-	FADS2	D6D|DES6|FADSD6|LLCDL2|SLL0262|TU13	9606	Homo sapiens	ligand	target	Ge L (2003)	12713571	158520	126	Alpha-Linolenic Acid	9,12,15-Octadecatrienoic acid|all-cis-9,12,15-Octadecatrienoic acid|alpha-Linolenic acid|(9Z,12Z,15Z)-Octadecatrienoic acid|9-cis,12-cis,15-cis-octadecatrienoic acid|-linolenic acid|(9,12,15)-linolenic acid|ALA|(Z,Z,Z)-9,12,15-octadecatrienoic acid|cis-delta(9,12,15)-Octadecatrienoic acid|Linolenic acid|cis,cis,cis-9,12,15-Octadecatrienoic acid	folcaps omega-3|ultimatecare o	DRUGBANK	DB00132	C18H30O2	small molecule	-	463-40-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTOSIQBPPRVQHS-PDBXOOCHSA-N
2152	114810	9415	-	FADS2	D6D|DES6|FADSD6|LLCDL2|SLL0262|TU13	9606	Homo sapiens	ligand	target	Tan L (2011)	21210105	110703	126	Alpha-Linolenic Acid	9,12,15-Octadecatrienoic acid|all-cis-9,12,15-Octadecatrienoic acid|alpha-Linolenic acid|(9Z,12Z,15Z)-Octadecatrienoic acid|9-cis,12-cis,15-cis-octadecatrienoic acid|-linolenic acid|(9,12,15)-linolenic acid|ALA|(Z,Z,Z)-9,12,15-octadecatrienoic acid|cis-delta(9,12,15)-Octadecatrienoic acid|Linolenic acid|cis,cis,cis-9,12,15-Octadecatrienoic acid	folcaps omega-3|ultimatecare o	DRUGBANK	DB00132	C18H30O2	small molecule	-	463-40-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTOSIQBPPRVQHS-PDBXOOCHSA-N
2559	109137	2879	-	GPX4	GPx-4|GSHPx-4|MCSP|PHGPx|snGPx|snPHGPx	9606	Homo sapiens	cofactor	target	Imming P (2006)	17016423	171742	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2560	109137	2879	-	GPX4	GPx-4|GSHPx-4|MCSP|PHGPx|snGPx|snPHGPx	9606	Homo sapiens	cofactor	target	Baek IJ (2007)	17503194	173309	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2561	109137	2879	-	GPX4	GPx-4|GSHPx-4|MCSP|PHGPx|snGPx|snPHGPx	9606	Homo sapiens	cofactor	target	Overington JP (2006)	17139284	171741	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2562	109137	2879	-	GPX4	GPx-4|GSHPx-4|MCSP|PHGPx|snGPx|snPHGPx	9606	Homo sapiens	cofactor	target	Nam SY (2003)	14967915	173311	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2563	109137	2879	-	GPX4	GPx-4|GSHPx-4|MCSP|PHGPx|snGPx|snPHGPx	9606	Homo sapiens	cofactor	target	Moreno SG (2003)	12751792	173310	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2564	110234	4056	-	LTC4S	-	9606	Homo sapiens	unknown	target	Ago H (2007)	17632548	160488	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2565	110234	4056	-	LTC4S	-	9606	Homo sapiens	unknown	target	Martinez Molina D (2007)	17632546	160398	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2574	110414	4258	-	MGST2	GST2|MGST-II	9606	Homo sapiens	unknown	target	Ago H (2007)	17632548	160488	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2590	109135	2877	-	GPX2	GI-GPx|GPRP|GPRP-2|GPx-2|GPx-GI|GSHPX-GI|GSHPx-2	9606	Homo sapiens	cofactor	target	Walshe J (2007)	17510403	173331	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2591	109134	2876	-	GPX1	GPXD|GSHPX1	9606	Homo sapiens	cofactor	target	Imming P (2006)	17016423	171742	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2592	109134	2876	-	GPX1	GPXD|GSHPX1	9606	Homo sapiens	cofactor	target	Liddell JR (2006)	16721761	173334	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2593	109134	2876	-	GPX1	GPXD|GSHPX1	9606	Homo sapiens	cofactor	target	Overington JP (2006)	17139284	171741	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2594	109134	2876	-	GPX1	GPXD|GSHPX1	9606	Homo sapiens	cofactor	target	Destro-Bisol G (1989)	2742004	173333	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2595	109134	2876	-	GPX1	GPXD|GSHPX1	9606	Homo sapiens	cofactor	target	Ursini F (2005)	15679624	173332	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2600	110415	4259	RP11-466F5.1	MGST3	GST-III	9606	Homo sapiens	unknown	target	Ago H (2007)	17632548	160488	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2624	108946	2678	-	GGT1	CD224|D22S672|D22S732|GGT|GGT 1|GTG	9606	Homo sapiens	unknown	target	Ohkama-Ohtsu N (2007)	17316176	173353	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2625	108946	2678	-	GGT1	CD224|D22S672|D22S732|GGT|GGT 1|GTG	9606	Homo sapiens	unknown	target	Adamis PD (2007)	17644279	73689	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2626	108946	2678	-	GGT1	CD224|D22S672|D22S732|GGT|GGT 1|GTG	9606	Homo sapiens	unknown	target	Anilakumar KR (2007)	17569287	173356	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2627	108946	2678	-	GGT1	CD224|D22S672|D22S732|GGT|GGT 1|GTG	9606	Homo sapiens	unknown	target	Zhu Y (2007)	17291629	173355	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2628	108946	2678	-	GGT1	CD224|D22S672|D22S732|GGT|GGT 1|GTG	9606	Homo sapiens	unknown	target	Martin MN (2007)	17545509	173354	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2659	109134	2876	-	GPX1	GPXD|GSHPX1	9606	Homo sapiens	unknown	target	Walshe J (2007)	17510403	173331	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2660	109134	2876	-	GPX1	GPXD|GSHPX1	9606	Homo sapiens	unknown	target	Chattopadhyay S (2007)	17561443	173375	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2661	109134	2876	-	GPX1	GPXD|GSHPX1	9606	Homo sapiens	unknown	target	Du X (2007)	17387467	71461	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2662	109134	2876	-	GPX1	GPXD|GSHPX1	9606	Homo sapiens	unknown	target	Sordillo LM (2007)	17297093	173377	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2663	109134	2876	-	GPX1	GPXD|GSHPX1	9606	Homo sapiens	unknown	target	Sheridan PA (2007)	17513408	173376	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2664	118128	27306	-	HPGDS	GSTS|GSTS1-1|PGD2|PGDS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2665	118128	27306	-	HPGDS	GSTS|GSTS1-1|PGD2|PGDS	9606	Homo sapiens	unknown	target	Urade Y (1993)	8415655	173378	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2666	118128	27306	-	HPGDS	GSTS|GSTS1-1|PGD2|PGDS	9606	Homo sapiens	unknown	target	Aritake K (2006)	16547010	152941	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2667	118128	27306	-	HPGDS	GSTS|GSTS1-1|PGD2|PGDS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2668	118128	27306	-	HPGDS	GSTS|GSTS1-1|PGD2|PGDS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2669	118128	27306	-	HPGDS	GSTS|GSTS1-1|PGD2|PGDS	9606	Homo sapiens	unknown	target	Inoue T (2004)	15113825	152402	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2688	109136	2878	-	GPX3	GPx-P|GSHPx-3|GSHPx-P	9606	Homo sapiens	cofactor	target	Carmeli E (2007)	17578749	173388	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2689	109136	2878	-	GPX3	GPx-P|GSHPx-3|GSHPx-P	9606	Homo sapiens	cofactor	target	Jacobson GA (2007)	17558897	173389	137	Glutathione	Glutathione-SH|Glutathione|5-L-Glutamyl-L-cysteinylglycine|N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine|gamma-L-Glutamyl-L-cysteinyl-glycine|Reduced glutathione|GSH	amo endosol extra|bss plus|nav	DRUGBANK	DB00143	C10H17N3O6S	small molecule	V03AB32	70-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RWSXRVCMGQZWBV-WDSKDSINSA-N
2801	107046	570	-	BAAT	BACAT|BAT	9606	Homo sapiens	unknown	target	Pellicoro A (2007)	17256745	158237	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2802	107046	570	-	BAAT	BACAT|BAT	9606	Homo sapiens	unknown	target	Styles NA (2007)	17379925	173482	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2803	107046	570	-	BAAT	BACAT|BAT	9606	Homo sapiens	unknown	target	Nakamura K (2007)	16931649	173481	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2804	107046	570	-	BAAT	BACAT|BAT	9606	Homo sapiens	unknown	target	Visser WF (2007)	17416343	173480	139	Glycine	Aminoacetic acid|Glycine|G|Glycin|Aminoessigsaeure|Hgly|Glycocoll|Gly|Aminoethanoic acid|Leimzucker|Glyzin|H2N-CH2-COOH|Glykokoll	2.5% travasol amino acid injec	DRUGBANK	DB00145	C2H5NO2	small molecule	B05CX03	56-40-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHMQDGOQFOQNFH-UHFFFAOYSA-N
2939	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	148	Dihomo-gamma-linolenic acid	(Z,Z,Z)-8,11,14-Eicosatrienoic acid|(Z,Z,Z)-8,11,14-Icosatrienoate|all-cis-Eicosa-8,11,14-triensaeure|Homo-gamma-linolenic acid|all-cis-icosa-8,11,14-trienoic acid|(Z,Z,Z)-8,11,14-Icosatrienoic acid|Homo-gamma-linolensaeure|gamma-Homolinolenic acid|Dihomo--linolenic acid|DGLA|20:3, n-6,9,12 all-cis|8,11,14-Eicosatrienoic Acid|all-cis-8,11,14-eicosatrienoic acid|eicosa-8Z,11Z,14Z-trienoic acid|C20:3, n-6,9,12 all-cis|cis,cis,cis-8,11,14-eicosatrienoic acid|(8Z,11Z,14Z)-Icosatrienoic acid|all-cis-eicosa-8,11,14-trienoic acid|8c,11c,14c-Eicosatriensaeure|8c,11c,14c-eicosatrienoic acid|all-cis-8,11,14-icosatrienoic acid	-	DRUGBANK	DB00154	C20H34O2	small molecule	-	1783-84-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HOBAELRKJCKHQD-QNEBEIHSSA-N
2940	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Das UN (2005)	15990700	173594	148	Dihomo-gamma-linolenic acid	(Z,Z,Z)-8,11,14-Eicosatrienoic acid|(Z,Z,Z)-8,11,14-Icosatrienoate|all-cis-Eicosa-8,11,14-triensaeure|Homo-gamma-linolenic acid|all-cis-icosa-8,11,14-trienoic acid|(Z,Z,Z)-8,11,14-Icosatrienoic acid|Homo-gamma-linolensaeure|gamma-Homolinolenic acid|Dihomo--linolenic acid|DGLA|20:3, n-6,9,12 all-cis|8,11,14-Eicosatrienoic Acid|all-cis-8,11,14-eicosatrienoic acid|eicosa-8Z,11Z,14Z-trienoic acid|C20:3, n-6,9,12 all-cis|cis,cis,cis-8,11,14-eicosatrienoic acid|(8Z,11Z,14Z)-Icosatrienoic acid|all-cis-eicosa-8,11,14-trienoic acid|8c,11c,14c-Eicosatriensaeure|8c,11c,14c-eicosatrienoic acid|all-cis-8,11,14-icosatrienoic acid	-	DRUGBANK	DB00154	C20H34O2	small molecule	-	1783-84-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HOBAELRKJCKHQD-QNEBEIHSSA-N
2941	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Das UN (2005)	16190133	173591	148	Dihomo-gamma-linolenic acid	(Z,Z,Z)-8,11,14-Eicosatrienoic acid|(Z,Z,Z)-8,11,14-Icosatrienoate|all-cis-Eicosa-8,11,14-triensaeure|Homo-gamma-linolenic acid|all-cis-icosa-8,11,14-trienoic acid|(Z,Z,Z)-8,11,14-Icosatrienoic acid|Homo-gamma-linolensaeure|gamma-Homolinolenic acid|Dihomo--linolenic acid|DGLA|20:3, n-6,9,12 all-cis|8,11,14-Eicosatrienoic Acid|all-cis-8,11,14-eicosatrienoic acid|eicosa-8Z,11Z,14Z-trienoic acid|C20:3, n-6,9,12 all-cis|cis,cis,cis-8,11,14-eicosatrienoic acid|(8Z,11Z,14Z)-Icosatrienoic acid|all-cis-eicosa-8,11,14-trienoic acid|8c,11c,14c-Eicosatriensaeure|8c,11c,14c-eicosatrienoic acid|all-cis-8,11,14-icosatrienoic acid	-	DRUGBANK	DB00154	C20H34O2	small molecule	-	1783-84-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HOBAELRKJCKHQD-QNEBEIHSSA-N
2942	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Thuresson ED (2001)	11121413	173590	148	Dihomo-gamma-linolenic acid	(Z,Z,Z)-8,11,14-Eicosatrienoic acid|(Z,Z,Z)-8,11,14-Icosatrienoate|all-cis-Eicosa-8,11,14-triensaeure|Homo-gamma-linolenic acid|all-cis-icosa-8,11,14-trienoic acid|(Z,Z,Z)-8,11,14-Icosatrienoic acid|Homo-gamma-linolensaeure|gamma-Homolinolenic acid|Dihomo--linolenic acid|DGLA|20:3, n-6,9,12 all-cis|8,11,14-Eicosatrienoic Acid|all-cis-8,11,14-eicosatrienoic acid|eicosa-8Z,11Z,14Z-trienoic acid|C20:3, n-6,9,12 all-cis|cis,cis,cis-8,11,14-eicosatrienoic acid|(8Z,11Z,14Z)-Icosatrienoic acid|all-cis-eicosa-8,11,14-trienoic acid|8c,11c,14c-Eicosatriensaeure|8c,11c,14c-eicosatrienoic acid|all-cis-8,11,14-icosatrienoic acid	-	DRUGBANK	DB00154	C20H34O2	small molecule	-	1783-84-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HOBAELRKJCKHQD-QNEBEIHSSA-N
2943	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Malkowski MG (2001)	11477109	173593	148	Dihomo-gamma-linolenic acid	(Z,Z,Z)-8,11,14-Eicosatrienoic acid|(Z,Z,Z)-8,11,14-Icosatrienoate|all-cis-Eicosa-8,11,14-triensaeure|Homo-gamma-linolenic acid|all-cis-icosa-8,11,14-trienoic acid|(Z,Z,Z)-8,11,14-Icosatrienoic acid|Homo-gamma-linolensaeure|gamma-Homolinolenic acid|Dihomo--linolenic acid|DGLA|20:3, n-6,9,12 all-cis|8,11,14-Eicosatrienoic Acid|all-cis-8,11,14-eicosatrienoic acid|eicosa-8Z,11Z,14Z-trienoic acid|C20:3, n-6,9,12 all-cis|cis,cis,cis-8,11,14-eicosatrienoic acid|(8Z,11Z,14Z)-Icosatrienoic acid|all-cis-eicosa-8,11,14-trienoic acid|8c,11c,14c-Eicosatriensaeure|8c,11c,14c-eicosatrienoic acid|all-cis-8,11,14-icosatrienoic acid	-	DRUGBANK	DB00154	C20H34O2	small molecule	-	1783-84-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HOBAELRKJCKHQD-QNEBEIHSSA-N
2944	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Levin G (2002)	11939906	173592	148	Dihomo-gamma-linolenic acid	(Z,Z,Z)-8,11,14-Eicosatrienoic acid|(Z,Z,Z)-8,11,14-Icosatrienoate|all-cis-Eicosa-8,11,14-triensaeure|Homo-gamma-linolenic acid|all-cis-icosa-8,11,14-trienoic acid|(Z,Z,Z)-8,11,14-Icosatrienoic acid|Homo-gamma-linolensaeure|gamma-Homolinolenic acid|Dihomo--linolenic acid|DGLA|20:3, n-6,9,12 all-cis|8,11,14-Eicosatrienoic Acid|all-cis-8,11,14-eicosatrienoic acid|eicosa-8Z,11Z,14Z-trienoic acid|C20:3, n-6,9,12 all-cis|cis,cis,cis-8,11,14-eicosatrienoic acid|(8Z,11Z,14Z)-Icosatrienoic acid|all-cis-eicosa-8,11,14-trienoic acid|8c,11c,14c-Eicosatriensaeure|8c,11c,14c-eicosatrienoic acid|all-cis-8,11,14-icosatrienoic acid	-	DRUGBANK	DB00154	C20H34O2	small molecule	-	1783-84-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HOBAELRKJCKHQD-QNEBEIHSSA-N
2945	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	unknown	target	Das UN (2005)	15990700	173594	148	Dihomo-gamma-linolenic acid	(Z,Z,Z)-8,11,14-Eicosatrienoic acid|(Z,Z,Z)-8,11,14-Icosatrienoate|all-cis-Eicosa-8,11,14-triensaeure|Homo-gamma-linolenic acid|all-cis-icosa-8,11,14-trienoic acid|(Z,Z,Z)-8,11,14-Icosatrienoic acid|Homo-gamma-linolensaeure|gamma-Homolinolenic acid|Dihomo--linolenic acid|DGLA|20:3, n-6,9,12 all-cis|8,11,14-Eicosatrienoic Acid|all-cis-8,11,14-eicosatrienoic acid|eicosa-8Z,11Z,14Z-trienoic acid|C20:3, n-6,9,12 all-cis|cis,cis,cis-8,11,14-eicosatrienoic acid|(8Z,11Z,14Z)-Icosatrienoic acid|all-cis-eicosa-8,11,14-trienoic acid|8c,11c,14c-Eicosatriensaeure|8c,11c,14c-eicosatrienoic acid|all-cis-8,11,14-icosatrienoic acid	-	DRUGBANK	DB00154	C20H34O2	small molecule	-	1783-84-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HOBAELRKJCKHQD-QNEBEIHSSA-N
2946	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	unknown	target	Das UN (2005)	16190133	173591	148	Dihomo-gamma-linolenic acid	(Z,Z,Z)-8,11,14-Eicosatrienoic acid|(Z,Z,Z)-8,11,14-Icosatrienoate|all-cis-Eicosa-8,11,14-triensaeure|Homo-gamma-linolenic acid|all-cis-icosa-8,11,14-trienoic acid|(Z,Z,Z)-8,11,14-Icosatrienoic acid|Homo-gamma-linolensaeure|gamma-Homolinolenic acid|Dihomo--linolenic acid|DGLA|20:3, n-6,9,12 all-cis|8,11,14-Eicosatrienoic Acid|all-cis-8,11,14-eicosatrienoic acid|eicosa-8Z,11Z,14Z-trienoic acid|C20:3, n-6,9,12 all-cis|cis,cis,cis-8,11,14-eicosatrienoic acid|(8Z,11Z,14Z)-Icosatrienoic acid|all-cis-eicosa-8,11,14-trienoic acid|8c,11c,14c-Eicosatriensaeure|8c,11c,14c-eicosatrienoic acid|all-cis-8,11,14-icosatrienoic acid	-	DRUGBANK	DB00154	C20H34O2	small molecule	-	1783-84-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HOBAELRKJCKHQD-QNEBEIHSSA-N
2947	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	unknown	target	Thuresson ED (2001)	11121413	173590	148	Dihomo-gamma-linolenic acid	(Z,Z,Z)-8,11,14-Eicosatrienoic acid|(Z,Z,Z)-8,11,14-Icosatrienoate|all-cis-Eicosa-8,11,14-triensaeure|Homo-gamma-linolenic acid|all-cis-icosa-8,11,14-trienoic acid|(Z,Z,Z)-8,11,14-Icosatrienoic acid|Homo-gamma-linolensaeure|gamma-Homolinolenic acid|Dihomo--linolenic acid|DGLA|20:3, n-6,9,12 all-cis|8,11,14-Eicosatrienoic Acid|all-cis-8,11,14-eicosatrienoic acid|eicosa-8Z,11Z,14Z-trienoic acid|C20:3, n-6,9,12 all-cis|cis,cis,cis-8,11,14-eicosatrienoic acid|(8Z,11Z,14Z)-Icosatrienoic acid|all-cis-eicosa-8,11,14-trienoic acid|8c,11c,14c-Eicosatriensaeure|8c,11c,14c-eicosatrienoic acid|all-cis-8,11,14-icosatrienoic acid	-	DRUGBANK	DB00154	C20H34O2	small molecule	-	1783-84-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HOBAELRKJCKHQD-QNEBEIHSSA-N
2948	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	unknown	target	Levin G (2002)	11939906	173592	148	Dihomo-gamma-linolenic acid	(Z,Z,Z)-8,11,14-Eicosatrienoic acid|(Z,Z,Z)-8,11,14-Icosatrienoate|all-cis-Eicosa-8,11,14-triensaeure|Homo-gamma-linolenic acid|all-cis-icosa-8,11,14-trienoic acid|(Z,Z,Z)-8,11,14-Icosatrienoic acid|Homo-gamma-linolensaeure|gamma-Homolinolenic acid|Dihomo--linolenic acid|DGLA|20:3, n-6,9,12 all-cis|8,11,14-Eicosatrienoic Acid|all-cis-8,11,14-eicosatrienoic acid|eicosa-8Z,11Z,14Z-trienoic acid|C20:3, n-6,9,12 all-cis|cis,cis,cis-8,11,14-eicosatrienoic acid|(8Z,11Z,14Z)-Icosatrienoic acid|all-cis-eicosa-8,11,14-trienoic acid|8c,11c,14c-Eicosatriensaeure|8c,11c,14c-eicosatrienoic acid|all-cis-8,11,14-icosatrienoic acid	-	DRUGBANK	DB00154	C20H34O2	small molecule	-	1783-84-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HOBAELRKJCKHQD-QNEBEIHSSA-N
2973	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Giraldi-Guimaraes A (1999)	10681601	173616	149	L-Citrulline	N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid	-	DRUGBANK	DB00155	C6H13N3O3	small molecule	-	372-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHGKLRLOHDJJDR-BYPYZUCNSA-N
2974	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Perry JM (2000)	10799481	173617	149	L-Citrulline	N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid	-	DRUGBANK	DB00155	C6H13N3O3	small molecule	-	372-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHGKLRLOHDJJDR-BYPYZUCNSA-N
2975	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Yu W (2000)	10962148	173614	149	L-Citrulline	N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid	-	DRUGBANK	DB00155	C6H13N3O3	small molecule	-	372-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHGKLRLOHDJJDR-BYPYZUCNSA-N
2976	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Adak S (2000)	10945985	173615	149	L-Citrulline	N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid	-	DRUGBANK	DB00155	C6H13N3O3	small molecule	-	372-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHGKLRLOHDJJDR-BYPYZUCNSA-N
2977	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Kominami S (1999)	10502685	173613	149	L-Citrulline	N5-(Aminocarbonyl)ornithine|N(delta)-Carbamylornithine|L-2-Amino-5-ureidovaleric acid|-amino--ureidovaleric acid|N5-carbamoylornithine|2-Amino-5-ureidovaleric acid|N5-Carbamoyl-L-ornithine|L-Citrulline|Citrulline|-ureidonorvaline|Cit|(S)-2-Amino-5-ureidopentanoic acid|N(5)-(Aminocarbonyl)-L-ornithine|delta-Ureidonorvaline|alpha-amino-delta-Ureidovaleric acid	-	DRUGBANK	DB00155	C6H13N3O3	small molecule	-	372-75-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RHGKLRLOHDJJDR-BYPYZUCNSA-N
3119	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Linster CL (2007)	17222174	173683	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3120	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Ido Y (2007)	17508915	173682	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3182	114196	8644	-	AKR1C3	DD3|DDX|HA1753|HAKRB|HAKRe|HSD17B5|PGFS|hluPGFS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3183	114196	8644	-	AKR1C3	DD3|DDX|HA1753|HAKRB|HAKRe|HSD17B5|PGFS|hluPGFS	9606	Homo sapiens	unknown	target	Pineda JA (1989)	2615366	173675	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3184	114196	8644	-	AKR1C3	DD3|DDX|HA1753|HAKRB|HAKRe|HSD17B5|PGFS|hluPGFS	9606	Homo sapiens	unknown	target	Pineda JA (1990)	2146972	173706	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3185	114196	8644	-	AKR1C3	DD3|DDX|HA1753|HAKRB|HAKRe|HSD17B5|PGFS|hluPGFS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3186	114196	8644	-	AKR1C3	DD3|DDX|HA1753|HAKRB|HAKRe|HSD17B5|PGFS|hluPGFS	9606	Homo sapiens	unknown	target	Nicolas JC (1983)	6584048	173707	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3196	108012	1645	RP11-69D4.1	AKR1C1	2-ALPHA-HSD|20-ALPHA-HSD|C9|DD1|DD1/DD2|DDH|DDH1|H-37|HAKRC|HBAB|MBAB	9606	Homo sapiens	unknown	target	Burczynski ME (2001)	11060293	173710	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3197	108012	1645	RP11-69D4.1	AKR1C1	2-ALPHA-HSD|20-ALPHA-HSD|C9|DD1|DD1/DD2|DDH|DDH1|H-37|HAKRC|HBAB|MBAB	9606	Homo sapiens	unknown	target	Fukuda T (1986)	3463506	173674	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3198	108012	1645	RP11-69D4.1	AKR1C1	2-ALPHA-HSD|20-ALPHA-HSD|C9|DD1|DD1/DD2|DDH|DDH1|H-37|HAKRC|HBAB|MBAB	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3199	108012	1645	RP11-69D4.1	AKR1C1	2-ALPHA-HSD|20-ALPHA-HSD|C9|DD1|DD1/DD2|DDH|DDH1|H-37|HAKRC|HBAB|MBAB	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3200	108012	1645	RP11-69D4.1	AKR1C1	2-ALPHA-HSD|20-ALPHA-HSD|C9|DD1|DD1/DD2|DDH|DDH1|H-37|HAKRC|HBAB|MBAB	9606	Homo sapiens	unknown	target	Pineda JA (1989)	2615366	173675	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3329	109485	3248	-	HPGD	15-PGDH|PGDH|PGDH1|PHOAR1|SDR36C1	9606	Homo sapiens	unknown	target	Gao L (2007)	17463062	173761	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3346	108013	1646	-	AKR1C2	AKR1C-pseudo|BABP|DD|DD-2|DD/BABP|DD2|DDH2|HAKRD|HBAB|MCDR2|SRXY8|TDD	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3347	108013	1646	-	AKR1C2	AKR1C-pseudo|BABP|DD|DD-2|DD/BABP|DD2|DDH2|HAKRD|HBAB|MCDR2|SRXY8|TDD	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3348	108013	1646	-	AKR1C2	AKR1C-pseudo|BABP|DD|DD-2|DD/BABP|DD2|DDH2|HAKRD|HBAB|MCDR2|SRXY8|TDD	9606	Homo sapiens	unknown	target	Rizner TL (2003)	12810547	173768	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3349	108013	1646	-	AKR1C2	AKR1C-pseudo|BABP|DD|DD-2|DD/BABP|DD2|DDH2|HAKRD|HBAB|MCDR2|SRXY8|TDD	9606	Homo sapiens	unknown	target	Trauger JW (2002)	12416991	173769	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3350	107951	1579	-	CYP4A11	CP4Y|CYP4A2|CYP4AII	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3351	107951	1579	-	CYP4A11	CP4Y|CYP4A2|CYP4AII	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3352	107951	1579	-	CYP4A11	CP4Y|CYP4A2|CYP4AII	9606	Homo sapiens	unknown	target	Ngo S (2000)	11246504	173770	151	NADH	DPNH|Reduced nicotinamide adenine diphosphate|Nicotinamide-adenine dinucleotide, reduced|1,4-dihydronicotinamide adenine dinucleotide|Reduced nicotinamide-adenine dinucleotide|NAD reduced form|Nicotinamide adenine dinucleotide (reduced)	-	DRUGBANK	DB00157	C21H29N7O14P2	small molecule	-	58-68-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BOPGDPNILDQYTO-NNYOXOHSSA-N
3424	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Yang P (2004)	14993240	173821	153	Icosapent	all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA	natelle one|gesticare dha|ulti	DRUGBANK	DB00159	C20H30O2	small molecule	-	10417-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAZBEHYOTPTENJ-JLNKQSITSA-N
3425	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Machida T (2005)	16141635	173820	153	Icosapent	all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA	natelle one|gesticare dha|ulti	DRUGBANK	DB00159	C20H30O2	small molecule	-	10417-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAZBEHYOTPTENJ-JLNKQSITSA-N
3426	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Lee JY (2003)	12562875	173822	153	Icosapent	all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA	natelle one|gesticare dha|ulti	DRUGBANK	DB00159	C20H30O2	small molecule	-	10417-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAZBEHYOTPTENJ-JLNKQSITSA-N
3427	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Vecchio AJ (2010)	20463020	173819	153	Icosapent	all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA	natelle one|gesticare dha|ulti	DRUGBANK	DB00159	C20H30O2	small molecule	-	10417-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAZBEHYOTPTENJ-JLNKQSITSA-N
3428	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Das UN (2005)	15990700	173594	153	Icosapent	all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA	natelle one|gesticare dha|ulti	DRUGBANK	DB00159	C20H30O2	small molecule	-	10417-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAZBEHYOTPTENJ-JLNKQSITSA-N
3429	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Das UN (2005)	16190133	173591	153	Icosapent	all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA	natelle one|gesticare dha|ulti	DRUGBANK	DB00159	C20H30O2	small molecule	-	10417-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAZBEHYOTPTENJ-JLNKQSITSA-N
3430	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Malkowski MG (2001)	11477109	173593	153	Icosapent	all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA	natelle one|gesticare dha|ulti	DRUGBANK	DB00159	C20H30O2	small molecule	-	10417-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAZBEHYOTPTENJ-JLNKQSITSA-N
3431	110180	3992	-	FADS1	D5D|FADS6|FADSD5|LLCDL1|TU12	9606	Homo sapiens	agonist	target	Engler MM (2000)	11026622	173823	153	Icosapent	all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA	natelle one|gesticare dha|ulti	DRUGBANK	DB00159	C20H30O2	small molecule	-	10417-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAZBEHYOTPTENJ-JLNKQSITSA-N
3432	110180	3992	-	FADS1	D5D|FADS6|FADSD5|LLCDL1|TU12	9606	Homo sapiens	agonist	target	Watts JL (1999)	9917342	173825	153	Icosapent	all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA	natelle one|gesticare dha|ulti	DRUGBANK	DB00159	C20H30O2	small molecule	-	10417-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAZBEHYOTPTENJ-JLNKQSITSA-N
3433	110180	3992	-	FADS1	D5D|FADS6|FADSD5|LLCDL1|TU12	9606	Homo sapiens	agonist	target	Navarro E (2000)	10685788	173824	153	Icosapent	all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA	natelle one|gesticare dha|ulti	DRUGBANK	DB00159	C20H30O2	small molecule	-	10417-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAZBEHYOTPTENJ-JLNKQSITSA-N
3434	110180	3992	-	FADS1	D5D|FADS6|FADSD5|LLCDL1|TU12	9606	Homo sapiens	agonist	target	Barham JB (2000)	10917903	173827	153	Icosapent	all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA	natelle one|gesticare dha|ulti	DRUGBANK	DB00159	C20H30O2	small molecule	-	10417-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAZBEHYOTPTENJ-JLNKQSITSA-N
3435	110180	3992	-	FADS1	D5D|FADS6|FADSD5|LLCDL1|TU12	9606	Homo sapiens	agonist	target	Chavali SR (1998)	9610840	173826	153	Icosapent	all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA	natelle one|gesticare dha|ulti	DRUGBANK	DB00159	C20H30O2	small molecule	-	10417-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAZBEHYOTPTENJ-JLNKQSITSA-N
3436	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Horia E (2007)	17052999	173829	153	Icosapent	all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA	natelle one|gesticare dha|ulti	DRUGBANK	DB00159	C20H30O2	small molecule	-	10417-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAZBEHYOTPTENJ-JLNKQSITSA-N
3437	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Ramakers JD (2007)	17610002	173828	153	Icosapent	all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA	natelle one|gesticare dha|ulti	DRUGBANK	DB00159	C20H30O2	small molecule	-	10417-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAZBEHYOTPTENJ-JLNKQSITSA-N
3438	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Selvaraj RK (2006)	16702329	173830	153	Icosapent	all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA	natelle one|gesticare dha|ulti	DRUGBANK	DB00159	C20H30O2	small molecule	-	10417-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAZBEHYOTPTENJ-JLNKQSITSA-N
3439	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Chambrier C (2002)	12055328	173831	153	Icosapent	all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA	natelle one|gesticare dha|ulti	DRUGBANK	DB00159	C20H30O2	small molecule	-	10417-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAZBEHYOTPTENJ-JLNKQSITSA-N
3440	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Iwata Y (2001)	11552681	173832	153	Icosapent	all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA	natelle one|gesticare dha|ulti	DRUGBANK	DB00159	C20H30O2	small molecule	-	10417-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAZBEHYOTPTENJ-JLNKQSITSA-N
3442	108478	2182	-	ACSL4	ACS4|FACL4|LACS4|MRX63|MRX68	9606	Homo sapiens	inducer	target	Heimli H (2003)	12784866	173834	153	Icosapent	all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA	natelle one|gesticare dha|ulti	DRUGBANK	DB00159	C20H30O2	small molecule	-	10417-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAZBEHYOTPTENJ-JLNKQSITSA-N
3443	108478	2182	-	ACSL4	ACS4|FACL4|LACS4|MRX63|MRX68	9606	Homo sapiens	inducer	target	Covault J (2004)	15108178	173835	153	Icosapent	all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA	natelle one|gesticare dha|ulti	DRUGBANK	DB00159	C20H30O2	small molecule	-	10417-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAZBEHYOTPTENJ-JLNKQSITSA-N
3451	108477	2181	-	ACSL3	ACS3|FACL3|PRO2194	9606	Homo sapiens	inducer	target	Imming P (2006)	17016423	171742	153	Icosapent	all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA	natelle one|gesticare dha|ulti	DRUGBANK	DB00159	C20H30O2	small molecule	-	10417-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAZBEHYOTPTENJ-JLNKQSITSA-N
3452	108477	2181	-	ACSL3	ACS3|FACL3|PRO2194	9606	Homo sapiens	inducer	target	Overington JP (2006)	17139284	171741	153	Icosapent	all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA	natelle one|gesticare dha|ulti	DRUGBANK	DB00159	C20H30O2	small molecule	-	10417-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAZBEHYOTPTENJ-JLNKQSITSA-N
3453	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Machida T (2005)	16141635	173820	153	Icosapent	all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA	natelle one|gesticare dha|ulti	DRUGBANK	DB00159	C20H30O2	small molecule	-	10417-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAZBEHYOTPTENJ-JLNKQSITSA-N
3454	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Lee JY (2003)	12562875	173822	153	Icosapent	all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA	natelle one|gesticare dha|ulti	DRUGBANK	DB00159	C20H30O2	small molecule	-	10417-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAZBEHYOTPTENJ-JLNKQSITSA-N
3455	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chene G (2007)	17459764	173843	153	Icosapent	all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA	natelle one|gesticare dha|ulti	DRUGBANK	DB00159	C20H30O2	small molecule	-	10417-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAZBEHYOTPTENJ-JLNKQSITSA-N
3456	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Vecchio AJ (2010)	20463020	173819	153	Icosapent	all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA	natelle one|gesticare dha|ulti	DRUGBANK	DB00159	C20H30O2	small molecule	-	10417-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAZBEHYOTPTENJ-JLNKQSITSA-N
3457	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Das UN (2005)	16190133	173591	153	Icosapent	all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA	natelle one|gesticare dha|ulti	DRUGBANK	DB00159	C20H30O2	small molecule	-	10417-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAZBEHYOTPTENJ-JLNKQSITSA-N
3458	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Ait-Said F (2003)	12573452	173842	153	Icosapent	all-cis-5,8,11,14,17-eicosapentaenoic acid|(all-Z)-5,8,11,14,17-Eicosapentaenoic acid|cis-5,8,11,14,17-Eicosapentaenoic acid|Icosapent|EPA|Timnodonic acid|Eicosapentaenoic acid|5,8,11,14,17-Icosapentaenoic acid|Icosapentum|(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid|cis, cis, cis, cis, cis-Eicosa-5,8,11,14,17-pentaenoic acid|5,8,11,14,17-EICOSAPENTAENOIC acid|all-cis-5,8,11,14,17-icosapentaenoic acid|all-cis-icosa-5,8,11,14,17-pentaenoic acid|Icosapentaenoic acid|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate|(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid|Icosapento|cis-delta(5,8,11,14,17)-Eicosapentaenoic acid|cis-5,8,11,14,17-EPA	natelle one|gesticare dha|ulti	DRUGBANK	DB00159	C20H30O2	small molecule	-	10417-94-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JAZBEHYOTPTENJ-JLNKQSITSA-N
3584	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	unknown	target	Taccone-Gallucci M (2006)	16531984	173928	157	Vitamin E	(R,R,R)--tocopherol|(2R,4'R,8'R)--tocopherol|(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL|5,7,8-trimethyltocol|d--tocopherol|alpha-tocopherol|(+)--tocopherol	maltlevol liq|mnps formula sup	DRUGBANK	DB00163	C29H50O2	small molecule	-	59-02-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GVJHHUAWPYXKBD-IEOSBIPESA-N
3694	106609	94	-	ACVRL1	ACVRLK1|ALK-1|ALK1|HHT|HHT2|ORW2|SKR3|TSR-I	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3695	106609	94	-	ACVRL1	ACVRLK1|ALK-1|ALK1|HHT|HHT2|ORW2|SKR3|TSR-I	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3737	107647	1244	RP11-114F7.2	ABCC2	ABC30|CMOAT|DJS|MRP2|cMRP	9606	Homo sapiens	unknown	target	Li GX (2007)	17467962	174035	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3738	107647	1244	RP11-114F7.2	ABCC2	ABC30|CMOAT|DJS|MRP2|cMRP	9606	Homo sapiens	unknown	target	Rau T (2006)	17112803	174034	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3739	107647	1244	RP11-114F7.2	ABCC2	ABC30|CMOAT|DJS|MRP2|cMRP	9606	Homo sapiens	unknown	target	Materna V (2006)	16876126	174033	164	Adenosine triphosphate	Adenosine 5'-triphosphate|Adenosine-5'-triphosphate|ATP	-	DRUGBANK	DB00171	C10H16N5O13P3	small molecule	-	56-65-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKHQWZAMYRWXGA-YPLCUDRINA-N
3856	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Criscione L (1993)	8242249	174107	170	Valsartan	Diovan|N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine|N-(P-(O-1H-Tetrazol-5-ylphenyl)benzyl)-N-valeryl-L-valine|(S)-N-Valeryl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]-methyl}-valine	diovan|amlodipine, valsartan, 	DRUGBANK	DB00177	C24H29N5O3	small molecule	C09DB08|C09CA03|C09DA03|C09DB01|C09DX01|C09DX02|C09DX04|C10BX10	137862-53-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ACWBQPMHZXGDFX-QFIPXVFZSA-N
3857	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	de Gasparo M (1995)	8577935	174106	170	Valsartan	Diovan|N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine|N-(P-(O-1H-Tetrazol-5-ylphenyl)benzyl)-N-valeryl-L-valine|(S)-N-Valeryl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]-methyl}-valine	diovan|amlodipine, valsartan, 	DRUGBANK	DB00177	C24H29N5O3	small molecule	C09DB08|C09CA03|C09DA03|C09DB01|C09DX01|C09DX02|C09DX04|C10BX10	137862-53-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ACWBQPMHZXGDFX-QFIPXVFZSA-N
3858	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Azizi M (2004)	15579516	174105	170	Valsartan	Diovan|N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine|N-(P-(O-1H-Tetrazol-5-ylphenyl)benzyl)-N-valeryl-L-valine|(S)-N-Valeryl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]-methyl}-valine	diovan|amlodipine, valsartan, 	DRUGBANK	DB00177	C24H29N5O3	small molecule	C09DB08|C09CA03|C09DA03|C09DB01|C09DX01|C09DX02|C09DX04|C10BX10	137862-53-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ACWBQPMHZXGDFX-QFIPXVFZSA-N
3859	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Shargorodsky M (2002)	12460705	174104	170	Valsartan	Diovan|N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine|N-(P-(O-1H-Tetrazol-5-ylphenyl)benzyl)-N-valeryl-L-valine|(S)-N-Valeryl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]-methyl}-valine	diovan|amlodipine, valsartan, 	DRUGBANK	DB00177	C24H29N5O3	small molecule	C09DB08|C09CA03|C09DA03|C09DB01|C09DX01|C09DX02|C09DX04|C10BX10	137862-53-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ACWBQPMHZXGDFX-QFIPXVFZSA-N
3860	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	170	Valsartan	Diovan|N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine|N-(P-(O-1H-Tetrazol-5-ylphenyl)benzyl)-N-valeryl-L-valine|(S)-N-Valeryl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]-methyl}-valine	diovan|amlodipine, valsartan, 	DRUGBANK	DB00177	C24H29N5O3	small molecule	C09DB08|C09CA03|C09DA03|C09DB01|C09DX01|C09DX02|C09DX04|C10BX10	137862-53-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ACWBQPMHZXGDFX-QFIPXVFZSA-N
3861	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Siragy HM (2002)	12023686	174108	170	Valsartan	Diovan|N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine|N-(P-(O-1H-Tetrazol-5-ylphenyl)benzyl)-N-valeryl-L-valine|(S)-N-Valeryl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]-methyl}-valine	diovan|amlodipine, valsartan, 	DRUGBANK	DB00177	C24H29N5O3	small molecule	C09DB08|C09CA03|C09DA03|C09DB01|C09DX01|C09DX02|C09DX04|C10BX10	137862-53-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ACWBQPMHZXGDFX-QFIPXVFZSA-N
3862	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Piepho RW (2000)	11030016	174112	171	Ramipril	Ramiprilum|(2S-(1(R*(r*)),2alpha,3abeta,6abeta))-1-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)octahydrocyclopenta(b)pyrrole-2-carboxylic acid|Ramipril|Altace (tn)|Tritace	ava-ramipril|altace hct|ramipr	DRUGBANK	DB00178	C23H32N2O5	small molecule	C09AA05|C09BA05|C09BB05|C09BB07|C10BX04|C10BX06	87333-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HDACQVRGBOVJII-JBDAPHQKSA-N
3863	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Levitt DG (2006)	16398929	174113	171	Ramipril	Ramiprilum|(2S-(1(R*(r*)),2alpha,3abeta,6abeta))-1-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)octahydrocyclopenta(b)pyrrole-2-carboxylic acid|Ramipril|Altace (tn)|Tritace	ava-ramipril|altace hct|ramipr	DRUGBANK	DB00178	C23H32N2O5	small molecule	C09AA05|C09BA05|C09BB05|C09BB07|C10BX04|C10BX06	87333-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HDACQVRGBOVJII-JBDAPHQKSA-N
3864	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Song JC (2002)	11929321	174114	171	Ramipril	Ramiprilum|(2S-(1(R*(r*)),2alpha,3abeta,6abeta))-1-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)octahydrocyclopenta(b)pyrrole-2-carboxylic acid|Ramipril|Altace (tn)|Tritace	ava-ramipril|altace hct|ramipr	DRUGBANK	DB00178	C23H32N2O5	small molecule	C09AA05|C09BA05|C09BB05|C09BB07|C10BX04|C10BX06	87333-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HDACQVRGBOVJII-JBDAPHQKSA-N
3865	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	171	Ramipril	Ramiprilum|(2S-(1(R*(r*)),2alpha,3abeta,6abeta))-1-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)octahydrocyclopenta(b)pyrrole-2-carboxylic acid|Ramipril|Altace (tn)|Tritace	ava-ramipril|altace hct|ramipr	DRUGBANK	DB00178	C23H32N2O5	small molecule	C09AA05|C09BA05|C09BB05|C09BB07|C10BX04|C10BX06	87333-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HDACQVRGBOVJII-JBDAPHQKSA-N
3866	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	172	Masoprocol	meso-nordihydroguaiaretic acid|erythro-nordihydroguaiaretic acid|meso-4,4'-(2,3-dimethyl-1,4-butanediyl)bis(pyrocatechol)|meso-1,4-bis(3,4-dihydroxyphenyl)-2,3-dimethylbutane|CHX-100|meso-4-[4-(3,4-dihydroxyphenyl)-2,3-dimethylbutyl]benzene-1,2-diol|meso-4,4'-(2,3-dimethyltetramethylene)dipyrocatechol|CHX 100|meso-NDGA|Masoprocolum|meso-2,3-bis(3,4-dihydroxyphenylmethyl)butane|meso-,-dimethyl-,-bis(3,4-dihydroxyphenyl)butan	-	DRUGBANK	DB00179	C18H22O4	small molecule	L01XX10	27686-84-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCZKYJDFEPMADG-TXEJJXNPSA-N
3867	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Lambert JD (2001)	11318430	174118	172	Masoprocol	meso-nordihydroguaiaretic acid|erythro-nordihydroguaiaretic acid|meso-4,4'-(2,3-dimethyl-1,4-butanediyl)bis(pyrocatechol)|meso-1,4-bis(3,4-dihydroxyphenyl)-2,3-dimethylbutane|CHX-100|meso-4-[4-(3,4-dihydroxyphenyl)-2,3-dimethylbutyl]benzene-1,2-diol|meso-4,4'-(2,3-dimethyltetramethylene)dipyrocatechol|CHX 100|meso-NDGA|Masoprocolum|meso-2,3-bis(3,4-dihydroxyphenylmethyl)butane|meso-,-dimethyl-,-bis(3,4-dihydroxyphenyl)butan	-	DRUGBANK	DB00179	C18H22O4	small molecule	L01XX10	27686-84-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCZKYJDFEPMADG-TXEJJXNPSA-N
3868	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	West M (2004)	15379894	174119	172	Masoprocol	meso-nordihydroguaiaretic acid|erythro-nordihydroguaiaretic acid|meso-4,4'-(2,3-dimethyl-1,4-butanediyl)bis(pyrocatechol)|meso-1,4-bis(3,4-dihydroxyphenyl)-2,3-dimethylbutane|CHX-100|meso-4-[4-(3,4-dihydroxyphenyl)-2,3-dimethylbutyl]benzene-1,2-diol|meso-4,4'-(2,3-dimethyltetramethylene)dipyrocatechol|CHX 100|meso-NDGA|Masoprocolum|meso-2,3-bis(3,4-dihydroxyphenylmethyl)butane|meso-,-dimethyl-,-bis(3,4-dihydroxyphenyl)butan	-	DRUGBANK	DB00179	C18H22O4	small molecule	L01XX10	27686-84-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCZKYJDFEPMADG-TXEJJXNPSA-N
3869	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Jeon SB (2005)	15694390	174121	172	Masoprocol	meso-nordihydroguaiaretic acid|erythro-nordihydroguaiaretic acid|meso-4,4'-(2,3-dimethyl-1,4-butanediyl)bis(pyrocatechol)|meso-1,4-bis(3,4-dihydroxyphenyl)-2,3-dimethylbutane|CHX-100|meso-4-[4-(3,4-dihydroxyphenyl)-2,3-dimethylbutyl]benzene-1,2-diol|meso-4,4'-(2,3-dimethyltetramethylene)dipyrocatechol|CHX 100|meso-NDGA|Masoprocolum|meso-2,3-bis(3,4-dihydroxyphenylmethyl)butane|meso-,-dimethyl-,-bis(3,4-dihydroxyphenyl)butan	-	DRUGBANK	DB00179	C18H22O4	small molecule	L01XX10	27686-84-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCZKYJDFEPMADG-TXEJJXNPSA-N
3870	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Azadzoi KM (2004)	15098224	174120	172	Masoprocol	meso-nordihydroguaiaretic acid|erythro-nordihydroguaiaretic acid|meso-4,4'-(2,3-dimethyl-1,4-butanediyl)bis(pyrocatechol)|meso-1,4-bis(3,4-dihydroxyphenyl)-2,3-dimethylbutane|CHX-100|meso-4-[4-(3,4-dihydroxyphenyl)-2,3-dimethylbutyl]benzene-1,2-diol|meso-4,4'-(2,3-dimethyltetramethylene)dipyrocatechol|CHX 100|meso-NDGA|Masoprocolum|meso-2,3-bis(3,4-dihydroxyphenylmethyl)butane|meso-,-dimethyl-,-bis(3,4-dihydroxyphenyl)butan	-	DRUGBANK	DB00179	C18H22O4	small molecule	L01XX10	27686-84-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCZKYJDFEPMADG-TXEJJXNPSA-N
3871	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Audouin C (2001)	11277534	174117	172	Masoprocol	meso-nordihydroguaiaretic acid|erythro-nordihydroguaiaretic acid|meso-4,4'-(2,3-dimethyl-1,4-butanediyl)bis(pyrocatechol)|meso-1,4-bis(3,4-dihydroxyphenyl)-2,3-dimethylbutane|CHX-100|meso-4-[4-(3,4-dihydroxyphenyl)-2,3-dimethylbutyl]benzene-1,2-diol|meso-4,4'-(2,3-dimethyltetramethylene)dipyrocatechol|CHX 100|meso-NDGA|Masoprocolum|meso-2,3-bis(3,4-dihydroxyphenylmethyl)butane|meso-,-dimethyl-,-bis(3,4-dihydroxyphenyl)butan	-	DRUGBANK	DB00179	C18H22O4	small molecule	L01XX10	27686-84-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCZKYJDFEPMADG-TXEJJXNPSA-N
3908	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	binder	target	Innis RB (1992)	1532675	174155	175	Amphetamine	beta-Phenylisopropylamine|-methylbenzeneethaneamine|Amphetamin|Amfetaminum|beta-Phenylisopropylamin|alpha-Methylbenzeneethaneamine|1-Phenylpropan-2-amin|1-phenyl-2-aminopropane|-methylphenethylamine|rac-(2R)-1-phenylpropan-2-amine|Desoxynorephedrine|alpha-Methylphenylethylamine|beta-Aminopropylbenzene|-phenylisopropylamine|rac-amphetamine|Amphetamine|-aminopropylbenzene|Amfetamine	pms-amphetamines xr|act amphet	DRUGBANK	DB00182	C9H13N	small molecule	N06BA01	300-62-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWTSXDURSIMDCE-UHFFFAOYSA-N
4143	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	190	Troglitazone	-	-	DRUGBANK	DB00197	C24H27NO5S	small molecule	A10BG01	97322-87-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GXPHKUHSUJUWKP-UHFFFAOYSA-N
4144	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Demetri GD (1999)	10097144	174284	190	Troglitazone	-	-	DRUGBANK	DB00197	C24H27NO5S	small molecule	A10BG01	97322-87-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GXPHKUHSUJUWKP-UHFFFAOYSA-N
4145	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Petrova TV (1999)	10200320	174285	190	Troglitazone	-	-	DRUGBANK	DB00197	C24H27NO5S	small molecule	A10BG01	97322-87-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GXPHKUHSUJUWKP-UHFFFAOYSA-N
4146	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Kitamura S (1999)	10076568	174286	190	Troglitazone	-	-	DRUGBANK	DB00197	C24H27NO5S	small molecule	A10BG01	97322-87-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GXPHKUHSUJUWKP-UHFFFAOYSA-N
4147	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Baek SJ (2003)	12475986	174281	190	Troglitazone	-	-	DRUGBANK	DB00197	C24H27NO5S	small molecule	A10BG01	97322-87-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GXPHKUHSUJUWKP-UHFFFAOYSA-N
4148	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Camp HS (1999)	10214942	174282	190	Troglitazone	-	-	DRUGBANK	DB00197	C24H27NO5S	small molecule	A10BG01	97322-87-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GXPHKUHSUJUWKP-UHFFFAOYSA-N
4149	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Satoh T (1999)	10222233	174283	190	Troglitazone	-	-	DRUGBANK	DB00197	C24H27NO5S	small molecule	A10BG01	97322-87-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GXPHKUHSUJUWKP-UHFFFAOYSA-N
4151	108478	2182	-	ACSL4	ACS4|FACL4|LACS4|MRX63|MRX68	9606	Homo sapiens	inhibitor	target	Lewin TM (2002)	12147264	174287	190	Troglitazone	-	-	DRUGBANK	DB00197	C24H27NO5S	small molecule	A10BG01	97322-87-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GXPHKUHSUJUWKP-UHFFFAOYSA-N
4152	108478	2182	-	ACSL4	ACS4|FACL4|LACS4|MRX63|MRX68	9606	Homo sapiens	inhibitor	target	Kim JH (2001)	11319222	174288	190	Troglitazone	-	-	DRUGBANK	DB00197	C24H27NO5S	small molecule	A10BG01	97322-87-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GXPHKUHSUJUWKP-UHFFFAOYSA-N
4153	108478	2182	-	ACSL4	ACS4|FACL4|LACS4|MRX63|MRX68	9606	Homo sapiens	inhibitor	target	Lewin TM (2001)	11319232	174289	190	Troglitazone	-	-	DRUGBANK	DB00197	C24H27NO5S	small molecule	A10BG01	97322-87-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GXPHKUHSUJUWKP-UHFFFAOYSA-N
4340	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	205	Remikiren	-	-	DRUGBANK	DB00212	C33H50N4O6S	small molecule	C09XA01	126222-34-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UXIGZRQVLGFTOU-VQXQMPIVSA-N
4341	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	inhibitor	target	van Paassen P (1999)	10583449	174413	205	Remikiren	-	-	DRUGBANK	DB00212	C33H50N4O6S	small molecule	C09XA01	126222-34-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UXIGZRQVLGFTOU-VQXQMPIVSA-N
4342	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	inhibitor	target	Hilgers KF (1994)	8206619	174415	205	Remikiren	-	-	DRUGBANK	DB00212	C33H50N4O6S	small molecule	C09XA01	126222-34-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UXIGZRQVLGFTOU-VQXQMPIVSA-N
4343	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	inhibitor	target	Kiowski W (1994)	7994817	174414	205	Remikiren	-	-	DRUGBANK	DB00212	C33H50N4O6S	small molecule	C09XA01	126222-34-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UXIGZRQVLGFTOU-VQXQMPIVSA-N
4344	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	inhibitor	target	Clozel JP (1993)	8319997	174417	205	Remikiren	-	-	DRUGBANK	DB00212	C33H50N4O6S	small molecule	C09XA01	126222-34-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UXIGZRQVLGFTOU-VQXQMPIVSA-N
4345	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	inhibitor	target	MacFadyen RJ (1995)	7769797	174416	205	Remikiren	-	-	DRUGBANK	DB00212	C33H50N4O6S	small molecule	C09XA01	126222-34-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UXIGZRQVLGFTOU-VQXQMPIVSA-N
4564	119038	30814	-	PLA2G2E	GIIE sPLA2|sPLA2-IIE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	226	Aminosalicylic Acid	PAS|4-amino-2-hydroxybenzoic acid|para-amino salicylic acid|p-aminosalicylic acid|4-aminosalicylic acid|para-aminosalicylic acid|4-aminosalicylate	paser|nemasol sodium tab 500mg	DRUGBANK	DB00233	C7H7NO3	small molecule	J04AA03|J04AA02|J04AA01	65-49-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WUBBRNOQWQTFEX-UHFFFAOYSA-N
4565	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Nielsen OH (1987)	2882965	174547	226	Aminosalicylic Acid	PAS|4-amino-2-hydroxybenzoic acid|para-amino salicylic acid|p-aminosalicylic acid|4-aminosalicylic acid|para-aminosalicylic acid|4-aminosalicylate	paser|nemasol sodium tab 500mg	DRUGBANK	DB00233	C7H7NO3	small molecule	J04AA03|J04AA02|J04AA01	65-49-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WUBBRNOQWQTFEX-UHFFFAOYSA-N
4566	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Sircar JC (1983)	6131674	174549	226	Aminosalicylic Acid	PAS|4-amino-2-hydroxybenzoic acid|para-amino salicylic acid|p-aminosalicylic acid|4-aminosalicylic acid|para-aminosalicylic acid|4-aminosalicylate	paser|nemasol sodium tab 500mg	DRUGBANK	DB00233	C7H7NO3	small molecule	J04AA03|J04AA02|J04AA01	65-49-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WUBBRNOQWQTFEX-UHFFFAOYSA-N
4567	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Allgayer H (1984)	6428914	174548	226	Aminosalicylic Acid	PAS|4-amino-2-hydroxybenzoic acid|para-amino salicylic acid|p-aminosalicylic acid|4-aminosalicylic acid|para-aminosalicylic acid|4-aminosalicylate	paser|nemasol sodium tab 500mg	DRUGBANK	DB00233	C7H7NO3	small molecule	J04AA03|J04AA02|J04AA01	65-49-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WUBBRNOQWQTFEX-UHFFFAOYSA-N
4568	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Cipolla G (2002)	12208114	174550	226	Aminosalicylic Acid	PAS|4-amino-2-hydroxybenzoic acid|para-amino salicylic acid|p-aminosalicylic acid|4-aminosalicylic acid|para-aminosalicylic acid|4-aminosalicylate	paser|nemasol sodium tab 500mg	DRUGBANK	DB00233	C7H7NO3	small molecule	J04AA03|J04AA02|J04AA01	65-49-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WUBBRNOQWQTFEX-UHFFFAOYSA-N
4569	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Generini S (2002)	12463455	174551	226	Aminosalicylic Acid	PAS|4-amino-2-hydroxybenzoic acid|para-amino salicylic acid|p-aminosalicylic acid|4-aminosalicylic acid|para-aminosalicylic acid|4-aminosalicylate	paser|nemasol sodium tab 500mg	DRUGBANK	DB00233	C7H7NO3	small molecule	J04AA03|J04AA02|J04AA01	65-49-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WUBBRNOQWQTFEX-UHFFFAOYSA-N
4570	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Mifflin RC (2004)	14742690	174552	226	Aminosalicylic Acid	PAS|4-amino-2-hydroxybenzoic acid|para-amino salicylic acid|p-aminosalicylic acid|4-aminosalicylic acid|para-aminosalicylic acid|4-aminosalicylate	paser|nemasol sodium tab 500mg	DRUGBANK	DB00233	C7H7NO3	small molecule	J04AA03|J04AA02|J04AA01	65-49-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WUBBRNOQWQTFEX-UHFFFAOYSA-N
4571	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Pruzanski W (1997)	9256165	174553	226	Aminosalicylic Acid	PAS|4-amino-2-hydroxybenzoic acid|para-amino salicylic acid|p-aminosalicylic acid|4-aminosalicylic acid|para-aminosalicylic acid|4-aminosalicylate	paser|nemasol sodium tab 500mg	DRUGBANK	DB00233	C7H7NO3	small molecule	J04AA03|J04AA02|J04AA01	65-49-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WUBBRNOQWQTFEX-UHFFFAOYSA-N
4572	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Distrutti E (2006)	16855178	174554	226	Aminosalicylic Acid	PAS|4-amino-2-hydroxybenzoic acid|para-amino salicylic acid|p-aminosalicylic acid|4-aminosalicylic acid|para-aminosalicylic acid|4-aminosalicylate	paser|nemasol sodium tab 500mg	DRUGBANK	DB00233	C7H7NO3	small molecule	J04AA03|J04AA02|J04AA01	65-49-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WUBBRNOQWQTFEX-UHFFFAOYSA-N
4691	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	237	Mesalazine	Pentasa|m-Aminosalicylic acid|Mesasal|5-ASA|Mesalazina|Canasa|Mesalazinum|Mesalamine|Mesalazine|P-Aminosalicylsaeure|Asacolitin|Rowasa|Fisalamine|Claversal|Asacol|Salofalk|Iialda|5-aminosalicylic acid|3-carboxy-4-hydroxyaniline|Lixacol	asacol 800|pentasa|pentasa sup	DRUGBANK	DB00244	C7H7NO3	small molecule	A07EC02	89-57-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KBOPZPXVLCULAV-UHFFFAOYSA-N
4692	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Allgayer H (2003)	12950415	174544	237	Mesalazine	Pentasa|m-Aminosalicylic acid|Mesasal|5-ASA|Mesalazina|Canasa|Mesalazinum|Mesalamine|Mesalazine|P-Aminosalicylsaeure|Asacolitin|Rowasa|Fisalamine|Claversal|Asacol|Salofalk|Iialda|5-aminosalicylic acid|3-carboxy-4-hydroxyaniline|Lixacol	asacol 800|pentasa|pentasa sup	DRUGBANK	DB00244	C7H7NO3	small molecule	A07EC02	89-57-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KBOPZPXVLCULAV-UHFFFAOYSA-N
4693	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Desreumaux P (2006)	16939423	174608	237	Mesalazine	Pentasa|m-Aminosalicylic acid|Mesasal|5-ASA|Mesalazina|Canasa|Mesalazinum|Mesalamine|Mesalazine|P-Aminosalicylsaeure|Asacolitin|Rowasa|Fisalamine|Claversal|Asacol|Salofalk|Iialda|5-aminosalicylic acid|3-carboxy-4-hydroxyaniline|Lixacol	asacol 800|pentasa|pentasa sup	DRUGBANK	DB00244	C7H7NO3	small molecule	A07EC02	89-57-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KBOPZPXVLCULAV-UHFFFAOYSA-N
4694	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Schwab M (2008)	18544567	174605	237	Mesalazine	Pentasa|m-Aminosalicylic acid|Mesasal|5-ASA|Mesalazina|Canasa|Mesalazinum|Mesalamine|Mesalazine|P-Aminosalicylsaeure|Asacolitin|Rowasa|Fisalamine|Claversal|Asacol|Salofalk|Iialda|5-aminosalicylic acid|3-carboxy-4-hydroxyaniline|Lixacol	asacol 800|pentasa|pentasa sup	DRUGBANK	DB00244	C7H7NO3	small molecule	A07EC02	89-57-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KBOPZPXVLCULAV-UHFFFAOYSA-N
4695	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Linard C (2008)	18077625	174606	237	Mesalazine	Pentasa|m-Aminosalicylic acid|Mesasal|5-ASA|Mesalazina|Canasa|Mesalazinum|Mesalamine|Mesalazine|P-Aminosalicylsaeure|Asacolitin|Rowasa|Fisalamine|Claversal|Asacol|Salofalk|Iialda|5-aminosalicylic acid|3-carboxy-4-hydroxyaniline|Lixacol	asacol 800|pentasa|pentasa sup	DRUGBANK	DB00244	C7H7NO3	small molecule	A07EC02	89-57-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KBOPZPXVLCULAV-UHFFFAOYSA-N
4696	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Rousseaux C (2005)	15824083	174607	237	Mesalazine	Pentasa|m-Aminosalicylic acid|Mesasal|5-ASA|Mesalazina|Canasa|Mesalazinum|Mesalamine|Mesalazine|P-Aminosalicylsaeure|Asacolitin|Rowasa|Fisalamine|Claversal|Asacol|Salofalk|Iialda|5-aminosalicylic acid|3-carboxy-4-hydroxyaniline|Lixacol	asacol 800|pentasa|pentasa sup	DRUGBANK	DB00244	C7H7NO3	small molecule	A07EC02	89-57-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KBOPZPXVLCULAV-UHFFFAOYSA-N
4697	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Nielsen OH (1987)	2882965	174547	237	Mesalazine	Pentasa|m-Aminosalicylic acid|Mesasal|5-ASA|Mesalazina|Canasa|Mesalazinum|Mesalamine|Mesalazine|P-Aminosalicylsaeure|Asacolitin|Rowasa|Fisalamine|Claversal|Asacol|Salofalk|Iialda|5-aminosalicylic acid|3-carboxy-4-hydroxyaniline|Lixacol	asacol 800|pentasa|pentasa sup	DRUGBANK	DB00244	C7H7NO3	small molecule	A07EC02	89-57-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KBOPZPXVLCULAV-UHFFFAOYSA-N
4698	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Sircar JC (1983)	6131674	174549	237	Mesalazine	Pentasa|m-Aminosalicylic acid|Mesasal|5-ASA|Mesalazina|Canasa|Mesalazinum|Mesalamine|Mesalazine|P-Aminosalicylsaeure|Asacolitin|Rowasa|Fisalamine|Claversal|Asacol|Salofalk|Iialda|5-aminosalicylic acid|3-carboxy-4-hydroxyaniline|Lixacol	asacol 800|pentasa|pentasa sup	DRUGBANK	DB00244	C7H7NO3	small molecule	A07EC02	89-57-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KBOPZPXVLCULAV-UHFFFAOYSA-N
4699	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Allgayer H (1984)	6428914	174548	237	Mesalazine	Pentasa|m-Aminosalicylic acid|Mesasal|5-ASA|Mesalazina|Canasa|Mesalazinum|Mesalamine|Mesalazine|P-Aminosalicylsaeure|Asacolitin|Rowasa|Fisalamine|Claversal|Asacol|Salofalk|Iialda|5-aminosalicylic acid|3-carboxy-4-hydroxyaniline|Lixacol	asacol 800|pentasa|pentasa sup	DRUGBANK	DB00244	C7H7NO3	small molecule	A07EC02	89-57-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KBOPZPXVLCULAV-UHFFFAOYSA-N
4707	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Cipolla G (2002)	12208114	174550	237	Mesalazine	Pentasa|m-Aminosalicylic acid|Mesasal|5-ASA|Mesalazina|Canasa|Mesalazinum|Mesalamine|Mesalazine|P-Aminosalicylsaeure|Asacolitin|Rowasa|Fisalamine|Claversal|Asacol|Salofalk|Iialda|5-aminosalicylic acid|3-carboxy-4-hydroxyaniline|Lixacol	asacol 800|pentasa|pentasa sup	DRUGBANK	DB00244	C7H7NO3	small molecule	A07EC02	89-57-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KBOPZPXVLCULAV-UHFFFAOYSA-N
4708	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Generini S (2002)	12463455	174551	237	Mesalazine	Pentasa|m-Aminosalicylic acid|Mesasal|5-ASA|Mesalazina|Canasa|Mesalazinum|Mesalamine|Mesalazine|P-Aminosalicylsaeure|Asacolitin|Rowasa|Fisalamine|Claversal|Asacol|Salofalk|Iialda|5-aminosalicylic acid|3-carboxy-4-hydroxyaniline|Lixacol	asacol 800|pentasa|pentasa sup	DRUGBANK	DB00244	C7H7NO3	small molecule	A07EC02	89-57-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KBOPZPXVLCULAV-UHFFFAOYSA-N
4709	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Mifflin RC (2004)	14742690	174552	237	Mesalazine	Pentasa|m-Aminosalicylic acid|Mesasal|5-ASA|Mesalazina|Canasa|Mesalazinum|Mesalamine|Mesalazine|P-Aminosalicylsaeure|Asacolitin|Rowasa|Fisalamine|Claversal|Asacol|Salofalk|Iialda|5-aminosalicylic acid|3-carboxy-4-hydroxyaniline|Lixacol	asacol 800|pentasa|pentasa sup	DRUGBANK	DB00244	C7H7NO3	small molecule	A07EC02	89-57-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KBOPZPXVLCULAV-UHFFFAOYSA-N
4710	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Pruzanski W (1997)	9256165	174553	237	Mesalazine	Pentasa|m-Aminosalicylic acid|Mesasal|5-ASA|Mesalazina|Canasa|Mesalazinum|Mesalamine|Mesalazine|P-Aminosalicylsaeure|Asacolitin|Rowasa|Fisalamine|Claversal|Asacol|Salofalk|Iialda|5-aminosalicylic acid|3-carboxy-4-hydroxyaniline|Lixacol	asacol 800|pentasa|pentasa sup	DRUGBANK	DB00244	C7H7NO3	small molecule	A07EC02	89-57-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KBOPZPXVLCULAV-UHFFFAOYSA-N
4711	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Distrutti E (2006)	16855178	174554	237	Mesalazine	Pentasa|m-Aminosalicylic acid|Mesasal|5-ASA|Mesalazina|Canasa|Mesalazinum|Mesalamine|Mesalazine|P-Aminosalicylsaeure|Asacolitin|Rowasa|Fisalamine|Claversal|Asacol|Salofalk|Iialda|5-aminosalicylic acid|3-carboxy-4-hydroxyaniline|Lixacol	asacol 800|pentasa|pentasa sup	DRUGBANK	DB00244	C7H7NO3	small molecule	A07EC02	89-57-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KBOPZPXVLCULAV-UHFFFAOYSA-N
4722	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	239	Ziprasidone	Ziprasidone|Ziprasidona|Ziprasidonum	zeldox|ziprasidone hydrochlori	DRUGBANK	DB00246	C21H21ClN4OS	small molecule	N05AE04	146939-27-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVWVFYHBGMAFLY-UHFFFAOYSA-N
4723	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	239	Ziprasidone	Ziprasidone|Ziprasidona|Ziprasidonum	zeldox|ziprasidone hydrochlori	DRUGBANK	DB00246	C21H21ClN4OS	small molecule	N05AE04	146939-27-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVWVFYHBGMAFLY-UHFFFAOYSA-N
4738	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	239	Ziprasidone	Ziprasidone|Ziprasidona|Ziprasidonum	zeldox|ziprasidone hydrochlori	DRUGBANK	DB00246	C21H21ClN4OS	small molecule	N05AE04	146939-27-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVWVFYHBGMAFLY-UHFFFAOYSA-N
4739	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	239	Ziprasidone	Ziprasidone|Ziprasidona|Ziprasidonum	zeldox|ziprasidone hydrochlori	DRUGBANK	DB00246	C21H21ClN4OS	small molecule	N05AE04	146939-27-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVWVFYHBGMAFLY-UHFFFAOYSA-N
4752	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Kopecek M (2005)	15726024	174628	239	Ziprasidone	Ziprasidone|Ziprasidona|Ziprasidonum	zeldox|ziprasidone hydrochlori	DRUGBANK	DB00246	C21H21ClN4OS	small molecule	N05AE04	146939-27-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVWVFYHBGMAFLY-UHFFFAOYSA-N
4753	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Seeman P (2002)	11873706	174626	239	Ziprasidone	Ziprasidone|Ziprasidona|Ziprasidonum	zeldox|ziprasidone hydrochlori	DRUGBANK	DB00246	C21H21ClN4OS	small molecule	N05AE04	146939-27-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVWVFYHBGMAFLY-UHFFFAOYSA-N
4754	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Seeger TF (1995)	7562537	174627	239	Ziprasidone	Ziprasidone|Ziprasidona|Ziprasidonum	zeldox|ziprasidone hydrochlori	DRUGBANK	DB00246	C21H21ClN4OS	small molecule	N05AE04	146939-27-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVWVFYHBGMAFLY-UHFFFAOYSA-N
4755	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	239	Ziprasidone	Ziprasidone|Ziprasidona|Ziprasidonum	zeldox|ziprasidone hydrochlori	DRUGBANK	DB00246	C21H21ClN4OS	small molecule	N05AE04	146939-27-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVWVFYHBGMAFLY-UHFFFAOYSA-N
4756	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Stahl SM (2004)	14728084	174620	239	Ziprasidone	Ziprasidone|Ziprasidona|Ziprasidonum	zeldox|ziprasidone hydrochlori	DRUGBANK	DB00246	C21H21ClN4OS	small molecule	N05AE04	146939-27-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVWVFYHBGMAFLY-UHFFFAOYSA-N
4757	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	239	Ziprasidone	Ziprasidone|Ziprasidona|Ziprasidonum	zeldox|ziprasidone hydrochlori	DRUGBANK	DB00246	C21H21ClN4OS	small molecule	N05AE04	146939-27-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MVWVFYHBGMAFLY-UHFFFAOYSA-N
4795	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Kageyama K (2002)	12008749	174661	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4796	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4797	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Ichikawa K (2001)	11436517	174659	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4798	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Pastor P (2003)	12721865	174660	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4799	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Linazasoro G (2008)	18303487	174658	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4800	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Curran MP (2004)	15341508	174657	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4801	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Miyagi M (1996)	8951172	174656	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4802	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Lombardi G (2002)	12464354	174655	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4810	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4811	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	agonist	target	Lam YW (2000)	10641988	174664	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4812	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	agonist	target	Sharif NA (2009)	18992242	174665	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4846	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4847	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	agonist	target	Newman-Tancredi A (2002)	12388667	174663	241	Cabergoline	(8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|Cabergolinum|Cabergolina|1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline|(8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide	apo-cabergoline|cabergoline|ac	DRUGBANK	DB00248	C26H37N5O2	small molecule	G02CB03|N04BC06	81409-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KORNTPPJEAJQIU-KJXAQDMKSA-N
4945	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	261	Ropinirole	Ropinirolum|Ropinirole|Ropinirol	apo-ropinirole|phl-ropinirole|	DRUGBANK	DB00268	C16H24N2O	small molecule	N04BC04	91374-21-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UHSKFQJFRQCDBE-UHFFFAOYSA-N
4946	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	261	Ropinirole	Ropinirolum|Ropinirole|Ropinirol	apo-ropinirole|phl-ropinirole|	DRUGBANK	DB00268	C16H24N2O	small molecule	N04BC04	91374-21-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UHSKFQJFRQCDBE-UHFFFAOYSA-N
4947	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Iida M (1999)	10446316	174765	261	Ropinirole	Ropinirolum|Ropinirole|Ropinirol	apo-ropinirole|phl-ropinirole|	DRUGBANK	DB00268	C16H24N2O	small molecule	N04BC04	91374-21-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UHSKFQJFRQCDBE-UHFFFAOYSA-N
4948	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Matsukawa N (2007)	17573046	174764	261	Ropinirole	Ropinirolum|Ropinirole|Ropinirol	apo-ropinirole|phl-ropinirole|	DRUGBANK	DB00268	C16H24N2O	small molecule	N04BC04	91374-21-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UHSKFQJFRQCDBE-UHFFFAOYSA-N
4949	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	de Mey C (1991)	1683559	174763	261	Ropinirole	Ropinirolum|Ropinirole|Ropinirol	apo-ropinirole|phl-ropinirole|	DRUGBANK	DB00268	C16H24N2O	small molecule	N04BC04	91374-21-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UHSKFQJFRQCDBE-UHFFFAOYSA-N
4950	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Lam YW (2000)	10641988	174664	261	Ropinirole	Ropinirolum|Ropinirole|Ropinirol	apo-ropinirole|phl-ropinirole|	DRUGBANK	DB00268	C16H24N2O	small molecule	N04BC04	91374-21-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UHSKFQJFRQCDBE-UHFFFAOYSA-N
4953	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	261	Ropinirole	Ropinirolum|Ropinirole|Ropinirol	apo-ropinirole|phl-ropinirole|	DRUGBANK	DB00268	C16H24N2O	small molecule	N04BC04	91374-21-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UHSKFQJFRQCDBE-UHFFFAOYSA-N
4954	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	261	Ropinirole	Ropinirolum|Ropinirole|Ropinirol	apo-ropinirole|phl-ropinirole|	DRUGBANK	DB00268	C16H24N2O	small molecule	N04BC04	91374-21-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UHSKFQJFRQCDBE-UHFFFAOYSA-N
4955	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	agonist	target	Lam YW (2000)	10641988	174664	261	Ropinirole	Ropinirolum|Ropinirole|Ropinirol	apo-ropinirole|phl-ropinirole|	DRUGBANK	DB00268	C16H24N2O	small molecule	N04BC04	91374-21-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UHSKFQJFRQCDBE-UHFFFAOYSA-N
4956	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	261	Ropinirole	Ropinirolum|Ropinirole|Ropinirol	apo-ropinirole|phl-ropinirole|	DRUGBANK	DB00268	C16H24N2O	small molecule	N04BC04	91374-21-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UHSKFQJFRQCDBE-UHFFFAOYSA-N
4957	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	261	Ropinirole	Ropinirolum|Ropinirole|Ropinirol	apo-ropinirole|phl-ropinirole|	DRUGBANK	DB00268	C16H24N2O	small molecule	N04BC04	91374-21-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UHSKFQJFRQCDBE-UHFFFAOYSA-N
5019	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	268	Olmesartan	4-(1-hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid|4-(hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid	olmesartan medoxomil / amlodip	DRUGBANK	DB00275	C24H26N6O3	small molecule	C09DA08|C09CA08|C09DX03|C09DB02	144689-24-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VTRAEEWXHOVJFV-UHFFFAOYSA-N
5020	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Kreutz R (2006)	17163232	174806	268	Olmesartan	4-(1-hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid|4-(hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid	olmesartan medoxomil / amlodip	DRUGBANK	DB00275	C24H26N6O3	small molecule	C09DA08|C09CA08|C09DX03|C09DB02	144689-24-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VTRAEEWXHOVJFV-UHFFFAOYSA-N
5021	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Koike H (2001)	11451212	174807	268	Olmesartan	4-(1-hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid|4-(hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid	olmesartan medoxomil / amlodip	DRUGBANK	DB00275	C24H26N6O3	small molecule	C09DA08|C09CA08|C09DX03|C09DB02	144689-24-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VTRAEEWXHOVJFV-UHFFFAOYSA-N
5022	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Warner GT (2002)	12076183	174810	268	Olmesartan	4-(1-hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid|4-(hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid	olmesartan medoxomil / amlodip	DRUGBANK	DB00275	C24H26N6O3	small molecule	C09DA08|C09CA08|C09DX03|C09DB02	144689-24-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VTRAEEWXHOVJFV-UHFFFAOYSA-N
5023	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Mire DE (2005)	16220064	174808	268	Olmesartan	4-(1-hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid|4-(hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid	olmesartan medoxomil / amlodip	DRUGBANK	DB00275	C24H26N6O3	small molecule	C09DA08|C09CA08|C09DX03|C09DB02	144689-24-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VTRAEEWXHOVJFV-UHFFFAOYSA-N
5024	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Ochiai K (2006)	16775509	174809	268	Olmesartan	4-(1-hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid|4-(hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid	olmesartan medoxomil / amlodip	DRUGBANK	DB00275	C24H26N6O3	small molecule	C09DA08|C09CA08|C09DX03|C09DB02	144689-24-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VTRAEEWXHOVJFV-UHFFFAOYSA-N
5159	111709	5737	RP5-944H6.1	PTGFR	FP	9606	Homo sapiens	agonist	target	Thieme H (2006)	16505027	161229	280	Travoprost	Travoprostum|Isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-{(1e,3R)-3-hydroxy-4-[(alpha,alpha,alpha-trifluoro-m-tolyl)oxy]-1-butenyl}cyclopentyl)-5-heptenoate|Travoprost|Travatan|Travatan Z	izba|mylan-travoprost z|apo-tr	DRUGBANK	DB00287	C26H35F3O6	small molecule	S01EE04	157283-68-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKPLKVHSHYCHOC-AHTXBMBWSA-N
5160	111709	5737	RP5-944H6.1	PTGFR	FP	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	280	Travoprost	Travoprostum|Isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-{(1e,3R)-3-hydroxy-4-[(alpha,alpha,alpha-trifluoro-m-tolyl)oxy]-1-butenyl}cyclopentyl)-5-heptenoate|Travoprost|Travatan|Travatan Z	izba|mylan-travoprost z|apo-tr	DRUGBANK	DB00287	C26H35F3O6	small molecule	S01EE04	157283-68-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKPLKVHSHYCHOC-AHTXBMBWSA-N
5161	111709	5737	RP5-944H6.1	PTGFR	FP	9606	Homo sapiens	agonist	target	Toris CB (2008)	19038618	174972	280	Travoprost	Travoprostum|Isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-{(1e,3R)-3-hydroxy-4-[(alpha,alpha,alpha-trifluoro-m-tolyl)oxy]-1-butenyl}cyclopentyl)-5-heptenoate|Travoprost|Travatan|Travatan Z	izba|mylan-travoprost z|apo-tr	DRUGBANK	DB00287	C26H35F3O6	small molecule	S01EE04	157283-68-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKPLKVHSHYCHOC-AHTXBMBWSA-N
5162	111709	5737	RP5-944H6.1	PTGFR	FP	9606	Homo sapiens	agonist	target	Costagliola C (2009)	19929706	174973	280	Travoprost	Travoprostum|Isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-{(1e,3R)-3-hydroxy-4-[(alpha,alpha,alpha-trifluoro-m-tolyl)oxy]-1-butenyl}cyclopentyl)-5-heptenoate|Travoprost|Travatan|Travatan Z	izba|mylan-travoprost z|apo-tr	DRUGBANK	DB00287	C26H35F3O6	small molecule	S01EE04	157283-68-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKPLKVHSHYCHOC-AHTXBMBWSA-N
5163	111709	5737	RP5-944H6.1	PTGFR	FP	9606	Homo sapiens	agonist	target	Ota T (2005)	16249494	174971	280	Travoprost	Travoprostum|Isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-{(1e,3R)-3-hydroxy-4-[(alpha,alpha,alpha-trifluoro-m-tolyl)oxy]-1-butenyl}cyclopentyl)-5-heptenoate|Travoprost|Travatan|Travatan Z	izba|mylan-travoprost z|apo-tr	DRUGBANK	DB00287	C26H35F3O6	small molecule	S01EE04	157283-68-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKPLKVHSHYCHOC-AHTXBMBWSA-N
5164	111709	5737	RP5-944H6.1	PTGFR	FP	9606	Homo sapiens	agonist	target	Lim KS (2008)	18452763	174976	280	Travoprost	Travoprostum|Isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-{(1e,3R)-3-hydroxy-4-[(alpha,alpha,alpha-trifluoro-m-tolyl)oxy]-1-butenyl}cyclopentyl)-5-heptenoate|Travoprost|Travatan|Travatan Z	izba|mylan-travoprost z|apo-tr	DRUGBANK	DB00287	C26H35F3O6	small molecule	S01EE04	157283-68-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKPLKVHSHYCHOC-AHTXBMBWSA-N
5165	111709	5737	RP5-944H6.1	PTGFR	FP	9606	Homo sapiens	agonist	target	Arranz-Marquez E (2008)	18983226	174977	280	Travoprost	Travoprostum|Isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-{(1e,3R)-3-hydroxy-4-[(alpha,alpha,alpha-trifluoro-m-tolyl)oxy]-1-butenyl}cyclopentyl)-5-heptenoate|Travoprost|Travatan|Travatan Z	izba|mylan-travoprost z|apo-tr	DRUGBANK	DB00287	C26H35F3O6	small molecule	S01EE04	157283-68-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKPLKVHSHYCHOC-AHTXBMBWSA-N
5166	111709	5737	RP5-944H6.1	PTGFR	FP	9606	Homo sapiens	agonist	target	Neacsu AM (2009)	19697832	174974	280	Travoprost	Travoprostum|Isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-{(1e,3R)-3-hydroxy-4-[(alpha,alpha,alpha-trifluoro-m-tolyl)oxy]-1-butenyl}cyclopentyl)-5-heptenoate|Travoprost|Travatan|Travatan Z	izba|mylan-travoprost z|apo-tr	DRUGBANK	DB00287	C26H35F3O6	small molecule	S01EE04	157283-68-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKPLKVHSHYCHOC-AHTXBMBWSA-N
5167	111709	5737	RP5-944H6.1	PTGFR	FP	9606	Homo sapiens	agonist	target	Ferrari G (1996)	9038626	174975	280	Travoprost	Travoprostum|Isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-{(1e,3R)-3-hydroxy-4-[(alpha,alpha,alpha-trifluoro-m-tolyl)oxy]-1-butenyl}cyclopentyl)-5-heptenoate|Travoprost|Travatan|Travatan Z	izba|mylan-travoprost z|apo-tr	DRUGBANK	DB00287	C26H35F3O6	small molecule	S01EE04	157283-68-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MKPLKVHSHYCHOC-AHTXBMBWSA-N
5168	106798	301	RP11-71A24.1	ANXA1	ANX1|LPC1	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	281	Amcinonide	Triamcinolonacetatcyclopentanonid|Amcinonidum|Amcinonida	cyclocort ont 0.1%|taro-amcino	DRUGBANK	DB00288	C28H35FO7	small molecule	D07AC11	51022-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ILKJAFIWWBXGDU-MOGDOJJUSA-N
5169	106798	301	RP11-71A24.1	ANXA1	ANX1|LPC1	9606	Homo sapiens	agonist	target	Serres M (1994)	7981624	174978	281	Amcinonide	Triamcinolonacetatcyclopentanonid|Amcinonidum|Amcinonida	cyclocort ont 0.1%|taro-amcino	DRUGBANK	DB00288	C28H35FO7	small molecule	D07AC11	51022-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ILKJAFIWWBXGDU-MOGDOJJUSA-N
5170	106798	301	RP11-71A24.1	ANXA1	ANX1|LPC1	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	281	Amcinonide	Triamcinolonacetatcyclopentanonid|Amcinonidum|Amcinonida	cyclocort ont 0.1%|taro-amcino	DRUGBANK	DB00288	C28H35FO7	small molecule	D07AC11	51022-69-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ILKJAFIWWBXGDU-MOGDOJJUSA-N
5242	111703	5731	-	PTGER1	EP1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	290	Bupivacaine	1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide|dl-1-Butyl-2',6'-pipecoloxylidide|(RS)-bupivacaine|Bupivacainum|1-Butyl-2',6'-pipecoloxylidide|racemic bupivacaine|()-bupivacaine|DL-Bupivacaine|Bupivacaina	bupivacaine hydrochloride inje	DRUGBANK	DB00297	C18H28N2O	small molecule	N01BB01|N01BB51	38396-39-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LEBVLXFERQHONN-UHFFFAOYSA-N
5243	111703	5731	-	PTGER1	EP1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	290	Bupivacaine	1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide|dl-1-Butyl-2',6'-pipecoloxylidide|(RS)-bupivacaine|Bupivacainum|1-Butyl-2',6'-pipecoloxylidide|racemic bupivacaine|()-bupivacaine|DL-Bupivacaine|Bupivacaina	bupivacaine hydrochloride inje	DRUGBANK	DB00297	C18H28N2O	small molecule	N01BB01|N01BB51	38396-39-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LEBVLXFERQHONN-UHFFFAOYSA-N
5244	111703	5731	-	PTGER1	EP1	9606	Homo sapiens	unknown	target	Beloeil H (2009)	19690271	175037	290	Bupivacaine	1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide|dl-1-Butyl-2',6'-pipecoloxylidide|(RS)-bupivacaine|Bupivacainum|1-Butyl-2',6'-pipecoloxylidide|racemic bupivacaine|()-bupivacaine|DL-Bupivacaine|Bupivacaina	bupivacaine hydrochloride inje	DRUGBANK	DB00297	C18H28N2O	small molecule	N01BB01|N01BB51	38396-39-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LEBVLXFERQHONN-UHFFFAOYSA-N
5476	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	309	Acetaminophen	actaminophne|p-hydroxyacetanilide|p-acetamidophenol|p-hydroxy-acetanilid|p-acetaminophenol|Acenol|N-acetyl-p-aminophenol|4-(Acetylamino)phenol|Paracetamolum|4'-hydroxyacetanilide|Paractamol|p-Acetylaminophenol|Acetaminophen|p-hydroxyphenolacetamide|Paracetamol|4-acetamidophenol|APAP|acetaminofn	tylenol cold and flu nighttime	DRUGBANK	DB00316	C8H9NO2	small molecule	N02BE71|N02BE01|N02BE51	103-90-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZVAJINKPMORJF-UHFFFAOYSA-N
5477	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Lee YS (2007)	17175104	175138	309	Acetaminophen	actaminophne|p-hydroxyacetanilide|p-acetamidophenol|p-hydroxy-acetanilid|p-acetaminophenol|Acenol|N-acetyl-p-aminophenol|4-(Acetylamino)phenol|Paracetamolum|4'-hydroxyacetanilide|Paractamol|p-Acetylaminophenol|Acetaminophen|p-hydroxyphenolacetamide|Paracetamol|4-acetamidophenol|APAP|acetaminofn	tylenol cold and flu nighttime	DRUGBANK	DB00316	C8H9NO2	small molecule	N02BE71|N02BE01|N02BE51	103-90-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZVAJINKPMORJF-UHFFFAOYSA-N
5478	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	309	Acetaminophen	actaminophne|p-hydroxyacetanilide|p-acetamidophenol|p-hydroxy-acetanilid|p-acetaminophenol|Acenol|N-acetyl-p-aminophenol|4-(Acetylamino)phenol|Paracetamolum|4'-hydroxyacetanilide|Paractamol|p-Acetylaminophenol|Acetaminophen|p-hydroxyphenolacetamide|Paracetamol|4-acetamidophenol|APAP|acetaminofn	tylenol cold and flu nighttime	DRUGBANK	DB00316	C8H9NO2	small molecule	N02BE71|N02BE01|N02BE51	103-90-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZVAJINKPMORJF-UHFFFAOYSA-N
5479	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Weinheimer EM (2007)	17322116	175137	309	Acetaminophen	actaminophne|p-hydroxyacetanilide|p-acetamidophenol|p-hydroxy-acetanilid|p-acetaminophenol|Acenol|N-acetyl-p-aminophenol|4-(Acetylamino)phenol|Paracetamolum|4'-hydroxyacetanilide|Paractamol|p-Acetylaminophenol|Acetaminophen|p-hydroxyphenolacetamide|Paracetamol|4-acetamidophenol|APAP|acetaminofn	tylenol cold and flu nighttime	DRUGBANK	DB00316	C8H9NO2	small molecule	N02BE71|N02BE01|N02BE51	103-90-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZVAJINKPMORJF-UHFFFAOYSA-N
5480	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Hinz B (2008)	17884974	175136	309	Acetaminophen	actaminophne|p-hydroxyacetanilide|p-acetamidophenol|p-hydroxy-acetanilid|p-acetaminophenol|Acenol|N-acetyl-p-aminophenol|4-(Acetylamino)phenol|Paracetamolum|4'-hydroxyacetanilide|Paractamol|p-Acetylaminophenol|Acetaminophen|p-hydroxyphenolacetamide|Paracetamol|4-acetamidophenol|APAP|acetaminofn	tylenol cold and flu nighttime	DRUGBANK	DB00316	C8H9NO2	small molecule	N02BE71|N02BE01|N02BE51	103-90-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZVAJINKPMORJF-UHFFFAOYSA-N
5601	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Fornai M (2005)	15831902	175237	321	Indomethacin	Indomethacin|Indometacinum|1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid|Indocin|{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid|Aconip|Indometacin|Indometacine|Indometacina	indocid cap 25mg|tivorbex|apo 	DRUGBANK	DB00328	C19H16ClNO4	small molecule	M01AB51|S01BC01|M02AA23|S01CC02|M01AB01|C01EB03	53-86-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CGIGDMFJXJATDK-UHFFFAOYSA-N
5602	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Bobadilla L RA (2005)	15743404	175241	321	Indomethacin	Indomethacin|Indometacinum|1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid|Indocin|{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid|Aconip|Indometacin|Indometacine|Indometacina	indocid cap 25mg|tivorbex|apo 	DRUGBANK	DB00328	C19H16ClNO4	small molecule	M01AB51|S01BC01|M02AA23|S01CC02|M01AB01|C01EB03	53-86-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CGIGDMFJXJATDK-UHFFFAOYSA-N
5603	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Higuchi K (2005)	15700751	175240	321	Indomethacin	Indomethacin|Indometacinum|1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid|Indocin|{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid|Aconip|Indometacin|Indometacine|Indometacina	indocid cap 25mg|tivorbex|apo 	DRUGBANK	DB00328	C19H16ClNO4	small molecule	M01AB51|S01BC01|M02AA23|S01CC02|M01AB01|C01EB03	53-86-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CGIGDMFJXJATDK-UHFFFAOYSA-N
5604	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Kundu N (2005)	15891886	175238	321	Indomethacin	Indomethacin|Indometacinum|1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid|Indocin|{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid|Aconip|Indometacin|Indometacine|Indometacina	indocid cap 25mg|tivorbex|apo 	DRUGBANK	DB00328	C19H16ClNO4	small molecule	M01AB51|S01BC01|M02AA23|S01CC02|M01AB01|C01EB03	53-86-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CGIGDMFJXJATDK-UHFFFAOYSA-N
5605	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Moth CW (2005)	15887968	175239	321	Indomethacin	Indomethacin|Indometacinum|1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid|Indocin|{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid|Aconip|Indometacin|Indometacine|Indometacina	indocid cap 25mg|tivorbex|apo 	DRUGBANK	DB00328	C19H16ClNO4	small molecule	M01AB51|S01BC01|M02AA23|S01CC02|M01AB01|C01EB03	53-86-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CGIGDMFJXJATDK-UHFFFAOYSA-N
5606	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	activator	target	Cho MC (2003)	12689521	175243	321	Indomethacin	Indomethacin|Indometacinum|1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid|Indocin|{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid|Aconip|Indometacin|Indometacine|Indometacina	indocid cap 25mg|tivorbex|apo 	DRUGBANK	DB00328	C19H16ClNO4	small molecule	M01AB51|S01BC01|M02AA23|S01CC02|M01AB01|C01EB03	53-86-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CGIGDMFJXJATDK-UHFFFAOYSA-N
5607	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	activator	target	Lehmann JM (1997)	9013583	175242	321	Indomethacin	Indomethacin|Indometacinum|1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid|Indocin|{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid|Aconip|Indometacin|Indometacine|Indometacina	indocid cap 25mg|tivorbex|apo 	DRUGBANK	DB00328	C19H16ClNO4	small molecule	M01AB51|S01BC01|M02AA23|S01CC02|M01AB01|C01EB03	53-86-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CGIGDMFJXJATDK-UHFFFAOYSA-N
5608	126915	145482	-	PTGR2	HEL-S-298|PGR2|ZADH1	9606	Homo sapiens	inhibitor	target	Wu YH (2008)	19000823	175244	321	Indomethacin	Indomethacin|Indometacinum|1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid|Indocin|{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid|Aconip|Indometacin|Indometacine|Indometacina	indocid cap 25mg|tivorbex|apo 	DRUGBANK	DB00328	C19H16ClNO4	small molecule	M01AB51|S01BC01|M02AA23|S01CC02|M01AB01|C01EB03	53-86-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CGIGDMFJXJATDK-UHFFFAOYSA-N
5609	116412	11251	-	PTGDR2	CD294|CRTH2|DL1R|DP2|GPR44	9606	Homo sapiens	unknown	target	Hata AN (2005)	16030019	168216	321	Indomethacin	Indomethacin|Indometacinum|1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid|Indocin|{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid|Aconip|Indometacin|Indometacine|Indometacina	indocid cap 25mg|tivorbex|apo 	DRUGBANK	DB00328	C19H16ClNO4	small molecule	M01AB51|S01BC01|M02AA23|S01CC02|M01AB01|C01EB03	53-86-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CGIGDMFJXJATDK-UHFFFAOYSA-N
5610	116412	11251	-	PTGDR2	CD294|CRTH2|DL1R|DP2|GPR44	9606	Homo sapiens	unknown	target	Hata AN (2005)	15563582	161179	321	Indomethacin	Indomethacin|Indometacinum|1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid|Indocin|{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid|Aconip|Indometacin|Indometacine|Indometacina	indocid cap 25mg|tivorbex|apo 	DRUGBANK	DB00328	C19H16ClNO4	small molecule	M01AB51|S01BC01|M02AA23|S01CC02|M01AB01|C01EB03	53-86-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CGIGDMFJXJATDK-UHFFFAOYSA-N
5611	116412	11251	-	PTGDR2	CD294|CRTH2|DL1R|DP2|GPR44	9606	Homo sapiens	unknown	target	Mathiesen JM (2005)	15870392	175245	321	Indomethacin	Indomethacin|Indometacinum|1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid|Indocin|{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid|Aconip|Indometacin|Indometacine|Indometacina	indocid cap 25mg|tivorbex|apo 	DRUGBANK	DB00328	C19H16ClNO4	small molecule	M01AB51|S01BC01|M02AA23|S01CC02|M01AB01|C01EB03	53-86-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CGIGDMFJXJATDK-UHFFFAOYSA-N
5614	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Pilane CM (2005)	15668944	175250	321	Indomethacin	Indomethacin|Indometacinum|1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid|Indocin|{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid|Aconip|Indometacin|Indometacine|Indometacina	indocid cap 25mg|tivorbex|apo 	DRUGBANK	DB00328	C19H16ClNO4	small molecule	M01AB51|S01BC01|M02AA23|S01CC02|M01AB01|C01EB03	53-86-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CGIGDMFJXJATDK-UHFFFAOYSA-N
5615	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Jerde TJ (2005)	15667901	175249	321	Indomethacin	Indomethacin|Indometacinum|1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid|Indocin|{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid|Aconip|Indometacin|Indometacine|Indometacina	indocid cap 25mg|tivorbex|apo 	DRUGBANK	DB00328	C19H16ClNO4	small molecule	M01AB51|S01BC01|M02AA23|S01CC02|M01AB01|C01EB03	53-86-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CGIGDMFJXJATDK-UHFFFAOYSA-N
5616	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Yokota A (2005)	15831440	175248	321	Indomethacin	Indomethacin|Indometacinum|1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid|Indocin|{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid|Aconip|Indometacin|Indometacine|Indometacina	indocid cap 25mg|tivorbex|apo 	DRUGBANK	DB00328	C19H16ClNO4	small molecule	M01AB51|S01BC01|M02AA23|S01CC02|M01AB01|C01EB03	53-86-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CGIGDMFJXJATDK-UHFFFAOYSA-N
5617	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Armstrong PJ (2005)	15770365	175247	321	Indomethacin	Indomethacin|Indometacinum|1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid|Indocin|{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid|Aconip|Indometacin|Indometacine|Indometacina	indocid cap 25mg|tivorbex|apo 	DRUGBANK	DB00328	C19H16ClNO4	small molecule	M01AB51|S01BC01|M02AA23|S01CC02|M01AB01|C01EB03	53-86-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CGIGDMFJXJATDK-UHFFFAOYSA-N
5618	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Zhang GS (2004)	15730717	175251	321	Indomethacin	Indomethacin|Indometacinum|1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid|Indocin|{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid|Aconip|Indometacin|Indometacine|Indometacina	indocid cap 25mg|tivorbex|apo 	DRUGBANK	DB00328	C19H16ClNO4	small molecule	M01AB51|S01BC01|M02AA23|S01CC02|M01AB01|C01EB03	53-86-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CGIGDMFJXJATDK-UHFFFAOYSA-N
5642	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5643	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	antagonist	target	Hutchison KE (2006)	16237394	175302	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5670	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5671	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5697	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5698	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Nasrallah HA (2008)	17848919	174616	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5699	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Lencz T (2006)	16513877	175319	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5700	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Jordan S (2007)	17092971	175318	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5701	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Weizman T (2003)	14575800	175315	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5702	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Thacker SK (2006)	17067304	175317	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5703	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Naiker DV (2006)	16730699	175316	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5704	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Uchida S (2007)	17316700	175303	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5705	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5706	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5707	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Lencz T (2006)	16513877	175319	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5708	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Jordan S (2007)	17092971	175318	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5709	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Weizman T (2003)	14575800	175315	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5710	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Thacker SK (2006)	17067304	175317	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5711	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Naiker DV (2006)	16730699	175316	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5712	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Uchida S (2007)	17316700	175303	326	Olanzapine	Olanzapinum|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|Olanzapine|Zyprexa|Olanzapina	olanzapine and fluoxetine|sand	DRUGBANK	DB00334	C17H20N4S	small molecule	N05AH03	132539-06-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KVWDHTXUZHCGIO-UHFFFAOYSA-N
5879	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inducer	target	Gaffar A (1995)	7560228	175418	342	Minoxidil	Minoxidil|Normoxidil|2,4-Diamino-6-piperidinopyrimidine 3-oxide|Minoximen|Minoxidilum|Tricoxidil|6-Piperidin-1-ylpyrimidine-2,4-diamine 3-oxide|Lonolox|Loniten|Regaine|Minossidile|Alostil|Rogaine|Apo-gain	mens rogaine extra strength|mi	DRUGBANK	DB00350	C9H15N5O	small molecule	C02DC01|D11AX01	38304-91-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZFMITUMMTDLWHR-UHFFFAOYSA-N
5880	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inducer	target	Kurbel S (1999)	10616041	175416	342	Minoxidil	Minoxidil|Normoxidil|2,4-Diamino-6-piperidinopyrimidine 3-oxide|Minoximen|Minoxidilum|Tricoxidil|6-Piperidin-1-ylpyrimidine-2,4-diamine 3-oxide|Lonolox|Loniten|Regaine|Minossidile|Alostil|Rogaine|Apo-gain	mens rogaine extra strength|mi	DRUGBANK	DB00350	C9H15N5O	small molecule	C02DC01|D11AX01	38304-91-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZFMITUMMTDLWHR-UHFFFAOYSA-N
5881	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inducer	target	Michelet JF (1997)	9008235	175417	342	Minoxidil	Minoxidil|Normoxidil|2,4-Diamino-6-piperidinopyrimidine 3-oxide|Minoximen|Minoxidilum|Tricoxidil|6-Piperidin-1-ylpyrimidine-2,4-diamine 3-oxide|Lonolox|Loniten|Regaine|Minossidile|Alostil|Rogaine|Apo-gain	mens rogaine extra strength|mi	DRUGBANK	DB00350	C9H15N5O	small molecule	C02DC01|D11AX01	38304-91-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZFMITUMMTDLWHR-UHFFFAOYSA-N
5962	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	355	Clozapine	Clozapine|Clozapina|Clozapin|Clozapinum	sandoz clozapine|auro-clozapin	DRUGBANK	DB00363	C18H19ClN4	small molecule	N05AH02	5786-21-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZUDBNBUXVUHMW-UHFFFAOYSA-N
5963	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	antagonist	target	Glatt SJ (2003)	13129658	175503	355	Clozapine	Clozapine|Clozapina|Clozapin|Clozapinum	sandoz clozapine|auro-clozapin	DRUGBANK	DB00363	C18H19ClN4	small molecule	N05AH02	5786-21-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZUDBNBUXVUHMW-UHFFFAOYSA-N
5964	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	antagonist	target	Patel S (2003)	12763097	175504	355	Clozapine	Clozapine|Clozapina|Clozapin|Clozapinum	sandoz clozapine|auro-clozapin	DRUGBANK	DB00363	C18H19ClN4	small molecule	N05AH02	5786-21-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZUDBNBUXVUHMW-UHFFFAOYSA-N
5965	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	antagonist	target	Zhao AL (2005)	16223700	175505	355	Clozapine	Clozapine|Clozapina|Clozapin|Clozapinum	sandoz clozapine|auro-clozapin	DRUGBANK	DB00363	C18H19ClN4	small molecule	N05AH02	5786-21-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZUDBNBUXVUHMW-UHFFFAOYSA-N
5966	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	antagonist	target	Kuballa G (2005)	15886414	175506	355	Clozapine	Clozapine|Clozapina|Clozapin|Clozapinum	sandoz clozapine|auro-clozapin	DRUGBANK	DB00363	C18H19ClN4	small molecule	N05AH02	5786-21-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZUDBNBUXVUHMW-UHFFFAOYSA-N
5967	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	antagonist	target	Nakane M (2005)	15992586	175502	355	Clozapine	Clozapine|Clozapina|Clozapin|Clozapinum	sandoz clozapine|auro-clozapin	DRUGBANK	DB00363	C18H19ClN4	small molecule	N05AH02	5786-21-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZUDBNBUXVUHMW-UHFFFAOYSA-N
5981	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	355	Clozapine	Clozapine|Clozapina|Clozapin|Clozapinum	sandoz clozapine|auro-clozapin	DRUGBANK	DB00363	C18H19ClN4	small molecule	N05AH02	5786-21-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZUDBNBUXVUHMW-UHFFFAOYSA-N
5994	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	355	Clozapine	Clozapine|Clozapina|Clozapin|Clozapinum	sandoz clozapine|auro-clozapin	DRUGBANK	DB00363	C18H19ClN4	small molecule	N05AH02	5786-21-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZUDBNBUXVUHMW-UHFFFAOYSA-N
5995	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Stonehouse AH (2005)	15781964	175516	355	Clozapine	Clozapine|Clozapina|Clozapin|Clozapinum	sandoz clozapine|auro-clozapin	DRUGBANK	DB00363	C18H19ClN4	small molecule	N05AH02	5786-21-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZUDBNBUXVUHMW-UHFFFAOYSA-N
5996	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Green AI (2002)	12769622	175515	355	Clozapine	Clozapine|Clozapina|Clozapin|Clozapinum	sandoz clozapine|auro-clozapin	DRUGBANK	DB00363	C18H19ClN4	small molecule	N05AH02	5786-21-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZUDBNBUXVUHMW-UHFFFAOYSA-N
5997	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Young RM (2004)	15286066	175514	355	Clozapine	Clozapine|Clozapina|Clozapin|Clozapinum	sandoz clozapine|auro-clozapin	DRUGBANK	DB00363	C18H19ClN4	small molecule	N05AH02	5786-21-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZUDBNBUXVUHMW-UHFFFAOYSA-N
5998	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Takano A (2006)	16040180	175513	355	Clozapine	Clozapine|Clozapina|Clozapin|Clozapinum	sandoz clozapine|auro-clozapin	DRUGBANK	DB00363	C18H19ClN4	small molecule	N05AH02	5786-21-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZUDBNBUXVUHMW-UHFFFAOYSA-N
5999	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Weizman T (2003)	14575800	175315	355	Clozapine	Clozapine|Clozapina|Clozapin|Clozapinum	sandoz clozapine|auro-clozapin	DRUGBANK	DB00363	C18H19ClN4	small molecule	N05AH02	5786-21-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QZUDBNBUXVUHMW-UHFFFAOYSA-N
6122	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	unknown	target	Fernandez J (2005)	15771415	175310	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6123	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	unknown	target	Wikstroem HV (2002)	12109911	175612	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6124	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	unknown	target	de Boer TH (1988)	3419539	175611	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6125	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	binder	target	Fernandez J (2005)	15771415	175310	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6126	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	binder	target	Wikstroem HV (2002)	12109911	175612	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6127	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	binder	target	de Boer TH (1988)	3419539	175611	362	Mirtazapine	Mirtazapinum|Mirtazapin|Mepirzapine|Mirtazapina|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|6-Azamianserin|Mirtazapine	dom-mirtazapine|ratio-mirtazap	DRUGBANK	DB00370	C17H19N3	small molecule	N06AX11	85650-52-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RONZAEMNMFQXRA-UHFFFAOYSA-N
6193	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	364	Thiethylperazine	Thiethylperazine|Tietilperazina|Thithylprazine|Norzine|Thiethylperazin|Thiethylperazinum|2-(ethylthio)-10-[3-(4-methylpiperazin-1-yl)propyl]-10H-phenothiazine	-	DRUGBANK	DB00372	C22H29N3S2	small molecule	R06AD03	1420-55-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCTYLCDETUVOIP-UHFFFAOYSA-N
6194	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	364	Thiethylperazine	Thiethylperazine|Tietilperazina|Thithylprazine|Norzine|Thiethylperazin|Thiethylperazinum|2-(ethylthio)-10-[3-(4-methylpiperazin-1-yl)propyl]-10H-phenothiazine	-	DRUGBANK	DB00372	C22H29N3S2	small molecule	R06AD03	1420-55-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCTYLCDETUVOIP-UHFFFAOYSA-N
6195	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Briani C (2004)	15469457	175635	364	Thiethylperazine	Thiethylperazine|Tietilperazina|Thithylprazine|Norzine|Thiethylperazin|Thiethylperazinum|2-(ethylthio)-10-[3-(4-methylpiperazin-1-yl)propyl]-10H-phenothiazine	-	DRUGBANK	DB00372	C22H29N3S2	small molecule	R06AD03	1420-55-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCTYLCDETUVOIP-UHFFFAOYSA-N
6198	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	364	Thiethylperazine	Thiethylperazine|Tietilperazina|Thithylprazine|Norzine|Thiethylperazin|Thiethylperazinum|2-(ethylthio)-10-[3-(4-methylpiperazin-1-yl)propyl]-10H-phenothiazine	-	DRUGBANK	DB00372	C22H29N3S2	small molecule	R06AD03	1420-55-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCTYLCDETUVOIP-UHFFFAOYSA-N
6199	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	364	Thiethylperazine	Thiethylperazine|Tietilperazina|Thithylprazine|Norzine|Thiethylperazin|Thiethylperazinum|2-(ethylthio)-10-[3-(4-methylpiperazin-1-yl)propyl]-10H-phenothiazine	-	DRUGBANK	DB00372	C22H29N3S2	small molecule	R06AD03	1420-55-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCTYLCDETUVOIP-UHFFFAOYSA-N
6216	111711	5739	-	PTGIR	IP|PRIPR	9606	Homo sapiens	agonist	target	Falcetti E (2010)	20622039	152865	366	Treprostinil	[[(1R,2R,3aS,9aS)-2-Hydroxy-1-[(3S)-3-hydroxyoctyl]-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[b]naphtalen-5-yl]oxy]acetic acid|Treprostinilo|(1R,2R,3aS,9aS)-[[2,3,3a,4,9,9a-hexahydro-2-hydroxy- 1-[(3S)-3-hydroxyoctyl]-1H-benz[f]inden-5-yl] oxy]acetic acid|Treprostinil|Treprostinilum|Uniprost	remodulin|tyvaso|orenitram	DRUGBANK	DB00374	C23H34O5	small molecule	B01AC21	81846-19-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PAJMKGZZBBTTOY-ZFORQUDYSA-N
6217	111711	5739	-	PTGIR	IP|PRIPR	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	366	Treprostinil	[[(1R,2R,3aS,9aS)-2-Hydroxy-1-[(3S)-3-hydroxyoctyl]-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[b]naphtalen-5-yl]oxy]acetic acid|Treprostinilo|(1R,2R,3aS,9aS)-[[2,3,3a,4,9,9a-hexahydro-2-hydroxy- 1-[(3S)-3-hydroxyoctyl]-1H-benz[f]inden-5-yl] oxy]acetic acid|Treprostinil|Treprostinilum|Uniprost	remodulin|tyvaso|orenitram	DRUGBANK	DB00374	C23H34O5	small molecule	B01AC21	81846-19-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PAJMKGZZBBTTOY-ZFORQUDYSA-N
6218	111711	5739	-	PTGIR	IP|PRIPR	9606	Homo sapiens	agonist	target	Sprague RS (2008)	18574748	175649	366	Treprostinil	[[(1R,2R,3aS,9aS)-2-Hydroxy-1-[(3S)-3-hydroxyoctyl]-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[b]naphtalen-5-yl]oxy]acetic acid|Treprostinilo|(1R,2R,3aS,9aS)-[[2,3,3a,4,9,9a-hexahydro-2-hydroxy- 1-[(3S)-3-hydroxyoctyl]-1H-benz[f]inden-5-yl] oxy]acetic acid|Treprostinil|Treprostinilum|Uniprost	remodulin|tyvaso|orenitram	DRUGBANK	DB00374	C23H34O5	small molecule	B01AC21	81846-19-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PAJMKGZZBBTTOY-ZFORQUDYSA-N
6219	111711	5739	-	PTGIR	IP|PRIPR	9606	Homo sapiens	agonist	target	Olschewski H (2004)	15163595	175648	366	Treprostinil	[[(1R,2R,3aS,9aS)-2-Hydroxy-1-[(3S)-3-hydroxyoctyl]-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[b]naphtalen-5-yl]oxy]acetic acid|Treprostinilo|(1R,2R,3aS,9aS)-[[2,3,3a,4,9,9a-hexahydro-2-hydroxy- 1-[(3S)-3-hydroxyoctyl]-1H-benz[f]inden-5-yl] oxy]acetic acid|Treprostinil|Treprostinilum|Uniprost	remodulin|tyvaso|orenitram	DRUGBANK	DB00374	C23H34O5	small molecule	B01AC21	81846-19-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PAJMKGZZBBTTOY-ZFORQUDYSA-N
6391	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Jaber M (1994)	7518029	175760	383	Sulpiride	N-((1-Ethyl-2-pyrrolidinyl)methyl)-5-sulfamoyl-O-anisamide|Levosulpiridum|5-(Aminosulfonyl)-N-((1-ethyl-2-pyrrolidinyl)methyl)-2-methoxybenzamide|Sulpirida|Sulpirid|Sulpiridum|Levosulpirida|Levosulpiride|(+-)-Sulpiride|N-((1-Ethyl-2-pyrrolidinyl)methyl)-2-methoxy-5-sulfamoylbenzamide|Sulpyrid	-	DRUGBANK	DB00391	C15H23N3O4S	small molecule	N05AL01|N05AL07	15676-16-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BGRJTUBHPOOWDU-UHFFFAOYSA-N
6392	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	383	Sulpiride	N-((1-Ethyl-2-pyrrolidinyl)methyl)-5-sulfamoyl-O-anisamide|Levosulpiridum|5-(Aminosulfonyl)-N-((1-ethyl-2-pyrrolidinyl)methyl)-2-methoxybenzamide|Sulpirida|Sulpirid|Sulpiridum|Levosulpirida|Levosulpiride|(+-)-Sulpiride|N-((1-Ethyl-2-pyrrolidinyl)methyl)-2-methoxy-5-sulfamoylbenzamide|Sulpyrid	-	DRUGBANK	DB00391	C15H23N3O4S	small molecule	N05AL01|N05AL07	15676-16-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BGRJTUBHPOOWDU-UHFFFAOYSA-N
6393	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Cavallotti C (2002)	12010185	175759	383	Sulpiride	N-((1-Ethyl-2-pyrrolidinyl)methyl)-5-sulfamoyl-O-anisamide|Levosulpiridum|5-(Aminosulfonyl)-N-((1-ethyl-2-pyrrolidinyl)methyl)-2-methoxybenzamide|Sulpirida|Sulpirid|Sulpiridum|Levosulpirida|Levosulpiride|(+-)-Sulpiride|N-((1-Ethyl-2-pyrrolidinyl)methyl)-2-methoxy-5-sulfamoylbenzamide|Sulpyrid	-	DRUGBANK	DB00391	C15H23N3O4S	small molecule	N05AL01|N05AL07	15676-16-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BGRJTUBHPOOWDU-UHFFFAOYSA-N
6394	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	antagonist	target	Collo G (2008)	18973551	175761	383	Sulpiride	N-((1-Ethyl-2-pyrrolidinyl)methyl)-5-sulfamoyl-O-anisamide|Levosulpiridum|5-(Aminosulfonyl)-N-((1-ethyl-2-pyrrolidinyl)methyl)-2-methoxybenzamide|Sulpirida|Sulpirid|Sulpiridum|Levosulpirida|Levosulpiride|(+-)-Sulpiride|N-((1-Ethyl-2-pyrrolidinyl)methyl)-2-methoxy-5-sulfamoylbenzamide|Sulpyrid	-	DRUGBANK	DB00391	C15H23N3O4S	small molecule	N05AL01|N05AL07	15676-16-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BGRJTUBHPOOWDU-UHFFFAOYSA-N
6395	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	antagonist	target	Lipina TV (2009)	19795811	175762	383	Sulpiride	N-((1-Ethyl-2-pyrrolidinyl)methyl)-5-sulfamoyl-O-anisamide|Levosulpiridum|5-(Aminosulfonyl)-N-((1-ethyl-2-pyrrolidinyl)methyl)-2-methoxybenzamide|Sulpirida|Sulpirid|Sulpiridum|Levosulpirida|Levosulpiride|(+-)-Sulpiride|N-((1-Ethyl-2-pyrrolidinyl)methyl)-2-methoxy-5-sulfamoylbenzamide|Sulpyrid	-	DRUGBANK	DB00391	C15H23N3O4S	small molecule	N05AL01|N05AL07	15676-16-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BGRJTUBHPOOWDU-UHFFFAOYSA-N
6602	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	400	Loxapine	Loxapinum|2-Chloro-11-(4-methyl-1-piperazinyl)dibenz[b,f][1,4]oxazepine|Cloxazepine|oxilapine|Loxapine|Loxapina	loxapine succinate tablets 50m	DRUGBANK	DB00408	C18H18ClN3O	small molecule	N05AH01	1977-10-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJGVXQDUIWGIRW-UHFFFAOYSA-N
6603	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Lang AE (1995)	8665533	175881	400	Loxapine	Loxapinum|2-Chloro-11-(4-methyl-1-piperazinyl)dibenz[b,f][1,4]oxazepine|Cloxazepine|oxilapine|Loxapine|Loxapina	loxapine succinate tablets 50m	DRUGBANK	DB00408	C18H18ClN3O	small molecule	N05AH01	1977-10-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJGVXQDUIWGIRW-UHFFFAOYSA-N
6604	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Hjerde E (2005)	15694653	175879	400	Loxapine	Loxapinum|2-Chloro-11-(4-methyl-1-piperazinyl)dibenz[b,f][1,4]oxazepine|Cloxazepine|oxilapine|Loxapine|Loxapina	loxapine succinate tablets 50m	DRUGBANK	DB00408	C18H18ClN3O	small molecule	N05AH01	1977-10-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJGVXQDUIWGIRW-UHFFFAOYSA-N
6605	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Froimowitz M (1997)	9342550	175878	400	Loxapine	Loxapinum|2-Chloro-11-(4-methyl-1-piperazinyl)dibenz[b,f][1,4]oxazepine|Cloxazepine|oxilapine|Loxapine|Loxapina	loxapine succinate tablets 50m	DRUGBANK	DB00408	C18H18ClN3O	small molecule	N05AH01	1977-10-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJGVXQDUIWGIRW-UHFFFAOYSA-N
6606	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Lee T (1984)	6239298	175876	400	Loxapine	Loxapinum|2-Chloro-11-(4-methyl-1-piperazinyl)dibenz[b,f][1,4]oxazepine|Cloxazepine|oxilapine|Loxapine|Loxapina	loxapine succinate tablets 50m	DRUGBANK	DB00408	C18H18ClN3O	small molecule	N05AH01	1977-10-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJGVXQDUIWGIRW-UHFFFAOYSA-N
6607	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Froimowitz M (1993)	8101879	175877	400	Loxapine	Loxapinum|2-Chloro-11-(4-methyl-1-piperazinyl)dibenz[b,f][1,4]oxazepine|Cloxazepine|oxilapine|Loxapine|Loxapina	loxapine succinate tablets 50m	DRUGBANK	DB00408	C18H18ClN3O	small molecule	N05AH01	1977-10-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJGVXQDUIWGIRW-UHFFFAOYSA-N
6608	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Kalkman HO (1998)	9570468	175880	400	Loxapine	Loxapinum|2-Chloro-11-(4-methyl-1-piperazinyl)dibenz[b,f][1,4]oxazepine|Cloxazepine|oxilapine|Loxapine|Loxapina	loxapine succinate tablets 50m	DRUGBANK	DB00408	C18H18ClN3O	small molecule	N05AH01	1977-10-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJGVXQDUIWGIRW-UHFFFAOYSA-N
6612	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Seeman P (2002)	11873706	174626	401	Remoxipride	Remoxipridum|Roxiam|Romoxipride|FLA-731|a-33547|Remoxipride|Remoxiprida	-	DRUGBANK	DB00409	C16H23BrN2O3	small molecule	N05AL04	80125-14-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GUJRSXAPGDDABA-NSHDSACASA-N
6613	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	401	Remoxipride	Remoxipridum|Roxiam|Romoxipride|FLA-731|a-33547|Remoxipride|Remoxiprida	-	DRUGBANK	DB00409	C16H23BrN2O3	small molecule	N05AL04	80125-14-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GUJRSXAPGDDABA-NSHDSACASA-N
6614	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Lang AE (1995)	8665533	175881	401	Remoxipride	Remoxipridum|Roxiam|Romoxipride|FLA-731|a-33547|Remoxipride|Remoxiprida	-	DRUGBANK	DB00409	C16H23BrN2O3	small molecule	N05AL04	80125-14-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GUJRSXAPGDDABA-NSHDSACASA-N
6615	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	antagonist	target	Christian AJ (2001)	11325388	175885	401	Remoxipride	Remoxipridum|Roxiam|Romoxipride|FLA-731|a-33547|Remoxipride|Remoxiprida	-	DRUGBANK	DB00409	C16H23BrN2O3	small molecule	N05AL04	80125-14-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GUJRSXAPGDDABA-NSHDSACASA-N
6616	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	antagonist	target	Seeman P (1997)	9015795	175886	401	Remoxipride	Remoxipridum|Roxiam|Romoxipride|FLA-731|a-33547|Remoxipride|Remoxiprida	-	DRUGBANK	DB00409	C16H23BrN2O3	small molecule	N05AL04	80125-14-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GUJRSXAPGDDABA-NSHDSACASA-N
6628	108478	2182	-	ACSL4	ACS4|FACL4|LACS4|MRX63|MRX68	9606	Homo sapiens	inhibitor	target	Askari B (2007)	17259370	160377	404	Rosiglitazone	(RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion|Rosiglitazon|Rosiglitazonum|Rosiglitazone|()-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione|Rosiglitazona|BDBM50030474	phl-rosiglitazone|avandaryl|av	DRUGBANK	DB00412	C18H19N3O3S	small molecule	A10BD03|A10BG02|A10BD04	122320-73-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YASAKCUCGLMORW-UHFFFAOYNA-N
6629	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Johnson BA (2000)	10764590	175913	404	Rosiglitazone	(RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion|Rosiglitazon|Rosiglitazonum|Rosiglitazone|()-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione|Rosiglitazona|BDBM50030474	phl-rosiglitazone|avandaryl|av	DRUGBANK	DB00412	C18H19N3O3S	small molecule	A10BD03|A10BG02|A10BD04	122320-73-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YASAKCUCGLMORW-UHFFFAOYNA-N
6630	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Camp HS (2000)	10871190	175912	404	Rosiglitazone	(RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion|Rosiglitazon|Rosiglitazonum|Rosiglitazone|()-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione|Rosiglitazona|BDBM50030474	phl-rosiglitazone|avandaryl|av	DRUGBANK	DB00412	C18H19N3O3S	small molecule	A10BD03|A10BG02|A10BD04	122320-73-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YASAKCUCGLMORW-UHFFFAOYNA-N
6631	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Rieusset J (1999)	10548525	175911	404	Rosiglitazone	(RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion|Rosiglitazon|Rosiglitazonum|Rosiglitazone|()-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione|Rosiglitazona|BDBM50030474	phl-rosiglitazone|avandaryl|av	DRUGBANK	DB00412	C18H19N3O3S	small molecule	A10BD03|A10BG02|A10BD04	122320-73-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YASAKCUCGLMORW-UHFFFAOYNA-N
6632	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Kameda N (2000)	10707565	175910	404	Rosiglitazone	(RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion|Rosiglitazon|Rosiglitazonum|Rosiglitazone|()-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione|Rosiglitazona|BDBM50030474	phl-rosiglitazone|avandaryl|av	DRUGBANK	DB00412	C18H19N3O3S	small molecule	A10BD03|A10BG02|A10BD04	122320-73-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YASAKCUCGLMORW-UHFFFAOYNA-N
6633	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	404	Rosiglitazone	(RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion|Rosiglitazon|Rosiglitazonum|Rosiglitazone|()-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione|Rosiglitazona|BDBM50030474	phl-rosiglitazone|avandaryl|av	DRUGBANK	DB00412	C18H19N3O3S	small molecule	A10BD03|A10BG02|A10BD04	122320-73-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YASAKCUCGLMORW-UHFFFAOYNA-N
6634	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Su JL (1999)	10475242	175909	404	Rosiglitazone	(RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion|Rosiglitazon|Rosiglitazonum|Rosiglitazone|()-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione|Rosiglitazona|BDBM50030474	phl-rosiglitazone|avandaryl|av	DRUGBANK	DB00412	C18H19N3O3S	small molecule	A10BD03|A10BG02|A10BD04	122320-73-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YASAKCUCGLMORW-UHFFFAOYNA-N
6635	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	405	Pramipexole	(S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine|Pramipexol|Pramipexole|2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N(sup 6)-propyl-, (S)-|(-)-Pramipexole|Pramipexolum	auro-pramipexole|mylan-pramipe	DRUGBANK	DB00413	C10H17N3S	small molecule	N04BC05	104632-26-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FASDKYOPVNHBLU-ZETCQYMHSA-N
6636	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	405	Pramipexole	(S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine|Pramipexol|Pramipexole|2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N(sup 6)-propyl-, (S)-|(-)-Pramipexole|Pramipexolum	auro-pramipexole|mylan-pramipe	DRUGBANK	DB00413	C10H17N3S	small molecule	N04BC05	104632-26-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FASDKYOPVNHBLU-ZETCQYMHSA-N
6637	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Lam YW (2000)	10641988	174664	405	Pramipexole	(S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine|Pramipexol|Pramipexole|2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N(sup 6)-propyl-, (S)-|(-)-Pramipexole|Pramipexolum	auro-pramipexole|mylan-pramipe	DRUGBANK	DB00413	C10H17N3S	small molecule	N04BC05	104632-26-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FASDKYOPVNHBLU-ZETCQYMHSA-N
6642	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	405	Pramipexole	(S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine|Pramipexol|Pramipexole|2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N(sup 6)-propyl-, (S)-|(-)-Pramipexole|Pramipexolum	auro-pramipexole|mylan-pramipe	DRUGBANK	DB00413	C10H17N3S	small molecule	N04BC05	104632-26-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FASDKYOPVNHBLU-ZETCQYMHSA-N
6643	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	405	Pramipexole	(S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine|Pramipexol|Pramipexole|2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N(sup 6)-propyl-, (S)-|(-)-Pramipexole|Pramipexolum	auro-pramipexole|mylan-pramipe	DRUGBANK	DB00413	C10H17N3S	small molecule	N04BC05	104632-26-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FASDKYOPVNHBLU-ZETCQYMHSA-N
6644	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	agonist	target	Lam YW (2000)	10641988	174664	405	Pramipexole	(S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine|Pramipexol|Pramipexole|2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N(sup 6)-propyl-, (S)-|(-)-Pramipexole|Pramipexolum	auro-pramipexole|mylan-pramipe	DRUGBANK	DB00413	C10H17N3S	small molecule	N04BC05	104632-26-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FASDKYOPVNHBLU-ZETCQYMHSA-N
6645	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	405	Pramipexole	(S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine|Pramipexol|Pramipexole|2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N(sup 6)-propyl-, (S)-|(-)-Pramipexole|Pramipexolum	auro-pramipexole|mylan-pramipe	DRUGBANK	DB00413	C10H17N3S	small molecule	N04BC05	104632-26-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FASDKYOPVNHBLU-ZETCQYMHSA-N
6646	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	405	Pramipexole	(S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine|Pramipexol|Pramipexole|2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N(sup 6)-propyl-, (S)-|(-)-Pramipexole|Pramipexolum	auro-pramipexole|mylan-pramipe	DRUGBANK	DB00413	C10H17N3S	small molecule	N04BC05	104632-26-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FASDKYOPVNHBLU-ZETCQYMHSA-N
6720	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	412	Promazine	10-(3-(Dimethylamino)propyl)phenothiazine|Promazine|N-Dimethylamino-1-methylethyl thiodiphenylamine|Promazinum|N-(3-Dimethylaminopropyl)phenothiazine|Promazina|Frenil|Promazin|N,N-dimethyl-3-(10H-phenothiazin-10-yl)-propan-1-amine	promazine hcl inj 50mg/ml	DRUGBANK	DB00420	C17H20N2S	small molecule	N05AA03	58-40-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZGUGWUXLJSTTMA-UHFFFAOYSA-N
6721	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	412	Promazine	10-(3-(Dimethylamino)propyl)phenothiazine|Promazine|N-Dimethylamino-1-methylethyl thiodiphenylamine|Promazinum|N-(3-Dimethylaminopropyl)phenothiazine|Promazina|Frenil|Promazin|N,N-dimethyl-3-(10H-phenothiazin-10-yl)-propan-1-amine	promazine hcl inj 50mg/ml	DRUGBANK	DB00420	C17H20N2S	small molecule	N05AA03	58-40-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZGUGWUXLJSTTMA-UHFFFAOYSA-N
6729	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	412	Promazine	10-(3-(Dimethylamino)propyl)phenothiazine|Promazine|N-Dimethylamino-1-methylethyl thiodiphenylamine|Promazinum|N-(3-Dimethylaminopropyl)phenothiazine|Promazina|Frenil|Promazin|N,N-dimethyl-3-(10H-phenothiazin-10-yl)-propan-1-amine	promazine hcl inj 50mg/ml	DRUGBANK	DB00420	C17H20N2S	small molecule	N05AA03	58-40-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZGUGWUXLJSTTMA-UHFFFAOYSA-N
6730	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	412	Promazine	10-(3-(Dimethylamino)propyl)phenothiazine|Promazine|N-Dimethylamino-1-methylethyl thiodiphenylamine|Promazinum|N-(3-Dimethylaminopropyl)phenothiazine|Promazina|Frenil|Promazin|N,N-dimethyl-3-(10H-phenothiazin-10-yl)-propan-1-amine	promazine hcl inj 50mg/ml	DRUGBANK	DB00420	C17H20N2S	small molecule	N05AA03	58-40-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZGUGWUXLJSTTMA-UHFFFAOYSA-N
6759	107957	1585	-	CYP11B2	ALDOS|CPN2|CYP11B|CYP11BL|CYPXIB2|P-450C18|P450C18|P450aldo	9606	Homo sapiens	antagonist	target	Cheng SC (1976)	976190	175953	413	Spironolactone	Spironolactone|Spironolactonum|Spironolattone|Espironolactona	apo-spirozide tab|ntp-spironol	DRUGBANK	DB00421	C24H32O4S	small molecule	C03DA01	52-01-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXMSZDCAJNLERA-ZHYRCANASA-N
6850	111703	5731	-	PTGER1	EP1	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	421	Carboprost Tromethamine	1,3-Dihydroxy-2-(hydroxymethyl)propan-2-aminium (5Z,9alpha,11beta,13e,15S)-9,11,15-trihydroxy-15-methylprosta-5,13-dien-1-oate|Methyldinoprost|Carboprost|15(S)-15-Methylprostaglandin F2alpha tromethamine|(15S)-15-Methylprostaglandin F2alpha tromethamine|(15S)-15-Methyl-pgf2alpha tromethamine salt|Carboprost trometamol|15(S)-15-Methyl-pgf2alpha tromethamine salt	hemabate	DRUGBANK	DB00429	C25H47NO8	small molecule	G02AD04	58551-69-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UMMADZJLZAPZAW-OVXHCKHTSA-N
6851	111703	5731	-	PTGER1	EP1	9606	Homo sapiens	agonist	target	Carrasco MP (1997)	9462300	175997	421	Carboprost Tromethamine	1,3-Dihydroxy-2-(hydroxymethyl)propan-2-aminium (5Z,9alpha,11beta,13e,15S)-9,11,15-trihydroxy-15-methylprosta-5,13-dien-1-oate|Methyldinoprost|Carboprost|15(S)-15-Methylprostaglandin F2alpha tromethamine|(15S)-15-Methylprostaglandin F2alpha tromethamine|(15S)-15-Methyl-pgf2alpha tromethamine salt|Carboprost trometamol|15(S)-15-Methyl-pgf2alpha tromethamine salt	hemabate	DRUGBANK	DB00429	C25H47NO8	small molecule	G02AD04	58551-69-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UMMADZJLZAPZAW-OVXHCKHTSA-N
6852	111703	5731	-	PTGER1	EP1	9606	Homo sapiens	agonist	target	Hay A (2010)	20519365	175996	421	Carboprost Tromethamine	1,3-Dihydroxy-2-(hydroxymethyl)propan-2-aminium (5Z,9alpha,11beta,13e,15S)-9,11,15-trihydroxy-15-methylprosta-5,13-dien-1-oate|Methyldinoprost|Carboprost|15(S)-15-Methylprostaglandin F2alpha tromethamine|(15S)-15-Methylprostaglandin F2alpha tromethamine|(15S)-15-Methyl-pgf2alpha tromethamine salt|Carboprost trometamol|15(S)-15-Methyl-pgf2alpha tromethamine salt	hemabate	DRUGBANK	DB00429	C25H47NO8	small molecule	G02AD04	58551-69-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UMMADZJLZAPZAW-OVXHCKHTSA-N
6853	111703	5731	-	PTGER1	EP1	9606	Homo sapiens	agonist	target	Tsuboi K (2001)	11338376	175995	421	Carboprost Tromethamine	1,3-Dihydroxy-2-(hydroxymethyl)propan-2-aminium (5Z,9alpha,11beta,13e,15S)-9,11,15-trihydroxy-15-methylprosta-5,13-dien-1-oate|Methyldinoprost|Carboprost|15(S)-15-Methylprostaglandin F2alpha tromethamine|(15S)-15-Methylprostaglandin F2alpha tromethamine|(15S)-15-Methyl-pgf2alpha tromethamine salt|Carboprost trometamol|15(S)-15-Methyl-pgf2alpha tromethamine salt	hemabate	DRUGBANK	DB00429	C25H47NO8	small molecule	G02AD04	58551-69-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UMMADZJLZAPZAW-OVXHCKHTSA-N
6898	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Hamik A (1989)	2527092	176028	425	Prochlorperazine	3-Chloro-10-(3-(1-methyl-4-piperazinyl)propyl)phenothiazine|Prochlorperazinum|Procloperazine|Prochlorpromazine|Prochlorprazine|3-Chloro-10-(3-(4-methyl-1-piperazinyl)propyl)phenothiazine|Prochlorpermazine|Capazine|Emetiral|Chloropernazine|2-Chloro-10-(3-(4-methyl-1-piperazinyl)propyl)phenothiazine|N-(gamma-(4'-Methylpiperazinyl-1')propyl)-3-chlorophenothiazine|Proclorperazina|Chlormeprazine|2-Chloro-10-(3-(1-methyl-4-piperazinyl)propyl)-phenothiazine|Prochlorperazin|Chloro-3 (N-methylpiperazinyl-3 propyl)-10 phenothiazine	prochlorperazine maleate|sando	DRUGBANK	DB00433	C20H24ClN3S	small molecule	N05AB04	58-38-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WIKYUJGCLQQFNW-UHFFFAOYSA-N
6899	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Callan JE (2008)	18534808	176029	425	Prochlorperazine	3-Chloro-10-(3-(1-methyl-4-piperazinyl)propyl)phenothiazine|Prochlorperazinum|Procloperazine|Prochlorpromazine|Prochlorprazine|3-Chloro-10-(3-(4-methyl-1-piperazinyl)propyl)phenothiazine|Prochlorpermazine|Capazine|Emetiral|Chloropernazine|2-Chloro-10-(3-(4-methyl-1-piperazinyl)propyl)phenothiazine|N-(gamma-(4'-Methylpiperazinyl-1')propyl)-3-chlorophenothiazine|Proclorperazina|Chlormeprazine|2-Chloro-10-(3-(1-methyl-4-piperazinyl)propyl)-phenothiazine|Prochlorperazin|Chloro-3 (N-methylpiperazinyl-3 propyl)-10 phenothiazine	prochlorperazine maleate|sando	DRUGBANK	DB00433	C20H24ClN3S	small molecule	N05AB04	58-38-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WIKYUJGCLQQFNW-UHFFFAOYSA-N
6900	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Roberge RJ (2006)	16677982	176027	425	Prochlorperazine	3-Chloro-10-(3-(1-methyl-4-piperazinyl)propyl)phenothiazine|Prochlorperazinum|Procloperazine|Prochlorpromazine|Prochlorprazine|3-Chloro-10-(3-(4-methyl-1-piperazinyl)propyl)phenothiazine|Prochlorpermazine|Capazine|Emetiral|Chloropernazine|2-Chloro-10-(3-(4-methyl-1-piperazinyl)propyl)phenothiazine|N-(gamma-(4'-Methylpiperazinyl-1')propyl)-3-chlorophenothiazine|Proclorperazina|Chlormeprazine|2-Chloro-10-(3-(1-methyl-4-piperazinyl)propyl)-phenothiazine|Prochlorperazin|Chloro-3 (N-methylpiperazinyl-3 propyl)-10 phenothiazine	prochlorperazine maleate|sando	DRUGBANK	DB00433	C20H24ClN3S	small molecule	N05AB04	58-38-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WIKYUJGCLQQFNW-UHFFFAOYSA-N
6901	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	425	Prochlorperazine	3-Chloro-10-(3-(1-methyl-4-piperazinyl)propyl)phenothiazine|Prochlorperazinum|Procloperazine|Prochlorpromazine|Prochlorprazine|3-Chloro-10-(3-(4-methyl-1-piperazinyl)propyl)phenothiazine|Prochlorpermazine|Capazine|Emetiral|Chloropernazine|2-Chloro-10-(3-(4-methyl-1-piperazinyl)propyl)phenothiazine|N-(gamma-(4'-Methylpiperazinyl-1')propyl)-3-chlorophenothiazine|Proclorperazina|Chlormeprazine|2-Chloro-10-(3-(1-methyl-4-piperazinyl)propyl)-phenothiazine|Prochlorperazin|Chloro-3 (N-methylpiperazinyl-3 propyl)-10 phenothiazine	prochlorperazine maleate|sando	DRUGBANK	DB00433	C20H24ClN3S	small molecule	N05AB04	58-38-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WIKYUJGCLQQFNW-UHFFFAOYSA-N
6902	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Narita M (2008)	18955042	176031	425	Prochlorperazine	3-Chloro-10-(3-(1-methyl-4-piperazinyl)propyl)phenothiazine|Prochlorperazinum|Procloperazine|Prochlorpromazine|Prochlorprazine|3-Chloro-10-(3-(4-methyl-1-piperazinyl)propyl)phenothiazine|Prochlorpermazine|Capazine|Emetiral|Chloropernazine|2-Chloro-10-(3-(4-methyl-1-piperazinyl)propyl)phenothiazine|N-(gamma-(4'-Methylpiperazinyl-1')propyl)-3-chlorophenothiazine|Proclorperazina|Chlormeprazine|2-Chloro-10-(3-(1-methyl-4-piperazinyl)propyl)-phenothiazine|Prochlorperazin|Chloro-3 (N-methylpiperazinyl-3 propyl)-10 phenothiazine	prochlorperazine maleate|sando	DRUGBANK	DB00433	C20H24ClN3S	small molecule	N05AB04	58-38-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WIKYUJGCLQQFNW-UHFFFAOYSA-N
6903	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Golembiewski J (2006)	17169748	176030	425	Prochlorperazine	3-Chloro-10-(3-(1-methyl-4-piperazinyl)propyl)phenothiazine|Prochlorperazinum|Procloperazine|Prochlorpromazine|Prochlorprazine|3-Chloro-10-(3-(4-methyl-1-piperazinyl)propyl)phenothiazine|Prochlorpermazine|Capazine|Emetiral|Chloropernazine|2-Chloro-10-(3-(4-methyl-1-piperazinyl)propyl)phenothiazine|N-(gamma-(4'-Methylpiperazinyl-1')propyl)-3-chlorophenothiazine|Proclorperazina|Chlormeprazine|2-Chloro-10-(3-(1-methyl-4-piperazinyl)propyl)-phenothiazine|Prochlorperazin|Chloro-3 (N-methylpiperazinyl-3 propyl)-10 phenothiazine	prochlorperazine maleate|sando	DRUGBANK	DB00433	C20H24ClN3S	small molecule	N05AB04	58-38-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WIKYUJGCLQQFNW-UHFFFAOYSA-N
6904	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Vinson DR (2006)	17044574	176032	425	Prochlorperazine	3-Chloro-10-(3-(1-methyl-4-piperazinyl)propyl)phenothiazine|Prochlorperazinum|Procloperazine|Prochlorpromazine|Prochlorprazine|3-Chloro-10-(3-(4-methyl-1-piperazinyl)propyl)phenothiazine|Prochlorpermazine|Capazine|Emetiral|Chloropernazine|2-Chloro-10-(3-(4-methyl-1-piperazinyl)propyl)phenothiazine|N-(gamma-(4'-Methylpiperazinyl-1')propyl)-3-chlorophenothiazine|Proclorperazina|Chlormeprazine|2-Chloro-10-(3-(1-methyl-4-piperazinyl)propyl)-phenothiazine|Prochlorperazin|Chloro-3 (N-methylpiperazinyl-3 propyl)-10 phenothiazine	prochlorperazine maleate|sando	DRUGBANK	DB00433	C20H24ClN3S	small molecule	N05AB04	58-38-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WIKYUJGCLQQFNW-UHFFFAOYSA-N
7011	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Grip G (1992)	1549935	176149	442	Droperidol	Droperidol|Droperidolum|1-(1-(3-(P-Fluorobenzoyl)propyl)-1,2,3,6-tetrahydro-4-pyridyl)-2-benzimidazolinone|1-{1-[4-(4-fluoro-phenyl)-4-oxo-butyl]-1,2,3,6-tetrahydro-pyridin-4-yl}-1,3-dihydro-benzoimidazol-2-one|Dropridol|1-(1-(4-(P-Fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydro-4-pyridyl)-2-benzimidazolinone|1-{1-[4-(4-fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydro-4-pyridinyl}-2,3-dihydro-1H-benzo[D]imidazol-2-one|Droperidolo	inapsine|droperidol|innovar in	DRUGBANK	DB00450	C22H22FN3O2	small molecule	N05AD08	548-73-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMEDXOLNCUSCGS-UHFFFAOYSA-N
7012	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Larson MD (2003)	14633536	176148	442	Droperidol	Droperidol|Droperidolum|1-(1-(3-(P-Fluorobenzoyl)propyl)-1,2,3,6-tetrahydro-4-pyridyl)-2-benzimidazolinone|1-{1-[4-(4-fluoro-phenyl)-4-oxo-butyl]-1,2,3,6-tetrahydro-pyridin-4-yl}-1,3-dihydro-benzoimidazol-2-one|Dropridol|1-(1-(4-(P-Fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydro-4-pyridyl)-2-benzimidazolinone|1-{1-[4-(4-fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydro-4-pyridinyl}-2,3-dihydro-1H-benzo[D]imidazol-2-one|Droperidolo	inapsine|droperidol|innovar in	DRUGBANK	DB00450	C22H22FN3O2	small molecule	N05AD08	548-73-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMEDXOLNCUSCGS-UHFFFAOYSA-N
7013	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Hamik A (1989)	2527092	176028	442	Droperidol	Droperidol|Droperidolum|1-(1-(3-(P-Fluorobenzoyl)propyl)-1,2,3,6-tetrahydro-4-pyridyl)-2-benzimidazolinone|1-{1-[4-(4-fluoro-phenyl)-4-oxo-butyl]-1,2,3,6-tetrahydro-pyridin-4-yl}-1,3-dihydro-benzoimidazol-2-one|Dropridol|1-(1-(4-(P-Fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydro-4-pyridyl)-2-benzimidazolinone|1-{1-[4-(4-fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydro-4-pyridinyl}-2,3-dihydro-1H-benzo[D]imidazol-2-one|Droperidolo	inapsine|droperidol|innovar in	DRUGBANK	DB00450	C22H22FN3O2	small molecule	N05AD08	548-73-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMEDXOLNCUSCGS-UHFFFAOYSA-N
7014	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Gao HR (2010)	20358234	176150	442	Droperidol	Droperidol|Droperidolum|1-(1-(3-(P-Fluorobenzoyl)propyl)-1,2,3,6-tetrahydro-4-pyridyl)-2-benzimidazolinone|1-{1-[4-(4-fluoro-phenyl)-4-oxo-butyl]-1,2,3,6-tetrahydro-pyridin-4-yl}-1,3-dihydro-benzoimidazol-2-one|Dropridol|1-(1-(4-(P-Fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydro-4-pyridyl)-2-benzimidazolinone|1-{1-[4-(4-fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydro-4-pyridinyl}-2,3-dihydro-1H-benzo[D]imidazol-2-one|Droperidolo	inapsine|droperidol|innovar in	DRUGBANK	DB00450	C22H22FN3O2	small molecule	N05AD08	548-73-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMEDXOLNCUSCGS-UHFFFAOYSA-N
7124	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	binder	target	Peddi S (2004)	15081025	176220	450	Imipramine	N-(-dimethylaminopropyl)iminodibenzyl|Imipraminum|Antideprin|3-(5H-DIBENZO[b,F]azepin-5-yl)-N,N-dimethylpropan-1-amine|10,11-dihydro-N,N-Dimethyl-5H-dibenz[b,F]azepine-5-propanamine|Irmin|Imipramine|Imizine|5-[3-(dimethylamino)Propyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Melipramine|N-(gamma-Dimethylaminopropyl)iminodibenzyl|Imipramin	tofranil|imipramine tab 25mg|i	DRUGBANK	DB00458	C19H24N2	small molecule	N06AA02	50-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCGWQEUPMDMJNV-UHFFFAOYSA-N
7150	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Bensen W (1998)	9481468	176239	453	Nabumetone	Nabumtone|4-(6-Methoxy-2-naphthalenyl)-2-butanone|Nabumetona|4-(6-Methoxy-2-naphthyl)-2-butanone|Nabumeton|Nabumetonum|Relafen|Nabumetone	apo-nabumetone|relafen tablets	DRUGBANK	DB00461	C15H16O2	small molecule	M01AX01	42924-53-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLXXJMDCKKHMKV-UHFFFAOYSA-N
7151	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Takeuchi K (2006)	16469680	176238	453	Nabumetone	Nabumtone|4-(6-Methoxy-2-naphthalenyl)-2-butanone|Nabumetona|4-(6-Methoxy-2-naphthyl)-2-butanone|Nabumeton|Nabumetonum|Relafen|Nabumetone	apo-nabumetone|relafen tablets	DRUGBANK	DB00461	C15H16O2	small molecule	M01AX01	42924-53-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLXXJMDCKKHMKV-UHFFFAOYSA-N
7152	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Cipollone F (1995)	7554708	176237	453	Nabumetone	Nabumtone|4-(6-Methoxy-2-naphthalenyl)-2-butanone|Nabumetona|4-(6-Methoxy-2-naphthyl)-2-butanone|Nabumeton|Nabumetonum|Relafen|Nabumetone	apo-nabumetone|relafen tablets	DRUGBANK	DB00461	C15H16O2	small molecule	M01AX01	42924-53-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLXXJMDCKKHMKV-UHFFFAOYSA-N
7153	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Giuliano F (2001)	11525777	176240	453	Nabumetone	Nabumtone|4-(6-Methoxy-2-naphthalenyl)-2-butanone|Nabumetona|4-(6-Methoxy-2-naphthyl)-2-butanone|Nabumeton|Nabumetonum|Relafen|Nabumetone	apo-nabumetone|relafen tablets	DRUGBANK	DB00461	C15H16O2	small molecule	M01AX01	42924-53-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLXXJMDCKKHMKV-UHFFFAOYSA-N
7154	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	453	Nabumetone	Nabumtone|4-(6-Methoxy-2-naphthalenyl)-2-butanone|Nabumetona|4-(6-Methoxy-2-naphthyl)-2-butanone|Nabumeton|Nabumetonum|Relafen|Nabumetone	apo-nabumetone|relafen tablets	DRUGBANK	DB00461	C15H16O2	small molecule	M01AX01	42924-53-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLXXJMDCKKHMKV-UHFFFAOYSA-N
7155	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Elliott SN (1995)	7615202	176244	453	Nabumetone	Nabumtone|4-(6-Methoxy-2-naphthalenyl)-2-butanone|Nabumetona|4-(6-Methoxy-2-naphthyl)-2-butanone|Nabumeton|Nabumetonum|Relafen|Nabumetone	apo-nabumetone|relafen tablets	DRUGBANK	DB00461	C15H16O2	small molecule	M01AX01	42924-53-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLXXJMDCKKHMKV-UHFFFAOYSA-N
7156	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Roy HK (2001)	11304699	176245	453	Nabumetone	Nabumtone|4-(6-Methoxy-2-naphthalenyl)-2-butanone|Nabumetona|4-(6-Methoxy-2-naphthyl)-2-butanone|Nabumeton|Nabumetonum|Relafen|Nabumetone	apo-nabumetone|relafen tablets	DRUGBANK	DB00461	C15H16O2	small molecule	M01AX01	42924-53-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLXXJMDCKKHMKV-UHFFFAOYSA-N
7157	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Hedner T (2004)	15456329	176242	453	Nabumetone	Nabumtone|4-(6-Methoxy-2-naphthalenyl)-2-butanone|Nabumetona|4-(6-Methoxy-2-naphthyl)-2-butanone|Nabumeton|Nabumetonum|Relafen|Nabumetone	apo-nabumetone|relafen tablets	DRUGBANK	DB00461	C15H16O2	small molecule	M01AX01	42924-53-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLXXJMDCKKHMKV-UHFFFAOYSA-N
7158	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	van Kraaij DJ (2002)	12047490	176243	453	Nabumetone	Nabumtone|4-(6-Methoxy-2-naphthalenyl)-2-butanone|Nabumetona|4-(6-Methoxy-2-naphthyl)-2-butanone|Nabumeton|Nabumetonum|Relafen|Nabumetone	apo-nabumetone|relafen tablets	DRUGBANK	DB00461	C15H16O2	small molecule	M01AX01	42924-53-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLXXJMDCKKHMKV-UHFFFAOYSA-N
7159	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Fackovcova D (2001)	11153163	176241	453	Nabumetone	Nabumtone|4-(6-Methoxy-2-naphthalenyl)-2-butanone|Nabumetona|4-(6-Methoxy-2-naphthyl)-2-butanone|Nabumeton|Nabumetonum|Relafen|Nabumetone	apo-nabumetone|relafen tablets	DRUGBANK	DB00461	C15H16O2	small molecule	M01AX01	42924-53-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLXXJMDCKKHMKV-UHFFFAOYSA-N
7200	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Dionne RA (2001)	11695255	176255	457	Ketorolac	Ketorolacum|Ketorolaco|Ktorolac|(+-)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid|rac-Ketorolac|(+-)-Ketorolac|Ketorolac	toradol|acular ls|toradol tab 	DRUGBANK	DB00465	C15H13NO3	small molecule	M01AB15|S01BC05	74103-06-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZWKMVRBQXNZKK-UHFFFAOYSA-N
7201	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Uzan A (2005)	16262557	176257	457	Ketorolac	Ketorolacum|Ketorolaco|Ktorolac|(+-)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid|rac-Ketorolac|(+-)-Ketorolac|Ketorolac	toradol|acular ls|toradol tab 	DRUGBANK	DB00465	C15H13NO3	small molecule	M01AB15|S01BC05	74103-06-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZWKMVRBQXNZKK-UHFFFAOYSA-N
7202	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Blais V (2005)	16277613	176256	457	Ketorolac	Ketorolacum|Ketorolaco|Ktorolac|(+-)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid|rac-Ketorolac|(+-)-Ketorolac|Ketorolac	toradol|acular ls|toradol tab 	DRUGBANK	DB00465	C15H13NO3	small molecule	M01AB15|S01BC05	74103-06-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZWKMVRBQXNZKK-UHFFFAOYSA-N
7203	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Bosch-Marce M (1999)	10220509	176259	457	Ketorolac	Ketorolacum|Ketorolaco|Ktorolac|(+-)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid|rac-Ketorolac|(+-)-Ketorolac|Ketorolac	toradol|acular ls|toradol tab 	DRUGBANK	DB00465	C15H13NO3	small molecule	M01AB15|S01BC05	74103-06-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZWKMVRBQXNZKK-UHFFFAOYSA-N
7204	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Lashbrook JM (1999)	10422661	176258	457	Ketorolac	Ketorolacum|Ketorolaco|Ktorolac|(+-)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid|rac-Ketorolac|(+-)-Ketorolac|Ketorolac	toradol|acular ls|toradol tab 	DRUGBANK	DB00465	C15H13NO3	small molecule	M01AB15|S01BC05	74103-06-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZWKMVRBQXNZKK-UHFFFAOYSA-N
7205	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Blais V (2002)	12446609	176260	457	Ketorolac	Ketorolacum|Ketorolaco|Ktorolac|(+-)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid|rac-Ketorolac|(+-)-Ketorolac|Ketorolac	toradol|acular ls|toradol tab 	DRUGBANK	DB00465	C15H13NO3	small molecule	M01AB15|S01BC05	74103-06-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZWKMVRBQXNZKK-UHFFFAOYSA-N
7206	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Ma W (2003)	14568028	176261	457	Ketorolac	Ketorolacum|Ketorolaco|Ktorolac|(+-)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid|rac-Ketorolac|(+-)-Ketorolac|Ketorolac	toradol|acular ls|toradol tab 	DRUGBANK	DB00465	C15H13NO3	small molecule	M01AB15|S01BC05	74103-06-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZWKMVRBQXNZKK-UHFFFAOYSA-N
7207	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Padi SS (2004)	15102535	176262	457	Ketorolac	Ketorolacum|Ketorolaco|Ktorolac|(+-)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid|rac-Ketorolac|(+-)-Ketorolac|Ketorolac	toradol|acular ls|toradol tab 	DRUGBANK	DB00465	C15H13NO3	small molecule	M01AB15|S01BC05	74103-06-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZWKMVRBQXNZKK-UHFFFAOYSA-N
7208	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Hoecherl K (2002)	12110513	176263	457	Ketorolac	Ketorolacum|Ketorolaco|Ktorolac|(+-)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid|rac-Ketorolac|(+-)-Ketorolac|Ketorolac	toradol|acular ls|toradol tab 	DRUGBANK	DB00465	C15H13NO3	small molecule	M01AB15|S01BC05	74103-06-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZWKMVRBQXNZKK-UHFFFAOYSA-N
7209	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Ma W (2003)	14568029	176264	457	Ketorolac	Ketorolacum|Ketorolaco|Ktorolac|(+-)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid|rac-Ketorolac|(+-)-Ketorolac|Ketorolac	toradol|acular ls|toradol tab 	DRUGBANK	DB00465	C15H13NO3	small molecule	M01AB15|S01BC05	74103-06-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZWKMVRBQXNZKK-UHFFFAOYSA-N
7227	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Yamada M (1997)	9152412	176290	461	Tenoxicam	Tenoxicamum|Tnoxicam|Tenoxicam	tenoxicam tablets|tenoxicam-20	DRUGBANK	DB00469	C13H11N3O4S2	small molecule	M01AC02	59804-37-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LZNWYQJJBLGYLT-UHFFFAOYSA-N
7228	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Kothekar V (2001)	11563332	176288	461	Tenoxicam	Tenoxicamum|Tnoxicam|Tenoxicam	tenoxicam tablets|tenoxicam-20	DRUGBANK	DB00469	C13H11N3O4S2	small molecule	M01AC02	59804-37-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LZNWYQJJBLGYLT-UHFFFAOYSA-N
7229	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Ozgocmen S (2005)	15943176	176289	461	Tenoxicam	Tenoxicamum|Tnoxicam|Tenoxicam	tenoxicam tablets|tenoxicam-20	DRUGBANK	DB00469	C13H11N3O4S2	small molecule	M01AC02	59804-37-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LZNWYQJJBLGYLT-UHFFFAOYSA-N
7230	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Lucio M (2006)	17017983	176286	461	Tenoxicam	Tenoxicamum|Tnoxicam|Tenoxicam	tenoxicam tablets|tenoxicam-20	DRUGBANK	DB00469	C13H11N3O4S2	small molecule	M01AC02	59804-37-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LZNWYQJJBLGYLT-UHFFFAOYSA-N
7231	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Lora M (1997)	9175172	176287	461	Tenoxicam	Tenoxicamum|Tnoxicam|Tenoxicam	tenoxicam tablets|tenoxicam-20	DRUGBANK	DB00469	C13H11N3O4S2	small molecule	M01AC02	59804-37-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LZNWYQJJBLGYLT-UHFFFAOYSA-N
7232	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	461	Tenoxicam	Tenoxicamum|Tnoxicam|Tenoxicam	tenoxicam tablets|tenoxicam-20	DRUGBANK	DB00469	C13H11N3O4S2	small molecule	M01AC02	59804-37-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LZNWYQJJBLGYLT-UHFFFAOYSA-N
7233	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Galvao RI (2005)	15756931	176291	461	Tenoxicam	Tenoxicamum|Tnoxicam|Tenoxicam	tenoxicam tablets|tenoxicam-20	DRUGBANK	DB00469	C13H11N3O4S2	small molecule	M01AC02	59804-37-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LZNWYQJJBLGYLT-UHFFFAOYSA-N
7234	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Yamada M (1997)	9152412	176290	461	Tenoxicam	Tenoxicamum|Tnoxicam|Tenoxicam	tenoxicam tablets|tenoxicam-20	DRUGBANK	DB00469	C13H11N3O4S2	small molecule	M01AC02	59804-37-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LZNWYQJJBLGYLT-UHFFFAOYSA-N
7235	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Yilmaz H (2005)	16245223	176292	461	Tenoxicam	Tenoxicamum|Tnoxicam|Tenoxicam	tenoxicam tablets|tenoxicam-20	DRUGBANK	DB00469	C13H11N3O4S2	small molecule	M01AC02	59804-37-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LZNWYQJJBLGYLT-UHFFFAOYSA-N
7236	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Kothekar V (2001)	11563332	176288	461	Tenoxicam	Tenoxicamum|Tnoxicam|Tenoxicam	tenoxicam tablets|tenoxicam-20	DRUGBANK	DB00469	C13H11N3O4S2	small molecule	M01AC02	59804-37-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LZNWYQJJBLGYLT-UHFFFAOYSA-N
7237	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Ozgocmen S (2005)	15943176	176289	461	Tenoxicam	Tenoxicamum|Tnoxicam|Tenoxicam	tenoxicam tablets|tenoxicam-20	DRUGBANK	DB00469	C13H11N3O4S2	small molecule	M01AC02	59804-37-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LZNWYQJJBLGYLT-UHFFFAOYSA-N
7245	116014	10800	-	CYSLTR1	CYSLT1|CYSLT1R|CYSLTR|HMTMF81	9606	Homo sapiens	antagonist	target	Nayak A (2004)	15013935	176301	463	Montelukast	Montelukast|Montelukastum|(R-(e))-1-(((1-(3-(2-(7-Chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropaneacetic acid|Montlukast|1-[[[(1 R)-1-[3-[(1e)-2-(7-chloro-2-Quinolinyl)ethenyl] phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]sulfanyl]methyl]cyclopropaneacetic acid	riva-montelukast fc|sandoz mon	DRUGBANK	DB00471	C35H36ClNO3S	small molecule	R03DC53|R03DC03	158966-92-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCHDWCPVSPXUMX-TZIWLTJVSA-N
7246	116014	10800	-	CYSLTR1	CYSLT1|CYSLT1R|CYSLTR|HMTMF81	9606	Homo sapiens	antagonist	target	Zhang YJ (2004)	15456537	176300	463	Montelukast	Montelukast|Montelukastum|(R-(e))-1-(((1-(3-(2-(7-Chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropaneacetic acid|Montlukast|1-[[[(1 R)-1-[3-[(1e)-2-(7-chloro-2-Quinolinyl)ethenyl] phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]sulfanyl]methyl]cyclopropaneacetic acid	riva-montelukast fc|sandoz mon	DRUGBANK	DB00471	C35H36ClNO3S	small molecule	R03DC53|R03DC03	158966-92-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCHDWCPVSPXUMX-TZIWLTJVSA-N
7247	116014	10800	-	CYSLTR1	CYSLT1|CYSLT1R|CYSLTR|HMTMF81	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	463	Montelukast	Montelukast|Montelukastum|(R-(e))-1-(((1-(3-(2-(7-Chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropaneacetic acid|Montlukast|1-[[[(1 R)-1-[3-[(1e)-2-(7-chloro-2-Quinolinyl)ethenyl] phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]sulfanyl]methyl]cyclopropaneacetic acid	riva-montelukast fc|sandoz mon	DRUGBANK	DB00471	C35H36ClNO3S	small molecule	R03DC53|R03DC03	158966-92-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCHDWCPVSPXUMX-TZIWLTJVSA-N
7248	116014	10800	-	CYSLTR1	CYSLT1|CYSLT1R|CYSLTR|HMTMF81	9606	Homo sapiens	antagonist	target	Langlois A (2006)	16815146	176297	463	Montelukast	Montelukast|Montelukastum|(R-(e))-1-(((1-(3-(2-(7-Chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropaneacetic acid|Montlukast|1-[[[(1 R)-1-[3-[(1e)-2-(7-chloro-2-Quinolinyl)ethenyl] phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]sulfanyl]methyl]cyclopropaneacetic acid	riva-montelukast fc|sandoz mon	DRUGBANK	DB00471	C35H36ClNO3S	small molecule	R03DC53|R03DC03	158966-92-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCHDWCPVSPXUMX-TZIWLTJVSA-N
7249	116014	10800	-	CYSLTR1	CYSLT1|CYSLT1R|CYSLTR|HMTMF81	9606	Homo sapiens	antagonist	target	Hamacher J (2006)	16815057	176299	463	Montelukast	Montelukast|Montelukastum|(R-(e))-1-(((1-(3-(2-(7-Chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropaneacetic acid|Montlukast|1-[[[(1 R)-1-[3-[(1e)-2-(7-chloro-2-Quinolinyl)ethenyl] phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]sulfanyl]methyl]cyclopropaneacetic acid	riva-montelukast fc|sandoz mon	DRUGBANK	DB00471	C35H36ClNO3S	small molecule	R03DC53|R03DC03	158966-92-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCHDWCPVSPXUMX-TZIWLTJVSA-N
7250	116014	10800	-	CYSLTR1	CYSLT1|CYSLT1R|CYSLTR|HMTMF81	9606	Homo sapiens	antagonist	target	Alfieri AB (2007)	17199874	176298	463	Montelukast	Montelukast|Montelukastum|(R-(e))-1-(((1-(3-(2-(7-Chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropaneacetic acid|Montlukast|1-[[[(1 R)-1-[3-[(1e)-2-(7-chloro-2-Quinolinyl)ethenyl] phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]sulfanyl]methyl]cyclopropaneacetic acid	riva-montelukast fc|sandoz mon	DRUGBANK	DB00471	C35H36ClNO3S	small molecule	R03DC53|R03DC03	158966-92-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCHDWCPVSPXUMX-TZIWLTJVSA-N
7251	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	unknown	target	Ramires R (2004)	15474500	176302	463	Montelukast	Montelukast|Montelukastum|(R-(e))-1-(((1-(3-(2-(7-Chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropaneacetic acid|Montlukast|1-[[[(1 R)-1-[3-[(1e)-2-(7-chloro-2-Quinolinyl)ethenyl] phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]sulfanyl]methyl]cyclopropaneacetic acid	riva-montelukast fc|sandoz mon	DRUGBANK	DB00471	C35H36ClNO3S	small molecule	R03DC53|R03DC03	158966-92-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCHDWCPVSPXUMX-TZIWLTJVSA-N
7320	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	binder	target	Roth BL (1995)	8524985	176332	469	Chlorpromazine	Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine	chlorpromanyl 20 syr|chlorprom	DRUGBANK	DB00477	C17H19ClN2S	small molecule	N05AA01	50-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPEIMTDSQAKGNT-UHFFFAOYSA-N
7332	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	unknown	target	Freedman SB (1994)	8301582	176340	469	Chlorpromazine	Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine	chlorpromanyl 20 syr|chlorprom	DRUGBANK	DB00477	C17H19ClN2S	small molecule	N05AA01	50-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPEIMTDSQAKGNT-UHFFFAOYSA-N
7348	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Seeman P (2002)	11873706	174626	469	Chlorpromazine	Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine	chlorpromanyl 20 syr|chlorprom	DRUGBANK	DB00477	C17H19ClN2S	small molecule	N05AA01	50-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPEIMTDSQAKGNT-UHFFFAOYSA-N
7349	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	469	Chlorpromazine	Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine	chlorpromanyl 20 syr|chlorprom	DRUGBANK	DB00477	C17H19ClN2S	small molecule	N05AA01	50-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPEIMTDSQAKGNT-UHFFFAOYSA-N
7350	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Wu S (2005)	15694263	176350	469	Chlorpromazine	Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine	chlorpromanyl 20 syr|chlorprom	DRUGBANK	DB00477	C17H19ClN2S	small molecule	N05AA01	50-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPEIMTDSQAKGNT-UHFFFAOYSA-N
7351	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Oades RD (2000)	11103886	176351	469	Chlorpromazine	Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine	chlorpromanyl 20 syr|chlorprom	DRUGBANK	DB00477	C17H19ClN2S	small molecule	N05AA01	50-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPEIMTDSQAKGNT-UHFFFAOYSA-N
7352	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Seeman P (2010)	20643630	176352	469	Chlorpromazine	Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine	chlorpromanyl 20 syr|chlorprom	DRUGBANK	DB00477	C17H19ClN2S	small molecule	N05AA01	50-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPEIMTDSQAKGNT-UHFFFAOYSA-N
7353	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Wu SN (2006)	16867246	176349	469	Chlorpromazine	Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine	chlorpromanyl 20 syr|chlorprom	DRUGBANK	DB00477	C17H19ClN2S	small molecule	N05AA01	50-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPEIMTDSQAKGNT-UHFFFAOYSA-N
7354	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Roth BL (1995)	8524985	176332	469	Chlorpromazine	Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine	chlorpromanyl 20 syr|chlorprom	DRUGBANK	DB00477	C17H19ClN2S	small molecule	N05AA01	50-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPEIMTDSQAKGNT-UHFFFAOYSA-N
7355	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Roth BL (1994)	7908055	176335	469	Chlorpromazine	Chlorpromazine|Chloropromazine|Largactil|CPZ|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|Aminazine|Chlorpromados|Chlorpromazinum|Clorpromazina|Chlorderazin|3-(2-chloro-10H-Phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|Contomin|3-(2-Chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|Thorazine	chlorpromanyl 20 syr|chlorprom	DRUGBANK	DB00477	C17H19ClN2S	small molecule	N05AA01	50-53-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPEIMTDSQAKGNT-UHFFFAOYSA-N
7368	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	negative modulator	target	Payvandi F (2004)	15598423	176374	472	Lenalidomide	1-oxo-2-(2,6-Dioxopiperidin-3-yl)-4-aminoisoindoline|IMid-1|CC-5013|IMiD3|Revlimid|3-(4-Amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione|CDC 501	revlimid	DRUGBANK	DB00480	C13H13N3O3	small molecule	L04AX04	191732-72-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GOTYRUGSSMKFNF-UHFFFAOYSA-N
7369	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	negative modulator	target	Zeldis JB (2003)	12720152	176373	472	Lenalidomide	1-oxo-2-(2,6-Dioxopiperidin-3-yl)-4-aminoisoindoline|IMid-1|CC-5013|IMiD3|Revlimid|3-(4-Amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione|CDC 501	revlimid	DRUGBANK	DB00480	C13H13N3O3	small molecule	L04AX04	191732-72-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GOTYRUGSSMKFNF-UHFFFAOYSA-N
7390	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	474	Celecoxib	P-(5-P-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide|Celecoxibum|Celecoxib|Celebrex|Clcoxib	lupin-celecoxib|bio-celecoxib|	DRUGBANK	DB00482	C17H14F3N3O2S	small molecule	L01XX33|M01AH01	169590-42-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZEKVGVHFLEQIL-UHFFFAOYSA-N
7391	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Ahmad SR (2002)	12093311	176398	474	Celecoxib	P-(5-P-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide|Celecoxibum|Celecoxib|Celebrex|Clcoxib	lupin-celecoxib|bio-celecoxib|	DRUGBANK	DB00482	C17H14F3N3O2S	small molecule	L01XX33|M01AH01	169590-42-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZEKVGVHFLEQIL-UHFFFAOYSA-N
7392	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Scheiman JM (2002)	12086292	176394	474	Celecoxib	P-(5-P-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide|Celecoxibum|Celecoxib|Celebrex|Clcoxib	lupin-celecoxib|bio-celecoxib|	DRUGBANK	DB00482	C17H14F3N3O2S	small molecule	L01XX33|M01AH01	169590-42-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZEKVGVHFLEQIL-UHFFFAOYSA-N
7393	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Reddy BS (2002)	12086402	176395	474	Celecoxib	P-(5-P-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide|Celecoxibum|Celecoxib|Celebrex|Clcoxib	lupin-celecoxib|bio-celecoxib|	DRUGBANK	DB00482	C17H14F3N3O2S	small molecule	L01XX33|M01AH01	169590-42-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZEKVGVHFLEQIL-UHFFFAOYSA-N
7394	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Lu S (2002)	12104042	176396	474	Celecoxib	P-(5-P-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide|Celecoxibum|Celecoxib|Celebrex|Clcoxib	lupin-celecoxib|bio-celecoxib|	DRUGBANK	DB00482	C17H14F3N3O2S	small molecule	L01XX33|M01AH01	169590-42-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZEKVGVHFLEQIL-UHFFFAOYSA-N
7395	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Sigthorsson G (2002)	12055598	176397	474	Celecoxib	P-(5-P-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide|Celecoxibum|Celecoxib|Celebrex|Clcoxib	lupin-celecoxib|bio-celecoxib|	DRUGBANK	DB00482	C17H14F3N3O2S	small molecule	L01XX33|M01AH01	169590-42-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZEKVGVHFLEQIL-UHFFFAOYSA-N
7460	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Malt EA (2003)	12781354	176464	482	Buspirone	Buspirone|Buspirona|Buspironum|Buspiron|8-(4-(4-(2-Pyrimidinyl)-1-piperizinyl)butyl)-8-azaspiro(4,5)decane-7,9-dione	ftp-buspirone|pms-buspirone|ri	DRUGBANK	DB00490	C21H31N5O2	small molecule	N05BE01	36505-84-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWCRAEMEVRGPNT-UHFFFAOYSA-N
7461	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Nader MA (1993)	11224194	176462	482	Buspirone	Buspirone|Buspirona|Buspironum|Buspiron|8-(4-(4-(2-Pyrimidinyl)-1-piperizinyl)butyl)-8-azaspiro(4,5)decane-7,9-dione	ftp-buspirone|pms-buspirone|ri	DRUGBANK	DB00490	C21H31N5O2	small molecule	N05BE01	36505-84-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWCRAEMEVRGPNT-UHFFFAOYSA-N
7462	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Fernandez-Perez S (2005)	16214127	176463	482	Buspirone	Buspirone|Buspirona|Buspironum|Buspiron|8-(4-(4-(2-Pyrimidinyl)-1-piperizinyl)butyl)-8-azaspiro(4,5)decane-7,9-dione	ftp-buspirone|pms-buspirone|ri	DRUGBANK	DB00490	C21H31N5O2	small molecule	N05BE01	36505-84-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWCRAEMEVRGPNT-UHFFFAOYSA-N
7463	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Pache DM (2003)	14522358	176460	482	Buspirone	Buspirone|Buspirona|Buspironum|Buspiron|8-(4-(4-(2-Pyrimidinyl)-1-piperizinyl)butyl)-8-azaspiro(4,5)decane-7,9-dione	ftp-buspirone|pms-buspirone|ri	DRUGBANK	DB00490	C21H31N5O2	small molecule	N05BE01	36505-84-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWCRAEMEVRGPNT-UHFFFAOYSA-N
7464	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Boido A (2001)	11421254	176461	482	Buspirone	Buspirone|Buspirona|Buspironum|Buspiron|8-(4-(4-(2-Pyrimidinyl)-1-piperizinyl)butyl)-8-azaspiro(4,5)decane-7,9-dione	ftp-buspirone|pms-buspirone|ri	DRUGBANK	DB00490	C21H31N5O2	small molecule	N05BE01	36505-84-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWCRAEMEVRGPNT-UHFFFAOYSA-N
7479	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Ondetti MA (1988)	2836111	176471	484	Fosinopril	Fosinopril|(2S,4S)-4-Cyclohexyl-1-{2-[(2-methyl-1-propionyloxy-propoxy)-(4-phenyl-butyl)-phosphinoyl]-acetyl}-pyrrolidine-2-carboxylic acid|(S)-4-Cyclohexyl-1-{2-[(2-methyl-1-propionyloxy-propoxy)-(4-phenyl-butyl)-phosphinoyl]-acetyl}-pyrrolidine-2-carboxylic acid|(2S,4S)-4-Cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid	ava-fosinopril|fosinopril-20|r	DRUGBANK	DB00492	C30H46NO7P	small molecule	C09AA09|C09BA09	98048-97-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BIDNLKIUORFRQP-FKDWWROVSA-N
7480	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Piepho RW (2000)	11030016	174112	484	Fosinopril	Fosinopril|(2S,4S)-4-Cyclohexyl-1-{2-[(2-methyl-1-propionyloxy-propoxy)-(4-phenyl-butyl)-phosphinoyl]-acetyl}-pyrrolidine-2-carboxylic acid|(S)-4-Cyclohexyl-1-{2-[(2-methyl-1-propionyloxy-propoxy)-(4-phenyl-butyl)-phosphinoyl]-acetyl}-pyrrolidine-2-carboxylic acid|(2S,4S)-4-Cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid	ava-fosinopril|fosinopril-20|r	DRUGBANK	DB00492	C30H46NO7P	small molecule	C09AA09|C09BA09	98048-97-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BIDNLKIUORFRQP-FKDWWROVSA-N
7481	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	484	Fosinopril	Fosinopril|(2S,4S)-4-Cyclohexyl-1-{2-[(2-methyl-1-propionyloxy-propoxy)-(4-phenyl-butyl)-phosphinoyl]-acetyl}-pyrrolidine-2-carboxylic acid|(S)-4-Cyclohexyl-1-{2-[(2-methyl-1-propionyloxy-propoxy)-(4-phenyl-butyl)-phosphinoyl]-acetyl}-pyrrolidine-2-carboxylic acid|(2S,4S)-4-Cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid	ava-fosinopril|fosinopril-20|r	DRUGBANK	DB00492	C30H46NO7P	small molecule	C09AA09|C09BA09	98048-97-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BIDNLKIUORFRQP-FKDWWROVSA-N
7482	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Sharma S (1999)	11329095	176470	484	Fosinopril	Fosinopril|(2S,4S)-4-Cyclohexyl-1-{2-[(2-methyl-1-propionyloxy-propoxy)-(4-phenyl-butyl)-phosphinoyl]-acetyl}-pyrrolidine-2-carboxylic acid|(S)-4-Cyclohexyl-1-{2-[(2-methyl-1-propionyloxy-propoxy)-(4-phenyl-butyl)-phosphinoyl]-acetyl}-pyrrolidine-2-carboxylic acid|(2S,4S)-4-Cyclohexyl-1-[2-[(2-methyl-1-propanoyloxypropoxy)-(4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid	ava-fosinopril|fosinopril-20|r	DRUGBANK	DB00492	C30H46NO7P	small molecule	C09AA09|C09BA09	98048-97-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BIDNLKIUORFRQP-FKDWWROVSA-N
7533	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Kennedy JH (2003)	14613550	176516	492	Tolmetin	Tolmetina|1-Methyl-5-(4-methylbenzoyl)-pyrrole-2-acetic acid|Tolmetino|5-(P-Toluoyl)-1-methylpyrrole-2-acetic acid|1-Methyl-5-P-toluoylpyrrole-2-acetic acid|Tolmetin|Tolmtine|Tolmetinum	tolectin 400 cap 400mg|tolmeti	DRUGBANK	DB00500	C15H15NO3	small molecule	M01AB03|M02AA21	26171-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UPSPUYADGBWSHF-UHFFFAOYSA-N
7534	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Burdan F (2005)	16182428	176517	492	Tolmetin	Tolmetina|1-Methyl-5-(4-methylbenzoyl)-pyrrole-2-acetic acid|Tolmetino|5-(P-Toluoyl)-1-methylpyrrole-2-acetic acid|1-Methyl-5-P-toluoylpyrrole-2-acetic acid|Tolmetin|Tolmtine|Tolmetinum	tolectin 400 cap 400mg|tolmeti	DRUGBANK	DB00500	C15H15NO3	small molecule	M01AB03|M02AA21	26171-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UPSPUYADGBWSHF-UHFFFAOYSA-N
7535	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Capasso A (1997)	9253954	176515	492	Tolmetin	Tolmetina|1-Methyl-5-(4-methylbenzoyl)-pyrrole-2-acetic acid|Tolmetino|5-(P-Toluoyl)-1-methylpyrrole-2-acetic acid|1-Methyl-5-P-toluoylpyrrole-2-acetic acid|Tolmetin|Tolmtine|Tolmetinum	tolectin 400 cap 400mg|tolmeti	DRUGBANK	DB00500	C15H15NO3	small molecule	M01AB03|M02AA21	26171-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UPSPUYADGBWSHF-UHFFFAOYSA-N
7536	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Capasso A (1999)	10465690	176518	492	Tolmetin	Tolmetina|1-Methyl-5-(4-methylbenzoyl)-pyrrole-2-acetic acid|Tolmetino|5-(P-Toluoyl)-1-methylpyrrole-2-acetic acid|1-Methyl-5-P-toluoylpyrrole-2-acetic acid|Tolmetin|Tolmtine|Tolmetinum	tolectin 400 cap 400mg|tolmeti	DRUGBANK	DB00500	C15H15NO3	small molecule	M01AB03|M02AA21	26171-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UPSPUYADGBWSHF-UHFFFAOYSA-N
7537	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	492	Tolmetin	Tolmetina|1-Methyl-5-(4-methylbenzoyl)-pyrrole-2-acetic acid|Tolmetino|5-(P-Toluoyl)-1-methylpyrrole-2-acetic acid|1-Methyl-5-P-toluoylpyrrole-2-acetic acid|Tolmetin|Tolmtine|Tolmetinum	tolectin 400 cap 400mg|tolmeti	DRUGBANK	DB00500	C15H15NO3	small molecule	M01AB03|M02AA21	26171-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UPSPUYADGBWSHF-UHFFFAOYSA-N
7538	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Kennedy JH (2003)	14613550	176516	492	Tolmetin	Tolmetina|1-Methyl-5-(4-methylbenzoyl)-pyrrole-2-acetic acid|Tolmetino|5-(P-Toluoyl)-1-methylpyrrole-2-acetic acid|1-Methyl-5-P-toluoylpyrrole-2-acetic acid|Tolmetin|Tolmtine|Tolmetinum	tolectin 400 cap 400mg|tolmeti	DRUGBANK	DB00500	C15H15NO3	small molecule	M01AB03|M02AA21	26171-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UPSPUYADGBWSHF-UHFFFAOYSA-N
7539	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Capasso A (1997)	9253954	176515	492	Tolmetin	Tolmetina|1-Methyl-5-(4-methylbenzoyl)-pyrrole-2-acetic acid|Tolmetino|5-(P-Toluoyl)-1-methylpyrrole-2-acetic acid|1-Methyl-5-P-toluoylpyrrole-2-acetic acid|Tolmetin|Tolmtine|Tolmetinum	tolectin 400 cap 400mg|tolmeti	DRUGBANK	DB00500	C15H15NO3	small molecule	M01AB03|M02AA21	26171-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UPSPUYADGBWSHF-UHFFFAOYSA-N
7540	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Burdan F (2004)	15458776	176519	492	Tolmetin	Tolmetina|1-Methyl-5-(4-methylbenzoyl)-pyrrole-2-acetic acid|Tolmetino|5-(P-Toluoyl)-1-methylpyrrole-2-acetic acid|1-Methyl-5-P-toluoylpyrrole-2-acetic acid|Tolmetin|Tolmtine|Tolmetinum	tolectin 400 cap 400mg|tolmeti	DRUGBANK	DB00500	C15H15NO3	small molecule	M01AB03|M02AA21	26171-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UPSPUYADGBWSHF-UHFFFAOYSA-N
7541	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Capasso A (1999)	10465690	176518	492	Tolmetin	Tolmetina|1-Methyl-5-(4-methylbenzoyl)-pyrrole-2-acetic acid|Tolmetino|5-(P-Toluoyl)-1-methylpyrrole-2-acetic acid|1-Methyl-5-P-toluoylpyrrole-2-acetic acid|Tolmetin|Tolmtine|Tolmetinum	tolectin 400 cap 400mg|tolmeti	DRUGBANK	DB00500	C15H15NO3	small molecule	M01AB03|M02AA21	26171-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UPSPUYADGBWSHF-UHFFFAOYSA-N
7542	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Kirkova M (2007)	17391279	176520	492	Tolmetin	Tolmetina|1-Methyl-5-(4-methylbenzoyl)-pyrrole-2-acetic acid|Tolmetino|5-(P-Toluoyl)-1-methylpyrrole-2-acetic acid|1-Methyl-5-P-toluoylpyrrole-2-acetic acid|Tolmetin|Tolmtine|Tolmetinum	tolectin 400 cap 400mg|tolmeti	DRUGBANK	DB00500	C15H15NO3	small molecule	M01AB03|M02AA21	26171-23-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UPSPUYADGBWSHF-UHFFFAOYSA-N
7547	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	inverse agonist	target	Tadori Y (2008)	18831971	176538	494	Haloperidol	1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine|Haloperidolum|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one|4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone|gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone|4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone|Haldol	apo-haloperidol tab 2mg|teva-h	DRUGBANK	DB00502	C21H23ClFNO2	small molecule	N05AD01	52-86-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNEPOXFFQSENCJ-UHFFFAOYSA-N
7548	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	inverse agonist	target	Leysen JE (1994)	7520908	175510	494	Haloperidol	1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine|Haloperidolum|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one|4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone|gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone|4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone|Haldol	apo-haloperidol tab 2mg|teva-h	DRUGBANK	DB00502	C21H23ClFNO2	small molecule	N05AD01	52-86-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNEPOXFFQSENCJ-UHFFFAOYSA-N
7549	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	inverse agonist	target	Malmberg (1998)	9536001	176535	494	Haloperidol	1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine|Haloperidolum|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one|4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone|gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone|4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone|Haldol	apo-haloperidol tab 2mg|teva-h	DRUGBANK	DB00502	C21H23ClFNO2	small molecule	N05AD01	52-86-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNEPOXFFQSENCJ-UHFFFAOYSA-N
7550	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	inverse agonist	target	Tuppurainen H (2009)	19496999	176536	494	Haloperidol	1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine|Haloperidolum|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one|4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone|gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone|4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone|Haldol	apo-haloperidol tab 2mg|teva-h	DRUGBANK	DB00502	C21H23ClFNO2	small molecule	N05AD01	52-86-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNEPOXFFQSENCJ-UHFFFAOYSA-N
7551	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	inverse agonist	target	Kessler RM (2005)	16123775	176537	494	Haloperidol	1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine|Haloperidolum|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one|4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone|gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone|4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone|Haldol	apo-haloperidol tab 2mg|teva-h	DRUGBANK	DB00502	C21H23ClFNO2	small molecule	N05AD01	52-86-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNEPOXFFQSENCJ-UHFFFAOYSA-N
7552	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	494	Haloperidol	1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine|Haloperidolum|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one|4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone|gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone|4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone|Haldol	apo-haloperidol tab 2mg|teva-h	DRUGBANK	DB00502	C21H23ClFNO2	small molecule	N05AD01	52-86-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNEPOXFFQSENCJ-UHFFFAOYSA-N
7553	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Leysen JE (1994)	7520908	175510	494	Haloperidol	1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine|Haloperidolum|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one|4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone|gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone|4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone|Haldol	apo-haloperidol tab 2mg|teva-h	DRUGBANK	DB00502	C21H23ClFNO2	small molecule	N05AD01	52-86-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNEPOXFFQSENCJ-UHFFFAOYSA-N
7554	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Seeman P (2010)	20643630	176352	494	Haloperidol	1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine|Haloperidolum|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one|4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone|gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone|4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone|Haldol	apo-haloperidol tab 2mg|teva-h	DRUGBANK	DB00502	C21H23ClFNO2	small molecule	N05AD01	52-86-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNEPOXFFQSENCJ-UHFFFAOYSA-N
7555	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Bustillo J (2006)	16132064	176540	494	Haloperidol	1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine|Haloperidolum|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one|4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone|gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone|4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone|Haldol	apo-haloperidol tab 2mg|teva-h	DRUGBANK	DB00502	C21H23ClFNO2	small molecule	N05AD01	52-86-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNEPOXFFQSENCJ-UHFFFAOYSA-N
7556	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Osinski MA (2005)	15894081	176541	494	Haloperidol	1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine|Haloperidolum|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one|4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone|gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone|4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone|Haldol	apo-haloperidol tab 2mg|teva-h	DRUGBANK	DB00502	C21H23ClFNO2	small molecule	N05AD01	52-86-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNEPOXFFQSENCJ-UHFFFAOYSA-N
7557	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Ishiwata K (2006)	17134027	176539	494	Haloperidol	1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine|Haloperidolum|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one|4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone|gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone|4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone|Haldol	apo-haloperidol tab 2mg|teva-h	DRUGBANK	DB00502	C21H23ClFNO2	small molecule	N05AD01	52-86-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNEPOXFFQSENCJ-UHFFFAOYSA-N
7558	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Naiker DV (2006)	16730699	175316	494	Haloperidol	1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine|Haloperidolum|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one|4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone|gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone|4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone|Haldol	apo-haloperidol tab 2mg|teva-h	DRUGBANK	DB00502	C21H23ClFNO2	small molecule	N05AD01	52-86-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNEPOXFFQSENCJ-UHFFFAOYSA-N
7559	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Uchida S (2007)	17316700	175303	494	Haloperidol	1-(3-P-Fluorobenzoylpropyl)-4-P-chlorophenyl-4-hydroxypiperidine|Haloperidolum|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one|4'-Fluoro-4-(4-(P-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone|gamma-(4-(P-Chlorophenyl)-4-hydroxpiperidino)-P-fluorbutyrophenone|4-(4-(Para-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone|Haldol	apo-haloperidol tab 2mg|teva-h	DRUGBANK	DB00502	C21H23ClFNO2	small molecule	N05AD01	52-86-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNEPOXFFQSENCJ-UHFFFAOYSA-N
7591	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	499	Triflupromazine	Fluopromazine|Triflupromazine|2-Trifluoromethyl-10-(gamma-dimethylaminopropyl)phenothiazine|Triflupromazinum|Triflupromazina|2-(Trifluoromethyl)promazine|Triflupromazin|10-(3-(Dimethylamino)propyl)-2-(trifluoromethyl)phenothiazine	-	DRUGBANK	DB00508	C18H19F3N2S	small molecule	N05AA05	146-54-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSCGXQMFQXDFCW-UHFFFAOYSA-N
7592	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	499	Triflupromazine	Fluopromazine|Triflupromazine|2-Trifluoromethyl-10-(gamma-dimethylaminopropyl)phenothiazine|Triflupromazinum|Triflupromazina|2-(Trifluoromethyl)promazine|Triflupromazin|10-(3-(Dimethylamino)propyl)-2-(trifluoromethyl)phenothiazine	-	DRUGBANK	DB00508	C18H19F3N2S	small molecule	N05AA05	146-54-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XSCGXQMFQXDFCW-UHFFFAOYSA-N
7682	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Piepho RW (2000)	11030016	174112	509	Trandolapril	Trandolaprilum|Mavik	tarka|mavik|trandolapril and v	DRUGBANK	DB00519	C24H34N2O5	small molecule	C09AA10|C09BB10	87679-37-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VXFJYXUZANRPDJ-WTNASJBWSA-N
7683	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Song JC (2002)	11929321	174114	509	Trandolapril	Trandolaprilum|Mavik	tarka|mavik|trandolapril and v	DRUGBANK	DB00519	C24H34N2O5	small molecule	C09AA10|C09BB10	87679-37-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VXFJYXUZANRPDJ-WTNASJBWSA-N
7684	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	509	Trandolapril	Trandolaprilum|Mavik	tarka|mavik|trandolapril and v	DRUGBANK	DB00519	C24H34N2O5	small molecule	C09AA10|C09BB10	87679-37-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VXFJYXUZANRPDJ-WTNASJBWSA-N
7774	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Malmstrom K (1999)	10566562	176707	523	Rofecoxib	-	vioxx tab 25mg|vioxx suspensio	DRUGBANK	DB00533	C17H14O4S	small molecule	M01AH02	162011-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZJQGNCSTQAWON-UHFFFAOYSA-N
7775	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Matheson AJ (2001)	11398914	176706	523	Rofecoxib	-	vioxx tab 25mg|vioxx suspensio	DRUGBANK	DB00533	C17H14O4S	small molecule	M01AH02	162011-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZJQGNCSTQAWON-UHFFFAOYSA-N
7776	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Langman MJ (1999)	10580458	176705	523	Rofecoxib	-	vioxx tab 25mg|vioxx suspensio	DRUGBANK	DB00533	C17H14O4S	small molecule	M01AH02	162011-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZJQGNCSTQAWON-UHFFFAOYSA-N
7777	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chakraborti AK (2010)	20166930	176704	523	Rofecoxib	-	vioxx tab 25mg|vioxx suspensio	DRUGBANK	DB00533	C17H14O4S	small molecule	M01AH02	162011-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZJQGNCSTQAWON-UHFFFAOYSA-N
7778	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Ashok V (2011)	20724158	176703	523	Rofecoxib	-	vioxx tab 25mg|vioxx suspensio	DRUGBANK	DB00533	C17H14O4S	small molecule	M01AH02	162011-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZJQGNCSTQAWON-UHFFFAOYSA-N
7779	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Baron JA (2008)	18922570	176702	523	Rofecoxib	-	vioxx tab 25mg|vioxx suspensio	DRUGBANK	DB00533	C17H14O4S	small molecule	M01AH02	162011-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZJQGNCSTQAWON-UHFFFAOYSA-N
7780	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	523	Rofecoxib	-	vioxx tab 25mg|vioxx suspensio	DRUGBANK	DB00533	C17H14O4S	small molecule	M01AH02	162011-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZJQGNCSTQAWON-UHFFFAOYSA-N
7781	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Pascucci RA (1999)	10643177	176709	523	Rofecoxib	-	vioxx tab 25mg|vioxx suspensio	DRUGBANK	DB00533	C17H14O4S	small molecule	M01AH02	162011-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZJQGNCSTQAWON-UHFFFAOYSA-N
7782	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Hawkey C (2000)	10693877	176708	523	Rofecoxib	-	vioxx tab 25mg|vioxx suspensio	DRUGBANK	DB00533	C17H14O4S	small molecule	M01AH02	162011-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZJQGNCSTQAWON-UHFFFAOYSA-N
7783	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Ehrich EW (1999)	10555907	176710	523	Rofecoxib	-	vioxx tab 25mg|vioxx suspensio	DRUGBANK	DB00533	C17H14O4S	small molecule	M01AH02	162011-90-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RZJQGNCSTQAWON-UHFFFAOYSA-N
7848	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Peroutka SJ (1982)	6121969	176755	530	Nortriptyline	Ateben|Demethylamitriptyline|Noritren|Avantyl|Nortriptyline|Psychostyl|Desmethylamitriptyline|3-(10,11-dihydro-5H-Dibenzo[a,D]cyclohepten-5-ylidene)-N-methyl-1-propanamine|Sensaval|10,11-dihydro-N-Methyl-5H-dibenzo[a,D]cycloheptene-delta(5,gamma)-propylamine|Aventyl	nu-nortriptyline - cap 25mg|pa	DRUGBANK	DB00540	C19H21N	small molecule	N06AA10	72-69-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHVGLTMQBUFIQQ-UHFFFAOYSA-N
7861	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	532	Benazepril	Benazeprilum|Benazepril|1H-1-Benzazepine-1-acetic acid, 3-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-2,3,4,5-tetrahydro-2-oxo-, (S-(r*,r*))-	amlodipine and benazepril hydr	DRUGBANK	DB00542	C24H28N2O5	small molecule	C09AA07|C09BA07	86541-75-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XPCFTKFZXHTYIP-PMACEKPBSA-N
7862	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Song JC (2002)	11929321	174114	532	Benazepril	Benazeprilum|Benazepril|1H-1-Benzazepine-1-acetic acid, 3-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-2,3,4,5-tetrahydro-2-oxo-, (S-(r*,r*))-	amlodipine and benazepril hydr	DRUGBANK	DB00542	C24H28N2O5	small molecule	C09AA07|C09BA07	86541-75-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XPCFTKFZXHTYIP-PMACEKPBSA-N
7863	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	antagonist	target	Burstein ES (2005)	16135699	176776	533	Amoxapine	2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum	asendin tab 25mg|asendin - tab	DRUGBANK	DB00543	C17H16ClN3O	small molecule	N06AA17	14028-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWGDMFLQWFTERH-UHFFFAOYSA-N
7873	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	antagonist	target	Burstein ES (2005)	16135699	176776	533	Amoxapine	2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum	asendin tab 25mg|asendin - tab	DRUGBANK	DB00543	C17H16ClN3O	small molecule	N06AA17	14028-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWGDMFLQWFTERH-UHFFFAOYSA-N
7894	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Nasu R (2000)	11180191	176779	533	Amoxapine	2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum	asendin tab 25mg|asendin - tab	DRUGBANK	DB00543	C17H16ClN3O	small molecule	N06AA17	14028-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWGDMFLQWFTERH-UHFFFAOYSA-N
7895	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Wei HB (1990)	1966571	176782	533	Amoxapine	2-Chloro-11-(1-piperazinyl)dibenz(b,F)(1,4)oxazepine|Amoxapina|Amoxapin|Amoxepine|Desmethylloxapin|Amoxapinum	asendin tab 25mg|asendin - tab	DRUGBANK	DB00543	C17H16ClN3O	small molecule	N06AA17	14028-44-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWGDMFLQWFTERH-UHFFFAOYSA-N
7987	116014	10800	-	CYSLTR1	CYSLT1|CYSLT1R|CYSLTR|HMTMF81	9606	Homo sapiens	antagonist	target	Wang S (2000)	11006272	176822	539	Zafirlukast	Cyclopentyl 3-(2-methoxy-4-((O-tolylsulfonyl)carbamoyl)benzyl)-1-methylindole-5-carbamate|Accolate|4-(5-Cyclopentyloxycarbonylamino-1-methyl-1H-indol-3-ylmethyl)-3-methoxy-N-O-tolylsulfonylbenzamide|ICI-204,219	accolate|zafirlukast|accolate 	DRUGBANK	DB00549	C31H33N3O6S	small molecule	R03DC01	107753-78-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YEEZWCHGZNKEEK-UHFFFAOYSA-N
7988	116014	10800	-	CYSLTR1	CYSLT1|CYSLT1R|CYSLTR|HMTMF81	9606	Homo sapiens	antagonist	target	Cazzola M (2000)	11061985	176823	539	Zafirlukast	Cyclopentyl 3-(2-methoxy-4-((O-tolylsulfonyl)carbamoyl)benzyl)-1-methylindole-5-carbamate|Accolate|4-(5-Cyclopentyloxycarbonylamino-1-methyl-1H-indol-3-ylmethyl)-3-methoxy-N-O-tolylsulfonylbenzamide|ICI-204,219	accolate|zafirlukast|accolate 	DRUGBANK	DB00549	C31H33N3O6S	small molecule	R03DC01	107753-78-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YEEZWCHGZNKEEK-UHFFFAOYSA-N
7989	116014	10800	-	CYSLTR1	CYSLT1|CYSLT1R|CYSLTR|HMTMF81	9606	Homo sapiens	antagonist	target	O'Byrne PM (1997)	9042024	176820	539	Zafirlukast	Cyclopentyl 3-(2-methoxy-4-((O-tolylsulfonyl)carbamoyl)benzyl)-1-methylindole-5-carbamate|Accolate|4-(5-Cyclopentyloxycarbonylamino-1-methyl-1H-indol-3-ylmethyl)-3-methoxy-N-O-tolylsulfonylbenzamide|ICI-204,219	accolate|zafirlukast|accolate 	DRUGBANK	DB00549	C31H33N3O6S	small molecule	R03DC01	107753-78-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YEEZWCHGZNKEEK-UHFFFAOYSA-N
7990	116014	10800	-	CYSLTR1	CYSLT1|CYSLT1R|CYSLTR|HMTMF81	9606	Homo sapiens	antagonist	target	Murata Y (2002)	11979731	176821	539	Zafirlukast	Cyclopentyl 3-(2-methoxy-4-((O-tolylsulfonyl)carbamoyl)benzyl)-1-methylindole-5-carbamate|Accolate|4-(5-Cyclopentyloxycarbonylamino-1-methyl-1H-indol-3-ylmethyl)-3-methoxy-N-O-tolylsulfonylbenzamide|ICI-204,219	accolate|zafirlukast|accolate 	DRUGBANK	DB00549	C31H33N3O6S	small molecule	R03DC01	107753-78-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YEEZWCHGZNKEEK-UHFFFAOYSA-N
7991	116014	10800	-	CYSLTR1	CYSLT1|CYSLT1R|CYSLTR|HMTMF81	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	539	Zafirlukast	Cyclopentyl 3-(2-methoxy-4-((O-tolylsulfonyl)carbamoyl)benzyl)-1-methylindole-5-carbamate|Accolate|4-(5-Cyclopentyloxycarbonylamino-1-methyl-1H-indol-3-ylmethyl)-3-methoxy-N-O-tolylsulfonylbenzamide|ICI-204,219	accolate|zafirlukast|accolate 	DRUGBANK	DB00549	C31H33N3O6S	small molecule	R03DC01	107753-78-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YEEZWCHGZNKEEK-UHFFFAOYSA-N
7992	116014	10800	-	CYSLTR1	CYSLT1|CYSLT1R|CYSLTR|HMTMF81	9606	Homo sapiens	antagonist	target	Heise CE (2000)	10851239	12727	539	Zafirlukast	Cyclopentyl 3-(2-methoxy-4-((O-tolylsulfonyl)carbamoyl)benzyl)-1-methylindole-5-carbamate|Accolate|4-(5-Cyclopentyloxycarbonylamino-1-methyl-1H-indol-3-ylmethyl)-3-methoxy-N-O-tolylsulfonylbenzamide|ICI-204,219	accolate|zafirlukast|accolate 	DRUGBANK	DB00549	C31H33N3O6S	small molecule	R03DC01	107753-78-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YEEZWCHGZNKEEK-UHFFFAOYSA-N
8007	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Blanco FJ (1999)	10381057	176844	544	Piroxicam	4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazin-3-caboxyamid-1,1-dioxid|Feldene|Pyroxycam|Piroxicam|Piroxicamum	feldene cap 20mg|nu-pirox cap 	DRUGBANK	DB00554	C15H13N3O4S	small molecule	M01AC01|M02AA07|S01BC06	36322-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QYSPLQLAKJAUJT-UHFFFAOYSA-N
8008	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Bugajski J (2001)	11785774	176845	544	Piroxicam	4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazin-3-caboxyamid-1,1-dioxid|Feldene|Pyroxycam|Piroxicam|Piroxicamum	feldene cap 20mg|nu-pirox cap 	DRUGBANK	DB00554	C15H13N3O4S	small molecule	M01AC01|M02AA07|S01BC06	36322-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QYSPLQLAKJAUJT-UHFFFAOYSA-N
8009	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Raju J (2002)	11952155	176846	544	Piroxicam	4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazin-3-caboxyamid-1,1-dioxid|Feldene|Pyroxycam|Piroxicam|Piroxicamum	feldene cap 20mg|nu-pirox cap 	DRUGBANK	DB00554	C15H13N3O4S	small molecule	M01AC01|M02AA07|S01BC06	36322-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QYSPLQLAKJAUJT-UHFFFAOYSA-N
8010	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Veiga AP (2004)	15464832	176843	544	Piroxicam	4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazin-3-caboxyamid-1,1-dioxid|Feldene|Pyroxycam|Piroxicam|Piroxicamum	feldene cap 20mg|nu-pirox cap 	DRUGBANK	DB00554	C15H13N3O4S	small molecule	M01AC01|M02AA07|S01BC06	36322-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QYSPLQLAKJAUJT-UHFFFAOYSA-N
8011	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Fackovcova D (2001)	11153163	176241	544	Piroxicam	4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazin-3-caboxyamid-1,1-dioxid|Feldene|Pyroxycam|Piroxicam|Piroxicamum	feldene cap 20mg|nu-pirox cap 	DRUGBANK	DB00554	C15H13N3O4S	small molecule	M01AC01|M02AA07|S01BC06	36322-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QYSPLQLAKJAUJT-UHFFFAOYSA-N
8012	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	544	Piroxicam	4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazin-3-caboxyamid-1,1-dioxid|Feldene|Pyroxycam|Piroxicam|Piroxicamum	feldene cap 20mg|nu-pirox cap 	DRUGBANK	DB00554	C15H13N3O4S	small molecule	M01AC01|M02AA07|S01BC06	36322-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QYSPLQLAKJAUJT-UHFFFAOYSA-N
8013	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Fackovcova D (2001)	11153163	176241	544	Piroxicam	4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazin-3-caboxyamid-1,1-dioxid|Feldene|Pyroxycam|Piroxicam|Piroxicamum	feldene cap 20mg|nu-pirox cap 	DRUGBANK	DB00554	C15H13N3O4S	small molecule	M01AC01|M02AA07|S01BC06	36322-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QYSPLQLAKJAUJT-UHFFFAOYSA-N
8014	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Blanco FJ (1999)	10381057	176844	544	Piroxicam	4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazin-3-caboxyamid-1,1-dioxid|Feldene|Pyroxycam|Piroxicam|Piroxicamum	feldene cap 20mg|nu-pirox cap 	DRUGBANK	DB00554	C15H13N3O4S	small molecule	M01AC01|M02AA07|S01BC06	36322-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QYSPLQLAKJAUJT-UHFFFAOYSA-N
8015	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Bugajski J (2001)	11785774	176845	544	Piroxicam	4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazin-3-caboxyamid-1,1-dioxid|Feldene|Pyroxycam|Piroxicam|Piroxicamum	feldene cap 20mg|nu-pirox cap 	DRUGBANK	DB00554	C15H13N3O4S	small molecule	M01AC01|M02AA07|S01BC06	36322-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QYSPLQLAKJAUJT-UHFFFAOYSA-N
8016	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Raju J (2002)	11952155	176846	544	Piroxicam	4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazin-3-caboxyamid-1,1-dioxid|Feldene|Pyroxycam|Piroxicam|Piroxicamum	feldene cap 20mg|nu-pirox cap 	DRUGBANK	DB00554	C15H13N3O4S	small molecule	M01AC01|M02AA07|S01BC06	36322-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QYSPLQLAKJAUJT-UHFFFAOYSA-N
8017	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Veiga AP (2004)	15464832	176843	544	Piroxicam	4-Hydroxy-2-methyl-N-(2-pyridyl)-2H-1,2-benzothiazin-3-caboxyamid-1,1-dioxid|Feldene|Pyroxycam|Piroxicam|Piroxicamum	feldene cap 20mg|nu-pirox cap 	DRUGBANK	DB00554	C15H13N3O4S	small molecule	M01AC01|M02AA07|S01BC06	36322-90-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QYSPLQLAKJAUJT-UHFFFAOYSA-N
8027	108231	1909	-	EDNRA	ET-A|ETA|ETA-R|ETAR|ETRA|hET-AR	9606	Homo sapiens	antagonist	target	Kramp R (2001)	11704565	176862	549	Bosentan	4-(1,1-Dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl) benzenesulfornamide|bosentn|p-tert-Butyl-N-(6-(2-hydroxyethoxy)-5-(o-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl)benzenesulfonamide|bosentan|bosentanum	ipg-bosentan|tracleer|mylan-bo	DRUGBANK	DB00559	C27H29N5O6S	small molecule	C02KX01	147536-97-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJPICJJJRGTNOD-UHFFFAOYSA-N
8028	108231	1909	-	EDNRA	ET-A|ETA|ETA-R|ETAR|ETRA|hET-AR	9606	Homo sapiens	antagonist	target	Kiowski W (2001)	11447307	176863	549	Bosentan	4-(1,1-Dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl) benzenesulfornamide|bosentn|p-tert-Butyl-N-(6-(2-hydroxyethoxy)-5-(o-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl)benzenesulfonamide|bosentan|bosentanum	ipg-bosentan|tracleer|mylan-bo	DRUGBANK	DB00559	C27H29N5O6S	small molecule	C02KX01	147536-97-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJPICJJJRGTNOD-UHFFFAOYSA-N
8029	108231	1909	-	EDNRA	ET-A|ETA|ETA-R|ETAR|ETRA|hET-AR	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	549	Bosentan	4-(1,1-Dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl) benzenesulfornamide|bosentn|p-tert-Butyl-N-(6-(2-hydroxyethoxy)-5-(o-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl)benzenesulfonamide|bosentan|bosentanum	ipg-bosentan|tracleer|mylan-bo	DRUGBANK	DB00559	C27H29N5O6S	small molecule	C02KX01	147536-97-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJPICJJJRGTNOD-UHFFFAOYSA-N
8030	108231	1909	-	EDNRA	ET-A|ETA|ETA-R|ETAR|ETRA|hET-AR	9606	Homo sapiens	antagonist	target	Sihvola RK (2002)	11849873	176861	549	Bosentan	4-(1,1-Dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl) benzenesulfornamide|bosentn|p-tert-Butyl-N-(6-(2-hydroxyethoxy)-5-(o-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl)benzenesulfonamide|bosentan|bosentanum	ipg-bosentan|tracleer|mylan-bo	DRUGBANK	DB00559	C27H29N5O6S	small molecule	C02KX01	147536-97-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJPICJJJRGTNOD-UHFFFAOYSA-N
8031	108231	1909	-	EDNRA	ET-A|ETA|ETA-R|ETAR|ETRA|hET-AR	9606	Homo sapiens	antagonist	target	Martin C (2000)	10961375	176864	549	Bosentan	4-(1,1-Dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl) benzenesulfornamide|bosentn|p-tert-Butyl-N-(6-(2-hydroxyethoxy)-5-(o-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl)benzenesulfonamide|bosentan|bosentanum	ipg-bosentan|tracleer|mylan-bo	DRUGBANK	DB00559	C27H29N5O6S	small molecule	C02KX01	147536-97-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJPICJJJRGTNOD-UHFFFAOYSA-N
8032	108231	1909	-	EDNRA	ET-A|ETA|ETA-R|ETAR|ETRA|hET-AR	9606	Homo sapiens	antagonist	target	Albertini M (2001)	11728166	176865	549	Bosentan	4-(1,1-Dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl) benzenesulfornamide|bosentn|p-tert-Butyl-N-(6-(2-hydroxyethoxy)-5-(o-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl)benzenesulfonamide|bosentan|bosentanum	ipg-bosentan|tracleer|mylan-bo	DRUGBANK	DB00559	C27H29N5O6S	small molecule	C02KX01	147536-97-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJPICJJJRGTNOD-UHFFFAOYSA-N
8033	108232	1910	RP11-318G21.1	EDNRB	ABCDS|ET-B|ET-BR|ETB|ETBR|ETRB|HSCR|HSCR2|WS4A	9606	Homo sapiens	antagonist	target	Richard V (1994)	7858879	176868	549	Bosentan	4-(1,1-Dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl) benzenesulfornamide|bosentn|p-tert-Butyl-N-(6-(2-hydroxyethoxy)-5-(o-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl)benzenesulfonamide|bosentan|bosentanum	ipg-bosentan|tracleer|mylan-bo	DRUGBANK	DB00559	C27H29N5O6S	small molecule	C02KX01	147536-97-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJPICJJJRGTNOD-UHFFFAOYSA-N
8034	108232	1910	RP11-318G21.1	EDNRB	ABCDS|ET-B|ET-BR|ETB|ETBR|ETRB|HSCR|HSCR2|WS4A	9606	Homo sapiens	antagonist	target	Marano G (1998)	9806221	176869	549	Bosentan	4-(1,1-Dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl) benzenesulfornamide|bosentn|p-tert-Butyl-N-(6-(2-hydroxyethoxy)-5-(o-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl)benzenesulfonamide|bosentan|bosentanum	ipg-bosentan|tracleer|mylan-bo	DRUGBANK	DB00559	C27H29N5O6S	small molecule	C02KX01	147536-97-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJPICJJJRGTNOD-UHFFFAOYSA-N
8035	108232	1910	RP11-318G21.1	EDNRB	ABCDS|ET-B|ET-BR|ETB|ETBR|ETRB|HSCR|HSCR2|WS4A	9606	Homo sapiens	antagonist	target	Gardiner SM (1994)	7921608	176870	549	Bosentan	4-(1,1-Dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl) benzenesulfornamide|bosentn|p-tert-Butyl-N-(6-(2-hydroxyethoxy)-5-(o-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl)benzenesulfonamide|bosentan|bosentanum	ipg-bosentan|tracleer|mylan-bo	DRUGBANK	DB00559	C27H29N5O6S	small molecule	C02KX01	147536-97-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJPICJJJRGTNOD-UHFFFAOYSA-N
8036	108232	1910	RP11-318G21.1	EDNRB	ABCDS|ET-B|ET-BR|ETB|ETBR|ETRB|HSCR|HSCR2|WS4A	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	549	Bosentan	4-(1,1-Dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl) benzenesulfornamide|bosentn|p-tert-Butyl-N-(6-(2-hydroxyethoxy)-5-(o-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl)benzenesulfonamide|bosentan|bosentanum	ipg-bosentan|tracleer|mylan-bo	DRUGBANK	DB00559	C27H29N5O6S	small molecule	C02KX01	147536-97-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJPICJJJRGTNOD-UHFFFAOYSA-N
8037	108232	1910	RP11-318G21.1	EDNRB	ABCDS|ET-B|ET-BR|ETB|ETBR|ETRB|HSCR|HSCR2|WS4A	9606	Homo sapiens	antagonist	target	Said SA (2005)	15629255	176866	549	Bosentan	4-(1,1-Dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl) benzenesulfornamide|bosentn|p-tert-Butyl-N-(6-(2-hydroxyethoxy)-5-(o-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl)benzenesulfonamide|bosentan|bosentanum	ipg-bosentan|tracleer|mylan-bo	DRUGBANK	DB00559	C27H29N5O6S	small molecule	C02KX01	147536-97-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJPICJJJRGTNOD-UHFFFAOYSA-N
8038	108232	1910	RP11-318G21.1	EDNRB	ABCDS|ET-B|ET-BR|ETB|ETBR|ETRB|HSCR|HSCR2|WS4A	9606	Homo sapiens	antagonist	target	Gupta SK (2005)	16335785	176867	549	Bosentan	4-(1,1-Dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl) benzenesulfornamide|bosentn|p-tert-Butyl-N-(6-(2-hydroxyethoxy)-5-(o-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl)benzenesulfonamide|bosentan|bosentanum	ipg-bosentan|tracleer|mylan-bo	DRUGBANK	DB00559	C27H29N5O6S	small molecule	C02KX01	147536-97-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GJPICJJJRGTNOD-UHFFFAOYSA-N
8099	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	unknown	target	Kuzuhara S (1997)	9014432	176935	558	Cinnarizine	1-Cinnamyl-4-(diphenylmethyl)piperazine|Cinnarizin|1-(Diphenylmethyl)-4-(3-phenyl-2-propenyl)piperazine|Cinnarizine|Cinarizina|1-Benzhydryl-4-cinnamylpiperazin|Cinnarizinum	-	DRUGBANK	DB00568	C26H28N2	small molecule	N07CA02|N07CA52	298-57-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DERZBLKQOCDDDZ-JLHYYAGUSA-N
8100	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	unknown	target	Bruecke T (1995)	7714010	176936	558	Cinnarizine	1-Cinnamyl-4-(diphenylmethyl)piperazine|Cinnarizin|1-(Diphenylmethyl)-4-(3-phenyl-2-propenyl)piperazine|Cinnarizine|Cinarizina|1-Benzhydryl-4-cinnamylpiperazin|Cinnarizinum	-	DRUGBANK	DB00568	C26H28N2	small molecule	N07CA02|N07CA52	298-57-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DERZBLKQOCDDDZ-JLHYYAGUSA-N
8175	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Poggi JC (2006)	17050798	176976	563	Fenoprofen	2-(3-phenoxyphenyl)propionic acid|Fenoprofen|(+/-)-m-phenoxyhydratropic acid|DL-2-(3-phenoxyphenyl)propionic acid|alpha-(m-Phenoxyphenyl)propionic acid|(+/-)-fenoprofen|Fenoprofeno|Fnoprofne|(+-)-2-(3-Phenoxyphenyl)propionic acid|3-phenoxyhydratropic acid|2-(m-phenoxyphenyl)propionic acid|Fenoprofenum|alpha-Methyl-3-phenoxybenzeneacetic acid	nalfon tab 600mg|fenoprofen|na	DRUGBANK	DB00573	C15H14O3	small molecule	M01AE04	29679-58-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RDJGLLICXDHJDY-UHFFFAOYSA-N
8176	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Poggi JC (2006)	17050798	176976	563	Fenoprofen	2-(3-phenoxyphenyl)propionic acid|Fenoprofen|(+/-)-m-phenoxyhydratropic acid|DL-2-(3-phenoxyphenyl)propionic acid|alpha-(m-Phenoxyphenyl)propionic acid|(+/-)-fenoprofen|Fenoprofeno|Fnoprofne|(+-)-2-(3-Phenoxyphenyl)propionic acid|3-phenoxyhydratropic acid|2-(m-phenoxyphenyl)propionic acid|Fenoprofenum|alpha-Methyl-3-phenoxybenzeneacetic acid	nalfon tab 600mg|fenoprofen|na	DRUGBANK	DB00573	C15H14O3	small molecule	M01AE04	29679-58-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RDJGLLICXDHJDY-UHFFFAOYSA-N
8219	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Talley JJ (2000)	10715145	177027	570	Valdecoxib	-	-	DRUGBANK	DB00580	C16H14N2O3S	small molecule	M01AH03	181695-72-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNPDTQAFDNKSHK-UHFFFAOYSA-N
8220	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Hood WF (2003)	12644588	177026	570	Valdecoxib	-	-	DRUGBANK	DB00580	C16H14N2O3S	small molecule	M01AH03	181695-72-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNPDTQAFDNKSHK-UHFFFAOYSA-N
8221	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Jain KK (2000)	11060833	177030	570	Valdecoxib	-	-	DRUGBANK	DB00580	C16H14N2O3S	small molecule	M01AH03	181695-72-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNPDTQAFDNKSHK-UHFFFAOYSA-N
8222	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Gierse JK (2005)	15494548	177031	570	Valdecoxib	-	-	DRUGBANK	DB00580	C16H14N2O3S	small molecule	M01AH03	181695-72-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNPDTQAFDNKSHK-UHFFFAOYSA-N
8223	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	570	Valdecoxib	-	-	DRUGBANK	DB00580	C16H14N2O3S	small molecule	M01AH03	181695-72-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNPDTQAFDNKSHK-UHFFFAOYSA-N
8224	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Tacconelli S (2003)	12564662	177029	570	Valdecoxib	-	-	DRUGBANK	DB00580	C16H14N2O3S	small molecule	M01AH03	181695-72-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNPDTQAFDNKSHK-UHFFFAOYSA-N
8225	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Yuan JJ (2002)	12167567	177028	570	Valdecoxib	-	-	DRUGBANK	DB00580	C16H14N2O3S	small molecule	M01AH03	181695-72-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LNPDTQAFDNKSHK-UHFFFAOYSA-N
8284	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Natesh R (2004)	15236580	177072	574	Enalapril	Enalaprila|Enalaprilum|Enalapril|Analapril|(S)-1-{(S)-2-[1-((S)-ethoxycarbonyl)-3-phenyl-propylamino]-propionyl}-pyrrolidine-2-carboxylic acid|(S)-1-(N-(1-(Ethoxycarbonyl)-3-phenylpropyl)-L-alanyl)-L-proline|1-(N-((S)-1-Carboxy-3-phenylpropyl)-L-alanyl)-L-proline 1'-ethyl ester	riva-enalapril|apo-enalapril t	DRUGBANK	DB00584	C20H28N2O5	small molecule	C09BA02|C09AA02|C09BB02|C09BB06	75847-73-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GBXSMTUPTTWBMN-XIRDDKMYSA-N
8285	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Andujar-Sanchez M (2007)	17618628	177073	574	Enalapril	Enalaprila|Enalaprilum|Enalapril|Analapril|(S)-1-{(S)-2-[1-((S)-ethoxycarbonyl)-3-phenyl-propylamino]-propionyl}-pyrrolidine-2-carboxylic acid|(S)-1-(N-(1-(Ethoxycarbonyl)-3-phenylpropyl)-L-alanyl)-L-proline|1-(N-((S)-1-Carboxy-3-phenylpropyl)-L-alanyl)-L-proline 1'-ethyl ester	riva-enalapril|apo-enalapril t	DRUGBANK	DB00584	C20H28N2O5	small molecule	C09BA02|C09AA02|C09BB02|C09BB06	75847-73-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GBXSMTUPTTWBMN-XIRDDKMYSA-N
8286	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	574	Enalapril	Enalaprila|Enalaprilum|Enalapril|Analapril|(S)-1-{(S)-2-[1-((S)-ethoxycarbonyl)-3-phenyl-propylamino]-propionyl}-pyrrolidine-2-carboxylic acid|(S)-1-(N-(1-(Ethoxycarbonyl)-3-phenylpropyl)-L-alanyl)-L-proline|1-(N-((S)-1-Carboxy-3-phenylpropyl)-L-alanyl)-L-proline 1'-ethyl ester	riva-enalapril|apo-enalapril t	DRUGBANK	DB00584	C20H28N2O5	small molecule	C09BA02|C09AA02|C09BB02|C09BB06	75847-73-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GBXSMTUPTTWBMN-XIRDDKMYSA-N
8287	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Liu YH (2006)	16424790	177074	574	Enalapril	Enalaprila|Enalaprilum|Enalapril|Analapril|(S)-1-{(S)-2-[1-((S)-ethoxycarbonyl)-3-phenyl-propylamino]-propionyl}-pyrrolidine-2-carboxylic acid|(S)-1-(N-(1-(Ethoxycarbonyl)-3-phenylpropyl)-L-alanyl)-L-proline|1-(N-((S)-1-Carboxy-3-phenylpropyl)-L-alanyl)-L-proline 1'-ethyl ester	riva-enalapril|apo-enalapril t	DRUGBANK	DB00584	C20H28N2O5	small molecule	C09BA02|C09AA02|C09BB02|C09BB06	75847-73-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GBXSMTUPTTWBMN-XIRDDKMYSA-N
8294	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Calkin AC (2002)	12414874	177087	576	Diclofenac	2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco	dom-diclofenac|diclofenac sodi	DRUGBANK	DB00586	C14H11Cl2NO2	small molecule	D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05	15307-86-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCOPUUMXTXDBNB-UHFFFAOYSA-N
8295	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Kaempfer H (2003)	12713596	177086	576	Diclofenac	2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco	dom-diclofenac|diclofenac sodi	DRUGBANK	DB00586	C14H11Cl2NO2	small molecule	D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05	15307-86-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCOPUUMXTXDBNB-UHFFFAOYSA-N
8296	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Chavez ML (2003)	12852704	177085	576	Diclofenac	2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco	dom-diclofenac|diclofenac sodi	DRUGBANK	DB00586	C14H11Cl2NO2	small molecule	D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05	15307-86-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCOPUUMXTXDBNB-UHFFFAOYSA-N
8297	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Hinz B (2003)	12966366	177084	576	Diclofenac	2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco	dom-diclofenac|diclofenac sodi	DRUGBANK	DB00586	C14H11Cl2NO2	small molecule	D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05	15307-86-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCOPUUMXTXDBNB-UHFFFAOYSA-N
8298	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Kirchheiner J (2003)	12534640	177083	576	Diclofenac	2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco	dom-diclofenac|diclofenac sodi	DRUGBANK	DB00586	C14H11Cl2NO2	small molecule	D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05	15307-86-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCOPUUMXTXDBNB-UHFFFAOYSA-N
8299	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	576	Diclofenac	2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco	dom-diclofenac|diclofenac sodi	DRUGBANK	DB00586	C14H11Cl2NO2	small molecule	D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05	15307-86-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCOPUUMXTXDBNB-UHFFFAOYSA-N
8300	111337	5320	-	PLA2G2A	MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2	9606	Homo sapiens	inhibitor	target	Singh N (2006)	16552142	177090	576	Diclofenac	2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco	dom-diclofenac|diclofenac sodi	DRUGBANK	DB00586	C14H11Cl2NO2	small molecule	D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05	15307-86-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCOPUUMXTXDBNB-UHFFFAOYSA-N
8301	111337	5320	-	PLA2G2A	MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2	9606	Homo sapiens	inhibitor	target	Maekelae A (1997)	9279965	177089	576	Diclofenac	2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco	dom-diclofenac|diclofenac sodi	DRUGBANK	DB00586	C14H11Cl2NO2	small molecule	D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05	15307-86-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCOPUUMXTXDBNB-UHFFFAOYSA-N
8302	111337	5320	-	PLA2G2A	MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2	9606	Homo sapiens	inhibitor	target	Madanick RD (2005)	15906762	177088	576	Diclofenac	2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco	dom-diclofenac|diclofenac sodi	DRUGBANK	DB00586	C14H11Cl2NO2	small molecule	D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05	15307-86-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCOPUUMXTXDBNB-UHFFFAOYSA-N
8306	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	potentiator	target	Whittle BJ (2004)	15525540	177094	576	Diclofenac	2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco	dom-diclofenac|diclofenac sodi	DRUGBANK	DB00586	C14H11Cl2NO2	small molecule	D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05	15307-86-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCOPUUMXTXDBNB-UHFFFAOYSA-N
8307	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	potentiator	target	Charlier C (2003)	12932896	177095	576	Diclofenac	2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco	dom-diclofenac|diclofenac sodi	DRUGBANK	DB00586	C14H11Cl2NO2	small molecule	D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05	15307-86-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCOPUUMXTXDBNB-UHFFFAOYSA-N
8308	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	potentiator	target	Kudo C (2003)	12826271	177096	576	Diclofenac	2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco	dom-diclofenac|diclofenac sodi	DRUGBANK	DB00586	C14H11Cl2NO2	small molecule	D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05	15307-86-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCOPUUMXTXDBNB-UHFFFAOYSA-N
8314	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Kirchheiner J (2003)	12534640	177083	576	Diclofenac	2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco	dom-diclofenac|diclofenac sodi	DRUGBANK	DB00586	C14H11Cl2NO2	small molecule	D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05	15307-86-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCOPUUMXTXDBNB-UHFFFAOYSA-N
8315	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chavez ML (2003)	12852704	177085	576	Diclofenac	2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco	dom-diclofenac|diclofenac sodi	DRUGBANK	DB00586	C14H11Cl2NO2	small molecule	D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05	15307-86-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCOPUUMXTXDBNB-UHFFFAOYSA-N
8316	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Rowlinson SW (2003)	12925531	177102	576	Diclofenac	2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco	dom-diclofenac|diclofenac sodi	DRUGBANK	DB00586	C14H11Cl2NO2	small molecule	D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05	15307-86-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCOPUUMXTXDBNB-UHFFFAOYSA-N
8317	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Beubler E (2003)	12705061	177100	576	Diclofenac	2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco	dom-diclofenac|diclofenac sodi	DRUGBANK	DB00586	C14H11Cl2NO2	small molecule	D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05	15307-86-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCOPUUMXTXDBNB-UHFFFAOYSA-N
8318	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Blomme EA (2003)	12588370	177101	576	Diclofenac	2-((2,6-dichlorophenyl)amino)benzeneacetic acid|[2-(2,6-dichloroanilino)phenyl]acetic acid|Diclofenac Acid|Diclofenacum|Diclofenaco	dom-diclofenac|diclofenac sodi	DRUGBANK	DB00586	C14H11Cl2NO2	small molecule	D11AX18|S01BC03|M01AB55|M02AA15|S01CC01|M01AB05	15307-86-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DCOPUUMXTXDBNB-UHFFFAOYSA-N
8319	116014	10800	-	CYSLTR1	CYSLT1|CYSLT1R|CYSLTR|HMTMF81	9606	Homo sapiens	antagonist	target	Foller M (2009)	19826192	177107	577	Cinalukast	3'-((e)-2-(4-Cyclobutyl-2-thiazolyl)vinyl)-2,2-diethylsuccinanilic acid|Cinalukast	-	DRUGBANK	DB00587	C23H28N2O3S	small molecule	-	128312-51-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BZMKNPGKXJAIDV-VAWYXSNFSA-N
8320	116014	10800	-	CYSLTR1	CYSLT1|CYSLT1R|CYSLTR|HMTMF81	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	577	Cinalukast	3'-((e)-2-(4-Cyclobutyl-2-thiazolyl)vinyl)-2,2-diethylsuccinanilic acid|Cinalukast	-	DRUGBANK	DB00587	C23H28N2O3S	small molecule	-	128312-51-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BZMKNPGKXJAIDV-VAWYXSNFSA-N
8321	116014	10800	-	CYSLTR1	CYSLT1|CYSLT1R|CYSLTR|HMTMF81	9606	Homo sapiens	antagonist	target	Adelroth E (1997)	9042047	177108	577	Cinalukast	3'-((e)-2-(4-Cyclobutyl-2-thiazolyl)vinyl)-2,2-diethylsuccinanilic acid|Cinalukast	-	DRUGBANK	DB00587	C23H28N2O3S	small molecule	-	128312-51-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BZMKNPGKXJAIDV-VAWYXSNFSA-N
8332	111338	5321	-	PLA2G4A	PLA2G4|cPLA2-alpha	9606	Homo sapiens	inhibitor	target	Sano A (1999)	10351938	177115	578	Fluticasone Propionate	Fluticason|Fluticasona|Fluticasone|Fluticasonum|Fluticasone propionate|Cutivate	topcare childrens allergy reli	DRUGBANK	DB00588	C25H31F3O5S	small molecule	D07AC17|R03BA05|R01AD08|R03AK06|R03AK11|R01AD58	80474-14-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WMWTYOKRWGGJOA-CENSZEJFSA-N
8333	111338	5321	-	PLA2G4A	PLA2G4|cPLA2-alpha	9606	Homo sapiens	inhibitor	target	Myo S (2004)	15083746	177116	578	Fluticasone Propionate	Fluticason|Fluticasona|Fluticasone|Fluticasonum|Fluticasone propionate|Cutivate	topcare childrens allergy reli	DRUGBANK	DB00588	C25H31F3O5S	small molecule	D07AC17|R03BA05|R01AD08|R03AK06|R03AK11|R01AD58	80474-14-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WMWTYOKRWGGJOA-CENSZEJFSA-N
8334	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	579	Lisuride	N'-((8alpha)-9,10-didehydro-6-methylergolin-8-yl)-N,N-diethylurea|Lisuridum|Lisuride|Lisurid|Lisurida	-	DRUGBANK	DB00589	C20H26N4O	small molecule	G02CB02|N02CA07	18016-80-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BKRGVLQUQGGVSM-KBXCAEBGSA-N
8335	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	579	Lisuride	N'-((8alpha)-9,10-didehydro-6-methylergolin-8-yl)-N,N-diethylurea|Lisuridum|Lisuride|Lisurid|Lisurida	-	DRUGBANK	DB00589	C20H26N4O	small molecule	G02CB02|N02CA07	18016-80-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BKRGVLQUQGGVSM-KBXCAEBGSA-N
8338	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	579	Lisuride	N'-((8alpha)-9,10-didehydro-6-methylergolin-8-yl)-N,N-diethylurea|Lisuridum|Lisuride|Lisurid|Lisurida	-	DRUGBANK	DB00589	C20H26N4O	small molecule	G02CB02|N02CA07	18016-80-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BKRGVLQUQGGVSM-KBXCAEBGSA-N
8339	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	579	Lisuride	N'-((8alpha)-9,10-didehydro-6-methylergolin-8-yl)-N,N-diethylurea|Lisuridum|Lisuride|Lisurid|Lisurida	-	DRUGBANK	DB00589	C20H26N4O	small molecule	G02CB02|N02CA07	18016-80-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BKRGVLQUQGGVSM-KBXCAEBGSA-N
8538	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Cheng ZJ (2003)	12586211	177227	595	Sulindac	cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum	sulindac|clinoril tab 150mg|ap	DRUGBANK	DB00605	C20H17FO3S	small molecule	M01AB02	38194-50-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLKXDPUZXIRXEP-MFOYZWKCSA-N
8539	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Lim JT (1999)	10484067	177226	595	Sulindac	cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum	sulindac|clinoril tab 150mg|ap	DRUGBANK	DB00605	C20H17FO3S	small molecule	M01AB02	38194-50-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLKXDPUZXIRXEP-MFOYZWKCSA-N
8540	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Cheng ZJ (2002)	12512695	177225	595	Sulindac	cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum	sulindac|clinoril tab 150mg|ap	DRUGBANK	DB00605	C20H17FO3S	small molecule	M01AB02	38194-50-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLKXDPUZXIRXEP-MFOYZWKCSA-N
8541	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Giuliano F (1999)	10372826	177229	595	Sulindac	cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum	sulindac|clinoril tab 150mg|ap	DRUGBANK	DB00605	C20H17FO3S	small molecule	M01AB02	38194-50-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLKXDPUZXIRXEP-MFOYZWKCSA-N
8542	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Soriano AF (1999)	10626810	177228	595	Sulindac	cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum	sulindac|clinoril tab 150mg|ap	DRUGBANK	DB00605	C20H17FO3S	small molecule	M01AB02	38194-50-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLKXDPUZXIRXEP-MFOYZWKCSA-N
8543	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	595	Sulindac	cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum	sulindac|clinoril tab 150mg|ap	DRUGBANK	DB00605	C20H17FO3S	small molecule	M01AB02	38194-50-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLKXDPUZXIRXEP-MFOYZWKCSA-N
8544	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	inhibitor	target	Jacobson M (1983)	6413448	177230	595	Sulindac	cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum	sulindac|clinoril tab 150mg|ap	DRUGBANK	DB00605	C20H17FO3S	small molecule	M01AB02	38194-50-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLKXDPUZXIRXEP-MFOYZWKCSA-N
8545	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	inhibitor	target	Sharma YR (1989)	2632448	177231	595	Sulindac	cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum	sulindac|clinoril tab 150mg|ap	DRUGBANK	DB00605	C20H17FO3S	small molecule	M01AB02	38194-50-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLKXDPUZXIRXEP-MFOYZWKCSA-N
8546	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	inhibitor	target	Chaudhry PS (1983)	6409111	177232	595	Sulindac	cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum	sulindac|clinoril tab 150mg|ap	DRUGBANK	DB00605	C20H17FO3S	small molecule	M01AB02	38194-50-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLKXDPUZXIRXEP-MFOYZWKCSA-N
8547	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	inhibitor	target	Crabbe MJ (1985)	3920599	177233	595	Sulindac	cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum	sulindac|clinoril tab 150mg|ap	DRUGBANK	DB00605	C20H17FO3S	small molecule	M01AB02	38194-50-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLKXDPUZXIRXEP-MFOYZWKCSA-N
8548	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	inhibitor	target	van der Sloot P (1995)	8529171	177234	595	Sulindac	cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum	sulindac|clinoril tab 150mg|ap	DRUGBANK	DB00605	C20H17FO3S	small molecule	M01AB02	38194-50-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLKXDPUZXIRXEP-MFOYZWKCSA-N
8549	116412	11251	-	PTGDR2	CD294|CRTH2|DL1R|DP2|GPR44	9606	Homo sapiens	antagonist	target	Hata AN (2005)	15563582	161179	595	Sulindac	cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum	sulindac|clinoril tab 150mg|ap	DRUGBANK	DB00605	C20H17FO3S	small molecule	M01AB02	38194-50-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLKXDPUZXIRXEP-MFOYZWKCSA-N
8560	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Giuliano F (1999)	10372826	177229	595	Sulindac	cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum	sulindac|clinoril tab 150mg|ap	DRUGBANK	DB00605	C20H17FO3S	small molecule	M01AB02	38194-50-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLKXDPUZXIRXEP-MFOYZWKCSA-N
8561	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Yip-Schneider MT (2000)	10657949	177245	595	Sulindac	cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum	sulindac|clinoril tab 150mg|ap	DRUGBANK	DB00605	C20H17FO3S	small molecule	M01AB02	38194-50-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLKXDPUZXIRXEP-MFOYZWKCSA-N
8562	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Fosslien E (2000)	11078056	177244	595	Sulindac	cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum	sulindac|clinoril tab 150mg|ap	DRUGBANK	DB00605	C20H17FO3S	small molecule	M01AB02	38194-50-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLKXDPUZXIRXEP-MFOYZWKCSA-N
8563	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Molina MA (1999)	10485483	177247	595	Sulindac	cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum	sulindac|clinoril tab 150mg|ap	DRUGBANK	DB00605	C20H17FO3S	small molecule	M01AB02	38194-50-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLKXDPUZXIRXEP-MFOYZWKCSA-N
8564	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Taylor MT (2000)	11118042	177246	595	Sulindac	cis-5-Fluoro-2-methyl-1-((P-methylsulfinyl)benzylidene)indene-3-acetic acid|Sulindac|Clinoril|Sulindaco|(Z)-5-Fluoro-2-methyl-1-((P-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|cis-5-Fluoro-2-methyl-1-((4-(methylsulfinyl)phenyl)methylene)-1H-indene-3-acetic acid|Sulindacum	sulindac|clinoril tab 150mg|ap	DRUGBANK	DB00605	C20H17FO3S	small molecule	M01AB02	38194-50-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLKXDPUZXIRXEP-MFOYZWKCSA-N
8637	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Srethapakdi M (2000)	10919672	177312	605	Rifabutin	Mycobutin (tn)|Ansamicin|Rifabutinum|Rifabutine|4-Deoxo-3,4-(2-spiro(N-isobutyl-4-piperidyl)-2,5-dihydro-1H-imidazo)-rifamycin S|Ansamycin|Rifabutina|4-N-Isobutylspiropiperidylrifamycin S|1,4-Dihydro-1-deoxy-1',4-didehydro-5'-(2-methylpropyl)-1-oxorifamycin xiv|Rifabutin	mycobutin|rifabutin	DRUGBANK	DB00615	C46H62N4O11	small molecule	J04AB04	72559-06-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ATEBXHFBFRCZMA-VXTBVIBXSA-N
8638	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Yang J (2001)	11358819	177311	605	Rifabutin	Mycobutin (tn)|Ansamicin|Rifabutinum|Rifabutine|4-Deoxo-3,4-(2-spiro(N-isobutyl-4-piperidyl)-2,5-dihydro-1H-imidazo)-rifamycin S|Ansamycin|Rifabutina|4-N-Isobutylspiropiperidylrifamycin S|1,4-Dihydro-1-deoxy-1',4-didehydro-5'-(2-methylpropyl)-1-oxorifamycin xiv|Rifabutin	mycobutin|rifabutin	DRUGBANK	DB00615	C46H62N4O11	small molecule	J04AB04	72559-06-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ATEBXHFBFRCZMA-VXTBVIBXSA-N
8639	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Neckers L (2000)	10759403	177310	605	Rifabutin	Mycobutin (tn)|Ansamicin|Rifabutinum|Rifabutine|4-Deoxo-3,4-(2-spiro(N-isobutyl-4-piperidyl)-2,5-dihydro-1H-imidazo)-rifamycin S|Ansamycin|Rifabutina|4-N-Isobutylspiropiperidylrifamycin S|1,4-Dihydro-1-deoxy-1',4-didehydro-5'-(2-methylpropyl)-1-oxorifamycin xiv|Rifabutin	mycobutin|rifabutin	DRUGBANK	DB00615	C46H62N4O11	small molecule	J04AB04	72559-06-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ATEBXHFBFRCZMA-VXTBVIBXSA-N
8640	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Schnaider T (2000)	10701840	177308	605	Rifabutin	Mycobutin (tn)|Ansamicin|Rifabutinum|Rifabutine|4-Deoxo-3,4-(2-spiro(N-isobutyl-4-piperidyl)-2,5-dihydro-1H-imidazo)-rifamycin S|Ansamycin|Rifabutina|4-N-Isobutylspiropiperidylrifamycin S|1,4-Dihydro-1-deoxy-1',4-didehydro-5'-(2-methylpropyl)-1-oxorifamycin xiv|Rifabutin	mycobutin|rifabutin	DRUGBANK	DB00615	C46H62N4O11	small molecule	J04AB04	72559-06-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ATEBXHFBFRCZMA-VXTBVIBXSA-N
8641	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Muenster PN (2001)	11306472	177309	605	Rifabutin	Mycobutin (tn)|Ansamicin|Rifabutinum|Rifabutine|4-Deoxo-3,4-(2-spiro(N-isobutyl-4-piperidyl)-2,5-dihydro-1H-imidazo)-rifamycin S|Ansamycin|Rifabutina|4-N-Isobutylspiropiperidylrifamycin S|1,4-Dihydro-1-deoxy-1',4-didehydro-5'-(2-methylpropyl)-1-oxorifamycin xiv|Rifabutin	mycobutin|rifabutin	DRUGBANK	DB00615	C46H62N4O11	small molecule	J04AB04	72559-06-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ATEBXHFBFRCZMA-VXTBVIBXSA-N
8645	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Dumoulin MJ (2001)	11300648	177316	606	Candoxatril	4-({1-[(S)-2-(indan-5-yloxycarbonyl)-3-(2-methoxy-ethoxy)-propyl]-cyclopentanecarbonyl}-amino)-cyclohexanecarboxylic acid|[4(S)-cis]-4-[[[1-[3-[(2,3-dihydro-1H-Indeb5-yl)oxy]-2-[(2-methoxyethoxy)methyl]-3-oxopropyl]cyclopentyl]carbonyl]amino]cyclohexanecarboxylic acid	-	DRUGBANK	DB00616	C29H41NO7	small molecule	-	123122-55-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZTWZVMIYIIVABD-OEMFJLHTSA-N
8646	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Kostova E (2006)	16642666	177315	606	Candoxatril	4-({1-[(S)-2-(indan-5-yloxycarbonyl)-3-(2-methoxy-ethoxy)-propyl]-cyclopentanecarbonyl}-amino)-cyclohexanecarboxylic acid|[4(S)-cis]-4-[[[1-[3-[(2,3-dihydro-1H-Indeb5-yl)oxy]-2-[(2-methoxyethoxy)methyl]-3-oxopropyl]cyclopentyl]carbonyl]amino]cyclohexanecarboxylic acid	-	DRUGBANK	DB00616	C29H41NO7	small molecule	-	123122-55-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZTWZVMIYIIVABD-OEMFJLHTSA-N
8723	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Seeman P (2002)	11873706	174626	613	Fluphenazine	Fluphnazine|Fluphenazin|2-(Trifluoromethyl)-10-(3-(1-(beta-hydroxyethyl)-4-piperazinyl)propyl)phenothiazine|Flufenazina|Fluorfenazine|Triflumethazine|10-(3-(2-Hydroxyethyl)piperazinopropyl)-2-(trifluoromethyl)phenothiazine|1-(2-Hydroxyethyl)-4-(3-(trifluoromethyl-10-phenothiazinyl)propyl)-piperazine|Fluorophenazine|4-(3-(2-(Trifluoromethyl)-10H-phenothiazin-10-yl)propyl)-1-piperazineethanol|Fluorphenazine|4-(3-(2-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|4-(3-(-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|2-(4-(3-[2-(Trifluoromethyl)-10H-phenothiazin-10-yl]propyl)-1-piperazinyl)ethanol|Fluphenazinum|10-(3'-(4''-(beta-hydroxyethyl)-1''-piperazinyl)-propyl)-3-trifluoromethylphenothiazine	apo fluphenazine tab 2.5mg|apo	DRUGBANK	DB00623	C22H26F3N3OS	small molecule	N05AB02	69-23-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PLDUPXSUYLZYBN-UHFFFAOYSA-N
8724	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Hoyberg OJ (1993)	7508675	177392	613	Fluphenazine	Fluphnazine|Fluphenazin|2-(Trifluoromethyl)-10-(3-(1-(beta-hydroxyethyl)-4-piperazinyl)propyl)phenothiazine|Flufenazina|Fluorfenazine|Triflumethazine|10-(3-(2-Hydroxyethyl)piperazinopropyl)-2-(trifluoromethyl)phenothiazine|1-(2-Hydroxyethyl)-4-(3-(trifluoromethyl-10-phenothiazinyl)propyl)-piperazine|Fluorophenazine|4-(3-(2-(Trifluoromethyl)-10H-phenothiazin-10-yl)propyl)-1-piperazineethanol|Fluorphenazine|4-(3-(2-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|4-(3-(-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|2-(4-(3-[2-(Trifluoromethyl)-10H-phenothiazin-10-yl]propyl)-1-piperazinyl)ethanol|Fluphenazinum|10-(3'-(4''-(beta-hydroxyethyl)-1''-piperazinyl)-propyl)-3-trifluoromethylphenothiazine	apo fluphenazine tab 2.5mg|apo	DRUGBANK	DB00623	C22H26F3N3OS	small molecule	N05AB02	69-23-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PLDUPXSUYLZYBN-UHFFFAOYSA-N
8725	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	613	Fluphenazine	Fluphnazine|Fluphenazin|2-(Trifluoromethyl)-10-(3-(1-(beta-hydroxyethyl)-4-piperazinyl)propyl)phenothiazine|Flufenazina|Fluorfenazine|Triflumethazine|10-(3-(2-Hydroxyethyl)piperazinopropyl)-2-(trifluoromethyl)phenothiazine|1-(2-Hydroxyethyl)-4-(3-(trifluoromethyl-10-phenothiazinyl)propyl)-piperazine|Fluorophenazine|4-(3-(2-(Trifluoromethyl)-10H-phenothiazin-10-yl)propyl)-1-piperazineethanol|Fluorphenazine|4-(3-(2-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|4-(3-(-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|2-(4-(3-[2-(Trifluoromethyl)-10H-phenothiazin-10-yl]propyl)-1-piperazinyl)ethanol|Fluphenazinum|10-(3'-(4''-(beta-hydroxyethyl)-1''-piperazinyl)-propyl)-3-trifluoromethylphenothiazine	apo fluphenazine tab 2.5mg|apo	DRUGBANK	DB00623	C22H26F3N3OS	small molecule	N05AB02	69-23-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PLDUPXSUYLZYBN-UHFFFAOYSA-N
8726	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Qin ZH (1994)	7828655	177391	613	Fluphenazine	Fluphnazine|Fluphenazin|2-(Trifluoromethyl)-10-(3-(1-(beta-hydroxyethyl)-4-piperazinyl)propyl)phenothiazine|Flufenazina|Fluorfenazine|Triflumethazine|10-(3-(2-Hydroxyethyl)piperazinopropyl)-2-(trifluoromethyl)phenothiazine|1-(2-Hydroxyethyl)-4-(3-(trifluoromethyl-10-phenothiazinyl)propyl)-piperazine|Fluorophenazine|4-(3-(2-(Trifluoromethyl)-10H-phenothiazin-10-yl)propyl)-1-piperazineethanol|Fluorphenazine|4-(3-(2-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|4-(3-(-Trifluoromethyl-10-phenothiazyl)-propyl)-1-piperazineethanol|2-(4-(3-[2-(Trifluoromethyl)-10H-phenothiazin-10-yl]propyl)-1-piperazinyl)ethanol|Fluphenazinum|10-(3'-(4''-(beta-hydroxyethyl)-1''-piperazinyl)-propyl)-3-trifluoromethylphenothiazine	apo fluphenazine tab 2.5mg|apo	DRUGBANK	DB00623	C22H26F3N3OS	small molecule	N05AB02	69-23-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PLDUPXSUYLZYBN-UHFFFAOYSA-N
8987	107956	1584	-	CYP11B1	CPN1|CYP11B|FHI|P450C11	9606	Homo sapiens	inducer	target	Lindhe O (2002)	11889204	177554	638	Mitotane	Piprine-DDD, O-|Lysodren|Mitotan|Mitotane|Mitotano|Mitotanum	lysodren	DRUGBANK	DB00648	C14H10Cl4	small molecule	L01XX23	53-19-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JWBOIMRXGHLCPP-UHFFFAOYSA-N
9040	111709	5737	RP5-944H6.1	PTGFR	FP	9606	Homo sapiens	agonist	target	Takagi Y (2004)	15037111	177577	644	Latanoprost	Propan-2-yl (5Z)-7-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl}hept-5-enoate|Isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((3R)-3-hydroxy-5-phenylpentyl)cyclopentyl)-5-heptenoate|Latanoprostum|Latanoprost|PhXA 41|Xalatan	teva-latanoprost/timolol|apo-l	DRUGBANK	DB00654	C26H40O5	small molecule	S01EE01	130209-82-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GGXICVAJURFBLW-CEYXHVGTSA-N
9041	111709	5737	RP5-944H6.1	PTGFR	FP	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	644	Latanoprost	Propan-2-yl (5Z)-7-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl}hept-5-enoate|Isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((3R)-3-hydroxy-5-phenylpentyl)cyclopentyl)-5-heptenoate|Latanoprostum|Latanoprost|PhXA 41|Xalatan	teva-latanoprost/timolol|apo-l	DRUGBANK	DB00654	C26H40O5	small molecule	S01EE01	130209-82-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GGXICVAJURFBLW-CEYXHVGTSA-N
9042	111709	5737	RP5-944H6.1	PTGFR	FP	9606	Homo sapiens	agonist	target	Nakajima T (2003)	14646172	177579	644	Latanoprost	Propan-2-yl (5Z)-7-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl}hept-5-enoate|Isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((3R)-3-hydroxy-5-phenylpentyl)cyclopentyl)-5-heptenoate|Latanoprostum|Latanoprost|PhXA 41|Xalatan	teva-latanoprost/timolol|apo-l	DRUGBANK	DB00654	C26H40O5	small molecule	S01EE01	130209-82-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GGXICVAJURFBLW-CEYXHVGTSA-N
9043	111709	5737	RP5-944H6.1	PTGFR	FP	9606	Homo sapiens	agonist	target	Ocklind A (1998)	9733584	177578	644	Latanoprost	Propan-2-yl (5Z)-7-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl}hept-5-enoate|Isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((3R)-3-hydroxy-5-phenylpentyl)cyclopentyl)-5-heptenoate|Latanoprostum|Latanoprost|PhXA 41|Xalatan	teva-latanoprost/timolol|apo-l	DRUGBANK	DB00654	C26H40O5	small molecule	S01EE01	130209-82-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GGXICVAJURFBLW-CEYXHVGTSA-N
9044	111709	5737	RP5-944H6.1	PTGFR	FP	9606	Homo sapiens	agonist	target	Ota T (2005)	16249494	174971	644	Latanoprost	Propan-2-yl (5Z)-7-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl}hept-5-enoate|Isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((3R)-3-hydroxy-5-phenylpentyl)cyclopentyl)-5-heptenoate|Latanoprostum|Latanoprost|PhXA 41|Xalatan	teva-latanoprost/timolol|apo-l	DRUGBANK	DB00654	C26H40O5	small molecule	S01EE01	130209-82-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GGXICVAJURFBLW-CEYXHVGTSA-N
9045	111709	5737	RP5-944H6.1	PTGFR	FP	9606	Homo sapiens	agonist	target	Maxey KM (2002)	12204699	177580	644	Latanoprost	Propan-2-yl (5Z)-7-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl}hept-5-enoate|Isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((3R)-3-hydroxy-5-phenylpentyl)cyclopentyl)-5-heptenoate|Latanoprostum|Latanoprost|PhXA 41|Xalatan	teva-latanoprost/timolol|apo-l	DRUGBANK	DB00654	C26H40O5	small molecule	S01EE01	130209-82-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GGXICVAJURFBLW-CEYXHVGTSA-N
9411	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	668	Losartan	Losartan|(2-Butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazol-5-yl)methanol|2-N-Butyl-4-chloro-5-hydroxymethyl-1-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]imidazole|DuP 89	jamp-losartan hctz|losartan/hc	DRUGBANK	DB00678	C22H23ClN6O	small molecule	C09CA01|C09DA01|C09DB06	114798-26-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PSIFNNKUMBGKDQ-UHFFFAOYSA-N
9412	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Sardo MA (2004)	15026875	177762	668	Losartan	Losartan|(2-Butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazol-5-yl)methanol|2-N-Butyl-4-chloro-5-hydroxymethyl-1-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]imidazole|DuP 89	jamp-losartan hctz|losartan/hc	DRUGBANK	DB00678	C22H23ClN6O	small molecule	C09CA01|C09DA01|C09DB06	114798-26-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PSIFNNKUMBGKDQ-UHFFFAOYSA-N
9413	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Anand-Srivastava MB (2003)	12710529	177763	668	Losartan	Losartan|(2-Butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazol-5-yl)methanol|2-N-Butyl-4-chloro-5-hydroxymethyl-1-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]imidazole|DuP 89	jamp-losartan hctz|losartan/hc	DRUGBANK	DB00678	C22H23ClN6O	small molecule	C09CA01|C09DA01|C09DB06	114798-26-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PSIFNNKUMBGKDQ-UHFFFAOYSA-N
9414	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Rocha I (2003)	12719755	177760	668	Losartan	Losartan|(2-Butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazol-5-yl)methanol|2-N-Butyl-4-chloro-5-hydroxymethyl-1-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]imidazole|DuP 89	jamp-losartan hctz|losartan/hc	DRUGBANK	DB00678	C22H23ClN6O	small molecule	C09CA01|C09DA01|C09DB06	114798-26-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PSIFNNKUMBGKDQ-UHFFFAOYSA-N
9415	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Dickstein K (1998)	15991937	177761	668	Losartan	Losartan|(2-Butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazol-5-yl)methanol|2-N-Butyl-4-chloro-5-hydroxymethyl-1-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]imidazole|DuP 89	jamp-losartan hctz|losartan/hc	DRUGBANK	DB00678	C22H23ClN6O	small molecule	C09CA01|C09DA01|C09DB06	114798-26-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PSIFNNKUMBGKDQ-UHFFFAOYSA-N
9416	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Guan J (2004)	15573751	177764	668	Losartan	Losartan|(2-Butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazol-5-yl)methanol|2-N-Butyl-4-chloro-5-hydroxymethyl-1-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]imidazole|DuP 89	jamp-losartan hctz|losartan/hc	DRUGBANK	DB00678	C22H23ClN6O	small molecule	C09CA01|C09DA01|C09DB06	114798-26-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PSIFNNKUMBGKDQ-UHFFFAOYSA-N
9417	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Seeman P (1990)	1978482	177771	669	Thioridazine	Mellaril|10-[2-(1-Methyl-2-piperidyl)ethyl]-2-methylsulfanyl-phenothiazine|Sonapax|2-Methylmercapto-10-(2-(N-methyl-2-piperidyl)ethyl)phenothiazine|Mellaril-S|Orsanil|Meleril|3-Methylmercapto-N-(2'-(N-methyl-2-piperidyl)ethyl)phenothiazine|Thioridazinum|Mellerets|Mallorol|Malloryl|Tioridazina|Thioridazin|Mellerette|Melleril	thioridazine tab 50mg|novo-rid	DRUGBANK	DB00679	C21H26N2S2	small molecule	N05AC02	50-52-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KLBQZWRITKRQQV-UHFFFAOYSA-N
9418	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Barth VN (2006)	16434058	177773	669	Thioridazine	Mellaril|10-[2-(1-Methyl-2-piperidyl)ethyl]-2-methylsulfanyl-phenothiazine|Sonapax|2-Methylmercapto-10-(2-(N-methyl-2-piperidyl)ethyl)phenothiazine|Mellaril-S|Orsanil|Meleril|3-Methylmercapto-N-(2'-(N-methyl-2-piperidyl)ethyl)phenothiazine|Thioridazinum|Mellerets|Mallorol|Malloryl|Tioridazina|Thioridazin|Mellerette|Melleril	thioridazine tab 50mg|novo-rid	DRUGBANK	DB00679	C21H26N2S2	small molecule	N05AC02	50-52-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KLBQZWRITKRQQV-UHFFFAOYSA-N
9419	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Assie MB (1993)	7689973	177772	669	Thioridazine	Mellaril|10-[2-(1-Methyl-2-piperidyl)ethyl]-2-methylsulfanyl-phenothiazine|Sonapax|2-Methylmercapto-10-(2-(N-methyl-2-piperidyl)ethyl)phenothiazine|Mellaril-S|Orsanil|Meleril|3-Methylmercapto-N-(2'-(N-methyl-2-piperidyl)ethyl)phenothiazine|Thioridazinum|Mellerets|Mallorol|Malloryl|Tioridazina|Thioridazin|Mellerette|Melleril	thioridazine tab 50mg|novo-rid	DRUGBANK	DB00679	C21H26N2S2	small molecule	N05AC02	50-52-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KLBQZWRITKRQQV-UHFFFAOYSA-N
9420	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Carey GJ (1997)	9292626	177775	669	Thioridazine	Mellaril|10-[2-(1-Methyl-2-piperidyl)ethyl]-2-methylsulfanyl-phenothiazine|Sonapax|2-Methylmercapto-10-(2-(N-methyl-2-piperidyl)ethyl)phenothiazine|Mellaril-S|Orsanil|Meleril|3-Methylmercapto-N-(2'-(N-methyl-2-piperidyl)ethyl)phenothiazine|Thioridazinum|Mellerets|Mallorol|Malloryl|Tioridazina|Thioridazin|Mellerette|Melleril	thioridazine tab 50mg|novo-rid	DRUGBANK	DB00679	C21H26N2S2	small molecule	N05AC02	50-52-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KLBQZWRITKRQQV-UHFFFAOYSA-N
9421	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Dimpfel W (1992)	1352051	177774	669	Thioridazine	Mellaril|10-[2-(1-Methyl-2-piperidyl)ethyl]-2-methylsulfanyl-phenothiazine|Sonapax|2-Methylmercapto-10-(2-(N-methyl-2-piperidyl)ethyl)phenothiazine|Mellaril-S|Orsanil|Meleril|3-Methylmercapto-N-(2'-(N-methyl-2-piperidyl)ethyl)phenothiazine|Thioridazinum|Mellerets|Mallorol|Malloryl|Tioridazina|Thioridazin|Mellerette|Melleril	thioridazine tab 50mg|novo-rid	DRUGBANK	DB00679	C21H26N2S2	small molecule	N05AC02	50-52-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KLBQZWRITKRQQV-UHFFFAOYSA-N
9552	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Chrysant SG (2004)	15286086	177842	681	Moexipril	Moexiprilum|Univasc|Moexipril|Uniretic	univasc|moexipril hydrochlorid	DRUGBANK	DB00691	C27H34N2O7	small molecule	C09AA13|C09BA13	103775-10-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UWWDHYUMIORJTA-HSQYWUDLSA-N
9553	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Edling O (1995)	7473177	177841	681	Moexipril	Moexiprilum|Univasc|Moexipril|Uniretic	univasc|moexipril hydrochlorid	DRUGBANK	DB00691	C27H34N2O7	small molecule	C09AA13|C09BA13	103775-10-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UWWDHYUMIORJTA-HSQYWUDLSA-N
9554	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Song JC (2002)	11929321	174114	681	Moexipril	Moexiprilum|Univasc|Moexipril|Uniretic	univasc|moexipril hydrochlorid	DRUGBANK	DB00691	C27H34N2O7	small molecule	C09AA13|C09BA13	103775-10-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UWWDHYUMIORJTA-HSQYWUDLSA-N
9555	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	681	Moexipril	Moexiprilum|Univasc|Moexipril|Uniretic	univasc|moexipril hydrochlorid	DRUGBANK	DB00691	C27H34N2O7	small molecule	C09AA13|C09BA13	103775-10-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UWWDHYUMIORJTA-HSQYWUDLSA-N
9580	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Larson BT (1995)	7665369	177878	686	Ergotamine	Ergotamina|Ergotamine|Ergotamin|Gynergen|12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione|Ergotaminum|(5'alpha)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione	gravergol capsules|ergomar sub	DRUGBANK	DB00696	C33H35N5O5	small molecule	N02CA02|N02CA72|N02CA52	113-15-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCGSFFUVFURLIX-VFGNJEKYSA-N
9581	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Verhoeff NP (1993)	8242725	177879	686	Ergotamine	Ergotamina|Ergotamine|Ergotamin|Gynergen|12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione|Ergotaminum|(5'alpha)-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione	gravergol capsules|ergomar sub	DRUGBANK	DB00696	C33H35N5O5	small molecule	N02CA02|N02CA72|N02CA52	113-15-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XCGSFFUVFURLIX-VFGNJEKYSA-N
9706	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	McGarry HF (2005)	15932636	177964	701	Diethylcarbamazine	N,N-Diethyl-4-methyl-1-piperazinecarboxamide|Camin|Dithylcarbamazine|Diethylcarbamazin|Dietilcarbamazina|Carbamazine|Diethylcarbamazinum	hetrazan tab 50mg	DRUGBANK	DB00711	C10H21N3O	small molecule	P02CB02	90-89-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RCKMWOKWVGPNJF-UHFFFAOYSA-N
9707	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	701	Diethylcarbamazine	N,N-Diethyl-4-methyl-1-piperazinecarboxamide|Camin|Dithylcarbamazine|Diethylcarbamazin|Dietilcarbamazina|Carbamazine|Diethylcarbamazinum	hetrazan tab 50mg	DRUGBANK	DB00711	C10H21N3O	small molecule	P02CB02	90-89-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RCKMWOKWVGPNJF-UHFFFAOYSA-N
9708	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Cernak I (1996)	8606397	177968	701	Diethylcarbamazine	N,N-Diethyl-4-methyl-1-piperazinecarboxamide|Camin|Dithylcarbamazine|Diethylcarbamazin|Dietilcarbamazina|Carbamazine|Diethylcarbamazinum	hetrazan tab 50mg	DRUGBANK	DB00711	C10H21N3O	small molecule	P02CB02	90-89-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RCKMWOKWVGPNJF-UHFFFAOYSA-N
9709	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Bach MK (1986)	3004501	177969	701	Diethylcarbamazine	N,N-Diethyl-4-methyl-1-piperazinecarboxamide|Camin|Dithylcarbamazine|Diethylcarbamazin|Dietilcarbamazina|Carbamazine|Diethylcarbamazinum	hetrazan tab 50mg	DRUGBANK	DB00711	C10H21N3O	small molecule	P02CB02	90-89-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RCKMWOKWVGPNJF-UHFFFAOYSA-N
9710	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Davidson D (1992)	1400062	177965	701	Diethylcarbamazine	N,N-Diethyl-4-methyl-1-piperazinecarboxamide|Camin|Dithylcarbamazine|Diethylcarbamazin|Dietilcarbamazina|Carbamazine|Diethylcarbamazinum	hetrazan tab 50mg	DRUGBANK	DB00711	C10H21N3O	small molecule	P02CB02	90-89-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RCKMWOKWVGPNJF-UHFFFAOYSA-N
9711	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Gross NJ (1991)	1886988	177966	701	Diethylcarbamazine	N,N-Diethyl-4-methyl-1-piperazinecarboxamide|Camin|Dithylcarbamazine|Diethylcarbamazin|Dietilcarbamazina|Carbamazine|Diethylcarbamazinum	hetrazan tab 50mg	DRUGBANK	DB00711	C10H21N3O	small molecule	P02CB02	90-89-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RCKMWOKWVGPNJF-UHFFFAOYSA-N
9712	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Zunic G (1999)	10518442	177967	701	Diethylcarbamazine	N,N-Diethyl-4-methyl-1-piperazinecarboxamide|Camin|Dithylcarbamazine|Diethylcarbamazin|Dietilcarbamazina|Carbamazine|Diethylcarbamazinum	hetrazan tab 50mg	DRUGBANK	DB00711	C10H21N3O	small molecule	P02CB02	90-89-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RCKMWOKWVGPNJF-UHFFFAOYSA-N
9713	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Nivsarkar M (2008)	19066416	177973	702	Flurbiprofen	Flurbiprofenum|3-Fluoro-4-phenylhydratropic acid|S-flurbiprofen|2-Fluoro-alpha-methyl-(1,1'-biphenyl)-4-acetic acid|(+-)-2-Fluoro-alpha-methyl-4-biphenylacetic acid|2-(2-Fluorobiphenyl-4-yl)propanoic acid|Flurbiprofen|Flurbiprofeno|FLP|Ansaid|Flurbiprofene	nu-flurbiprofen tab 50mg|ratio	DRUGBANK	DB00712	C15H13FO2	small molecule	M02AA19|S01BC04|M01AE09|R02AX01	5104-49-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYTBZMRGLBWNTM-UHFFFAOYSA-N
9714	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Kurahashi K (2001)	11811354	177972	702	Flurbiprofen	Flurbiprofenum|3-Fluoro-4-phenylhydratropic acid|S-flurbiprofen|2-Fluoro-alpha-methyl-(1,1'-biphenyl)-4-acetic acid|(+-)-2-Fluoro-alpha-methyl-4-biphenylacetic acid|2-(2-Fluorobiphenyl-4-yl)propanoic acid|Flurbiprofen|Flurbiprofeno|FLP|Ansaid|Flurbiprofene	nu-flurbiprofen tab 50mg|ratio	DRUGBANK	DB00712	C15H13FO2	small molecule	M02AA19|S01BC04|M01AE09|R02AX01	5104-49-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYTBZMRGLBWNTM-UHFFFAOYSA-N
9715	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Hewett SJ (2000)	10773011	177971	702	Flurbiprofen	Flurbiprofenum|3-Fluoro-4-phenylhydratropic acid|S-flurbiprofen|2-Fluoro-alpha-methyl-(1,1'-biphenyl)-4-acetic acid|(+-)-2-Fluoro-alpha-methyl-4-biphenylacetic acid|2-(2-Fluorobiphenyl-4-yl)propanoic acid|Flurbiprofen|Flurbiprofeno|FLP|Ansaid|Flurbiprofene	nu-flurbiprofen tab 50mg|ratio	DRUGBANK	DB00712	C15H13FO2	small molecule	M02AA19|S01BC04|M01AE09|R02AX01	5104-49-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYTBZMRGLBWNTM-UHFFFAOYSA-N
9716	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Basselin M (2007)	17562170	177977	702	Flurbiprofen	Flurbiprofenum|3-Fluoro-4-phenylhydratropic acid|S-flurbiprofen|2-Fluoro-alpha-methyl-(1,1'-biphenyl)-4-acetic acid|(+-)-2-Fluoro-alpha-methyl-4-biphenylacetic acid|2-(2-Fluorobiphenyl-4-yl)propanoic acid|Flurbiprofen|Flurbiprofeno|FLP|Ansaid|Flurbiprofene	nu-flurbiprofen tab 50mg|ratio	DRUGBANK	DB00712	C15H13FO2	small molecule	M02AA19|S01BC04|M01AE09|R02AX01	5104-49-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYTBZMRGLBWNTM-UHFFFAOYSA-N
9717	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Rieke CJ (1999)	10358065	177976	702	Flurbiprofen	Flurbiprofenum|3-Fluoro-4-phenylhydratropic acid|S-flurbiprofen|2-Fluoro-alpha-methyl-(1,1'-biphenyl)-4-acetic acid|(+-)-2-Fluoro-alpha-methyl-4-biphenylacetic acid|2-(2-Fluorobiphenyl-4-yl)propanoic acid|Flurbiprofen|Flurbiprofeno|FLP|Ansaid|Flurbiprofene	nu-flurbiprofen tab 50mg|ratio	DRUGBANK	DB00712	C15H13FO2	small molecule	M02AA19|S01BC04|M01AE09|R02AX01	5104-49-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYTBZMRGLBWNTM-UHFFFAOYSA-N
9718	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Droege MJ (2003)	12711844	177975	702	Flurbiprofen	Flurbiprofenum|3-Fluoro-4-phenylhydratropic acid|S-flurbiprofen|2-Fluoro-alpha-methyl-(1,1'-biphenyl)-4-acetic acid|(+-)-2-Fluoro-alpha-methyl-4-biphenylacetic acid|2-(2-Fluorobiphenyl-4-yl)propanoic acid|Flurbiprofen|Flurbiprofeno|FLP|Ansaid|Flurbiprofene	nu-flurbiprofen tab 50mg|ratio	DRUGBANK	DB00712	C15H13FO2	small molecule	M02AA19|S01BC04|M01AE09|R02AX01	5104-49-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYTBZMRGLBWNTM-UHFFFAOYSA-N
9719	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Klegeris A (2002)	12392782	177974	702	Flurbiprofen	Flurbiprofenum|3-Fluoro-4-phenylhydratropic acid|S-flurbiprofen|2-Fluoro-alpha-methyl-(1,1'-biphenyl)-4-acetic acid|(+-)-2-Fluoro-alpha-methyl-4-biphenylacetic acid|2-(2-Fluorobiphenyl-4-yl)propanoic acid|Flurbiprofen|Flurbiprofeno|FLP|Ansaid|Flurbiprofene	nu-flurbiprofen tab 50mg|ratio	DRUGBANK	DB00712	C15H13FO2	small molecule	M02AA19|S01BC04|M01AE09|R02AX01	5104-49-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYTBZMRGLBWNTM-UHFFFAOYSA-N
9720	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Bayly CI (1999)	10091674	177979	702	Flurbiprofen	Flurbiprofenum|3-Fluoro-4-phenylhydratropic acid|S-flurbiprofen|2-Fluoro-alpha-methyl-(1,1'-biphenyl)-4-acetic acid|(+-)-2-Fluoro-alpha-methyl-4-biphenylacetic acid|2-(2-Fluorobiphenyl-4-yl)propanoic acid|Flurbiprofen|Flurbiprofeno|FLP|Ansaid|Flurbiprofene	nu-flurbiprofen tab 50mg|ratio	DRUGBANK	DB00712	C15H13FO2	small molecule	M02AA19|S01BC04|M01AE09|R02AX01	5104-49-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYTBZMRGLBWNTM-UHFFFAOYSA-N
9721	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Hinz B (2001)	11405284	177978	702	Flurbiprofen	Flurbiprofenum|3-Fluoro-4-phenylhydratropic acid|S-flurbiprofen|2-Fluoro-alpha-methyl-(1,1'-biphenyl)-4-acetic acid|(+-)-2-Fluoro-alpha-methyl-4-biphenylacetic acid|2-(2-Fluorobiphenyl-4-yl)propanoic acid|Flurbiprofen|Flurbiprofeno|FLP|Ansaid|Flurbiprofene	nu-flurbiprofen tab 50mg|ratio	DRUGBANK	DB00712	C15H13FO2	small molecule	M02AA19|S01BC04|M01AE09|R02AX01	5104-49-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYTBZMRGLBWNTM-UHFFFAOYSA-N
9722	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	van Haeringen NJ (2000)	10977131	177980	702	Flurbiprofen	Flurbiprofenum|3-Fluoro-4-phenylhydratropic acid|S-flurbiprofen|2-Fluoro-alpha-methyl-(1,1'-biphenyl)-4-acetic acid|(+-)-2-Fluoro-alpha-methyl-4-biphenylacetic acid|2-(2-Fluorobiphenyl-4-yl)propanoic acid|Flurbiprofen|Flurbiprofeno|FLP|Ansaid|Flurbiprofene	nu-flurbiprofen tab 50mg|ratio	DRUGBANK	DB00712	C15H13FO2	small molecule	M02AA19|S01BC04|M01AE09|R02AX01	5104-49-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYTBZMRGLBWNTM-UHFFFAOYSA-N
9723	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Nivsarkar M (2008)	19066416	177973	702	Flurbiprofen	Flurbiprofenum|3-Fluoro-4-phenylhydratropic acid|S-flurbiprofen|2-Fluoro-alpha-methyl-(1,1'-biphenyl)-4-acetic acid|(+-)-2-Fluoro-alpha-methyl-4-biphenylacetic acid|2-(2-Fluorobiphenyl-4-yl)propanoic acid|Flurbiprofen|Flurbiprofeno|FLP|Ansaid|Flurbiprofene	nu-flurbiprofen tab 50mg|ratio	DRUGBANK	DB00712	C15H13FO2	small molecule	M02AA19|S01BC04|M01AE09|R02AX01	5104-49-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYTBZMRGLBWNTM-UHFFFAOYSA-N
9724	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Smith T (2000)	11006278	160486	702	Flurbiprofen	Flurbiprofenum|3-Fluoro-4-phenylhydratropic acid|S-flurbiprofen|2-Fluoro-alpha-methyl-(1,1'-biphenyl)-4-acetic acid|(+-)-2-Fluoro-alpha-methyl-4-biphenylacetic acid|2-(2-Fluorobiphenyl-4-yl)propanoic acid|Flurbiprofen|Flurbiprofeno|FLP|Ansaid|Flurbiprofene	nu-flurbiprofen tab 50mg|ratio	DRUGBANK	DB00712	C15H13FO2	small molecule	M02AA19|S01BC04|M01AE09|R02AX01	5104-49-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYTBZMRGLBWNTM-UHFFFAOYSA-N
9725	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Hewett SJ (2000)	10773011	177971	702	Flurbiprofen	Flurbiprofenum|3-Fluoro-4-phenylhydratropic acid|S-flurbiprofen|2-Fluoro-alpha-methyl-(1,1'-biphenyl)-4-acetic acid|(+-)-2-Fluoro-alpha-methyl-4-biphenylacetic acid|2-(2-Fluorobiphenyl-4-yl)propanoic acid|Flurbiprofen|Flurbiprofeno|FLP|Ansaid|Flurbiprofene	nu-flurbiprofen tab 50mg|ratio	DRUGBANK	DB00712	C15H13FO2	small molecule	M02AA19|S01BC04|M01AE09|R02AX01	5104-49-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYTBZMRGLBWNTM-UHFFFAOYSA-N
9726	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Basselin M (2007)	17562170	177977	702	Flurbiprofen	Flurbiprofenum|3-Fluoro-4-phenylhydratropic acid|S-flurbiprofen|2-Fluoro-alpha-methyl-(1,1'-biphenyl)-4-acetic acid|(+-)-2-Fluoro-alpha-methyl-4-biphenylacetic acid|2-(2-Fluorobiphenyl-4-yl)propanoic acid|Flurbiprofen|Flurbiprofeno|FLP|Ansaid|Flurbiprofene	nu-flurbiprofen tab 50mg|ratio	DRUGBANK	DB00712	C15H13FO2	small molecule	M02AA19|S01BC04|M01AE09|R02AX01	5104-49-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SYTBZMRGLBWNTM-UHFFFAOYSA-N
9727	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	agonist	target	Melis MR (2006)	17067298	177986	704	Apomorphine	(-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin	movapo|apokyn	DRUGBANK	DB00714	C17H17NO2	small molecule	G04BE07|N04BC07	58-00-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMWNQDUVQKEIOC-CYBMUJFWSA-N
9728	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	704	Apomorphine	(-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin	movapo|apokyn	DRUGBANK	DB00714	C17H17NO2	small molecule	G04BE07|N04BC07	58-00-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMWNQDUVQKEIOC-CYBMUJFWSA-N
9729	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	704	Apomorphine	(-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin	movapo|apokyn	DRUGBANK	DB00714	C17H17NO2	small molecule	G04BE07|N04BC07	58-00-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMWNQDUVQKEIOC-CYBMUJFWSA-N
9730	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	agonist	target	Mansbach RS (1998)	9497025	177984	704	Apomorphine	(-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin	movapo|apokyn	DRUGBANK	DB00714	C17H17NO2	small molecule	G04BE07|N04BC07	58-00-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMWNQDUVQKEIOC-CYBMUJFWSA-N
9731	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	agonist	target	Boeckler F (2004)	15007532	177985	704	Apomorphine	(-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin	movapo|apokyn	DRUGBANK	DB00714	C17H17NO2	small molecule	G04BE07|N04BC07	58-00-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMWNQDUVQKEIOC-CYBMUJFWSA-N
9732	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	agonist	target	Succu S (2007)	17164075	177983	704	Apomorphine	(-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin	movapo|apokyn	DRUGBANK	DB00714	C17H17NO2	small molecule	G04BE07|N04BC07	58-00-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMWNQDUVQKEIOC-CYBMUJFWSA-N
9735	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	704	Apomorphine	(-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin	movapo|apokyn	DRUGBANK	DB00714	C17H17NO2	small molecule	G04BE07|N04BC07	58-00-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMWNQDUVQKEIOC-CYBMUJFWSA-N
9736	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	704	Apomorphine	(-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin	movapo|apokyn	DRUGBANK	DB00714	C17H17NO2	small molecule	G04BE07|N04BC07	58-00-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMWNQDUVQKEIOC-CYBMUJFWSA-N
9737	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	704	Apomorphine	(-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin	movapo|apokyn	DRUGBANK	DB00714	C17H17NO2	small molecule	G04BE07|N04BC07	58-00-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMWNQDUVQKEIOC-CYBMUJFWSA-N
9738	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Berlin I (2000)	11343576	177987	704	Apomorphine	(-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin	movapo|apokyn	DRUGBANK	DB00714	C17H17NO2	small molecule	G04BE07|N04BC07	58-00-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMWNQDUVQKEIOC-CYBMUJFWSA-N
9739	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Yamada S (2000)	11215397	177991	704	Apomorphine	(-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin	movapo|apokyn	DRUGBANK	DB00714	C17H17NO2	small molecule	G04BE07|N04BC07	58-00-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMWNQDUVQKEIOC-CYBMUJFWSA-N
9740	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Lucht MJ (2001)	11692072	177990	704	Apomorphine	(-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin	movapo|apokyn	DRUGBANK	DB00714	C17H17NO2	small molecule	G04BE07|N04BC07	58-00-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMWNQDUVQKEIOC-CYBMUJFWSA-N
9741	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Lam YW (2000)	10641988	174664	704	Apomorphine	(-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin	movapo|apokyn	DRUGBANK	DB00714	C17H17NO2	small molecule	G04BE07|N04BC07	58-00-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMWNQDUVQKEIOC-CYBMUJFWSA-N
9742	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Yamada S (1999)	10494453	177988	704	Apomorphine	(-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin	movapo|apokyn	DRUGBANK	DB00714	C17H17NO2	small molecule	G04BE07|N04BC07	58-00-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMWNQDUVQKEIOC-CYBMUJFWSA-N
9743	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Kim HJ (2001)	11212866	177989	704	Apomorphine	(-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin	movapo|apokyn	DRUGBANK	DB00714	C17H17NO2	small molecule	G04BE07|N04BC07	58-00-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMWNQDUVQKEIOC-CYBMUJFWSA-N
9775	116014	10800	-	CYSLTR1	CYSLT1|CYSLT1R|CYSLTR|HMTMF81	9606	Homo sapiens	suppressor	target	Yazid S (2010)	20558817	178002	706	Nedocromil	9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)quinoline-2,8-dicarboxylic acid|Nedocromilo|Nedocromilum|9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)chinolin-2,8-dicarbonsaeure|Nedocromil	alocril|mireze|tilade inhaler 	DRUGBANK	DB00716	C19H17NO7	small molecule	S01GX04|R01AC07|R03BC03	69049-73-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RQTOOFIXOKYGAN-UHFFFAOYSA-N
9776	116014	10800	-	CYSLTR1	CYSLT1|CYSLT1R|CYSLTR|HMTMF81	9606	Homo sapiens	suppressor	target	Radeau T (1993)	8386571	178003	706	Nedocromil	9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)quinoline-2,8-dicarboxylic acid|Nedocromilo|Nedocromilum|9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)chinolin-2,8-dicarbonsaeure|Nedocromil	alocril|mireze|tilade inhaler 	DRUGBANK	DB00716	C19H17NO7	small molecule	S01GX04|R01AC07|R03BC03	69049-73-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RQTOOFIXOKYGAN-UHFFFAOYSA-N
9777	116014	10800	-	CYSLTR1	CYSLT1|CYSLT1R|CYSLTR|HMTMF81	9606	Homo sapiens	suppressor	target	Overington JP (2006)	17139284	171741	706	Nedocromil	9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)quinoline-2,8-dicarboxylic acid|Nedocromilo|Nedocromilum|9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)chinolin-2,8-dicarbonsaeure|Nedocromil	alocril|mireze|tilade inhaler 	DRUGBANK	DB00716	C19H17NO7	small molecule	S01GX04|R01AC07|R03BC03	69049-73-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RQTOOFIXOKYGAN-UHFFFAOYSA-N
9778	116014	10800	-	CYSLTR1	CYSLT1|CYSLT1R|CYSLTR|HMTMF81	9606	Homo sapiens	suppressor	target	Monteseirin J (2005)	16164449	178004	706	Nedocromil	9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)quinoline-2,8-dicarboxylic acid|Nedocromilo|Nedocromilum|9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)chinolin-2,8-dicarbonsaeure|Nedocromil	alocril|mireze|tilade inhaler 	DRUGBANK	DB00716	C19H17NO7	small molecule	S01GX04|R01AC07|R03BC03	69049-73-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RQTOOFIXOKYGAN-UHFFFAOYSA-N
9779	116014	10800	-	CYSLTR1	CYSLT1|CYSLT1R|CYSLTR|HMTMF81	9606	Homo sapiens	suppressor	target	Imming P (2006)	17016423	171742	706	Nedocromil	9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)quinoline-2,8-dicarboxylic acid|Nedocromilo|Nedocromilum|9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)chinolin-2,8-dicarbonsaeure|Nedocromil	alocril|mireze|tilade inhaler 	DRUGBANK	DB00716	C19H17NO7	small molecule	S01GX04|R01AC07|R03BC03	69049-73-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RQTOOFIXOKYGAN-UHFFFAOYSA-N
9780	111701	5729	-	PTGDR	AS1|ASRT1|DP|DP1|PTGDR1	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	706	Nedocromil	9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)quinoline-2,8-dicarboxylic acid|Nedocromilo|Nedocromilum|9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)chinolin-2,8-dicarbonsaeure|Nedocromil	alocril|mireze|tilade inhaler 	DRUGBANK	DB00716	C19H17NO7	small molecule	S01GX04|R01AC07|R03BC03	69049-73-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RQTOOFIXOKYGAN-UHFFFAOYSA-N
9781	111701	5729	-	PTGDR	AS1|ASRT1|DP|DP1|PTGDR1	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	706	Nedocromil	9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)quinoline-2,8-dicarboxylic acid|Nedocromilo|Nedocromilum|9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)chinolin-2,8-dicarbonsaeure|Nedocromil	alocril|mireze|tilade inhaler 	DRUGBANK	DB00716	C19H17NO7	small molecule	S01GX04|R01AC07|R03BC03	69049-73-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RQTOOFIXOKYGAN-UHFFFAOYSA-N
9782	111701	5729	-	PTGDR	AS1|ASRT1|DP|DP1|PTGDR1	9606	Homo sapiens	unknown	target	Lane SJ (1996)	8939179	178006	706	Nedocromil	9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)quinoline-2,8-dicarboxylic acid|Nedocromilo|Nedocromilum|9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)chinolin-2,8-dicarbonsaeure|Nedocromil	alocril|mireze|tilade inhaler 	DRUGBANK	DB00716	C19H17NO7	small molecule	S01GX04|R01AC07|R03BC03	69049-73-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RQTOOFIXOKYGAN-UHFFFAOYSA-N
9783	111701	5729	-	PTGDR	AS1|ASRT1|DP|DP1|PTGDR1	9606	Homo sapiens	unknown	target	Ahluwalia P (2001)	11544467	178005	706	Nedocromil	9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)quinoline-2,8-dicarboxylic acid|Nedocromilo|Nedocromilum|9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)chinolin-2,8-dicarbonsaeure|Nedocromil	alocril|mireze|tilade inhaler 	DRUGBANK	DB00716	C19H17NO7	small molecule	S01GX04|R01AC07|R03BC03	69049-73-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RQTOOFIXOKYGAN-UHFFFAOYSA-N
9784	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Okada M (2003)	12803546	178008	706	Nedocromil	9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)quinoline-2,8-dicarboxylic acid|Nedocromilo|Nedocromilum|9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)chinolin-2,8-dicarbonsaeure|Nedocromil	alocril|mireze|tilade inhaler 	DRUGBANK	DB00716	C19H17NO7	small molecule	S01GX04|R01AC07|R03BC03	69049-73-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RQTOOFIXOKYGAN-UHFFFAOYSA-N
9785	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Nishikawa M (2008)	17980980	178007	706	Nedocromil	9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)quinoline-2,8-dicarboxylic acid|Nedocromilo|Nedocromilum|9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)chinolin-2,8-dicarbonsaeure|Nedocromil	alocril|mireze|tilade inhaler 	DRUGBANK	DB00716	C19H17NO7	small molecule	S01GX04|R01AC07|R03BC03	69049-73-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RQTOOFIXOKYGAN-UHFFFAOYSA-N
9786	121371	57105	PSEC0146	CYSLTR2	CYSLT2|CYSLT2R|HG57|HPN321|KPG_011|hGPCR21	9606	Homo sapiens	antagonist	target	Yazid S (2010)	20558817	178002	706	Nedocromil	9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)quinoline-2,8-dicarboxylic acid|Nedocromilo|Nedocromilum|9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)chinolin-2,8-dicarbonsaeure|Nedocromil	alocril|mireze|tilade inhaler 	DRUGBANK	DB00716	C19H17NO7	small molecule	S01GX04|R01AC07|R03BC03	69049-73-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RQTOOFIXOKYGAN-UHFFFAOYSA-N
9787	121371	57105	PSEC0146	CYSLTR2	CYSLT2|CYSLT2R|HG57|HPN321|KPG_011|hGPCR21	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	706	Nedocromil	9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)quinoline-2,8-dicarboxylic acid|Nedocromilo|Nedocromilum|9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)chinolin-2,8-dicarbonsaeure|Nedocromil	alocril|mireze|tilade inhaler 	DRUGBANK	DB00716	C19H17NO7	small molecule	S01GX04|R01AC07|R03BC03	69049-73-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RQTOOFIXOKYGAN-UHFFFAOYSA-N
9788	121371	57105	PSEC0146	CYSLTR2	CYSLT2|CYSLT2R|HG57|HPN321|KPG_011|hGPCR21	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	706	Nedocromil	9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)quinoline-2,8-dicarboxylic acid|Nedocromilo|Nedocromilum|9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)chinolin-2,8-dicarbonsaeure|Nedocromil	alocril|mireze|tilade inhaler 	DRUGBANK	DB00716	C19H17NO7	small molecule	S01GX04|R01AC07|R03BC03	69049-73-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RQTOOFIXOKYGAN-UHFFFAOYSA-N
9789	121371	57105	PSEC0146	CYSLTR2	CYSLT2|CYSLT2R|HG57|HPN321|KPG_011|hGPCR21	9606	Homo sapiens	antagonist	target	Monteseirin J (2005)	16164449	178004	706	Nedocromil	9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)quinoline-2,8-dicarboxylic acid|Nedocromilo|Nedocromilum|9-Ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano(3,2-g)chinolin-2,8-dicarbonsaeure|Nedocromil	alocril|mireze|tilade inhaler 	DRUGBANK	DB00716	C19H17NO7	small molecule	S01GX04|R01AC07|R03BC03	69049-73-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RQTOOFIXOKYGAN-UHFFFAOYSA-N
9834	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Andujar-Sanchez M (2007)	17618628	177073	712	Lisinopril	Lisinopril anhydrous|(S)-1-(N(2)-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline|Lisinoprilum|[N2-[(S)-1-CARBOXY-3-phenylpropyl]-L-lysyl-L-proline|Lisinopril	ava-lisinopril hct|apo-lisinop	DRUGBANK	DB00722	C21H31N3O5	small molecule	C09AA03|C09BA03|C09BB03|C10BX07	83915-83-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RLAWWYSOJDYHDC-BZSNNMDCSA-N
9835	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Piepho RW (2000)	11030016	174112	712	Lisinopril	Lisinopril anhydrous|(S)-1-(N(2)-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline|Lisinoprilum|[N2-[(S)-1-CARBOXY-3-phenylpropyl]-L-lysyl-L-proline|Lisinopril	ava-lisinopril hct|apo-lisinop	DRUGBANK	DB00722	C21H31N3O5	small molecule	C09AA03|C09BA03|C09BB03|C10BX07	83915-83-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RLAWWYSOJDYHDC-BZSNNMDCSA-N
9836	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Song JC (2002)	11929321	174114	712	Lisinopril	Lisinopril anhydrous|(S)-1-(N(2)-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline|Lisinoprilum|[N2-[(S)-1-CARBOXY-3-phenylpropyl]-L-lysyl-L-proline|Lisinopril	ava-lisinopril hct|apo-lisinop	DRUGBANK	DB00722	C21H31N3O5	small molecule	C09AA03|C09BA03|C09BB03|C10BX07	83915-83-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RLAWWYSOJDYHDC-BZSNNMDCSA-N
9837	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	712	Lisinopril	Lisinopril anhydrous|(S)-1-(N(2)-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline|Lisinoprilum|[N2-[(S)-1-CARBOXY-3-phenylpropyl]-L-lysyl-L-proline|Lisinopril	ava-lisinopril hct|apo-lisinop	DRUGBANK	DB00722	C21H31N3O5	small molecule	C09AA03|C09BA03|C09BB03|C10BX07	83915-83-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RLAWWYSOJDYHDC-BZSNNMDCSA-N
9838	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Tellez-Sanz R (1998)	9506845	178040	712	Lisinopril	Lisinopril anhydrous|(S)-1-(N(2)-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline|Lisinoprilum|[N2-[(S)-1-CARBOXY-3-phenylpropyl]-L-lysyl-L-proline|Lisinopril	ava-lisinopril hct|apo-lisinop	DRUGBANK	DB00722	C21H31N3O5	small molecule	C09AA03|C09BA03|C09BB03|C10BX07	83915-83-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RLAWWYSOJDYHDC-BZSNNMDCSA-N
9892	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	unknown	target	Berger M (1996)	8863001	178063	716	Trimipramine	Trimipramine|Trimeproprimine|RP-7162|Trimipramina|10,11-dihydro-N,N,beta-Trimethyl-5H-dibenz[b,F]azepine-5-propanamine|5-(gamma-dimethylamino-beta-Methylpropyl)-10,11-dihydro-5H-dibenzo[b,F]azepine|Trimeprimina|Trimeprimine|Trimipraminum|beta-Methylimipramine|5-[3-(dimethylamino)-2-Methylpropyl]-10,11-dihydro-5H-dibenz[b,F]azepine|Sapilent	nu-trimipramine tab 100mg|trim	DRUGBANK	DB00726	C20H26N2	small molecule	N06AA06	739-71-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZSCDBOWYZJWBIY-UHFFFAOYSA-N
9928	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Scarsi M (2007)	17082235	178076	721	Nateglinide	-	starlix|starlix 180mg|nateglin	DRUGBANK	DB00731	C19H27NO3	small molecule	A10BX03	105816-04-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OELFLUMRDSZNSF-YJEKIOLLSA-N
9944	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Remington G (2006)	16513859	178091	724	Risperidone	Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone	risperdal m-tab|risperidone - 	DRUGBANK	DB00734	C23H27FN4O2	small molecule	N05AX08	106266-06-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAPZEAPATHNIPO-UHFFFAOYSA-N
9945	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Lane HY (2004)	15140279	178090	724	Risperidone	Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone	risperdal m-tab|risperidone - 	DRUGBANK	DB00734	C23H27FN4O2	small molecule	N05AX08	106266-06-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAPZEAPATHNIPO-UHFFFAOYSA-N
9946	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Fenton C (2005)	15907153	178092	724	Risperidone	Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone	risperdal m-tab|risperidone - 	DRUGBANK	DB00734	C23H27FN4O2	small molecule	N05AX08	106266-06-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAPZEAPATHNIPO-UHFFFAOYSA-N
9947	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	724	Risperidone	Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone	risperdal m-tab|risperidone - 	DRUGBANK	DB00734	C23H27FN4O2	small molecule	N05AX08	106266-06-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAPZEAPATHNIPO-UHFFFAOYSA-N
9948	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Catafau AM (2006)	17059881	178089	724	Risperidone	Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone	risperdal m-tab|risperidone - 	DRUGBANK	DB00734	C23H27FN4O2	small molecule	N05AX08	106266-06-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAPZEAPATHNIPO-UHFFFAOYSA-N
9949	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Richelson E (2000)	11132243	174623	724	Risperidone	Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone	risperdal m-tab|risperidone - 	DRUGBANK	DB00734	C23H27FN4O2	small molecule	N05AX08	106266-06-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAPZEAPATHNIPO-UHFFFAOYSA-N
9950	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Naiker DV (2006)	16730699	175316	724	Risperidone	Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone	risperdal m-tab|risperidone - 	DRUGBANK	DB00734	C23H27FN4O2	small molecule	N05AX08	106266-06-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAPZEAPATHNIPO-UHFFFAOYSA-N
9968	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	antagonist	target	Leysen JE (1994)	7520908	175510	724	Risperidone	Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone	risperdal m-tab|risperidone - 	DRUGBANK	DB00734	C23H27FN4O2	small molecule	N05AX08	106266-06-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAPZEAPATHNIPO-UHFFFAOYSA-N
9969	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	antagonist	target	Megens AA (1994)	7531353	178096	724	Risperidone	Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone	risperdal m-tab|risperidone - 	DRUGBANK	DB00734	C23H27FN4O2	small molecule	N05AX08	106266-06-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAPZEAPATHNIPO-UHFFFAOYSA-N
9970	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	antagonist	target	Leysen JE (1994)	7520908	175510	724	Risperidone	Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone	risperdal m-tab|risperidone - 	DRUGBANK	DB00734	C23H27FN4O2	small molecule	N05AX08	106266-06-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAPZEAPATHNIPO-UHFFFAOYSA-N
9971	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	antagonist	target	Megens AA (1994)	7531353	178096	724	Risperidone	Rispolept|Risperdal|Sequinan|Rispolin|Risperidona|Risperidonum|Risperin|risperdone	risperdal m-tab|risperidone - 	DRUGBANK	DB00734	C23H27FN4O2	small molecule	N05AX08	106266-06-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RAPZEAPATHNIPO-UHFFFAOYSA-N
10013	106798	301	RP11-71A24.1	ANXA1	ANX1|LPC1	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	731	Hydrocortisone	11beta,17alpha,21-Trihydroxy-4-pregnene-3,20-dione|Hidrocortisona|(11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione|11beta-hydrocortisone|Hydrocortisonum|Reichstein's substance M|Hydrocortisone|(11beta)-11,17,21-Trihydroxypregn-4-ene-3,20-dione|Cortisol|4-Pregnen-11beta,17alpha,21-triol-3,20-dione|11-hydrocortisone|Kendall's compound F|17-Hydroxycorticosterone	kaiser permanente hydrocortiso	DRUGBANK	DB00741	C21H30O5	small molecule	S01BB01|D07XA01|S01CA03|D07BA04|D07AA02|D07CA01|A07EA02|A01AC03|D07AB02|D07AC16|S03CA04|S02CA03|C05AA01|H02AB09|D07BB04|S01CB03|S02BA01|R01AD60|S01BA02	50-23-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JYGXADMDTFJGBT-VWUMJDOOSA-N
10014	106798	301	RP11-71A24.1	ANXA1	ANX1|LPC1	9606	Homo sapiens	agonist	target	Sato-Matsumura KC (2000)	11142771	178123	731	Hydrocortisone	11beta,17alpha,21-Trihydroxy-4-pregnene-3,20-dione|Hidrocortisona|(11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione|11beta-hydrocortisone|Hydrocortisonum|Reichstein's substance M|Hydrocortisone|(11beta)-11,17,21-Trihydroxypregn-4-ene-3,20-dione|Cortisol|4-Pregnen-11beta,17alpha,21-triol-3,20-dione|11-hydrocortisone|Kendall's compound F|17-Hydroxycorticosterone	kaiser permanente hydrocortiso	DRUGBANK	DB00741	C21H30O5	small molecule	S01BB01|D07XA01|S01CA03|D07BA04|D07AA02|D07CA01|A07EA02|A01AC03|D07AB02|D07AC16|S03CA04|S02CA03|C05AA01|H02AB09|D07BB04|S01CB03|S02BA01|R01AD60|S01BA02	50-23-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JYGXADMDTFJGBT-VWUMJDOOSA-N
10015	106798	301	RP11-71A24.1	ANXA1	ANX1|LPC1	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	731	Hydrocortisone	11beta,17alpha,21-Trihydroxy-4-pregnene-3,20-dione|Hidrocortisona|(11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione|11beta-hydrocortisone|Hydrocortisonum|Reichstein's substance M|Hydrocortisone|(11beta)-11,17,21-Trihydroxypregn-4-ene-3,20-dione|Cortisol|4-Pregnen-11beta,17alpha,21-triol-3,20-dione|11-hydrocortisone|Kendall's compound F|17-Hydroxycorticosterone	kaiser permanente hydrocortiso	DRUGBANK	DB00741	C21H30O5	small molecule	S01BB01|D07XA01|S01CA03|D07BA04|D07AA02|D07CA01|A07EA02|A01AC03|D07AB02|D07AC16|S03CA04|S02CA03|C05AA01|H02AB09|D07BB04|S01CB03|S02BA01|R01AD60|S01BA02	50-23-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JYGXADMDTFJGBT-VWUMJDOOSA-N
10016	106798	301	RP11-71A24.1	ANXA1	ANX1|LPC1	9606	Homo sapiens	agonist	target	Serres M (1994)	8060156	178125	731	Hydrocortisone	11beta,17alpha,21-Trihydroxy-4-pregnene-3,20-dione|Hidrocortisona|(11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione|11beta-hydrocortisone|Hydrocortisonum|Reichstein's substance M|Hydrocortisone|(11beta)-11,17,21-Trihydroxypregn-4-ene-3,20-dione|Cortisol|4-Pregnen-11beta,17alpha,21-triol-3,20-dione|11-hydrocortisone|Kendall's compound F|17-Hydroxycorticosterone	kaiser permanente hydrocortiso	DRUGBANK	DB00741	C21H30O5	small molecule	S01BB01|D07XA01|S01CA03|D07BA04|D07AA02|D07CA01|A07EA02|A01AC03|D07AB02|D07AC16|S03CA04|S02CA03|C05AA01|H02AB09|D07BB04|S01CB03|S02BA01|R01AD60|S01BA02	50-23-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JYGXADMDTFJGBT-VWUMJDOOSA-N
10017	106798	301	RP11-71A24.1	ANXA1	ANX1|LPC1	9606	Homo sapiens	agonist	target	White MV (1991)	1712816	178124	731	Hydrocortisone	11beta,17alpha,21-Trihydroxy-4-pregnene-3,20-dione|Hidrocortisona|(11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione|11beta-hydrocortisone|Hydrocortisonum|Reichstein's substance M|Hydrocortisone|(11beta)-11,17,21-Trihydroxypregn-4-ene-3,20-dione|Cortisol|4-Pregnen-11beta,17alpha,21-triol-3,20-dione|11-hydrocortisone|Kendall's compound F|17-Hydroxycorticosterone	kaiser permanente hydrocortiso	DRUGBANK	DB00741	C21H30O5	small molecule	S01BB01|D07XA01|S01CA03|D07BA04|D07AA02|D07CA01|A07EA02|A01AC03|D07AB02|D07AC16|S03CA04|S02CA03|C05AA01|H02AB09|D07BB04|S01CB03|S02BA01|R01AD60|S01BA02	50-23-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JYGXADMDTFJGBT-VWUMJDOOSA-N
10023	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Berger W (2007)	17394438	178138	734	Zileuton	N-[1-(Benzo[b]thiophen-2-yl)ethyl]-N-hydroxyurea|Zyflo|Zileutonum|Leutrol|N-(1-Benzo(b)thien-2-ylethyl)-N-hydroxyurea|Zileuton|(+-)-1-(1-Benzo[b]thien-2-ylethyl)-1-hydroxyurea	zileuton|zyflo cr|zyflo	DRUGBANK	DB00744	C11H12N2O2S	small molecule	-	111406-87-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWLSOWXNZPKENC-UHFFFAOYSA-N
10024	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Hardy DB (1999)	10377029	178139	734	Zileuton	N-[1-(Benzo[b]thiophen-2-yl)ethyl]-N-hydroxyurea|Zyflo|Zileutonum|Leutrol|N-(1-Benzo(b)thien-2-ylethyl)-N-hydroxyurea|Zileuton|(+-)-1-(1-Benzo[b]thien-2-ylethyl)-1-hydroxyurea	zileuton|zyflo cr|zyflo	DRUGBANK	DB00744	C11H12N2O2S	small molecule	-	111406-87-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWLSOWXNZPKENC-UHFFFAOYSA-N
10025	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Qian C (2001)	11529688	178143	734	Zileuton	N-[1-(Benzo[b]thiophen-2-yl)ethyl]-N-hydroxyurea|Zyflo|Zileutonum|Leutrol|N-(1-Benzo(b)thien-2-ylethyl)-N-hydroxyurea|Zileuton|(+-)-1-(1-Benzo[b]thien-2-ylethyl)-1-hydroxyurea	zileuton|zyflo cr|zyflo	DRUGBANK	DB00744	C11H12N2O2S	small molecule	-	111406-87-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWLSOWXNZPKENC-UHFFFAOYSA-N
10026	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	734	Zileuton	N-[1-(Benzo[b]thiophen-2-yl)ethyl]-N-hydroxyurea|Zyflo|Zileutonum|Leutrol|N-(1-Benzo(b)thien-2-ylethyl)-N-hydroxyurea|Zileuton|(+-)-1-(1-Benzo[b]thien-2-ylethyl)-1-hydroxyurea	zileuton|zyflo cr|zyflo	DRUGBANK	DB00744	C11H12N2O2S	small molecule	-	111406-87-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWLSOWXNZPKENC-UHFFFAOYSA-N
10027	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Zouboulis CC (2009)	20436887	178144	734	Zileuton	N-[1-(Benzo[b]thiophen-2-yl)ethyl]-N-hydroxyurea|Zyflo|Zileutonum|Leutrol|N-(1-Benzo(b)thien-2-ylethyl)-N-hydroxyurea|Zileuton|(+-)-1-(1-Benzo[b]thien-2-ylethyl)-1-hydroxyurea	zileuton|zyflo cr|zyflo	DRUGBANK	DB00744	C11H12N2O2S	small molecule	-	111406-87-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWLSOWXNZPKENC-UHFFFAOYSA-N
10028	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Zouboulis CC (2010)	19645854	178136	734	Zileuton	N-[1-(Benzo[b]thiophen-2-yl)ethyl]-N-hydroxyurea|Zyflo|Zileutonum|Leutrol|N-(1-Benzo(b)thien-2-ylethyl)-N-hydroxyurea|Zileuton|(+-)-1-(1-Benzo[b]thien-2-ylethyl)-1-hydroxyurea	zileuton|zyflo cr|zyflo	DRUGBANK	DB00744	C11H12N2O2S	small molecule	-	111406-87-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWLSOWXNZPKENC-UHFFFAOYSA-N
10029	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Coffey MJ (2001)	11561080	178137	734	Zileuton	N-[1-(Benzo[b]thiophen-2-yl)ethyl]-N-hydroxyurea|Zyflo|Zileutonum|Leutrol|N-(1-Benzo(b)thien-2-ylethyl)-N-hydroxyurea|Zileuton|(+-)-1-(1-Benzo[b]thien-2-ylethyl)-1-hydroxyurea	zileuton|zyflo cr|zyflo	DRUGBANK	DB00744	C11H12N2O2S	small molecule	-	111406-87-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWLSOWXNZPKENC-UHFFFAOYSA-N
10030	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Wenzel SE (1999)	10322101	178141	734	Zileuton	N-[1-(Benzo[b]thiophen-2-yl)ethyl]-N-hydroxyurea|Zyflo|Zileutonum|Leutrol|N-(1-Benzo(b)thien-2-ylethyl)-N-hydroxyurea|Zileuton|(+-)-1-(1-Benzo[b]thien-2-ylethyl)-1-hydroxyurea	zileuton|zyflo cr|zyflo	DRUGBANK	DB00744	C11H12N2O2S	small molecule	-	111406-87-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWLSOWXNZPKENC-UHFFFAOYSA-N
10031	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Yamashita M (2000)	10694244	178140	734	Zileuton	N-[1-(Benzo[b]thiophen-2-yl)ethyl]-N-hydroxyurea|Zyflo|Zileutonum|Leutrol|N-(1-Benzo(b)thien-2-ylethyl)-N-hydroxyurea|Zileuton|(+-)-1-(1-Benzo[b]thien-2-ylethyl)-1-hydroxyurea	zileuton|zyflo cr|zyflo	DRUGBANK	DB00744	C11H12N2O2S	small molecule	-	111406-87-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWLSOWXNZPKENC-UHFFFAOYSA-N
10032	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Wenzel SE (1996)	8826571	178142	734	Zileuton	N-[1-(Benzo[b]thiophen-2-yl)ethyl]-N-hydroxyurea|Zyflo|Zileutonum|Leutrol|N-(1-Benzo(b)thien-2-ylethyl)-N-hydroxyurea|Zileuton|(+-)-1-(1-Benzo[b]thien-2-ylethyl)-1-hydroxyurea	zileuton|zyflo cr|zyflo	DRUGBANK	DB00744	C11H12N2O2S	small molecule	-	111406-87-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWLSOWXNZPKENC-UHFFFAOYSA-N
10033	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Guidot DM (1994)	8058773	178145	734	Zileuton	N-[1-(Benzo[b]thiophen-2-yl)ethyl]-N-hydroxyurea|Zyflo|Zileutonum|Leutrol|N-(1-Benzo(b)thien-2-ylethyl)-N-hydroxyurea|Zileuton|(+-)-1-(1-Benzo[b]thien-2-ylethyl)-1-hydroxyurea	zileuton|zyflo cr|zyflo	DRUGBANK	DB00744	C11H12N2O2S	small molecule	-	111406-87-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWLSOWXNZPKENC-UHFFFAOYSA-N
10055	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Glaser K (1995)	8566109	178167	739	Etodolac	Etodolac|(1,8-Diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indol-1-yl)-acetic acid|todolac|1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-ylacetic acid|1,3,4,9-Tetrahydro-1,8-diethylpyrano(3,4-b)indole-1-acetic acid|Etodolaco|Etodolacum|Etodolsure|Etodolic acid|(+-)-1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid|1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid	taro-etodolac 200 mg|etodolac|	DRUGBANK	DB00749	C17H21NO3	small molecule	M01AB08	41340-25-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NNYBQONXHNTVIJ-UHFFFAOYSA-N
10056	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Riendeau D (1997)	9146894	178169	739	Etodolac	Etodolac|(1,8-Diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indol-1-yl)-acetic acid|todolac|1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-ylacetic acid|1,3,4,9-Tetrahydro-1,8-diethylpyrano(3,4-b)indole-1-acetic acid|Etodolaco|Etodolacum|Etodolsure|Etodolic acid|(+-)-1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid|1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid	taro-etodolac 200 mg|etodolac|	DRUGBANK	DB00749	C17H21NO3	small molecule	M01AB08	41340-25-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NNYBQONXHNTVIJ-UHFFFAOYSA-N
10057	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Hirate K (2006)	16473424	178168	739	Etodolac	Etodolac|(1,8-Diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indol-1-yl)-acetic acid|todolac|1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-ylacetic acid|1,3,4,9-Tetrahydro-1,8-diethylpyrano(3,4-b)indole-1-acetic acid|Etodolaco|Etodolacum|Etodolsure|Etodolic acid|(+-)-1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid|1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid	taro-etodolac 200 mg|etodolac|	DRUGBANK	DB00749	C17H21NO3	small molecule	M01AB08	41340-25-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NNYBQONXHNTVIJ-UHFFFAOYSA-N
10058	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Campbell NB (2002)	12358053	178170	739	Etodolac	Etodolac|(1,8-Diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indol-1-yl)-acetic acid|todolac|1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-ylacetic acid|1,3,4,9-Tetrahydro-1,8-diethylpyrano(3,4-b)indole-1-acetic acid|Etodolaco|Etodolacum|Etodolsure|Etodolic acid|(+-)-1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid|1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid	taro-etodolac 200 mg|etodolac|	DRUGBANK	DB00749	C17H21NO3	small molecule	M01AB08	41340-25-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NNYBQONXHNTVIJ-UHFFFAOYSA-N
10059	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Wilson JE (2004)	15198222	178171	739	Etodolac	Etodolac|(1,8-Diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indol-1-yl)-acetic acid|todolac|1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-ylacetic acid|1,3,4,9-Tetrahydro-1,8-diethylpyrano(3,4-b)indole-1-acetic acid|Etodolaco|Etodolacum|Etodolsure|Etodolic acid|(+-)-1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid|1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid	taro-etodolac 200 mg|etodolac|	DRUGBANK	DB00749	C17H21NO3	small molecule	M01AB08	41340-25-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NNYBQONXHNTVIJ-UHFFFAOYSA-N
10061	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen WS (2001)	11275997	178176	739	Etodolac	Etodolac|(1,8-Diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indol-1-yl)-acetic acid|todolac|1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-ylacetic acid|1,3,4,9-Tetrahydro-1,8-diethylpyrano(3,4-b)indole-1-acetic acid|Etodolaco|Etodolacum|Etodolsure|Etodolic acid|(+-)-1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid|1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid	taro-etodolac 200 mg|etodolac|	DRUGBANK	DB00749	C17H21NO3	small molecule	M01AB08	41340-25-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NNYBQONXHNTVIJ-UHFFFAOYSA-N
10062	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Svendsen KB (2000)	11009046	178174	739	Etodolac	Etodolac|(1,8-Diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indol-1-yl)-acetic acid|todolac|1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-ylacetic acid|1,3,4,9-Tetrahydro-1,8-diethylpyrano(3,4-b)indole-1-acetic acid|Etodolaco|Etodolacum|Etodolsure|Etodolic acid|(+-)-1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid|1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid	taro-etodolac 200 mg|etodolac|	DRUGBANK	DB00749	C17H21NO3	small molecule	M01AB08	41340-25-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NNYBQONXHNTVIJ-UHFFFAOYSA-N
10063	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Kusuhara H (1999)	10594327	178175	739	Etodolac	Etodolac|(1,8-Diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indol-1-yl)-acetic acid|todolac|1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-ylacetic acid|1,3,4,9-Tetrahydro-1,8-diethylpyrano(3,4-b)indole-1-acetic acid|Etodolaco|Etodolacum|Etodolsure|Etodolic acid|(+-)-1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid|1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid	taro-etodolac 200 mg|etodolac|	DRUGBANK	DB00749	C17H21NO3	small molecule	M01AB08	41340-25-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NNYBQONXHNTVIJ-UHFFFAOYSA-N
10064	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen WS (2003)	12824918	178173	739	Etodolac	Etodolac|(1,8-Diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indol-1-yl)-acetic acid|todolac|1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-ylacetic acid|1,3,4,9-Tetrahydro-1,8-diethylpyrano(3,4-b)indole-1-acetic acid|Etodolaco|Etodolacum|Etodolsure|Etodolic acid|(+-)-1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid|1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid	taro-etodolac 200 mg|etodolac|	DRUGBANK	DB00749	C17H21NO3	small molecule	M01AB08	41340-25-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NNYBQONXHNTVIJ-UHFFFAOYSA-N
10065	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Wilson JE (2004)	15198222	178171	739	Etodolac	Etodolac|(1,8-Diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indol-1-yl)-acetic acid|todolac|1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-ylacetic acid|1,3,4,9-Tetrahydro-1,8-diethylpyrano(3,4-b)indole-1-acetic acid|Etodolaco|Etodolacum|Etodolsure|Etodolic acid|(+-)-1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid|1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid	taro-etodolac 200 mg|etodolac|	DRUGBANK	DB00749	C17H21NO3	small molecule	M01AB08	41340-25-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NNYBQONXHNTVIJ-UHFFFAOYSA-N
10066	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	739	Etodolac	Etodolac|(1,8-Diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indol-1-yl)-acetic acid|todolac|1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-ylacetic acid|1,3,4,9-Tetrahydro-1,8-diethylpyrano(3,4-b)indole-1-acetic acid|Etodolaco|Etodolacum|Etodolsure|Etodolic acid|(+-)-1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid|1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid	taro-etodolac 200 mg|etodolac|	DRUGBANK	DB00749	C17H21NO3	small molecule	M01AB08	41340-25-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NNYBQONXHNTVIJ-UHFFFAOYSA-N
10286	111704	5732	-	PTGER2	EP2	9606	Homo sapiens	agonist	target	Dijkstra BG (1999)	10509658	178309	760	Alprostadil	(13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate|Prostaglandin e1|PGE|Alprostadil|Alprostadil Alfadex|11alpha,15alpha-Dihydroxy-9-oxo-13-trans-prostenoic acid|Prostin vr|Edex|Befar|Caverject|Muse|Alprostadilum|PGE1 -CD|PGE-1|(11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid	prostin vr sterile solution|ca	DRUGBANK	DB00770	C20H34O5	small molecule	G04BE01|C01EA01	745-65-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMVPRGQOIOIIMI-DWKJAMRDSA-N
10287	111704	5732	-	PTGER2	EP2	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	760	Alprostadil	(13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate|Prostaglandin e1|PGE|Alprostadil|Alprostadil Alfadex|11alpha,15alpha-Dihydroxy-9-oxo-13-trans-prostenoic acid|Prostin vr|Edex|Befar|Caverject|Muse|Alprostadilum|PGE1 -CD|PGE-1|(11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid	prostin vr sterile solution|ca	DRUGBANK	DB00770	C20H34O5	small molecule	G04BE01|C01EA01	745-65-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMVPRGQOIOIIMI-DWKJAMRDSA-N
10288	111704	5732	-	PTGER2	EP2	9606	Homo sapiens	agonist	target	Takahashi HK (2005)	15840408	178310	760	Alprostadil	(13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate|Prostaglandin e1|PGE|Alprostadil|Alprostadil Alfadex|11alpha,15alpha-Dihydroxy-9-oxo-13-trans-prostenoic acid|Prostin vr|Edex|Befar|Caverject|Muse|Alprostadilum|PGE1 -CD|PGE-1|(11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid	prostin vr sterile solution|ca	DRUGBANK	DB00770	C20H34O5	small molecule	G04BE01|C01EA01	745-65-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMVPRGQOIOIIMI-DWKJAMRDSA-N
10289	111703	5731	-	PTGER1	EP1	9606	Homo sapiens	agonist	target	Ito Y (2000)	10670413	178312	760	Alprostadil	(13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate|Prostaglandin e1|PGE|Alprostadil|Alprostadil Alfadex|11alpha,15alpha-Dihydroxy-9-oxo-13-trans-prostenoic acid|Prostin vr|Edex|Befar|Caverject|Muse|Alprostadilum|PGE1 -CD|PGE-1|(11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid	prostin vr sterile solution|ca	DRUGBANK	DB00770	C20H34O5	small molecule	G04BE01|C01EA01	745-65-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMVPRGQOIOIIMI-DWKJAMRDSA-N
10290	111703	5731	-	PTGER1	EP1	9606	Homo sapiens	agonist	target	Norel X (2004)	15560119	178313	760	Alprostadil	(13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate|Prostaglandin e1|PGE|Alprostadil|Alprostadil Alfadex|11alpha,15alpha-Dihydroxy-9-oxo-13-trans-prostenoic acid|Prostin vr|Edex|Befar|Caverject|Muse|Alprostadilum|PGE1 -CD|PGE-1|(11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid	prostin vr sterile solution|ca	DRUGBANK	DB00770	C20H34O5	small molecule	G04BE01|C01EA01	745-65-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMVPRGQOIOIIMI-DWKJAMRDSA-N
10291	111703	5731	-	PTGER1	EP1	9606	Homo sapiens	agonist	target	Takahashi HK (2003)	14561849	178311	760	Alprostadil	(13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate|Prostaglandin e1|PGE|Alprostadil|Alprostadil Alfadex|11alpha,15alpha-Dihydroxy-9-oxo-13-trans-prostenoic acid|Prostin vr|Edex|Befar|Caverject|Muse|Alprostadilum|PGE1 -CD|PGE-1|(11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid	prostin vr sterile solution|ca	DRUGBANK	DB00770	C20H34O5	small molecule	G04BE01|C01EA01	745-65-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMVPRGQOIOIIMI-DWKJAMRDSA-N
10292	111703	5731	-	PTGER1	EP1	9606	Homo sapiens	agonist	target	Matlhagela K (2006)	16516814	178314	760	Alprostadil	(13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate|Prostaglandin e1|PGE|Alprostadil|Alprostadil Alfadex|11alpha,15alpha-Dihydroxy-9-oxo-13-trans-prostenoic acid|Prostin vr|Edex|Befar|Caverject|Muse|Alprostadilum|PGE1 -CD|PGE-1|(11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid	prostin vr sterile solution|ca	DRUGBANK	DB00770	C20H34O5	small molecule	G04BE01|C01EA01	745-65-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMVPRGQOIOIIMI-DWKJAMRDSA-N
10293	111703	5731	-	PTGER1	EP1	9606	Homo sapiens	agonist	target	Tokuda H (2001)	11524243	178315	760	Alprostadil	(13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate|Prostaglandin e1|PGE|Alprostadil|Alprostadil Alfadex|11alpha,15alpha-Dihydroxy-9-oxo-13-trans-prostenoic acid|Prostin vr|Edex|Befar|Caverject|Muse|Alprostadilum|PGE1 -CD|PGE-1|(11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid	prostin vr sterile solution|ca	DRUGBANK	DB00770	C20H34O5	small molecule	G04BE01|C01EA01	745-65-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMVPRGQOIOIIMI-DWKJAMRDSA-N
10351	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	767	Propiomazine	10-(2-Dimethylaminopropyl)-2-propionylphenothiazine|3-Propionyl-10-dimethylaminoisopropylphenothiazine|Propiomazine|Propiomazin|2-Propionyl-10-(2-(dimethylamino)propyl)phenothiazine|Propiomazina|Propiomazinum	-	DRUGBANK	DB00777	C20H24N2OS	small molecule	N05CM06	362-29-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UVOIBTBFPOZKGP-UHFFFAOYSA-N
10352	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	767	Propiomazine	10-(2-Dimethylaminopropyl)-2-propionylphenothiazine|3-Propionyl-10-dimethylaminoisopropylphenothiazine|Propiomazine|Propiomazin|2-Propionyl-10-(2-(dimethylamino)propyl)phenothiazine|Propiomazina|Propiomazinum	-	DRUGBANK	DB00777	C20H24N2OS	small molecule	N05CM06	362-29-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UVOIBTBFPOZKGP-UHFFFAOYSA-N
10361	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	767	Propiomazine	10-(2-Dimethylaminopropyl)-2-propionylphenothiazine|3-Propionyl-10-dimethylaminoisopropylphenothiazine|Propiomazine|Propiomazin|2-Propionyl-10-(2-(dimethylamino)propyl)phenothiazine|Propiomazina|Propiomazinum	-	DRUGBANK	DB00777	C20H24N2OS	small molecule	N05CM06	362-29-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UVOIBTBFPOZKGP-UHFFFAOYSA-N
10362	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	767	Propiomazine	10-(2-Dimethylaminopropyl)-2-propionylphenothiazine|3-Propionyl-10-dimethylaminoisopropylphenothiazine|Propiomazine|Propiomazin|2-Propionyl-10-(2-(dimethylamino)propyl)phenothiazine|Propiomazina|Propiomazinum	-	DRUGBANK	DB00777	C20H24N2OS	small molecule	N05CM06	362-29-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UVOIBTBFPOZKGP-UHFFFAOYSA-N
10421	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Cryer B (1998)	9626023	178378	774	Mefenamic acid	CN 35355|CN-35355|Mefenaminsaeure|Acidum mefenamicum|Acido mefenamico|Mefenaminsure|INF-3355|INF 3355|N-(2,3-Xylyl)-2-aminobenzoic acid|Ponstel|N-2,3-Xylylanthranilic acid|Acide mfnamique|CI-473	mefenamic acid|nu-mefenamic 25	DRUGBANK	DB00784	C15H15NO2	small molecule	M01AG01	61-68-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYYBABOKPJLUIN-UHFFFAOYSA-N
10422	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Joo Y (2006)	16223958	178379	774	Mefenamic acid	CN 35355|CN-35355|Mefenaminsaeure|Acidum mefenamicum|Acido mefenamico|Mefenaminsure|INF-3355|INF 3355|N-(2,3-Xylyl)-2-aminobenzoic acid|Ponstel|N-2,3-Xylylanthranilic acid|Acide mfnamique|CI-473	mefenamic acid|nu-mefenamic 25	DRUGBANK	DB00784	C15H15NO2	small molecule	M01AG01	61-68-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYYBABOKPJLUIN-UHFFFAOYSA-N
10423	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Gierse JK (1995)	7832763	178380	774	Mefenamic acid	CN 35355|CN-35355|Mefenaminsaeure|Acidum mefenamicum|Acido mefenamico|Mefenaminsure|INF-3355|INF 3355|N-(2,3-Xylyl)-2-aminobenzoic acid|Ponstel|N-2,3-Xylylanthranilic acid|Acide mfnamique|CI-473	mefenamic acid|nu-mefenamic 25	DRUGBANK	DB00784	C15H15NO2	small molecule	M01AG01	61-68-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYYBABOKPJLUIN-UHFFFAOYSA-N
10424	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Sinniah R (2001)	11316248	178376	774	Mefenamic acid	CN 35355|CN-35355|Mefenaminsaeure|Acidum mefenamicum|Acido mefenamico|Mefenaminsure|INF-3355|INF 3355|N-(2,3-Xylyl)-2-aminobenzoic acid|Ponstel|N-2,3-Xylylanthranilic acid|Acide mfnamique|CI-473	mefenamic acid|nu-mefenamic 25	DRUGBANK	DB00784	C15H15NO2	small molecule	M01AG01	61-68-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYYBABOKPJLUIN-UHFFFAOYSA-N
10425	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Laudanno OM (1998)	9773153	178377	774	Mefenamic acid	CN 35355|CN-35355|Mefenaminsaeure|Acidum mefenamicum|Acido mefenamico|Mefenaminsure|INF-3355|INF 3355|N-(2,3-Xylyl)-2-aminobenzoic acid|Ponstel|N-2,3-Xylylanthranilic acid|Acide mfnamique|CI-473	mefenamic acid|nu-mefenamic 25	DRUGBANK	DB00784	C15H15NO2	small molecule	M01AG01	61-68-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYYBABOKPJLUIN-UHFFFAOYSA-N
10426	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Bhat AS (2005)	15792781	65577	774	Mefenamic acid	CN 35355|CN-35355|Mefenaminsaeure|Acidum mefenamicum|Acido mefenamico|Mefenaminsure|INF-3355|INF 3355|N-(2,3-Xylyl)-2-aminobenzoic acid|Ponstel|N-2,3-Xylylanthranilic acid|Acide mfnamique|CI-473	mefenamic acid|nu-mefenamic 25	DRUGBANK	DB00784	C15H15NO2	small molecule	M01AG01	61-68-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYYBABOKPJLUIN-UHFFFAOYSA-N
10427	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Walton LJ (1999)	10393680	178381	774	Mefenamic acid	CN 35355|CN-35355|Mefenaminsaeure|Acidum mefenamicum|Acido mefenamico|Mefenaminsure|INF-3355|INF 3355|N-(2,3-Xylyl)-2-aminobenzoic acid|Ponstel|N-2,3-Xylylanthranilic acid|Acide mfnamique|CI-473	mefenamic acid|nu-mefenamic 25	DRUGBANK	DB00784	C15H15NO2	small molecule	M01AG01	61-68-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYYBABOKPJLUIN-UHFFFAOYSA-N
10428	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Gierse JK (1995)	7832763	178380	774	Mefenamic acid	CN 35355|CN-35355|Mefenaminsaeure|Acidum mefenamicum|Acido mefenamico|Mefenaminsure|INF-3355|INF 3355|N-(2,3-Xylyl)-2-aminobenzoic acid|Ponstel|N-2,3-Xylylanthranilic acid|Acide mfnamique|CI-473	mefenamic acid|nu-mefenamic 25	DRUGBANK	DB00784	C15H15NO2	small molecule	M01AG01	61-68-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYYBABOKPJLUIN-UHFFFAOYSA-N
10429	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	774	Mefenamic acid	CN 35355|CN-35355|Mefenaminsaeure|Acidum mefenamicum|Acido mefenamico|Mefenaminsure|INF-3355|INF 3355|N-(2,3-Xylyl)-2-aminobenzoic acid|Ponstel|N-2,3-Xylylanthranilic acid|Acide mfnamique|CI-473	mefenamic acid|nu-mefenamic 25	DRUGBANK	DB00784	C15H15NO2	small molecule	M01AG01	61-68-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYYBABOKPJLUIN-UHFFFAOYSA-N
10430	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Bhat AS (2007)	17150210	178382	774	Mefenamic acid	CN 35355|CN-35355|Mefenaminsaeure|Acidum mefenamicum|Acido mefenamico|Mefenaminsure|INF-3355|INF 3355|N-(2,3-Xylyl)-2-aminobenzoic acid|Ponstel|N-2,3-Xylylanthranilic acid|Acide mfnamique|CI-473	mefenamic acid|nu-mefenamic 25	DRUGBANK	DB00784	C15H15NO2	small molecule	M01AG01	61-68-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYYBABOKPJLUIN-UHFFFAOYSA-N
10431	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Cryer B (1998)	9626023	178378	774	Mefenamic acid	CN 35355|CN-35355|Mefenaminsaeure|Acidum mefenamicum|Acido mefenamico|Mefenaminsure|INF-3355|INF 3355|N-(2,3-Xylyl)-2-aminobenzoic acid|Ponstel|N-2,3-Xylylanthranilic acid|Acide mfnamique|CI-473	mefenamic acid|nu-mefenamic 25	DRUGBANK	DB00784	C15H15NO2	small molecule	M01AG01	61-68-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYYBABOKPJLUIN-UHFFFAOYSA-N
10500	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	James MJ (2007)	17541796	178397	778	Naproxen	(S)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid|(+)-(S)-Naproxen|Naproxne|Naproxeno|(+)-Naproxen|Naproxenum|(S)-(+)-Naproxen|(+)-2-(6-Methoxy-2-naphthyl)propionic acid|(+)-2-(Methoxy-2-naphthyl)-propionic acid|(+)-(S)-6-Methoxy--methyl-2-naphthaleneacetic acid|(S)-Naproxen|(S)-2-(6-Methoxy-2-naphthyl)propionic acid|(+)-2-(Methoxy-2-naphthyl)-propionsure|Naproxen|Naprolag|(S)-2-(6-Methoxy-2-naphthyl)propanoic acid|(S)-(+)-2-(6-Methoxy-2-naphthyl)propionic acid	ntp-naproxen sodium|naprosyn 5	DRUGBANK	DB00788	C14H14O3	small molecule	M01AE56|G02CC02|M02AA12|M01AE52|M01AE02	22204-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CMWTZPSULFXXJA-VIFPVBQESA-N
10501	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Dhir A (2007)	17604186	178398	778	Naproxen	(S)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid|(+)-(S)-Naproxen|Naproxne|Naproxeno|(+)-Naproxen|Naproxenum|(S)-(+)-Naproxen|(+)-2-(6-Methoxy-2-naphthyl)propionic acid|(+)-2-(Methoxy-2-naphthyl)-propionic acid|(+)-(S)-6-Methoxy--methyl-2-naphthaleneacetic acid|(S)-Naproxen|(S)-2-(6-Methoxy-2-naphthyl)propionic acid|(+)-2-(Methoxy-2-naphthyl)-propionsure|Naproxen|Naprolag|(S)-2-(6-Methoxy-2-naphthyl)propanoic acid|(S)-(+)-2-(6-Methoxy-2-naphthyl)propionic acid	ntp-naproxen sodium|naprosyn 5	DRUGBANK	DB00788	C14H14O3	small molecule	M01AE56|G02CC02|M02AA12|M01AE52|M01AE02	22204-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CMWTZPSULFXXJA-VIFPVBQESA-N
10502	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	White WB (2007)	17612049	178399	778	Naproxen	(S)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid|(+)-(S)-Naproxen|Naproxne|Naproxeno|(+)-Naproxen|Naproxenum|(S)-(+)-Naproxen|(+)-2-(6-Methoxy-2-naphthyl)propionic acid|(+)-2-(Methoxy-2-naphthyl)-propionic acid|(+)-(S)-6-Methoxy--methyl-2-naphthaleneacetic acid|(S)-Naproxen|(S)-2-(6-Methoxy-2-naphthyl)propionic acid|(+)-2-(Methoxy-2-naphthyl)-propionsure|Naproxen|Naprolag|(S)-2-(6-Methoxy-2-naphthyl)propanoic acid|(S)-(+)-2-(6-Methoxy-2-naphthyl)propionic acid	ntp-naproxen sodium|naprosyn 5	DRUGBANK	DB00788	C14H14O3	small molecule	M01AE56|G02CC02|M02AA12|M01AE52|M01AE02	22204-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CMWTZPSULFXXJA-VIFPVBQESA-N
10503	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	778	Naproxen	(S)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid|(+)-(S)-Naproxen|Naproxne|Naproxeno|(+)-Naproxen|Naproxenum|(S)-(+)-Naproxen|(+)-2-(6-Methoxy-2-naphthyl)propionic acid|(+)-2-(Methoxy-2-naphthyl)-propionic acid|(+)-(S)-6-Methoxy--methyl-2-naphthaleneacetic acid|(S)-Naproxen|(S)-2-(6-Methoxy-2-naphthyl)propionic acid|(+)-2-(Methoxy-2-naphthyl)-propionsure|Naproxen|Naprolag|(S)-2-(6-Methoxy-2-naphthyl)propanoic acid|(S)-(+)-2-(6-Methoxy-2-naphthyl)propionic acid	ntp-naproxen sodium|naprosyn 5	DRUGBANK	DB00788	C14H14O3	small molecule	M01AE56|G02CC02|M02AA12|M01AE52|M01AE02	22204-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CMWTZPSULFXXJA-VIFPVBQESA-N
10504	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Hassan-Alin M (2007)	17532719	178402	778	Naproxen	(S)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid|(+)-(S)-Naproxen|Naproxne|Naproxeno|(+)-Naproxen|Naproxenum|(S)-(+)-Naproxen|(+)-2-(6-Methoxy-2-naphthyl)propionic acid|(+)-2-(Methoxy-2-naphthyl)-propionic acid|(+)-(S)-6-Methoxy--methyl-2-naphthaleneacetic acid|(S)-Naproxen|(S)-2-(6-Methoxy-2-naphthyl)propionic acid|(+)-2-(Methoxy-2-naphthyl)-propionsure|Naproxen|Naprolag|(S)-2-(6-Methoxy-2-naphthyl)propanoic acid|(S)-(+)-2-(6-Methoxy-2-naphthyl)propionic acid	ntp-naproxen sodium|naprosyn 5	DRUGBANK	DB00788	C14H14O3	small molecule	M01AE56|G02CC02|M02AA12|M01AE52|M01AE02	22204-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CMWTZPSULFXXJA-VIFPVBQESA-N
10505	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Kumar P (2007)	17521299	178400	778	Naproxen	(S)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid|(+)-(S)-Naproxen|Naproxne|Naproxeno|(+)-Naproxen|Naproxenum|(S)-(+)-Naproxen|(+)-2-(6-Methoxy-2-naphthyl)propionic acid|(+)-2-(Methoxy-2-naphthyl)-propionic acid|(+)-(S)-6-Methoxy--methyl-2-naphthaleneacetic acid|(S)-Naproxen|(S)-2-(6-Methoxy-2-naphthyl)propionic acid|(+)-2-(Methoxy-2-naphthyl)-propionsure|Naproxen|Naprolag|(S)-2-(6-Methoxy-2-naphthyl)propanoic acid|(S)-(+)-2-(6-Methoxy-2-naphthyl)propionic acid	ntp-naproxen sodium|naprosyn 5	DRUGBANK	DB00788	C14H14O3	small molecule	M01AE56|G02CC02|M02AA12|M01AE52|M01AE02	22204-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CMWTZPSULFXXJA-VIFPVBQESA-N
10506	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Albertini R (2007)	17607546	178401	778	Naproxen	(S)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid|(+)-(S)-Naproxen|Naproxne|Naproxeno|(+)-Naproxen|Naproxenum|(S)-(+)-Naproxen|(+)-2-(6-Methoxy-2-naphthyl)propionic acid|(+)-2-(Methoxy-2-naphthyl)-propionic acid|(+)-(S)-6-Methoxy--methyl-2-naphthaleneacetic acid|(S)-Naproxen|(S)-2-(6-Methoxy-2-naphthyl)propionic acid|(+)-2-(Methoxy-2-naphthyl)-propionsure|Naproxen|Naprolag|(S)-2-(6-Methoxy-2-naphthyl)propanoic acid|(S)-(+)-2-(6-Methoxy-2-naphthyl)propionic acid	ntp-naproxen sodium|naprosyn 5	DRUGBANK	DB00788	C14H14O3	small molecule	M01AE56|G02CC02|M02AA12|M01AE52|M01AE02	22204-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CMWTZPSULFXXJA-VIFPVBQESA-N
10509	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Alfakih K (2006)	16370923	178404	780	Perindopril	(2S,3AS,7as)-1-[(2S)-2-{[(2S)-1-ethoxy-1-oxopentan-2-yl]amino}propanoyl]octahydro-1H-indole-2-carboxylic acid|Perindoprilum	arcosyl plus|viacoram|coversyl	DRUGBANK	DB00790	C19H32N2O5	small molecule	C09BX02|C09BX01|C09BA04|C09AA04|C09BB04|C10BX11	82834-16-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPVQLZZIHOAWMC-QXKUPLGCSA-N
10510	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	780	Perindopril	(2S,3AS,7as)-1-[(2S)-2-{[(2S)-1-ethoxy-1-oxopentan-2-yl]amino}propanoyl]octahydro-1H-indole-2-carboxylic acid|Perindoprilum	arcosyl plus|viacoram|coversyl	DRUGBANK	DB00790	C19H32N2O5	small molecule	C09BX02|C09BX01|C09BA04|C09AA04|C09BB04|C10BX11	82834-16-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPVQLZZIHOAWMC-QXKUPLGCSA-N
10511	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Song JC (2002)	11929321	174114	780	Perindopril	(2S,3AS,7as)-1-[(2S)-2-{[(2S)-1-ethoxy-1-oxopentan-2-yl]amino}propanoyl]octahydro-1H-indole-2-carboxylic acid|Perindoprilum	arcosyl plus|viacoram|coversyl	DRUGBANK	DB00790	C19H32N2O5	small molecule	C09BX02|C09BX01|C09BA04|C09AA04|C09BB04|C10BX11	82834-16-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPVQLZZIHOAWMC-QXKUPLGCSA-N
10512	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Brugts JJ (2009)	19379059	178403	780	Perindopril	(2S,3AS,7as)-1-[(2S)-2-{[(2S)-1-ethoxy-1-oxopentan-2-yl]amino}propanoyl]octahydro-1H-indole-2-carboxylic acid|Perindoprilum	arcosyl plus|viacoram|coversyl	DRUGBANK	DB00790	C19H32N2O5	small molecule	C09BX02|C09BX01|C09BA04|C09AA04|C09BB04|C10BX11	82834-16-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPVQLZZIHOAWMC-QXKUPLGCSA-N
10545	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Allgayer H (2003)	12950415	174544	785	Sulfasalazine	Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid	ratio-sulfasalazine tab 500mg|	DRUGBANK	DB00795	C18H14N4O5S	small molecule	A07EC01	599-79-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NCEXYHBECQHGNR-QZQOTICOSA-N
10548	112778	6916	-	TBXAS1	BDPLT14|CYP5|CYP5A1|GHOSAL|THAS|TS|TXAS|TXS	9606	Homo sapiens	antagonist	target	Stenson WF (1983)	6135423	178412	785	Sulfasalazine	Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid	ratio-sulfasalazine tab 500mg|	DRUGBANK	DB00795	C18H14N4O5S	small molecule	A07EC01	599-79-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NCEXYHBECQHGNR-QZQOTICOSA-N
10549	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Desreumaux P (2006)	16939423	174608	785	Sulfasalazine	Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid	ratio-sulfasalazine tab 500mg|	DRUGBANK	DB00795	C18H14N4O5S	small molecule	A07EC01	599-79-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NCEXYHBECQHGNR-QZQOTICOSA-N
10550	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Schwab M (2008)	18544567	174605	785	Sulfasalazine	Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid	ratio-sulfasalazine tab 500mg|	DRUGBANK	DB00795	C18H14N4O5S	small molecule	A07EC01	599-79-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NCEXYHBECQHGNR-QZQOTICOSA-N
10551	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Linard C (2008)	18077625	174606	785	Sulfasalazine	Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid	ratio-sulfasalazine tab 500mg|	DRUGBANK	DB00795	C18H14N4O5S	small molecule	A07EC01	599-79-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NCEXYHBECQHGNR-QZQOTICOSA-N
10552	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Rousseaux C (2005)	15824083	174607	785	Sulfasalazine	Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid	ratio-sulfasalazine tab 500mg|	DRUGBANK	DB00795	C18H14N4O5S	small molecule	A07EC01	599-79-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NCEXYHBECQHGNR-QZQOTICOSA-N
10553	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Nielsen OH (1987)	2882965	174547	785	Sulfasalazine	Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid	ratio-sulfasalazine tab 500mg|	DRUGBANK	DB00795	C18H14N4O5S	small molecule	A07EC01	599-79-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NCEXYHBECQHGNR-QZQOTICOSA-N
10554	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Sircar JC (1983)	6131674	174549	785	Sulfasalazine	Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid	ratio-sulfasalazine tab 500mg|	DRUGBANK	DB00795	C18H14N4O5S	small molecule	A07EC01	599-79-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NCEXYHBECQHGNR-QZQOTICOSA-N
10555	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Allgayer H (1984)	6428914	174548	785	Sulfasalazine	Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid	ratio-sulfasalazine tab 500mg|	DRUGBANK	DB00795	C18H14N4O5S	small molecule	A07EC01	599-79-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NCEXYHBECQHGNR-QZQOTICOSA-N
10556	111336	5319	-	PLA2G1B	PLA2|PLA2A|PPLA2	9606	Homo sapiens	antagonist	target	Pruzanski W (1997)	9256165	174553	785	Sulfasalazine	Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid	ratio-sulfasalazine tab 500mg|	DRUGBANK	DB00795	C18H14N4O5S	small molecule	A07EC01	599-79-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NCEXYHBECQHGNR-QZQOTICOSA-N
10557	106556	38	-	ACAT1	ACAT|MAT|T2|THIL	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	785	Sulfasalazine	Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid	ratio-sulfasalazine tab 500mg|	DRUGBANK	DB00795	C18H14N4O5S	small molecule	A07EC01	599-79-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NCEXYHBECQHGNR-QZQOTICOSA-N
10558	106556	38	-	ACAT1	ACAT|MAT|T2|THIL	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	785	Sulfasalazine	Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid	ratio-sulfasalazine tab 500mg|	DRUGBANK	DB00795	C18H14N4O5S	small molecule	A07EC01	599-79-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NCEXYHBECQHGNR-QZQOTICOSA-N
10559	106556	38	-	ACAT1	ACAT|MAT|T2|THIL	9606	Homo sapiens	inhibitor	target	Faison LD (1992)	1357724	178413	785	Sulfasalazine	Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid	ratio-sulfasalazine tab 500mg|	DRUGBANK	DB00795	C18H14N4O5S	small molecule	A07EC01	599-79-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NCEXYHBECQHGNR-QZQOTICOSA-N
10564	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Cipolla G (2002)	12208114	174550	785	Sulfasalazine	Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid	ratio-sulfasalazine tab 500mg|	DRUGBANK	DB00795	C18H14N4O5S	small molecule	A07EC01	599-79-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NCEXYHBECQHGNR-QZQOTICOSA-N
10565	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Generini S (2002)	12463455	174551	785	Sulfasalazine	Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid	ratio-sulfasalazine tab 500mg|	DRUGBANK	DB00795	C18H14N4O5S	small molecule	A07EC01	599-79-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NCEXYHBECQHGNR-QZQOTICOSA-N
10566	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Mifflin RC (2004)	14742690	174552	785	Sulfasalazine	Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid	ratio-sulfasalazine tab 500mg|	DRUGBANK	DB00795	C18H14N4O5S	small molecule	A07EC01	599-79-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NCEXYHBECQHGNR-QZQOTICOSA-N
10567	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Pruzanski W (1997)	9256165	174553	785	Sulfasalazine	Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid	ratio-sulfasalazine tab 500mg|	DRUGBANK	DB00795	C18H14N4O5S	small molecule	A07EC01	599-79-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NCEXYHBECQHGNR-QZQOTICOSA-N
10568	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Distrutti E (2006)	16855178	174554	785	Sulfasalazine	Sulfasalazinum|Azopyrin|Salicylazosulfapyridine|Salazosulfapyridinum|Sulfasalazine|5-(4-(2-Pyridylsulfamoyl)phenylazo)-2-hydroxybenzoic acid|Azulfidine|Sulfasalazin|Salazosulfapiridina|5-((P-(2-Pyridylsulfamoyl)phenyl)azo)salicylic acid|4-(Pyridyl-2-amidosulfonyl)-3'-carboxy-4'-hydroxyazobenzene|5-(P-(2-Pyridylsulfamyl)phenylazo)salicylic acid|Salazosulfapyridine|2-Hydroxy-5-[4-(pyridin-2-ylsulfamoyl)-phenylazo]-benzoic acid|Sulfasalazina|2-Hydroxy-5-((4-((2-pyridinylamino)sulfonyl)phenyl)azo)benzoic acid	ratio-sulfasalazine tab 500mg|	DRUGBANK	DB00795	C18H14N4O5S	small molecule	A07EC01	599-79-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NCEXYHBECQHGNR-QZQOTICOSA-N
10569	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Caballero-George C (2003)	12504781	178423	786	Candesartan	2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid|Candesartan cilexetil|CV-11974|2-Ethoxy-1-(P-(O-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxylic acid|Blopress|2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4ethyl]}-1H-benzimidazole-7-carboxylic acid	auro-candesartan|atacand plus|	DRUGBANK	DB00796	C24H20N6O3	small molecule	C09DB07|C09DA06|C09CA06	139481-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HTQMVQVXFRQIKW-UHFFFAOYSA-N
10570	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Engelhorn T (2006)	16901636	178419	786	Candesartan	2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid|Candesartan cilexetil|CV-11974|2-Ethoxy-1-(P-(O-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxylic acid|Blopress|2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4ethyl]}-1H-benzimidazole-7-carboxylic acid	auro-candesartan|atacand plus|	DRUGBANK	DB00796	C24H20N6O3	small molecule	C09DB07|C09DA06|C09CA06	139481-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HTQMVQVXFRQIKW-UHFFFAOYSA-N
10571	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Wada T (1996)	10968199	178418	786	Candesartan	2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid|Candesartan cilexetil|CV-11974|2-Ethoxy-1-(P-(O-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxylic acid|Blopress|2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4ethyl]}-1H-benzimidazole-7-carboxylic acid	auro-candesartan|atacand plus|	DRUGBANK	DB00796	C24H20N6O3	small molecule	C09DB07|C09DA06|C09CA06	139481-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HTQMVQVXFRQIKW-UHFFFAOYSA-N
10572	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Vauquelin G (2006)	16601569	178415	786	Candesartan	2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid|Candesartan cilexetil|CV-11974|2-Ethoxy-1-(P-(O-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxylic acid|Blopress|2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4ethyl]}-1H-benzimidazole-7-carboxylic acid	auro-candesartan|atacand plus|	DRUGBANK	DB00796	C24H20N6O3	small molecule	C09DB07|C09DA06|C09CA06	139481-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HTQMVQVXFRQIKW-UHFFFAOYSA-N
10573	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Meredith PA (2007)	17588300	178421	786	Candesartan	2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid|Candesartan cilexetil|CV-11974|2-Ethoxy-1-(P-(O-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxylic acid|Blopress|2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4ethyl]}-1H-benzimidazole-7-carboxylic acid	auro-candesartan|atacand plus|	DRUGBANK	DB00796	C24H20N6O3	small molecule	C09DB07|C09DA06|C09CA06	139481-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HTQMVQVXFRQIKW-UHFFFAOYSA-N
10574	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Malmqvist K (2000)	10826401	178417	786	Candesartan	2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid|Candesartan cilexetil|CV-11974|2-Ethoxy-1-(P-(O-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxylic acid|Blopress|2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4ethyl]}-1H-benzimidazole-7-carboxylic acid	auro-candesartan|atacand plus|	DRUGBANK	DB00796	C24H20N6O3	small molecule	C09DB07|C09DA06|C09CA06	139481-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HTQMVQVXFRQIKW-UHFFFAOYSA-N
10575	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Mendis B (2009)	19563275	178416	786	Candesartan	2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid|Candesartan cilexetil|CV-11974|2-Ethoxy-1-(P-(O-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxylic acid|Blopress|2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4ethyl]}-1H-benzimidazole-7-carboxylic acid	auro-candesartan|atacand plus|	DRUGBANK	DB00796	C24H20N6O3	small molecule	C09DB07|C09DA06|C09CA06	139481-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HTQMVQVXFRQIKW-UHFFFAOYSA-N
10576	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Cervenka L (1999)	9892163	178424	786	Candesartan	2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid|Candesartan cilexetil|CV-11974|2-Ethoxy-1-(P-(O-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxylic acid|Blopress|2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4ethyl]}-1H-benzimidazole-7-carboxylic acid	auro-candesartan|atacand plus|	DRUGBANK	DB00796	C24H20N6O3	small molecule	C09DB07|C09DA06|C09CA06	139481-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HTQMVQVXFRQIKW-UHFFFAOYSA-N
10577	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	McInnes GT (2000)	10805052	178420	786	Candesartan	2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid|Candesartan cilexetil|CV-11974|2-Ethoxy-1-(P-(O-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxylic acid|Blopress|2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4ethyl]}-1H-benzimidazole-7-carboxylic acid	auro-candesartan|atacand plus|	DRUGBANK	DB00796	C24H20N6O3	small molecule	C09DB07|C09DA06|C09CA06	139481-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HTQMVQVXFRQIKW-UHFFFAOYSA-N
10578	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	786	Candesartan	2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid|Candesartan cilexetil|CV-11974|2-Ethoxy-1-(P-(O-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxylic acid|Blopress|2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4ethyl]}-1H-benzimidazole-7-carboxylic acid	auro-candesartan|atacand plus|	DRUGBANK	DB00796	C24H20N6O3	small molecule	C09DB07|C09DA06|C09CA06	139481-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HTQMVQVXFRQIKW-UHFFFAOYSA-N
10579	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Baguet JP (2009)	19436650	178422	786	Candesartan	2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid|Candesartan cilexetil|CV-11974|2-Ethoxy-1-(P-(O-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxylic acid|Blopress|2-Ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4ethyl]}-1H-benzimidazole-7-carboxylic acid	auro-candesartan|atacand plus|	DRUGBANK	DB00796	C24H20N6O3	small molecule	C09DB07|C09DA06|C09CA06	139481-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HTQMVQVXFRQIKW-UHFFFAOYSA-N
10689	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	795	Minaprine	4-(2-((4-Methyl-6-phenyl-3-pyridazinyl)amino)ethyl)morpholine|Minaprinum|4-Methyl-3-(2-morpholinoethylamino)-6-phenylpyridazin|Minaprina|N-(4-Methyl-6-phenyl-3-pyridazinyl)-4-morpholineethanamine	-	DRUGBANK	DB00805	C17H22N4O	small molecule	N06AX07	25905-77-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LDMWSLGGVTVJPG-UHFFFAOYSA-N
10690	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	795	Minaprine	4-(2-((4-Methyl-6-phenyl-3-pyridazinyl)amino)ethyl)morpholine|Minaprinum|4-Methyl-3-(2-morpholinoethylamino)-6-phenylpyridazin|Minaprina|N-(4-Methyl-6-phenyl-3-pyridazinyl)-4-morpholineethanamine	-	DRUGBANK	DB00805	C17H22N4O	small molecule	N06AX07	25905-77-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LDMWSLGGVTVJPG-UHFFFAOYSA-N
10747	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Morton AJ (2005)	15563928	178490	802	Phenylbutazone	Phenylbutazon|3,5-Dioxo-1,2-diphenyl-4-n-butylpyrazolidine|Phenylbutazonum|4-BUTYL-1,2-diphenyl-pyrazolidine-3,5-dione|Phenylbutazone|Phenbutazone|4-n-Butyl-1,2-diphenyl-3,5-pyrazolidinedione|Fenilbutazona	alka phenyl tab|novo-butazone 	DRUGBANK	DB00812	C19H20N2O2	small molecule	M01AA01|M02AA01|M01BA01	50-33-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYMDGNCVAMGZFE-UHFFFAOYSA-N
10748	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Zitova A (2010)	19849999	178488	802	Phenylbutazone	Phenylbutazon|3,5-Dioxo-1,2-diphenyl-4-n-butylpyrazolidine|Phenylbutazonum|4-BUTYL-1,2-diphenyl-pyrazolidine-3,5-dione|Phenylbutazone|Phenbutazone|4-n-Butyl-1,2-diphenyl-3,5-pyrazolidinedione|Fenilbutazona	alka phenyl tab|novo-butazone 	DRUGBANK	DB00812	C19H20N2O2	small molecule	M01AA01|M02AA01|M01BA01	50-33-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYMDGNCVAMGZFE-UHFFFAOYSA-N
10749	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Beretta C (2005)	15939622	178489	802	Phenylbutazone	Phenylbutazon|3,5-Dioxo-1,2-diphenyl-4-n-butylpyrazolidine|Phenylbutazonum|4-BUTYL-1,2-diphenyl-pyrazolidine-3,5-dione|Phenylbutazone|Phenbutazone|4-n-Butyl-1,2-diphenyl-3,5-pyrazolidinedione|Fenilbutazona	alka phenyl tab|novo-butazone 	DRUGBANK	DB00812	C19H20N2O2	small molecule	M01AA01|M02AA01|M01BA01	50-33-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYMDGNCVAMGZFE-UHFFFAOYSA-N
10750	111712	5740	-	PTGIS	CYP8|CYP8A1|PGIS|PTGI	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	802	Phenylbutazone	Phenylbutazon|3,5-Dioxo-1,2-diphenyl-4-n-butylpyrazolidine|Phenylbutazonum|4-BUTYL-1,2-diphenyl-pyrazolidine-3,5-dione|Phenylbutazone|Phenbutazone|4-n-Butyl-1,2-diphenyl-3,5-pyrazolidinedione|Fenilbutazona	alka phenyl tab|novo-butazone 	DRUGBANK	DB00812	C19H20N2O2	small molecule	M01AA01|M02AA01|M01BA01	50-33-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYMDGNCVAMGZFE-UHFFFAOYSA-N
10751	111712	5740	-	PTGIS	CYP8|CYP8A1|PGIS|PTGI	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	802	Phenylbutazone	Phenylbutazon|3,5-Dioxo-1,2-diphenyl-4-n-butylpyrazolidine|Phenylbutazonum|4-BUTYL-1,2-diphenyl-pyrazolidine-3,5-dione|Phenylbutazone|Phenbutazone|4-n-Butyl-1,2-diphenyl-3,5-pyrazolidinedione|Fenilbutazona	alka phenyl tab|novo-butazone 	DRUGBANK	DB00812	C19H20N2O2	small molecule	M01AA01|M02AA01|M01BA01	50-33-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYMDGNCVAMGZFE-UHFFFAOYSA-N
10752	111712	5740	-	PTGIS	CYP8|CYP8A1|PGIS|PTGI	9606	Homo sapiens	inhibitor	target	Marnett LJ (1984)	6434940	178491	802	Phenylbutazone	Phenylbutazon|3,5-Dioxo-1,2-diphenyl-4-n-butylpyrazolidine|Phenylbutazonum|4-BUTYL-1,2-diphenyl-pyrazolidine-3,5-dione|Phenylbutazone|Phenbutazone|4-n-Butyl-1,2-diphenyl-3,5-pyrazolidinedione|Fenilbutazona	alka phenyl tab|novo-butazone 	DRUGBANK	DB00812	C19H20N2O2	small molecule	M01AA01|M02AA01|M01BA01	50-33-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYMDGNCVAMGZFE-UHFFFAOYSA-N
10753	111712	5740	-	PTGIS	CYP8|CYP8A1|PGIS|PTGI	9606	Homo sapiens	inhibitor	target	Reed GA (1985)	3917545	178493	802	Phenylbutazone	Phenylbutazon|3,5-Dioxo-1,2-diphenyl-4-n-butylpyrazolidine|Phenylbutazonum|4-BUTYL-1,2-diphenyl-pyrazolidine-3,5-dione|Phenylbutazone|Phenbutazone|4-n-Butyl-1,2-diphenyl-3,5-pyrazolidinedione|Fenilbutazona	alka phenyl tab|novo-butazone 	DRUGBANK	DB00812	C19H20N2O2	small molecule	M01AA01|M02AA01|M01BA01	50-33-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYMDGNCVAMGZFE-UHFFFAOYSA-N
10754	111712	5740	-	PTGIS	CYP8|CYP8A1|PGIS|PTGI	9606	Homo sapiens	inhibitor	target	Tobin T (1986)	3517382	178492	802	Phenylbutazone	Phenylbutazon|3,5-Dioxo-1,2-diphenyl-4-n-butylpyrazolidine|Phenylbutazonum|4-BUTYL-1,2-diphenyl-pyrazolidine-3,5-dione|Phenylbutazone|Phenbutazone|4-n-Butyl-1,2-diphenyl-3,5-pyrazolidinedione|Fenilbutazona	alka phenyl tab|novo-butazone 	DRUGBANK	DB00812	C19H20N2O2	small molecule	M01AA01|M02AA01|M01BA01	50-33-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYMDGNCVAMGZFE-UHFFFAOYSA-N
10755	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Takada Y (2004)	15489888	178495	802	Phenylbutazone	Phenylbutazon|3,5-Dioxo-1,2-diphenyl-4-n-butylpyrazolidine|Phenylbutazonum|4-BUTYL-1,2-diphenyl-pyrazolidine-3,5-dione|Phenylbutazone|Phenbutazone|4-n-Butyl-1,2-diphenyl-3,5-pyrazolidinedione|Fenilbutazona	alka phenyl tab|novo-butazone 	DRUGBANK	DB00812	C19H20N2O2	small molecule	M01AA01|M02AA01|M01BA01	50-33-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYMDGNCVAMGZFE-UHFFFAOYSA-N
10756	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Arifah AK (2002)	12213119	178494	802	Phenylbutazone	Phenylbutazon|3,5-Dioxo-1,2-diphenyl-4-n-butylpyrazolidine|Phenylbutazonum|4-BUTYL-1,2-diphenyl-pyrazolidine-3,5-dione|Phenylbutazone|Phenbutazone|4-n-Butyl-1,2-diphenyl-3,5-pyrazolidinedione|Fenilbutazona	alka phenyl tab|novo-butazone 	DRUGBANK	DB00812	C19H20N2O2	small molecule	M01AA01|M02AA01|M01BA01	50-33-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYMDGNCVAMGZFE-UHFFFAOYSA-N
10757	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	802	Phenylbutazone	Phenylbutazon|3,5-Dioxo-1,2-diphenyl-4-n-butylpyrazolidine|Phenylbutazonum|4-BUTYL-1,2-diphenyl-pyrazolidine-3,5-dione|Phenylbutazone|Phenbutazone|4-n-Butyl-1,2-diphenyl-3,5-pyrazolidinedione|Fenilbutazona	alka phenyl tab|novo-butazone 	DRUGBANK	DB00812	C19H20N2O2	small molecule	M01AA01|M02AA01|M01BA01	50-33-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYMDGNCVAMGZFE-UHFFFAOYSA-N
10758	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Beretta C (2005)	15939622	178489	802	Phenylbutazone	Phenylbutazon|3,5-Dioxo-1,2-diphenyl-4-n-butylpyrazolidine|Phenylbutazonum|4-BUTYL-1,2-diphenyl-pyrazolidine-3,5-dione|Phenylbutazone|Phenbutazone|4-n-Butyl-1,2-diphenyl-3,5-pyrazolidinedione|Fenilbutazona	alka phenyl tab|novo-butazone 	DRUGBANK	DB00812	C19H20N2O2	small molecule	M01AA01|M02AA01|M01BA01	50-33-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYMDGNCVAMGZFE-UHFFFAOYSA-N
10773	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Blanco FJ (1999)	10381057	176844	804	Meloxicam	Mloxicam|Meloxicamum|UNII-vg2qf83cgl|Mobic|Meloxicam	ava-meloxicam|auro-meloxicam|a	DRUGBANK	DB00814	C14H13N3O4S2	small molecule	M01AC56|M01AC06	71125-38-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRVUJXDFFKFLMG-UHFFFAOYSA-N
10774	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Panara MR (1999)	10381787	178508	804	Meloxicam	Mloxicam|Meloxicamum|UNII-vg2qf83cgl|Mobic|Meloxicam	ava-meloxicam|auro-meloxicam|a	DRUGBANK	DB00814	C14H13N3O4S2	small molecule	M01AC56|M01AC06	71125-38-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRVUJXDFFKFLMG-UHFFFAOYSA-N
10775	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Tegeder I (1999)	10340919	178510	804	Meloxicam	Mloxicam|Meloxicamum|UNII-vg2qf83cgl|Mobic|Meloxicam	ava-meloxicam|auro-meloxicam|a	DRUGBANK	DB00814	C14H13N3O4S2	small molecule	M01AC56|M01AC06	71125-38-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRVUJXDFFKFLMG-UHFFFAOYSA-N
10776	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Poulsen Nautrup B (1999)	10220944	178511	804	Meloxicam	Mloxicam|Meloxicamum|UNII-vg2qf83cgl|Mobic|Meloxicam	ava-meloxicam|auro-meloxicam|a	DRUGBANK	DB00814	C14H13N3O4S2	small molecule	M01AC56|M01AC06	71125-38-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRVUJXDFFKFLMG-UHFFFAOYSA-N
10777	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	804	Meloxicam	Mloxicam|Meloxicamum|UNII-vg2qf83cgl|Mobic|Meloxicam	ava-meloxicam|auro-meloxicam|a	DRUGBANK	DB00814	C14H13N3O4S2	small molecule	M01AC56|M01AC06	71125-38-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRVUJXDFFKFLMG-UHFFFAOYSA-N
10778	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Blanco FJ (1999)	10381057	176844	804	Meloxicam	Mloxicam|Meloxicamum|UNII-vg2qf83cgl|Mobic|Meloxicam	ava-meloxicam|auro-meloxicam|a	DRUGBANK	DB00814	C14H13N3O4S2	small molecule	M01AC56|M01AC06	71125-38-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRVUJXDFFKFLMG-UHFFFAOYSA-N
10779	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Gross JM (1999)	10567199	178509	804	Meloxicam	Mloxicam|Meloxicamum|UNII-vg2qf83cgl|Mobic|Meloxicam	ava-meloxicam|auro-meloxicam|a	DRUGBANK	DB00814	C14H13N3O4S2	small molecule	M01AC56|M01AC06	71125-38-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRVUJXDFFKFLMG-UHFFFAOYSA-N
10780	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Panara MR (1999)	10381787	178508	804	Meloxicam	Mloxicam|Meloxicamum|UNII-vg2qf83cgl|Mobic|Meloxicam	ava-meloxicam|auro-meloxicam|a	DRUGBANK	DB00814	C14H13N3O4S2	small molecule	M01AC56|M01AC06	71125-38-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZRVUJXDFFKFLMG-UHFFFAOYSA-N
10826	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Beretta C (2005)	15939622	178489	811	Carprofen	(+-)-6-chloro-alpha-Methylcarbazole-2-acetic acid|Carprofeno|2-(6-Chloro-9H-carbazol-2-yl)-propionic acid|6-chloro-alpha-Methyl-9H-carbazole-2-acetic acid|Carprofne|Carprofen|Carprofenum|(+/-)-2-(3-chloro-9H-carbazol-7-yl)propanoic acid	-	DRUGBANK	DB00821	C15H12ClNO2	small molecule	-	53716-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PUXBGTOOZJQSKH-UHFFFAOYSA-N
10827	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Wilson JE (2004)	15198222	178171	811	Carprofen	(+-)-6-chloro-alpha-Methylcarbazole-2-acetic acid|Carprofeno|2-(6-Chloro-9H-carbazol-2-yl)-propionic acid|6-chloro-alpha-Methyl-9H-carbazole-2-acetic acid|Carprofne|Carprofen|Carprofenum|(+/-)-2-(3-chloro-9H-carbazol-7-yl)propanoic acid	-	DRUGBANK	DB00821	C15H12ClNO2	small molecule	-	53716-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PUXBGTOOZJQSKH-UHFFFAOYSA-N
10828	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	811	Carprofen	(+-)-6-chloro-alpha-Methylcarbazole-2-acetic acid|Carprofeno|2-(6-Chloro-9H-carbazol-2-yl)-propionic acid|6-chloro-alpha-Methyl-9H-carbazole-2-acetic acid|Carprofne|Carprofen|Carprofenum|(+/-)-2-(3-chloro-9H-carbazol-7-yl)propanoic acid	-	DRUGBANK	DB00821	C15H12ClNO2	small molecule	-	53716-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PUXBGTOOZJQSKH-UHFFFAOYSA-N
10829	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Brideau C (2001)	11703020	178550	811	Carprofen	(+-)-6-chloro-alpha-Methylcarbazole-2-acetic acid|Carprofeno|2-(6-Chloro-9H-carbazol-2-yl)-propionic acid|6-chloro-alpha-Methyl-9H-carbazole-2-acetic acid|Carprofne|Carprofen|Carprofenum|(+/-)-2-(3-chloro-9H-carbazol-7-yl)propanoic acid	-	DRUGBANK	DB00821	C15H12ClNO2	small molecule	-	53716-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PUXBGTOOZJQSKH-UHFFFAOYSA-N
10830	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Narlawar R (2006)	17181139	178551	811	Carprofen	(+-)-6-chloro-alpha-Methylcarbazole-2-acetic acid|Carprofeno|2-(6-Chloro-9H-carbazol-2-yl)-propionic acid|6-chloro-alpha-Methyl-9H-carbazole-2-acetic acid|Carprofne|Carprofen|Carprofenum|(+/-)-2-(3-chloro-9H-carbazol-7-yl)propanoic acid	-	DRUGBANK	DB00821	C15H12ClNO2	small molecule	-	53716-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PUXBGTOOZJQSKH-UHFFFAOYSA-N
10831	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Kay-Mugford P (2000)	10895904	178552	811	Carprofen	(+-)-6-chloro-alpha-Methylcarbazole-2-acetic acid|Carprofeno|2-(6-Chloro-9H-carbazol-2-yl)-propionic acid|6-chloro-alpha-Methyl-9H-carbazole-2-acetic acid|Carprofne|Carprofen|Carprofenum|(+/-)-2-(3-chloro-9H-carbazol-7-yl)propanoic acid	-	DRUGBANK	DB00821	C15H12ClNO2	small molecule	-	53716-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PUXBGTOOZJQSKH-UHFFFAOYSA-N
10832	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Beretta C (2005)	15939622	178489	811	Carprofen	(+-)-6-chloro-alpha-Methylcarbazole-2-acetic acid|Carprofeno|2-(6-Chloro-9H-carbazol-2-yl)-propionic acid|6-chloro-alpha-Methyl-9H-carbazole-2-acetic acid|Carprofne|Carprofen|Carprofenum|(+/-)-2-(3-chloro-9H-carbazol-7-yl)propanoic acid	-	DRUGBANK	DB00821	C15H12ClNO2	small molecule	-	53716-49-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PUXBGTOOZJQSKH-UHFFFAOYSA-N
10924	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Seeman P (2002)	11873706	174626	821	Trifluoperazine	10-[3-(4-Methyl-1-piperazinyl)propyl]-2-(trifluoromethyl)-10H-phenothiazine|10-[3-(4-METHYL-piperazin-1-yl)-propyl]-2-trifluoromethyl-10H-phenothiazine|Trifluoroperazine|Trifluoperazinum|Trifluoperazina|Trifluoromethyl-10-(3'-(1-methyl-4-piperazinyl)propyl)phenothiazine|Trifluperazine|Trifluoperazine	pms trifluoperazine hcl syrup 	DRUGBANK	DB00831	C21H24F3N3S	small molecule	N05AB06	117-89-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEWQUBUPAILYHI-UHFFFAOYSA-N
10925	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	821	Trifluoperazine	10-[3-(4-Methyl-1-piperazinyl)propyl]-2-(trifluoromethyl)-10H-phenothiazine|10-[3-(4-METHYL-piperazin-1-yl)-propyl]-2-trifluoromethyl-10H-phenothiazine|Trifluoroperazine|Trifluoperazinum|Trifluoperazina|Trifluoromethyl-10-(3'-(1-methyl-4-piperazinyl)propyl)phenothiazine|Trifluperazine|Trifluoperazine	pms trifluoperazine hcl syrup 	DRUGBANK	DB00831	C21H24F3N3S	small molecule	N05AB06	117-89-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEWQUBUPAILYHI-UHFFFAOYSA-N
10926	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Schmidt MH (1991)	1676523	178589	821	Trifluoperazine	10-[3-(4-Methyl-1-piperazinyl)propyl]-2-(trifluoromethyl)-10H-phenothiazine|10-[3-(4-METHYL-piperazin-1-yl)-propyl]-2-trifluoromethyl-10H-phenothiazine|Trifluoroperazine|Trifluoperazinum|Trifluoperazina|Trifluoromethyl-10-(3'-(1-methyl-4-piperazinyl)propyl)phenothiazine|Trifluperazine|Trifluoperazine	pms trifluoperazine hcl syrup 	DRUGBANK	DB00831	C21H24F3N3S	small molecule	N05AB06	117-89-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEWQUBUPAILYHI-UHFFFAOYSA-N
10927	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Seeman P (1976)	945467	178588	821	Trifluoperazine	10-[3-(4-Methyl-1-piperazinyl)propyl]-2-(trifluoromethyl)-10H-phenothiazine|10-[3-(4-METHYL-piperazin-1-yl)-propyl]-2-trifluoromethyl-10H-phenothiazine|Trifluoroperazine|Trifluoperazinum|Trifluoperazina|Trifluoromethyl-10-(3'-(1-methyl-4-piperazinyl)propyl)phenothiazine|Trifluperazine|Trifluoperazine	pms trifluoperazine hcl syrup 	DRUGBANK	DB00831	C21H24F3N3S	small molecule	N05AB06	117-89-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEWQUBUPAILYHI-UHFFFAOYSA-N
10928	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Lahti RA (1993)	8102973	178587	821	Trifluoperazine	10-[3-(4-Methyl-1-piperazinyl)propyl]-2-(trifluoromethyl)-10H-phenothiazine|10-[3-(4-METHYL-piperazin-1-yl)-propyl]-2-trifluoromethyl-10H-phenothiazine|Trifluoroperazine|Trifluoperazinum|Trifluoperazina|Trifluoromethyl-10-(3'-(1-methyl-4-piperazinyl)propyl)phenothiazine|Trifluperazine|Trifluoperazine	pms trifluoperazine hcl syrup 	DRUGBANK	DB00831	C21H24F3N3S	small molecule	N05AB06	117-89-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEWQUBUPAILYHI-UHFFFAOYSA-N
10929	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Cahir M (2005)	15695070	176331	821	Trifluoperazine	10-[3-(4-Methyl-1-piperazinyl)propyl]-2-(trifluoromethyl)-10H-phenothiazine|10-[3-(4-METHYL-piperazin-1-yl)-propyl]-2-trifluoromethyl-10H-phenothiazine|Trifluoroperazine|Trifluoperazinum|Trifluoperazina|Trifluoromethyl-10-(3'-(1-methyl-4-piperazinyl)propyl)phenothiazine|Trifluperazine|Trifluoperazine	pms trifluoperazine hcl syrup 	DRUGBANK	DB00831	C21H24F3N3S	small molecule	N05AB06	117-89-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEWQUBUPAILYHI-UHFFFAOYSA-N
11143	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Talvik M (2004)	15007534	178691	840	Perphenazine	Perphenazin|Chlorpiprazine|Etaperazin|Etaperazine|gamma-(4-(beta-Hydroxyethyl)piperazin-1-yl)propyl-2-chlorophenothiazine|4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazineethanol|Perphnazine|2-chloro-10-(3-(4-(2-Hydroxyethyl)piperazin-1-yl)propyl)phenothiazine|2-(4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazinyl)ethanol|Trilafon|4-[3-(2-Chlorophenothiazin-10-yl)propyl]-1-piperazineethanol|Ethaperazine|Perfenazine|Perfenazina|Perphenazinum	pms perphenazine tab 16mg|perp	DRUGBANK	DB00850	C21H26ClN3OS	small molecule	N05AB03	58-39-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGCVKNLCSQQDEP-UHFFFAOYSA-N
11144	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Farde L (1989)	2573104	178690	840	Perphenazine	Perphenazin|Chlorpiprazine|Etaperazin|Etaperazine|gamma-(4-(beta-Hydroxyethyl)piperazin-1-yl)propyl-2-chlorophenothiazine|4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazineethanol|Perphnazine|2-chloro-10-(3-(4-(2-Hydroxyethyl)piperazin-1-yl)propyl)phenothiazine|2-(4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazinyl)ethanol|Trilafon|4-[3-(2-Chlorophenothiazin-10-yl)propyl]-1-piperazineethanol|Ethaperazine|Perfenazine|Perfenazina|Perphenazinum	pms perphenazine tab 16mg|perp	DRUGBANK	DB00850	C21H26ClN3OS	small molecule	N05AB03	58-39-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGCVKNLCSQQDEP-UHFFFAOYSA-N
11145	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Seeman P (2002)	11873706	174626	840	Perphenazine	Perphenazin|Chlorpiprazine|Etaperazin|Etaperazine|gamma-(4-(beta-Hydroxyethyl)piperazin-1-yl)propyl-2-chlorophenothiazine|4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazineethanol|Perphnazine|2-chloro-10-(3-(4-(2-Hydroxyethyl)piperazin-1-yl)propyl)phenothiazine|2-(4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazinyl)ethanol|Trilafon|4-[3-(2-Chlorophenothiazin-10-yl)propyl]-1-piperazineethanol|Ethaperazine|Perfenazine|Perfenazina|Perphenazinum	pms perphenazine tab 16mg|perp	DRUGBANK	DB00850	C21H26ClN3OS	small molecule	N05AB03	58-39-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGCVKNLCSQQDEP-UHFFFAOYSA-N
11146	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Hoyberg OJ (1993)	7508675	177392	840	Perphenazine	Perphenazin|Chlorpiprazine|Etaperazin|Etaperazine|gamma-(4-(beta-Hydroxyethyl)piperazin-1-yl)propyl-2-chlorophenothiazine|4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazineethanol|Perphnazine|2-chloro-10-(3-(4-(2-Hydroxyethyl)piperazin-1-yl)propyl)phenothiazine|2-(4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazinyl)ethanol|Trilafon|4-[3-(2-Chlorophenothiazin-10-yl)propyl]-1-piperazineethanol|Ethaperazine|Perfenazine|Perfenazina|Perphenazinum	pms perphenazine tab 16mg|perp	DRUGBANK	DB00850	C21H26ClN3OS	small molecule	N05AB03	58-39-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGCVKNLCSQQDEP-UHFFFAOYSA-N
11147	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Qin ZH (1994)	7828655	177391	840	Perphenazine	Perphenazin|Chlorpiprazine|Etaperazin|Etaperazine|gamma-(4-(beta-Hydroxyethyl)piperazin-1-yl)propyl-2-chlorophenothiazine|4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazineethanol|Perphnazine|2-chloro-10-(3-(4-(2-Hydroxyethyl)piperazin-1-yl)propyl)phenothiazine|2-(4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazinyl)ethanol|Trilafon|4-[3-(2-Chlorophenothiazin-10-yl)propyl]-1-piperazineethanol|Ethaperazine|Perfenazine|Perfenazina|Perphenazinum	pms perphenazine tab 16mg|perp	DRUGBANK	DB00850	C21H26ClN3OS	small molecule	N05AB03	58-39-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGCVKNLCSQQDEP-UHFFFAOYSA-N
11148	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	840	Perphenazine	Perphenazin|Chlorpiprazine|Etaperazin|Etaperazine|gamma-(4-(beta-Hydroxyethyl)piperazin-1-yl)propyl-2-chlorophenothiazine|4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazineethanol|Perphnazine|2-chloro-10-(3-(4-(2-Hydroxyethyl)piperazin-1-yl)propyl)phenothiazine|2-(4-[3-(2-chloro-10H-Phenothiazin-10-yl)propyl]-1-piperazinyl)ethanol|Trilafon|4-[3-(2-Chlorophenothiazin-10-yl)propyl]-1-piperazineethanol|Ethaperazine|Perfenazine|Perfenazina|Perphenazinum	pms perphenazine tab 16mg|perp	DRUGBANK	DB00850	C21H26ClN3OS	small molecule	N05AB03	58-39-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RGCVKNLCSQQDEP-UHFFFAOYSA-N
11213	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Cappon GD (2003)	12852483	178741	851	Diflunisal	2',4'-Difluoro-4-hydroxy-3-biphenylcarboxylic acid|Dolobid|Diflunisalum|5-(2,4-Difluorophenyl)salicylic acid|2-(Hydroxy)-5-(2,4-difluorophenyl)benzoic acid|Diflunisal	diflunisal-500 - tab 500mg|nu-	DRUGBANK	DB00861	C13H8F2O3	small molecule	N02BA11	22494-42-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HUPFGZXOMWLGNK-UHFFFAOYSA-N
11214	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Chen QH (2005)	15755648	178740	851	Diflunisal	2',4'-Difluoro-4-hydroxy-3-biphenylcarboxylic acid|Dolobid|Diflunisalum|5-(2,4-Difluorophenyl)salicylic acid|2-(Hydroxy)-5-(2,4-difluorophenyl)benzoic acid|Diflunisal	diflunisal-500 - tab 500mg|nu-	DRUGBANK	DB00861	C13H8F2O3	small molecule	N02BA11	22494-42-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HUPFGZXOMWLGNK-UHFFFAOYSA-N
11215	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Young JM (1996)	8737748	178742	851	Diflunisal	2',4'-Difluoro-4-hydroxy-3-biphenylcarboxylic acid|Dolobid|Diflunisalum|5-(2,4-Difluorophenyl)salicylic acid|2-(Hydroxy)-5-(2,4-difluorophenyl)benzoic acid|Diflunisal	diflunisal-500 - tab 500mg|nu-	DRUGBANK	DB00861	C13H8F2O3	small molecule	N02BA11	22494-42-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HUPFGZXOMWLGNK-UHFFFAOYSA-N
11216	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Cappon GD (2003)	12852483	178741	851	Diflunisal	2',4'-Difluoro-4-hydroxy-3-biphenylcarboxylic acid|Dolobid|Diflunisalum|5-(2,4-Difluorophenyl)salicylic acid|2-(Hydroxy)-5-(2,4-difluorophenyl)benzoic acid|Diflunisal	diflunisal-500 - tab 500mg|nu-	DRUGBANK	DB00861	C13H8F2O3	small molecule	N02BA11	22494-42-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HUPFGZXOMWLGNK-UHFFFAOYSA-N
11217	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	851	Diflunisal	2',4'-Difluoro-4-hydroxy-3-biphenylcarboxylic acid|Dolobid|Diflunisalum|5-(2,4-Difluorophenyl)salicylic acid|2-(Hydroxy)-5-(2,4-difluorophenyl)benzoic acid|Diflunisal	diflunisal-500 - tab 500mg|nu-	DRUGBANK	DB00861	C13H8F2O3	small molecule	N02BA11	22494-42-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HUPFGZXOMWLGNK-UHFFFAOYSA-N
11218	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Young JM (1996)	8737748	178742	851	Diflunisal	2',4'-Difluoro-4-hydroxy-3-biphenylcarboxylic acid|Dolobid|Diflunisalum|5-(2,4-Difluorophenyl)salicylic acid|2-(Hydroxy)-5-(2,4-difluorophenyl)benzoic acid|Diflunisal	diflunisal-500 - tab 500mg|nu-	DRUGBANK	DB00861	C13H8F2O3	small molecule	N02BA11	22494-42-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HUPFGZXOMWLGNK-UHFFFAOYSA-N
11219	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Jeske AH (1999)	10825891	178745	851	Diflunisal	2',4'-Difluoro-4-hydroxy-3-biphenylcarboxylic acid|Dolobid|Diflunisalum|5-(2,4-Difluorophenyl)salicylic acid|2-(Hydroxy)-5-(2,4-difluorophenyl)benzoic acid|Diflunisal	diflunisal-500 - tab 500mg|nu-	DRUGBANK	DB00861	C13H8F2O3	small molecule	N02BA11	22494-42-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HUPFGZXOMWLGNK-UHFFFAOYSA-N
11220	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Mao H (2001)	11673972	178744	851	Diflunisal	2',4'-Difluoro-4-hydroxy-3-biphenylcarboxylic acid|Dolobid|Diflunisalum|5-(2,4-Difluorophenyl)salicylic acid|2-(Hydroxy)-5-(2,4-difluorophenyl)benzoic acid|Diflunisal	diflunisal-500 - tab 500mg|nu-	DRUGBANK	DB00861	C13H8F2O3	small molecule	N02BA11	22494-42-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HUPFGZXOMWLGNK-UHFFFAOYSA-N
11221	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Moore PA (2001)	11315375	178743	851	Diflunisal	2',4'-Difluoro-4-hydroxy-3-biphenylcarboxylic acid|Dolobid|Diflunisalum|5-(2,4-Difluorophenyl)salicylic acid|2-(Hydroxy)-5-(2,4-difluorophenyl)benzoic acid|Diflunisal	diflunisal-500 - tab 500mg|nu-	DRUGBANK	DB00861	C13H8F2O3	small molecule	N02BA11	22494-42-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HUPFGZXOMWLGNK-UHFFFAOYSA-N
11277	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	860	Suprofen	alpha-Methyl-4-(2-thienylcarbonyl)benzeneacetic acid|Suprofenum|2-[4-(Thiophene-2-carbonyl)-phenyl]-propionic acid|Suprofne|2-(4-(2-Thenoyl)phenyl)propionsaeure|4-(2-Thenoyl)hydratropsaeure|Suprofene|SUTOPROFEN|(+-)-2-(P-(2-Thenoyl)phenyl)propionic acid|P-2-Thenoylhydratropic acid|Suprofeno|Suprofen|PROFENAL	-	DRUGBANK	DB00870	C14H12O3S	small molecule	M01AE07	40828-46-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MDKGKXOCJGEUJW-UHFFFAOYSA-N
11278	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Loll PJ (1996)	8652509	178801	860	Suprofen	alpha-Methyl-4-(2-thienylcarbonyl)benzeneacetic acid|Suprofenum|2-[4-(Thiophene-2-carbonyl)-phenyl]-propionic acid|Suprofne|2-(4-(2-Thenoyl)phenyl)propionsaeure|4-(2-Thenoyl)hydratropsaeure|Suprofene|SUTOPROFEN|(+-)-2-(P-(2-Thenoyl)phenyl)propionic acid|P-2-Thenoylhydratropic acid|Suprofeno|Suprofen|PROFENAL	-	DRUGBANK	DB00870	C14H12O3S	small molecule	M01AE07	40828-46-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MDKGKXOCJGEUJW-UHFFFAOYSA-N
11279	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Llorens O (2002)	11885959	178800	860	Suprofen	alpha-Methyl-4-(2-thienylcarbonyl)benzeneacetic acid|Suprofenum|2-[4-(Thiophene-2-carbonyl)-phenyl]-propionic acid|Suprofne|2-(4-(2-Thenoyl)phenyl)propionsaeure|4-(2-Thenoyl)hydratropsaeure|Suprofene|SUTOPROFEN|(+-)-2-(P-(2-Thenoyl)phenyl)propionic acid|P-2-Thenoylhydratropic acid|Suprofeno|Suprofen|PROFENAL	-	DRUGBANK	DB00870	C14H12O3S	small molecule	M01AE07	40828-46-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MDKGKXOCJGEUJW-UHFFFAOYSA-N
11280	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Bender A (2007)	17477341	178799	860	Suprofen	alpha-Methyl-4-(2-thienylcarbonyl)benzeneacetic acid|Suprofenum|2-[4-(Thiophene-2-carbonyl)-phenyl]-propionic acid|Suprofne|2-(4-(2-Thenoyl)phenyl)propionsaeure|4-(2-Thenoyl)hydratropsaeure|Suprofene|SUTOPROFEN|(+-)-2-(P-(2-Thenoyl)phenyl)propionic acid|P-2-Thenoylhydratropic acid|Suprofeno|Suprofen|PROFENAL	-	DRUGBANK	DB00870	C14H12O3S	small molecule	M01AE07	40828-46-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MDKGKXOCJGEUJW-UHFFFAOYSA-N
11281	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	860	Suprofen	alpha-Methyl-4-(2-thienylcarbonyl)benzeneacetic acid|Suprofenum|2-[4-(Thiophene-2-carbonyl)-phenyl]-propionic acid|Suprofne|2-(4-(2-Thenoyl)phenyl)propionsaeure|4-(2-Thenoyl)hydratropsaeure|Suprofene|SUTOPROFEN|(+-)-2-(P-(2-Thenoyl)phenyl)propionic acid|P-2-Thenoylhydratropic acid|Suprofeno|Suprofen|PROFENAL	-	DRUGBANK	DB00870	C14H12O3S	small molecule	M01AE07	40828-46-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MDKGKXOCJGEUJW-UHFFFAOYSA-N
11282	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Llorens O (2002)	11885959	178800	860	Suprofen	alpha-Methyl-4-(2-thienylcarbonyl)benzeneacetic acid|Suprofenum|2-[4-(Thiophene-2-carbonyl)-phenyl]-propionic acid|Suprofne|2-(4-(2-Thenoyl)phenyl)propionsaeure|4-(2-Thenoyl)hydratropsaeure|Suprofene|SUTOPROFEN|(+-)-2-(P-(2-Thenoyl)phenyl)propionic acid|P-2-Thenoylhydratropic acid|Suprofeno|Suprofen|PROFENAL	-	DRUGBANK	DB00870	C14H12O3S	small molecule	M01AE07	40828-46-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MDKGKXOCJGEUJW-UHFFFAOYSA-N
11283	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	860	Suprofen	alpha-Methyl-4-(2-thienylcarbonyl)benzeneacetic acid|Suprofenum|2-[4-(Thiophene-2-carbonyl)-phenyl]-propionic acid|Suprofne|2-(4-(2-Thenoyl)phenyl)propionsaeure|4-(2-Thenoyl)hydratropsaeure|Suprofene|SUTOPROFEN|(+-)-2-(P-(2-Thenoyl)phenyl)propionic acid|P-2-Thenoylhydratropic acid|Suprofeno|Suprofen|PROFENAL	-	DRUGBANK	DB00870	C14H12O3S	small molecule	M01AE07	40828-46-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MDKGKXOCJGEUJW-UHFFFAOYSA-N
11321	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Huettl P (1991)	1674528	178828	865	Flupentixol	Flupentixol|Flupentixolum|Flupenthixole|Flupenthixol|Flupentixolo	fluanxol depot inj 20mg/ml|flu	DRUGBANK	DB00875	C23H27F3N2OS	small molecule	N05AF01	2709-56-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTTVNHWDONBIKE-DVZOWYKESA-N
11322	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Nilsson CL (1996)	8797192	178829	865	Flupentixol	Flupentixol|Flupentixolum|Flupenthixole|Flupenthixol|Flupentixolo	fluanxol depot inj 20mg/ml|flu	DRUGBANK	DB00875	C23H27F3N2OS	small molecule	N05AF01	2709-56-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTTVNHWDONBIKE-DVZOWYKESA-N
11323	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Seeman P (2002)	11873706	174626	865	Flupentixol	Flupentixol|Flupentixolum|Flupenthixole|Flupenthixol|Flupentixolo	fluanxol depot inj 20mg/ml|flu	DRUGBANK	DB00875	C23H27F3N2OS	small molecule	N05AF01	2709-56-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTTVNHWDONBIKE-DVZOWYKESA-N
11324	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	865	Flupentixol	Flupentixol|Flupentixolum|Flupenthixole|Flupenthixol|Flupentixolo	fluanxol depot inj 20mg/ml|flu	DRUGBANK	DB00875	C23H27F3N2OS	small molecule	N05AF01	2709-56-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTTVNHWDONBIKE-DVZOWYKESA-N
11325	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Reimold M (2007)	17111172	178827	865	Flupentixol	Flupentixol|Flupentixolum|Flupenthixole|Flupenthixol|Flupentixolo	fluanxol depot inj 20mg/ml|flu	DRUGBANK	DB00875	C23H27F3N2OS	small molecule	N05AF01	2709-56-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTTVNHWDONBIKE-DVZOWYKESA-N
11326	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Arnt J (1995)	7498321	174624	865	Flupentixol	Flupentixol|Flupentixolum|Flupenthixole|Flupenthixol|Flupentixolo	fluanxol depot inj 20mg/ml|flu	DRUGBANK	DB00875	C23H27F3N2OS	small molecule	N05AF01	2709-56-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTTVNHWDONBIKE-DVZOWYKESA-N
11327	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Ogren SO (1984)	6149133	178826	865	Flupentixol	Flupentixol|Flupentixolum|Flupenthixole|Flupenthixol|Flupentixolo	fluanxol depot inj 20mg/ml|flu	DRUGBANK	DB00875	C23H27F3N2OS	small molecule	N05AF01	2709-56-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DTTVNHWDONBIKE-DVZOWYKESA-N
11336	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	de la Sierra A (2007)	18093407	178839	866	Eprosartan	(e)-2-Butyl-1-(P-carboxybenzyl)-alpha-2-thenylimidazole-5-acrylic acid|Eprosartanum|Eprosartan|(e)-3-[2-N-Butyl-1-{(4-carboxyphenyl)methyl}-1H-imidazol-5-yl]-2-(2-thienyl)methyl-2-propenoic acid|(e)-Alpha{[2-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazole-5-yl]methylene}-2-thiopheneproprionic acid|prosartan	teveten|teveten tablets 300 mg	DRUGBANK	DB00876	C23H24N2O4S	small molecule	C09DA02|C09CA02	133040-01-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OROAFUQRIXKEMV-LDADJPATSA-N
11337	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Ilson BE (1998)	9602957	178838	866	Eprosartan	(e)-2-Butyl-1-(P-carboxybenzyl)-alpha-2-thenylimidazole-5-acrylic acid|Eprosartanum|Eprosartan|(e)-3-[2-N-Butyl-1-{(4-carboxyphenyl)methyl}-1H-imidazol-5-yl]-2-(2-thienyl)methyl-2-propenoic acid|(e)-Alpha{[2-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazole-5-yl]methylene}-2-thiopheneproprionic acid|prosartan	teveten|teveten tablets 300 mg	DRUGBANK	DB00876	C23H24N2O4S	small molecule	C09DA02|C09CA02	133040-01-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OROAFUQRIXKEMV-LDADJPATSA-N
11338	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	866	Eprosartan	(e)-2-Butyl-1-(P-carboxybenzyl)-alpha-2-thenylimidazole-5-acrylic acid|Eprosartanum|Eprosartan|(e)-3-[2-N-Butyl-1-{(4-carboxyphenyl)methyl}-1H-imidazol-5-yl]-2-(2-thienyl)methyl-2-propenoic acid|(e)-Alpha{[2-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazole-5-yl]methylene}-2-thiopheneproprionic acid|prosartan	teveten|teveten tablets 300 mg	DRUGBANK	DB00876	C23H24N2O4S	small molecule	C09DA02|C09CA02	133040-01-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OROAFUQRIXKEMV-LDADJPATSA-N
11339	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Hedner T (2002)	12184062	178837	866	Eprosartan	(e)-2-Butyl-1-(P-carboxybenzyl)-alpha-2-thenylimidazole-5-acrylic acid|Eprosartanum|Eprosartan|(e)-3-[2-N-Butyl-1-{(4-carboxyphenyl)methyl}-1H-imidazol-5-yl]-2-(2-thienyl)methyl-2-propenoic acid|(e)-Alpha{[2-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazole-5-yl]methylene}-2-thiopheneproprionic acid|prosartan	teveten|teveten tablets 300 mg	DRUGBANK	DB00876	C23H24N2O4S	small molecule	C09DA02|C09CA02	133040-01-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OROAFUQRIXKEMV-LDADJPATSA-N
11340	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Gremmler B (2000)	10856732	178846	866	Eprosartan	(e)-2-Butyl-1-(P-carboxybenzyl)-alpha-2-thenylimidazole-5-acrylic acid|Eprosartanum|Eprosartan|(e)-3-[2-N-Butyl-1-{(4-carboxyphenyl)methyl}-1H-imidazol-5-yl]-2-(2-thienyl)methyl-2-propenoic acid|(e)-Alpha{[2-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazole-5-yl]methylene}-2-thiopheneproprionic acid|prosartan	teveten|teveten tablets 300 mg	DRUGBANK	DB00876	C23H24N2O4S	small molecule	C09DA02|C09CA02	133040-01-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OROAFUQRIXKEMV-LDADJPATSA-N
11341	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Heusser K (2003)	12927226	178844	866	Eprosartan	(e)-2-Butyl-1-(P-carboxybenzyl)-alpha-2-thenylimidazole-5-acrylic acid|Eprosartanum|Eprosartan|(e)-3-[2-N-Butyl-1-{(4-carboxyphenyl)methyl}-1H-imidazol-5-yl]-2-(2-thienyl)methyl-2-propenoic acid|(e)-Alpha{[2-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazole-5-yl]methylene}-2-thiopheneproprionic acid|prosartan	teveten|teveten tablets 300 mg	DRUGBANK	DB00876	C23H24N2O4S	small molecule	C09DA02|C09CA02	133040-01-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OROAFUQRIXKEMV-LDADJPATSA-N
11342	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Puig JG (2002)	12766389	178845	866	Eprosartan	(e)-2-Butyl-1-(P-carboxybenzyl)-alpha-2-thenylimidazole-5-acrylic acid|Eprosartanum|Eprosartan|(e)-3-[2-N-Butyl-1-{(4-carboxyphenyl)methyl}-1H-imidazol-5-yl]-2-(2-thienyl)methyl-2-propenoic acid|(e)-Alpha{[2-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazole-5-yl]methylene}-2-thiopheneproprionic acid|prosartan	teveten|teveten tablets 300 mg	DRUGBANK	DB00876	C23H24N2O4S	small molecule	C09DA02|C09CA02	133040-01-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OROAFUQRIXKEMV-LDADJPATSA-N
11343	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Murdoch DR (2001)	11320369	178842	866	Eprosartan	(e)-2-Butyl-1-(P-carboxybenzyl)-alpha-2-thenylimidazole-5-acrylic acid|Eprosartanum|Eprosartan|(e)-3-[2-N-Butyl-1-{(4-carboxyphenyl)methyl}-1H-imidazol-5-yl]-2-(2-thienyl)methyl-2-propenoic acid|(e)-Alpha{[2-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazole-5-yl]methylene}-2-thiopheneproprionic acid|prosartan	teveten|teveten tablets 300 mg	DRUGBANK	DB00876	C23H24N2O4S	small molecule	C09DA02|C09CA02	133040-01-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OROAFUQRIXKEMV-LDADJPATSA-N
11344	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Nap A (2003)	12782193	178843	866	Eprosartan	(e)-2-Butyl-1-(P-carboxybenzyl)-alpha-2-thenylimidazole-5-acrylic acid|Eprosartanum|Eprosartan|(e)-3-[2-N-Butyl-1-{(4-carboxyphenyl)methyl}-1H-imidazol-5-yl]-2-(2-thienyl)methyl-2-propenoic acid|(e)-Alpha{[2-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazole-5-yl]methylene}-2-thiopheneproprionic acid|prosartan	teveten|teveten tablets 300 mg	DRUGBANK	DB00876	C23H24N2O4S	small molecule	C09DA02|C09CA02	133040-01-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OROAFUQRIXKEMV-LDADJPATSA-N
11345	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Suzuki G (2003)	12540520	178840	866	Eprosartan	(e)-2-Butyl-1-(P-carboxybenzyl)-alpha-2-thenylimidazole-5-acrylic acid|Eprosartanum|Eprosartan|(e)-3-[2-N-Butyl-1-{(4-carboxyphenyl)methyl}-1H-imidazol-5-yl]-2-(2-thienyl)methyl-2-propenoic acid|(e)-Alpha{[2-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazole-5-yl]methylene}-2-thiopheneproprionic acid|prosartan	teveten|teveten tablets 300 mg	DRUGBANK	DB00876	C23H24N2O4S	small molecule	C09DA02|C09CA02	133040-01-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OROAFUQRIXKEMV-LDADJPATSA-N
11346	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Ruilope L (2003)	12517247	178841	866	Eprosartan	(e)-2-Butyl-1-(P-carboxybenzyl)-alpha-2-thenylimidazole-5-acrylic acid|Eprosartanum|Eprosartan|(e)-3-[2-N-Butyl-1-{(4-carboxyphenyl)methyl}-1H-imidazol-5-yl]-2-(2-thienyl)methyl-2-propenoic acid|(e)-Alpha{[2-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazole-5-yl]methylene}-2-thiopheneproprionic acid|prosartan	teveten|teveten tablets 300 mg	DRUGBANK	DB00876	C23H24N2O4S	small molecule	C09DA02|C09CA02	133040-01-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OROAFUQRIXKEMV-LDADJPATSA-N
11367	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	871	Quinapril	Quinaprilum|Quinapril	accuretic|quinapril hydrochlor	DRUGBANK	DB00881	C25H30N2O5	small molecule	C09BA06|C09AA06	85441-61-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JSDRRTOADPPCHY-HSQYWUDLSA-N
11368	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Song JC (2002)	11929321	174114	871	Quinapril	Quinaprilum|Quinapril	accuretic|quinapril hydrochlor	DRUGBANK	DB00881	C25H30N2O5	small molecule	C09BA06|C09AA06	85441-61-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JSDRRTOADPPCHY-HSQYWUDLSA-N
11369	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Klutchko S (1986)	3020249	178865	871	Quinapril	Quinaprilum|Quinapril	accuretic|quinapril hydrochlor	DRUGBANK	DB00881	C25H30N2O5	small molecule	C09BA06|C09AA06	85441-61-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JSDRRTOADPPCHY-HSQYWUDLSA-N
11370	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Culy CR (2002)	11817979	178866	871	Quinapril	Quinaprilum|Quinapril	accuretic|quinapril hydrochlor	DRUGBANK	DB00881	C25H30N2O5	small molecule	C09BA06|C09AA06	85441-61-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JSDRRTOADPPCHY-HSQYWUDLSA-N
11400	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	unknown	target	Neal B (2002)	12584671	178882	876	Omapatrilat	Omapatrilate	-	DRUGBANK	DB00886	C19H24N2O4S2	small molecule	-	167305-00-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LVRLSYPNFFBYCZ-VGWMRTNUSA-N
11401	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	unknown	target	Trippodo NC (1999)	10598120	178883	876	Omapatrilat	Omapatrilate	-	DRUGBANK	DB00886	C19H24N2O4S2	small molecule	-	167305-00-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LVRLSYPNFFBYCZ-VGWMRTNUSA-N
11402	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	unknown	target	Ferdinand KC (2001)	11588409	178881	876	Omapatrilat	Omapatrilate	-	DRUGBANK	DB00886	C19H24N2O4S2	small molecule	-	167305-00-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LVRLSYPNFFBYCZ-VGWMRTNUSA-N
11403	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	unknown	target	Azizi M (2000)	10856268	178884	876	Omapatrilat	Omapatrilate	-	DRUGBANK	DB00886	C19H24N2O4S2	small molecule	-	167305-00-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LVRLSYPNFFBYCZ-VGWMRTNUSA-N
11404	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	unknown	target	Heudi O (2002)	12487427	178885	876	Omapatrilat	Omapatrilate	-	DRUGBANK	DB00886	C19H24N2O4S2	small molecule	-	167305-00-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LVRLSYPNFFBYCZ-VGWMRTNUSA-N
11457	108499	2205	RP11-550P17.3	FCER1A	FCE1A|FcERI	9606	Homo sapiens	agonist	target	Imming P (2006)	17016423	171742	885	Benzylpenicilloyl Polylysine	Benzyl penicilloyl-polylysine|Benzylpenicilloyl-polylysine|Benzylpenicilloyl G polylysine	pre-pen	DRUGBANK	DB00895	C28H46N6O8S	small molecule	-	31855-75-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IMPVZRLKKKXMKQ-SGDOCVTFSA-N
11458	108499	2205	RP11-550P17.3	FCER1A	FCE1A|FcERI	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	885	Benzylpenicilloyl Polylysine	Benzyl penicilloyl-polylysine|Benzylpenicilloyl-polylysine|Benzylpenicilloyl G polylysine	pre-pen	DRUGBANK	DB00895	C28H46N6O8S	small molecule	-	31855-75-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IMPVZRLKKKXMKQ-SGDOCVTFSA-N
11459	108499	2205	RP11-550P17.3	FCER1A	FCE1A|FcERI	9606	Homo sapiens	agonist	target	Overington JP (2006)	17139284	171741	885	Benzylpenicilloyl Polylysine	Benzyl penicilloyl-polylysine|Benzylpenicilloyl-polylysine|Benzylpenicilloyl G polylysine	pre-pen	DRUGBANK	DB00895	C28H46N6O8S	small molecule	-	31855-75-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IMPVZRLKKKXMKQ-SGDOCVTFSA-N
11460	108499	2205	RP11-550P17.3	FCER1A	FCE1A|FcERI	9606	Homo sapiens	agonist	target	Chandra RK (1980)	7436456	178934	885	Benzylpenicilloyl Polylysine	Benzyl penicilloyl-polylysine|Benzylpenicilloyl-polylysine|Benzylpenicilloyl G polylysine	pre-pen	DRUGBANK	DB00895	C28H46N6O8S	small molecule	-	31855-75-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IMPVZRLKKKXMKQ-SGDOCVTFSA-N
11587	111705	5733	RP5-952N6.2	PTGER3	EP3|EP3-I|EP3-II|EP3-III|EP3-IV|EP3e|PGE2-R	9606	Homo sapiens	agonist	target	Gabelt BT (2009)	19232013	178983	895	Bimatoprost	Bimatoprostum|(Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((1e,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-5-heptenamide	latisse|lumigan rc|bimatoprost	DRUGBANK	DB00905	C25H37NO4	small molecule	S01EE03	155206-00-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQOKCDNYWBIDND-FTOWTWDKSA-N
11588	111705	5733	RP5-952N6.2	PTGER3	EP3|EP3-I|EP3-II|EP3-III|EP3-IV|EP3e|PGE2-R	9606	Homo sapiens	agonist	target	Ota T (2006)	16877408	178985	895	Bimatoprost	Bimatoprostum|(Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((1e,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-5-heptenamide	latisse|lumigan rc|bimatoprost	DRUGBANK	DB00905	C25H37NO4	small molecule	S01EE03	155206-00-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQOKCDNYWBIDND-FTOWTWDKSA-N
11589	111705	5733	RP5-952N6.2	PTGER3	EP3|EP3-I|EP3-II|EP3-III|EP3-IV|EP3e|PGE2-R	9606	Homo sapiens	agonist	target	Sharif NA (2003)	14733708	178984	895	Bimatoprost	Bimatoprostum|(Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((1e,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-5-heptenamide	latisse|lumigan rc|bimatoprost	DRUGBANK	DB00905	C25H37NO4	small molecule	S01EE03	155206-00-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQOKCDNYWBIDND-FTOWTWDKSA-N
11590	111703	5731	-	PTGER1	EP1	9606	Homo sapiens	agonist	target	Ota T (2006)	16877408	178985	895	Bimatoprost	Bimatoprostum|(Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((1e,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-5-heptenamide	latisse|lumigan rc|bimatoprost	DRUGBANK	DB00905	C25H37NO4	small molecule	S01EE03	155206-00-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQOKCDNYWBIDND-FTOWTWDKSA-N
11591	111703	5731	-	PTGER1	EP1	9606	Homo sapiens	agonist	target	Sharif NA (2003)	14733708	178984	895	Bimatoprost	Bimatoprostum|(Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((1e,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-5-heptenamide	latisse|lumigan rc|bimatoprost	DRUGBANK	DB00905	C25H37NO4	small molecule	S01EE03	155206-00-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQOKCDNYWBIDND-FTOWTWDKSA-N
11592	114196	8644	-	AKR1C3	DD3|DDX|HA1753|HAKRB|HAKRe|HSD17B5|PGFS|hluPGFS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	895	Bimatoprost	Bimatoprostum|(Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((1e,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-5-heptenamide	latisse|lumigan rc|bimatoprost	DRUGBANK	DB00905	C25H37NO4	small molecule	S01EE03	155206-00-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQOKCDNYWBIDND-FTOWTWDKSA-N
11593	111709	5737	RP5-944H6.1	PTGFR	FP	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	895	Bimatoprost	Bimatoprostum|(Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((1e,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-5-heptenamide	latisse|lumigan rc|bimatoprost	DRUGBANK	DB00905	C25H37NO4	small molecule	S01EE03	155206-00-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQOKCDNYWBIDND-FTOWTWDKSA-N
11594	111709	5737	RP5-944H6.1	PTGFR	FP	9606	Homo sapiens	agonist	target	Sharif NA (2002)	12222762	178987	895	Bimatoprost	Bimatoprostum|(Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((1e,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-5-heptenamide	latisse|lumigan rc|bimatoprost	DRUGBANK	DB00905	C25H37NO4	small molecule	S01EE03	155206-00-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQOKCDNYWBIDND-FTOWTWDKSA-N
11595	111709	5737	RP5-944H6.1	PTGFR	FP	9606	Homo sapiens	agonist	target	Mintz EE (1978)	689791	178986	895	Bimatoprost	Bimatoprostum|(Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((1e,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-5-heptenamide	latisse|lumigan rc|bimatoprost	DRUGBANK	DB00905	C25H37NO4	small molecule	S01EE03	155206-00-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQOKCDNYWBIDND-FTOWTWDKSA-N
11596	111709	5737	RP5-944H6.1	PTGFR	FP	9606	Homo sapiens	agonist	target	Sharif NA (2003)	14733708	178984	895	Bimatoprost	Bimatoprostum|(Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((1e,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-5-heptenamide	latisse|lumigan rc|bimatoprost	DRUGBANK	DB00905	C25H37NO4	small molecule	S01EE03	155206-00-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQOKCDNYWBIDND-FTOWTWDKSA-N
11597	111709	5737	RP5-944H6.1	PTGFR	FP	9606	Homo sapiens	agonist	target	Wan Z (2007)	17724194	178989	895	Bimatoprost	Bimatoprostum|(Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((1e,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-5-heptenamide	latisse|lumigan rc|bimatoprost	DRUGBANK	DB00905	C25H37NO4	small molecule	S01EE03	155206-00-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQOKCDNYWBIDND-FTOWTWDKSA-N
11598	111709	5737	RP5-944H6.1	PTGFR	FP	9606	Homo sapiens	agonist	target	Sharif NA (2001)	11740958	178988	895	Bimatoprost	Bimatoprostum|(Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((1e,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-5-heptenamide	latisse|lumigan rc|bimatoprost	DRUGBANK	DB00905	C25H37NO4	small molecule	S01EE03	155206-00-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQOKCDNYWBIDND-FTOWTWDKSA-N
11599	111709	5737	RP5-944H6.1	PTGFR	FP	9606	Homo sapiens	agonist	target	Lim KS (2008)	18452763	174976	895	Bimatoprost	Bimatoprostum|(Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((1e,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-5-heptenamide	latisse|lumigan rc|bimatoprost	DRUGBANK	DB00905	C25H37NO4	small molecule	S01EE03	155206-00-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQOKCDNYWBIDND-FTOWTWDKSA-N
11600	111709	5737	RP5-944H6.1	PTGFR	FP	9606	Homo sapiens	agonist	target	Neacsu AM (2009)	19697832	174974	895	Bimatoprost	Bimatoprostum|(Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((1e,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-5-heptenamide	latisse|lumigan rc|bimatoprost	DRUGBANK	DB00905	C25H37NO4	small molecule	S01EE03	155206-00-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQOKCDNYWBIDND-FTOWTWDKSA-N
11859	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Scarsi M (2007)	17082235	178076	902	Repaglinide	Repaglinidum|Surepost|AG-EE 388 ZW|Prandin|Repaglinida|AG-EE 623 ZW	apo-repaglinide|repaglinide an	DRUGBANK	DB00912	C27H36N2O4	small molecule	A10BD14|A10BX02	135062-02-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAEKWTJYAYMJKF-QHCPKHFHSA-N
11875	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Tomitaka S (1995)	8566141	179067	905	Amantadine	Amantidine|Amantadinum|Tricyclo[3.3.1.1(3,7)]decane-1-amine|Tricyclo[3.3.1.1(3,7)]decan-1-ylamine|Tricyclo[3.3.1.1(3,7)]decan-1-amine|Virosol|Viregyt|1-adamantylamine|1-adamantanamine|Amantadina|1-aminoadamantane|Amantadine|Aminoadamantane	symmetrel syrup 10mg/ml|gapeam	DRUGBANK	DB00915	C10H17N	small molecule	N04BB01	768-94-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKNWSYNQZKUICI-UHFFFAOYSA-N
11876	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Cousins MS (1997)	9098680	179066	905	Amantadine	Amantidine|Amantadinum|Tricyclo[3.3.1.1(3,7)]decane-1-amine|Tricyclo[3.3.1.1(3,7)]decan-1-ylamine|Tricyclo[3.3.1.1(3,7)]decan-1-amine|Virosol|Viregyt|1-adamantylamine|1-adamantanamine|Amantadina|1-aminoadamantane|Amantadine|Aminoadamantane	symmetrel syrup 10mg/ml|gapeam	DRUGBANK	DB00915	C10H17N	small molecule	N04BB01	768-94-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKNWSYNQZKUICI-UHFFFAOYSA-N
11877	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Hesselink MB (1999)	10443547	179064	905	Amantadine	Amantidine|Amantadinum|Tricyclo[3.3.1.1(3,7)]decane-1-amine|Tricyclo[3.3.1.1(3,7)]decan-1-ylamine|Tricyclo[3.3.1.1(3,7)]decan-1-amine|Virosol|Viregyt|1-adamantylamine|1-adamantanamine|Amantadina|1-aminoadamantane|Amantadine|Aminoadamantane	symmetrel syrup 10mg/ml|gapeam	DRUGBANK	DB00915	C10H17N	small molecule	N04BB01	768-94-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKNWSYNQZKUICI-UHFFFAOYSA-N
11878	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Ameri A (1998)	9806328	179068	905	Amantadine	Amantidine|Amantadinum|Tricyclo[3.3.1.1(3,7)]decane-1-amine|Tricyclo[3.3.1.1(3,7)]decan-1-ylamine|Tricyclo[3.3.1.1(3,7)]decan-1-amine|Virosol|Viregyt|1-adamantylamine|1-adamantanamine|Amantadina|1-aminoadamantane|Amantadine|Aminoadamantane	symmetrel syrup 10mg/ml|gapeam	DRUGBANK	DB00915	C10H17N	small molecule	N04BB01	768-94-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKNWSYNQZKUICI-UHFFFAOYSA-N
11879	111704	5732	-	PTGER2	EP2	9606	Homo sapiens	agonist	target	Legler DF (2010)	19788928	179085	907	Dinoprostone	Dinoprostone|(e,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid|Dinoprostone Prostaglandin E2|Prostaglandin E2|Dinoproston|Prepidil|Prostin e2|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate|(Z)-7-((1R,2R,3R)-3-Hydroxy-2-((S,e)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid|PGE2|Dinoprostonum|(15S)-Prostaglandin e2|Propess|(5Z,11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid|Dinoprostona|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate	dinoprostone|prostin e2 tablet	DRUGBANK	DB00917	C20H32O5	small molecule	G02AD02	363-24-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XEYBRNLFEZDVAW-ARSRFYASSA-N
11880	111704	5732	-	PTGER2	EP2	9606	Homo sapiens	agonist	target	Sugimoto Y (2007)	17329241	179083	907	Dinoprostone	Dinoprostone|(e,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid|Dinoprostone Prostaglandin E2|Prostaglandin E2|Dinoproston|Prepidil|Prostin e2|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate|(Z)-7-((1R,2R,3R)-3-Hydroxy-2-((S,e)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid|PGE2|Dinoprostonum|(15S)-Prostaglandin e2|Propess|(5Z,11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid|Dinoprostona|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate	dinoprostone|prostin e2 tablet	DRUGBANK	DB00917	C20H32O5	small molecule	G02AD02	363-24-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XEYBRNLFEZDVAW-ARSRFYASSA-N
11881	111704	5732	-	PTGER2	EP2	9606	Homo sapiens	agonist	target	Tamiji J (2010)	20599704	179082	907	Dinoprostone	Dinoprostone|(e,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid|Dinoprostone Prostaglandin E2|Prostaglandin E2|Dinoproston|Prepidil|Prostin e2|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate|(Z)-7-((1R,2R,3R)-3-Hydroxy-2-((S,e)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid|PGE2|Dinoprostonum|(15S)-Prostaglandin e2|Propess|(5Z,11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid|Dinoprostona|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate	dinoprostone|prostin e2 tablet	DRUGBANK	DB00917	C20H32O5	small molecule	G02AD02	363-24-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XEYBRNLFEZDVAW-ARSRFYASSA-N
11882	111704	5732	-	PTGER2	EP2	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	907	Dinoprostone	Dinoprostone|(e,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid|Dinoprostone Prostaglandin E2|Prostaglandin E2|Dinoproston|Prepidil|Prostin e2|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate|(Z)-7-((1R,2R,3R)-3-Hydroxy-2-((S,e)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid|PGE2|Dinoprostonum|(15S)-Prostaglandin e2|Propess|(5Z,11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid|Dinoprostona|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate	dinoprostone|prostin e2 tablet	DRUGBANK	DB00917	C20H32O5	small molecule	G02AD02	363-24-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XEYBRNLFEZDVAW-ARSRFYASSA-N
11883	111704	5732	-	PTGER2	EP2	9606	Homo sapiens	agonist	target	Baryawno N (2008)	18715952	179084	907	Dinoprostone	Dinoprostone|(e,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid|Dinoprostone Prostaglandin E2|Prostaglandin E2|Dinoproston|Prepidil|Prostin e2|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate|(Z)-7-((1R,2R,3R)-3-Hydroxy-2-((S,e)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid|PGE2|Dinoprostonum|(15S)-Prostaglandin e2|Propess|(5Z,11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid|Dinoprostona|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate	dinoprostone|prostin e2 tablet	DRUGBANK	DB00917	C20H32O5	small molecule	G02AD02	363-24-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XEYBRNLFEZDVAW-ARSRFYASSA-N
11884	111703	5731	-	PTGER1	EP1	9606	Homo sapiens	agonist	target	Sugimoto Y (2007)	17329241	179083	907	Dinoprostone	Dinoprostone|(e,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid|Dinoprostone Prostaglandin E2|Prostaglandin E2|Dinoproston|Prepidil|Prostin e2|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate|(Z)-7-((1R,2R,3R)-3-Hydroxy-2-((S,e)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid|PGE2|Dinoprostonum|(15S)-Prostaglandin e2|Propess|(5Z,11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid|Dinoprostona|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate	dinoprostone|prostin e2 tablet	DRUGBANK	DB00917	C20H32O5	small molecule	G02AD02	363-24-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XEYBRNLFEZDVAW-ARSRFYASSA-N
11885	111703	5731	-	PTGER1	EP1	9606	Homo sapiens	agonist	target	Tamiji J (2010)	20599704	179082	907	Dinoprostone	Dinoprostone|(e,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid|Dinoprostone Prostaglandin E2|Prostaglandin E2|Dinoproston|Prepidil|Prostin e2|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate|(Z)-7-((1R,2R,3R)-3-Hydroxy-2-((S,e)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid|PGE2|Dinoprostonum|(15S)-Prostaglandin e2|Propess|(5Z,11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid|Dinoprostona|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate	dinoprostone|prostin e2 tablet	DRUGBANK	DB00917	C20H32O5	small molecule	G02AD02	363-24-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XEYBRNLFEZDVAW-ARSRFYASSA-N
11886	111703	5731	-	PTGER1	EP1	9606	Homo sapiens	agonist	target	Legler DF (2010)	19788928	179085	907	Dinoprostone	Dinoprostone|(e,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid|Dinoprostone Prostaglandin E2|Prostaglandin E2|Dinoproston|Prepidil|Prostin e2|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate|(Z)-7-((1R,2R,3R)-3-Hydroxy-2-((S,e)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid|PGE2|Dinoprostonum|(15S)-Prostaglandin e2|Propess|(5Z,11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid|Dinoprostona|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate	dinoprostone|prostin e2 tablet	DRUGBANK	DB00917	C20H32O5	small molecule	G02AD02	363-24-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XEYBRNLFEZDVAW-ARSRFYASSA-N
11887	111703	5731	-	PTGER1	EP1	9606	Homo sapiens	agonist	target	Baryawno N (2008)	18715952	179084	907	Dinoprostone	Dinoprostone|(e,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid|Dinoprostone Prostaglandin E2|Prostaglandin E2|Dinoproston|Prepidil|Prostin e2|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate|(Z)-7-((1R,2R,3R)-3-Hydroxy-2-((S,e)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid|PGE2|Dinoprostonum|(15S)-Prostaglandin e2|Propess|(5Z,11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid|Dinoprostona|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate	dinoprostone|prostin e2 tablet	DRUGBANK	DB00917	C20H32O5	small molecule	G02AD02	363-24-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XEYBRNLFEZDVAW-ARSRFYASSA-N
11888	111706	5734	-	PTGER4	EP4|EP4R	9606	Homo sapiens	agonist	target	Sugimoto Y (2007)	17329241	179083	907	Dinoprostone	Dinoprostone|(e,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid|Dinoprostone Prostaglandin E2|Prostaglandin E2|Dinoproston|Prepidil|Prostin e2|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate|(Z)-7-((1R,2R,3R)-3-Hydroxy-2-((S,e)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid|PGE2|Dinoprostonum|(15S)-Prostaglandin e2|Propess|(5Z,11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid|Dinoprostona|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate	dinoprostone|prostin e2 tablet	DRUGBANK	DB00917	C20H32O5	small molecule	G02AD02	363-24-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XEYBRNLFEZDVAW-ARSRFYASSA-N
11889	111706	5734	-	PTGER4	EP4|EP4R	9606	Homo sapiens	agonist	target	Tamiji J (2010)	20599704	179082	907	Dinoprostone	Dinoprostone|(e,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid|Dinoprostone Prostaglandin E2|Prostaglandin E2|Dinoproston|Prepidil|Prostin e2|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate|(Z)-7-((1R,2R,3R)-3-Hydroxy-2-((S,e)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid|PGE2|Dinoprostonum|(15S)-Prostaglandin e2|Propess|(5Z,11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid|Dinoprostona|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate	dinoprostone|prostin e2 tablet	DRUGBANK	DB00917	C20H32O5	small molecule	G02AD02	363-24-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XEYBRNLFEZDVAW-ARSRFYASSA-N
11890	111706	5734	-	PTGER4	EP4|EP4R	9606	Homo sapiens	agonist	target	Legler DF (2010)	19788928	179085	907	Dinoprostone	Dinoprostone|(e,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid|Dinoprostone Prostaglandin E2|Prostaglandin E2|Dinoproston|Prepidil|Prostin e2|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate|(Z)-7-((1R,2R,3R)-3-Hydroxy-2-((S,e)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid|PGE2|Dinoprostonum|(15S)-Prostaglandin e2|Propess|(5Z,11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid|Dinoprostona|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate	dinoprostone|prostin e2 tablet	DRUGBANK	DB00917	C20H32O5	small molecule	G02AD02	363-24-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XEYBRNLFEZDVAW-ARSRFYASSA-N
11891	111706	5734	-	PTGER4	EP4|EP4R	9606	Homo sapiens	agonist	target	Baryawno N (2008)	18715952	179084	907	Dinoprostone	Dinoprostone|(e,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid|Dinoprostone Prostaglandin E2|Prostaglandin E2|Dinoproston|Prepidil|Prostin e2|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate|(Z)-7-((1R,2R,3R)-3-Hydroxy-2-((S,e)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid|PGE2|Dinoprostonum|(15S)-Prostaglandin e2|Propess|(5Z,11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid|Dinoprostona|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate	dinoprostone|prostin e2 tablet	DRUGBANK	DB00917	C20H32O5	small molecule	G02AD02	363-24-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XEYBRNLFEZDVAW-ARSRFYASSA-N
11892	111706	5734	-	PTGER4	EP4|EP4R	9606	Homo sapiens	agonist	target	Wise H (2006)	16545798	179086	907	Dinoprostone	Dinoprostone|(e,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid|Dinoprostone Prostaglandin E2|Prostaglandin E2|Dinoproston|Prepidil|Prostin e2|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate|(Z)-7-((1R,2R,3R)-3-Hydroxy-2-((S,e)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid|PGE2|Dinoprostonum|(15S)-Prostaglandin e2|Propess|(5Z,11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid|Dinoprostona|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate	dinoprostone|prostin e2 tablet	DRUGBANK	DB00917	C20H32O5	small molecule	G02AD02	363-24-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XEYBRNLFEZDVAW-ARSRFYASSA-N
11893	111705	5733	RP5-952N6.2	PTGER3	EP3|EP3-I|EP3-II|EP3-III|EP3-IV|EP3e|PGE2-R	9606	Homo sapiens	agonist	target	Sugimoto Y (2007)	17329241	179083	907	Dinoprostone	Dinoprostone|(e,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid|Dinoprostone Prostaglandin E2|Prostaglandin E2|Dinoproston|Prepidil|Prostin e2|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate|(Z)-7-((1R,2R,3R)-3-Hydroxy-2-((S,e)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid|PGE2|Dinoprostonum|(15S)-Prostaglandin e2|Propess|(5Z,11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid|Dinoprostona|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate	dinoprostone|prostin e2 tablet	DRUGBANK	DB00917	C20H32O5	small molecule	G02AD02	363-24-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XEYBRNLFEZDVAW-ARSRFYASSA-N
11894	111705	5733	RP5-952N6.2	PTGER3	EP3|EP3-I|EP3-II|EP3-III|EP3-IV|EP3e|PGE2-R	9606	Homo sapiens	agonist	target	Tamiji J (2010)	20599704	179082	907	Dinoprostone	Dinoprostone|(e,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid|Dinoprostone Prostaglandin E2|Prostaglandin E2|Dinoproston|Prepidil|Prostin e2|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate|(Z)-7-((1R,2R,3R)-3-Hydroxy-2-((S,e)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid|PGE2|Dinoprostonum|(15S)-Prostaglandin e2|Propess|(5Z,11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid|Dinoprostona|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate	dinoprostone|prostin e2 tablet	DRUGBANK	DB00917	C20H32O5	small molecule	G02AD02	363-24-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XEYBRNLFEZDVAW-ARSRFYASSA-N
11895	111705	5733	RP5-952N6.2	PTGER3	EP3|EP3-I|EP3-II|EP3-III|EP3-IV|EP3e|PGE2-R	9606	Homo sapiens	agonist	target	Legler DF (2010)	19788928	179085	907	Dinoprostone	Dinoprostone|(e,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid|Dinoprostone Prostaglandin E2|Prostaglandin E2|Dinoproston|Prepidil|Prostin e2|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate|(Z)-7-((1R,2R,3R)-3-Hydroxy-2-((S,e)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid|PGE2|Dinoprostonum|(15S)-Prostaglandin e2|Propess|(5Z,11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid|Dinoprostona|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate	dinoprostone|prostin e2 tablet	DRUGBANK	DB00917	C20H32O5	small molecule	G02AD02	363-24-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XEYBRNLFEZDVAW-ARSRFYASSA-N
11896	111705	5733	RP5-952N6.2	PTGER3	EP3|EP3-I|EP3-II|EP3-III|EP3-IV|EP3e|PGE2-R	9606	Homo sapiens	agonist	target	Baryawno N (2008)	18715952	179084	907	Dinoprostone	Dinoprostone|(e,Z)-(1R,2R,3R)-7-(3-Hydroxy-2-((3S)-(3-hydroxy-1-octenyl))-5-oxocyclopentyl)-5-heptenoic acid|Dinoprostone Prostaglandin E2|Prostaglandin E2|Dinoproston|Prepidil|Prostin e2|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprosta-5,13-dienoate|(Z)-7-((1R,2R,3R)-3-Hydroxy-2-((S,e)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)hept-5-enoic acid|PGE2|Dinoprostonum|(15S)-Prostaglandin e2|Propess|(5Z,11alpha,13e,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid|Dinoprostona|(5Z,13e)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate	dinoprostone|prostin e2 tablet	DRUGBANK	DB00917	C20H32O5	small molecule	G02AD02	363-24-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XEYBRNLFEZDVAW-ARSRFYASSA-N
12014	111705	5733	RP5-952N6.2	PTGER3	EP3|EP3-I|EP3-II|EP3-III|EP3-IV|EP3e|PGE2-R	9606	Homo sapiens	agonist	target	Li J (2008)	18472336	179162	919	Misoprostol	Cytotec|Misoprostolum	pms-misoprostol (0.2mg)|arthro	DRUGBANK	DB00929	C22H38O5	small molecule	M01AE56|A02BB01|G02AD06	59122-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJLOPKGSLYJEMD-URPKTTJQSA-N
12015	111705	5733	RP5-952N6.2	PTGER3	EP3|EP3-I|EP3-II|EP3-III|EP3-IV|EP3e|PGE2-R	9606	Homo sapiens	agonist	target	Guan Y (2002)	12097143	179163	919	Misoprostol	Cytotec|Misoprostolum	pms-misoprostol (0.2mg)|arthro	DRUGBANK	DB00929	C22H38O5	small molecule	M01AE56|A02BB01|G02AD06	59122-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJLOPKGSLYJEMD-URPKTTJQSA-N
12016	111705	5733	RP5-952N6.2	PTGER3	EP3|EP3-I|EP3-II|EP3-III|EP3-IV|EP3e|PGE2-R	9606	Homo sapiens	agonist	target	Nataraj C (2001)	11602631	179160	919	Misoprostol	Cytotec|Misoprostolum	pms-misoprostol (0.2mg)|arthro	DRUGBANK	DB00929	C22H38O5	small molecule	M01AE56|A02BB01|G02AD06	59122-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJLOPKGSLYJEMD-URPKTTJQSA-N
12017	111705	5733	RP5-952N6.2	PTGER3	EP3|EP3-I|EP3-II|EP3-III|EP3-IV|EP3e|PGE2-R	9606	Homo sapiens	agonist	target	Nakae K (2005)	16039053	179161	919	Misoprostol	Cytotec|Misoprostolum	pms-misoprostol (0.2mg)|arthro	DRUGBANK	DB00929	C22H38O5	small molecule	M01AE56|A02BB01|G02AD06	59122-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJLOPKGSLYJEMD-URPKTTJQSA-N
12018	111705	5733	RP5-952N6.2	PTGER3	EP3|EP3-I|EP3-II|EP3-III|EP3-IV|EP3e|PGE2-R	9606	Homo sapiens	agonist	target	Kiriyama M (1997)	9313928	179164	919	Misoprostol	Cytotec|Misoprostolum	pms-misoprostol (0.2mg)|arthro	DRUGBANK	DB00929	C22H38O5	small molecule	M01AE56|A02BB01|G02AD06	59122-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJLOPKGSLYJEMD-URPKTTJQSA-N
12019	111706	5734	-	PTGER4	EP4|EP4R	9606	Homo sapiens	agonist	target	Li J (2008)	18472336	179162	919	Misoprostol	Cytotec|Misoprostolum	pms-misoprostol (0.2mg)|arthro	DRUGBANK	DB00929	C22H38O5	small molecule	M01AE56|A02BB01|G02AD06	59122-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJLOPKGSLYJEMD-URPKTTJQSA-N
12020	111706	5734	-	PTGER4	EP4|EP4R	9606	Homo sapiens	agonist	target	Guan Y (2002)	12097143	179163	919	Misoprostol	Cytotec|Misoprostolum	pms-misoprostol (0.2mg)|arthro	DRUGBANK	DB00929	C22H38O5	small molecule	M01AE56|A02BB01|G02AD06	59122-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJLOPKGSLYJEMD-URPKTTJQSA-N
12021	111706	5734	-	PTGER4	EP4|EP4R	9606	Homo sapiens	agonist	target	Nataraj C (2001)	11602631	179160	919	Misoprostol	Cytotec|Misoprostolum	pms-misoprostol (0.2mg)|arthro	DRUGBANK	DB00929	C22H38O5	small molecule	M01AE56|A02BB01|G02AD06	59122-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJLOPKGSLYJEMD-URPKTTJQSA-N
12022	111706	5734	-	PTGER4	EP4|EP4R	9606	Homo sapiens	agonist	target	Nakae K (2005)	16039053	179161	919	Misoprostol	Cytotec|Misoprostolum	pms-misoprostol (0.2mg)|arthro	DRUGBANK	DB00929	C22H38O5	small molecule	M01AE56|A02BB01|G02AD06	59122-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJLOPKGSLYJEMD-URPKTTJQSA-N
12023	111706	5734	-	PTGER4	EP4|EP4R	9606	Homo sapiens	agonist	target	Crider JY (2002)	11993717	160612	919	Misoprostol	Cytotec|Misoprostolum	pms-misoprostol (0.2mg)|arthro	DRUGBANK	DB00929	C22H38O5	small molecule	M01AE56|A02BB01|G02AD06	59122-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJLOPKGSLYJEMD-URPKTTJQSA-N
12024	111706	5734	-	PTGER4	EP4|EP4R	9606	Homo sapiens	agonist	target	Kiriyama M (1997)	9313928	179164	919	Misoprostol	Cytotec|Misoprostolum	pms-misoprostol (0.2mg)|arthro	DRUGBANK	DB00929	C22H38O5	small molecule	M01AE56|A02BB01|G02AD06	59122-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJLOPKGSLYJEMD-URPKTTJQSA-N
12025	111704	5732	-	PTGER2	EP2	9606	Homo sapiens	agonist	target	Li J (2008)	18472336	179162	919	Misoprostol	Cytotec|Misoprostolum	pms-misoprostol (0.2mg)|arthro	DRUGBANK	DB00929	C22H38O5	small molecule	M01AE56|A02BB01|G02AD06	59122-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJLOPKGSLYJEMD-URPKTTJQSA-N
12026	111704	5732	-	PTGER2	EP2	9606	Homo sapiens	agonist	target	Guan Y (2002)	12097143	179163	919	Misoprostol	Cytotec|Misoprostolum	pms-misoprostol (0.2mg)|arthro	DRUGBANK	DB00929	C22H38O5	small molecule	M01AE56|A02BB01|G02AD06	59122-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJLOPKGSLYJEMD-URPKTTJQSA-N
12027	111704	5732	-	PTGER2	EP2	9606	Homo sapiens	agonist	target	Nataraj C (2001)	11602631	179160	919	Misoprostol	Cytotec|Misoprostolum	pms-misoprostol (0.2mg)|arthro	DRUGBANK	DB00929	C22H38O5	small molecule	M01AE56|A02BB01|G02AD06	59122-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJLOPKGSLYJEMD-URPKTTJQSA-N
12028	111704	5732	-	PTGER2	EP2	9606	Homo sapiens	agonist	target	Nakae K (2005)	16039053	179161	919	Misoprostol	Cytotec|Misoprostolum	pms-misoprostol (0.2mg)|arthro	DRUGBANK	DB00929	C22H38O5	small molecule	M01AE56|A02BB01|G02AD06	59122-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJLOPKGSLYJEMD-URPKTTJQSA-N
12029	111704	5732	-	PTGER2	EP2	9606	Homo sapiens	agonist	target	Kiriyama M (1997)	9313928	179164	919	Misoprostol	Cytotec|Misoprostolum	pms-misoprostol (0.2mg)|arthro	DRUGBANK	DB00929	C22H38O5	small molecule	M01AE56|A02BB01|G02AD06	59122-46-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJLOPKGSLYJEMD-URPKTTJQSA-N
12038	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	923	Mesoridazine	10-(2-(1-Methyl-2-piperidyl)ethyl)-2-methylsulfinyl phenothiazine|Thioridazine Thiomethyl Sulfoxide|10-(2(1-Methyl-2-piperidyl)ethyl)-2-(methylsulfinyl)phenothiazine|TPS-23|2-Methanesulfinyl-10-[2-(1-methyl-piperidin-2-yl)-ethyl]-10H-phenothiazine|Mesoridazinum|Mesoridazine|thioridazine-2-sulfoxide|Mesoridazina	serentil tab 25mg|serentil tab	DRUGBANK	DB00933	C21H26N2OS2	small molecule	N05AC03	5588-33-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SLVMESMUVMCQIY-UHFFFAOYSA-N
12039	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Burstein ES (2005)	16135699	176776	923	Mesoridazine	10-(2-(1-Methyl-2-piperidyl)ethyl)-2-methylsulfinyl phenothiazine|Thioridazine Thiomethyl Sulfoxide|10-(2(1-Methyl-2-piperidyl)ethyl)-2-(methylsulfinyl)phenothiazine|TPS-23|2-Methanesulfinyl-10-[2-(1-methyl-piperidin-2-yl)-ethyl]-10H-phenothiazine|Mesoridazinum|Mesoridazine|thioridazine-2-sulfoxide|Mesoridazina	serentil tab 25mg|serentil tab	DRUGBANK	DB00933	C21H26N2OS2	small molecule	N05AC03	5588-33-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SLVMESMUVMCQIY-UHFFFAOYSA-N
12040	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Choi S (2004)	15357957	179174	923	Mesoridazine	10-(2-(1-Methyl-2-piperidyl)ethyl)-2-methylsulfinyl phenothiazine|Thioridazine Thiomethyl Sulfoxide|10-(2(1-Methyl-2-piperidyl)ethyl)-2-(methylsulfinyl)phenothiazine|TPS-23|2-Methanesulfinyl-10-[2-(1-methyl-piperidin-2-yl)-ethyl]-10H-phenothiazine|Mesoridazinum|Mesoridazine|thioridazine-2-sulfoxide|Mesoridazina	serentil tab 25mg|serentil tab	DRUGBANK	DB00933	C21H26N2OS2	small molecule	N05AC03	5588-33-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SLVMESMUVMCQIY-UHFFFAOYSA-N
12052	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	binder	target	Richelson E (1984)	6086881	176781	924	Maprotiline	Maprotilinum|Maprotylina|Maprotilina	ludiomil tab 75mg|novo-maproti	DRUGBANK	DB00934	C20H23N	small molecule	N06AA21	10262-69-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QSLMDECMDJKHMQ-UHFFFAOYSA-N
12097	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Celik G (2005)	15871445	179199	926	Salicylic acid	2-Carboxyphenol|2-Hydroxybenzoic acid|O-hydroxybenzoic acid|O-carboxyphenol	md cell scalp|neutrogena oil f	DRUGBANK	DB00936	C7H6O3	small molecule	N02BA04|D01AE12|S01BC08	69-72-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YGSDEFSMJLZEOE-UHFFFAOYSA-N
12098	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	926	Salicylic acid	2-Carboxyphenol|2-Hydroxybenzoic acid|O-hydroxybenzoic acid|O-carboxyphenol	md cell scalp|neutrogena oil f	DRUGBANK	DB00936	C7H6O3	small molecule	N02BA04|D01AE12|S01BC08	69-72-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YGSDEFSMJLZEOE-UHFFFAOYSA-N
12099	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Sun R (2005)	15840771	179203	926	Salicylic acid	2-Carboxyphenol|2-Hydroxybenzoic acid|O-hydroxybenzoic acid|O-carboxyphenol	md cell scalp|neutrogena oil f	DRUGBANK	DB00936	C7H6O3	small molecule	N02BA04|D01AE12|S01BC08	69-72-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YGSDEFSMJLZEOE-UHFFFAOYSA-N
12100	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Liu X (2006)	16368818	179202	926	Salicylic acid	2-Carboxyphenol|2-Hydroxybenzoic acid|O-hydroxybenzoic acid|O-carboxyphenol	md cell scalp|neutrogena oil f	DRUGBANK	DB00936	C7H6O3	small molecule	N02BA04|D01AE12|S01BC08	69-72-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YGSDEFSMJLZEOE-UHFFFAOYSA-N
12101	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Graham GG (2004)	15035793	179201	926	Salicylic acid	2-Carboxyphenol|2-Hydroxybenzoic acid|O-hydroxybenzoic acid|O-carboxyphenol	md cell scalp|neutrogena oil f	DRUGBANK	DB00936	C7H6O3	small molecule	N02BA04|D01AE12|S01BC08	69-72-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YGSDEFSMJLZEOE-UHFFFAOYSA-N
12102	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Moon C (2004)	14746879	179200	926	Salicylic acid	2-Carboxyphenol|2-Hydroxybenzoic acid|O-hydroxybenzoic acid|O-carboxyphenol	md cell scalp|neutrogena oil f	DRUGBANK	DB00936	C7H6O3	small molecule	N02BA04|D01AE12|S01BC08	69-72-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YGSDEFSMJLZEOE-UHFFFAOYSA-N
12103	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Vane JR (1971)	5284360	179204	926	Salicylic acid	2-Carboxyphenol|2-Hydroxybenzoic acid|O-hydroxybenzoic acid|O-carboxyphenol	md cell scalp|neutrogena oil f	DRUGBANK	DB00936	C7H6O3	small molecule	N02BA04|D01AE12|S01BC08	69-72-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YGSDEFSMJLZEOE-UHFFFAOYSA-N
12104	108012	1645	RP11-69D4.1	AKR1C1	2-ALPHA-HSD|20-ALPHA-HSD|C9|DD1|DD1/DD2|DDH|DDH1|H-37|HAKRC|HBAB|MBAB	9606	Homo sapiens	inhibitor	target	Dhagat U (2007)	18045204	179205	926	Salicylic acid	2-Carboxyphenol|2-Hydroxybenzoic acid|O-hydroxybenzoic acid|O-carboxyphenol	md cell scalp|neutrogena oil f	DRUGBANK	DB00936	C7H6O3	small molecule	N02BA04|D01AE12|S01BC08	69-72-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YGSDEFSMJLZEOE-UHFFFAOYSA-N
12105	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Graham GG (2004)	15035793	179201	926	Salicylic acid	2-Carboxyphenol|2-Hydroxybenzoic acid|O-hydroxybenzoic acid|O-carboxyphenol	md cell scalp|neutrogena oil f	DRUGBANK	DB00936	C7H6O3	small molecule	N02BA04|D01AE12|S01BC08	69-72-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YGSDEFSMJLZEOE-UHFFFAOYSA-N
12106	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chae HJ (2004)	15106733	179207	926	Salicylic acid	2-Carboxyphenol|2-Hydroxybenzoic acid|O-hydroxybenzoic acid|O-carboxyphenol	md cell scalp|neutrogena oil f	DRUGBANK	DB00936	C7H6O3	small molecule	N02BA04|D01AE12|S01BC08	69-72-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YGSDEFSMJLZEOE-UHFFFAOYSA-N
12107	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Fiebich BL (2004)	15070163	179206	926	Salicylic acid	2-Carboxyphenol|2-Hydroxybenzoic acid|O-hydroxybenzoic acid|O-carboxyphenol	md cell scalp|neutrogena oil f	DRUGBANK	DB00936	C7H6O3	small molecule	N02BA04|D01AE12|S01BC08	69-72-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YGSDEFSMJLZEOE-UHFFFAOYSA-N
12108	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Vane JR (1971)	5284360	179204	926	Salicylic acid	2-Carboxyphenol|2-Hydroxybenzoic acid|O-hydroxybenzoic acid|O-carboxyphenol	md cell scalp|neutrogena oil f	DRUGBANK	DB00936	C7H6O3	small molecule	N02BA04|D01AE12|S01BC08	69-72-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YGSDEFSMJLZEOE-UHFFFAOYSA-N
12109	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Wu KK (2003)	15199473	179209	926	Salicylic acid	2-Carboxyphenol|2-Hydroxybenzoic acid|O-hydroxybenzoic acid|O-carboxyphenol	md cell scalp|neutrogena oil f	DRUGBANK	DB00936	C7H6O3	small molecule	N02BA04|D01AE12|S01BC08	69-72-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YGSDEFSMJLZEOE-UHFFFAOYSA-N
12110	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Elvira C (2001)	15348270	179208	926	Salicylic acid	2-Carboxyphenol|2-Hydroxybenzoic acid|O-hydroxybenzoic acid|O-carboxyphenol	md cell scalp|neutrogena oil f	DRUGBANK	DB00936	C7H6O3	small molecule	N02BA04|D01AE12|S01BC08	69-72-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YGSDEFSMJLZEOE-UHFFFAOYSA-N
12122	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Shiels IA (2000)	11094641	179221	929	Meclofenamic acid	N-(3-Methyl-2,6-dichlorophenyl)anthranilic acid|Acide meclofenamique|Acidum meclofenamicum|Meclofenamate|N-(2,6-Dichloro-3-methylphenyl)anthranilic acid|INF 4668|N-(2,6-Dichloro-m-tolyl)anthranilic acid|CI-583|Acido meclofenamico	meclofenamate sodium	DRUGBANK	DB00939	C14H11Cl2NO2	small molecule	M01AG04|M02AA18	644-62-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SBDNJUWAMKYJOX-UHFFFAOYSA-N
12123	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Meade EA (1993)	8454631	179220	929	Meclofenamic acid	N-(3-Methyl-2,6-dichlorophenyl)anthranilic acid|Acide meclofenamique|Acidum meclofenamicum|Meclofenamate|N-(2,6-Dichloro-3-methylphenyl)anthranilic acid|INF 4668|N-(2,6-Dichloro-m-tolyl)anthranilic acid|CI-583|Acido meclofenamico	meclofenamate sodium	DRUGBANK	DB00939	C14H11Cl2NO2	small molecule	M01AG04|M02AA18	644-62-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SBDNJUWAMKYJOX-UHFFFAOYSA-N
12124	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Kalgutkar AS (2000)	10639181	179223	929	Meclofenamic acid	N-(3-Methyl-2,6-dichlorophenyl)anthranilic acid|Acide meclofenamique|Acidum meclofenamicum|Meclofenamate|N-(2,6-Dichloro-3-methylphenyl)anthranilic acid|INF 4668|N-(2,6-Dichloro-m-tolyl)anthranilic acid|CI-583|Acido meclofenamico	meclofenamate sodium	DRUGBANK	DB00939	C14H11Cl2NO2	small molecule	M01AG04|M02AA18	644-62-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SBDNJUWAMKYJOX-UHFFFAOYSA-N
12125	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Perez-Vizcaino F (2002)	12225961	179222	929	Meclofenamic acid	N-(3-Methyl-2,6-dichlorophenyl)anthranilic acid|Acide meclofenamique|Acidum meclofenamicum|Meclofenamate|N-(2,6-Dichloro-3-methylphenyl)anthranilic acid|INF 4668|N-(2,6-Dichloro-m-tolyl)anthranilic acid|CI-583|Acido meclofenamico	meclofenamate sodium	DRUGBANK	DB00939	C14H11Cl2NO2	small molecule	M01AG04|M02AA18	644-62-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SBDNJUWAMKYJOX-UHFFFAOYSA-N
12126	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Wilson JE (2004)	15198222	178171	929	Meclofenamic acid	N-(3-Methyl-2,6-dichlorophenyl)anthranilic acid|Acide meclofenamique|Acidum meclofenamicum|Meclofenamate|N-(2,6-Dichloro-3-methylphenyl)anthranilic acid|INF 4668|N-(2,6-Dichloro-m-tolyl)anthranilic acid|CI-583|Acido meclofenamico	meclofenamate sodium	DRUGBANK	DB00939	C14H11Cl2NO2	small molecule	M01AG04|M02AA18	644-62-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SBDNJUWAMKYJOX-UHFFFAOYSA-N
12129	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Boctor AM (1986)	3020588	179225	929	Meclofenamic acid	N-(3-Methyl-2,6-dichlorophenyl)anthranilic acid|Acide meclofenamique|Acidum meclofenamicum|Meclofenamate|N-(2,6-Dichloro-3-methylphenyl)anthranilic acid|INF 4668|N-(2,6-Dichloro-m-tolyl)anthranilic acid|CI-583|Acido meclofenamico	meclofenamate sodium	DRUGBANK	DB00939	C14H11Cl2NO2	small molecule	M01AG04|M02AA18	644-62-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SBDNJUWAMKYJOX-UHFFFAOYSA-N
12130	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Yu XY (1992)	1539679	179224	929	Meclofenamic acid	N-(3-Methyl-2,6-dichlorophenyl)anthranilic acid|Acide meclofenamique|Acidum meclofenamicum|Meclofenamate|N-(2,6-Dichloro-3-methylphenyl)anthranilic acid|INF 4668|N-(2,6-Dichloro-m-tolyl)anthranilic acid|CI-583|Acido meclofenamico	meclofenamate sodium	DRUGBANK	DB00939	C14H11Cl2NO2	small molecule	M01AG04|M02AA18	644-62-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SBDNJUWAMKYJOX-UHFFFAOYSA-N
12131	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Narsinghani T (2006)	16290292	179228	929	Meclofenamic acid	N-(3-Methyl-2,6-dichlorophenyl)anthranilic acid|Acide meclofenamique|Acidum meclofenamicum|Meclofenamate|N-(2,6-Dichloro-3-methylphenyl)anthranilic acid|INF 4668|N-(2,6-Dichloro-m-tolyl)anthranilic acid|CI-583|Acido meclofenamico	meclofenamate sodium	DRUGBANK	DB00939	C14H11Cl2NO2	small molecule	M01AG04|M02AA18	644-62-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SBDNJUWAMKYJOX-UHFFFAOYSA-N
12132	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Kalgutkar AS (2000)	10639181	179223	929	Meclofenamic acid	N-(3-Methyl-2,6-dichlorophenyl)anthranilic acid|Acide meclofenamique|Acidum meclofenamicum|Meclofenamate|N-(2,6-Dichloro-3-methylphenyl)anthranilic acid|INF 4668|N-(2,6-Dichloro-m-tolyl)anthranilic acid|CI-583|Acido meclofenamico	meclofenamate sodium	DRUGBANK	DB00939	C14H11Cl2NO2	small molecule	M01AG04|M02AA18	644-62-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SBDNJUWAMKYJOX-UHFFFAOYSA-N
12133	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Wilson JE (2004)	15198222	178171	929	Meclofenamic acid	N-(3-Methyl-2,6-dichlorophenyl)anthranilic acid|Acide meclofenamique|Acidum meclofenamicum|Meclofenamate|N-(2,6-Dichloro-3-methylphenyl)anthranilic acid|INF 4668|N-(2,6-Dichloro-m-tolyl)anthranilic acid|CI-583|Acido meclofenamico	meclofenamate sodium	DRUGBANK	DB00939	C14H11Cl2NO2	small molecule	M01AG04|M02AA18	644-62-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SBDNJUWAMKYJOX-UHFFFAOYSA-N
12134	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Traupe T (2002)	12409963	179227	929	Meclofenamic acid	N-(3-Methyl-2,6-dichlorophenyl)anthranilic acid|Acide meclofenamique|Acidum meclofenamicum|Meclofenamate|N-(2,6-Dichloro-3-methylphenyl)anthranilic acid|INF 4668|N-(2,6-Dichloro-m-tolyl)anthranilic acid|CI-583|Acido meclofenamico	meclofenamate sodium	DRUGBANK	DB00939	C14H11Cl2NO2	small molecule	M01AG04|M02AA18	644-62-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SBDNJUWAMKYJOX-UHFFFAOYSA-N
12135	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Smith WL (1994)	7825862	179226	929	Meclofenamic acid	N-(3-Methyl-2,6-dichlorophenyl)anthranilic acid|Acide meclofenamique|Acidum meclofenamicum|Meclofenamate|N-(2,6-Dichloro-3-methylphenyl)anthranilic acid|INF 4668|N-(2,6-Dichloro-m-tolyl)anthranilic acid|CI-583|Acido meclofenamico	meclofenamate sodium	DRUGBANK	DB00939	C14H11Cl2NO2	small molecule	M01AG04|M02AA18	644-62-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SBDNJUWAMKYJOX-UHFFFAOYSA-N
12149	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Birnbaum Y (2007)	17259075	179239	935	Acetylsalicylic acid	2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin	medique medi seltzer|asatab 80	DRUGBANK	DB00945	C9H8O4	small molecule	N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01	50-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BSYNRYMUTXBXSQ-UHFFFAOYSA-N
12150	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	935	Acetylsalicylic acid	2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin	medique medi seltzer|asatab 80	DRUGBANK	DB00945	C9H8O4	small molecule	N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01	50-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BSYNRYMUTXBXSQ-UHFFFAOYSA-N
12151	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Flipo RM (2006)	17078596	179243	935	Acetylsalicylic acid	2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin	medique medi seltzer|asatab 80	DRUGBANK	DB00945	C9H8O4	small molecule	N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01	50-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BSYNRYMUTXBXSQ-UHFFFAOYSA-N
12152	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Guthikonda S (2007)	17319904	179242	935	Acetylsalicylic acid	2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin	medique medi seltzer|asatab 80	DRUGBANK	DB00945	C9H8O4	small molecule	N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01	50-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BSYNRYMUTXBXSQ-UHFFFAOYSA-N
12153	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Stevenson DD (2006)	17030227	179241	935	Acetylsalicylic acid	2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin	medique medi seltzer|asatab 80	DRUGBANK	DB00945	C9H8O4	small molecule	N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01	50-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BSYNRYMUTXBXSQ-UHFFFAOYSA-N
12154	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Schwartz KA (2006)	17131625	179240	935	Acetylsalicylic acid	2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin	medique medi seltzer|asatab 80	DRUGBANK	DB00945	C9H8O4	small molecule	N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01	50-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BSYNRYMUTXBXSQ-UHFFFAOYSA-N
12155	108012	1645	RP11-69D4.1	AKR1C1	2-ALPHA-HSD|20-ALPHA-HSD|C9|DD1|DD1/DD2|DDH|DDH1|H-37|HAKRC|HBAB|MBAB	9606	Homo sapiens	inhibitor	target	Dhagat U (2007)	18045204	179205	935	Acetylsalicylic acid	2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin	medique medi seltzer|asatab 80	DRUGBANK	DB00945	C9H8O4	small molecule	N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01	50-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BSYNRYMUTXBXSQ-UHFFFAOYSA-N
12175	108231	1909	-	EDNRA	ET-A|ETA|ETA-R|ETAR|ETRA|hET-AR	9606	Homo sapiens	unknown	target	Talbodec A (2000)	10727528	179250	935	Acetylsalicylic acid	2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin	medique medi seltzer|asatab 80	DRUGBANK	DB00945	C9H8O4	small molecule	N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01	50-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BSYNRYMUTXBXSQ-UHFFFAOYSA-N
12177	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Shen J (2006)	17181859	179252	935	Acetylsalicylic acid	2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin	medique medi seltzer|asatab 80	DRUGBANK	DB00945	C9H8O4	small molecule	N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01	50-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BSYNRYMUTXBXSQ-UHFFFAOYSA-N
12178	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Nakano M (2007)	17258197	179253	935	Acetylsalicylic acid	2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin	medique medi seltzer|asatab 80	DRUGBANK	DB00945	C9H8O4	small molecule	N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01	50-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BSYNRYMUTXBXSQ-UHFFFAOYSA-N
12179	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Wang HJ (2006)	17037745	179254	935	Acetylsalicylic acid	2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin	medique medi seltzer|asatab 80	DRUGBANK	DB00945	C9H8O4	small molecule	N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01	50-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BSYNRYMUTXBXSQ-UHFFFAOYSA-N
12180	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Hall MN (2007)	17301265	179255	935	Acetylsalicylic acid	2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin	medique medi seltzer|asatab 80	DRUGBANK	DB00945	C9H8O4	small molecule	N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01	50-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BSYNRYMUTXBXSQ-UHFFFAOYSA-N
12181	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Brzozowski T (2006)	17033106	179256	935	Acetylsalicylic acid	2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin	medique medi seltzer|asatab 80	DRUGBANK	DB00945	C9H8O4	small molecule	N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01	50-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BSYNRYMUTXBXSQ-UHFFFAOYSA-N
12182	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	935	Acetylsalicylic acid	2-Acetoxybenzenecarboxylic acid|cido acetilsaliclico|Polopiryna|Easprin|Azetylsalizylsaeure|Salicylic acid acetate|2-Acetoxybenzoic acid|Acide actylsalicylique|O-acetylsalicylic acid|ASA|Acide 2-(acetyloxy)benzoique|Acetylsalicylsaeure|Acetylsalicylic acid|o-acetoxybenzoic acid|Azetylsalizylsure|2-(ACETYLOXY)benzoic acid|Acidum acetylsalicylicum|Acetylsalicylate|o-carboxyphenyl acetate|Aspirin	medique medi seltzer|asatab 80	DRUGBANK	DB00945	C9H8O4	small molecule	N02BA51|A01AD05|B01AC06|C10BX06|N02BA71|B01AC56|C10BX01|C10BX02|C10BX05|C10BX04|M01BA03|C10BX08|N02BA01	50-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BSYNRYMUTXBXSQ-UHFFFAOYSA-N
12328	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	953	Bromfenac	Bromfenaco|2-amino-3-(4-Bromobenzoyl)benzeneacetic acid|[2-Amino-3-(4-bromo-benzoyl)-phenyl]-acetic acid|Bromfenacum	prolensa|bromsite 0.075%|bromd	DRUGBANK	DB00963	C15H12BrNO3	small molecule	S01BC11	91714-94-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBPLOVFIXSTCRZ-UHFFFAOYSA-N
12329	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Waterbury LD (2006)	16846546	179366	953	Bromfenac	Bromfenaco|2-amino-3-(4-Bromobenzoyl)benzeneacetic acid|[2-Amino-3-(4-bromo-benzoyl)-phenyl]-acetic acid|Bromfenacum	prolensa|bromsite 0.075%|bromd	DRUGBANK	DB00963	C15H12BrNO3	small molecule	S01BC11	91714-94-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBPLOVFIXSTCRZ-UHFFFAOYSA-N
12330	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Sanchez-Matienzo D (2006)	16982289	179368	953	Bromfenac	Bromfenaco|2-amino-3-(4-Bromobenzoyl)benzeneacetic acid|[2-Amino-3-(4-bromo-benzoyl)-phenyl]-acetic acid|Bromfenacum	prolensa|bromsite 0.075%|bromd	DRUGBANK	DB00963	C15H12BrNO3	small molecule	S01BC11	91714-94-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBPLOVFIXSTCRZ-UHFFFAOYSA-N
12331	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Waterbury LD (2006)	16846546	179366	953	Bromfenac	Bromfenaco|2-amino-3-(4-Bromobenzoyl)benzeneacetic acid|[2-Amino-3-(4-bromo-benzoyl)-phenyl]-acetic acid|Bromfenacum	prolensa|bromsite 0.075%|bromd	DRUGBANK	DB00963	C15H12BrNO3	small molecule	S01BC11	91714-94-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBPLOVFIXSTCRZ-UHFFFAOYSA-N
12332	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chitturi S (2002)	12016548	179367	953	Bromfenac	Bromfenaco|2-amino-3-(4-Bromobenzoyl)benzeneacetic acid|[2-Amino-3-(4-bromo-benzoyl)-phenyl]-acetic acid|Bromfenacum	prolensa|bromsite 0.075%|bromd	DRUGBANK	DB00963	C15H12BrNO3	small molecule	S01BC11	91714-94-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZBPLOVFIXSTCRZ-UHFFFAOYSA-N
12352	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	partial agonist	target	Yamagishi S (2004)	15617852	179382	956	Telmisartan	4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid|4'-[(1,7'-Dimethyl-2'-propyl-1H,3'h-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid|Telmisartan|4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid|Micardis|BIBR 277|4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid	telmisartan/hctz|telmisartan|t	DRUGBANK	DB00966	C33H30N4O2	small molecule	C09DA07|C09CA07|C09DB04	144701-48-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMMXLENWKUUMAY-UHFFFAOYSA-N
12353	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	partial agonist	target	Yamagishi S (2007)	17691961	179383	956	Telmisartan	4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid|4'-[(1,7'-Dimethyl-2'-propyl-1H,3'h-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid|Telmisartan|4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid|Micardis|BIBR 277|4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid	telmisartan/hctz|telmisartan|t	DRUGBANK	DB00966	C33H30N4O2	small molecule	C09DA07|C09CA07|C09DB04	144701-48-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMMXLENWKUUMAY-UHFFFAOYSA-N
12354	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	partial agonist	target	Kurtz TW (2008)	18580862	179381	956	Telmisartan	4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid|4'-[(1,7'-Dimethyl-2'-propyl-1H,3'h-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid|Telmisartan|4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid|Micardis|BIBR 277|4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid	telmisartan/hctz|telmisartan|t	DRUGBANK	DB00966	C33H30N4O2	small molecule	C09DA07|C09CA07|C09DB04	144701-48-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMMXLENWKUUMAY-UHFFFAOYSA-N
12355	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	partial agonist	target	Kurtz TW (2005)	15868121	179386	956	Telmisartan	4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid|4'-[(1,7'-Dimethyl-2'-propyl-1H,3'h-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid|Telmisartan|4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid|Micardis|BIBR 277|4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid	telmisartan/hctz|telmisartan|t	DRUGBANK	DB00966	C33H30N4O2	small molecule	C09DA07|C09CA07|C09DB04	144701-48-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMMXLENWKUUMAY-UHFFFAOYSA-N
12356	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	partial agonist	target	Imayama I (2006)	16938288	179384	956	Telmisartan	4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid|4'-[(1,7'-Dimethyl-2'-propyl-1H,3'h-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid|Telmisartan|4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid|Micardis|BIBR 277|4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid	telmisartan/hctz|telmisartan|t	DRUGBANK	DB00966	C33H30N4O2	small molecule	C09DA07|C09CA07|C09DB04	144701-48-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMMXLENWKUUMAY-UHFFFAOYSA-N
12357	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	partial agonist	target	Yamagishi S (2005)	16154710	179385	956	Telmisartan	4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid|4'-[(1,7'-Dimethyl-2'-propyl-1H,3'h-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid|Telmisartan|4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid|Micardis|BIBR 277|4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid	telmisartan/hctz|telmisartan|t	DRUGBANK	DB00966	C33H30N4O2	small molecule	C09DA07|C09CA07|C09DB04	144701-48-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMMXLENWKUUMAY-UHFFFAOYSA-N
12358	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	partial agonist	target	Tagami T (2009)	19147680	171006	956	Telmisartan	4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid|4'-[(1,7'-Dimethyl-2'-propyl-1H,3'h-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid|Telmisartan|4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid|Micardis|BIBR 277|4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid	telmisartan/hctz|telmisartan|t	DRUGBANK	DB00966	C33H30N4O2	small molecule	C09DA07|C09CA07|C09DB04	144701-48-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMMXLENWKUUMAY-UHFFFAOYSA-N
12359	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Yamagishi S (2004)	15617852	179382	956	Telmisartan	4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid|4'-[(1,7'-Dimethyl-2'-propyl-1H,3'h-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid|Telmisartan|4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid|Micardis|BIBR 277|4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid	telmisartan/hctz|telmisartan|t	DRUGBANK	DB00966	C33H30N4O2	small molecule	C09DA07|C09CA07|C09DB04	144701-48-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMMXLENWKUUMAY-UHFFFAOYSA-N
12360	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Strohmenger HU (1997)	9259062	179390	956	Telmisartan	4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid|4'-[(1,7'-Dimethyl-2'-propyl-1H,3'h-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid|Telmisartan|4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid|Micardis|BIBR 277|4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid	telmisartan/hctz|telmisartan|t	DRUGBANK	DB00966	C33H30N4O2	small molecule	C09DA07|C09CA07|C09DB04	144701-48-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMMXLENWKUUMAY-UHFFFAOYSA-N
12361	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Fujimoto M (2004)	15498586	179393	956	Telmisartan	4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid|4'-[(1,7'-Dimethyl-2'-propyl-1H,3'h-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid|Telmisartan|4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid|Micardis|BIBR 277|4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid	telmisartan/hctz|telmisartan|t	DRUGBANK	DB00966	C33H30N4O2	small molecule	C09DA07|C09CA07|C09DB04	144701-48-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMMXLENWKUUMAY-UHFFFAOYSA-N
12362	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Kurtz TW (2008)	18580862	179381	956	Telmisartan	4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid|4'-[(1,7'-Dimethyl-2'-propyl-1H,3'h-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid|Telmisartan|4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid|Micardis|BIBR 277|4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid	telmisartan/hctz|telmisartan|t	DRUGBANK	DB00966	C33H30N4O2	small molecule	C09DA07|C09CA07|C09DB04	144701-48-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMMXLENWKUUMAY-UHFFFAOYSA-N
12363	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Balt JC (2001)	11444497	179387	956	Telmisartan	4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid|4'-[(1,7'-Dimethyl-2'-propyl-1H,3'h-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid|Telmisartan|4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid|Micardis|BIBR 277|4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid	telmisartan/hctz|telmisartan|t	DRUGBANK	DB00966	C33H30N4O2	small molecule	C09DA07|C09CA07|C09DB04	144701-48-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMMXLENWKUUMAY-UHFFFAOYSA-N
12364	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Imayama I (2006)	16938288	179384	956	Telmisartan	4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid|4'-[(1,7'-Dimethyl-2'-propyl-1H,3'h-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid|Telmisartan|4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid|Micardis|BIBR 277|4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid	telmisartan/hctz|telmisartan|t	DRUGBANK	DB00966	C33H30N4O2	small molecule	C09DA07|C09CA07|C09DB04	144701-48-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMMXLENWKUUMAY-UHFFFAOYSA-N
12365	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Yamagishi S (2007)	17691961	179383	956	Telmisartan	4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid|4'-[(1,7'-Dimethyl-2'-propyl-1H,3'h-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid|Telmisartan|4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid|Micardis|BIBR 277|4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid	telmisartan/hctz|telmisartan|t	DRUGBANK	DB00966	C33H30N4O2	small molecule	C09DA07|C09CA07|C09DB04	144701-48-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMMXLENWKUUMAY-UHFFFAOYSA-N
12366	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Gohlke P (2001)	11408526	179388	956	Telmisartan	4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid|4'-[(1,7'-Dimethyl-2'-propyl-1H,3'h-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid|Telmisartan|4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid|Micardis|BIBR 277|4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid	telmisartan/hctz|telmisartan|t	DRUGBANK	DB00966	C33H30N4O2	small molecule	C09DA07|C09CA07|C09DB04	144701-48-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMMXLENWKUUMAY-UHFFFAOYSA-N
12367	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	McClellan KJ (1998)	9878991	179389	956	Telmisartan	4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid|4'-[(1,7'-Dimethyl-2'-propyl-1H,3'h-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid|Telmisartan|4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid|Micardis|BIBR 277|4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid	telmisartan/hctz|telmisartan|t	DRUGBANK	DB00966	C33H30N4O2	small molecule	C09DA07|C09CA07|C09DB04	144701-48-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMMXLENWKUUMAY-UHFFFAOYSA-N
12368	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Karlberg BE (1999)	10067800	179391	956	Telmisartan	4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid|4'-[(1,7'-Dimethyl-2'-propyl-1H,3'h-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid|Telmisartan|4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid|Micardis|BIBR 277|4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid	telmisartan/hctz|telmisartan|t	DRUGBANK	DB00966	C33H30N4O2	small molecule	C09DA07|C09CA07|C09DB04	144701-48-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMMXLENWKUUMAY-UHFFFAOYSA-N
12369	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Sharpe M (2001)	11558835	179392	956	Telmisartan	4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid|4'-[(1,7'-Dimethyl-2'-propyl-1H,3'h-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid|Telmisartan|4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid|Micardis|BIBR 277|4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid	telmisartan/hctz|telmisartan|t	DRUGBANK	DB00966	C33H30N4O2	small molecule	C09DA07|C09CA07|C09DB04	144701-48-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMMXLENWKUUMAY-UHFFFAOYSA-N
12370	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	956	Telmisartan	4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid|4'-[(1,7'-Dimethyl-2'-propyl-1H,3'h-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid|Telmisartan|4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid|Micardis|BIBR 277|4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid	telmisartan/hctz|telmisartan|t	DRUGBANK	DB00966	C33H30N4O2	small molecule	C09DA07|C09CA07|C09DB04	144701-48-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMMXLENWKUUMAY-UHFFFAOYSA-N
12371	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Galzerano D (2010)	20448797	179394	956	Telmisartan	4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid|4'-[(1,7'-Dimethyl-2'-propyl-1H,3'h-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid|Telmisartan|4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid|Micardis|BIBR 277|4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid	telmisartan/hctz|telmisartan|t	DRUGBANK	DB00966	C33H30N4O2	small molecule	C09DA07|C09CA07|C09DB04	144701-48-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMMXLENWKUUMAY-UHFFFAOYSA-N
12415	112529	6646	RP11-215I23.1	SOAT1	ACACT|ACAT|ACAT-1|ACAT1|SOAT|STAT	9606	Homo sapiens	inhibitor	target	Wang HH (2008)	18442485	179432	963	Ezetimibe	Ezetrol|Ezetimiba|Zetia|Ezetimibum|Ezedoc	liptruzet|mar-ezetimibe|zetia|	DRUGBANK	DB00973	C24H21F2NO3	small molecule	C10BA02|C10BA05|C10BA06|C10AX09	163222-33-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OLNTVTPDXPETLC-XPWALMASSA-N
12416	112529	6646	RP11-215I23.1	SOAT1	ACACT|ACAT|ACAT-1|ACAT1|SOAT|STAT	9606	Homo sapiens	inhibitor	target	Costet P (2010)	20227438	179433	963	Ezetimibe	Ezetrol|Ezetimiba|Zetia|Ezetimibum|Ezedoc	liptruzet|mar-ezetimibe|zetia|	DRUGBANK	DB00973	C24H21F2NO3	small molecule	C10BA02|C10BA05|C10BA06|C10AX09	163222-33-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OLNTVTPDXPETLC-XPWALMASSA-N
12417	112529	6646	RP11-215I23.1	SOAT1	ACACT|ACAT|ACAT-1|ACAT1|SOAT|STAT	9606	Homo sapiens	inhibitor	target	Singh A (2009)	19669185	179434	963	Ezetimibe	Ezetrol|Ezetimiba|Zetia|Ezetimibum|Ezedoc	liptruzet|mar-ezetimibe|zetia|	DRUGBANK	DB00973	C24H21F2NO3	small molecule	C10BA02|C10BA05|C10BA06|C10AX09	163222-33-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OLNTVTPDXPETLC-XPWALMASSA-N
12418	106787	290	-	ANPEP	APN|CD13|GP150|LAP1|P150|PEPN	9606	Homo sapiens	unknown	target	Kramer W (2005)	15494415	179435	963	Ezetimibe	Ezetrol|Ezetimiba|Zetia|Ezetimibum|Ezedoc	liptruzet|mar-ezetimibe|zetia|	DRUGBANK	DB00973	C24H21F2NO3	small molecule	C10BA02|C10BA05|C10BA06|C10AX09	163222-33-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OLNTVTPDXPETLC-XPWALMASSA-N
12508	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	978	Dopamine	4-(2-Aminoethyl)benzene-1,2-diol|Deoxyepinephrine|4-(2-Aminoethyl)pyrocatechol|Dopaminum|4-(2-Aminoethyl)-1,2-benzenediol|2-(3,4-Dihydroxyphenyl)ethylamine|Dopamina|Dophamine|Dopamine|3,4-Dihydroxyphenethylamine|Dopamin|Oxytyramine|Hydroxytyramine|4-(2-Aminoethyl)catechol|3-Hydroxytyramine|Hydroxytyramin	dopamine hydrochloride and dex	DRUGBANK	DB00988	C8H11NO2	small molecule	C01CA04	51-61-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYFYYTLLBUKUHU-UHFFFAOYSA-N
12509	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Ostadali MR (2004)	17301410	179521	978	Dopamine	4-(2-Aminoethyl)benzene-1,2-diol|Deoxyepinephrine|4-(2-Aminoethyl)pyrocatechol|Dopaminum|4-(2-Aminoethyl)-1,2-benzenediol|2-(3,4-Dihydroxyphenyl)ethylamine|Dopamina|Dophamine|Dopamine|3,4-Dihydroxyphenethylamine|Dopamin|Oxytyramine|Hydroxytyramine|4-(2-Aminoethyl)catechol|3-Hydroxytyramine|Hydroxytyramin	dopamine hydrochloride and dex	DRUGBANK	DB00988	C8H11NO2	small molecule	C01CA04	51-61-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYFYYTLLBUKUHU-UHFFFAOYSA-N
12512	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	agonist	target	Ostadali MR (2004)	17301410	179521	978	Dopamine	4-(2-Aminoethyl)benzene-1,2-diol|Deoxyepinephrine|4-(2-Aminoethyl)pyrocatechol|Dopaminum|4-(2-Aminoethyl)-1,2-benzenediol|2-(3,4-Dihydroxyphenyl)ethylamine|Dopamina|Dophamine|Dopamine|3,4-Dihydroxyphenethylamine|Dopamin|Oxytyramine|Hydroxytyramine|4-(2-Aminoethyl)catechol|3-Hydroxytyramine|Hydroxytyramin	dopamine hydrochloride and dex	DRUGBANK	DB00988	C8H11NO2	small molecule	C01CA04	51-61-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYFYYTLLBUKUHU-UHFFFAOYSA-N
12529	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	agonist	target	Ostadali MR (2004)	17301410	179521	978	Dopamine	4-(2-Aminoethyl)benzene-1,2-diol|Deoxyepinephrine|4-(2-Aminoethyl)pyrocatechol|Dopaminum|4-(2-Aminoethyl)-1,2-benzenediol|2-(3,4-Dihydroxyphenyl)ethylamine|Dopamina|Dophamine|Dopamine|3,4-Dihydroxyphenethylamine|Dopamin|Oxytyramine|Hydroxytyramine|4-(2-Aminoethyl)catechol|3-Hydroxytyramine|Hydroxytyramin	dopamine hydrochloride and dex	DRUGBANK	DB00988	C8H11NO2	small molecule	C01CA04	51-61-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VYFYYTLLBUKUHU-UHFFFAOYSA-N
12560	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Ottonello L (2009)	19338579	179563	981	Oxaprozin	Duraprox|Walix|Daypro|Dayrun|Oxaprozinum|Danoprox|Oxaprozina|Deflam|Oxaprozine	apo-oxaprozin|rhoxal-oxaprozin	DRUGBANK	DB00991	C18H15NO3	small molecule	M01AE12	21256-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFPXSFXSNFPTHF-UHFFFAOYSA-N
12561	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Kawai S (1998)	9831331	179562	981	Oxaprozin	Duraprox|Walix|Daypro|Dayrun|Oxaprozinum|Danoprox|Oxaprozina|Deflam|Oxaprozine	apo-oxaprozin|rhoxal-oxaprozin	DRUGBANK	DB00991	C18H15NO3	small molecule	M01AE12	21256-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFPXSFXSNFPTHF-UHFFFAOYSA-N
12562	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Yood MU (2006)	17024689	179560	981	Oxaprozin	Duraprox|Walix|Daypro|Dayrun|Oxaprozinum|Danoprox|Oxaprozina|Deflam|Oxaprozine	apo-oxaprozin|rhoxal-oxaprozin	DRUGBANK	DB00991	C18H15NO3	small molecule	M01AE12	21256-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFPXSFXSNFPTHF-UHFFFAOYSA-N
12563	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Kean WF (2004)	15324530	179559	981	Oxaprozin	Duraprox|Walix|Daypro|Dayrun|Oxaprozinum|Danoprox|Oxaprozina|Deflam|Oxaprozine	apo-oxaprozin|rhoxal-oxaprozin	DRUGBANK	DB00991	C18H15NO3	small molecule	M01AE12	21256-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFPXSFXSNFPTHF-UHFFFAOYSA-N
12564	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Zhou XP (2009)	19952416	179561	981	Oxaprozin	Duraprox|Walix|Daypro|Dayrun|Oxaprozinum|Danoprox|Oxaprozina|Deflam|Oxaprozine	apo-oxaprozin|rhoxal-oxaprozin	DRUGBANK	DB00991	C18H15NO3	small molecule	M01AE12	21256-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFPXSFXSNFPTHF-UHFFFAOYSA-N
12565	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Kawai S (1998)	9650852	159681	981	Oxaprozin	Duraprox|Walix|Daypro|Dayrun|Oxaprozinum|Danoprox|Oxaprozina|Deflam|Oxaprozine	apo-oxaprozin|rhoxal-oxaprozin	DRUGBANK	DB00991	C18H15NO3	small molecule	M01AE12	21256-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFPXSFXSNFPTHF-UHFFFAOYSA-N
12566	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Yamazaki R (2002)	12065695	179564	981	Oxaprozin	Duraprox|Walix|Daypro|Dayrun|Oxaprozinum|Danoprox|Oxaprozina|Deflam|Oxaprozine	apo-oxaprozin|rhoxal-oxaprozin	DRUGBANK	DB00991	C18H15NO3	small molecule	M01AE12	21256-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFPXSFXSNFPTHF-UHFFFAOYSA-N
12567	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Kawai S (1998)	9831331	179562	981	Oxaprozin	Duraprox|Walix|Daypro|Dayrun|Oxaprozinum|Danoprox|Oxaprozina|Deflam|Oxaprozine	apo-oxaprozin|rhoxal-oxaprozin	DRUGBANK	DB00991	C18H15NO3	small molecule	M01AE12	21256-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFPXSFXSNFPTHF-UHFFFAOYSA-N
12568	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Ottonello L (2009)	19338579	179563	981	Oxaprozin	Duraprox|Walix|Daypro|Dayrun|Oxaprozinum|Danoprox|Oxaprozina|Deflam|Oxaprozine	apo-oxaprozin|rhoxal-oxaprozin	DRUGBANK	DB00991	C18H15NO3	small molecule	M01AE12	21256-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFPXSFXSNFPTHF-UHFFFAOYSA-N
12569	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Yood MU (2006)	17024689	179560	981	Oxaprozin	Duraprox|Walix|Daypro|Dayrun|Oxaprozinum|Danoprox|Oxaprozina|Deflam|Oxaprozine	apo-oxaprozin|rhoxal-oxaprozin	DRUGBANK	DB00991	C18H15NO3	small molecule	M01AE12	21256-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFPXSFXSNFPTHF-UHFFFAOYSA-N
12570	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Zhou XP (2009)	19952416	179561	981	Oxaprozin	Duraprox|Walix|Daypro|Dayrun|Oxaprozinum|Danoprox|Oxaprozina|Deflam|Oxaprozine	apo-oxaprozin|rhoxal-oxaprozin	DRUGBANK	DB00991	C18H15NO3	small molecule	M01AE12	21256-18-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFPXSFXSNFPTHF-UHFFFAOYSA-N
12695	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Kurahashi K (2001)	11811354	177972	999	Ketoprofen	m-Benzoylhydratropic acid|3-Benzoyl--methylbenzeneacetic acid|3-Benzoyl-alpha-methylbenzeneacetic acid|2-(3-Benzoylphenyl)propionic acid|Ketoprofen|3-Benzoylhydratropic acid|Orudis (tn)|L'Acide (benzoyl-3-phenyl)-2-propionique	nu-ketoprofen-e ect 50mg|orudi	DRUGBANK	DB01009	C16H14O3	small molecule	M01AE53|M01AE03|M02AA10	22071-15-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKYWVDODHFEZIM-UHFFFAOYSA-N
12696	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Zuniga J (2003)	14513718	179627	999	Ketoprofen	m-Benzoylhydratropic acid|3-Benzoyl--methylbenzeneacetic acid|3-Benzoyl-alpha-methylbenzeneacetic acid|2-(3-Benzoylphenyl)propionic acid|Ketoprofen|3-Benzoylhydratropic acid|Orudis (tn)|L'Acide (benzoyl-3-phenyl)-2-propionique	nu-ketoprofen-e ect 50mg|orudi	DRUGBANK	DB01009	C16H14O3	small molecule	M01AE53|M01AE03|M02AA10	22071-15-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKYWVDODHFEZIM-UHFFFAOYSA-N
12697	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Parsadaniantz SM (2000)	10929089	179629	999	Ketoprofen	m-Benzoylhydratropic acid|3-Benzoyl--methylbenzeneacetic acid|3-Benzoyl-alpha-methylbenzeneacetic acid|2-(3-Benzoylphenyl)propionic acid|Ketoprofen|3-Benzoylhydratropic acid|Orudis (tn)|L'Acide (benzoyl-3-phenyl)-2-propionique	nu-ketoprofen-e ect 50mg|orudi	DRUGBANK	DB01009	C16H14O3	small molecule	M01AE53|M01AE03|M02AA10	22071-15-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKYWVDODHFEZIM-UHFFFAOYSA-N
12698	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Levoin N (2004)	15476667	179628	999	Ketoprofen	m-Benzoylhydratropic acid|3-Benzoyl--methylbenzeneacetic acid|3-Benzoyl-alpha-methylbenzeneacetic acid|2-(3-Benzoylphenyl)propionic acid|Ketoprofen|3-Benzoylhydratropic acid|Orudis (tn)|L'Acide (benzoyl-3-phenyl)-2-propionique	nu-ketoprofen-e ect 50mg|orudi	DRUGBANK	DB01009	C16H14O3	small molecule	M01AE53|M01AE03|M02AA10	22071-15-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKYWVDODHFEZIM-UHFFFAOYSA-N
12699	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Martic M (2004)	14987823	179630	999	Ketoprofen	m-Benzoylhydratropic acid|3-Benzoyl--methylbenzeneacetic acid|3-Benzoyl-alpha-methylbenzeneacetic acid|2-(3-Benzoylphenyl)propionic acid|Ketoprofen|3-Benzoylhydratropic acid|Orudis (tn)|L'Acide (benzoyl-3-phenyl)-2-propionique	nu-ketoprofen-e ect 50mg|orudi	DRUGBANK	DB01009	C16H14O3	small molecule	M01AE53|M01AE03|M02AA10	22071-15-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKYWVDODHFEZIM-UHFFFAOYSA-N
12703	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Wilson JE (2004)	15198222	178171	999	Ketoprofen	m-Benzoylhydratropic acid|3-Benzoyl--methylbenzeneacetic acid|3-Benzoyl-alpha-methylbenzeneacetic acid|2-(3-Benzoylphenyl)propionic acid|Ketoprofen|3-Benzoylhydratropic acid|Orudis (tn)|L'Acide (benzoyl-3-phenyl)-2-propionique	nu-ketoprofen-e ect 50mg|orudi	DRUGBANK	DB01009	C16H14O3	small molecule	M01AE53|M01AE03|M02AA10	22071-15-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKYWVDODHFEZIM-UHFFFAOYSA-N
12704	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Zuniga J (2003)	14513718	179627	999	Ketoprofen	m-Benzoylhydratropic acid|3-Benzoyl--methylbenzeneacetic acid|3-Benzoyl-alpha-methylbenzeneacetic acid|2-(3-Benzoylphenyl)propionic acid|Ketoprofen|3-Benzoylhydratropic acid|Orudis (tn)|L'Acide (benzoyl-3-phenyl)-2-propionique	nu-ketoprofen-e ect 50mg|orudi	DRUGBANK	DB01009	C16H14O3	small molecule	M01AE53|M01AE03|M02AA10	22071-15-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKYWVDODHFEZIM-UHFFFAOYSA-N
12705	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Sommerauer M (2001)	11729362	179635	999	Ketoprofen	m-Benzoylhydratropic acid|3-Benzoyl--methylbenzeneacetic acid|3-Benzoyl-alpha-methylbenzeneacetic acid|2-(3-Benzoylphenyl)propionic acid|Ketoprofen|3-Benzoylhydratropic acid|Orudis (tn)|L'Acide (benzoyl-3-phenyl)-2-propionique	nu-ketoprofen-e ect 50mg|orudi	DRUGBANK	DB01009	C16H14O3	small molecule	M01AE53|M01AE03|M02AA10	22071-15-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKYWVDODHFEZIM-UHFFFAOYSA-N
12706	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Levoin N (2002)	11814865	179634	999	Ketoprofen	m-Benzoylhydratropic acid|3-Benzoyl--methylbenzeneacetic acid|3-Benzoyl-alpha-methylbenzeneacetic acid|2-(3-Benzoylphenyl)propionic acid|Ketoprofen|3-Benzoylhydratropic acid|Orudis (tn)|L'Acide (benzoyl-3-phenyl)-2-propionique	nu-ketoprofen-e ect 50mg|orudi	DRUGBANK	DB01009	C16H14O3	small molecule	M01AE53|M01AE03|M02AA10	22071-15-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKYWVDODHFEZIM-UHFFFAOYSA-N
12707	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	999	Ketoprofen	m-Benzoylhydratropic acid|3-Benzoyl--methylbenzeneacetic acid|3-Benzoyl-alpha-methylbenzeneacetic acid|2-(3-Benzoylphenyl)propionic acid|Ketoprofen|3-Benzoylhydratropic acid|Orudis (tn)|L'Acide (benzoyl-3-phenyl)-2-propionique	nu-ketoprofen-e ect 50mg|orudi	DRUGBANK	DB01009	C16H14O3	small molecule	M01AE53|M01AE03|M02AA10	22071-15-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKYWVDODHFEZIM-UHFFFAOYSA-N
12708	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Kay-Mugford P (2000)	10895904	178552	999	Ketoprofen	m-Benzoylhydratropic acid|3-Benzoyl--methylbenzeneacetic acid|3-Benzoyl-alpha-methylbenzeneacetic acid|2-(3-Benzoylphenyl)propionic acid|Ketoprofen|3-Benzoylhydratropic acid|Orudis (tn)|L'Acide (benzoyl-3-phenyl)-2-propionique	nu-ketoprofen-e ect 50mg|orudi	DRUGBANK	DB01009	C16H14O3	small molecule	M01AE53|M01AE03|M02AA10	22071-15-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DKYWVDODHFEZIM-UHFFFAOYSA-N
12718	107956	1584	-	CYP11B1	CPN1|CYP11B|FHI|P450C11	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1001	Metyrapone	Metopirone|Metyrapone|Metopiron|Metyraponum|Metirapona	metopirone	DRUGBANK	DB01011	C14H14N2O	small molecule	V04CD01	54-36-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FJLBFSROUSIWMA-UHFFFAOYSA-N
12719	107956	1584	-	CYP11B1	CPN1|CYP11B|FHI|P450C11	9606	Homo sapiens	inhibitor	target	Young EA (2007)	17462829	179646	1001	Metyrapone	Metopirone|Metyrapone|Metopiron|Metyraponum|Metirapona	metopirone	DRUGBANK	DB01011	C14H14N2O	small molecule	V04CD01	54-36-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FJLBFSROUSIWMA-UHFFFAOYSA-N
12720	107956	1584	-	CYP11B1	CPN1|CYP11B|FHI|P450C11	9606	Homo sapiens	inhibitor	target	Johansson MK (2002)	11869873	179645	1001	Metyrapone	Metopirone|Metyrapone|Metopiron|Metyraponum|Metirapona	metopirone	DRUGBANK	DB01011	C14H14N2O	small molecule	V04CD01	54-36-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FJLBFSROUSIWMA-UHFFFAOYSA-N
12721	107956	1584	-	CYP11B1	CPN1|CYP11B|FHI|P450C11	9606	Homo sapiens	inhibitor	target	Hermansson V (2007)	17487473	179644	1001	Metyrapone	Metopirone|Metyrapone|Metopiron|Metyraponum|Metirapona	metopirone	DRUGBANK	DB01011	C14H14N2O	small molecule	V04CD01	54-36-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FJLBFSROUSIWMA-UHFFFAOYSA-N
12734	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	1004	Balsalazide	Balsalazida|Balsalazido|(e)-5-({p-[(2-carboxyethyl)carbamoyl]phenyl}azo)-2-salicylic acid|Balsalazidum|5-[4-(2-Carboxy-ethylcarbamoyl)-phenylazo]-2-hydroxy-benzoic acid|(e)-5-((4-(((2-Carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acid|3-(2-{4-[(2-carboxyethyl)carbamoyl]phenyl}hydrazinylidene)-6-oxocyclohexa-1,4-diene-1-carboxylic acid	balsalazide disodium|colazal|g	DRUGBANK	DB01014	C17H15N3O6	small molecule	A07EC04	80573-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPOKCKJONYRRHP-FMQUCBEESA-N
12735	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1004	Balsalazide	Balsalazida|Balsalazido|(e)-5-({p-[(2-carboxyethyl)carbamoyl]phenyl}azo)-2-salicylic acid|Balsalazidum|5-[4-(2-Carboxy-ethylcarbamoyl)-phenylazo]-2-hydroxy-benzoic acid|(e)-5-((4-(((2-Carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acid|3-(2-{4-[(2-carboxyethyl)carbamoyl]phenyl}hydrazinylidene)-6-oxocyclohexa-1,4-diene-1-carboxylic acid	balsalazide disodium|colazal|g	DRUGBANK	DB01014	C17H15N3O6	small molecule	A07EC04	80573-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPOKCKJONYRRHP-FMQUCBEESA-N
12736	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	1004	Balsalazide	Balsalazida|Balsalazido|(e)-5-({p-[(2-carboxyethyl)carbamoyl]phenyl}azo)-2-salicylic acid|Balsalazidum|5-[4-(2-Carboxy-ethylcarbamoyl)-phenylazo]-2-hydroxy-benzoic acid|(e)-5-((4-(((2-Carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acid|3-(2-{4-[(2-carboxyethyl)carbamoyl]phenyl}hydrazinylidene)-6-oxocyclohexa-1,4-diene-1-carboxylic acid	balsalazide disodium|colazal|g	DRUGBANK	DB01014	C17H15N3O6	small molecule	A07EC04	80573-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPOKCKJONYRRHP-FMQUCBEESA-N
12737	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Wiggins JB (2009)	19743890	179656	1004	Balsalazide	Balsalazida|Balsalazido|(e)-5-({p-[(2-carboxyethyl)carbamoyl]phenyl}azo)-2-salicylic acid|Balsalazidum|5-[4-(2-Carboxy-ethylcarbamoyl)-phenylazo]-2-hydroxy-benzoic acid|(e)-5-((4-(((2-Carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acid|3-(2-{4-[(2-carboxyethyl)carbamoyl]phenyl}hydrazinylidene)-6-oxocyclohexa-1,4-diene-1-carboxylic acid	balsalazide disodium|colazal|g	DRUGBANK	DB01014	C17H15N3O6	small molecule	A07EC04	80573-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPOKCKJONYRRHP-FMQUCBEESA-N
12738	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Allgayer H (2003)	12950415	174544	1004	Balsalazide	Balsalazida|Balsalazido|(e)-5-({p-[(2-carboxyethyl)carbamoyl]phenyl}azo)-2-salicylic acid|Balsalazidum|5-[4-(2-Carboxy-ethylcarbamoyl)-phenylazo]-2-hydroxy-benzoic acid|(e)-5-((4-(((2-Carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acid|3-(2-{4-[(2-carboxyethyl)carbamoyl]phenyl}hydrazinylidene)-6-oxocyclohexa-1,4-diene-1-carboxylic acid	balsalazide disodium|colazal|g	DRUGBANK	DB01014	C17H15N3O6	small molecule	A07EC04	80573-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPOKCKJONYRRHP-FMQUCBEESA-N
12739	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Desreumaux P (2006)	16939423	174608	1004	Balsalazide	Balsalazida|Balsalazido|(e)-5-({p-[(2-carboxyethyl)carbamoyl]phenyl}azo)-2-salicylic acid|Balsalazidum|5-[4-(2-Carboxy-ethylcarbamoyl)-phenylazo]-2-hydroxy-benzoic acid|(e)-5-((4-(((2-Carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acid|3-(2-{4-[(2-carboxyethyl)carbamoyl]phenyl}hydrazinylidene)-6-oxocyclohexa-1,4-diene-1-carboxylic acid	balsalazide disodium|colazal|g	DRUGBANK	DB01014	C17H15N3O6	small molecule	A07EC04	80573-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPOKCKJONYRRHP-FMQUCBEESA-N
12740	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Iacucci M (2010)	20151072	179657	1004	Balsalazide	Balsalazida|Balsalazido|(e)-5-({p-[(2-carboxyethyl)carbamoyl]phenyl}azo)-2-salicylic acid|Balsalazidum|5-[4-(2-Carboxy-ethylcarbamoyl)-phenylazo]-2-hydroxy-benzoic acid|(e)-5-((4-(((2-Carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acid|3-(2-{4-[(2-carboxyethyl)carbamoyl]phenyl}hydrazinylidene)-6-oxocyclohexa-1,4-diene-1-carboxylic acid	balsalazide disodium|colazal|g	DRUGBANK	DB01014	C17H15N3O6	small molecule	A07EC04	80573-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPOKCKJONYRRHP-FMQUCBEESA-N
12741	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Tursi A (2009)	19708827	179658	1004	Balsalazide	Balsalazida|Balsalazido|(e)-5-({p-[(2-carboxyethyl)carbamoyl]phenyl}azo)-2-salicylic acid|Balsalazidum|5-[4-(2-Carboxy-ethylcarbamoyl)-phenylazo]-2-hydroxy-benzoic acid|(e)-5-((4-(((2-Carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acid|3-(2-{4-[(2-carboxyethyl)carbamoyl]phenyl}hydrazinylidene)-6-oxocyclohexa-1,4-diene-1-carboxylic acid	balsalazide disodium|colazal|g	DRUGBANK	DB01014	C17H15N3O6	small molecule	A07EC04	80573-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPOKCKJONYRRHP-FMQUCBEESA-N
12742	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Linard C (2008)	18077625	174606	1004	Balsalazide	Balsalazida|Balsalazido|(e)-5-({p-[(2-carboxyethyl)carbamoyl]phenyl}azo)-2-salicylic acid|Balsalazidum|5-[4-(2-Carboxy-ethylcarbamoyl)-phenylazo]-2-hydroxy-benzoic acid|(e)-5-((4-(((2-Carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acid|3-(2-{4-[(2-carboxyethyl)carbamoyl]phenyl}hydrazinylidene)-6-oxocyclohexa-1,4-diene-1-carboxylic acid	balsalazide disodium|colazal|g	DRUGBANK	DB01014	C17H15N3O6	small molecule	A07EC04	80573-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPOKCKJONYRRHP-FMQUCBEESA-N
12743	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Wiggins JB (2009)	19743890	179656	1004	Balsalazide	Balsalazida|Balsalazido|(e)-5-({p-[(2-carboxyethyl)carbamoyl]phenyl}azo)-2-salicylic acid|Balsalazidum|5-[4-(2-Carboxy-ethylcarbamoyl)-phenylazo]-2-hydroxy-benzoic acid|(e)-5-((4-(((2-Carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acid|3-(2-{4-[(2-carboxyethyl)carbamoyl]phenyl}hydrazinylidene)-6-oxocyclohexa-1,4-diene-1-carboxylic acid	balsalazide disodium|colazal|g	DRUGBANK	DB01014	C17H15N3O6	small molecule	A07EC04	80573-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPOKCKJONYRRHP-FMQUCBEESA-N
12744	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Rask-Madsen J (1992)	1359745	179659	1004	Balsalazide	Balsalazida|Balsalazido|(e)-5-({p-[(2-carboxyethyl)carbamoyl]phenyl}azo)-2-salicylic acid|Balsalazidum|5-[4-(2-Carboxy-ethylcarbamoyl)-phenylazo]-2-hydroxy-benzoic acid|(e)-5-((4-(((2-Carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acid|3-(2-{4-[(2-carboxyethyl)carbamoyl]phenyl}hydrazinylidene)-6-oxocyclohexa-1,4-diene-1-carboxylic acid	balsalazide disodium|colazal|g	DRUGBANK	DB01014	C17H15N3O6	small molecule	A07EC04	80573-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPOKCKJONYRRHP-FMQUCBEESA-N
12745	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	1004	Balsalazide	Balsalazida|Balsalazido|(e)-5-({p-[(2-carboxyethyl)carbamoyl]phenyl}azo)-2-salicylic acid|Balsalazidum|5-[4-(2-Carboxy-ethylcarbamoyl)-phenylazo]-2-hydroxy-benzoic acid|(e)-5-((4-(((2-Carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acid|3-(2-{4-[(2-carboxyethyl)carbamoyl]phenyl}hydrazinylidene)-6-oxocyclohexa-1,4-diene-1-carboxylic acid	balsalazide disodium|colazal|g	DRUGBANK	DB01014	C17H15N3O6	small molecule	A07EC04	80573-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPOKCKJONYRRHP-FMQUCBEESA-N
12746	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Stolfi C (2008)	17981262	179660	1004	Balsalazide	Balsalazida|Balsalazido|(e)-5-({p-[(2-carboxyethyl)carbamoyl]phenyl}azo)-2-salicylic acid|Balsalazidum|5-[4-(2-Carboxy-ethylcarbamoyl)-phenylazo]-2-hydroxy-benzoic acid|(e)-5-((4-(((2-Carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acid|3-(2-{4-[(2-carboxyethyl)carbamoyl]phenyl}hydrazinylidene)-6-oxocyclohexa-1,4-diene-1-carboxylic acid	balsalazide disodium|colazal|g	DRUGBANK	DB01014	C17H15N3O6	small molecule	A07EC04	80573-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPOKCKJONYRRHP-FMQUCBEESA-N
12747	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	1004	Balsalazide	Balsalazida|Balsalazido|(e)-5-({p-[(2-carboxyethyl)carbamoyl]phenyl}azo)-2-salicylic acid|Balsalazidum|5-[4-(2-Carboxy-ethylcarbamoyl)-phenylazo]-2-hydroxy-benzoic acid|(e)-5-((4-(((2-Carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acid|3-(2-{4-[(2-carboxyethyl)carbamoyl]phenyl}hydrazinylidene)-6-oxocyclohexa-1,4-diene-1-carboxylic acid	balsalazide disodium|colazal|g	DRUGBANK	DB01014	C17H15N3O6	small molecule	A07EC04	80573-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPOKCKJONYRRHP-FMQUCBEESA-N
12748	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Allgayer H (2003)	12950415	174544	1004	Balsalazide	Balsalazida|Balsalazido|(e)-5-({p-[(2-carboxyethyl)carbamoyl]phenyl}azo)-2-salicylic acid|Balsalazidum|5-[4-(2-Carboxy-ethylcarbamoyl)-phenylazo]-2-hydroxy-benzoic acid|(e)-5-((4-(((2-Carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acid|3-(2-{4-[(2-carboxyethyl)carbamoyl]phenyl}hydrazinylidene)-6-oxocyclohexa-1,4-diene-1-carboxylic acid	balsalazide disodium|colazal|g	DRUGBANK	DB01014	C17H15N3O6	small molecule	A07EC04	80573-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPOKCKJONYRRHP-FMQUCBEESA-N
12749	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Wiggins JB (2009)	19743890	179656	1004	Balsalazide	Balsalazida|Balsalazido|(e)-5-({p-[(2-carboxyethyl)carbamoyl]phenyl}azo)-2-salicylic acid|Balsalazidum|5-[4-(2-Carboxy-ethylcarbamoyl)-phenylazo]-2-hydroxy-benzoic acid|(e)-5-((4-(((2-Carboxyethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acid|3-(2-{4-[(2-carboxyethyl)carbamoyl]phenyl}hydrazinylidene)-6-oxocyclohexa-1,4-diene-1-carboxylic acid	balsalazide disodium|colazal|g	DRUGBANK	DB01014	C17H15N3O6	small molecule	A07EC04	80573-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPOKCKJONYRRHP-FMQUCBEESA-N
12797	109769	3553	-	IL1B	IL-1|IL1-BETA|IL1F2	9606	Homo sapiens	modulator	target	Steinmeyer J (1998)	9413935	179698	1007	Minocycline	Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide	solodyn|phl-minocycline|apo-mi	DRUGBANK	DB01017	C23H27N3O7	small molecule	J01AA08|A01AB23	10118-90-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYKFCLLONBREIL-KVUCHLLUSA-N
12798	109769	3553	-	IL1B	IL-1|IL1-BETA|IL1F2	9606	Homo sapiens	modulator	target	Sadowski T (2001)	11246672	179699	1007	Minocycline	Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide	solodyn|phl-minocycline|apo-mi	DRUGBANK	DB01017	C23H27N3O7	small molecule	J01AA08|A01AB23	10118-90-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYKFCLLONBREIL-KVUCHLLUSA-N
12799	109769	3553	-	IL1B	IL-1|IL1-BETA|IL1F2	9606	Homo sapiens	modulator	target	Amin AR (1996)	8943052	179700	1007	Minocycline	Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide	solodyn|phl-minocycline|apo-mi	DRUGBANK	DB01017	C23H27N3O7	small molecule	J01AA08|A01AB23	10118-90-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYKFCLLONBREIL-KVUCHLLUSA-N
12800	109769	3553	-	IL1B	IL-1|IL1-BETA|IL1F2	9606	Homo sapiens	modulator	target	Oringer RJ (2002)	12211491	179701	1007	Minocycline	Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide	solodyn|phl-minocycline|apo-mi	DRUGBANK	DB01017	C23H27N3O7	small molecule	J01AA08|A01AB23	10118-90-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYKFCLLONBREIL-KVUCHLLUSA-N
12811	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Song Y (2004)	15371729	179711	1007	Minocycline	Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide	solodyn|phl-minocycline|apo-mi	DRUGBANK	DB01017	C23H27N3O7	small molecule	J01AA08|A01AB23	10118-90-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYKFCLLONBREIL-KVUCHLLUSA-N
12812	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Song Y (2006)	16574083	179710	1007	Minocycline	Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide	solodyn|phl-minocycline|apo-mi	DRUGBANK	DB01017	C23H27N3O7	small molecule	J01AA08|A01AB23	10118-90-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYKFCLLONBREIL-KVUCHLLUSA-N
12813	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Chu LS (2007)	17506934	179709	1007	Minocycline	Minocyclinum|Minocyclin|Minociclina|7-Dimethylamino-6-demethyl-6-deoxytetracycline|Minociclinum|(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide	solodyn|phl-minocycline|apo-mi	DRUGBANK	DB01017	C23H27N3O7	small molecule	J01AA08|A01AB23	10118-90-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYKFCLLONBREIL-KVUCHLLUSA-N
12947	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1018	Irbesartan	2-Butyl-3-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one|Irbesartan|Avapro|BMS 186295	ipg-irbesartan|dom-irbesartan|	DRUGBANK	DB01029	C25H28N6O	small molecule	C09DA04|C09CA04|C09DB05	138402-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YOSHYTLCDANDAN-UHFFFAOYSA-N
12948	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Waeber B (2003)	15030294	179779	1018	Irbesartan	2-Butyl-3-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one|Irbesartan|Avapro|BMS 186295	ipg-irbesartan|dom-irbesartan|	DRUGBANK	DB01029	C25H28N6O	small molecule	C09DA04|C09CA04|C09DB05	138402-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YOSHYTLCDANDAN-UHFFFAOYSA-N
12949	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Croom KF (2004)	15101793	179778	1018	Irbesartan	2-Butyl-3-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one|Irbesartan|Avapro|BMS 186295	ipg-irbesartan|dom-irbesartan|	DRUGBANK	DB01029	C25H28N6O	small molecule	C09DA04|C09CA04|C09DB05	138402-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YOSHYTLCDANDAN-UHFFFAOYSA-N
12950	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Adams MA (2000)	10822210	179782	1018	Irbesartan	2-Butyl-3-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one|Irbesartan|Avapro|BMS 186295	ipg-irbesartan|dom-irbesartan|	DRUGBANK	DB01029	C25H28N6O	small molecule	C09DA04|C09CA04|C09DB05	138402-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YOSHYTLCDANDAN-UHFFFAOYSA-N
12951	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Voigt JP (2007)	17408613	179780	1018	Irbesartan	2-Butyl-3-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one|Irbesartan|Avapro|BMS 186295	ipg-irbesartan|dom-irbesartan|	DRUGBANK	DB01029	C25H28N6O	small molecule	C09DA04|C09CA04|C09DB05	138402-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YOSHYTLCDANDAN-UHFFFAOYSA-N
12952	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Dol F (2001)	11486244	179781	1018	Irbesartan	2-Butyl-3-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one|Irbesartan|Avapro|BMS 186295	ipg-irbesartan|dom-irbesartan|	DRUGBANK	DB01029	C25H28N6O	small molecule	C09DA04|C09CA04|C09DB05	138402-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YOSHYTLCDANDAN-UHFFFAOYSA-N
12953	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	van den Meiracker AH (1995)	7843749	179773	1018	Irbesartan	2-Butyl-3-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one|Irbesartan|Avapro|BMS 186295	ipg-irbesartan|dom-irbesartan|	DRUGBANK	DB01029	C25H28N6O	small molecule	C09DA04|C09CA04|C09DB05	138402-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YOSHYTLCDANDAN-UHFFFAOYSA-N
12954	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Mazzolai L (1999)	10082498	179772	1018	Irbesartan	2-Butyl-3-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one|Irbesartan|Avapro|BMS 186295	ipg-irbesartan|dom-irbesartan|	DRUGBANK	DB01029	C25H28N6O	small molecule	C09DA04|C09CA04|C09DB05	138402-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YOSHYTLCDANDAN-UHFFFAOYSA-N
12955	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Carraway JW (1999)	10069682	179771	1018	Irbesartan	2-Butyl-3-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one|Irbesartan|Avapro|BMS 186295	ipg-irbesartan|dom-irbesartan|	DRUGBANK	DB01029	C25H28N6O	small molecule	C09DA04|C09CA04|C09DB05	138402-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YOSHYTLCDANDAN-UHFFFAOYSA-N
12956	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Martin G (2004)	14716205	179777	1018	Irbesartan	2-Butyl-3-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one|Irbesartan|Avapro|BMS 186295	ipg-irbesartan|dom-irbesartan|	DRUGBANK	DB01029	C25H28N6O	small molecule	C09DA04|C09CA04|C09DB05	138402-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YOSHYTLCDANDAN-UHFFFAOYSA-N
12957	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Croom KF (2008)	18627212	179776	1018	Irbesartan	2-Butyl-3-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one|Irbesartan|Avapro|BMS 186295	ipg-irbesartan|dom-irbesartan|	DRUGBANK	DB01029	C25H28N6O	small molecule	C09DA04|C09CA04|C09DB05	138402-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YOSHYTLCDANDAN-UHFFFAOYSA-N
12958	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Morsing P (1999)	10373224	179775	1018	Irbesartan	2-Butyl-3-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one|Irbesartan|Avapro|BMS 186295	ipg-irbesartan|dom-irbesartan|	DRUGBANK	DB01029	C25H28N6O	small molecule	C09DA04|C09CA04|C09DB05	138402-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YOSHYTLCDANDAN-UHFFFAOYSA-N
12959	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Hope S (1999)	10075381	179774	1018	Irbesartan	2-Butyl-3-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one|Irbesartan|Avapro|BMS 186295	ipg-irbesartan|dom-irbesartan|	DRUGBANK	DB01029	C25H28N6O	small molecule	C09DA04|C09CA04|C09DB05	138402-11-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YOSHYTLCDANDAN-UHFFFAOYSA-N
13069	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1027	Carphenazine	Carphenazin|Carfenazine	-	DRUGBANK	DB01038	C23H29N3O2S	small molecule	-	2622-30-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYCNETKPCXPXNW-UHFFFAOYSA-N
13070	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Bora G (1968)	4887393	179838	1027	Carphenazine	Carphenazin|Carfenazine	-	DRUGBANK	DB01038	C23H29N3O2S	small molecule	-	2622-30-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYCNETKPCXPXNW-UHFFFAOYSA-N
13071	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Platz AR (1967)	4861216	179839	1027	Carphenazine	Carphenazin|Carfenazine	-	DRUGBANK	DB01038	C23H29N3O2S	small molecule	-	2622-30-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYCNETKPCXPXNW-UHFFFAOYSA-N
13072	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Vinar O (1967)	4889058	179840	1027	Carphenazine	Carphenazin|Carfenazine	-	DRUGBANK	DB01038	C23H29N3O2S	small molecule	-	2622-30-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DYCNETKPCXPXNW-UHFFFAOYSA-N
13098	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	antagonist	target	Kim JH (2011)	21507989	179857	1030	Thalidomide	alpha-N-Phthalylglutaramide|-phthalimidoglutarimide|2,6-dioxo-3-phthalimidopiperidine|3-Phthalimidoglutarimide|(+-)-N-(2,6-dioxo-3-Piperidyl)phthalimide|(+-)-Thalidomide|N-Phthalylglutamic acid imide|alpha-(N-Phthalimido)glutarimide|N-Phthalyl-glutaminsaeure-imid|-N-phthalylglutaramide|N-Phthaloylglutamimide|Thalidomidum|-(N-phthalimido)glutarimide|()-N-(2,6-dioxo-3-piperidyl)phthalimide|1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline|Talidomida|N-(2,6-dioxo-3-piperidyl)phthalimide|()-thalidomide	thalomid	DRUGBANK	DB01041	C13H10N2O4	small molecule	L04AX02	50-35-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UEJJHQNACJXSKW-UHFFFAOYSA-N
13099	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	antagonist	target	Payvandi F (2004)	15598423	176374	1030	Thalidomide	alpha-N-Phthalylglutaramide|-phthalimidoglutarimide|2,6-dioxo-3-phthalimidopiperidine|3-Phthalimidoglutarimide|(+-)-N-(2,6-dioxo-3-Piperidyl)phthalimide|(+-)-Thalidomide|N-Phthalylglutamic acid imide|alpha-(N-Phthalimido)glutarimide|N-Phthalyl-glutaminsaeure-imid|-N-phthalylglutaramide|N-Phthaloylglutamimide|Thalidomidum|-(N-phthalimido)glutarimide|()-N-(2,6-dioxo-3-piperidyl)phthalimide|1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline|Talidomida|N-(2,6-dioxo-3-piperidyl)phthalimide|()-thalidomide	thalomid	DRUGBANK	DB01041	C13H10N2O4	small molecule	L04AX02	50-35-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UEJJHQNACJXSKW-UHFFFAOYSA-N
13100	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	antagonist	target	Hada M (2004)	15446566	179858	1030	Thalidomide	alpha-N-Phthalylglutaramide|-phthalimidoglutarimide|2,6-dioxo-3-phthalimidopiperidine|3-Phthalimidoglutarimide|(+-)-N-(2,6-dioxo-3-Piperidyl)phthalimide|(+-)-Thalidomide|N-Phthalylglutamic acid imide|alpha-(N-Phthalimido)glutarimide|N-Phthalyl-glutaminsaeure-imid|-N-phthalylglutaramide|N-Phthaloylglutamimide|Thalidomidum|-(N-phthalimido)glutarimide|()-N-(2,6-dioxo-3-piperidyl)phthalimide|1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline|Talidomida|N-(2,6-dioxo-3-piperidyl)phthalimide|()-thalidomide	thalomid	DRUGBANK	DB01041	C13H10N2O4	small molecule	L04AX02	50-35-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UEJJHQNACJXSKW-UHFFFAOYSA-N
13101	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	antagonist	target	Horrobin DF (2003)	12710892	179859	1030	Thalidomide	alpha-N-Phthalylglutaramide|-phthalimidoglutarimide|2,6-dioxo-3-phthalimidopiperidine|3-Phthalimidoglutarimide|(+-)-N-(2,6-dioxo-3-Piperidyl)phthalimide|(+-)-Thalidomide|N-Phthalylglutamic acid imide|alpha-(N-Phthalimido)glutarimide|N-Phthalyl-glutaminsaeure-imid|-N-phthalylglutaramide|N-Phthaloylglutamimide|Thalidomidum|-(N-phthalimido)glutarimide|()-N-(2,6-dioxo-3-piperidyl)phthalimide|1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline|Talidomida|N-(2,6-dioxo-3-piperidyl)phthalimide|()-thalidomide	thalomid	DRUGBANK	DB01041	C13H10N2O4	small molecule	L04AX02	50-35-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UEJJHQNACJXSKW-UHFFFAOYSA-N
13102	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	antagonist	target	Wiedmann MW (2005)	15892618	179861	1030	Thalidomide	alpha-N-Phthalylglutaramide|-phthalimidoglutarimide|2,6-dioxo-3-phthalimidopiperidine|3-Phthalimidoglutarimide|(+-)-N-(2,6-dioxo-3-Piperidyl)phthalimide|(+-)-Thalidomide|N-Phthalylglutamic acid imide|alpha-(N-Phthalimido)glutarimide|N-Phthalyl-glutaminsaeure-imid|-N-phthalylglutaramide|N-Phthaloylglutamimide|Thalidomidum|-(N-phthalimido)glutarimide|()-N-(2,6-dioxo-3-piperidyl)phthalimide|1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline|Talidomida|N-(2,6-dioxo-3-piperidyl)phthalimide|()-thalidomide	thalomid	DRUGBANK	DB01041	C13H10N2O4	small molecule	L04AX02	50-35-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UEJJHQNACJXSKW-UHFFFAOYSA-N
13103	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	antagonist	target	Du GJ (2005)	15982930	179860	1030	Thalidomide	alpha-N-Phthalylglutaramide|-phthalimidoglutarimide|2,6-dioxo-3-phthalimidopiperidine|3-Phthalimidoglutarimide|(+-)-N-(2,6-dioxo-3-Piperidyl)phthalimide|(+-)-Thalidomide|N-Phthalylglutamic acid imide|alpha-(N-Phthalimido)glutarimide|N-Phthalyl-glutaminsaeure-imid|-N-phthalylglutaramide|N-Phthaloylglutamimide|Thalidomidum|-(N-phthalimido)glutarimide|()-N-(2,6-dioxo-3-piperidyl)phthalimide|1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)isoindoline|Talidomida|N-(2,6-dioxo-3-piperidyl)phthalimide|()-thalidomide	thalomid	DRUGBANK	DB01041	C13H10N2O4	small molecule	L04AX02	50-35-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UEJJHQNACJXSKW-UHFFFAOYSA-N
13104	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Seeman P (2008)	18000814	179862	1032	Memantine	3,5-Dimethyltricyclo(3.3.1.1(3,7))decan-1-amine|Memantine|1-Amino-3,5-dimethyladamantane|Memantina|1,3-Dimethyl-5-adamantanamine|3,5-Dimethyl-1-aminoadamantane|Memantinum|3,5-Dimethyl-1-adamantanamine	act memantine|mematine hydroch	DRUGBANK	DB01043	C12H21N	small molecule	N06DX01|N06DA52|N06DA53	19982-08-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BUGYDGFZZOZRHP-UHFFFAOYSA-N
13155	116442	11309	-	SLCO2B1	OATP-B|OATP2B1|OATPB|SLC21A9	9606	Homo sapiens	inhibitor	target	Lu WJ (2006)	16707409	179896	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13156	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Markstein R (1985)	2869188	179893	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13157	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Markstein R (1985)	2869188	179893	1038	Ergoloid mesylate	Dihydroergotoxine Methanesulfonate|codergocrine mesylate|dihydroergotoxine monomethanesulfonate|Dihydroergotoxine Mesylate|co-dergocrine mesilate|dihydroergotoxine methanesulfonate|co-dergocrine mesylate|ergoloid methanesulfonate|Ergoloid Mesylates|co-dergocrine methanesulfonate|ergoloid methanesulfonates|Dihydroergotoxine Mesilate|codergocrine methanesulfonate|codergocrine mesilate|dihydrogenated ergot alkaloids|dihydroergotoxine methanesulfonates|hydrogenated ergot alkaloids	hydergine tablets, 1mg	DRUGBANK	DB01049	C30H41N5O8S	small molecule	C04AE51|C04AE01	8067-24-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQHMMOGHDWAXDI-WUQHHHCFSA-N
13276	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	unknown	target	Chavez ML (2003)	12852704	177085	1039	Ibuprofen	Mynosedin|Para-Isobutylhydratropic Acid|Advil|Nuprin|(+-)-alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid|Apsifen|P-Isobutylhydratropic Acid|Butylenin|alpha-(4-Isobutylphenyl)propionic acid|4-Isobutylhydratropic acid|Rufen|Tabalon|Femadon|(RS)-ibuprofen|Buburone|Haltran|Anflagen|Dolo-dolgit|Epobron|Amibufen|Urem|Trendar|(+-)-Ibuprofen|(+-)-2-(P-Isobutylphenyl)propionic acid|(+-)-P-Isobutylhydratropic acid|Motrin|Ibuprophen|Nobfen|Brufort|Brufen|Dolgit|Ibutid|alpha-(P-Isobutylphenyl)propionic acid|Ebufac|Nurofen|Anco|Ibuprofen|Lebrufen|Suspren|Dolgirid|Bluton|Dolgin|Pediaprofen|2-(4-Isobutylphenyl)propanoic acid|Seclodin|Roidenin|Ibuprocin|Nobgen|Inoven|Ibu-attritin|Lamidon|(4-Isobutylphenyl)-alpha-methylacetic acid|Adran|Medipren|Ibumetin|Liptan|Inabrin	advil cold and sinus nighttime	DRUGBANK	DB01050	C13H18O2	small molecule	M01AE01|M02AA13|G02CC01|R02AX02|C01EB16|M01AE51	15687-27-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HEFNNWSXXWATRW-UHFFFAOYSA-N
13277	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	unknown	target	Chen X (2002)	11752352	171740	1039	Ibuprofen	Mynosedin|Para-Isobutylhydratropic Acid|Advil|Nuprin|(+-)-alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid|Apsifen|P-Isobutylhydratropic Acid|Butylenin|alpha-(4-Isobutylphenyl)propionic acid|4-Isobutylhydratropic acid|Rufen|Tabalon|Femadon|(RS)-ibuprofen|Buburone|Haltran|Anflagen|Dolo-dolgit|Epobron|Amibufen|Urem|Trendar|(+-)-Ibuprofen|(+-)-2-(P-Isobutylphenyl)propionic acid|(+-)-P-Isobutylhydratropic acid|Motrin|Ibuprophen|Nobfen|Brufort|Brufen|Dolgit|Ibutid|alpha-(P-Isobutylphenyl)propionic acid|Ebufac|Nurofen|Anco|Ibuprofen|Lebrufen|Suspren|Dolgirid|Bluton|Dolgin|Pediaprofen|2-(4-Isobutylphenyl)propanoic acid|Seclodin|Roidenin|Ibuprocin|Nobgen|Inoven|Ibu-attritin|Lamidon|(4-Isobutylphenyl)-alpha-methylacetic acid|Adran|Medipren|Ibumetin|Liptan|Inabrin	advil cold and sinus nighttime	DRUGBANK	DB01050	C13H18O2	small molecule	M01AE01|M02AA13|G02CC01|R02AX02|C01EB16|M01AE51	15687-27-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HEFNNWSXXWATRW-UHFFFAOYSA-N
13278	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	unknown	target	Martic M (2004)	14987823	179630	1039	Ibuprofen	Mynosedin|Para-Isobutylhydratropic Acid|Advil|Nuprin|(+-)-alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid|Apsifen|P-Isobutylhydratropic Acid|Butylenin|alpha-(4-Isobutylphenyl)propionic acid|4-Isobutylhydratropic acid|Rufen|Tabalon|Femadon|(RS)-ibuprofen|Buburone|Haltran|Anflagen|Dolo-dolgit|Epobron|Amibufen|Urem|Trendar|(+-)-Ibuprofen|(+-)-2-(P-Isobutylphenyl)propionic acid|(+-)-P-Isobutylhydratropic acid|Motrin|Ibuprophen|Nobfen|Brufort|Brufen|Dolgit|Ibutid|alpha-(P-Isobutylphenyl)propionic acid|Ebufac|Nurofen|Anco|Ibuprofen|Lebrufen|Suspren|Dolgirid|Bluton|Dolgin|Pediaprofen|2-(4-Isobutylphenyl)propanoic acid|Seclodin|Roidenin|Ibuprocin|Nobgen|Inoven|Ibu-attritin|Lamidon|(4-Isobutylphenyl)-alpha-methylacetic acid|Adran|Medipren|Ibumetin|Liptan|Inabrin	advil cold and sinus nighttime	DRUGBANK	DB01050	C13H18O2	small molecule	M01AE01|M02AA13|G02CC01|R02AX02|C01EB16|M01AE51	15687-27-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HEFNNWSXXWATRW-UHFFFAOYSA-N
13279	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	unknown	target	Gupta K (2004)	14741265	179900	1039	Ibuprofen	Mynosedin|Para-Isobutylhydratropic Acid|Advil|Nuprin|(+-)-alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid|Apsifen|P-Isobutylhydratropic Acid|Butylenin|alpha-(4-Isobutylphenyl)propionic acid|4-Isobutylhydratropic acid|Rufen|Tabalon|Femadon|(RS)-ibuprofen|Buburone|Haltran|Anflagen|Dolo-dolgit|Epobron|Amibufen|Urem|Trendar|(+-)-Ibuprofen|(+-)-2-(P-Isobutylphenyl)propionic acid|(+-)-P-Isobutylhydratropic acid|Motrin|Ibuprophen|Nobfen|Brufort|Brufen|Dolgit|Ibutid|alpha-(P-Isobutylphenyl)propionic acid|Ebufac|Nurofen|Anco|Ibuprofen|Lebrufen|Suspren|Dolgirid|Bluton|Dolgin|Pediaprofen|2-(4-Isobutylphenyl)propanoic acid|Seclodin|Roidenin|Ibuprocin|Nobgen|Inoven|Ibu-attritin|Lamidon|(4-Isobutylphenyl)-alpha-methylacetic acid|Adran|Medipren|Ibumetin|Liptan|Inabrin	advil cold and sinus nighttime	DRUGBANK	DB01050	C13H18O2	small molecule	M01AE01|M02AA13|G02CC01|R02AX02|C01EB16|M01AE51	15687-27-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HEFNNWSXXWATRW-UHFFFAOYSA-N
13280	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	unknown	target	Yu L (2013)	23536207	179901	1039	Ibuprofen	Mynosedin|Para-Isobutylhydratropic Acid|Advil|Nuprin|(+-)-alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid|Apsifen|P-Isobutylhydratropic Acid|Butylenin|alpha-(4-Isobutylphenyl)propionic acid|4-Isobutylhydratropic acid|Rufen|Tabalon|Femadon|(RS)-ibuprofen|Buburone|Haltran|Anflagen|Dolo-dolgit|Epobron|Amibufen|Urem|Trendar|(+-)-Ibuprofen|(+-)-2-(P-Isobutylphenyl)propionic acid|(+-)-P-Isobutylhydratropic acid|Motrin|Ibuprophen|Nobfen|Brufort|Brufen|Dolgit|Ibutid|alpha-(P-Isobutylphenyl)propionic acid|Ebufac|Nurofen|Anco|Ibuprofen|Lebrufen|Suspren|Dolgirid|Bluton|Dolgin|Pediaprofen|2-(4-Isobutylphenyl)propanoic acid|Seclodin|Roidenin|Ibuprocin|Nobgen|Inoven|Ibu-attritin|Lamidon|(4-Isobutylphenyl)-alpha-methylacetic acid|Adran|Medipren|Ibumetin|Liptan|Inabrin	advil cold and sinus nighttime	DRUGBANK	DB01050	C13H18O2	small molecule	M01AE01|M02AA13|G02CC01|R02AX02|C01EB16|M01AE51	15687-27-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HEFNNWSXXWATRW-UHFFFAOYSA-N
13281	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	unknown	target	Patrignani P (2003)	14592549	179902	1039	Ibuprofen	Mynosedin|Para-Isobutylhydratropic Acid|Advil|Nuprin|(+-)-alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid|Apsifen|P-Isobutylhydratropic Acid|Butylenin|alpha-(4-Isobutylphenyl)propionic acid|4-Isobutylhydratropic acid|Rufen|Tabalon|Femadon|(RS)-ibuprofen|Buburone|Haltran|Anflagen|Dolo-dolgit|Epobron|Amibufen|Urem|Trendar|(+-)-Ibuprofen|(+-)-2-(P-Isobutylphenyl)propionic acid|(+-)-P-Isobutylhydratropic acid|Motrin|Ibuprophen|Nobfen|Brufort|Brufen|Dolgit|Ibutid|alpha-(P-Isobutylphenyl)propionic acid|Ebufac|Nurofen|Anco|Ibuprofen|Lebrufen|Suspren|Dolgirid|Bluton|Dolgin|Pediaprofen|2-(4-Isobutylphenyl)propanoic acid|Seclodin|Roidenin|Ibuprocin|Nobgen|Inoven|Ibu-attritin|Lamidon|(4-Isobutylphenyl)-alpha-methylacetic acid|Adran|Medipren|Ibumetin|Liptan|Inabrin	advil cold and sinus nighttime	DRUGBANK	DB01050	C13H18O2	small molecule	M01AE01|M02AA13|G02CC01|R02AX02|C01EB16|M01AE51	15687-27-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HEFNNWSXXWATRW-UHFFFAOYSA-N
13282	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	unknown	target	Hillarp A (2004)	15575422	179899	1039	Ibuprofen	Mynosedin|Para-Isobutylhydratropic Acid|Advil|Nuprin|(+-)-alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid|Apsifen|P-Isobutylhydratropic Acid|Butylenin|alpha-(4-Isobutylphenyl)propionic acid|4-Isobutylhydratropic acid|Rufen|Tabalon|Femadon|(RS)-ibuprofen|Buburone|Haltran|Anflagen|Dolo-dolgit|Epobron|Amibufen|Urem|Trendar|(+-)-Ibuprofen|(+-)-2-(P-Isobutylphenyl)propionic acid|(+-)-P-Isobutylhydratropic acid|Motrin|Ibuprophen|Nobfen|Brufort|Brufen|Dolgit|Ibutid|alpha-(P-Isobutylphenyl)propionic acid|Ebufac|Nurofen|Anco|Ibuprofen|Lebrufen|Suspren|Dolgirid|Bluton|Dolgin|Pediaprofen|2-(4-Isobutylphenyl)propanoic acid|Seclodin|Roidenin|Ibuprocin|Nobgen|Inoven|Ibu-attritin|Lamidon|(4-Isobutylphenyl)-alpha-methylacetic acid|Adran|Medipren|Ibumetin|Liptan|Inabrin	advil cold and sinus nighttime	DRUGBANK	DB01050	C13H18O2	small molecule	M01AE01|M02AA13|G02CC01|R02AX02|C01EB16|M01AE51	15687-27-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HEFNNWSXXWATRW-UHFFFAOYSA-N
13284	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	activator	target	Dill J (2010)	20089905	179904	1039	Ibuprofen	Mynosedin|Para-Isobutylhydratropic Acid|Advil|Nuprin|(+-)-alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid|Apsifen|P-Isobutylhydratropic Acid|Butylenin|alpha-(4-Isobutylphenyl)propionic acid|4-Isobutylhydratropic acid|Rufen|Tabalon|Femadon|(RS)-ibuprofen|Buburone|Haltran|Anflagen|Dolo-dolgit|Epobron|Amibufen|Urem|Trendar|(+-)-Ibuprofen|(+-)-2-(P-Isobutylphenyl)propionic acid|(+-)-P-Isobutylhydratropic acid|Motrin|Ibuprophen|Nobfen|Brufort|Brufen|Dolgit|Ibutid|alpha-(P-Isobutylphenyl)propionic acid|Ebufac|Nurofen|Anco|Ibuprofen|Lebrufen|Suspren|Dolgirid|Bluton|Dolgin|Pediaprofen|2-(4-Isobutylphenyl)propanoic acid|Seclodin|Roidenin|Ibuprocin|Nobgen|Inoven|Ibu-attritin|Lamidon|(4-Isobutylphenyl)-alpha-methylacetic acid|Adran|Medipren|Ibumetin|Liptan|Inabrin	advil cold and sinus nighttime	DRUGBANK	DB01050	C13H18O2	small molecule	M01AE01|M02AA13|G02CC01|R02AX02|C01EB16|M01AE51	15687-27-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HEFNNWSXXWATRW-UHFFFAOYSA-N
13289	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chavez ML (2003)	12852704	177085	1039	Ibuprofen	Mynosedin|Para-Isobutylhydratropic Acid|Advil|Nuprin|(+-)-alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid|Apsifen|P-Isobutylhydratropic Acid|Butylenin|alpha-(4-Isobutylphenyl)propionic acid|4-Isobutylhydratropic acid|Rufen|Tabalon|Femadon|(RS)-ibuprofen|Buburone|Haltran|Anflagen|Dolo-dolgit|Epobron|Amibufen|Urem|Trendar|(+-)-Ibuprofen|(+-)-2-(P-Isobutylphenyl)propionic acid|(+-)-P-Isobutylhydratropic acid|Motrin|Ibuprophen|Nobfen|Brufort|Brufen|Dolgit|Ibutid|alpha-(P-Isobutylphenyl)propionic acid|Ebufac|Nurofen|Anco|Ibuprofen|Lebrufen|Suspren|Dolgirid|Bluton|Dolgin|Pediaprofen|2-(4-Isobutylphenyl)propanoic acid|Seclodin|Roidenin|Ibuprocin|Nobgen|Inoven|Ibu-attritin|Lamidon|(4-Isobutylphenyl)-alpha-methylacetic acid|Adran|Medipren|Ibumetin|Liptan|Inabrin	advil cold and sinus nighttime	DRUGBANK	DB01050	C13H18O2	small molecule	M01AE01|M02AA13|G02CC01|R02AX02|C01EB16|M01AE51	15687-27-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HEFNNWSXXWATRW-UHFFFAOYSA-N
13290	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1039	Ibuprofen	Mynosedin|Para-Isobutylhydratropic Acid|Advil|Nuprin|(+-)-alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid|Apsifen|P-Isobutylhydratropic Acid|Butylenin|alpha-(4-Isobutylphenyl)propionic acid|4-Isobutylhydratropic acid|Rufen|Tabalon|Femadon|(RS)-ibuprofen|Buburone|Haltran|Anflagen|Dolo-dolgit|Epobron|Amibufen|Urem|Trendar|(+-)-Ibuprofen|(+-)-2-(P-Isobutylphenyl)propionic acid|(+-)-P-Isobutylhydratropic acid|Motrin|Ibuprophen|Nobfen|Brufort|Brufen|Dolgit|Ibutid|alpha-(P-Isobutylphenyl)propionic acid|Ebufac|Nurofen|Anco|Ibuprofen|Lebrufen|Suspren|Dolgirid|Bluton|Dolgin|Pediaprofen|2-(4-Isobutylphenyl)propanoic acid|Seclodin|Roidenin|Ibuprocin|Nobgen|Inoven|Ibu-attritin|Lamidon|(4-Isobutylphenyl)-alpha-methylacetic acid|Adran|Medipren|Ibumetin|Liptan|Inabrin	advil cold and sinus nighttime	DRUGBANK	DB01050	C13H18O2	small molecule	M01AE01|M02AA13|G02CC01|R02AX02|C01EB16|M01AE51	15687-27-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HEFNNWSXXWATRW-UHFFFAOYSA-N
13291	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Gallego-Sandin S (2004)	15481334	179907	1039	Ibuprofen	Mynosedin|Para-Isobutylhydratropic Acid|Advil|Nuprin|(+-)-alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid|Apsifen|P-Isobutylhydratropic Acid|Butylenin|alpha-(4-Isobutylphenyl)propionic acid|4-Isobutylhydratropic acid|Rufen|Tabalon|Femadon|(RS)-ibuprofen|Buburone|Haltran|Anflagen|Dolo-dolgit|Epobron|Amibufen|Urem|Trendar|(+-)-Ibuprofen|(+-)-2-(P-Isobutylphenyl)propionic acid|(+-)-P-Isobutylhydratropic acid|Motrin|Ibuprophen|Nobfen|Brufort|Brufen|Dolgit|Ibutid|alpha-(P-Isobutylphenyl)propionic acid|Ebufac|Nurofen|Anco|Ibuprofen|Lebrufen|Suspren|Dolgirid|Bluton|Dolgin|Pediaprofen|2-(4-Isobutylphenyl)propanoic acid|Seclodin|Roidenin|Ibuprocin|Nobgen|Inoven|Ibu-attritin|Lamidon|(4-Isobutylphenyl)-alpha-methylacetic acid|Adran|Medipren|Ibumetin|Liptan|Inabrin	advil cold and sinus nighttime	DRUGBANK	DB01050	C13H18O2	small molecule	M01AE01|M02AA13|G02CC01|R02AX02|C01EB16|M01AE51	15687-27-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HEFNNWSXXWATRW-UHFFFAOYSA-N
13292	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Murphey LJ (2004)	15494133	179908	1039	Ibuprofen	Mynosedin|Para-Isobutylhydratropic Acid|Advil|Nuprin|(+-)-alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid|Apsifen|P-Isobutylhydratropic Acid|Butylenin|alpha-(4-Isobutylphenyl)propionic acid|4-Isobutylhydratropic acid|Rufen|Tabalon|Femadon|(RS)-ibuprofen|Buburone|Haltran|Anflagen|Dolo-dolgit|Epobron|Amibufen|Urem|Trendar|(+-)-Ibuprofen|(+-)-2-(P-Isobutylphenyl)propionic acid|(+-)-P-Isobutylhydratropic acid|Motrin|Ibuprophen|Nobfen|Brufort|Brufen|Dolgit|Ibutid|alpha-(P-Isobutylphenyl)propionic acid|Ebufac|Nurofen|Anco|Ibuprofen|Lebrufen|Suspren|Dolgirid|Bluton|Dolgin|Pediaprofen|2-(4-Isobutylphenyl)propanoic acid|Seclodin|Roidenin|Ibuprocin|Nobgen|Inoven|Ibu-attritin|Lamidon|(4-Isobutylphenyl)-alpha-methylacetic acid|Adran|Medipren|Ibumetin|Liptan|Inabrin	advil cold and sinus nighttime	DRUGBANK	DB01050	C13H18O2	small molecule	M01AE01|M02AA13|G02CC01|R02AX02|C01EB16|M01AE51	15687-27-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HEFNNWSXXWATRW-UHFFFAOYSA-N
13293	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Ouellet M (2004)	14510637	179909	1039	Ibuprofen	Mynosedin|Para-Isobutylhydratropic Acid|Advil|Nuprin|(+-)-alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid|Apsifen|P-Isobutylhydratropic Acid|Butylenin|alpha-(4-Isobutylphenyl)propionic acid|4-Isobutylhydratropic acid|Rufen|Tabalon|Femadon|(RS)-ibuprofen|Buburone|Haltran|Anflagen|Dolo-dolgit|Epobron|Amibufen|Urem|Trendar|(+-)-Ibuprofen|(+-)-2-(P-Isobutylphenyl)propionic acid|(+-)-P-Isobutylhydratropic acid|Motrin|Ibuprophen|Nobfen|Brufort|Brufen|Dolgit|Ibutid|alpha-(P-Isobutylphenyl)propionic acid|Ebufac|Nurofen|Anco|Ibuprofen|Lebrufen|Suspren|Dolgirid|Bluton|Dolgin|Pediaprofen|2-(4-Isobutylphenyl)propanoic acid|Seclodin|Roidenin|Ibuprocin|Nobgen|Inoven|Ibu-attritin|Lamidon|(4-Isobutylphenyl)-alpha-methylacetic acid|Adran|Medipren|Ibumetin|Liptan|Inabrin	advil cold and sinus nighttime	DRUGBANK	DB01050	C13H18O2	small molecule	M01AE01|M02AA13|G02CC01|R02AX02|C01EB16|M01AE51	15687-27-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HEFNNWSXXWATRW-UHFFFAOYSA-N
13294	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Sanchez-Fidalgo S (2004)	15556152	179910	1039	Ibuprofen	Mynosedin|Para-Isobutylhydratropic Acid|Advil|Nuprin|(+-)-alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid|Apsifen|P-Isobutylhydratropic Acid|Butylenin|alpha-(4-Isobutylphenyl)propionic acid|4-Isobutylhydratropic acid|Rufen|Tabalon|Femadon|(RS)-ibuprofen|Buburone|Haltran|Anflagen|Dolo-dolgit|Epobron|Amibufen|Urem|Trendar|(+-)-Ibuprofen|(+-)-2-(P-Isobutylphenyl)propionic acid|(+-)-P-Isobutylhydratropic acid|Motrin|Ibuprophen|Nobfen|Brufort|Brufen|Dolgit|Ibutid|alpha-(P-Isobutylphenyl)propionic acid|Ebufac|Nurofen|Anco|Ibuprofen|Lebrufen|Suspren|Dolgirid|Bluton|Dolgin|Pediaprofen|2-(4-Isobutylphenyl)propanoic acid|Seclodin|Roidenin|Ibuprocin|Nobgen|Inoven|Ibu-attritin|Lamidon|(4-Isobutylphenyl)-alpha-methylacetic acid|Adran|Medipren|Ibumetin|Liptan|Inabrin	advil cold and sinus nighttime	DRUGBANK	DB01050	C13H18O2	small molecule	M01AE01|M02AA13|G02CC01|R02AX02|C01EB16|M01AE51	15687-27-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HEFNNWSXXWATRW-UHFFFAOYSA-N
13337	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Seeman P (2002)	11873706	174626	1051	Acetophenazine	Acetophenazine	-	DRUGBANK	DB01063	C23H29N3O2S	small molecule	N05AB07	2751-68-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WNTYBHLDCKXEOT-UHFFFAOYSA-N
13338	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	1051	Acetophenazine	Acetophenazine	-	DRUGBANK	DB01063	C23H29N3O2S	small molecule	N05AB07	2751-68-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WNTYBHLDCKXEOT-UHFFFAOYSA-N
13339	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1051	Acetophenazine	Acetophenazine	-	DRUGBANK	DB01063	C23H29N3O2S	small molecule	N05AB07	2751-68-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WNTYBHLDCKXEOT-UHFFFAOYSA-N
13340	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	1051	Acetophenazine	Acetophenazine	-	DRUGBANK	DB01063	C23H29N3O2S	small molecule	N05AB07	2751-68-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WNTYBHLDCKXEOT-UHFFFAOYSA-N
13341	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Tam SW (1984)	6147851	179927	1051	Acetophenazine	Acetophenazine	-	DRUGBANK	DB01063	C23H29N3O2S	small molecule	N05AB07	2751-68-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WNTYBHLDCKXEOT-UHFFFAOYSA-N
13403	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Scarsi M (2007)	17082235	178076	1055	Glipizide	Glican|Glucotrol|Gluco-rite|Glibetin|Glipizida|Minidiab|Mindiab|Glipizidum|Glydiazinamide|Aldiab|Glucolip|Melizide|Dipazide|CP-28,720|Glibenese|Glidiab|Glipid|Glupitel|Minodiab|CP 28,720|CP 28720|Sucrazide|Glyde|1-Cyclohexyl-3-({p-[2-(5-methylpyrazinecarboxamido)ethyl]phenyl}sulfonyl)urea|Napizide|Glucozide|Glupizide|Minidab|Digrin|Ozidia|N-{4-[beta-(5-methylpyrazine-2-carboxamido)ethyl]benzenesulphonyl}-n'-cyclohexylurea|K 4024	glucotrol|glipizide|glipizidee	DRUGBANK	DB01067	C21H27N5O4S	small molecule	A10BB07	29094-61-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZJJXGWJIGJFDTL-UHFFFAOYSA-N
13457	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Golembiewski JA (2002)	12476402	179971	1057	Promethazine	Prometazina|N,N,-trimethyl-10H-phenothiazine-10-ethanamine|N,N,alpha-Trimethyl-10H-phenothiazine-10-ethanamine|Promethazinum|(2-dimethylamino-2-methyl)ethyl-N-dibenzoparathiazine|10-(2-Dimethylaminopropyl)phenothiazine|Promethazine|N-(2'-dimethylamino-2'-Methyl)ethylphenothiazine|Proazamine|10-[2-(dimethylamino)Propyl]phenothiazine	promethazine hcl, phenylephrin	DRUGBANK	DB01069	C17H20N2S	small molecule	R06AD52|V03AB05|D04AA10|R06AD02	60-87-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PWWVAXIEGOYWEE-UHFFFAOYSA-N
13638	111711	5739	-	PTGIR	IP|PRIPR	9606	Homo sapiens	agonist	target	Anderson JR (2010)	20395700	180078	1076	Iloprost	-	ventavis	DRUGBANK	DB01088	C22H32O4	small molecule	B01AC11	78919-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HIFJCPQKFCZDDL-ACWOEMLNSA-N
13639	111711	5739	-	PTGIR	IP|PRIPR	9606	Homo sapiens	agonist	target	Krug S (2009)	19475782	180074	1076	Iloprost	-	ventavis	DRUGBANK	DB01088	C22H32O4	small molecule	B01AC11	78919-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HIFJCPQKFCZDDL-ACWOEMLNSA-N
13640	111711	5739	-	PTGIR	IP|PRIPR	9606	Homo sapiens	agonist	target	Schermuly RT (2007)	17257398	180075	1076	Iloprost	-	ventavis	DRUGBANK	DB01088	C22H32O4	small molecule	B01AC11	78919-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HIFJCPQKFCZDDL-ACWOEMLNSA-N
13641	111711	5739	-	PTGIR	IP|PRIPR	9606	Homo sapiens	agonist	target	Tsai AL (1988)	2456096	180076	1076	Iloprost	-	ventavis	DRUGBANK	DB01088	C22H32O4	small molecule	B01AC11	78919-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HIFJCPQKFCZDDL-ACWOEMLNSA-N
13642	111711	5739	-	PTGIR	IP|PRIPR	9606	Homo sapiens	agonist	target	Idzko M (2007)	17273558	180077	1076	Iloprost	-	ventavis	DRUGBANK	DB01088	C22H32O4	small molecule	B01AC11	78919-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HIFJCPQKFCZDDL-ACWOEMLNSA-N
13643	111711	5739	-	PTGIR	IP|PRIPR	9606	Homo sapiens	agonist	target	Takamatsu H (2002)	11792366	180071	1076	Iloprost	-	ventavis	DRUGBANK	DB01088	C22H32O4	small molecule	B01AC11	78919-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HIFJCPQKFCZDDL-ACWOEMLNSA-N
13644	111711	5739	-	PTGIR	IP|PRIPR	9606	Homo sapiens	agonist	target	Mubarak KK (2010)	19683911	180072	1076	Iloprost	-	ventavis	DRUGBANK	DB01088	C22H32O4	small molecule	B01AC11	78919-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HIFJCPQKFCZDDL-ACWOEMLNSA-N
13645	111711	5739	-	PTGIR	IP|PRIPR	9606	Homo sapiens	agonist	target	Crutchley DJ (1992)	1375507	180073	1076	Iloprost	-	ventavis	DRUGBANK	DB01088	C22H32O4	small molecule	B01AC11	78919-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HIFJCPQKFCZDDL-ACWOEMLNSA-N
13646	111711	5739	-	PTGIR	IP|PRIPR	9606	Homo sapiens	agonist	target	Olschewski H (2004)	15163595	175648	1076	Iloprost	-	ventavis	DRUGBANK	DB01088	C22H32O4	small molecule	B01AC11	78919-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HIFJCPQKFCZDDL-ACWOEMLNSA-N
13652	111703	5731	-	PTGER1	EP1	9606	Homo sapiens	agonist	target	Walch L (2001)	11739243	180085	1076	Iloprost	-	ventavis	DRUGBANK	DB01088	C22H32O4	small molecule	B01AC11	78919-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HIFJCPQKFCZDDL-ACWOEMLNSA-N
13653	111703	5731	-	PTGER1	EP1	9606	Homo sapiens	agonist	target	Sharif NA (2002)	11999132	180084	1076	Iloprost	-	ventavis	DRUGBANK	DB01088	C22H32O4	small molecule	B01AC11	78919-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HIFJCPQKFCZDDL-ACWOEMLNSA-N
13681	112529	6646	RP11-215I23.1	SOAT1	ACACT|ACAT|ACAT-1|ACAT1|SOAT|STAT	9606	Homo sapiens	inhibitor	target	Chung MY (2004)	15114505	180100	1082	Hesperetin	Hesperitin|YSO2|3',5,7-Trihydroxy-4'-methoxyflavanone|(-)-Hesperetin|Hesperetin|(S)-2,3-dihydro-5,7-Dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-one|Cyanidanon 4'-Methyl Ether 1626|(-)-(S)-Hesperetin	-	DRUGBANK	DB01094	C16H14O6	small molecule	-	520-33-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AIONOLUJZLIMTK-AWEZNQCLSA-N
13682	112529	6646	RP11-215I23.1	SOAT1	ACACT|ACAT|ACAT-1|ACAT1|SOAT|STAT	9606	Homo sapiens	inhibitor	target	Wilcox LJ (2001)	11352979	180099	1082	Hesperetin	Hesperitin|YSO2|3',5,7-Trihydroxy-4'-methoxyflavanone|(-)-Hesperetin|Hesperetin|(S)-2,3-dihydro-5,7-Dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-one|Cyanidanon 4'-Methyl Ether 1626|(-)-(S)-Hesperetin	-	DRUGBANK	DB01094	C16H14O6	small molecule	-	520-33-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AIONOLUJZLIMTK-AWEZNQCLSA-N
13720	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Seeman P (2002)	11873706	174626	1088	Pimozide	Orap|Halomonth|Pimozida|Pimozide|Opiran|Pimozidum|Neoperidole	orap|pms-pimozide|orap tab 10m	DRUGBANK	DB01100	C28H29F2N3O	small molecule	N05AG02	2062-78-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YVUQSNJEYSNKRX-UHFFFAOYSA-N
13721	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1088	Pimozide	Orap|Halomonth|Pimozida|Pimozide|Opiran|Pimozidum|Neoperidole	orap|pms-pimozide|orap tab 10m	DRUGBANK	DB01100	C28H29F2N3O	small molecule	N05AG02	2062-78-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YVUQSNJEYSNKRX-UHFFFAOYSA-N
13722	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Silva MR (2003)	12828573	180126	1088	Pimozide	Orap|Halomonth|Pimozida|Pimozide|Opiran|Pimozidum|Neoperidole	orap|pms-pimozide|orap tab 10m	DRUGBANK	DB01100	C28H29F2N3O	small molecule	N05AG02	2062-78-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YVUQSNJEYSNKRX-UHFFFAOYSA-N
13723	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Murphy LL (1999)	10503726	180127	1088	Pimozide	Orap|Halomonth|Pimozida|Pimozide|Opiran|Pimozidum|Neoperidole	orap|pms-pimozide|orap tab 10m	DRUGBANK	DB01100	C28H29F2N3O	small molecule	N05AG02	2062-78-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YVUQSNJEYSNKRX-UHFFFAOYSA-N
13724	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Muscat R (1990)	2378927	180124	1088	Pimozide	Orap|Halomonth|Pimozida|Pimozide|Opiran|Pimozidum|Neoperidole	orap|pms-pimozide|orap tab 10m	DRUGBANK	DB01100	C28H29F2N3O	small molecule	N05AG02	2062-78-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YVUQSNJEYSNKRX-UHFFFAOYSA-N
13725	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Zarrindast MR (1994)	8082693	180125	1088	Pimozide	Orap|Halomonth|Pimozida|Pimozide|Opiran|Pimozidum|Neoperidole	orap|pms-pimozide|orap tab 10m	DRUGBANK	DB01100	C28H29F2N3O	small molecule	N05AG02	2062-78-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YVUQSNJEYSNKRX-UHFFFAOYSA-N
13726	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	1088	Pimozide	Orap|Halomonth|Pimozida|Pimozide|Opiran|Pimozidum|Neoperidole	orap|pms-pimozide|orap tab 10m	DRUGBANK	DB01100	C28H29F2N3O	small molecule	N05AG02	2062-78-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YVUQSNJEYSNKRX-UHFFFAOYSA-N
13727	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Freedman SB (1994)	8301582	176340	1088	Pimozide	Orap|Halomonth|Pimozida|Pimozide|Opiran|Pimozidum|Neoperidole	orap|pms-pimozide|orap tab 10m	DRUGBANK	DB01100	C28H29F2N3O	small molecule	N05AG02	2062-78-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YVUQSNJEYSNKRX-UHFFFAOYSA-N
13733	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	antagonist	target	Freedman SB (1994)	8301582	176340	1088	Pimozide	Orap|Halomonth|Pimozida|Pimozide|Opiran|Pimozidum|Neoperidole	orap|pms-pimozide|orap tab 10m	DRUGBANK	DB01100	C28H29F2N3O	small molecule	N05AG02	2062-78-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YVUQSNJEYSNKRX-UHFFFAOYSA-N
13749	113986	8398	CTA-228A9.2	PLA2G6	CaI-PLA2|GVI|INAD1|IPLA2-VIA|NBIA2|NBIA2A|NBIA2B|PARK14|PLA2|PNPLA9|iPLA2|iPLA2beta	9606	Homo sapiens	inhibitor	target	Sastry BV (1999)	10229494	180139	1091	Quinacrine	Mepacrine|6-chloro-9-((4-(Diethylamino)-1-methylbutyl)amino)-2-methoxyacridine|2-Methoxy-6-chloro-9-diethylaminopentylaminoacridine|3-chloro-7-Methoxy-9-(1-methyl-4-diethylaminobutylamino)acridine|Quinacrine|N(4)-(6-chloro-2-Methoxy-9-acridinyl)-N(1),N(1)-diethyl-1,4-pentanediamine	-	DRUGBANK	DB01103	C23H30ClN3O	small molecule	P01AX05	83-89-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GPKJTRJOBQGKQK-UHFFFAOYSA-N
13750	113986	8398	CTA-228A9.2	PLA2G6	CaI-PLA2|GVI|INAD1|IPLA2-VIA|NBIA2|NBIA2A|NBIA2B|PARK14|PLA2|PNPLA9|iPLA2|iPLA2beta	9606	Homo sapiens	inhibitor	target	Nuttle LC (1999)	10199854	180138	1091	Quinacrine	Mepacrine|6-chloro-9-((4-(Diethylamino)-1-methylbutyl)amino)-2-methoxyacridine|2-Methoxy-6-chloro-9-diethylaminopentylaminoacridine|3-chloro-7-Methoxy-9-(1-methyl-4-diethylaminobutylamino)acridine|Quinacrine|N(4)-(6-chloro-2-Methoxy-9-acridinyl)-N(1),N(1)-diethyl-1,4-pentanediamine	-	DRUGBANK	DB01103	C23H30ClN3O	small molecule	P01AX05	83-89-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GPKJTRJOBQGKQK-UHFFFAOYSA-N
13751	113986	8398	CTA-228A9.2	PLA2G6	CaI-PLA2|GVI|INAD1|IPLA2-VIA|NBIA2|NBIA2A|NBIA2B|PARK14|PLA2|PNPLA9|iPLA2|iPLA2beta	9606	Homo sapiens	inhibitor	target	Lohmann CH (1999)	10449625	180140	1091	Quinacrine	Mepacrine|6-chloro-9-((4-(Diethylamino)-1-methylbutyl)amino)-2-methoxyacridine|2-Methoxy-6-chloro-9-diethylaminopentylaminoacridine|3-chloro-7-Methoxy-9-(1-methyl-4-diethylaminobutylamino)acridine|Quinacrine|N(4)-(6-chloro-2-Methoxy-9-acridinyl)-N(1),N(1)-diethyl-1,4-pentanediamine	-	DRUGBANK	DB01103	C23H30ClN3O	small molecule	P01AX05	83-89-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GPKJTRJOBQGKQK-UHFFFAOYSA-N
13752	113986	8398	CTA-228A9.2	PLA2G6	CaI-PLA2|GVI|INAD1|IPLA2-VIA|NBIA2|NBIA2A|NBIA2B|PARK14|PLA2|PNPLA9|iPLA2|iPLA2beta	9606	Homo sapiens	inhibitor	target	Schwartz Z (2000)	10653606	180142	1091	Quinacrine	Mepacrine|6-chloro-9-((4-(Diethylamino)-1-methylbutyl)amino)-2-methoxyacridine|2-Methoxy-6-chloro-9-diethylaminopentylaminoacridine|3-chloro-7-Methoxy-9-(1-methyl-4-diethylaminobutylamino)acridine|Quinacrine|N(4)-(6-chloro-2-Methoxy-9-acridinyl)-N(1),N(1)-diethyl-1,4-pentanediamine	-	DRUGBANK	DB01103	C23H30ClN3O	small molecule	P01AX05	83-89-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GPKJTRJOBQGKQK-UHFFFAOYSA-N
13753	113986	8398	CTA-228A9.2	PLA2G6	CaI-PLA2|GVI|INAD1|IPLA2-VIA|NBIA2|NBIA2A|NBIA2B|PARK14|PLA2|PNPLA9|iPLA2|iPLA2beta	9606	Homo sapiens	inhibitor	target	Sylvia VL (2001)	11455568	180141	1091	Quinacrine	Mepacrine|6-chloro-9-((4-(Diethylamino)-1-methylbutyl)amino)-2-methoxyacridine|2-Methoxy-6-chloro-9-diethylaminopentylaminoacridine|3-chloro-7-Methoxy-9-(1-methyl-4-diethylaminobutylamino)acridine|Quinacrine|N(4)-(6-chloro-2-Methoxy-9-acridinyl)-N(1),N(1)-diethyl-1,4-pentanediamine	-	DRUGBANK	DB01103	C23H30ClN3O	small molecule	P01AX05	83-89-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GPKJTRJOBQGKQK-UHFFFAOYSA-N
13759	111338	5321	-	PLA2G4A	PLA2G4|cPLA2-alpha	9606	Homo sapiens	inhibitor	target	Ong WY (2003)	12582837	180148	1091	Quinacrine	Mepacrine|6-chloro-9-((4-(Diethylamino)-1-methylbutyl)amino)-2-methoxyacridine|2-Methoxy-6-chloro-9-diethylaminopentylaminoacridine|3-chloro-7-Methoxy-9-(1-methyl-4-diethylaminobutylamino)acridine|Quinacrine|N(4)-(6-chloro-2-Methoxy-9-acridinyl)-N(1),N(1)-diethyl-1,4-pentanediamine	-	DRUGBANK	DB01103	C23H30ClN3O	small molecule	P01AX05	83-89-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GPKJTRJOBQGKQK-UHFFFAOYSA-N
13760	111338	5321	-	PLA2G4A	PLA2G4|cPLA2-alpha	9606	Homo sapiens	inhibitor	target	Hellstrand M (2002)	12110374	180149	1091	Quinacrine	Mepacrine|6-chloro-9-((4-(Diethylamino)-1-methylbutyl)amino)-2-methoxyacridine|2-Methoxy-6-chloro-9-diethylaminopentylaminoacridine|3-chloro-7-Methoxy-9-(1-methyl-4-diethylaminobutylamino)acridine|Quinacrine|N(4)-(6-chloro-2-Methoxy-9-acridinyl)-N(1),N(1)-diethyl-1,4-pentanediamine	-	DRUGBANK	DB01103	C23H30ClN3O	small molecule	P01AX05	83-89-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GPKJTRJOBQGKQK-UHFFFAOYSA-N
13761	111338	5321	-	PLA2G4A	PLA2G4|cPLA2-alpha	9606	Homo sapiens	inhibitor	target	Kim BC (1998)	9480923	180150	1091	Quinacrine	Mepacrine|6-chloro-9-((4-(Diethylamino)-1-methylbutyl)amino)-2-methoxyacridine|2-Methoxy-6-chloro-9-diethylaminopentylaminoacridine|3-chloro-7-Methoxy-9-(1-methyl-4-diethylaminobutylamino)acridine|Quinacrine|N(4)-(6-chloro-2-Methoxy-9-acridinyl)-N(1),N(1)-diethyl-1,4-pentanediamine	-	DRUGBANK	DB01103	C23H30ClN3O	small molecule	P01AX05	83-89-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GPKJTRJOBQGKQK-UHFFFAOYSA-N
14035	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Miyazaki Y (2004)	15356026	180300	1120	Pioglitazone	Pioglitazonum|Pioglitazona|(+-)-5-((4-(2-(5-Ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-2,4-thiazolidinedione|Pioglitazone	phl-pioglitazone|pms-pioglitaz	DRUGBANK	DB01132	C19H20N2O3S	small molecule	A10BD12|A10BG03|A10BD09|A10BD05|A10BD06	111025-46-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYAFETHFCAUJAY-UHFFFAOYSA-N
14036	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	1120	Pioglitazone	Pioglitazonum|Pioglitazona|(+-)-5-((4-(2-(5-Ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-2,4-thiazolidinedione|Pioglitazone	phl-pioglitazone|pms-pioglitaz	DRUGBANK	DB01132	C19H20N2O3S	small molecule	A10BD12|A10BG03|A10BD09|A10BD05|A10BD06	111025-46-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYAFETHFCAUJAY-UHFFFAOYSA-N
14037	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Lehmann JM (1995)	7768881	180298	1120	Pioglitazone	Pioglitazonum|Pioglitazona|(+-)-5-((4-(2-(5-Ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-2,4-thiazolidinedione|Pioglitazone	phl-pioglitazone|pms-pioglitaz	DRUGBANK	DB01132	C19H20N2O3S	small molecule	A10BD12|A10BG03|A10BD09|A10BD05|A10BD06	111025-46-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYAFETHFCAUJAY-UHFFFAOYSA-N
14038	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Willson TM (1996)	8576907	180299	1120	Pioglitazone	Pioglitazonum|Pioglitazona|(+-)-5-((4-(2-(5-Ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-2,4-thiazolidinedione|Pioglitazone	phl-pioglitazone|pms-pioglitaz	DRUGBANK	DB01132	C19H20N2O3S	small molecule	A10BD12|A10BG03|A10BD09|A10BD05|A10BD06	111025-46-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYAFETHFCAUJAY-UHFFFAOYSA-N
14039	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Sugii S (2009)	20018750	180296	1120	Pioglitazone	Pioglitazonum|Pioglitazona|(+-)-5-((4-(2-(5-Ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-2,4-thiazolidinedione|Pioglitazone	phl-pioglitazone|pms-pioglitaz	DRUGBANK	DB01132	C19H20N2O3S	small molecule	A10BD12|A10BG03|A10BD09|A10BD05|A10BD06	111025-46-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYAFETHFCAUJAY-UHFFFAOYSA-N
14040	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Spiegelman BM (1998)	9568680	180297	1120	Pioglitazone	Pioglitazonum|Pioglitazona|(+-)-5-((4-(2-(5-Ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-2,4-thiazolidinedione|Pioglitazone	phl-pioglitazone|pms-pioglitaz	DRUGBANK	DB01132	C19H20N2O3S	small molecule	A10BD12|A10BG03|A10BD09|A10BD05|A10BD06	111025-46-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYAFETHFCAUJAY-UHFFFAOYSA-N
14091	110503	4363	-	ABCC1	ABC29|ABCC|GS-X|MRP|MRP1	9606	Homo sapiens	inhibitor	target	Evers R (2000)	10917554	173398	1126	Sulfinpyrazone	Anturane (tn)|Sulfinpyrazone|4-(2-Benzenesulfinylethyl)-1,2-diphenylpyrazolidine-3,5-dione|Sulfoxyphenylpyrazolidine|1,2-Diphenyl-3,5-dioxo-4-(2-phenylsulfinylethyl)pyrazolidine|1,2-Diphenyl-4-(2'-phenylsulfinethyl)-3,5-pyrazolidinedione	sulfinpyrazone tablets 200mg|s	DRUGBANK	DB01138	C23H20N2O3S	small molecule	M04AB02	57-96-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBGGBVCUIVRRBF-UHFFFAOYSA-N
14092	110503	4363	-	ABCC1	ABC29|ABCC|GS-X|MRP|MRP1	9606	Homo sapiens	inhibitor	target	Raggers RJ (1999)	9885294	180328	1126	Sulfinpyrazone	Anturane (tn)|Sulfinpyrazone|4-(2-Benzenesulfinylethyl)-1,2-diphenylpyrazolidine-3,5-dione|Sulfoxyphenylpyrazolidine|1,2-Diphenyl-3,5-dioxo-4-(2-phenylsulfinylethyl)pyrazolidine|1,2-Diphenyl-4-(2'-phenylsulfinethyl)-3,5-pyrazolidinedione	sulfinpyrazone tablets 200mg|s	DRUGBANK	DB01138	C23H20N2O3S	small molecule	M04AB02	57-96-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBGGBVCUIVRRBF-UHFFFAOYSA-N
14093	110503	4363	-	ABCC1	ABC29|ABCC|GS-X|MRP|MRP1	9606	Homo sapiens	inhibitor	target	Depeille P (2004)	15044619	180329	1126	Sulfinpyrazone	Anturane (tn)|Sulfinpyrazone|4-(2-Benzenesulfinylethyl)-1,2-diphenylpyrazolidine-3,5-dione|Sulfoxyphenylpyrazolidine|1,2-Diphenyl-3,5-dioxo-4-(2-phenylsulfinylethyl)pyrazolidine|1,2-Diphenyl-4-(2'-phenylsulfinethyl)-3,5-pyrazolidinedione	sulfinpyrazone tablets 200mg|s	DRUGBANK	DB01138	C23H20N2O3S	small molecule	M04AB02	57-96-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBGGBVCUIVRRBF-UHFFFAOYSA-N
14094	110503	4363	-	ABCC1	ABC29|ABCC|GS-X|MRP|MRP1	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1126	Sulfinpyrazone	Anturane (tn)|Sulfinpyrazone|4-(2-Benzenesulfinylethyl)-1,2-diphenylpyrazolidine-3,5-dione|Sulfoxyphenylpyrazolidine|1,2-Diphenyl-3,5-dioxo-4-(2-phenylsulfinylethyl)pyrazolidine|1,2-Diphenyl-4-(2'-phenylsulfinethyl)-3,5-pyrazolidinedione	sulfinpyrazone tablets 200mg|s	DRUGBANK	DB01138	C23H20N2O3S	small molecule	M04AB02	57-96-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBGGBVCUIVRRBF-UHFFFAOYSA-N
14095	110503	4363	-	ABCC1	ABC29|ABCC|GS-X|MRP|MRP1	9606	Homo sapiens	inhibitor	target	Bakos E (2000)	10727523	176911	1126	Sulfinpyrazone	Anturane (tn)|Sulfinpyrazone|4-(2-Benzenesulfinylethyl)-1,2-diphenylpyrazolidine-3,5-dione|Sulfoxyphenylpyrazolidine|1,2-Diphenyl-3,5-dioxo-4-(2-phenylsulfinylethyl)pyrazolidine|1,2-Diphenyl-4-(2'-phenylsulfinethyl)-3,5-pyrazolidinedione	sulfinpyrazone tablets 200mg|s	DRUGBANK	DB01138	C23H20N2O3S	small molecule	M04AB02	57-96-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBGGBVCUIVRRBF-UHFFFAOYSA-N
14096	110503	4363	-	ABCC1	ABC29|ABCC|GS-X|MRP|MRP1	9606	Homo sapiens	inhibitor	target	Morrow CS (1998)	9685354	180330	1126	Sulfinpyrazone	Anturane (tn)|Sulfinpyrazone|4-(2-Benzenesulfinylethyl)-1,2-diphenylpyrazolidine-3,5-dione|Sulfoxyphenylpyrazolidine|1,2-Diphenyl-3,5-dioxo-4-(2-phenylsulfinylethyl)pyrazolidine|1,2-Diphenyl-4-(2'-phenylsulfinethyl)-3,5-pyrazolidinedione	sulfinpyrazone tablets 200mg|s	DRUGBANK	DB01138	C23H20N2O3S	small molecule	M04AB02	57-96-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBGGBVCUIVRRBF-UHFFFAOYSA-N
14097	107647	1244	RP11-114F7.2	ABCC2	ABC30|CMOAT|DJS|MRP2|cMRP	9606	Homo sapiens	inhibitor	target	Flanagan SD (2002)	11834888	176952	1126	Sulfinpyrazone	Anturane (tn)|Sulfinpyrazone|4-(2-Benzenesulfinylethyl)-1,2-diphenylpyrazolidine-3,5-dione|Sulfoxyphenylpyrazolidine|1,2-Diphenyl-3,5-dioxo-4-(2-phenylsulfinylethyl)pyrazolidine|1,2-Diphenyl-4-(2'-phenylsulfinethyl)-3,5-pyrazolidinedione	sulfinpyrazone tablets 200mg|s	DRUGBANK	DB01138	C23H20N2O3S	small molecule	M04AB02	57-96-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBGGBVCUIVRRBF-UHFFFAOYSA-N
14098	107647	1244	RP11-114F7.2	ABCC2	ABC30|CMOAT|DJS|MRP2|cMRP	9606	Homo sapiens	inhibitor	target	Evers R (2000)	10917554	173398	1126	Sulfinpyrazone	Anturane (tn)|Sulfinpyrazone|4-(2-Benzenesulfinylethyl)-1,2-diphenylpyrazolidine-3,5-dione|Sulfoxyphenylpyrazolidine|1,2-Diphenyl-3,5-dioxo-4-(2-phenylsulfinylethyl)pyrazolidine|1,2-Diphenyl-4-(2'-phenylsulfinethyl)-3,5-pyrazolidinedione	sulfinpyrazone tablets 200mg|s	DRUGBANK	DB01138	C23H20N2O3S	small molecule	M04AB02	57-96-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBGGBVCUIVRRBF-UHFFFAOYSA-N
14099	107647	1244	RP11-114F7.2	ABCC2	ABC30|CMOAT|DJS|MRP2|cMRP	9606	Homo sapiens	inhibitor	target	Bakos E (2000)	10727523	176911	1126	Sulfinpyrazone	Anturane (tn)|Sulfinpyrazone|4-(2-Benzenesulfinylethyl)-1,2-diphenylpyrazolidine-3,5-dione|Sulfoxyphenylpyrazolidine|1,2-Diphenyl-3,5-dioxo-4-(2-phenylsulfinylethyl)pyrazolidine|1,2-Diphenyl-4-(2'-phenylsulfinethyl)-3,5-pyrazolidinedione	sulfinpyrazone tablets 200mg|s	DRUGBANK	DB01138	C23H20N2O3S	small molecule	M04AB02	57-96-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBGGBVCUIVRRBF-UHFFFAOYSA-N
14100	107647	1244	RP11-114F7.2	ABCC2	ABC30|CMOAT|DJS|MRP2|cMRP	9606	Homo sapiens	inhibitor	target	Ito K (2001)	11500505	180333	1126	Sulfinpyrazone	Anturane (tn)|Sulfinpyrazone|4-(2-Benzenesulfinylethyl)-1,2-diphenylpyrazolidine-3,5-dione|Sulfoxyphenylpyrazolidine|1,2-Diphenyl-3,5-dioxo-4-(2-phenylsulfinylethyl)pyrazolidine|1,2-Diphenyl-4-(2'-phenylsulfinethyl)-3,5-pyrazolidinedione	sulfinpyrazone tablets 200mg|s	DRUGBANK	DB01138	C23H20N2O3S	small molecule	M04AB02	57-96-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBGGBVCUIVRRBF-UHFFFAOYSA-N
14101	107647	1244	RP11-114F7.2	ABCC2	ABC30|CMOAT|DJS|MRP2|cMRP	9606	Homo sapiens	inhibitor	target	Morrow CS (2000)	11108662	180332	1126	Sulfinpyrazone	Anturane (tn)|Sulfinpyrazone|4-(2-Benzenesulfinylethyl)-1,2-diphenylpyrazolidine-3,5-dione|Sulfoxyphenylpyrazolidine|1,2-Diphenyl-3,5-dioxo-4-(2-phenylsulfinylethyl)pyrazolidine|1,2-Diphenyl-4-(2'-phenylsulfinethyl)-3,5-pyrazolidinedione	sulfinpyrazone tablets 200mg|s	DRUGBANK	DB01138	C23H20N2O3S	small molecule	M04AB02	57-96-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBGGBVCUIVRRBF-UHFFFAOYSA-N
14102	107647	1244	RP11-114F7.2	ABCC2	ABC30|CMOAT|DJS|MRP2|cMRP	9606	Homo sapiens	inhibitor	target	Hagos Y (2007)	17229912	180331	1126	Sulfinpyrazone	Anturane (tn)|Sulfinpyrazone|4-(2-Benzenesulfinylethyl)-1,2-diphenylpyrazolidine-3,5-dione|Sulfoxyphenylpyrazolidine|1,2-Diphenyl-3,5-dioxo-4-(2-phenylsulfinylethyl)pyrazolidine|1,2-Diphenyl-4-(2'-phenylsulfinethyl)-3,5-pyrazolidinedione	sulfinpyrazone tablets 200mg|s	DRUGBANK	DB01138	C23H20N2O3S	small molecule	M04AB02	57-96-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MBGGBVCUIVRRBF-UHFFFAOYSA-N
14147	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Richelson E (1984)	6086881	176781	1130	Doxepin	Sinequan|Cidoxepin|Doxepin|Zonalon	alti-doxepin-cap 25mg|ntp-doxe	DRUGBANK	DB01142	C19H21NO	small molecule	N06AA12	1668-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODQWQRRAPPTVAG-BOPFTXTBSA-N
14148	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Cusack B (1994)	7855217	175183	1130	Doxepin	Sinequan|Cidoxepin|Doxepin|Zonalon	alti-doxepin-cap 25mg|ntp-doxe	DRUGBANK	DB01142	C19H21NO	small molecule	N06AA12	1668-19-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ODQWQRRAPPTVAG-BOPFTXTBSA-N
14235	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	binder	target	Cusack B (1994)	7855217	175183	1139	Desipramine	N-(3-methylaminopropyl)iminobibenzyl|5-(-methylaminopropyl)iminodibenzyl|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI|Dmthylimipramine|Desipramine|Norimipramine|3-(10,11-DIHYDRO-5H-dibenzo[b,F]azepin-5-yl)-N-methylpropan-1-amine|Desipramina|Monodemethylimipramine|Desipraminum|Desmethylimipramine|Desipramin	pms-desipramine - tab 100mg|de	DRUGBANK	DB01151	C18H22N2	small molecule	N06AA01	50-47-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HCYAFALTSJYZDH-UHFFFAOYSA-N
14356	111711	5739	-	PTGIR	IP|PRIPR	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	1148	Dinoprost Tromethamine	PGF2alpha THAM|Prostaglandin F2a tromethamine|PGF2-alpha THAM|Prostaglandin F2alpha tham|Prostaglandin F2-alpha THAM|Prostin F2 Alpha|Dinoprost trometamol	prostin f2 alpha	DRUGBANK	DB01160	C24H45NO8	small molecule	-	38562-01-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IYGXEHDCSOYNKY-RZHHZEQLSA-N
14357	111711	5739	-	PTGIR	IP|PRIPR	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1148	Dinoprost Tromethamine	PGF2alpha THAM|Prostaglandin F2a tromethamine|PGF2-alpha THAM|Prostaglandin F2alpha tham|Prostaglandin F2-alpha THAM|Prostin F2 Alpha|Dinoprost trometamol	prostin f2 alpha	DRUGBANK	DB01160	C24H45NO8	small molecule	-	38562-01-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IYGXEHDCSOYNKY-RZHHZEQLSA-N
14358	111711	5739	-	PTGIR	IP|PRIPR	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	1148	Dinoprost Tromethamine	PGF2alpha THAM|Prostaglandin F2a tromethamine|PGF2-alpha THAM|Prostaglandin F2alpha tham|Prostaglandin F2-alpha THAM|Prostin F2 Alpha|Dinoprost trometamol	prostin f2 alpha	DRUGBANK	DB01160	C24H45NO8	small molecule	-	38562-01-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IYGXEHDCSOYNKY-RZHHZEQLSA-N
14359	111709	5737	RP5-944H6.1	PTGFR	FP	9606	Homo sapiens	agonist	target	Sakamoto K (1995)	8777582	180420	1148	Dinoprost Tromethamine	PGF2alpha THAM|Prostaglandin F2a tromethamine|PGF2-alpha THAM|Prostaglandin F2alpha tham|Prostaglandin F2-alpha THAM|Prostin F2 Alpha|Dinoprost trometamol	prostin f2 alpha	DRUGBANK	DB01160	C24H45NO8	small molecule	-	38562-01-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IYGXEHDCSOYNKY-RZHHZEQLSA-N
14518	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	1168	Rescinnamine	Tsuruselpi S|3,4,5-Trimethoxycinnamoyl methyl reserpate|Trimethoxy cinnamoyl reserpate de methyl|Rescinnamine	-	DRUGBANK	DB01180	C35H42N2O9	small molecule	C02AA01|C02LA52|C02LA02	24815-24-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SZLZWPPUNLXJEA-QEGASFHISA-N
14519	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1168	Rescinnamine	Tsuruselpi S|3,4,5-Trimethoxycinnamoyl methyl reserpate|Trimethoxy cinnamoyl reserpate de methyl|Rescinnamine	-	DRUGBANK	DB01180	C35H42N2O9	small molecule	C02AA01|C02LA52|C02LA02	24815-24-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SZLZWPPUNLXJEA-QEGASFHISA-N
14520	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	1168	Rescinnamine	Tsuruselpi S|3,4,5-Trimethoxycinnamoyl methyl reserpate|Trimethoxy cinnamoyl reserpate de methyl|Rescinnamine	-	DRUGBANK	DB01180	C35H42N2O9	small molecule	C02AA01|C02LA52|C02LA02	24815-24-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SZLZWPPUNLXJEA-QEGASFHISA-N
14521	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Azhar I (2005)	16431399	180495	1168	Rescinnamine	Tsuruselpi S|3,4,5-Trimethoxycinnamoyl methyl reserpate|Trimethoxy cinnamoyl reserpate de methyl|Rescinnamine	-	DRUGBANK	DB01180	C35H42N2O9	small molecule	C02AA01|C02LA52|C02LA02	24815-24-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SZLZWPPUNLXJEA-QEGASFHISA-N
14553	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Ali I (2006)	18970411	180517	1172	Domperidone	1-(3-(4-(5-chloro-2-oxo-2,3-Dihydrobenzo[D]imidazol-1-yl)piperidin-1-yl)propyl)-1H-benzo[D]imidazol-2(3H)-one|Domperidona|5-chloro-1-{1-[3-(2-oxo-2,3-dihydro-benzoimidazol-1-yl)-propyl]-piperidin-4-yl}-1,3-dihydro-benzoimidazol-2-one|5-chloro-1-(1-(3-(2-oxo-2,3-Dihydrobenzo[D]imidazol-1-yl)propyl)piperidin-4-yl)-1H-benzo[D]imidazol-2(3H)-one|Domperidonum|5-chloro-1-(1-(3-(2-oxo-1-Benzimidazolinyl)propyl)-4-piperidyl)-2-benzimidazolinone	ran-domperidone|motilium tab 1	DRUGBANK	DB01184	C22H24ClN5O2	small molecule	A03FA03	57808-66-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FGXWKSZFVQUSTL-UHFFFAOYSA-N
14554	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Osinski MA (2005)	15894081	176541	1172	Domperidone	1-(3-(4-(5-chloro-2-oxo-2,3-Dihydrobenzo[D]imidazol-1-yl)piperidin-1-yl)propyl)-1H-benzo[D]imidazol-2(3H)-one|Domperidona|5-chloro-1-{1-[3-(2-oxo-2,3-dihydro-benzoimidazol-1-yl)-propyl]-piperidin-4-yl}-1,3-dihydro-benzoimidazol-2-one|5-chloro-1-(1-(3-(2-oxo-2,3-Dihydrobenzo[D]imidazol-1-yl)propyl)piperidin-4-yl)-1H-benzo[D]imidazol-2(3H)-one|Domperidonum|5-chloro-1-(1-(3-(2-oxo-1-Benzimidazolinyl)propyl)-4-piperidyl)-2-benzimidazolinone	ran-domperidone|motilium tab 1	DRUGBANK	DB01184	C22H24ClN5O2	small molecule	A03FA03	57808-66-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FGXWKSZFVQUSTL-UHFFFAOYSA-N
14555	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1172	Domperidone	1-(3-(4-(5-chloro-2-oxo-2,3-Dihydrobenzo[D]imidazol-1-yl)piperidin-1-yl)propyl)-1H-benzo[D]imidazol-2(3H)-one|Domperidona|5-chloro-1-{1-[3-(2-oxo-2,3-dihydro-benzoimidazol-1-yl)-propyl]-piperidin-4-yl}-1,3-dihydro-benzoimidazol-2-one|5-chloro-1-(1-(3-(2-oxo-2,3-Dihydrobenzo[D]imidazol-1-yl)propyl)piperidin-4-yl)-1H-benzo[D]imidazol-2(3H)-one|Domperidonum|5-chloro-1-(1-(3-(2-oxo-1-Benzimidazolinyl)propyl)-4-piperidyl)-2-benzimidazolinone	ran-domperidone|motilium tab 1	DRUGBANK	DB01184	C22H24ClN5O2	small molecule	A03FA03	57808-66-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FGXWKSZFVQUSTL-UHFFFAOYSA-N
14556	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Cavallotti C (2002)	12010185	175759	1172	Domperidone	1-(3-(4-(5-chloro-2-oxo-2,3-Dihydrobenzo[D]imidazol-1-yl)piperidin-1-yl)propyl)-1H-benzo[D]imidazol-2(3H)-one|Domperidona|5-chloro-1-{1-[3-(2-oxo-2,3-dihydro-benzoimidazol-1-yl)-propyl]-piperidin-4-yl}-1,3-dihydro-benzoimidazol-2-one|5-chloro-1-(1-(3-(2-oxo-2,3-Dihydrobenzo[D]imidazol-1-yl)propyl)piperidin-4-yl)-1H-benzo[D]imidazol-2(3H)-one|Domperidonum|5-chloro-1-(1-(3-(2-oxo-1-Benzimidazolinyl)propyl)-4-piperidyl)-2-benzimidazolinone	ran-domperidone|motilium tab 1	DRUGBANK	DB01184	C22H24ClN5O2	small molecule	A03FA03	57808-66-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FGXWKSZFVQUSTL-UHFFFAOYSA-N
14557	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	de Mey C (1991)	1683559	174763	1172	Domperidone	1-(3-(4-(5-chloro-2-oxo-2,3-Dihydrobenzo[D]imidazol-1-yl)piperidin-1-yl)propyl)-1H-benzo[D]imidazol-2(3H)-one|Domperidona|5-chloro-1-{1-[3-(2-oxo-2,3-dihydro-benzoimidazol-1-yl)-propyl]-piperidin-4-yl}-1,3-dihydro-benzoimidazol-2-one|5-chloro-1-(1-(3-(2-oxo-2,3-Dihydrobenzo[D]imidazol-1-yl)propyl)piperidin-4-yl)-1H-benzo[D]imidazol-2(3H)-one|Domperidonum|5-chloro-1-(1-(3-(2-oxo-1-Benzimidazolinyl)propyl)-4-piperidyl)-2-benzimidazolinone	ran-domperidone|motilium tab 1	DRUGBANK	DB01184	C22H24ClN5O2	small molecule	A03FA03	57808-66-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FGXWKSZFVQUSTL-UHFFFAOYSA-N
14558	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	antagonist	target	Freedman SB (1994)	8301582	176340	1172	Domperidone	1-(3-(4-(5-chloro-2-oxo-2,3-Dihydrobenzo[D]imidazol-1-yl)piperidin-1-yl)propyl)-1H-benzo[D]imidazol-2(3H)-one|Domperidona|5-chloro-1-{1-[3-(2-oxo-2,3-dihydro-benzoimidazol-1-yl)-propyl]-piperidin-4-yl}-1,3-dihydro-benzoimidazol-2-one|5-chloro-1-(1-(3-(2-oxo-2,3-Dihydrobenzo[D]imidazol-1-yl)propyl)piperidin-4-yl)-1H-benzo[D]imidazol-2(3H)-one|Domperidonum|5-chloro-1-(1-(3-(2-oxo-1-Benzimidazolinyl)propyl)-4-piperidyl)-2-benzimidazolinone	ran-domperidone|motilium tab 1	DRUGBANK	DB01184	C22H24ClN5O2	small molecule	A03FA03	57808-66-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FGXWKSZFVQUSTL-UHFFFAOYSA-N
14573	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Huettl P (1991)	1674528	178828	1174	Pergolide	Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida	permax tab 0.25mg|permax tab 0	DRUGBANK	DB01186	C19H26N2S	small molecule	N04BC02	66104-22-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YEHCICAEULNIGD-MZMPZRCHSA-N
14574	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	1174	Pergolide	Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida	permax tab 0.25mg|permax tab 0	DRUGBANK	DB01186	C19H26N2S	small molecule	N04BC02	66104-22-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YEHCICAEULNIGD-MZMPZRCHSA-N
14575	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	1174	Pergolide	Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida	permax tab 0.25mg|permax tab 0	DRUGBANK	DB01186	C19H26N2S	small molecule	N04BC02	66104-22-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YEHCICAEULNIGD-MZMPZRCHSA-N
14576	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Mehta MA (2006)	16842172	180531	1174	Pergolide	Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida	permax tab 0.25mg|permax tab 0	DRUGBANK	DB01186	C19H26N2S	small molecule	N04BC02	66104-22-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YEHCICAEULNIGD-MZMPZRCHSA-N
14577	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Fuller RW (1985)	2860228	180530	1174	Pergolide	Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida	permax tab 0.25mg|permax tab 0	DRUGBANK	DB01186	C19H26N2S	small molecule	N04BC02	66104-22-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YEHCICAEULNIGD-MZMPZRCHSA-N
14578	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Lam YW (2000)	10641988	174664	1174	Pergolide	Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida	permax tab 0.25mg|permax tab 0	DRUGBANK	DB01186	C19H26N2S	small molecule	N04BC02	66104-22-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YEHCICAEULNIGD-MZMPZRCHSA-N
14579	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Linazasoro G (1999)	10516878	180532	1174	Pergolide	Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida	permax tab 0.25mg|permax tab 0	DRUGBANK	DB01186	C19H26N2S	small molecule	N04BC02	66104-22-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YEHCICAEULNIGD-MZMPZRCHSA-N
14580	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Paturle L (1987)	3828803	180529	1174	Pergolide	Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida	permax tab 0.25mg|permax tab 0	DRUGBANK	DB01186	C19H26N2S	small molecule	N04BC02	66104-22-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YEHCICAEULNIGD-MZMPZRCHSA-N
14587	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	1174	Pergolide	Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida	permax tab 0.25mg|permax tab 0	DRUGBANK	DB01186	C19H26N2S	small molecule	N04BC02	66104-22-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YEHCICAEULNIGD-MZMPZRCHSA-N
14588	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	agonist	target	Lam YW (2000)	10641988	174664	1174	Pergolide	Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida	permax tab 0.25mg|permax tab 0	DRUGBANK	DB01186	C19H26N2S	small molecule	N04BC02	66104-22-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YEHCICAEULNIGD-MZMPZRCHSA-N
14589	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	agonist	target	Wachtel H (1991)	1683537	180533	1174	Pergolide	Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida	permax tab 0.25mg|permax tab 0	DRUGBANK	DB01186	C19H26N2S	small molecule	N04BC02	66104-22-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YEHCICAEULNIGD-MZMPZRCHSA-N
14590	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	1174	Pergolide	Pergolide Methanesulfonate|Pergolidum|Pergolide Mesylate|Pergolida	permax tab 0.25mg|permax tab 0	DRUGBANK	DB01186	C19H26N2S	small molecule	N04BC02	66104-22-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YEHCICAEULNIGD-MZMPZRCHSA-N
14726	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Natesh R (2004)	15236580	177072	1185	Captopril	(2S)-1-[(2S)-2-Methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid|Captopryl|Apopril|Garranil|Tensoprel|Cesplon|Capoten|D-3-Mercapto-2-methylpropanoyl-L-proline|Captoprilum|D-2-Methyl-3-mercaptopropanoyl-L-proline|Dilabar|Captoril|Hypertil|Captolane|Tensobon|Acepress|CP|Tenosbon|L-Captopril|Lopirin	capoten tab 100mg|med captopri	DRUGBANK	DB01197	C9H15NO3S	small molecule	C09AA01|C09BA01	62571-86-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAKRSMQSSFJEIM-RQJHMYQMSA-N
14727	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Andujar-Sanchez M (2007)	17618628	177073	1185	Captopril	(2S)-1-[(2S)-2-Methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid|Captopryl|Apopril|Garranil|Tensoprel|Cesplon|Capoten|D-3-Mercapto-2-methylpropanoyl-L-proline|Captoprilum|D-2-Methyl-3-mercaptopropanoyl-L-proline|Dilabar|Captoril|Hypertil|Captolane|Tensobon|Acepress|CP|Tenosbon|L-Captopril|Lopirin	capoten tab 100mg|med captopri	DRUGBANK	DB01197	C9H15NO3S	small molecule	C09AA01|C09BA01	62571-86-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAKRSMQSSFJEIM-RQJHMYQMSA-N
14728	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Dalkas GA (2010)	20014331	180582	1185	Captopril	(2S)-1-[(2S)-2-Methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid|Captopryl|Apopril|Garranil|Tensoprel|Cesplon|Capoten|D-3-Mercapto-2-methylpropanoyl-L-proline|Captoprilum|D-2-Methyl-3-mercaptopropanoyl-L-proline|Dilabar|Captoril|Hypertil|Captolane|Tensobon|Acepress|CP|Tenosbon|L-Captopril|Lopirin	capoten tab 100mg|med captopri	DRUGBANK	DB01197	C9H15NO3S	small molecule	C09AA01|C09BA01	62571-86-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAKRSMQSSFJEIM-RQJHMYQMSA-N
14729	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Tzakos AG (2006)	16889963	180583	1185	Captopril	(2S)-1-[(2S)-2-Methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid|Captopryl|Apopril|Garranil|Tensoprel|Cesplon|Capoten|D-3-Mercapto-2-methylpropanoyl-L-proline|Captoprilum|D-2-Methyl-3-mercaptopropanoyl-L-proline|Dilabar|Captoril|Hypertil|Captolane|Tensobon|Acepress|CP|Tenosbon|L-Captopril|Lopirin	capoten tab 100mg|med captopri	DRUGBANK	DB01197	C9H15NO3S	small molecule	C09AA01|C09BA01	62571-86-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAKRSMQSSFJEIM-RQJHMYQMSA-N
14730	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Piepho RW (2000)	11030016	174112	1185	Captopril	(2S)-1-[(2S)-2-Methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid|Captopryl|Apopril|Garranil|Tensoprel|Cesplon|Capoten|D-3-Mercapto-2-methylpropanoyl-L-proline|Captoprilum|D-2-Methyl-3-mercaptopropanoyl-L-proline|Dilabar|Captoril|Hypertil|Captolane|Tensobon|Acepress|CP|Tenosbon|L-Captopril|Lopirin	capoten tab 100mg|med captopri	DRUGBANK	DB01197	C9H15NO3S	small molecule	C09AA01|C09BA01	62571-86-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAKRSMQSSFJEIM-RQJHMYQMSA-N
14731	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Song JC (2002)	11929321	174114	1185	Captopril	(2S)-1-[(2S)-2-Methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid|Captopryl|Apopril|Garranil|Tensoprel|Cesplon|Capoten|D-3-Mercapto-2-methylpropanoyl-L-proline|Captoprilum|D-2-Methyl-3-mercaptopropanoyl-L-proline|Dilabar|Captoril|Hypertil|Captolane|Tensobon|Acepress|CP|Tenosbon|L-Captopril|Lopirin	capoten tab 100mg|med captopri	DRUGBANK	DB01197	C9H15NO3S	small molecule	C09AA01|C09BA01	62571-86-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAKRSMQSSFJEIM-RQJHMYQMSA-N
14732	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1185	Captopril	(2S)-1-[(2S)-2-Methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid|Captopryl|Apopril|Garranil|Tensoprel|Cesplon|Capoten|D-3-Mercapto-2-methylpropanoyl-L-proline|Captoprilum|D-2-Methyl-3-mercaptopropanoyl-L-proline|Dilabar|Captoril|Hypertil|Captolane|Tensobon|Acepress|CP|Tenosbon|L-Captopril|Lopirin	capoten tab 100mg|med captopri	DRUGBANK	DB01197	C9H15NO3S	small molecule	C09AA01|C09BA01	62571-86-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAKRSMQSSFJEIM-RQJHMYQMSA-N
14737	110226	4048	-	LTA4H	-	9606	Homo sapiens	unknown	target	Thunnissen MM (2002)	12207002	152292	1185	Captopril	(2S)-1-[(2S)-2-Methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid|Captopryl|Apopril|Garranil|Tensoprel|Cesplon|Capoten|D-3-Mercapto-2-methylpropanoyl-L-proline|Captoprilum|D-2-Methyl-3-mercaptopropanoyl-L-proline|Dilabar|Captoril|Hypertil|Captolane|Tensobon|Acepress|CP|Tenosbon|L-Captopril|Lopirin	capoten tab 100mg|med captopri	DRUGBANK	DB01197	C9H15NO3S	small molecule	C09AA01|C09BA01	62571-86-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAKRSMQSSFJEIM-RQJHMYQMSA-N
14772	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Lahlou S (2000)	10626749	180597	1188	Bromocriptine	2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine	syn-bromocriptine cap 5mg|co b	DRUGBANK	DB01200	C32H40BrN5O5	small molecule	G02CB01|N04BC01	25614-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZVBMTJYIDMWIL-AYFBDAFISA-N
14773	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	1188	Bromocriptine	2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine	syn-bromocriptine cap 5mg|co b	DRUGBANK	DB01200	C32H40BrN5O5	small molecule	G02CB01|N04BC01	25614-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZVBMTJYIDMWIL-AYFBDAFISA-N
14774	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Lahlou S (2000)	10721819	180600	1188	Bromocriptine	2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine	syn-bromocriptine cap 5mg|co b	DRUGBANK	DB01200	C32H40BrN5O5	small molecule	G02CB01|N04BC01	25614-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZVBMTJYIDMWIL-AYFBDAFISA-N
14775	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	1188	Bromocriptine	2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine	syn-bromocriptine cap 5mg|co b	DRUGBANK	DB01200	C32H40BrN5O5	small molecule	G02CB01|N04BC01	25614-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZVBMTJYIDMWIL-AYFBDAFISA-N
14776	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Lam YW (2000)	10641988	174664	1188	Bromocriptine	2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine	syn-bromocriptine cap 5mg|co b	DRUGBANK	DB01200	C32H40BrN5O5	small molecule	G02CB01|N04BC01	25614-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZVBMTJYIDMWIL-AYFBDAFISA-N
14777	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Cavallotti C (2002)	12010185	175759	1188	Bromocriptine	2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine	syn-bromocriptine cap 5mg|co b	DRUGBANK	DB01200	C32H40BrN5O5	small molecule	G02CB01|N04BC01	25614-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZVBMTJYIDMWIL-AYFBDAFISA-N
14778	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Lahlou S (2003)	12753422	180599	1188	Bromocriptine	2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine	syn-bromocriptine cap 5mg|co b	DRUGBANK	DB01200	C32H40BrN5O5	small molecule	G02CB01|N04BC01	25614-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZVBMTJYIDMWIL-AYFBDAFISA-N
14779	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Stefaneanu L (2001)	11444429	180598	1188	Bromocriptine	2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine	syn-bromocriptine cap 5mg|co b	DRUGBANK	DB01200	C32H40BrN5O5	small molecule	G02CB01|N04BC01	25614-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZVBMTJYIDMWIL-AYFBDAFISA-N
14787	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	1188	Bromocriptine	2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine	syn-bromocriptine cap 5mg|co b	DRUGBANK	DB01200	C32H40BrN5O5	small molecule	G02CB01|N04BC01	25614-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZVBMTJYIDMWIL-AYFBDAFISA-N
14788	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	agonist	target	Lam YW (2000)	10641988	174664	1188	Bromocriptine	2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine	syn-bromocriptine cap 5mg|co b	DRUGBANK	DB01200	C32H40BrN5O5	small molecule	G02CB01|N04BC01	25614-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZVBMTJYIDMWIL-AYFBDAFISA-N
14809	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	antagonist	target	Kvernmo T (2008)	18691132	174662	1188	Bromocriptine	2-Bromo-alpha-ergokryptine|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|2-bromo--ergocryptine|Bromocryptine|2-Bromo-alpha-ergocryptine|2-bromo--ergokryptin|Bromocriptinum|2-bromo--ergokryptine|Bromoergocriptine|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|2-Bromo-alpha-ergokryptin|Bromocriptina|Bromoergocryptine	syn-bromocriptine cap 5mg|co b	DRUGBANK	DB01200	C32H40BrN5O5	small molecule	G02CB01|N04BC01	25614-03-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OZVBMTJYIDMWIL-AYFBDAFISA-N
14850	112778	6916	-	TBXAS1	BDPLT14|CYP5|CYP5A1|GHOSAL|THAS|TS|TXAS|TXS	9606	Homo sapiens	inhibitor	target	De Cree J (1993)	8376914	180632	1195	Ridogrel	Ridogrel|R-68070|Ridogrelum	-	DRUGBANK	DB01207	C18H17F3N2O3	small molecule	-	110140-89-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GLLPUTYLZIKEGF-HAVVHWLPSA-N
14851	112778	6916	-	TBXAS1	BDPLT14|CYP5|CYP5A1|GHOSAL|THAS|TS|TXAS|TXS	9606	Homo sapiens	inhibitor	target	Tytgat GN (2002)	11856082	180630	1195	Ridogrel	Ridogrel|R-68070|Ridogrelum	-	DRUGBANK	DB01207	C18H17F3N2O3	small molecule	-	110140-89-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GLLPUTYLZIKEGF-HAVVHWLPSA-N
14852	112778	6916	-	TBXAS1	BDPLT14|CYP5|CYP5A1|GHOSAL|THAS|TS|TXAS|TXS	9606	Homo sapiens	inhibitor	target	Carty E (2000)	10848666	180631	1195	Ridogrel	Ridogrel|R-68070|Ridogrelum	-	DRUGBANK	DB01207	C18H17F3N2O3	small molecule	-	110140-89-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GLLPUTYLZIKEGF-HAVVHWLPSA-N
14853	112778	6916	-	TBXAS1	BDPLT14|CYP5|CYP5A1|GHOSAL|THAS|TS|TXAS|TXS	9606	Homo sapiens	inhibitor	target	Park SJ (1999)	11270983	180629	1195	Ridogrel	Ridogrel|R-68070|Ridogrelum	-	DRUGBANK	DB01207	C18H17F3N2O3	small molecule	-	110140-89-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GLLPUTYLZIKEGF-HAVVHWLPSA-N
14854	112778	6916	-	TBXAS1	BDPLT14|CYP5|CYP5A1|GHOSAL|THAS|TS|TXAS|TXS	9606	Homo sapiens	inhibitor	target	Unknown Authors (1994)	8313547	180628	1195	Ridogrel	Ridogrel|R-68070|Ridogrelum	-	DRUGBANK	DB01207	C18H17F3N2O3	small molecule	-	110140-89-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GLLPUTYLZIKEGF-HAVVHWLPSA-N
14855	112778	6916	-	TBXAS1	BDPLT14|CYP5|CYP5A1|GHOSAL|THAS|TS|TXAS|TXS	9606	Homo sapiens	inhibitor	target	Berman HM (2000)	10592235	172122	1195	Ridogrel	Ridogrel|R-68070|Ridogrelum	-	DRUGBANK	DB01207	C18H17F3N2O3	small molecule	-	110140-89-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GLLPUTYLZIKEGF-HAVVHWLPSA-N
14856	112777	6915	-	TBXA2R	BDPLT13|TXA2-R	9606	Homo sapiens	antagonist	target	Ragni M (1996)	8697470	180633	1195	Ridogrel	Ridogrel|R-68070|Ridogrelum	-	DRUGBANK	DB01207	C18H17F3N2O3	small molecule	-	110140-89-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GLLPUTYLZIKEGF-HAVVHWLPSA-N
14857	112777	6915	-	TBXA2R	BDPLT13|TXA2-R	9606	Homo sapiens	antagonist	target	Hempelmann RG (1999)	10522750	180636	1195	Ridogrel	Ridogrel|R-68070|Ridogrelum	-	DRUGBANK	DB01207	C18H17F3N2O3	small molecule	-	110140-89-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GLLPUTYLZIKEGF-HAVVHWLPSA-N
14858	112777	6915	-	TBXA2R	BDPLT13|TXA2-R	9606	Homo sapiens	antagonist	target	Soyka R (1994)	8289199	180637	1195	Ridogrel	Ridogrel|R-68070|Ridogrelum	-	DRUGBANK	DB01207	C18H17F3N2O3	small molecule	-	110140-89-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GLLPUTYLZIKEGF-HAVVHWLPSA-N
14859	112777	6915	-	TBXA2R	BDPLT13|TXA2-R	9606	Homo sapiens	antagonist	target	Carvalho MH (1997)	9272380	180634	1195	Ridogrel	Ridogrel|R-68070|Ridogrelum	-	DRUGBANK	DB01207	C18H17F3N2O3	small molecule	-	110140-89-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GLLPUTYLZIKEGF-HAVVHWLPSA-N
14860	112777	6915	-	TBXA2R	BDPLT13|TXA2-R	9606	Homo sapiens	antagonist	target	Heinisch G (1996)	8831771	180635	1195	Ridogrel	Ridogrel|R-68070|Ridogrelum	-	DRUGBANK	DB01207	C18H17F3N2O3	small molecule	-	110140-89-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GLLPUTYLZIKEGF-HAVVHWLPSA-N
14861	112777	6915	-	TBXA2R	BDPLT13|TXA2-R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1195	Ridogrel	Ridogrel|R-68070|Ridogrelum	-	DRUGBANK	DB01207	C18H17F3N2O3	small molecule	-	110140-89-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GLLPUTYLZIKEGF-HAVVHWLPSA-N
14993	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	partial agonist	target	Seeman P (2009)	19391150	180698	1209	Ketamine	KETAMINE|Special k|2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone|Ketaminum|(+-)-Ketamine|2-(methylamino)-2-(2-chlorophenyl)cyclohexanone|NMDA|()-ketamine|2-(o-chlorophenyl)-2-(methylamino)-cyclohexanone|Ketamina|DL-ketamine	ketamine hydrochloride injecti	DRUGBANK	DB01221	C13H16ClNO	small molecule	N01AX03	6740-88-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YQEZLKZALYSWHR-UHFFFAOYSA-N
14994	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Seeman P (2009)	19391150	180698	1209	Ketamine	KETAMINE|Special k|2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone|Ketaminum|(+-)-Ketamine|2-(methylamino)-2-(2-chlorophenyl)cyclohexanone|NMDA|()-ketamine|2-(o-chlorophenyl)-2-(methylamino)-cyclohexanone|Ketamina|DL-ketamine	ketamine hydrochloride injecti	DRUGBANK	DB01221	C13H16ClNO	small molecule	N01AX03	6740-88-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YQEZLKZALYSWHR-UHFFFAOYSA-N
15042	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	1212	Quetiapine	Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate	sandoz quetiapine|quetiapine f	DRUGBANK	DB01224	C21H25N3O2S	small molecule	N05AH04	111974-69-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URKOMYMAXPYINW-UHFFFAOYSA-N
15047	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	1212	Quetiapine	Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate	sandoz quetiapine|quetiapine f	DRUGBANK	DB01224	C21H25N3O2S	small molecule	N05AH04	111974-69-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URKOMYMAXPYINW-UHFFFAOYSA-N
15066	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Seeman P (2002)	11873706	174626	1212	Quetiapine	Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate	sandoz quetiapine|quetiapine f	DRUGBANK	DB01224	C21H25N3O2S	small molecule	N05AH04	111974-69-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URKOMYMAXPYINW-UHFFFAOYSA-N
15067	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	1212	Quetiapine	Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate	sandoz quetiapine|quetiapine f	DRUGBANK	DB01224	C21H25N3O2S	small molecule	N05AH04	111974-69-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URKOMYMAXPYINW-UHFFFAOYSA-N
15068	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1212	Quetiapine	Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate	sandoz quetiapine|quetiapine f	DRUGBANK	DB01224	C21H25N3O2S	small molecule	N05AH04	111974-69-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URKOMYMAXPYINW-UHFFFAOYSA-N
15069	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Kapur S (2000)	10839333	180714	1212	Quetiapine	Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate	sandoz quetiapine|quetiapine f	DRUGBANK	DB01224	C21H25N3O2S	small molecule	N05AH04	111974-69-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URKOMYMAXPYINW-UHFFFAOYSA-N
15070	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Richelson E (2000)	11132243	174623	1212	Quetiapine	Quetiapine hemifumarate|2-[2-(4-Dibenzo[b,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapinum|Quetiapine fumarate	sandoz quetiapine|quetiapine f	DRUGBANK	DB01224	C21H25N3O2S	small molecule	N05AH04	111974-69-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	URKOMYMAXPYINW-UHFFFAOYSA-N
15150	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1221	Metoclopramide	Metoclopramida|4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-2-methoxybenzamide|Metoclopramidum|4-amino-5-chloro-2-Methoxy-N-(beta-diethylaminoethyl)benzamide|2-methoxy-5-chloroprocainamide|4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-O-anisamide|Elieten|Reliveran|2-Methoxy-4-amino-5-chloro-N,N-(dimethylaminoethyl)benzamide	metoclopramide omega|reglan|me	DRUGBANK	DB01233	C14H22ClN3O2	small molecule	A03FA01	364-62-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TTWJBBZEZQICBI-UHFFFAOYSA-N
15151	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Kishibayashi N (1995)	7745844	180758	1221	Metoclopramide	Metoclopramida|4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-2-methoxybenzamide|Metoclopramidum|4-amino-5-chloro-2-Methoxy-N-(beta-diethylaminoethyl)benzamide|2-methoxy-5-chloroprocainamide|4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-O-anisamide|Elieten|Reliveran|2-Methoxy-4-amino-5-chloro-N,N-(dimethylaminoethyl)benzamide	metoclopramide omega|reglan|me	DRUGBANK	DB01233	C14H22ClN3O2	small molecule	A03FA01	364-62-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TTWJBBZEZQICBI-UHFFFAOYSA-N
15152	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Hammer D (2005)	15835479	180755	1221	Metoclopramide	Metoclopramida|4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-2-methoxybenzamide|Metoclopramidum|4-amino-5-chloro-2-Methoxy-N-(beta-diethylaminoethyl)benzamide|2-methoxy-5-chloroprocainamide|4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-O-anisamide|Elieten|Reliveran|2-Methoxy-4-amino-5-chloro-N,N-(dimethylaminoethyl)benzamide	metoclopramide omega|reglan|me	DRUGBANK	DB01233	C14H22ClN3O2	small molecule	A03FA01	364-62-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TTWJBBZEZQICBI-UHFFFAOYSA-N
15153	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Dahloef CG (1998)	9876882	180754	1221	Metoclopramide	Metoclopramida|4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-2-methoxybenzamide|Metoclopramidum|4-amino-5-chloro-2-Methoxy-N-(beta-diethylaminoethyl)benzamide|2-methoxy-5-chloroprocainamide|4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-O-anisamide|Elieten|Reliveran|2-Methoxy-4-amino-5-chloro-N,N-(dimethylaminoethyl)benzamide	metoclopramide omega|reglan|me	DRUGBANK	DB01233	C14H22ClN3O2	small molecule	A03FA01	364-62-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TTWJBBZEZQICBI-UHFFFAOYSA-N
15154	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Chemnitius JM (1996)	8981558	180757	1221	Metoclopramide	Metoclopramida|4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-2-methoxybenzamide|Metoclopramidum|4-amino-5-chloro-2-Methoxy-N-(beta-diethylaminoethyl)benzamide|2-methoxy-5-chloroprocainamide|4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-O-anisamide|Elieten|Reliveran|2-Methoxy-4-amino-5-chloro-N,N-(dimethylaminoethyl)benzamide	metoclopramide omega|reglan|me	DRUGBANK	DB01233	C14H22ClN3O2	small molecule	A03FA01	364-62-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TTWJBBZEZQICBI-UHFFFAOYSA-N
15155	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	See RE (1996)	8730709	180756	1221	Metoclopramide	Metoclopramida|4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-2-methoxybenzamide|Metoclopramidum|4-amino-5-chloro-2-Methoxy-N-(beta-diethylaminoethyl)benzamide|2-methoxy-5-chloroprocainamide|4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-O-anisamide|Elieten|Reliveran|2-Methoxy-4-amino-5-chloro-N,N-(dimethylaminoethyl)benzamide	metoclopramide omega|reglan|me	DRUGBANK	DB01233	C14H22ClN3O2	small molecule	A03FA01	364-62-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TTWJBBZEZQICBI-UHFFFAOYSA-N
15156	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Harrold MW (1993)	8230103	180753	1221	Metoclopramide	Metoclopramida|4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-2-methoxybenzamide|Metoclopramidum|4-amino-5-chloro-2-Methoxy-N-(beta-diethylaminoethyl)benzamide|2-methoxy-5-chloroprocainamide|4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-O-anisamide|Elieten|Reliveran|2-Methoxy-4-amino-5-chloro-N,N-(dimethylaminoethyl)benzamide	metoclopramide omega|reglan|me	DRUGBANK	DB01233	C14H22ClN3O2	small molecule	A03FA01	364-62-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TTWJBBZEZQICBI-UHFFFAOYSA-N
15163	106798	301	RP11-71A24.1	ANXA1	ANX1|LPC1	9606	Homo sapiens	agonist	target	Morand EF (2006)	16883066	180762	1222	Dexamethasone	Decadron|9-Fluoro-16-methylprednisolone|Dexamethasonum|9alpha-Fluoro-16alpha-methylprednisolone|16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol|16-Methyl-9-fluoro-1-dehydrocortisol|1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone|Dexamethasone|Dexametasona|1-Dehydro-16-methyl-9-fluorohydrocortisone	cresophene liq|maxidex ont 0.1	DRUGBANK	DB01234	C22H29FO5	small molecule	S01CA01|D10AA03|S02BA06|S01CB01|S03BA01|A01AC02|S02CA06|H02AB02|D07AB19|S03CA01|R01AD53|R01AD03|S01BA01|D07XB05|C05AA09|D07CB04	50-02-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UREBDLICKHMUKA-CXSFZGCWSA-N
15164	106798	301	RP11-71A24.1	ANXA1	ANX1|LPC1	9606	Homo sapiens	agonist	target	Davies E (2007)	17158208	180763	1222	Dexamethasone	Decadron|9-Fluoro-16-methylprednisolone|Dexamethasonum|9alpha-Fluoro-16alpha-methylprednisolone|16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol|16-Methyl-9-fluoro-1-dehydrocortisol|1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone|Dexamethasone|Dexametasona|1-Dehydro-16-methyl-9-fluorohydrocortisone	cresophene liq|maxidex ont 0.1	DRUGBANK	DB01234	C22H29FO5	small molecule	S01CA01|D10AA03|S02BA06|S01CB01|S03BA01|A01AC02|S02CA06|H02AB02|D07AB19|S03CA01|R01AD53|R01AD03|S01BA01|D07XB05|C05AA09|D07CB04	50-02-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UREBDLICKHMUKA-CXSFZGCWSA-N
15165	106798	301	RP11-71A24.1	ANXA1	ANX1|LPC1	9606	Homo sapiens	agonist	target	John CD (2006)	17076770	180764	1222	Dexamethasone	Decadron|9-Fluoro-16-methylprednisolone|Dexamethasonum|9alpha-Fluoro-16alpha-methylprednisolone|16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol|16-Methyl-9-fluoro-1-dehydrocortisol|1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone|Dexamethasone|Dexametasona|1-Dehydro-16-methyl-9-fluorohydrocortisone	cresophene liq|maxidex ont 0.1	DRUGBANK	DB01234	C22H29FO5	small molecule	S01CA01|D10AA03|S02BA06|S01CB01|S03BA01|A01AC02|S02CA06|H02AB02|D07AB19|S03CA01|R01AD53|R01AD03|S01BA01|D07XB05|C05AA09|D07CB04	50-02-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UREBDLICKHMUKA-CXSFZGCWSA-N
15166	106798	301	RP11-71A24.1	ANXA1	ANX1|LPC1	9606	Homo sapiens	agonist	target	Wang C (2007)	17644190	180765	1222	Dexamethasone	Decadron|9-Fluoro-16-methylprednisolone|Dexamethasonum|9alpha-Fluoro-16alpha-methylprednisolone|16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol|16-Methyl-9-fluoro-1-dehydrocortisol|1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone|Dexamethasone|Dexametasona|1-Dehydro-16-methyl-9-fluorohydrocortisone	cresophene liq|maxidex ont 0.1	DRUGBANK	DB01234	C22H29FO5	small molecule	S01CA01|D10AA03|S02BA06|S01CB01|S03BA01|A01AC02|S02CA06|H02AB02|D07AB19|S03CA01|R01AD53|R01AD03|S01BA01|D07XB05|C05AA09|D07CB04	50-02-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UREBDLICKHMUKA-CXSFZGCWSA-N
15185	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	agonist	target	Koller WC (1998)	9633680	180775	1223	Levodopa	3-Hydroxy-L-tyrosine|(-)-3-(3,4-Dihydroxyphenyl)-L-alanine|L-beta-(3,4-Dihydroxyphenyl)alanine|3,4-Dihydroxy-L-phenylalanine|Dopar|()-3-(3,4-dihydroxyphenyl)-L-alanine|Dihydroxy-L-phenylalanine|(-)-Dopa|Levodopum|Levodopa|L-3,4-dihydroxyphenylalanine|3,4-DIHYDROXYPHENYLALANINE|L-DOPA|beta-(3,4-Dihydroxyphenyl)alanine|-(3,4-dihydroxyphenyl)alanine|beta-(3,4-Dihydroxyphenyl)-L-alanine|()-dopa	sinemet 100/25|sinemet 250/25|	DRUGBANK	DB01235	C9H11NO4	small molecule	N04BA02|N04BA03|N04BA01	59-92-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WTDRDQBEARUVNC-LURJTMIESA-N
15186	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	agonist	target	Deleu D (2002)	11978145	179837	1223	Levodopa	3-Hydroxy-L-tyrosine|(-)-3-(3,4-Dihydroxyphenyl)-L-alanine|L-beta-(3,4-Dihydroxyphenyl)alanine|3,4-Dihydroxy-L-phenylalanine|Dopar|()-3-(3,4-dihydroxyphenyl)-L-alanine|Dihydroxy-L-phenylalanine|(-)-Dopa|Levodopum|Levodopa|L-3,4-dihydroxyphenylalanine|3,4-DIHYDROXYPHENYLALANINE|L-DOPA|beta-(3,4-Dihydroxyphenyl)alanine|-(3,4-dihydroxyphenyl)alanine|beta-(3,4-Dihydroxyphenyl)-L-alanine|()-dopa	sinemet 100/25|sinemet 250/25|	DRUGBANK	DB01235	C9H11NO4	small molecule	N04BA02|N04BA03|N04BA01	59-92-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WTDRDQBEARUVNC-LURJTMIESA-N
15187	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	agonist	target	Onofrj M (2008)	18549347	180774	1223	Levodopa	3-Hydroxy-L-tyrosine|(-)-3-(3,4-Dihydroxyphenyl)-L-alanine|L-beta-(3,4-Dihydroxyphenyl)alanine|3,4-Dihydroxy-L-phenylalanine|Dopar|()-3-(3,4-dihydroxyphenyl)-L-alanine|Dihydroxy-L-phenylalanine|(-)-Dopa|Levodopum|Levodopa|L-3,4-dihydroxyphenylalanine|3,4-DIHYDROXYPHENYLALANINE|L-DOPA|beta-(3,4-Dihydroxyphenyl)alanine|-(3,4-dihydroxyphenyl)alanine|beta-(3,4-Dihydroxyphenyl)-L-alanine|()-dopa	sinemet 100/25|sinemet 250/25|	DRUGBANK	DB01235	C9H11NO4	small molecule	N04BA02|N04BA03|N04BA01	59-92-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WTDRDQBEARUVNC-LURJTMIESA-N
15188	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Zappia M (2005)	15824260	180777	1223	Levodopa	3-Hydroxy-L-tyrosine|(-)-3-(3,4-Dihydroxyphenyl)-L-alanine|L-beta-(3,4-Dihydroxyphenyl)alanine|3,4-Dihydroxy-L-phenylalanine|Dopar|()-3-(3,4-dihydroxyphenyl)-L-alanine|Dihydroxy-L-phenylalanine|(-)-Dopa|Levodopum|Levodopa|L-3,4-dihydroxyphenylalanine|3,4-DIHYDROXYPHENYLALANINE|L-DOPA|beta-(3,4-Dihydroxyphenyl)alanine|-(3,4-dihydroxyphenyl)alanine|beta-(3,4-Dihydroxyphenyl)-L-alanine|()-dopa	sinemet 100/25|sinemet 250/25|	DRUGBANK	DB01235	C9H11NO4	small molecule	N04BA02|N04BA03|N04BA01	59-92-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WTDRDQBEARUVNC-LURJTMIESA-N
15189	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Kovoor A (2005)	15728856	180776	1223	Levodopa	3-Hydroxy-L-tyrosine|(-)-3-(3,4-Dihydroxyphenyl)-L-alanine|L-beta-(3,4-Dihydroxyphenyl)alanine|3,4-Dihydroxy-L-phenylalanine|Dopar|()-3-(3,4-dihydroxyphenyl)-L-alanine|Dihydroxy-L-phenylalanine|(-)-Dopa|Levodopum|Levodopa|L-3,4-dihydroxyphenylalanine|3,4-DIHYDROXYPHENYLALANINE|L-DOPA|beta-(3,4-Dihydroxyphenyl)alanine|-(3,4-dihydroxyphenyl)alanine|beta-(3,4-Dihydroxyphenyl)-L-alanine|()-dopa	sinemet 100/25|sinemet 250/25|	DRUGBANK	DB01235	C9H11NO4	small molecule	N04BA02|N04BA03|N04BA01	59-92-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WTDRDQBEARUVNC-LURJTMIESA-N
15190	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Koller WC (1998)	9633680	180775	1223	Levodopa	3-Hydroxy-L-tyrosine|(-)-3-(3,4-Dihydroxyphenyl)-L-alanine|L-beta-(3,4-Dihydroxyphenyl)alanine|3,4-Dihydroxy-L-phenylalanine|Dopar|()-3-(3,4-dihydroxyphenyl)-L-alanine|Dihydroxy-L-phenylalanine|(-)-Dopa|Levodopum|Levodopa|L-3,4-dihydroxyphenylalanine|3,4-DIHYDROXYPHENYLALANINE|L-DOPA|beta-(3,4-Dihydroxyphenyl)alanine|-(3,4-dihydroxyphenyl)alanine|beta-(3,4-Dihydroxyphenyl)-L-alanine|()-dopa	sinemet 100/25|sinemet 250/25|	DRUGBANK	DB01235	C9H11NO4	small molecule	N04BA02|N04BA03|N04BA01	59-92-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WTDRDQBEARUVNC-LURJTMIESA-N
15191	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Deleu D (2002)	11978145	179837	1223	Levodopa	3-Hydroxy-L-tyrosine|(-)-3-(3,4-Dihydroxyphenyl)-L-alanine|L-beta-(3,4-Dihydroxyphenyl)alanine|3,4-Dihydroxy-L-phenylalanine|Dopar|()-3-(3,4-dihydroxyphenyl)-L-alanine|Dihydroxy-L-phenylalanine|(-)-Dopa|Levodopum|Levodopa|L-3,4-dihydroxyphenylalanine|3,4-DIHYDROXYPHENYLALANINE|L-DOPA|beta-(3,4-Dihydroxyphenyl)alanine|-(3,4-dihydroxyphenyl)alanine|beta-(3,4-Dihydroxyphenyl)-L-alanine|()-dopa	sinemet 100/25|sinemet 250/25|	DRUGBANK	DB01235	C9H11NO4	small molecule	N04BA02|N04BA03|N04BA01	59-92-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WTDRDQBEARUVNC-LURJTMIESA-N
15192	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Dupre KB (2007)	17553470	180779	1223	Levodopa	3-Hydroxy-L-tyrosine|(-)-3-(3,4-Dihydroxyphenyl)-L-alanine|L-beta-(3,4-Dihydroxyphenyl)alanine|3,4-Dihydroxy-L-phenylalanine|Dopar|()-3-(3,4-dihydroxyphenyl)-L-alanine|Dihydroxy-L-phenylalanine|(-)-Dopa|Levodopum|Levodopa|L-3,4-dihydroxyphenylalanine|3,4-DIHYDROXYPHENYLALANINE|L-DOPA|beta-(3,4-Dihydroxyphenyl)alanine|-(3,4-dihydroxyphenyl)alanine|beta-(3,4-Dihydroxyphenyl)-L-alanine|()-dopa	sinemet 100/25|sinemet 250/25|	DRUGBANK	DB01235	C9H11NO4	small molecule	N04BA02|N04BA03|N04BA01	59-92-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WTDRDQBEARUVNC-LURJTMIESA-N
15193	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Mori A (2005)	15710490	180778	1223	Levodopa	3-Hydroxy-L-tyrosine|(-)-3-(3,4-Dihydroxyphenyl)-L-alanine|L-beta-(3,4-Dihydroxyphenyl)alanine|3,4-Dihydroxy-L-phenylalanine|Dopar|()-3-(3,4-dihydroxyphenyl)-L-alanine|Dihydroxy-L-phenylalanine|(-)-Dopa|Levodopum|Levodopa|L-3,4-dihydroxyphenylalanine|3,4-DIHYDROXYPHENYLALANINE|L-DOPA|beta-(3,4-Dihydroxyphenyl)alanine|-(3,4-dihydroxyphenyl)alanine|beta-(3,4-Dihydroxyphenyl)-L-alanine|()-dopa	sinemet 100/25|sinemet 250/25|	DRUGBANK	DB01235	C9H11NO4	small molecule	N04BA02|N04BA03|N04BA01	59-92-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WTDRDQBEARUVNC-LURJTMIESA-N
15194	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Onofrj M (2008)	18549347	180774	1223	Levodopa	3-Hydroxy-L-tyrosine|(-)-3-(3,4-Dihydroxyphenyl)-L-alanine|L-beta-(3,4-Dihydroxyphenyl)alanine|3,4-Dihydroxy-L-phenylalanine|Dopar|()-3-(3,4-dihydroxyphenyl)-L-alanine|Dihydroxy-L-phenylalanine|(-)-Dopa|Levodopum|Levodopa|L-3,4-dihydroxyphenylalanine|3,4-DIHYDROXYPHENYLALANINE|L-DOPA|beta-(3,4-Dihydroxyphenyl)alanine|-(3,4-dihydroxyphenyl)alanine|beta-(3,4-Dihydroxyphenyl)-L-alanine|()-dopa	sinemet 100/25|sinemet 250/25|	DRUGBANK	DB01235	C9H11NO4	small molecule	N04BA02|N04BA03|N04BA01	59-92-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WTDRDQBEARUVNC-LURJTMIESA-N
15195	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	agonist	target	Koller WC (1998)	9633680	180775	1223	Levodopa	3-Hydroxy-L-tyrosine|(-)-3-(3,4-Dihydroxyphenyl)-L-alanine|L-beta-(3,4-Dihydroxyphenyl)alanine|3,4-Dihydroxy-L-phenylalanine|Dopar|()-3-(3,4-dihydroxyphenyl)-L-alanine|Dihydroxy-L-phenylalanine|(-)-Dopa|Levodopum|Levodopa|L-3,4-dihydroxyphenylalanine|3,4-DIHYDROXYPHENYLALANINE|L-DOPA|beta-(3,4-Dihydroxyphenyl)alanine|-(3,4-dihydroxyphenyl)alanine|beta-(3,4-Dihydroxyphenyl)-L-alanine|()-dopa	sinemet 100/25|sinemet 250/25|	DRUGBANK	DB01235	C9H11NO4	small molecule	N04BA02|N04BA03|N04BA01	59-92-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WTDRDQBEARUVNC-LURJTMIESA-N
15196	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	agonist	target	Deleu D (2002)	11978145	179837	1223	Levodopa	3-Hydroxy-L-tyrosine|(-)-3-(3,4-Dihydroxyphenyl)-L-alanine|L-beta-(3,4-Dihydroxyphenyl)alanine|3,4-Dihydroxy-L-phenylalanine|Dopar|()-3-(3,4-dihydroxyphenyl)-L-alanine|Dihydroxy-L-phenylalanine|(-)-Dopa|Levodopum|Levodopa|L-3,4-dihydroxyphenylalanine|3,4-DIHYDROXYPHENYLALANINE|L-DOPA|beta-(3,4-Dihydroxyphenyl)alanine|-(3,4-dihydroxyphenyl)alanine|beta-(3,4-Dihydroxyphenyl)-L-alanine|()-dopa	sinemet 100/25|sinemet 250/25|	DRUGBANK	DB01235	C9H11NO4	small molecule	N04BA02|N04BA03|N04BA01	59-92-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WTDRDQBEARUVNC-LURJTMIESA-N
15197	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	agonist	target	Onofrj M (2008)	18549347	180774	1223	Levodopa	3-Hydroxy-L-tyrosine|(-)-3-(3,4-Dihydroxyphenyl)-L-alanine|L-beta-(3,4-Dihydroxyphenyl)alanine|3,4-Dihydroxy-L-phenylalanine|Dopar|()-3-(3,4-dihydroxyphenyl)-L-alanine|Dihydroxy-L-phenylalanine|(-)-Dopa|Levodopum|Levodopa|L-3,4-dihydroxyphenylalanine|3,4-DIHYDROXYPHENYLALANINE|L-DOPA|beta-(3,4-Dihydroxyphenyl)alanine|-(3,4-dihydroxyphenyl)alanine|beta-(3,4-Dihydroxyphenyl)-L-alanine|()-dopa	sinemet 100/25|sinemet 250/25|	DRUGBANK	DB01235	C9H11NO4	small molecule	N04BA02|N04BA03|N04BA01	59-92-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WTDRDQBEARUVNC-LURJTMIESA-N
15224	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	partial agonist	target	Nasrallah HA (2008)	17848919	174616	1226	Aripiprazole	OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum	aristada|aripiprazole oral sol	DRUGBANK	DB01238	C23H27Cl2N3O2	small molecule	N05AX12	129722-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEUORZQYGODEFX-UHFFFAOYSA-N
15225	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	1226	Aripiprazole	OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum	aristada|aripiprazole oral sol	DRUGBANK	DB01238	C23H27Cl2N3O2	small molecule	N05AX12	129722-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEUORZQYGODEFX-UHFFFAOYSA-N
15228	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	partial agonist	target	Nasrallah HA (2008)	17848919	174616	1226	Aripiprazole	OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum	aristada|aripiprazole oral sol	DRUGBANK	DB01238	C23H27Cl2N3O2	small molecule	N05AX12	129722-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEUORZQYGODEFX-UHFFFAOYSA-N
15229	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	antagonist	target	Nasrallah HA (2008)	17848919	174616	1226	Aripiprazole	OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum	aristada|aripiprazole oral sol	DRUGBANK	DB01238	C23H27Cl2N3O2	small molecule	N05AX12	129722-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEUORZQYGODEFX-UHFFFAOYSA-N
15240	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	partial agonist	target	Kim E (2006)	16981227	180782	1226	Aripiprazole	OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum	aristada|aripiprazole oral sol	DRUGBANK	DB01238	C23H27Cl2N3O2	small molecule	N05AX12	129722-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEUORZQYGODEFX-UHFFFAOYSA-N
15241	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	partial agonist	target	Hirose T (2005)	16366516	180783	1226	Aripiprazole	OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum	aristada|aripiprazole oral sol	DRUGBANK	DB01238	C23H27Cl2N3O2	small molecule	N05AX12	129722-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEUORZQYGODEFX-UHFFFAOYSA-N
15242	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	partial agonist	target	Chen X (2002)	11752352	171740	1226	Aripiprazole	OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum	aristada|aripiprazole oral sol	DRUGBANK	DB01238	C23H27Cl2N3O2	small molecule	N05AX12	129722-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEUORZQYGODEFX-UHFFFAOYSA-N
15243	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	partial agonist	target	Wood M (2007)	17501690	180786	1226	Aripiprazole	OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum	aristada|aripiprazole oral sol	DRUGBANK	DB01238	C23H27Cl2N3O2	small molecule	N05AX12	129722-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEUORZQYGODEFX-UHFFFAOYSA-N
15244	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	partial agonist	target	Inoue A (1997)	9083792	180784	1226	Aripiprazole	OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum	aristada|aripiprazole oral sol	DRUGBANK	DB01238	C23H27Cl2N3O2	small molecule	N05AX12	129722-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEUORZQYGODEFX-UHFFFAOYSA-N
15245	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	partial agonist	target	Wood MD (2006)	16925992	180785	1226	Aripiprazole	OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum	aristada|aripiprazole oral sol	DRUGBANK	DB01238	C23H27Cl2N3O2	small molecule	N05AX12	129722-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEUORZQYGODEFX-UHFFFAOYSA-N
15246	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Kim E (2006)	16981227	180782	1226	Aripiprazole	OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum	aristada|aripiprazole oral sol	DRUGBANK	DB01238	C23H27Cl2N3O2	small molecule	N05AX12	129722-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEUORZQYGODEFX-UHFFFAOYSA-N
15247	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Hirose T (2005)	16366516	180783	1226	Aripiprazole	OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum	aristada|aripiprazole oral sol	DRUGBANK	DB01238	C23H27Cl2N3O2	small molecule	N05AX12	129722-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEUORZQYGODEFX-UHFFFAOYSA-N
15248	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1226	Aripiprazole	OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum	aristada|aripiprazole oral sol	DRUGBANK	DB01238	C23H27Cl2N3O2	small molecule	N05AX12	129722-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEUORZQYGODEFX-UHFFFAOYSA-N
15249	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Wood M (2007)	17501690	180786	1226	Aripiprazole	OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum	aristada|aripiprazole oral sol	DRUGBANK	DB01238	C23H27Cl2N3O2	small molecule	N05AX12	129722-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEUORZQYGODEFX-UHFFFAOYSA-N
15250	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Inoue A (1997)	9083792	180784	1226	Aripiprazole	OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum	aristada|aripiprazole oral sol	DRUGBANK	DB01238	C23H27Cl2N3O2	small molecule	N05AX12	129722-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEUORZQYGODEFX-UHFFFAOYSA-N
15251	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Wood MD (2006)	16925992	180785	1226	Aripiprazole	OPC 31|Abilify|Abilitat|Aripiprazol|Aripiprazole|Aripiprazolum	aristada|aripiprazole oral sol	DRUGBANK	DB01238	C23H27Cl2N3O2	small molecule	N05AX12	129722-12-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CEUORZQYGODEFX-UHFFFAOYSA-N
15267	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	von Coburg Y (2009)	19091563	180793	1227	Chlorprothixene	Chlorprotixene|Chlorprothixine|Alpha-Chlorprothixene|Chlorprotixen|Chlorprothixen|Chlothixen|Chlorprotixine	-	DRUGBANK	DB01239	C18H18ClNS	small molecule	N05AF03	113-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WSPOMRSOLSGNFJ-VGOFMYFVSA-N
15268	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Fux M (1991)	1830565	180792	1227	Chlorprothixene	Chlorprotixene|Chlorprothixine|Alpha-Chlorprothixene|Chlorprotixen|Chlorprothixen|Chlothixen|Chlorprotixine	-	DRUGBANK	DB01239	C18H18ClNS	small molecule	N05AF03	113-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WSPOMRSOLSGNFJ-VGOFMYFVSA-N
15269	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1227	Chlorprothixene	Chlorprotixene|Chlorprothixine|Alpha-Chlorprothixene|Chlorprotixen|Chlorprothixen|Chlothixen|Chlorprotixine	-	DRUGBANK	DB01239	C18H18ClNS	small molecule	N05AF03	113-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WSPOMRSOLSGNFJ-VGOFMYFVSA-N
15270	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Froimowitz M (1993)	8101879	175877	1227	Chlorprothixene	Chlorprotixene|Chlorprothixine|Alpha-Chlorprothixene|Chlorprotixen|Chlorprothixen|Chlothixen|Chlorprotixine	-	DRUGBANK	DB01239	C18H18ClNS	small molecule	N05AF03	113-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WSPOMRSOLSGNFJ-VGOFMYFVSA-N
15273	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	1227	Chlorprothixene	Chlorprotixene|Chlorprothixine|Alpha-Chlorprothixene|Chlorprotixen|Chlorprothixen|Chlothixen|Chlorprotixine	-	DRUGBANK	DB01239	C18H18ClNS	small molecule	N05AF03	113-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WSPOMRSOLSGNFJ-VGOFMYFVSA-N
15274	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	1227	Chlorprothixene	Chlorprotixene|Chlorprothixine|Alpha-Chlorprothixene|Chlorprotixen|Chlorprothixen|Chlothixen|Chlorprotixine	-	DRUGBANK	DB01239	C18H18ClNS	small molecule	N05AF03	113-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WSPOMRSOLSGNFJ-VGOFMYFVSA-N
15275	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	antagonist	target	Fux M (1991)	1830565	180792	1227	Chlorprothixene	Chlorprotixene|Chlorprothixine|Alpha-Chlorprothixene|Chlorprotixen|Chlorprothixen|Chlothixen|Chlorprotixine	-	DRUGBANK	DB01239	C18H18ClNS	small molecule	N05AF03	113-59-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WSPOMRSOLSGNFJ-VGOFMYFVSA-N
15292	111711	5739	-	PTGIR	IP|PRIPR	9606	Homo sapiens	agonist	target	Kasza Z (2009)	19302827	180799	1228	Epoprostenol	Flolan|Prostaglandin x|Prostacyclin|PGI2|(5Z,9alpha,11alpha,13e,15S)-6,9-Epoxy-11,15-dihydroxyprosta-5,13-dien-1-oic acid|(5Z,13e)-(15S)-6,9alpha-Epoxy-11alpha,15-dihydroxyprosta-5,13-dienoate|Epoprostenol|Prostaglandin I2|Vasocyclin|PGX	epoprostenol sodium|flolan|car	DRUGBANK	DB01240	C20H32O5	small molecule	B01AC09	35121-78-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KAQKFAOMNZTLHT-OZUDYXHBSA-N
15293	111711	5739	-	PTGIR	IP|PRIPR	9606	Homo sapiens	agonist	target	Yang J (2002)	12297509	180798	1228	Epoprostenol	Flolan|Prostaglandin x|Prostacyclin|PGI2|(5Z,9alpha,11alpha,13e,15S)-6,9-Epoxy-11,15-dihydroxyprosta-5,13-dien-1-oic acid|(5Z,13e)-(15S)-6,9alpha-Epoxy-11alpha,15-dihydroxyprosta-5,13-dienoate|Epoprostenol|Prostaglandin I2|Vasocyclin|PGX	epoprostenol sodium|flolan|car	DRUGBANK	DB01240	C20H32O5	small molecule	B01AC09	35121-78-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KAQKFAOMNZTLHT-OZUDYXHBSA-N
15294	111711	5739	-	PTGIR	IP|PRIPR	9606	Homo sapiens	agonist	target	Ibrahim S (2010)	20522800	160395	1228	Epoprostenol	Flolan|Prostaglandin x|Prostacyclin|PGI2|(5Z,9alpha,11alpha,13e,15S)-6,9-Epoxy-11,15-dihydroxyprosta-5,13-dien-1-oic acid|(5Z,13e)-(15S)-6,9alpha-Epoxy-11alpha,15-dihydroxyprosta-5,13-dienoate|Epoprostenol|Prostaglandin I2|Vasocyclin|PGX	epoprostenol sodium|flolan|car	DRUGBANK	DB01240	C20H32O5	small molecule	B01AC09	35121-78-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KAQKFAOMNZTLHT-OZUDYXHBSA-N
15295	111711	5739	-	PTGIR	IP|PRIPR	9606	Homo sapiens	agonist	target	Chen X (2002)	11752352	171740	1228	Epoprostenol	Flolan|Prostaglandin x|Prostacyclin|PGI2|(5Z,9alpha,11alpha,13e,15S)-6,9-Epoxy-11,15-dihydroxyprosta-5,13-dien-1-oic acid|(5Z,13e)-(15S)-6,9alpha-Epoxy-11alpha,15-dihydroxyprosta-5,13-dienoate|Epoprostenol|Prostaglandin I2|Vasocyclin|PGX	epoprostenol sodium|flolan|car	DRUGBANK	DB01240	C20H32O5	small molecule	B01AC09	35121-78-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KAQKFAOMNZTLHT-OZUDYXHBSA-N
15296	111712	5740	-	PTGIS	CYP8|CYP8A1|PGIS|PTGI	9606	Homo sapiens	inducer	target	Ruan KH (2008)	18081314	180801	1228	Epoprostenol	Flolan|Prostaglandin x|Prostacyclin|PGI2|(5Z,9alpha,11alpha,13e,15S)-6,9-Epoxy-11,15-dihydroxyprosta-5,13-dien-1-oic acid|(5Z,13e)-(15S)-6,9alpha-Epoxy-11alpha,15-dihydroxyprosta-5,13-dienoate|Epoprostenol|Prostaglandin I2|Vasocyclin|PGX	epoprostenol sodium|flolan|car	DRUGBANK	DB01240	C20H32O5	small molecule	B01AC09	35121-78-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KAQKFAOMNZTLHT-OZUDYXHBSA-N
15297	111712	5740	-	PTGIS	CYP8|CYP8A1|PGIS|PTGI	9606	Homo sapiens	inducer	target	Nakayama T (2010)	20357747	180800	1228	Epoprostenol	Flolan|Prostaglandin x|Prostacyclin|PGI2|(5Z,9alpha,11alpha,13e,15S)-6,9-Epoxy-11,15-dihydroxyprosta-5,13-dien-1-oic acid|(5Z,13e)-(15S)-6,9alpha-Epoxy-11alpha,15-dihydroxyprosta-5,13-dienoate|Epoprostenol|Prostaglandin I2|Vasocyclin|PGX	epoprostenol sodium|flolan|car	DRUGBANK	DB01240	C20H32O5	small molecule	B01AC09	35121-78-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KAQKFAOMNZTLHT-OZUDYXHBSA-N
15394	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Scarsi M (2007)	17082235	178076	1240	Mitiglinide	-	-	DRUGBANK	DB01252	C19H25NO3	small molecule	A10BX08	145375-43-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WPGGHFDDFPHPOB-BBWFWOEESA-N
15515	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	antagonist	target	Leysen JE (1994)	7520908	175510	1254	Paliperidone	Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone	invega|mylan-paliperidone|pali	DRUGBANK	DB01267	C23H27FN4O3	small molecule	N05AX13	144598-75-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMXMIIMHBWHSKN-UHFFFAOYSA-N
15516	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	antagonist	target	Megens AA (1994)	7531353	178096	1254	Paliperidone	Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone	invega|mylan-paliperidone|pali	DRUGBANK	DB01267	C23H27FN4O3	small molecule	N05AX13	144598-75-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMXMIIMHBWHSKN-UHFFFAOYSA-N
15536	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	antagonist	target	Leysen JE (1994)	7520908	175510	1254	Paliperidone	Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone	invega|mylan-paliperidone|pali	DRUGBANK	DB01267	C23H27FN4O3	small molecule	N05AX13	144598-75-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMXMIIMHBWHSKN-UHFFFAOYSA-N
15537	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	antagonist	target	Megens AA (1994)	7531353	178096	1254	Paliperidone	Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone	invega|mylan-paliperidone|pali	DRUGBANK	DB01267	C23H27FN4O3	small molecule	N05AX13	144598-75-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMXMIIMHBWHSKN-UHFFFAOYSA-N
15538	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Remington G (2006)	16513859	178091	1254	Paliperidone	Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone	invega|mylan-paliperidone|pali	DRUGBANK	DB01267	C23H27FN4O3	small molecule	N05AX13	144598-75-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMXMIIMHBWHSKN-UHFFFAOYSA-N
15539	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Megens AA (1994)	7531353	178096	1254	Paliperidone	Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone	invega|mylan-paliperidone|pali	DRUGBANK	DB01267	C23H27FN4O3	small molecule	N05AX13	144598-75-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMXMIIMHBWHSKN-UHFFFAOYSA-N
15540	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1254	Paliperidone	Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone	invega|mylan-paliperidone|pali	DRUGBANK	DB01267	C23H27FN4O3	small molecule	N05AX13	144598-75-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMXMIIMHBWHSKN-UHFFFAOYSA-N
15541	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Richelson E (2000)	11132243	174623	1254	Paliperidone	Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone	invega|mylan-paliperidone|pali	DRUGBANK	DB01267	C23H27FN4O3	small molecule	N05AX13	144598-75-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMXMIIMHBWHSKN-UHFFFAOYSA-N
15542	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Yamada Y (2002)	12211096	180926	1254	Paliperidone	Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone	invega|mylan-paliperidone|pali	DRUGBANK	DB01267	C23H27FN4O3	small molecule	N05AX13	144598-75-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMXMIIMHBWHSKN-UHFFFAOYSA-N
15543	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Cohen LJ (1994)	7524043	180924	1254	Paliperidone	Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone	invega|mylan-paliperidone|pali	DRUGBANK	DB01267	C23H27FN4O3	small molecule	N05AX13	144598-75-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMXMIIMHBWHSKN-UHFFFAOYSA-N
15544	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Regenthal R (2005)	16119512	180925	1254	Paliperidone	Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone	invega|mylan-paliperidone|pali	DRUGBANK	DB01267	C23H27FN4O3	small molecule	N05AX13	144598-75-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMXMIIMHBWHSKN-UHFFFAOYSA-N
15552	107940	1565	RP4-669P10.2	CYP2D6	CPD6|CYP2D|CYP2D7AP|CYP2D7BP|CYP2D7P2|CYP2D8P2|CYP2DL1|CYPIID6|P450-DB1|P450C2D|P450DB1	9606	Homo sapiens	unknown	target	Boerth JM (2005)	15767244	180928	1254	Paliperidone	Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone	invega|mylan-paliperidone|pali	DRUGBANK	DB01267	C23H27FN4O3	small molecule	N05AX13	144598-75-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMXMIIMHBWHSKN-UHFFFAOYSA-N
15554	107948	1576	-	CYP3A4	CP33|CP34|CYP3A|CYP3A3|CYPIIIA3|CYPIIIA4|HLP|NF-25|P450C3|P450PCN1	9606	Homo sapiens	unknown	target	Gunes A (2008)	18708991	180929	1254	Paliperidone	Invega|Ro-76477|9-Hydroxyrisperidone|Paliperidone	invega|mylan-paliperidone|pali	DRUGBANK	DB01267	C23H27FN4O3	small molecule	N05AX13	144598-75-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PMXMIIMHBWHSKN-UHFFFAOYSA-N
15726	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Esser R (2005)	15655513	181035	1270	Lumiracoxib	COX189|Lumiracoxibum|2-((2-chloro-6-Fluorophenyl)amino)-5-methylbenzeneacetic acid|COX 189|Prexige|COX-189	-	DRUGBANK	DB01283	C15H13ClFNO2	small molecule	M01AH06	220991-20-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KHPKQFYUPIUARC-UHFFFAOYSA-N
15727	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Warner TD (2006)	16403783	181034	1270	Lumiracoxib	COX189|Lumiracoxibum|2-((2-chloro-6-Fluorophenyl)amino)-5-methylbenzeneacetic acid|COX 189|Prexige|COX-189	-	DRUGBANK	DB01283	C15H13ClFNO2	small molecule	M01AH06	220991-20-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KHPKQFYUPIUARC-UHFFFAOYSA-N
15728	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Capone ML (2003)	14552704	181033	1270	Lumiracoxib	COX189|Lumiracoxibum|2-((2-chloro-6-Fluorophenyl)amino)-5-methylbenzeneacetic acid|COX 189|Prexige|COX-189	-	DRUGBANK	DB01283	C15H13ClFNO2	small molecule	M01AH06	220991-20-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KHPKQFYUPIUARC-UHFFFAOYSA-N
15729	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Blobaum AL (2007)	17434872	181032	1270	Lumiracoxib	COX189|Lumiracoxibum|2-((2-chloro-6-Fluorophenyl)amino)-5-methylbenzeneacetic acid|COX 189|Prexige|COX-189	-	DRUGBANK	DB01283	C15H13ClFNO2	small molecule	M01AH06	220991-20-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KHPKQFYUPIUARC-UHFFFAOYSA-N
15730	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Jermany J (2005)	16172182	181031	1270	Lumiracoxib	COX189|Lumiracoxibum|2-((2-chloro-6-Fluorophenyl)amino)-5-methylbenzeneacetic acid|COX 189|Prexige|COX-189	-	DRUGBANK	DB01283	C15H13ClFNO2	small molecule	M01AH06	220991-20-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KHPKQFYUPIUARC-UHFFFAOYSA-N
15731	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Kalbag J (2004)	15177307	181038	1270	Lumiracoxib	COX189|Lumiracoxibum|2-((2-chloro-6-Fluorophenyl)amino)-5-methylbenzeneacetic acid|COX 189|Prexige|COX-189	-	DRUGBANK	DB01283	C15H13ClFNO2	small molecule	M01AH06	220991-20-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KHPKQFYUPIUARC-UHFFFAOYSA-N
15732	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Tacconelli S (2004)	14965322	181037	1270	Lumiracoxib	COX189|Lumiracoxibum|2-((2-chloro-6-Fluorophenyl)amino)-5-methylbenzeneacetic acid|COX 189|Prexige|COX-189	-	DRUGBANK	DB01283	C15H13ClFNO2	small molecule	M01AH06	220991-20-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KHPKQFYUPIUARC-UHFFFAOYSA-N
15733	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Atherton C (2004)	15017615	181036	1270	Lumiracoxib	COX189|Lumiracoxibum|2-((2-chloro-6-Fluorophenyl)amino)-5-methylbenzeneacetic acid|COX 189|Prexige|COX-189	-	DRUGBANK	DB01283	C15H13ClFNO2	small molecule	M01AH06	220991-20-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KHPKQFYUPIUARC-UHFFFAOYSA-N
15734	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Esser R (2005)	15655513	181035	1270	Lumiracoxib	COX189|Lumiracoxibum|2-((2-chloro-6-Fluorophenyl)amino)-5-methylbenzeneacetic acid|COX 189|Prexige|COX-189	-	DRUGBANK	DB01283	C15H13ClFNO2	small molecule	M01AH06	220991-20-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KHPKQFYUPIUARC-UHFFFAOYSA-N
15735	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Capone ML (2003)	14552704	181033	1270	Lumiracoxib	COX189|Lumiracoxibum|2-((2-chloro-6-Fluorophenyl)amino)-5-methylbenzeneacetic acid|COX 189|Prexige|COX-189	-	DRUGBANK	DB01283	C15H13ClFNO2	small molecule	M01AH06	220991-20-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KHPKQFYUPIUARC-UHFFFAOYSA-N
15736	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1270	Lumiracoxib	COX189|Lumiracoxibum|2-((2-chloro-6-Fluorophenyl)amino)-5-methylbenzeneacetic acid|COX 189|Prexige|COX-189	-	DRUGBANK	DB01283	C15H13ClFNO2	small molecule	M01AH06	220991-20-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KHPKQFYUPIUARC-UHFFFAOYSA-N
15913	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Hannedouche T (1992)	1382161	181125	1306	Cilazapril	Cilazapril|Cilazaprilum|Cilazapril anhydrous	cilazapril|mylan-cilazapril|do	DRUGBANK	DB01340	C22H31N3O5	small molecule	C09BA08|C09AA08	88768-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HHHKFGXWKKUNCY-FHWLQOOXSA-N
15914	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Yoshiyama M (1999)	10205231	181124	1306	Cilazapril	Cilazapril|Cilazaprilum|Cilazapril anhydrous	cilazapril|mylan-cilazapril|do	DRUGBANK	DB01340	C22H31N3O5	small molecule	C09BA08|C09AA08	88768-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HHHKFGXWKKUNCY-FHWLQOOXSA-N
15915	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Kihara M (1999)	10398211	181121	1306	Cilazapril	Cilazapril|Cilazaprilum|Cilazapril anhydrous	cilazapril|mylan-cilazapril|do	DRUGBANK	DB01340	C22H31N3O5	small molecule	C09BA08|C09AA08	88768-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HHHKFGXWKKUNCY-FHWLQOOXSA-N
15916	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Mervaala E (1999)	10446934	181120	1306	Cilazapril	Cilazapril|Cilazaprilum|Cilazapril anhydrous	cilazapril|mylan-cilazapril|do	DRUGBANK	DB01340	C22H31N3O5	small molecule	C09BA08|C09AA08	88768-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HHHKFGXWKKUNCY-FHWLQOOXSA-N
15917	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Tylicki L (2008)	18423812	181123	1306	Cilazapril	Cilazapril|Cilazaprilum|Cilazapril anhydrous	cilazapril|mylan-cilazapril|do	DRUGBANK	DB01340	C22H31N3O5	small molecule	C09BA08|C09AA08	88768-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HHHKFGXWKKUNCY-FHWLQOOXSA-N
15918	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Rosendorff C (1992)	1382157	181122	1306	Cilazapril	Cilazapril|Cilazaprilum|Cilazapril anhydrous	cilazapril|mylan-cilazapril|do	DRUGBANK	DB01340	C22H31N3O5	small molecule	C09BA08|C09AA08	88768-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HHHKFGXWKKUNCY-FHWLQOOXSA-N
15919	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1306	Cilazapril	Cilazapril|Cilazaprilum|Cilazapril anhydrous	cilazapril|mylan-cilazapril|do	DRUGBANK	DB01340	C22H31N3O5	small molecule	C09BA08|C09AA08	88768-40-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HHHKFGXWKKUNCY-FHWLQOOXSA-N
15922	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Hagmann M (1997)	9156352	181127	1308	Forasartan	-	-	DRUGBANK	DB01342	C23H28N8	small molecule	-	145216-43-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YONOBYIBNBCDSJ-UHFFFAOYSA-N
15923	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Usune S (1996)	8981065	181126	1308	Forasartan	-	-	DRUGBANK	DB01342	C23H28N8	small molecule	-	145216-43-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YONOBYIBNBCDSJ-UHFFFAOYSA-N
15924	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1308	Forasartan	-	-	DRUGBANK	DB01342	C23H28N8	small molecule	-	145216-43-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YONOBYIBNBCDSJ-UHFFFAOYSA-N
15925	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Tokunaga R (2001)	11569611	181128	1308	Forasartan	-	-	DRUGBANK	DB01342	C23H28N8	small molecule	-	145216-43-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YONOBYIBNBCDSJ-UHFFFAOYSA-N
15953	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1312	Saprisartan	-	-	DRUGBANK	DB01347	C25H22BrF3N4O4S	small molecule	-	146623-69-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DUEWVPTZCSAMNB-UHFFFAOYSA-N
15954	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Timmermans PB (1999)	10579749	181135	1312	Saprisartan	-	-	DRUGBANK	DB01347	C25H22BrF3N4O4S	small molecule	-	146623-69-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DUEWVPTZCSAMNB-UHFFFAOYSA-N
15955	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Hermida RC (2010)	20524801	181136	1313	Spirapril	Spirapril|Renormax	-	DRUGBANK	DB01348	C22H30N2O5S2	small molecule	C09AA11	83647-97-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HRWCVUIFMSZDJS-SZMVWBNQSA-N
15956	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Maul B (2005)	16126915	181137	1313	Spirapril	Spirapril|Renormax	-	DRUGBANK	DB01348	C22H30N2O5S2	small molecule	C09AA11	83647-97-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HRWCVUIFMSZDJS-SZMVWBNQSA-N
15957	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1313	Spirapril	Spirapril|Renormax	-	DRUGBANK	DB01348	C22H30N2O5S2	small molecule	C09AA11	83647-97-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HRWCVUIFMSZDJS-SZMVWBNQSA-N
15958	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Song JC (2002)	11929321	174114	1313	Spirapril	Spirapril|Renormax	-	DRUGBANK	DB01348	C22H30N2O5S2	small molecule	C09AA11	83647-97-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HRWCVUIFMSZDJS-SZMVWBNQSA-N
15959	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Arend U (2002)	12613273	181138	1313	Spirapril	Spirapril|Renormax	-	DRUGBANK	DB01348	C22H30N2O5S2	small molecule	C09AA11	83647-97-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HRWCVUIFMSZDJS-SZMVWBNQSA-N
15960	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1314	Tasosartan	ANA-756|Tasosartan|WAY-ana-756	-	DRUGBANK	DB01349	C23H21N7O	small molecule	C09CA05	145733-36-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ADXGNEYLLLSOAR-UHFFFAOYSA-N
15961	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Elokdah HM (2002)	12113820	181140	1314	Tasosartan	ANA-756|Tasosartan|WAY-ana-756	-	DRUGBANK	DB01349	C23H21N7O	small molecule	C09CA05	145733-36-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ADXGNEYLLLSOAR-UHFFFAOYSA-N
15962	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Unger T (2001)	11683476	181141	1314	Tasosartan	ANA-756|Tasosartan|WAY-ana-756	-	DRUGBANK	DB01349	C23H21N7O	small molecule	C09CA05	145733-36-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ADXGNEYLLLSOAR-UHFFFAOYSA-N
15963	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Maillard MP (2000)	11046101	181139	1314	Tasosartan	ANA-756|Tasosartan|WAY-ana-756	-	DRUGBANK	DB01349	C23H21N7O	small molecule	C09CA05	145733-36-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ADXGNEYLLLSOAR-UHFFFAOYSA-N
15964	106692	186	-	AGTR2	AT2|ATGR2|MRX88	9606	Homo sapiens	antagonist	target	Unger T (2001)	11683476	181141	1314	Tasosartan	ANA-756|Tasosartan|WAY-ana-756	-	DRUGBANK	DB01349	C23H21N7O	small molecule	C09CA05	145733-36-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ADXGNEYLLLSOAR-UHFFFAOYSA-N
16265	111337	5320	-	PLA2G2A	MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2	9606	Homo sapiens	inhibitor	target	Lim H (2006)	16651744	181233	1337	Ginkgo biloba	Japanese Silver Apricot|Pei Go Su Ye|Yinhsing|Bai Guo Ye|Baiguo|Salisburia Adiantifolia|Maidenhair Tree|Fossil Tree|Yen Xing|Herba Ginkgo Biloba|Adiantifolia|Ginkgo Folium|Kew Tree	-	DRUGBANK	DB01381	-	small molecule	N06DX02|N06DA53	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
16266	111337	5320	-	PLA2G2A	MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2	9606	Homo sapiens	inhibitor	target	Kim HK (1999)	10418340	181232	1337	Ginkgo biloba	Japanese Silver Apricot|Pei Go Su Ye|Yinhsing|Bai Guo Ye|Baiguo|Salisburia Adiantifolia|Maidenhair Tree|Fossil Tree|Yen Xing|Herba Ginkgo Biloba|Adiantifolia|Ginkgo Folium|Kew Tree	-	DRUGBANK	DB01381	-	small molecule	N06DX02|N06DA53	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
16267	111337	5320	-	PLA2G2A	MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2	9606	Homo sapiens	inhibitor	target	Weichel O (1999)	10619176	181234	1337	Ginkgo biloba	Japanese Silver Apricot|Pei Go Su Ye|Yinhsing|Bai Guo Ye|Baiguo|Salisburia Adiantifolia|Maidenhair Tree|Fossil Tree|Yen Xing|Herba Ginkgo Biloba|Adiantifolia|Ginkgo Folium|Kew Tree	-	DRUGBANK	DB01381	-	small molecule	N06DX02|N06DA53	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
16354	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	antagonist	target	Millan MJ (2000)	10611634	181251	1342	Yohimbine	(+)-yohimbine|Quebrachin|17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester|Quebrachine|Johimbin|Yohimbine|Aphrodine|Yohimbin|Corynine|Yohimbic acid methyl ester|(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester	yohimbine hydrochloride tablet	DRUGBANK	DB01392	C21H26N2O3	small molecule	G04BE04	146-48-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLGXFZZNTVWLAY-SCYLSFHTSA-N
16355	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Millan MJ (2000)	10611634	181251	1342	Yohimbine	(+)-yohimbine|Quebrachin|17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester|Quebrachine|Johimbin|Yohimbine|Aphrodine|Yohimbin|Corynine|Yohimbic acid methyl ester|(16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester	yohimbine hydrochloride tablet	DRUGBANK	DB01392	C21H26N2O3	small molecule	G04BE04	146-48-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BLGXFZZNTVWLAY-SCYLSFHTSA-N
16372	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Tenenbaum A (2005)	16168052	181267	1343	Bezafibrate	2-(P-(2-(P-Chlorobenzamido)ethyl)phenoxy)-2-methylpropionic acid|Befizal|Bezatol sr (tn)|Bezafibratum|Bezafibrato|Cedur|Bezafibrat|Bezalip	pms-bezafibrate|bezalip tab 20	DRUGBANK	DB01393	C19H20ClNO4	small molecule	C10AB02	41859-67-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IIBYAHWJQTYFKB-UHFFFAOYSA-N
16409	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Sun R (2005)	15840771	179203	1347	Magnesium salicylate	Magnesium salicylate anhydrous	diurex water pills|herbogesic|	DRUGBANK	DB01397	C14H10MgO6	small molecule	-	18917-89-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MQHWFIOJQSCFNM-UHFFFAOYSA-L
16410	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Liu X (2006)	16368818	179202	1347	Magnesium salicylate	Magnesium salicylate anhydrous	diurex water pills|herbogesic|	DRUGBANK	DB01397	C14H10MgO6	small molecule	-	18917-89-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MQHWFIOJQSCFNM-UHFFFAOYSA-L
16411	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Graham GG (2004)	15035793	179201	1347	Magnesium salicylate	Magnesium salicylate anhydrous	diurex water pills|herbogesic|	DRUGBANK	DB01397	C14H10MgO6	small molecule	-	18917-89-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MQHWFIOJQSCFNM-UHFFFAOYSA-L
16412	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Moon C (2004)	14746879	179200	1347	Magnesium salicylate	Magnesium salicylate anhydrous	diurex water pills|herbogesic|	DRUGBANK	DB01397	C14H10MgO6	small molecule	-	18917-89-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MQHWFIOJQSCFNM-UHFFFAOYSA-L
16413	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Celik G (2005)	15871445	179199	1347	Magnesium salicylate	Magnesium salicylate anhydrous	diurex water pills|herbogesic|	DRUGBANK	DB01397	C14H10MgO6	small molecule	-	18917-89-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MQHWFIOJQSCFNM-UHFFFAOYSA-L
16414	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Graham GG (2004)	15035793	179201	1347	Magnesium salicylate	Magnesium salicylate anhydrous	diurex water pills|herbogesic|	DRUGBANK	DB01397	C14H10MgO6	small molecule	-	18917-89-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MQHWFIOJQSCFNM-UHFFFAOYSA-L
16415	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Elvira C (2001)	15348270	179208	1347	Magnesium salicylate	Magnesium salicylate anhydrous	diurex water pills|herbogesic|	DRUGBANK	DB01397	C14H10MgO6	small molecule	-	18917-89-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MQHWFIOJQSCFNM-UHFFFAOYSA-L
16416	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chae HJ (2004)	15106733	179207	1347	Magnesium salicylate	Magnesium salicylate anhydrous	diurex water pills|herbogesic|	DRUGBANK	DB01397	C14H10MgO6	small molecule	-	18917-89-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MQHWFIOJQSCFNM-UHFFFAOYSA-L
16417	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Fiebich BL (2004)	15070163	179206	1347	Magnesium salicylate	Magnesium salicylate anhydrous	diurex water pills|herbogesic|	DRUGBANK	DB01397	C14H10MgO6	small molecule	-	18917-89-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MQHWFIOJQSCFNM-UHFFFAOYSA-L
16418	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Wu KK (2003)	15199473	179209	1347	Magnesium salicylate	Magnesium salicylate anhydrous	diurex water pills|herbogesic|	DRUGBANK	DB01397	C14H10MgO6	small molecule	-	18917-89-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MQHWFIOJQSCFNM-UHFFFAOYSA-L
16431	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Stevenson DD (2004)	15242723	181293	1349	Salsalate	Sasapyrin|Disalicylsaeure|Sasapyrinum|2-Carboxyphenyl salicylate|Salsalato|salicylsalicylic acid|Salicyloxysalicylic acid|O-Salicylsalicylic acid|Salsalatum|O-Salicylcylsalicylsaeure|Disalicylic acid|Sasapyrine|Salicylic acid bimolecular ester|Disalcid|Salicyloylsalicylic acid	salsalate|disalcid tab 750mg|d	DRUGBANK	DB01399	C14H10O5	small molecule	N02BA06	552-94-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WVYADZUPLLSGPU-UHFFFAOYSA-N
16432	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Schmidt A (1991)	1680855	181292	1349	Salsalate	Sasapyrin|Disalicylsaeure|Sasapyrinum|2-Carboxyphenyl salicylate|Salsalato|salicylsalicylic acid|Salicyloxysalicylic acid|O-Salicylsalicylic acid|Salsalatum|O-Salicylcylsalicylsaeure|Disalicylic acid|Sasapyrine|Salicylic acid bimolecular ester|Disalcid|Salicyloylsalicylic acid	salsalate|disalcid tab 750mg|d	DRUGBANK	DB01399	C14H10O5	small molecule	N02BA06	552-94-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WVYADZUPLLSGPU-UHFFFAOYSA-N
16433	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1349	Salsalate	Sasapyrin|Disalicylsaeure|Sasapyrinum|2-Carboxyphenyl salicylate|Salsalato|salicylsalicylic acid|Salicyloxysalicylic acid|O-Salicylsalicylic acid|Salsalatum|O-Salicylcylsalicylsaeure|Disalicylic acid|Sasapyrine|Salicylic acid bimolecular ester|Disalcid|Salicyloylsalicylic acid	salsalate|disalcid tab 750mg|d	DRUGBANK	DB01399	C14H10O5	small molecule	N02BA06	552-94-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WVYADZUPLLSGPU-UHFFFAOYSA-N
16434	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Josephs MD (1999)	10452868	181294	1349	Salsalate	Sasapyrin|Disalicylsaeure|Sasapyrinum|2-Carboxyphenyl salicylate|Salsalato|salicylsalicylic acid|Salicyloxysalicylic acid|O-Salicylsalicylic acid|Salsalatum|O-Salicylcylsalicylsaeure|Disalicylic acid|Sasapyrine|Salicylic acid bimolecular ester|Disalcid|Salicyloylsalicylic acid	salsalate|disalcid tab 750mg|d	DRUGBANK	DB01399	C14H10O5	small molecule	N02BA06	552-94-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WVYADZUPLLSGPU-UHFFFAOYSA-N
16435	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Schaefer MG (2003)	12901032	181297	1349	Salsalate	Sasapyrin|Disalicylsaeure|Sasapyrinum|2-Carboxyphenyl salicylate|Salsalato|salicylsalicylic acid|Salicyloxysalicylic acid|O-Salicylsalicylic acid|Salsalatum|O-Salicylcylsalicylsaeure|Disalicylic acid|Sasapyrine|Salicylic acid bimolecular ester|Disalcid|Salicyloylsalicylic acid	salsalate|disalcid tab 750mg|d	DRUGBANK	DB01399	C14H10O5	small molecule	N02BA06	552-94-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WVYADZUPLLSGPU-UHFFFAOYSA-N
16436	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Motsko SP (2006)	16808554	181296	1349	Salsalate	Sasapyrin|Disalicylsaeure|Sasapyrinum|2-Carboxyphenyl salicylate|Salsalato|salicylsalicylic acid|Salicyloxysalicylic acid|O-Salicylsalicylic acid|Salsalatum|O-Salicylcylsalicylsaeure|Disalicylic acid|Sasapyrine|Salicylic acid bimolecular ester|Disalcid|Salicyloylsalicylic acid	salsalate|disalcid tab 750mg|d	DRUGBANK	DB01399	C14H10O5	small molecule	N02BA06	552-94-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WVYADZUPLLSGPU-UHFFFAOYSA-N
16437	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Stichtenoth DO (1998)	9711054	181295	1349	Salsalate	Sasapyrin|Disalicylsaeure|Sasapyrinum|2-Carboxyphenyl salicylate|Salsalato|salicylsalicylic acid|Salicyloxysalicylic acid|O-Salicylsalicylic acid|Salsalatum|O-Salicylcylsalicylsaeure|Disalicylic acid|Sasapyrine|Salicylic acid bimolecular ester|Disalcid|Salicyloylsalicylic acid	salsalate|disalcid tab 750mg|d	DRUGBANK	DB01399	C14H10O5	small molecule	N02BA06	552-94-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WVYADZUPLLSGPU-UHFFFAOYSA-N
16438	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Josephs MD (1999)	10452868	181294	1349	Salsalate	Sasapyrin|Disalicylsaeure|Sasapyrinum|2-Carboxyphenyl salicylate|Salsalato|salicylsalicylic acid|Salicyloxysalicylic acid|O-Salicylsalicylic acid|Salsalatum|O-Salicylcylsalicylsaeure|Disalicylic acid|Sasapyrine|Salicylic acid bimolecular ester|Disalcid|Salicyloylsalicylic acid	salsalate|disalcid tab 750mg|d	DRUGBANK	DB01399	C14H10O5	small molecule	N02BA06	552-94-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WVYADZUPLLSGPU-UHFFFAOYSA-N
16446	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Simon RA (2004)	14680616	181305	1351	Trisalicylate-choline	Tricosal	-	DRUGBANK	DB01401	C26H29MgNO10	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQCQGOZEWWPOKI-UHFFFAOYSA-K
16447	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Nizankowska E (1990)	2083404	181304	1351	Trisalicylate-choline	Tricosal	-	DRUGBANK	DB01401	C26H29MgNO10	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQCQGOZEWWPOKI-UHFFFAOYSA-K
16448	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Schwartz KA (2006)	17131625	179240	1351	Trisalicylate-choline	Tricosal	-	DRUGBANK	DB01401	C26H29MgNO10	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQCQGOZEWWPOKI-UHFFFAOYSA-K
16449	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Simon RA (2004)	14680616	181305	1351	Trisalicylate-choline	Tricosal	-	DRUGBANK	DB01401	C26H29MgNO10	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQCQGOZEWWPOKI-UHFFFAOYSA-K
16450	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Shen J (2006)	17181859	179252	1351	Trisalicylate-choline	Tricosal	-	DRUGBANK	DB01401	C26H29MgNO10	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQCQGOZEWWPOKI-UHFFFAOYSA-K
16451	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Nakano M (2007)	17258197	179253	1351	Trisalicylate-choline	Tricosal	-	DRUGBANK	DB01401	C26H29MgNO10	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQCQGOZEWWPOKI-UHFFFAOYSA-K
16452	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Wang HJ (2006)	17037745	179254	1351	Trisalicylate-choline	Tricosal	-	DRUGBANK	DB01401	C26H29MgNO10	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQCQGOZEWWPOKI-UHFFFAOYSA-K
16453	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Brzozowski T (2006)	17033106	179256	1351	Trisalicylate-choline	Tricosal	-	DRUGBANK	DB01401	C26H29MgNO10	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQCQGOZEWWPOKI-UHFFFAOYSA-K
16459	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Dahl SG (1986)	2870716	181307	1352	Methotrimeprazine	(-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine|Methotrimeprazine|2-Methoxytrimeprazine|(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine|Levomepromazine|Levomepromazina|Levomepromazinum	riva-meprazine 5mg tablets|riv	DRUGBANK	DB01403	C19H24N2OS	small molecule	N05AA02	60-99-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VRQVVMDWGGWHTJ-CQSZACIVSA-N
16460	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Green B (2004)	15701205	181306	1352	Methotrimeprazine	(-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine|Methotrimeprazine|2-Methoxytrimeprazine|(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine|Levomepromazine|Levomepromazina|Levomepromazinum	riva-meprazine 5mg tablets|riv	DRUGBANK	DB01403	C19H24N2OS	small molecule	N05AA02	60-99-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VRQVVMDWGGWHTJ-CQSZACIVSA-N
16461	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Berman HM (2000)	10592235	172122	1352	Methotrimeprazine	(-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine|Methotrimeprazine|2-Methoxytrimeprazine|(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine|Levomepromazine|Levomepromazina|Levomepromazinum	riva-meprazine 5mg tablets|riv	DRUGBANK	DB01403	C19H24N2OS	small molecule	N05AA02	60-99-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VRQVVMDWGGWHTJ-CQSZACIVSA-N
16470	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	antagonist	target	Green B (2004)	15701205	181306	1352	Methotrimeprazine	(-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine|Methotrimeprazine|2-Methoxytrimeprazine|(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine|Levomepromazine|Levomepromazina|Levomepromazinum	riva-meprazine 5mg tablets|riv	DRUGBANK	DB01403	C19H24N2OS	small molecule	N05AA02	60-99-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VRQVVMDWGGWHTJ-CQSZACIVSA-N
16487	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	antagonist	target	Green B (2004)	15701205	181306	1352	Methotrimeprazine	(-)-(2R)-3-(2-Methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine|Methotrimeprazine|2-Methoxytrimeprazine|(-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine|Levomepromazine|Levomepromazina|Levomepromazinum	riva-meprazine 5mg tablets|riv	DRUGBANK	DB01403	C19H24N2OS	small molecule	N05AA02	60-99-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VRQVVMDWGGWHTJ-CQSZACIVSA-N
16492	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Kim SJ (2007)	17436372	181309	1353	Ginseng	-	ginsana cap 100mg|siberian gin	DRUGBANK	DB01404	-	small molecule	-	50647-08-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
16493	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Yim HW (2005)	15753395	181312	1353	Ginseng	-	ginsana cap 100mg|siberian gin	DRUGBANK	DB01404	-	small molecule	-	50647-08-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
16494	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Seo JY (2005)	15778128	181313	1353	Ginseng	-	ginsana cap 100mg|siberian gin	DRUGBANK	DB01404	-	small molecule	-	50647-08-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
16564	116014	10800	-	CYSLTR1	CYSLT1|CYSLT1R|CYSLTR|HMTMF81	9606	Homo sapiens	antagonist	target	Shirasaki H (2006)	16864492	181369	1360	Pranlukast	ONO-RS 411	-	DRUGBANK	DB01411	C27H23N5O4	small molecule	R03DC02	103177-37-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NBQKINXMPLXUET-UHFFFAOYSA-N
16565	116014	10800	-	CYSLTR1	CYSLT1|CYSLT1R|CYSLTR|HMTMF81	9606	Homo sapiens	antagonist	target	Yoo SH (2001)	11264758	181368	1360	Pranlukast	ONO-RS 411	-	DRUGBANK	DB01411	C27H23N5O4	small molecule	R03DC02	103177-37-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NBQKINXMPLXUET-UHFFFAOYSA-N
16566	116014	10800	-	CYSLTR1	CYSLT1|CYSLT1R|CYSLTR|HMTMF81	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1360	Pranlukast	ONO-RS 411	-	DRUGBANK	DB01411	C27H23N5O4	small molecule	R03DC02	103177-37-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NBQKINXMPLXUET-UHFFFAOYSA-N
16567	116014	10800	-	CYSLTR1	CYSLT1|CYSLT1R|CYSLTR|HMTMF81	9606	Homo sapiens	antagonist	target	Ding Q (2006)	17112405	181367	1360	Pranlukast	ONO-RS 411	-	DRUGBANK	DB01411	C27H23N5O4	small molecule	R03DC02	103177-37-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NBQKINXMPLXUET-UHFFFAOYSA-N
16568	116014	10800	-	CYSLTR1	CYSLT1|CYSLT1R|CYSLTR|HMTMF81	9606	Homo sapiens	antagonist	target	Ogasawara H (2002)	11854273	181366	1360	Pranlukast	ONO-RS 411	-	DRUGBANK	DB01411	C27H23N5O4	small molecule	R03DC02	103177-37-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NBQKINXMPLXUET-UHFFFAOYSA-N
16569	116014	10800	-	CYSLTR1	CYSLT1|CYSLT1R|CYSLTR|HMTMF81	9606	Homo sapiens	antagonist	target	Ishinaga H (2005)	15475658	181365	1360	Pranlukast	ONO-RS 411	-	DRUGBANK	DB01411	C27H23N5O4	small molecule	R03DC02	103177-37-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NBQKINXMPLXUET-UHFFFAOYSA-N
16611	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Berry H (1983)	6342700	181384	1367	Antrafenine	-	-	DRUGBANK	DB01419	C30H26F6N4O2	small molecule	-	55300-29-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NWGGKKGAFZIVBJ-UHFFFAOYSA-N
16612	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	James MJ (2007)	17541796	178397	1367	Antrafenine	-	-	DRUGBANK	DB01419	C30H26F6N4O2	small molecule	-	55300-29-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NWGGKKGAFZIVBJ-UHFFFAOYSA-N
16613	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Hassan SM (1982)	7088753	181383	1367	Antrafenine	-	-	DRUGBANK	DB01419	C30H26F6N4O2	small molecule	-	55300-29-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NWGGKKGAFZIVBJ-UHFFFAOYSA-N
16614	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Dhir A (2007)	17604186	178398	1367	Antrafenine	-	-	DRUGBANK	DB01419	C30H26F6N4O2	small molecule	-	55300-29-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NWGGKKGAFZIVBJ-UHFFFAOYSA-N
16615	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	White WB (2007)	17612049	178399	1367	Antrafenine	-	-	DRUGBANK	DB01419	C30H26F6N4O2	small molecule	-	55300-29-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NWGGKKGAFZIVBJ-UHFFFAOYSA-N
16616	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1367	Antrafenine	-	-	DRUGBANK	DB01419	C30H26F6N4O2	small molecule	-	55300-29-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NWGGKKGAFZIVBJ-UHFFFAOYSA-N
16617	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Hassan-Alin M (2007)	17532719	178402	1367	Antrafenine	-	-	DRUGBANK	DB01419	C30H26F6N4O2	small molecule	-	55300-29-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NWGGKKGAFZIVBJ-UHFFFAOYSA-N
16618	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Kumar P (2007)	17521299	178400	1367	Antrafenine	-	-	DRUGBANK	DB01419	C30H26F6N4O2	small molecule	-	55300-29-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NWGGKKGAFZIVBJ-UHFFFAOYSA-N
16619	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Albertini R (2007)	17607546	178401	1367	Antrafenine	-	-	DRUGBANK	DB01419	C30H26F6N4O2	small molecule	-	55300-29-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NWGGKKGAFZIVBJ-UHFFFAOYSA-N
16627	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Kilpatrick GJ (1986)	2943980	181389	1373	Alizapride	Alizaprida|Plitican|Alizapridum	-	DRUGBANK	DB01425	C16H21N5O2	small molecule	A03FA05	59338-93-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KSEYRUGYKHXGFW-UHFFFAOYSA-N
16628	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Gomez F (1999)	10075867	181387	1373	Alizapride	Alizaprida|Plitican|Alizapridum	-	DRUGBANK	DB01425	C16H21N5O2	small molecule	A03FA05	59338-93-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KSEYRUGYKHXGFW-UHFFFAOYSA-N
16629	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Dhasmana KM (1993)	8103596	178446	1373	Alizapride	Alizaprida|Plitican|Alizapridum	-	DRUGBANK	DB01425	C16H21N5O2	small molecule	A03FA05	59338-93-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KSEYRUGYKHXGFW-UHFFFAOYSA-N
16630	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Szelenyi I (1994)	7865862	181388	1373	Alizapride	Alizaprida|Plitican|Alizapridum	-	DRUGBANK	DB01425	C16H21N5O2	small molecule	A03FA05	59338-93-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KSEYRUGYKHXGFW-UHFFFAOYSA-N
16672	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Brune K (2001)	11695253	181415	1383	Antipyrine	1,2-Dihydro-1,5-dimethyl-2-phenyl-3H-pyrazol-3-one|Phenazone|Fenazon|2,3-Dimethyl-1-phenyl-5-pyrazolone|Fenazona|Antipyrine|Analgesine|Phenazon	auralgan eardrops|antipyrine a	DRUGBANK	DB01435	C11H12N2O	small molecule	S02DA03|N02BB51|N02BB71|N02BB01	60-80-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VEQOALNAAJBPNY-UHFFFAOYSA-N
16673	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Brune K (2001)	11695253	181415	1383	Antipyrine	1,2-Dihydro-1,5-dimethyl-2-phenyl-3H-pyrazol-3-one|Phenazone|Fenazon|2,3-Dimethyl-1-phenyl-5-pyrazolone|Fenazona|Antipyrine|Analgesine|Phenazon	auralgan eardrops|antipyrine a	DRUGBANK	DB01435	C11H12N2O	small molecule	S02DA03|N02BB51|N02BB71|N02BB01	60-80-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VEQOALNAAJBPNY-UHFFFAOYSA-N
16884	114196	8644	-	AKR1C3	DD3|DDX|HA1753|HAKRB|HAKRe|HSD17B5|PGFS|hluPGFS	9606	Homo sapiens	inducer	target	Imming P (2006)	17016423	171742	1476	4-Androstenedione	4-Androstene-3,17-dione	-	DRUGBANK	DB01536	C19H26O2	small molecule	-	63-05-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AEMFNILZOJDQLW-QAGGRKNESA-N
16885	114196	8644	-	AKR1C3	DD3|DDX|HA1753|HAKRB|HAKRe|HSD17B5|PGFS|hluPGFS	9606	Homo sapiens	inducer	target	Overington JP (2006)	17139284	171741	1476	4-Androstenedione	4-Androstene-3,17-dione	-	DRUGBANK	DB01536	C19H26O2	small molecule	-	63-05-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AEMFNILZOJDQLW-QAGGRKNESA-N
16931	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	unknown	target	Seeman P (2009)	19391150	180698	1489	Rolicyclidine	Pyrrolidine analog of phencyclidine|Rolicyclidinum|Roliciclidina|PCPy|1-(1-phenylcyclohexyl)pyrrolidine	-	DRUGBANK	DB01549	C16H23N	small molecule	-	2201-39-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FYOWWXMGDATDQY-UHFFFAOYSA-N
17131	108013	1646	-	AKR1C2	AKR1C-pseudo|BABP|DD|DD-2|DD/BABP|DD2|DDH2|HAKRD|HBAB|MCDR2|SRXY8|TDD	9606	Homo sapiens	inducer	target	Amaral JD (2009)	19747134	181547	1525	Ursodeoxycholic acid	Actigall|Ursodeoxycholic acid|Acide ursodesoxycholique|Ursodeoxycholate|(3,5,7)-3,7-dihydroxycholan-24-oic acid|Ursodiol|UDCA|Acido ursodeoxicolico|Acidum ursodeoxycholicum|Acido ursodeossicolico|(3alpha,5beta,7beta)-3,7-dihydroxycholan-24-oic acid|3alpha,7beta-Dihydroxy-5beta-cholan-24-oic acid	actigall|urso 250|phl-ursodiol	DRUGBANK	DB01586	C24H40O4	small molecule	A05AA02	128-13-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RUDATBOHQWOJDD-UZVSRGJWSA-N
17132	108013	1646	-	AKR1C2	AKR1C-pseudo|BABP|DD|DD-2|DD/BABP|DD2|DDH2|HAKRD|HBAB|MCDR2|SRXY8|TDD	9606	Homo sapiens	inducer	target	Imming P (2006)	17016423	171742	1525	Ursodeoxycholic acid	Actigall|Ursodeoxycholic acid|Acide ursodesoxycholique|Ursodeoxycholate|(3,5,7)-3,7-dihydroxycholan-24-oic acid|Ursodiol|UDCA|Acido ursodeoxicolico|Acidum ursodeoxycholicum|Acido ursodeossicolico|(3alpha,5beta,7beta)-3,7-dihydroxycholan-24-oic acid|3alpha,7beta-Dihydroxy-5beta-cholan-24-oic acid	actigall|urso 250|phl-ursodiol	DRUGBANK	DB01586	C24H40O4	small molecule	A05AA02	128-13-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RUDATBOHQWOJDD-UZVSRGJWSA-N
17133	108013	1646	-	AKR1C2	AKR1C-pseudo|BABP|DD|DD-2|DD/BABP|DD2|DDH2|HAKRD|HBAB|MCDR2|SRXY8|TDD	9606	Homo sapiens	inducer	target	Overington JP (2006)	17139284	171741	1525	Ursodeoxycholic acid	Actigall|Ursodeoxycholic acid|Acide ursodesoxycholique|Ursodeoxycholate|(3,5,7)-3,7-dihydroxycholan-24-oic acid|Ursodiol|UDCA|Acido ursodeoxicolico|Acidum ursodeoxycholicum|Acido ursodeossicolico|(3alpha,5beta,7beta)-3,7-dihydroxycholan-24-oic acid|3alpha,7beta-Dihydroxy-5beta-cholan-24-oic acid	actigall|urso 250|phl-ursodiol	DRUGBANK	DB01586	C24H40O4	small molecule	A05AA02	128-13-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RUDATBOHQWOJDD-UZVSRGJWSA-N
17282	108134	1800	-	DPEP1	MBD1|MDP|RDP	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	1535	Cilastatin	Cilastatinum|(Z)-(S)-6-Carboxy-6-[(S)-2,2-dimethylcyclopropanecarboxamido]hex-5-enyl-L-cysteine|Cilastatine|Cilastatina|(L)-7-(2-Amino-2-carboxy-ethylsulfanyl)-2-[(2,2-dimethyl-cyclopropanecarbonyl)-amino]-hept-2-enoic acid|(Z)-7-((R)-2-Amino-2-carboxy-ethylsulfanyl)-2-[((S)-2,2-dimethyl-cyclopropanecarbonyl)-amino]-hept-2-enoic acid	primaxin iv|imipenem and cilas	DRUGBANK	DB01597	C16H26N2O5S	small molecule	-	82009-34-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHSUYTOATWAVLW-WFVMDLQDSA-N
17283	108134	1800	-	DPEP1	MBD1|MDP|RDP	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1535	Cilastatin	Cilastatinum|(Z)-(S)-6-Carboxy-6-[(S)-2,2-dimethylcyclopropanecarboxamido]hex-5-enyl-L-cysteine|Cilastatine|Cilastatina|(L)-7-(2-Amino-2-carboxy-ethylsulfanyl)-2-[(2,2-dimethyl-cyclopropanecarbonyl)-amino]-hept-2-enoic acid|(Z)-7-((R)-2-Amino-2-carboxy-ethylsulfanyl)-2-[((S)-2,2-dimethyl-cyclopropanecarbonyl)-amino]-hept-2-enoic acid	primaxin iv|imipenem and cilas	DRUGBANK	DB01597	C16H26N2O5S	small molecule	-	82009-34-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHSUYTOATWAVLW-WFVMDLQDSA-N
17284	108134	1800	-	DPEP1	MBD1|MDP|RDP	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	1535	Cilastatin	Cilastatinum|(Z)-(S)-6-Carboxy-6-[(S)-2,2-dimethylcyclopropanecarboxamido]hex-5-enyl-L-cysteine|Cilastatine|Cilastatina|(L)-7-(2-Amino-2-carboxy-ethylsulfanyl)-2-[(2,2-dimethyl-cyclopropanecarbonyl)-amino]-hept-2-enoic acid|(Z)-7-((R)-2-Amino-2-carboxy-ethylsulfanyl)-2-[((S)-2,2-dimethyl-cyclopropanecarbonyl)-amino]-hept-2-enoic acid	primaxin iv|imipenem and cilas	DRUGBANK	DB01597	C16H26N2O5S	small molecule	-	82009-34-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHSUYTOATWAVLW-WFVMDLQDSA-N
17285	108134	1800	-	DPEP1	MBD1|MDP|RDP	9606	Homo sapiens	inhibitor	target	Farrell CA (1987)	3038022	181569	1535	Cilastatin	Cilastatinum|(Z)-(S)-6-Carboxy-6-[(S)-2,2-dimethylcyclopropanecarboxamido]hex-5-enyl-L-cysteine|Cilastatine|Cilastatina|(L)-7-(2-Amino-2-carboxy-ethylsulfanyl)-2-[(2,2-dimethyl-cyclopropanecarbonyl)-amino]-hept-2-enoic acid|(Z)-7-((R)-2-Amino-2-carboxy-ethylsulfanyl)-2-[((S)-2,2-dimethyl-cyclopropanecarbonyl)-amino]-hept-2-enoic acid	primaxin iv|imipenem and cilas	DRUGBANK	DB01597	C16H26N2O5S	small molecule	-	82009-34-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHSUYTOATWAVLW-WFVMDLQDSA-N
17286	108134	1800	-	DPEP1	MBD1|MDP|RDP	9606	Homo sapiens	inhibitor	target	Keynan S (1995)	7492120	181568	1535	Cilastatin	Cilastatinum|(Z)-(S)-6-Carboxy-6-[(S)-2,2-dimethylcyclopropanecarboxamido]hex-5-enyl-L-cysteine|Cilastatine|Cilastatina|(L)-7-(2-Amino-2-carboxy-ethylsulfanyl)-2-[(2,2-dimethyl-cyclopropanecarbonyl)-amino]-hept-2-enoic acid|(Z)-7-((R)-2-Amino-2-carboxy-ethylsulfanyl)-2-[((S)-2,2-dimethyl-cyclopropanecarbonyl)-amino]-hept-2-enoic acid	primaxin iv|imipenem and cilas	DRUGBANK	DB01597	C16H26N2O5S	small molecule	-	82009-34-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHSUYTOATWAVLW-WFVMDLQDSA-N
17287	108134	1800	-	DPEP1	MBD1|MDP|RDP	9606	Homo sapiens	inhibitor	target	Hirota T (1986)	3780719	181565	1535	Cilastatin	Cilastatinum|(Z)-(S)-6-Carboxy-6-[(S)-2,2-dimethylcyclopropanecarboxamido]hex-5-enyl-L-cysteine|Cilastatine|Cilastatina|(L)-7-(2-Amino-2-carboxy-ethylsulfanyl)-2-[(2,2-dimethyl-cyclopropanecarbonyl)-amino]-hept-2-enoic acid|(Z)-7-((R)-2-Amino-2-carboxy-ethylsulfanyl)-2-[((S)-2,2-dimethyl-cyclopropanecarbonyl)-amino]-hept-2-enoic acid	primaxin iv|imipenem and cilas	DRUGBANK	DB01597	C16H26N2O5S	small molecule	-	82009-34-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHSUYTOATWAVLW-WFVMDLQDSA-N
17288	108134	1800	-	DPEP1	MBD1|MDP|RDP	9606	Homo sapiens	inhibitor	target	Kumon H (1987)	3480361	181567	1535	Cilastatin	Cilastatinum|(Z)-(S)-6-Carboxy-6-[(S)-2,2-dimethylcyclopropanecarboxamido]hex-5-enyl-L-cysteine|Cilastatine|Cilastatina|(L)-7-(2-Amino-2-carboxy-ethylsulfanyl)-2-[(2,2-dimethyl-cyclopropanecarbonyl)-amino]-hept-2-enoic acid|(Z)-7-((R)-2-Amino-2-carboxy-ethylsulfanyl)-2-[((S)-2,2-dimethyl-cyclopropanecarbonyl)-amino]-hept-2-enoic acid	primaxin iv|imipenem and cilas	DRUGBANK	DB01597	C16H26N2O5S	small molecule	-	82009-34-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHSUYTOATWAVLW-WFVMDLQDSA-N
17289	108134	1800	-	DPEP1	MBD1|MDP|RDP	9606	Homo sapiens	inhibitor	target	Lin JH (1989)	2571484	181566	1535	Cilastatin	Cilastatinum|(Z)-(S)-6-Carboxy-6-[(S)-2,2-dimethylcyclopropanecarboxamido]hex-5-enyl-L-cysteine|Cilastatine|Cilastatina|(L)-7-(2-Amino-2-carboxy-ethylsulfanyl)-2-[(2,2-dimethyl-cyclopropanecarbonyl)-amino]-hept-2-enoic acid|(Z)-7-((R)-2-Amino-2-carboxy-ethylsulfanyl)-2-[((S)-2,2-dimethyl-cyclopropanecarbonyl)-amino]-hept-2-enoic acid	primaxin iv|imipenem and cilas	DRUGBANK	DB01597	C16H26N2O5S	small molecule	-	82009-34-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHSUYTOATWAVLW-WFVMDLQDSA-N
17290	108134	1800	-	DPEP1	MBD1|MDP|RDP	9606	Homo sapiens	inhibitor	target	Richerson MA (1998)	9573653	181570	1535	Cilastatin	Cilastatinum|(Z)-(S)-6-Carboxy-6-[(S)-2,2-dimethylcyclopropanecarboxamido]hex-5-enyl-L-cysteine|Cilastatine|Cilastatina|(L)-7-(2-Amino-2-carboxy-ethylsulfanyl)-2-[(2,2-dimethyl-cyclopropanecarbonyl)-amino]-hept-2-enoic acid|(Z)-7-((R)-2-Amino-2-carboxy-ethylsulfanyl)-2-[((S)-2,2-dimethyl-cyclopropanecarbonyl)-amino]-hept-2-enoic acid	primaxin iv|imipenem and cilas	DRUGBANK	DB01597	C16H26N2O5S	small molecule	-	82009-34-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHSUYTOATWAVLW-WFVMDLQDSA-N
17291	108134	1800	-	DPEP1	MBD1|MDP|RDP	9606	Homo sapiens	inhibitor	target	Hirota T (1987)	3474745	181571	1535	Cilastatin	Cilastatinum|(Z)-(S)-6-Carboxy-6-[(S)-2,2-dimethylcyclopropanecarboxamido]hex-5-enyl-L-cysteine|Cilastatine|Cilastatina|(L)-7-(2-Amino-2-carboxy-ethylsulfanyl)-2-[(2,2-dimethyl-cyclopropanecarbonyl)-amino]-hept-2-enoic acid|(Z)-7-((R)-2-Amino-2-carboxy-ethylsulfanyl)-2-[((S)-2,2-dimethyl-cyclopropanecarbonyl)-amino]-hept-2-enoic acid	primaxin iv|imipenem and cilas	DRUGBANK	DB01597	C16H26N2O5S	small molecule	-	82009-34-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHSUYTOATWAVLW-WFVMDLQDSA-N
17307	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Gupta K (2004)	14741265	179900	1538	Tiaprofenic acid	Tiaprofensaeure|Tiaprofensure|Acide tiaprofenique|5-Benzoyl-alpha-methyl-2-thiopheneacetic acid|5-Benzoyl-alpha-methylthiophene-2-acetic acid|2-(5-Benzyl-2-thienyl)propionsaeure|alpha-Methyl-5-benzoyl-2-thienylacetic acid|Acido tiaprofenico|Acidum tiaprofenicum|2-(5-Benzoyl-thiophen-2-yl)-propionic acid	surgam|tiaprofenic-200 - tab|a	DRUGBANK	DB01600	C14H12O3S	small molecule	M01AE11	33005-95-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GUHPRPJDBZHYCJ-UHFFFAOYSA-N
17308	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Patrignani P (2003)	14592549	179902	1538	Tiaprofenic acid	Tiaprofensaeure|Tiaprofensure|Acide tiaprofenique|5-Benzoyl-alpha-methyl-2-thiopheneacetic acid|5-Benzoyl-alpha-methylthiophene-2-acetic acid|2-(5-Benzyl-2-thienyl)propionsaeure|alpha-Methyl-5-benzoyl-2-thienylacetic acid|Acido tiaprofenico|Acidum tiaprofenicum|2-(5-Benzoyl-thiophen-2-yl)-propionic acid	surgam|tiaprofenic-200 - tab|a	DRUGBANK	DB01600	C14H12O3S	small molecule	M01AE11	33005-95-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GUHPRPJDBZHYCJ-UHFFFAOYSA-N
17309	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Hillarp A (2004)	15575422	179899	1538	Tiaprofenic acid	Tiaprofensaeure|Tiaprofensure|Acide tiaprofenique|5-Benzoyl-alpha-methyl-2-thiopheneacetic acid|5-Benzoyl-alpha-methylthiophene-2-acetic acid|2-(5-Benzyl-2-thienyl)propionsaeure|alpha-Methyl-5-benzoyl-2-thienylacetic acid|Acido tiaprofenico|Acidum tiaprofenicum|2-(5-Benzoyl-thiophen-2-yl)-propionic acid	surgam|tiaprofenic-200 - tab|a	DRUGBANK	DB01600	C14H12O3S	small molecule	M01AE11	33005-95-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GUHPRPJDBZHYCJ-UHFFFAOYSA-N
17310	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Martic M (2004)	14987823	179630	1538	Tiaprofenic acid	Tiaprofensaeure|Tiaprofensure|Acide tiaprofenique|5-Benzoyl-alpha-methyl-2-thiopheneacetic acid|5-Benzoyl-alpha-methylthiophene-2-acetic acid|2-(5-Benzyl-2-thienyl)propionsaeure|alpha-Methyl-5-benzoyl-2-thienylacetic acid|Acido tiaprofenico|Acidum tiaprofenicum|2-(5-Benzoyl-thiophen-2-yl)-propionic acid	surgam|tiaprofenic-200 - tab|a	DRUGBANK	DB01600	C14H12O3S	small molecule	M01AE11	33005-95-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GUHPRPJDBZHYCJ-UHFFFAOYSA-N
17311	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Brandt KD (1990)	2277128	181583	1538	Tiaprofenic acid	Tiaprofensaeure|Tiaprofensure|Acide tiaprofenique|5-Benzoyl-alpha-methyl-2-thiopheneacetic acid|5-Benzoyl-alpha-methylthiophene-2-acetic acid|2-(5-Benzyl-2-thienyl)propionsaeure|alpha-Methyl-5-benzoyl-2-thienylacetic acid|Acido tiaprofenico|Acidum tiaprofenicum|2-(5-Benzoyl-thiophen-2-yl)-propionic acid	surgam|tiaprofenic-200 - tab|a	DRUGBANK	DB01600	C14H12O3S	small molecule	M01AE11	33005-95-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GUHPRPJDBZHYCJ-UHFFFAOYSA-N
17312	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	1538	Tiaprofenic acid	Tiaprofensaeure|Tiaprofensure|Acide tiaprofenique|5-Benzoyl-alpha-methyl-2-thiopheneacetic acid|5-Benzoyl-alpha-methylthiophene-2-acetic acid|2-(5-Benzyl-2-thienyl)propionsaeure|alpha-Methyl-5-benzoyl-2-thienylacetic acid|Acido tiaprofenico|Acidum tiaprofenicum|2-(5-Benzoyl-thiophen-2-yl)-propionic acid	surgam|tiaprofenic-200 - tab|a	DRUGBANK	DB01600	C14H12O3S	small molecule	M01AE11	33005-95-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GUHPRPJDBZHYCJ-UHFFFAOYSA-N
17313	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1538	Tiaprofenic acid	Tiaprofensaeure|Tiaprofensure|Acide tiaprofenique|5-Benzoyl-alpha-methyl-2-thiopheneacetic acid|5-Benzoyl-alpha-methylthiophene-2-acetic acid|2-(5-Benzyl-2-thienyl)propionsaeure|alpha-Methyl-5-benzoyl-2-thienylacetic acid|Acido tiaprofenico|Acidum tiaprofenicum|2-(5-Benzoyl-thiophen-2-yl)-propionic acid	surgam|tiaprofenic-200 - tab|a	DRUGBANK	DB01600	C14H12O3S	small molecule	M01AE11	33005-95-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GUHPRPJDBZHYCJ-UHFFFAOYSA-N
17314	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	1538	Tiaprofenic acid	Tiaprofensaeure|Tiaprofensure|Acide tiaprofenique|5-Benzoyl-alpha-methyl-2-thiopheneacetic acid|5-Benzoyl-alpha-methylthiophene-2-acetic acid|2-(5-Benzyl-2-thienyl)propionsaeure|alpha-Methyl-5-benzoyl-2-thienylacetic acid|Acido tiaprofenico|Acidum tiaprofenicum|2-(5-Benzoyl-thiophen-2-yl)-propionic acid	surgam|tiaprofenic-200 - tab|a	DRUGBANK	DB01600	C14H12O3S	small molecule	M01AE11	33005-95-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GUHPRPJDBZHYCJ-UHFFFAOYSA-N
17338	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Seeman P (2002)	11873706	174626	1552	Acepromazine	Acetylpromazine|1-[10-(3-DIMETHYLAMINO-propyl)-10H-phenothiazin-2-yl]-ethanone|10-(3-dimethylaminopropyl)phenothiazin-3-yl methyl ketone|Acetazine|Acetopromazine|10-(3-dimethylaminopropyl)phenothiazine-3-ethylone	-	DRUGBANK	DB01614	C19H22N2OS	small molecule	N05AA04	61-00-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NOSIYYJFMPDDSA-UHFFFAOYSA-N
17339	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1552	Acepromazine	Acetylpromazine|1-[10-(3-DIMETHYLAMINO-propyl)-10H-phenothiazin-2-yl]-ethanone|10-(3-dimethylaminopropyl)phenothiazin-3-yl methyl ketone|Acetazine|Acetopromazine|10-(3-dimethylaminopropyl)phenothiazine-3-ethylone	-	DRUGBANK	DB01614	C19H22N2OS	small molecule	N05AA04	61-00-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NOSIYYJFMPDDSA-UHFFFAOYSA-N
17340	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Wu S (2005)	15694263	176350	1552	Acepromazine	Acetylpromazine|1-[10-(3-DIMETHYLAMINO-propyl)-10H-phenothiazin-2-yl]-ethanone|10-(3-dimethylaminopropyl)phenothiazin-3-yl methyl ketone|Acetazine|Acetopromazine|10-(3-dimethylaminopropyl)phenothiazine-3-ethylone	-	DRUGBANK	DB01614	C19H22N2OS	small molecule	N05AA04	61-00-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NOSIYYJFMPDDSA-UHFFFAOYSA-N
17341	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Oades RD (2000)	11103886	176351	1552	Acepromazine	Acetylpromazine|1-[10-(3-DIMETHYLAMINO-propyl)-10H-phenothiazin-2-yl]-ethanone|10-(3-dimethylaminopropyl)phenothiazin-3-yl methyl ketone|Acetazine|Acetopromazine|10-(3-dimethylaminopropyl)phenothiazine-3-ethylone	-	DRUGBANK	DB01614	C19H22N2OS	small molecule	N05AA04	61-00-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NOSIYYJFMPDDSA-UHFFFAOYSA-N
17342	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Seeman P (2010)	20643630	176352	1552	Acepromazine	Acetylpromazine|1-[10-(3-DIMETHYLAMINO-propyl)-10H-phenothiazin-2-yl]-ethanone|10-(3-dimethylaminopropyl)phenothiazin-3-yl methyl ketone|Acetazine|Acetopromazine|10-(3-dimethylaminopropyl)phenothiazine-3-ethylone	-	DRUGBANK	DB01614	C19H22N2OS	small molecule	N05AA04	61-00-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NOSIYYJFMPDDSA-UHFFFAOYSA-N
17343	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Wu SN (2006)	16867246	176349	1552	Acepromazine	Acetylpromazine|1-[10-(3-DIMETHYLAMINO-propyl)-10H-phenothiazin-2-yl]-ethanone|10-(3-dimethylaminopropyl)phenothiazin-3-yl methyl ketone|Acetazine|Acetopromazine|10-(3-dimethylaminopropyl)phenothiazine-3-ethylone	-	DRUGBANK	DB01614	C19H22N2OS	small molecule	N05AA04	61-00-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NOSIYYJFMPDDSA-UHFFFAOYSA-N
17357	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	1555	Molindone	Molindona|Molindonum|Molindone|(+-)-molindone|Moban	molindone hydrochloride	DRUGBANK	DB01618	C16H24N2O2	small molecule	N05AE02	7416-34-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KLPWJLBORRMFGK-UHFFFAOYSA-N
17358	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1555	Molindone	Molindona|Molindonum|Molindone|(+-)-molindone|Moban	molindone hydrochloride	DRUGBANK	DB01618	C16H24N2O2	small molecule	N05AE02	7416-34-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KLPWJLBORRMFGK-UHFFFAOYSA-N
17359	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Froimowitz M (1997)	9342550	175878	1555	Molindone	Molindona|Molindonum|Molindone|(+-)-molindone|Moban	molindone hydrochloride	DRUGBANK	DB01618	C16H24N2O2	small molecule	N05AE02	7416-34-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KLPWJLBORRMFGK-UHFFFAOYSA-N
17360	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Seeman P (1998)	9577836	181592	1555	Molindone	Molindona|Molindonum|Molindone|(+-)-molindone|Moban	molindone hydrochloride	DRUGBANK	DB01618	C16H24N2O2	small molecule	N05AE02	7416-34-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KLPWJLBORRMFGK-UHFFFAOYSA-N
17361	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Lidow MS (1997)	9353417	181593	1555	Molindone	Molindona|Molindonum|Molindone|(+-)-molindone|Moban	molindone hydrochloride	DRUGBANK	DB01618	C16H24N2O2	small molecule	N05AE02	7416-34-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KLPWJLBORRMFGK-UHFFFAOYSA-N
17379	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Seeman P (2002)	11873706	174626	1558	Pipotiazine	Pipotiazina|Piportil|Pipothiazine|Pipotiazinum	piportil l4	DRUGBANK	DB01621	C24H33N3O3S2	small molecule	N05AC04	39860-99-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOMHSQGEWSNUKU-UHFFFAOYSA-N
17380	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1558	Pipotiazine	Pipotiazina|Piportil|Pipothiazine|Pipotiazinum	piportil l4	DRUGBANK	DB01621	C24H33N3O3S2	small molecule	N05AC04	39860-99-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOMHSQGEWSNUKU-UHFFFAOYSA-N
17381	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Seeman P (2010)	20643630	176352	1558	Pipotiazine	Pipotiazina|Piportil|Pipothiazine|Pipotiazinum	piportil l4	DRUGBANK	DB01621	C24H33N3O3S2	small molecule	N05AC04	39860-99-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOMHSQGEWSNUKU-UHFFFAOYSA-N
17382	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Wu S (2005)	15694263	176350	1558	Pipotiazine	Pipotiazina|Piportil|Pipothiazine|Pipotiazinum	piportil l4	DRUGBANK	DB01621	C24H33N3O3S2	small molecule	N05AC04	39860-99-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOMHSQGEWSNUKU-UHFFFAOYSA-N
17383	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Oades RD (2000)	11103886	176351	1558	Pipotiazine	Pipotiazina|Piportil|Pipothiazine|Pipotiazinum	piportil l4	DRUGBANK	DB01621	C24H33N3O3S2	small molecule	N05AC04	39860-99-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOMHSQGEWSNUKU-UHFFFAOYSA-N
17384	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Boireau A (1986)	2875894	181602	1558	Pipotiazine	Pipotiazina|Piportil|Pipothiazine|Pipotiazinum	piportil l4	DRUGBANK	DB01621	C24H33N3O3S2	small molecule	N05AC04	39860-99-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOMHSQGEWSNUKU-UHFFFAOYSA-N
17385	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Wu SN (2006)	16867246	176349	1558	Pipotiazine	Pipotiazina|Piportil|Pipothiazine|Pipotiazinum	piportil l4	DRUGBANK	DB01621	C24H33N3O3S2	small molecule	N05AC04	39860-99-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JOMHSQGEWSNUKU-UHFFFAOYSA-N
17389	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Seeman P (2002)	11873706	174626	1559	Thioproperazine	Tioproferazina|(Thioproperazine)-2-dimethylsulfamido-(10-(3-1-methylpiperazinyl-4)propyl)-phenothiazine|2-Dimethylsulfamido-(10-(3-1-methylpiperazinyl-4)propyl)-phenothiazine|N,N-Dimethyl-10-[3-(4-methyl-1-piperazinyl)propyl]phenothiazine-2-sulfonamide|Thioproperazin|Thioperazine|Thioproperazinum|N,N-Dimethyl-10-[3-(4-methyl-1-piperazinyl)propyl]-10H-phenothiazine-2-sulfonamide|Tioproperazina	majeptil tab 10mg	DRUGBANK	DB01622	C22H30N4O2S2	small molecule	N05AB08	316-81-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VZYCZNZBPPHOFY-UHFFFAOYSA-N
17390	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1559	Thioproperazine	Tioproferazina|(Thioproperazine)-2-dimethylsulfamido-(10-(3-1-methylpiperazinyl-4)propyl)-phenothiazine|2-Dimethylsulfamido-(10-(3-1-methylpiperazinyl-4)propyl)-phenothiazine|N,N-Dimethyl-10-[3-(4-methyl-1-piperazinyl)propyl]phenothiazine-2-sulfonamide|Thioproperazin|Thioperazine|Thioproperazinum|N,N-Dimethyl-10-[3-(4-methyl-1-piperazinyl)propyl]-10H-phenothiazine-2-sulfonamide|Tioproperazina	majeptil tab 10mg	DRUGBANK	DB01622	C22H30N4O2S2	small molecule	N05AB08	316-81-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VZYCZNZBPPHOFY-UHFFFAOYSA-N
17391	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Wu S (2005)	15694263	176350	1559	Thioproperazine	Tioproferazina|(Thioproperazine)-2-dimethylsulfamido-(10-(3-1-methylpiperazinyl-4)propyl)-phenothiazine|2-Dimethylsulfamido-(10-(3-1-methylpiperazinyl-4)propyl)-phenothiazine|N,N-Dimethyl-10-[3-(4-methyl-1-piperazinyl)propyl]phenothiazine-2-sulfonamide|Thioproperazin|Thioperazine|Thioproperazinum|N,N-Dimethyl-10-[3-(4-methyl-1-piperazinyl)propyl]-10H-phenothiazine-2-sulfonamide|Tioproperazina	majeptil tab 10mg	DRUGBANK	DB01622	C22H30N4O2S2	small molecule	N05AB08	316-81-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VZYCZNZBPPHOFY-UHFFFAOYSA-N
17392	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Oades RD (2000)	11103886	176351	1559	Thioproperazine	Tioproferazina|(Thioproperazine)-2-dimethylsulfamido-(10-(3-1-methylpiperazinyl-4)propyl)-phenothiazine|2-Dimethylsulfamido-(10-(3-1-methylpiperazinyl-4)propyl)-phenothiazine|N,N-Dimethyl-10-[3-(4-methyl-1-piperazinyl)propyl]phenothiazine-2-sulfonamide|Thioproperazin|Thioperazine|Thioproperazinum|N,N-Dimethyl-10-[3-(4-methyl-1-piperazinyl)propyl]-10H-phenothiazine-2-sulfonamide|Tioproperazina	majeptil tab 10mg	DRUGBANK	DB01622	C22H30N4O2S2	small molecule	N05AB08	316-81-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VZYCZNZBPPHOFY-UHFFFAOYSA-N
17393	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Seeman P (2010)	20643630	176352	1559	Thioproperazine	Tioproferazina|(Thioproperazine)-2-dimethylsulfamido-(10-(3-1-methylpiperazinyl-4)propyl)-phenothiazine|2-Dimethylsulfamido-(10-(3-1-methylpiperazinyl-4)propyl)-phenothiazine|N,N-Dimethyl-10-[3-(4-methyl-1-piperazinyl)propyl]phenothiazine-2-sulfonamide|Thioproperazin|Thioperazine|Thioproperazinum|N,N-Dimethyl-10-[3-(4-methyl-1-piperazinyl)propyl]-10H-phenothiazine-2-sulfonamide|Tioproperazina	majeptil tab 10mg	DRUGBANK	DB01622	C22H30N4O2S2	small molecule	N05AB08	316-81-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VZYCZNZBPPHOFY-UHFFFAOYSA-N
17394	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Wu SN (2006)	16867246	176349	1559	Thioproperazine	Tioproferazina|(Thioproperazine)-2-dimethylsulfamido-(10-(3-1-methylpiperazinyl-4)propyl)-phenothiazine|2-Dimethylsulfamido-(10-(3-1-methylpiperazinyl-4)propyl)-phenothiazine|N,N-Dimethyl-10-[3-(4-methyl-1-piperazinyl)propyl]phenothiazine-2-sulfonamide|Thioproperazin|Thioperazine|Thioproperazinum|N,N-Dimethyl-10-[3-(4-methyl-1-piperazinyl)propyl]-10H-phenothiazine-2-sulfonamide|Tioproperazina	majeptil tab 10mg	DRUGBANK	DB01622	C22H30N4O2S2	small molecule	N05AB08	316-81-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VZYCZNZBPPHOFY-UHFFFAOYSA-N
17402	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Seeman P (2002)	11873706	174626	1560	Thiothixene	Tiotixene|(e)-thiothixene|Tiotixeno|Thiothixine|cis-thiothixene|Tiotixenum	navane capsules 10mg|thiothixe	DRUGBANK	DB01623	C23H29N3O2S2	small molecule	N05AF04	3313-26-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GFBKORZTTCHDGY-UWVJOHFNSA-N
17403	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1560	Thiothixene	Tiotixene|(e)-thiothixene|Tiotixeno|Thiothixine|cis-thiothixene|Tiotixenum	navane capsules 10mg|thiothixe	DRUGBANK	DB01623	C23H29N3O2S2	small molecule	N05AF04	3313-26-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GFBKORZTTCHDGY-UWVJOHFNSA-N
17404	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Wu S (2005)	15694263	176350	1560	Thiothixene	Tiotixene|(e)-thiothixene|Tiotixeno|Thiothixine|cis-thiothixene|Tiotixenum	navane capsules 10mg|thiothixe	DRUGBANK	DB01623	C23H29N3O2S2	small molecule	N05AF04	3313-26-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GFBKORZTTCHDGY-UWVJOHFNSA-N
17405	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Oades RD (2000)	11103886	176351	1560	Thiothixene	Tiotixene|(e)-thiothixene|Tiotixeno|Thiothixine|cis-thiothixene|Tiotixenum	navane capsules 10mg|thiothixe	DRUGBANK	DB01623	C23H29N3O2S2	small molecule	N05AF04	3313-26-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GFBKORZTTCHDGY-UWVJOHFNSA-N
17406	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Seeman P (2010)	20643630	176352	1560	Thiothixene	Tiotixene|(e)-thiothixene|Tiotixeno|Thiothixine|cis-thiothixene|Tiotixenum	navane capsules 10mg|thiothixe	DRUGBANK	DB01623	C23H29N3O2S2	small molecule	N05AF04	3313-26-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GFBKORZTTCHDGY-UWVJOHFNSA-N
17407	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Shultz PJ (1987)	3039860	181603	1560	Thiothixene	Tiotixene|(e)-thiothixene|Tiotixeno|Thiothixine|cis-thiothixene|Tiotixenum	navane capsules 10mg|thiothixe	DRUGBANK	DB01623	C23H29N3O2S2	small molecule	N05AF04	3313-26-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GFBKORZTTCHDGY-UWVJOHFNSA-N
17408	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Wu SN (2006)	16867246	176349	1560	Thiothixene	Tiotixene|(e)-thiothixene|Tiotixeno|Thiothixine|cis-thiothixene|Tiotixenum	navane capsules 10mg|thiothixe	DRUGBANK	DB01623	C23H29N3O2S2	small molecule	N05AF04	3313-26-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GFBKORZTTCHDGY-UWVJOHFNSA-N
17416	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Nyberg S (1995)	8748043	181608	1561	Zuclopenthixol	Zuclopentixol|Zuclopenthixolum|cis-Clopenthixol	clopixol tablets 25mg|clopixol	DRUGBANK	DB01624	C22H25ClN2OS	small molecule	N05AF05	53772-83-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WFPIAZLQTJBIFN-DVZOWYKESA-N
17417	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	1561	Zuclopenthixol	Zuclopentixol|Zuclopenthixolum|cis-Clopenthixol	clopixol tablets 25mg|clopixol	DRUGBANK	DB01624	C22H25ClN2OS	small molecule	N05AF05	53772-83-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WFPIAZLQTJBIFN-DVZOWYKESA-N
17418	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Lublin H (1991)	1822319	181605	1561	Zuclopenthixol	Zuclopentixol|Zuclopenthixolum|cis-Clopenthixol	clopixol tablets 25mg|clopixol	DRUGBANK	DB01624	C22H25ClN2OS	small molecule	N05AF05	53772-83-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WFPIAZLQTJBIFN-DVZOWYKESA-N
17419	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Gareri P (2007)	17535043	181607	1561	Zuclopenthixol	Zuclopentixol|Zuclopenthixolum|cis-Clopenthixol	clopixol tablets 25mg|clopixol	DRUGBANK	DB01624	C22H25ClN2OS	small molecule	N05AF05	53772-83-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WFPIAZLQTJBIFN-DVZOWYKESA-N
17449	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	1565	Etoricoxib	5-chloro-6'-Methyl-3-(P-(methylsulfonyl)phenyl)-2,3'-bipyridine|5-chloro-2-(6-Methylpyridin-3-yl)-3-(4-(methylsulfonyl)phenyl)pyridine|Etoricoxibum|5-Chloro-3-(4-methanesulfonyl-phenyl)-6'-methyl-[2,3']bipyridinyl|L791456|ETORICOXIB	-	DRUGBANK	DB01628	C18H15ClN2O2S	small molecule	M01AH05	202409-33-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MNJVRJDLRVPLFE-UHFFFAOYSA-N
17450	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1565	Etoricoxib	5-chloro-6'-Methyl-3-(P-(methylsulfonyl)phenyl)-2,3'-bipyridine|5-chloro-2-(6-Methylpyridin-3-yl)-3-(4-(methylsulfonyl)phenyl)pyridine|Etoricoxibum|5-Chloro-3-(4-methanesulfonyl-phenyl)-6'-methyl-[2,3']bipyridinyl|L791456|ETORICOXIB	-	DRUGBANK	DB01628	C18H15ClN2O2S	small molecule	M01AH05	202409-33-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MNJVRJDLRVPLFE-UHFFFAOYSA-N
17451	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	1565	Etoricoxib	5-chloro-6'-Methyl-3-(P-(methylsulfonyl)phenyl)-2,3'-bipyridine|5-chloro-2-(6-Methylpyridin-3-yl)-3-(4-(methylsulfonyl)phenyl)pyridine|Etoricoxibum|5-Chloro-3-(4-methanesulfonyl-phenyl)-6'-methyl-[2,3']bipyridinyl|L791456|ETORICOXIB	-	DRUGBANK	DB01628	C18H15ClN2O2S	small molecule	M01AH05	202409-33-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MNJVRJDLRVPLFE-UHFFFAOYSA-N
17452	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Yuan Y (2007)	17691997	181616	1565	Etoricoxib	5-chloro-6'-Methyl-3-(P-(methylsulfonyl)phenyl)-2,3'-bipyridine|5-chloro-2-(6-Methylpyridin-3-yl)-3-(4-(methylsulfonyl)phenyl)pyridine|Etoricoxibum|5-Chloro-3-(4-methanesulfonyl-phenyl)-6'-methyl-[2,3']bipyridinyl|L791456|ETORICOXIB	-	DRUGBANK	DB01628	C18H15ClN2O2S	small molecule	M01AH05	202409-33-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MNJVRJDLRVPLFE-UHFFFAOYSA-N
17453	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Capone ML (2007)	17164136	181615	1565	Etoricoxib	5-chloro-6'-Methyl-3-(P-(methylsulfonyl)phenyl)-2,3'-bipyridine|5-chloro-2-(6-Methylpyridin-3-yl)-3-(4-(methylsulfonyl)phenyl)pyridine|Etoricoxibum|5-Chloro-3-(4-methanesulfonyl-phenyl)-6'-methyl-[2,3']bipyridinyl|L791456|ETORICOXIB	-	DRUGBANK	DB01628	C18H15ClN2O2S	small molecule	M01AH05	202409-33-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MNJVRJDLRVPLFE-UHFFFAOYSA-N
17454	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	FitzGerald GA (2007)	17573128	181614	1565	Etoricoxib	5-chloro-6'-Methyl-3-(P-(methylsulfonyl)phenyl)-2,3'-bipyridine|5-chloro-2-(6-Methylpyridin-3-yl)-3-(4-(methylsulfonyl)phenyl)pyridine|Etoricoxibum|5-Chloro-3-(4-methanesulfonyl-phenyl)-6'-methyl-[2,3']bipyridinyl|L791456|ETORICOXIB	-	DRUGBANK	DB01628	C18H15ClN2O2S	small molecule	M01AH05	202409-33-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MNJVRJDLRVPLFE-UHFFFAOYSA-N
17562	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1624	Inhibitor Idd 384	-	-	DRUGBANK	DB01689	C19H22N2O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CJKKMQCZOLCXAM-UHFFFAOYSA-N
17563	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1624	Inhibitor Idd 384	-	-	DRUGBANK	DB01689	C19H22N2O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CJKKMQCZOLCXAM-UHFFFAOYSA-N
17564	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1624	Inhibitor Idd 384	-	-	DRUGBANK	DB01689	C19H22N2O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CJKKMQCZOLCXAM-UHFFFAOYSA-N
17586	114196	8644	-	AKR1C3	DD3|DDX|HA1753|HAKRB|HAKRe|HSD17B5|PGFS|hluPGFS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1633	Rutin	rutoside|quercetin-3-rutinoside|Phytomelin|sophorin|2-(3,4-Dihydroxyphenyl)-5,7-Dihydroxy-4-Oxo-4h-Chromen-3-Yl 6-O-(6-Deoxy-Alpha-L-Mannopyranosyl)-Beta-D-Glucopyranoside	-	DRUGBANK	DB01698	C27H30O16	small molecule	C05CA01|C05CA51	153-18-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKGXIBQEEMLURG-BKUODXTLSA-N
17587	114196	8644	-	AKR1C3	DD3|DDX|HA1753|HAKRB|HAKRe|HSD17B5|PGFS|hluPGFS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1633	Rutin	rutoside|quercetin-3-rutinoside|Phytomelin|sophorin|2-(3,4-Dihydroxyphenyl)-5,7-Dihydroxy-4-Oxo-4h-Chromen-3-Yl 6-O-(6-Deoxy-Alpha-L-Mannopyranosyl)-Beta-D-Glucopyranoside	-	DRUGBANK	DB01698	C27H30O16	small molecule	C05CA01|C05CA51	153-18-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IKGXIBQEEMLURG-BKUODXTLSA-N
17868	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1751	L-N(Omega)-Nitroarginine-2,4-L-Diaminobutyric Amide	-	-	DRUGBANK	DB01821	C10H22N8O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KUZKVXUOMSVPOA-NKWVEPMBSA-N
17869	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1751	L-N(Omega)-Nitroarginine-2,4-L-Diaminobutyric Amide	-	-	DRUGBANK	DB01821	C10H22N8O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KUZKVXUOMSVPOA-NKWVEPMBSA-N
17870	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1751	L-N(Omega)-Nitroarginine-2,4-L-Diaminobutyric Amide	-	-	DRUGBANK	DB01821	C10H22N8O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KUZKVXUOMSVPOA-NKWVEPMBSA-N
17906	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1767	O-acetyl-L-serine	L-Serine, acetate (ester)|O3-acetyl-L-serine	-	DRUGBANK	DB01837	C5H9NO4	small molecule	-	5147-00-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VZXPDPZARILFQX-BYPYZUCNSA-N
17907	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1767	O-acetyl-L-serine	L-Serine, acetate (ester)|O3-acetyl-L-serine	-	DRUGBANK	DB01837	C5H9NO4	small molecule	-	5147-00-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VZXPDPZARILFQX-BYPYZUCNSA-N
17908	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1767	O-acetyl-L-serine	L-Serine, acetate (ester)|O3-acetyl-L-serine	-	DRUGBANK	DB01837	C5H9NO4	small molecule	-	5147-00-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VZXPDPZARILFQX-BYPYZUCNSA-N
17927	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1774	Dimethylformamide	-	-	DRUGBANK	DB01844	C3H7NO	small molecule	-	68-12-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZMXDDKWLCZADIW-UHFFFAOYSA-N
17928	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1774	Dimethylformamide	-	-	DRUGBANK	DB01844	C3H7NO	small molecule	-	68-12-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZMXDDKWLCZADIW-UHFFFAOYSA-N
17929	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1774	Dimethylformamide	-	-	DRUGBANK	DB01844	C3H7NO	small molecule	-	68-12-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZMXDDKWLCZADIW-UHFFFAOYSA-N
18011	110428	4282	-	MIF	GIF|GLIF|MMIF	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1808	3,4-Dihydroxycinnamic Acid	-	-	DRUGBANK	DB01880	C9H8O4	small molecule	-	331-39-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QAIPRVGONGVQAS-DUXPYHPUSA-N
18025	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1819	Hyperforin	Hiperforina|Hyperforine	-	DRUGBANK	DB01892	C35H52O4	small molecule	-	11079-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IWBJJCOKGLUQIZ-UHFFFAOYSA-N
18028	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1819	Hyperforin	Hiperforina|Hyperforine	-	DRUGBANK	DB01892	C35H52O4	small molecule	-	11079-53-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IWBJJCOKGLUQIZ-UHFFFAOYSA-N
18033	118128	27306	-	HPGDS	GSTS|GSTS1-1|PGD2|PGDS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1824	2-(2f-Benzothiazolyl)-5-Styryl-3-(4f-Phthalhydrazidyl)Tetrazolium Chloride	-	-	DRUGBANK	DB01897	C24H16N7O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BEIGFKLRGRRJJA-JLHYYAGUSA-O
18034	118128	27306	-	HPGDS	GSTS|GSTS1-1|PGD2|PGDS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1824	2-(2f-Benzothiazolyl)-5-Styryl-3-(4f-Phthalhydrazidyl)Tetrazolium Chloride	-	-	DRUGBANK	DB01897	C24H16N7O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BEIGFKLRGRRJJA-JLHYYAGUSA-O
18129	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1867	Formic Acid	Formate|Methanoic acid|bilorin|Hydrogen carboxylic acid|Acide formique|Formylic acid|Aminic acid|Ameisensure	prenate essential|prenate elit	DRUGBANK	DB01942	CH2O2	small molecule	-	64-18-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BDAGIHXWWSANSR-UHFFFAOYSA-N
18158	119038	30814	-	PLA2G2E	GIIE sPLA2|sPLA2-IIE	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1879	1,4-Butanediol	-	-	DRUGBANK	DB01955	C4H10O2	small molecule	-	110-63-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WERYXYBDKMZEQL-UHFFFAOYSA-N
18159	119038	30814	-	PLA2G2E	GIIE sPLA2|sPLA2-IIE	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1879	1,4-Butanediol	-	-	DRUGBANK	DB01955	C4H10O2	small molecule	-	110-63-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WERYXYBDKMZEQL-UHFFFAOYSA-N
18160	119038	30814	-	PLA2G2E	GIIE sPLA2|sPLA2-IIE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1879	1,4-Butanediol	-	-	DRUGBANK	DB01955	C4H10O2	small molecule	-	110-63-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WERYXYBDKMZEQL-UHFFFAOYSA-N
18161	111337	5320	-	PLA2G2A	MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1879	1,4-Butanediol	-	-	DRUGBANK	DB01955	C4H10O2	small molecule	-	110-63-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WERYXYBDKMZEQL-UHFFFAOYSA-N
18162	111337	5320	-	PLA2G2A	MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1879	1,4-Butanediol	-	-	DRUGBANK	DB01955	C4H10O2	small molecule	-	110-63-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WERYXYBDKMZEQL-UHFFFAOYSA-N
18163	111337	5320	-	PLA2G2A	MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1879	1,4-Butanediol	-	-	DRUGBANK	DB01955	C4H10O2	small molecule	-	110-63-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WERYXYBDKMZEQL-UHFFFAOYSA-N
18286	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1921	3-Bromo-7-Nitroindazole	-	-	DRUGBANK	DB01997	C7H3BrN3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CCYVFYFSJBZPAW-UHFFFAOYSA-N
18287	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1921	3-Bromo-7-Nitroindazole	-	-	DRUGBANK	DB01997	C7H3BrN3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CCYVFYFSJBZPAW-UHFFFAOYSA-N
18288	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1921	3-Bromo-7-Nitroindazole	-	-	DRUGBANK	DB01997	C7H3BrN3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CCYVFYFSJBZPAW-UHFFFAOYSA-N
18301	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1931	alpha-D-glucose 6-phosphate	6-O-phosphono--D-glucopyranose	-	DRUGBANK	DB02007	C6H13O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NBSCHQHZLSJFNQ-DVKNGEFBSA-N
18302	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1931	alpha-D-glucose 6-phosphate	6-O-phosphono--D-glucopyranose	-	DRUGBANK	DB02007	C6H13O9P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NBSCHQHZLSJFNQ-DVKNGEFBSA-N
18322	112717	6850	-	SYK	p72-Syk	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1934	Staurosporine	2GCD|BCPP000063|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-METHYLAMINO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-09|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- (9CI)|ANTIBIOTIC AM-2282|EX-A1777|9,13-EPOXY-1H,9H-DIINDOLO(1,2,3-GH:3',2',1'-LM)PYRROLO(3,4-J)(1,7)-BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S-(9ALPHA,10BETA,11BETA,13ALPHA)-|HMS3650B17|NCGC00162400-06|H88EPA0A3N|8-METHOXY-9-METHYL-7-(METHYLAMINO)-6,7,8,9-TETRAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-16-OL|BRD-K17953061-001-02-8|62996-74-1|BRD-K17953061-001-11-9|109189-95-9|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-16-ONE|1U59|CCG-208052|STAUROSPORINE & TUMOR NECROSIS FACTOR (TNF)|NCGC00162400-02|2DQ7|MEGXM0_000307|1NVR|STAUROSPORINE;9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)-|BRD-K17953061-001-05-1|NCGC00162400-03|7158-EP2289893A1|8,12-EPOXY-1H,8H-2,7B,12A-TRIAZADIBENZO(A,G)CYCLONONA(CDE)TRINDEN-1-ONE, 2,3,9,10,11,12-HEXAHYDRO-9-METHOXY-8-METHYL-10-(METHYLAMINO)-, (8ALPHA,9BETA,10BETA,12ALPHA)-(+)-|CGP 39360|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8(13),9,11,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|AM-2282|ANTIBIOTIC AM 2282|1XJD|STAUROSPORIN|STAUROSPORINE & TNF|7158-EP2311842A2|STAUROSPORIN, 4|DB02010|METHOXY-METHYL-(METHYLAMINO)[?]ONE|NCGC00162400-01|GNF-PF-1389|7158-EP2292617A1|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, [9S-(9ALPHA,10BETA,11BETA,13ALPHA)]-|ANTIBIOTIC 230|7158-EP2308855A1|ALKALOID AM-2282 FROM STREPTOMYCES|ST50826371|1STC|HY-15141|MOLMAP_000047|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-04|(+)-STAUROSPORINE|GTPL346|7158-EP2311809A1|Q5957181|CS-2716|STAUROSPORINE, 8|AKOS015897119|BIO1_000753|BRD-K17953061-001-04-4|SR-00000001485-4|STAUROSPORINE|7158-EP2308883A1|BRD-K17953061-001-10-1|NCGC00162400-05|[9S-(9?,10?,11?,13?)]-2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE|LS-64042|CBIOL_001978|1SM2|1Q3D|BIO1_000264|1YHS|ZINC3814434|S1421|SR-00000001485|UNII-H88EPA0A3N|7158-EP2270008A1|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-17-OXA-4B,9A,15-TRIAZA-5,9-METHANODIBENZO[B,H]CYCLONONA[JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- & TUMOR NECROSIS FACTOR (TNF)|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO [12.12.2.1<2,6>.0<7,28>.0<8,13>.0<15,19>.0<20,27>.0<21,26>]NONACOSA-8(13),9,11 ,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|QTL1_000078|HMS1990J07|BIO1_001242|1XBC|DTXSID30911019|CCRIS 3272|BSPBIO_001146|BRD-K17953061-001-08-5|BDBM2579	-	DRUGBANK	DB02010	C28H26N4O3	small molecule	-	62996-74-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HKSZLNNOFSGOKW-UCBFMKAXSA-N
18323	112717	6850	-	SYK	p72-Syk	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1934	Staurosporine	2GCD|BCPP000063|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-METHYLAMINO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-09|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- (9CI)|ANTIBIOTIC AM-2282|EX-A1777|9,13-EPOXY-1H,9H-DIINDOLO(1,2,3-GH:3',2',1'-LM)PYRROLO(3,4-J)(1,7)-BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S-(9ALPHA,10BETA,11BETA,13ALPHA)-|HMS3650B17|NCGC00162400-06|H88EPA0A3N|8-METHOXY-9-METHYL-7-(METHYLAMINO)-6,7,8,9-TETRAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-16-OL|BRD-K17953061-001-02-8|62996-74-1|BRD-K17953061-001-11-9|109189-95-9|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-16-ONE|1U59|CCG-208052|STAUROSPORINE & TUMOR NECROSIS FACTOR (TNF)|NCGC00162400-02|2DQ7|MEGXM0_000307|1NVR|STAUROSPORINE;9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)-|BRD-K17953061-001-05-1|NCGC00162400-03|7158-EP2289893A1|8,12-EPOXY-1H,8H-2,7B,12A-TRIAZADIBENZO(A,G)CYCLONONA(CDE)TRINDEN-1-ONE, 2,3,9,10,11,12-HEXAHYDRO-9-METHOXY-8-METHYL-10-(METHYLAMINO)-, (8ALPHA,9BETA,10BETA,12ALPHA)-(+)-|CGP 39360|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8(13),9,11,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|AM-2282|ANTIBIOTIC AM 2282|1XJD|STAUROSPORIN|STAUROSPORINE & TNF|7158-EP2311842A2|STAUROSPORIN, 4|DB02010|METHOXY-METHYL-(METHYLAMINO)[?]ONE|NCGC00162400-01|GNF-PF-1389|7158-EP2292617A1|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, [9S-(9ALPHA,10BETA,11BETA,13ALPHA)]-|ANTIBIOTIC 230|7158-EP2308855A1|ALKALOID AM-2282 FROM STREPTOMYCES|ST50826371|1STC|HY-15141|MOLMAP_000047|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-04|(+)-STAUROSPORINE|GTPL346|7158-EP2311809A1|Q5957181|CS-2716|STAUROSPORINE, 8|AKOS015897119|BIO1_000753|BRD-K17953061-001-04-4|SR-00000001485-4|STAUROSPORINE|7158-EP2308883A1|BRD-K17953061-001-10-1|NCGC00162400-05|[9S-(9?,10?,11?,13?)]-2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE|LS-64042|CBIOL_001978|1SM2|1Q3D|BIO1_000264|1YHS|ZINC3814434|S1421|SR-00000001485|UNII-H88EPA0A3N|7158-EP2270008A1|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-17-OXA-4B,9A,15-TRIAZA-5,9-METHANODIBENZO[B,H]CYCLONONA[JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- & TUMOR NECROSIS FACTOR (TNF)|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO [12.12.2.1<2,6>.0<7,28>.0<8,13>.0<15,19>.0<20,27>.0<21,26>]NONACOSA-8(13),9,11 ,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|QTL1_000078|HMS1990J07|BIO1_001242|1XBC|DTXSID30911019|CCRIS 3272|BSPBIO_001146|BRD-K17953061-001-08-5|BDBM2579	-	DRUGBANK	DB02010	C28H26N4O3	small molecule	-	62996-74-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HKSZLNNOFSGOKW-UCBFMKAXSA-N
18334	114683	9261	-	MAPKAPK2	MAPKAP-K2|MK-2|MK2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1934	Staurosporine	2GCD|BCPP000063|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-METHYLAMINO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-09|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- (9CI)|ANTIBIOTIC AM-2282|EX-A1777|9,13-EPOXY-1H,9H-DIINDOLO(1,2,3-GH:3',2',1'-LM)PYRROLO(3,4-J)(1,7)-BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S-(9ALPHA,10BETA,11BETA,13ALPHA)-|HMS3650B17|NCGC00162400-06|H88EPA0A3N|8-METHOXY-9-METHYL-7-(METHYLAMINO)-6,7,8,9-TETRAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-16-OL|BRD-K17953061-001-02-8|62996-74-1|BRD-K17953061-001-11-9|109189-95-9|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-16-ONE|1U59|CCG-208052|STAUROSPORINE & TUMOR NECROSIS FACTOR (TNF)|NCGC00162400-02|2DQ7|MEGXM0_000307|1NVR|STAUROSPORINE;9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)-|BRD-K17953061-001-05-1|NCGC00162400-03|7158-EP2289893A1|8,12-EPOXY-1H,8H-2,7B,12A-TRIAZADIBENZO(A,G)CYCLONONA(CDE)TRINDEN-1-ONE, 2,3,9,10,11,12-HEXAHYDRO-9-METHOXY-8-METHYL-10-(METHYLAMINO)-, (8ALPHA,9BETA,10BETA,12ALPHA)-(+)-|CGP 39360|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8(13),9,11,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|AM-2282|ANTIBIOTIC AM 2282|1XJD|STAUROSPORIN|STAUROSPORINE & TNF|7158-EP2311842A2|STAUROSPORIN, 4|DB02010|METHOXY-METHYL-(METHYLAMINO)[?]ONE|NCGC00162400-01|GNF-PF-1389|7158-EP2292617A1|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, [9S-(9ALPHA,10BETA,11BETA,13ALPHA)]-|ANTIBIOTIC 230|7158-EP2308855A1|ALKALOID AM-2282 FROM STREPTOMYCES|ST50826371|1STC|HY-15141|MOLMAP_000047|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-04|(+)-STAUROSPORINE|GTPL346|7158-EP2311809A1|Q5957181|CS-2716|STAUROSPORINE, 8|AKOS015897119|BIO1_000753|BRD-K17953061-001-04-4|SR-00000001485-4|STAUROSPORINE|7158-EP2308883A1|BRD-K17953061-001-10-1|NCGC00162400-05|[9S-(9?,10?,11?,13?)]-2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE|LS-64042|CBIOL_001978|1SM2|1Q3D|BIO1_000264|1YHS|ZINC3814434|S1421|SR-00000001485|UNII-H88EPA0A3N|7158-EP2270008A1|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-17-OXA-4B,9A,15-TRIAZA-5,9-METHANODIBENZO[B,H]CYCLONONA[JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- & TUMOR NECROSIS FACTOR (TNF)|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO [12.12.2.1<2,6>.0<7,28>.0<8,13>.0<15,19>.0<20,27>.0<21,26>]NONACOSA-8(13),9,11 ,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|QTL1_000078|HMS1990J07|BIO1_001242|1XBC|DTXSID30911019|CCRIS 3272|BSPBIO_001146|BRD-K17953061-001-08-5|BDBM2579	-	DRUGBANK	DB02010	C28H26N4O3	small molecule	-	62996-74-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HKSZLNNOFSGOKW-UCBFMKAXSA-N
18335	114683	9261	-	MAPKAPK2	MAPKAP-K2|MK-2|MK2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1934	Staurosporine	2GCD|BCPP000063|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-METHYLAMINO-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-09|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- (9CI)|ANTIBIOTIC AM-2282|EX-A1777|9,13-EPOXY-1H,9H-DIINDOLO(1,2,3-GH:3',2',1'-LM)PYRROLO(3,4-J)(1,7)-BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S-(9ALPHA,10BETA,11BETA,13ALPHA)-|HMS3650B17|NCGC00162400-06|H88EPA0A3N|8-METHOXY-9-METHYL-7-(METHYLAMINO)-6,7,8,9-TETRAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-16-OL|BRD-K17953061-001-02-8|62996-74-1|BRD-K17953061-001-11-9|109189-95-9|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8,10,12,14(28),15(19),20(27),21,23,25-NONAEN-16-ONE|1U59|CCG-208052|STAUROSPORINE & TUMOR NECROSIS FACTOR (TNF)|NCGC00162400-02|2DQ7|MEGXM0_000307|1NVR|STAUROSPORINE;9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)-|BRD-K17953061-001-05-1|NCGC00162400-03|7158-EP2289893A1|8,12-EPOXY-1H,8H-2,7B,12A-TRIAZADIBENZO(A,G)CYCLONONA(CDE)TRINDEN-1-ONE, 2,3,9,10,11,12-HEXAHYDRO-9-METHOXY-8-METHYL-10-(METHYLAMINO)-, (8ALPHA,9BETA,10BETA,12ALPHA)-(+)-|CGP 39360|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]NONACOSA-8(13),9,11,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|AM-2282|ANTIBIOTIC AM 2282|1XJD|STAUROSPORIN|STAUROSPORINE & TNF|7158-EP2311842A2|STAUROSPORIN, 4|DB02010|METHOXY-METHYL-(METHYLAMINO)[?]ONE|NCGC00162400-01|GNF-PF-1389|7158-EP2292617A1|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, [9S-(9ALPHA,10BETA,11BETA,13ALPHA)]-|ANTIBIOTIC 230|7158-EP2308855A1|ALKALOID AM-2282 FROM STREPTOMYCES|ST50826371|1STC|HY-15141|MOLMAP_000047|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-5,9-EPOXY-4B,9A,15-TRIAZADIBENZO[B,H]CYCLONONA[1,2,3,4-JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|NCGC00162400-04|(+)-STAUROSPORINE|GTPL346|7158-EP2311809A1|Q5957181|CS-2716|STAUROSPORINE, 8|AKOS015897119|BIO1_000753|BRD-K17953061-001-04-4|SR-00000001485-4|STAUROSPORINE|7158-EP2308883A1|BRD-K17953061-001-10-1|NCGC00162400-05|[9S-(9?,10?,11?,13?)]-2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE|LS-64042|CBIOL_001978|1SM2|1Q3D|BIO1_000264|1YHS|ZINC3814434|S1421|SR-00000001485|UNII-H88EPA0A3N|7158-EP2270008A1|(5S,6R,7R,9R)-6-METHOXY-5-METHYL-7-(METHYLAMINO)-6,7,8,9,15,16-HEXAHYDRO-5H,14H-17-OXA-4B,9A,15-TRIAZA-5,9-METHANODIBENZO[B,H]CYCLONONA[JKL]CYCLOPENTA[E]-AS-INDACEN-14-ONE|9,13-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1-ONE, 2,3,10,11,12,13-HEXAHYDRO-10-METHOXY-9-METHYL-11-(METHYLAMINO)-, (9S,10R,11R,13R)- & TUMOR NECROSIS FACTOR (TNF)|(2S,3R,4R,6R)-3-METHOXY-2-METHYL-4-(METHYLAMINO)-29-OXA-1,7,17-TRIAZAOCTACYCLO [12.12.2.1<2,6>.0<7,28>.0<8,13>.0<15,19>.0<20,27>.0<21,26>]NONACOSA-8(13),9,11 ,14(28),15(19),20(27),21(26),22,24-NONAEN-16-ONE|QTL1_000078|HMS1990J07|BIO1_001242|1XBC|DTXSID30911019|CCRIS 3272|BSPBIO_001146|BRD-K17953061-001-08-5|BDBM2579	-	DRUGBANK	DB02010	C28H26N4O3	small molecule	-	62996-74-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HKSZLNNOFSGOKW-UCBFMKAXSA-N
18355	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1943	Alrestatin	-	-	DRUGBANK	DB02020	C14H9NO4	small molecule	-	51411-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GCUCIFQCGJIRNT-UHFFFAOYSA-N
18356	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1943	Alrestatin	-	-	DRUGBANK	DB02020	C14H9NO4	small molecule	-	51411-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GCUCIFQCGJIRNT-UHFFFAOYSA-N
18357	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1943	Alrestatin	-	-	DRUGBANK	DB02020	C14H9NO4	small molecule	-	51411-04-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GCUCIFQCGJIRNT-UHFFFAOYSA-N
18358	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	1944	Fidarestat	Aldos|(S,S)-fidarestat	-	DRUGBANK	DB02021	C12H10FN3O4	small molecule	-	136087-85-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WAAPEIZFCHNLKK-UFBFGSQYSA-N
18365	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1950	N-{(4s)-4-Amino-5-[(2-Aminoethyl)Amino]Pentyl}-N'-Nitroguanidine	-	-	DRUGBANK	DB02027	C8H21N7O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMSWBHUVFNFNIZ-ZETCQYMHSA-N
18366	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1950	N-{(4s)-4-Amino-5-[(2-Aminoethyl)Amino]Pentyl}-N'-Nitroguanidine	-	-	DRUGBANK	DB02027	C8H21N7O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMSWBHUVFNFNIZ-ZETCQYMHSA-N
18367	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1950	N-{(4s)-4-Amino-5-[(2-Aminoethyl)Amino]Pentyl}-N'-Nitroguanidine	-	-	DRUGBANK	DB02027	C8H21N7O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMSWBHUVFNFNIZ-ZETCQYMHSA-N
18372	108367	2053	-	EPHX2	CEH|SEH	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1952	N-Cyclohexyl-N'-(4-Iodophenyl)Urea	-	-	DRUGBANK	DB02029	C13H17IN2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQTBUVAFYDVTFD-UHFFFAOYSA-N
18373	108367	2053	-	EPHX2	CEH|SEH	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1952	N-Cyclohexyl-N'-(4-Iodophenyl)Urea	-	-	DRUGBANK	DB02029	C13H17IN2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQTBUVAFYDVTFD-UHFFFAOYSA-N
18374	108367	2053	-	EPHX2	CEH|SEH	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1952	N-Cyclohexyl-N'-(4-Iodophenyl)Urea	-	-	DRUGBANK	DB02029	C13H17IN2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQTBUVAFYDVTFD-UHFFFAOYSA-N
18379	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1955	1-(3-Mercapto-2-Methyl-Propionyl)-Pyrrolidine-2-Carboxylic Acid	-	-	DRUGBANK	DB02032	C9H15NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAKRSMQSSFJEIM-BQBZGAKWSA-N
18380	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1955	1-(3-Mercapto-2-Methyl-Propionyl)-Pyrrolidine-2-Carboxylic Acid	-	-	DRUGBANK	DB02032	C9H15NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAKRSMQSSFJEIM-BQBZGAKWSA-N
18381	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1955	1-(3-Mercapto-2-Methyl-Propionyl)-Pyrrolidine-2-Carboxylic Acid	-	-	DRUGBANK	DB02032	C9H15NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FAKRSMQSSFJEIM-BQBZGAKWSA-N
18393	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1966	N-(3-(Aminomethyl)Benzyl)Acetamidine	-	-	DRUGBANK	DB02044	C10H15N3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RODUKNYOEVZQPR-UHFFFAOYSA-N
18400	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1969	2-(1,1'-Biphenyl-4-Yl)Propanoic Acid	-	-	DRUGBANK	DB02047	C15H14O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JALUUBQFLPUJMY-NSHDSACASA-N
18416	114196	8644	-	AKR1C3	DD3|DDX|HA1753|HAKRB|HAKRe|HSD17B5|PGFS|hluPGFS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1977	(5e,13e)-9,15-Dihydroxy-11-Oxoprosta-5,13-Dien-1-Oicacid	-	-	DRUGBANK	DB02056	C20H32O5	small molecule	-	41598-07-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BHMBVRSPMRCCGG-OUTUXVNYSA-N
18417	114196	8644	-	AKR1C3	DD3|DDX|HA1753|HAKRB|HAKRe|HSD17B5|PGFS|hluPGFS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1977	(5e,13e)-9,15-Dihydroxy-11-Oxoprosta-5,13-Dien-1-Oicacid	-	-	DRUGBANK	DB02056	C20H32O5	small molecule	-	41598-07-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BHMBVRSPMRCCGG-OUTUXVNYSA-N
18418	114196	8644	-	AKR1C3	DD3|DDX|HA1753|HAKRB|HAKRe|HSD17B5|PGFS|hluPGFS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1977	(5e,13e)-9,15-Dihydroxy-11-Oxoprosta-5,13-Dien-1-Oicacid	-	-	DRUGBANK	DB02056	C20H32O5	small molecule	-	41598-07-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BHMBVRSPMRCCGG-OUTUXVNYSA-N
18436	110226	4048	-	LTA4H	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1983	N-[3-[(1-Aminoethyl)(Hydroxy)Phosphoryl]-2-(1,1'-Biphenyl-4-Ylmethyl)Propanoyl]Alanine	-	-	DRUGBANK	DB02062	C21H27N2O5P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CWJPVKSBGVPXRD-QMTMVMCOSA-N
18478	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	1997	L-N(Omega)-Nitroarginine-(4r)-Amino-L-Proline Amide	-	-	DRUGBANK	DB02077	C11H22N8O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IUFRDGFKAVLPFZ-CSMHCCOUSA-N
18479	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	1997	L-N(Omega)-Nitroarginine-(4r)-Amino-L-Proline Amide	-	-	DRUGBANK	DB02077	C11H22N8O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IUFRDGFKAVLPFZ-CSMHCCOUSA-N
18480	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	1997	L-N(Omega)-Nitroarginine-(4r)-Amino-L-Proline Amide	-	-	DRUGBANK	DB02077	C11H22N8O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IUFRDGFKAVLPFZ-CSMHCCOUSA-N
18491	111337	5320	-	PLA2G2A	MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2000	1-{2-[2-(2-Methoxyethoxy)Ethoxy]Ethoxy}-4-(1,1,3,3-Tetramethylbutyl)Benzene	-	-	DRUGBANK	DB02080	C21H36O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HEUDUECKTWTQQR-UHFFFAOYSA-N
18530	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2021	(S,R)-fidarestat	(2S,4R)-2-aminoformyl-6-fluoro-spiro[chroman-4,4'-imidazolidine]-2',5'-dione|Fidarestat(stereoisomer)	-	DRUGBANK	DB02101	C12H10FN3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WAAPEIZFCHNLKK-QPUJVOFHSA-N
18531	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2021	(S,R)-fidarestat	(2S,4R)-2-aminoformyl-6-fluoro-spiro[chroman-4,4'-imidazolidine]-2',5'-dione|Fidarestat(stereoisomer)	-	DRUGBANK	DB02101	C12H10FN3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WAAPEIZFCHNLKK-QPUJVOFHSA-N
18551	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2030	Protoporphyrin Ix Containing Co	-	-	DRUGBANK	DB02110	C34H32CoN4O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKAUCPKZLCNDIC-RGGAHWMASA-L
18552	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2030	Protoporphyrin Ix Containing Co	-	-	DRUGBANK	DB02110	C34H32CoN4O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKAUCPKZLCNDIC-RGGAHWMASA-L
18553	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2030	Protoporphyrin Ix Containing Co	-	-	DRUGBANK	DB02110	C34H32CoN4O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKAUCPKZLCNDIC-RGGAHWMASA-L
18592	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2051	[3-(4-Bromo-2-Fluoro-Benzyl)-7-Chloro-2,4-Dioxo-3,4-Dihydro-2h-Quinazolin-1-Yl]-Acetic Acid	-	-	DRUGBANK	DB02132	C17H11BrClFN2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SXONDGSPUVNZLO-UHFFFAOYSA-N
18593	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2051	[3-(4-Bromo-2-Fluoro-Benzyl)-7-Chloro-2,4-Dioxo-3,4-Dihydro-2h-Quinazolin-1-Yl]-Acetic Acid	-	-	DRUGBANK	DB02132	C17H11BrClFN2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SXONDGSPUVNZLO-UHFFFAOYSA-N
18594	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2051	[3-(4-Bromo-2-Fluoro-Benzyl)-7-Chloro-2,4-Dioxo-3,4-Dihydro-2h-Quinazolin-1-Yl]-Acetic Acid	-	-	DRUGBANK	DB02132	C17H11BrClFN2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SXONDGSPUVNZLO-UHFFFAOYSA-N
18609	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2062	N-Isopropyl-N'-Hydroxyguanidine	-	-	DRUGBANK	DB02143	C4H11N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OITVEDMMUMUWTL-UHFFFAOYSA-N
18610	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2062	N-Isopropyl-N'-Hydroxyguanidine	-	-	DRUGBANK	DB02143	C4H11N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OITVEDMMUMUWTL-UHFFFAOYSA-N
18611	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2062	N-Isopropyl-N'-Hydroxyguanidine	-	-	DRUGBANK	DB02143	C4H11N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OITVEDMMUMUWTL-UHFFFAOYSA-N
18716	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2114	2-Bromoacetyl Group	-	-	DRUGBANK	DB02198	C2H3BrO2	small molecule	-	79-08-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDPAWGWELVVRCH-UHFFFAOYSA-N
18717	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2114	2-Bromoacetyl Group	-	-	DRUGBANK	DB02198	C2H3BrO2	small molecule	-	79-08-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDPAWGWELVVRCH-UHFFFAOYSA-N
18718	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2114	2-Bromoacetyl Group	-	-	DRUGBANK	DB02198	C2H3BrO2	small molecule	-	79-08-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KDPAWGWELVVRCH-UHFFFAOYSA-N
18737	111336	5319	-	PLA2G1B	PLA2|PLA2A|PPLA2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2123	Hexane-1,6-Diol	-	-	DRUGBANK	DB02210	C6H14O2	small molecule	-	629-11-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XXMIOPMDWAUFGU-UHFFFAOYSA-N
18738	111336	5319	-	PLA2G1B	PLA2|PLA2A|PPLA2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2123	Hexane-1,6-Diol	-	-	DRUGBANK	DB02210	C6H14O2	small molecule	-	629-11-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XXMIOPMDWAUFGU-UHFFFAOYSA-N
18739	111336	5319	-	PLA2G1B	PLA2|PLA2A|PPLA2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2123	Hexane-1,6-Diol	-	-	DRUGBANK	DB02210	C6H14O2	small molecule	-	629-11-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XXMIOPMDWAUFGU-UHFFFAOYSA-N
18836	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	unknown	target	Ouellet M (1995)	7864817	181626	2175	Flufenamic Acid	-	-	DRUGBANK	DB02266	C14H10F3NO2	small molecule	M01AG03	530-78-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LPEPZBJOKDYZAD-UHFFFAOYSA-N
18838	114196	8644	-	AKR1C3	DD3|DDX|HA1753|HAKRB|HAKRe|HSD17B5|PGFS|hluPGFS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2175	Flufenamic Acid	-	-	DRUGBANK	DB02266	C14H10F3NO2	small molecule	M01AG03	530-78-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LPEPZBJOKDYZAD-UHFFFAOYSA-N
18839	114196	8644	-	AKR1C3	DD3|DDX|HA1753|HAKRB|HAKRe|HSD17B5|PGFS|hluPGFS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2175	Flufenamic Acid	-	-	DRUGBANK	DB02266	C14H10F3NO2	small molecule	M01AG03	530-78-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LPEPZBJOKDYZAD-UHFFFAOYSA-N
18840	114196	8644	-	AKR1C3	DD3|DDX|HA1753|HAKRB|HAKRe|HSD17B5|PGFS|hluPGFS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2175	Flufenamic Acid	-	-	DRUGBANK	DB02266	C14H10F3NO2	small molecule	M01AG03	530-78-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LPEPZBJOKDYZAD-UHFFFAOYSA-N
18841	114196	8644	-	AKR1C3	DD3|DDX|HA1753|HAKRB|HAKRe|HSD17B5|PGFS|hluPGFS	9606	Homo sapiens	unknown	target	Lovering AL (2004)	14996743	159435	2175	Flufenamic Acid	-	-	DRUGBANK	DB02266	C14H10F3NO2	small molecule	M01AG03	530-78-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LPEPZBJOKDYZAD-UHFFFAOYSA-N
18842	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	unknown	target	Ouellet M (1995)	7864817	181626	2175	Flufenamic Acid	-	-	DRUGBANK	DB02266	C14H10F3NO2	small molecule	M01AG03	530-78-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LPEPZBJOKDYZAD-UHFFFAOYSA-N
18886	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2203	1-Hydroxy-3-Methylbutane	-	-	DRUGBANK	DB02296	C5H12O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHTQWCKDNZKARW-UHFFFAOYSA-N
18887	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2203	1-Hydroxy-3-Methylbutane	-	-	DRUGBANK	DB02296	C5H12O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHTQWCKDNZKARW-UHFFFAOYSA-N
18888	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2203	1-Hydroxy-3-Methylbutane	-	-	DRUGBANK	DB02296	C5H12O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHTQWCKDNZKARW-UHFFFAOYSA-N
18987	107925	1545	-	CYP1B1	CP1B|CYPIB1|GLC3A|P4501B1	9606	Homo sapiens	unknown	target	Dawling S (2003)	12810639	181629	2247	2-Methoxyestradiol	2-Hydroxyestradol 2-methyl ether|2-MeOE2|2-methoxy-17beta-estradiol|2ME2|2-methoxyestra-1(10),2,4-triene-3,17-diol|2-Hydroxyestradiol 2-methyl ether|ESM|2-Methoxyestradiol-17beta	-	DRUGBANK	DB02342	C19H26O3	small molecule	-	362-07-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CQOQDQWUFQDJMK-WRWXEFHESA-N
18989	107923	1543	-	CYP1A1	AHH|AHRR|CP11|CYP1|P1-450|P450-C|P450DX	9606	Homo sapiens	unknown	target	Dawling S (2003)	12810639	181629	2247	2-Methoxyestradiol	2-Hydroxyestradol 2-methyl ether|2-MeOE2|2-methoxy-17beta-estradiol|2ME2|2-methoxyestra-1(10),2,4-triene-3,17-diol|2-Hydroxyestradiol 2-methyl ether|ESM|2-Methoxyestradiol-17beta	-	DRUGBANK	DB02342	C19H26O3	small molecule	-	362-07-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CQOQDQWUFQDJMK-WRWXEFHESA-N
19015	110226	4048	-	LTA4H	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2257	3-(Benzyloxy)Pyridin-2-Amine	-	-	DRUGBANK	DB02352	C12H12N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NMCBWICNRJLKKM-UHFFFAOYSA-N
19023	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2264	9-Butyl-8-(2,5-Dimethoxy-Benzyl)-9h-Purin-6-Ylamine	-	-	DRUGBANK	DB02359	C18H23N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PPFZLLAIQRZNJE-UHFFFAOYSA-N
19110	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2284	Beta-D-Glucose	Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous	-	DRUGBANK	DB02379	C6H12O6	small molecule	-	492-61-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WQZGKKKJIJFFOK-VFUOTHLCSA-N
19111	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2284	Beta-D-Glucose	Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous	-	DRUGBANK	DB02379	C6H12O6	small molecule	-	492-61-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WQZGKKKJIJFFOK-VFUOTHLCSA-N
19112	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2284	Beta-D-Glucose	Glucose, beta-D-|Glucoside|beta-D-glucopyranose|Beta-D-glucose, anhydrous|Glucose, beta-D|Beta-D-glucose anhydrous	-	DRUGBANK	DB02379	C6H12O6	small molecule	-	492-61-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WQZGKKKJIJFFOK-VFUOTHLCSA-N
19119	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	2288	Tolrestat	-	-	DRUGBANK	DB02383	C16H14F3NO3S	small molecule	A10XA01	82964-04-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LUBHDINQXIHVLS-UHFFFAOYSA-N
19120	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	inhibitor	target	Berman HM (2000)	10592235	172122	2288	Tolrestat	-	-	DRUGBANK	DB02383	C16H14F3NO3S	small molecule	A10XA01	82964-04-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LUBHDINQXIHVLS-UHFFFAOYSA-N
19121	115610	10327	RP4-697E16.2	AKR1A1	ALDR1|ALR|ARM|DD3|HEL-S-6	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2288	Tolrestat	-	-	DRUGBANK	DB02383	C16H14F3NO3S	small molecule	A10XA01	82964-04-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LUBHDINQXIHVLS-UHFFFAOYSA-N
19175	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2327	Geldanamycin	-	-	DRUGBANK	DB02424	C29H40N2O9	small molecule	-	30562-34-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QTQAWLPCGQOSGP-KSRBKZBZSA-N
19176	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2327	Geldanamycin	-	-	DRUGBANK	DB02424	C29H40N2O9	small molecule	-	30562-34-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QTQAWLPCGQOSGP-KSRBKZBZSA-N
19222	111336	5319	-	PLA2G1B	PLA2|PLA2A|PPLA2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2349	N-Tridecanoic Acid	-	-	DRUGBANK	DB02448	C13H26O2	small molecule	-	638-53-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SZHOJFHSIKHZHA-UHFFFAOYSA-N
19223	119038	30814	-	PLA2G2E	GIIE sPLA2|sPLA2-IIE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2349	N-Tridecanoic Acid	-	-	DRUGBANK	DB02448	C13H26O2	small molecule	-	638-53-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SZHOJFHSIKHZHA-UHFFFAOYSA-N
19224	111337	5320	-	PLA2G2A	MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2349	N-Tridecanoic Acid	-	-	DRUGBANK	DB02448	C13H26O2	small molecule	-	638-53-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SZHOJFHSIKHZHA-UHFFFAOYSA-N
19354	111337	5320	-	PLA2G2A	MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2401	[3-(1-Benzyl-3-Carbamoylmethyl-2-Methyl-1h-Indol-5-Yloxy)-Propyl-]-Phosphonic Acid	-	-	DRUGBANK	DB02504	C21H25N2O5P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQEYCNKFBRLUOT-UHFFFAOYSA-N
19355	111337	5320	-	PLA2G2A	MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2401	[3-(1-Benzyl-3-Carbamoylmethyl-2-Methyl-1h-Indol-5-Yloxy)-Propyl-]-Phosphonic Acid	-	-	DRUGBANK	DB02504	C21H25N2O5P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQEYCNKFBRLUOT-UHFFFAOYSA-N
19356	111337	5320	-	PLA2G2A	MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2401	[3-(1-Benzyl-3-Carbamoylmethyl-2-Methyl-1h-Indol-5-Yloxy)-Propyl-]-Phosphonic Acid	-	-	DRUGBANK	DB02504	C21H25N2O5P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AQEYCNKFBRLUOT-UHFFFAOYSA-N
19362	107937	1559	RP11-208C17.6	CYP2C9	CPC9|CYP2C|CYP2C10|CYPIIC9|P450IIC9	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2404	4-Hydroxy-3-[(1s)-3-Oxo-1-Phenylbutyl]-2h-Chromen-2-One	-	-	DRUGBANK	DB02507	C19H16O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PJVWKTKQMONHTI-HNNXBMFYSA-N
19387	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2415	N-Acetylalanine	L-N-Acetylalanine|Acetylalanine|N-Acetyl-S-alanine|N-acetyl-L--alanine|Ac-Ala-OH|(S)-2-(acetylamino)propanoic acid|2-acetamidopropionic acid|N-acetyl-L-alanine|s-(-)-n-acetylalanine	-	DRUGBANK	DB02518	C5H9NO3	small molecule	-	97-69-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KTHDTJVBEPMMGL-VKHMYHEASA-N
19388	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2415	N-Acetylalanine	L-N-Acetylalanine|Acetylalanine|N-Acetyl-S-alanine|N-acetyl-L--alanine|Ac-Ala-OH|(S)-2-(acetylamino)propanoic acid|2-acetamidopropionic acid|N-acetyl-L-alanine|s-(-)-n-acetylalanine	-	DRUGBANK	DB02518	C5H9NO3	small molecule	-	97-69-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KTHDTJVBEPMMGL-VKHMYHEASA-N
19389	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2415	N-Acetylalanine	L-N-Acetylalanine|Acetylalanine|N-Acetyl-S-alanine|N-acetyl-L--alanine|Ac-Ala-OH|(S)-2-(acetylamino)propanoic acid|2-acetamidopropionic acid|N-acetyl-L-alanine|s-(-)-n-acetylalanine	-	DRUGBANK	DB02518	C5H9NO3	small molecule	-	97-69-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KTHDTJVBEPMMGL-VKHMYHEASA-N
19444	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2447	8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-2-Fluoro-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine	-	-	DRUGBANK	DB02550	C20H21ClFN5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KCIOVTSUEXGUFJ-UHFFFAOYSA-N
19586	119038	30814	-	PLA2G2E	GIIE sPLA2|sPLA2-IIE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2527	9-Hydroxy-8-Methoxy-6-Nitro-Phenanthrol[3,4-D][1,3]Dioxole-5-Carboxylic Acid	-	-	DRUGBANK	DB02636	C17H11NO8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UCLGCTLOEZZSLA-UHFFFAOYSA-N
19611	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2535	N-Omega-Propyl-L-Arginine	-	-	DRUGBANK	DB02644	C9H21N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AOMXURITGZJPKB-ZETCQYMHSA-O
19612	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2535	N-Omega-Propyl-L-Arginine	-	-	DRUGBANK	DB02644	C9H21N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AOMXURITGZJPKB-ZETCQYMHSA-O
19613	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2535	N-Omega-Propyl-L-Arginine	-	-	DRUGBANK	DB02644	C9H21N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AOMXURITGZJPKB-ZETCQYMHSA-O
19648	111336	5319	-	PLA2G1B	PLA2|PLA2A|PPLA2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2550	Cholic Acid	-	cholbam	DRUGBANK	DB02659	C24H40O5	small molecule	A05AA03	81-25-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BHQCQFFYRZLCQQ-OELDTZBJSA-N
19710	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2581	(6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin	-	-	DRUGBANK	DB02692	C9H15N5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	InChIKey=FNKQXYHWGSIFBK-KODRXGBYSA-N
19711	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2581	(6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin	-	-	DRUGBANK	DB02692	C9H15N5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	InChIKey=FNKQXYHWGSIFBK-KODRXGBYSA-N
19712	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2581	(6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin	-	-	DRUGBANK	DB02692	C9H15N5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	InChIKey=FNKQXYHWGSIFBK-KODRXGBYSA-N
19743	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	2597	Resveratrol	(E)-5-[2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol|trans-3,4',5-trihydroxystilbene|(E)-5-[2-(4-hydroxyphenyl)ethenyl]-1,3-benzendiol|3,4',5-Stilbenetriol|3,4',5-Trihydroxystilbene|(E)-5-(p-Hydroxystyryl)resorcinol|3,4',5-trihydroxy-stilbene|(E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol|(E)-resveratrol	co-veratrol	DRUGBANK	DB02709	C14H12O3	small molecule	-	501-36-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LUKBXSAWLPMMSZ-OWOJBTEDSA-N
19745	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	2597	Resveratrol	(E)-5-[2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol|trans-3,4',5-trihydroxystilbene|(E)-5-[2-(4-hydroxyphenyl)ethenyl]-1,3-benzendiol|3,4',5-Stilbenetriol|3,4',5-Trihydroxystilbene|(E)-5-(p-Hydroxystyryl)resorcinol|3,4',5-trihydroxy-stilbene|(E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol|(E)-resveratrol	co-veratrol	DRUGBANK	DB02709	C14H12O3	small molecule	-	501-36-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LUKBXSAWLPMMSZ-OWOJBTEDSA-N
19749	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	2600	Sorbinil	-	-	DRUGBANK	DB02712	C11H9FN2O3	small molecule	-	68367-52-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXANPKRCLVQAOG-NSHDSACASA-N
19750	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	inhibitor	target	Berman HM (2000)	10592235	172122	2600	Sorbinil	-	-	DRUGBANK	DB02712	C11H9FN2O3	small molecule	-	68367-52-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LXANPKRCLVQAOG-NSHDSACASA-N
19802	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2615	N-Butyl-N'-Hydroxyguanidine	-	-	DRUGBANK	DB02727	C5H13N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULDDTFAPYWLDGF-UHFFFAOYSA-N
19803	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2615	N-Butyl-N'-Hydroxyguanidine	-	-	DRUGBANK	DB02727	C5H13N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULDDTFAPYWLDGF-UHFFFAOYSA-N
19804	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2615	N-Butyl-N'-Hydroxyguanidine	-	-	DRUGBANK	DB02727	C5H13N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULDDTFAPYWLDGF-UHFFFAOYSA-N
19805	110428	4282	-	MIF	GIF|GLIF|MMIF	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2616	7-Hydroxy-2-Oxo-Chromene-3-Carboxylic Acid Ethyl Ester	-	-	DRUGBANK	DB02728	C12H10O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IETDBZQIWIJQJG-UHFFFAOYSA-N
19806	110428	4282	-	MIF	GIF|GLIF|MMIF	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2616	7-Hydroxy-2-Oxo-Chromene-3-Carboxylic Acid Ethyl Ester	-	-	DRUGBANK	DB02728	C12H10O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IETDBZQIWIJQJG-UHFFFAOYSA-N
19807	110428	4282	-	MIF	GIF|GLIF|MMIF	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2616	7-Hydroxy-2-Oxo-Chromene-3-Carboxylic Acid Ethyl Ester	-	-	DRUGBANK	DB02728	C12H10O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IETDBZQIWIJQJG-UHFFFAOYSA-N
19854	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2639	9-Butyl-8-(3,4,5-Trimethoxybenzyl)-9h-Purin-6-Amine	-	-	DRUGBANK	DB02754	C19H25N5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TUOSCZDRWRYPRS-UHFFFAOYSA-N
19861	119038	30814	-	PLA2G2E	GIIE sPLA2|sPLA2-IIE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2643	Indolylpropionic Acid	-	-	DRUGBANK	DB02758	C11H11NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GOLXRNDWAUTYKT-UHFFFAOYSA-N
19896	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2657	(3-Chloro-4-Propoxy-Phenyl)-Acetic Acid	-	-	DRUGBANK	DB02773	C11H13ClO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QEJHPAGTOOIBFT-UHFFFAOYSA-N
19922	111336	5319	-	PLA2G1B	PLA2|PLA2A|PPLA2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2677	P-Anisic Acid	-	-	DRUGBANK	DB02795	C8H8O3	small molecule	-	100-09-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEYHEAKUIGZSGI-UHFFFAOYSA-N
19923	111336	5319	-	PLA2G1B	PLA2|PLA2A|PPLA2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2677	P-Anisic Acid	-	-	DRUGBANK	DB02795	C8H8O3	small molecule	-	100-09-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEYHEAKUIGZSGI-UHFFFAOYSA-N
19924	111336	5319	-	PLA2G1B	PLA2|PLA2A|PPLA2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2677	P-Anisic Acid	-	-	DRUGBANK	DB02795	C8H8O3	small molecule	-	100-09-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEYHEAKUIGZSGI-UHFFFAOYSA-N
19925	119038	30814	-	PLA2G2E	GIIE sPLA2|sPLA2-IIE	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2677	P-Anisic Acid	-	-	DRUGBANK	DB02795	C8H8O3	small molecule	-	100-09-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEYHEAKUIGZSGI-UHFFFAOYSA-N
19926	119038	30814	-	PLA2G2E	GIIE sPLA2|sPLA2-IIE	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2677	P-Anisic Acid	-	-	DRUGBANK	DB02795	C8H8O3	small molecule	-	100-09-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEYHEAKUIGZSGI-UHFFFAOYSA-N
19927	119038	30814	-	PLA2G2E	GIIE sPLA2|sPLA2-IIE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2677	P-Anisic Acid	-	-	DRUGBANK	DB02795	C8H8O3	small molecule	-	100-09-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEYHEAKUIGZSGI-UHFFFAOYSA-N
19943	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2685	3-Phenyl-1,2-Propandiol	-	-	DRUGBANK	DB02803	C9H12O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JHWQMXKQJVAWKI-VIFPVBQESA-N
19944	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2685	3-Phenyl-1,2-Propandiol	-	-	DRUGBANK	DB02803	C9H12O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JHWQMXKQJVAWKI-VIFPVBQESA-N
19945	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2685	3-Phenyl-1,2-Propandiol	-	-	DRUGBANK	DB02803	C9H12O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JHWQMXKQJVAWKI-VIFPVBQESA-N
19990	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2716	IDD552	-	-	DRUGBANK	DB02834	C17H10F4N2O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZCAGEXZTORJQDZ-UHFFFAOYSA-N
19991	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2716	IDD552	-	-	DRUGBANK	DB02834	C17H10F4N2O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZCAGEXZTORJQDZ-UHFFFAOYSA-N
19992	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2716	IDD552	-	-	DRUGBANK	DB02834	C17H10F4N2O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZCAGEXZTORJQDZ-UHFFFAOYSA-N
20004	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2722	4-(1,3-Benzodioxol-5-Yl)-5-(5-Ethyl-2,4-Dihydroxyphenyl)-2h-Pyrazole-3-Carboxylic Acid	-	-	DRUGBANK	DB02840	C19H16N2O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LCTWZJKHOGKNMX-UHFFFAOYSA-N
20005	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2722	4-(1,3-Benzodioxol-5-Yl)-5-(5-Ethyl-2,4-Dihydroxyphenyl)-2h-Pyrazole-3-Carboxylic Acid	-	-	DRUGBANK	DB02840	C19H16N2O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LCTWZJKHOGKNMX-UHFFFAOYSA-N
20006	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2722	4-(1,3-Benzodioxol-5-Yl)-5-(5-Ethyl-2,4-Dihydroxyphenyl)-2h-Pyrazole-3-Carboxylic Acid	-	-	DRUGBANK	DB02840	C19H16N2O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LCTWZJKHOGKNMX-UHFFFAOYSA-N
20168	111337	5320	-	PLA2G2A	MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2814	4-(1-Benzyl-3-Carbamoylmethyl-2-Methyl-1h-Indol-5-Yloxy)-Butyric Acid	-	-	DRUGBANK	DB02936	C22H24N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STENXUCYNKOBHJ-UHFFFAOYSA-N
20169	111337	5320	-	PLA2G2A	MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2814	4-(1-Benzyl-3-Carbamoylmethyl-2-Methyl-1h-Indol-5-Yloxy)-Butyric Acid	-	-	DRUGBANK	DB02936	C22H24N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STENXUCYNKOBHJ-UHFFFAOYSA-N
20170	111337	5320	-	PLA2G2A	MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2814	4-(1-Benzyl-3-Carbamoylmethyl-2-Methyl-1h-Indol-5-Yloxy)-Butyric Acid	-	-	DRUGBANK	DB02936	C22H24N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	STENXUCYNKOBHJ-UHFFFAOYSA-N
20175	111336	5319	-	PLA2G1B	PLA2|PLA2A|PPLA2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2816	Heptanoic Acid	-	-	DRUGBANK	DB02938	C7H14O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MNWFXJYAOYHMED-UHFFFAOYSA-N
20218	107933	1555	-	CYP2B6	CPB6|CYP2B|CYP2B7|CYP2B7P|CYPIIB6|EFVM|IIB1|P450	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2851	4-(4-Chlorophenyl)Imidazole	-	-	DRUGBANK	DB02974	C9H6ClN2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
20219	107933	1555	-	CYP2B6	CPB6|CYP2B|CYP2B7|CYP2B7P|CYPIIB6|EFVM|IIB1|P450	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2851	4-(4-Chlorophenyl)Imidazole	-	-	DRUGBANK	DB02974	C9H6ClN2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
20220	107933	1555	-	CYP2B6	CPB6|CYP2B|CYP2B7|CYP2B7P|CYPIIB6|EFVM|IIB1|P450	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2851	4-(4-Chlorophenyl)Imidazole	-	-	DRUGBANK	DB02974	C9H6ClN2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
20247	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2868	S-Ethyl-N-[4-(Trifluoromethyl)Phenyl]Isothiourea	-	-	DRUGBANK	DB02991	C10H11F3N2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LCMOXIFARISMOH-UHFFFAOYSA-N
20251	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2871	Hydroxydimethylarsine Oxide	-	-	DRUGBANK	DB02994	C2H7AsO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGGXGZAMXPVRFZ-UHFFFAOYSA-N
20252	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2871	Hydroxydimethylarsine Oxide	-	-	DRUGBANK	DB02994	C2H7AsO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OGGXGZAMXPVRFZ-UHFFFAOYSA-N
20336	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2898	2-Methyl-3-(2-Aminothiazolo)Propanal	-	-	DRUGBANK	DB03024	C7H10N2OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KFMAJVLZSDMFBV-YFKPBYRVSA-N
20390	112778	6916	-	TBXAS1	BDPLT14|CYP5|CYP5A1|GHOSAL|THAS|TS|TXAS|TXS	9606	Homo sapiens	inhibitor	target	Imming P (2006)	17016423	171742	2924	Dazoxiben	Benzoic acid, 4-(2-(1H-imidazol-1-yl)ethoxy)-|Dazoxibene|Dazoxiben|Dazoxibenum	-	DRUGBANK	DB03052	C12H12N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XQGZSYKGWHUSDH-UHFFFAOYSA-N
20391	112778	6916	-	TBXAS1	BDPLT14|CYP5|CYP5A1|GHOSAL|THAS|TS|TXAS|TXS	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	2924	Dazoxiben	Benzoic acid, 4-(2-(1H-imidazol-1-yl)ethoxy)-|Dazoxibene|Dazoxiben|Dazoxibenum	-	DRUGBANK	DB03052	C12H12N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XQGZSYKGWHUSDH-UHFFFAOYSA-N
20392	112778	6916	-	TBXAS1	BDPLT14|CYP5|CYP5A1|GHOSAL|THAS|TS|TXAS|TXS	9606	Homo sapiens	inhibitor	target	Overington JP (2006)	17139284	171741	2924	Dazoxiben	Benzoic acid, 4-(2-(1H-imidazol-1-yl)ethoxy)-|Dazoxibene|Dazoxiben|Dazoxibenum	-	DRUGBANK	DB03052	C12H12N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XQGZSYKGWHUSDH-UHFFFAOYSA-N
20393	112778	6916	-	TBXAS1	BDPLT14|CYP5|CYP5A1|GHOSAL|THAS|TS|TXAS|TXS	9606	Homo sapiens	inhibitor	target	Berman HM (2000)	10592235	172122	2924	Dazoxiben	Benzoic acid, 4-(2-(1H-imidazol-1-yl)ethoxy)-|Dazoxibene|Dazoxiben|Dazoxibenum	-	DRUGBANK	DB03052	C12H12N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XQGZSYKGWHUSDH-UHFFFAOYSA-N
20430	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2951	17-Dmag	-	-	DRUGBANK	DB03080	C32H48N4O8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KUFRQPKVAWMTJO-QSTRRNJOSA-N
20431	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2951	17-Dmag	-	-	DRUGBANK	DB03080	C32H48N4O8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KUFRQPKVAWMTJO-QSTRRNJOSA-N
20432	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2951	17-Dmag	-	-	DRUGBANK	DB03080	C32H48N4O8	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KUFRQPKVAWMTJO-QSTRRNJOSA-N
20475	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2964	8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine	-	-	DRUGBANK	DB03093	C14H14FN5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWHAHELTVGJGFJ-UHFFFAOYSA-N
20522	111337	5320	-	PLA2G2A	MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	2992	1-Benzyl-5-Methoxy-2-Methyl-1h-Indol-3-Yl)-Acetic Acid	-	-	DRUGBANK	DB03121	C19H19NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEKCBTQHDTUHRJ-UHFFFAOYSA-N
20523	111337	5320	-	PLA2G2A	MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	2992	1-Benzyl-5-Methoxy-2-Methyl-1h-Indol-3-Yl)-Acetic Acid	-	-	DRUGBANK	DB03121	C19H19NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEKCBTQHDTUHRJ-UHFFFAOYSA-N
20524	111337	5320	-	PLA2G2A	MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	2992	1-Benzyl-5-Methoxy-2-Methyl-1h-Indol-3-Yl)-Acetic Acid	-	-	DRUGBANK	DB03121	C19H19NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZEKCBTQHDTUHRJ-UHFFFAOYSA-N
20571	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3005	8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9-Pent-9h-Purin-6-Ylamine	-	-	DRUGBANK	DB03137	C19H20FN5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMOYVWKKOKERSW-UHFFFAOYSA-N
20581	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3012	N-Omega-Hydroxy-L-Arginine	-	-	DRUGBANK	DB03144	C6H14N4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQWRAVYMZULPNK-BYPYZUCNSA-N
20582	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3012	N-Omega-Hydroxy-L-Arginine	-	-	DRUGBANK	DB03144	C6H14N4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQWRAVYMZULPNK-BYPYZUCNSA-N
20583	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3012	N-Omega-Hydroxy-L-Arginine	-	-	DRUGBANK	DB03144	C6H14N4O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FQWRAVYMZULPNK-BYPYZUCNSA-N
20650	111443	5447	-	POR	CPR|CYPOR|P450R	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20651	111443	5447	-	POR	CPR|CYPOR|P450R	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20652	111443	5447	-	POR	CPR|CYPOR|P450R	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20666	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20667	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20668	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3015	Flavin adenine dinucleotide	Riboflavin 5'-adenosine diphosphate|Adenosine 5'-[3-(riboflavin-5'-yl) dihydrogen diphosphate]|FLAVIN-adenine dinucleotide|FAD|Riboflavin 5'-(trihydrogen diphosphate), 5'-5'-ester with adenosine|Adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with riboflavine|Flavin adenine dinucleotide	-	DRUGBANK	DB03147	C27H33N9O15P2	small molecule	-	146-14-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWWQXMAJTJZDQX-UYBVJOGSSA-N
20737	117662	26279	UNQ768	PLA2G2D	PLA2IID|SPLASH|sPLA2-IID|sPLA2S	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3061	Stearic acid	Octadecoic acid|OLA|1-Heptadecanecarboxylic acid|Octadecanoic acid|Isooctadecanoic acid|Octadecansaeure|Cetylacetic acid|Stearate|Isostearic acid|Fatty acids C16-18|N-octadecanoic acidd|Stearinsaeure	for sope|obeo baby bubble|dr.g	DRUGBANK	DB03193	C18H36O2	small molecule	-	57-11-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QIQXTHQIDYTFRH-UHFFFAOYSA-N
20738	117662	26279	UNQ768	PLA2G2D	PLA2IID|SPLASH|sPLA2-IID|sPLA2S	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3061	Stearic acid	Octadecoic acid|OLA|1-Heptadecanecarboxylic acid|Octadecanoic acid|Isooctadecanoic acid|Octadecansaeure|Cetylacetic acid|Stearate|Isostearic acid|Fatty acids C16-18|N-octadecanoic acidd|Stearinsaeure	for sope|obeo baby bubble|dr.g	DRUGBANK	DB03193	C18H36O2	small molecule	-	57-11-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QIQXTHQIDYTFRH-UHFFFAOYSA-N
20739	117662	26279	UNQ768	PLA2G2D	PLA2IID|SPLASH|sPLA2-IID|sPLA2S	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3061	Stearic acid	Octadecoic acid|OLA|1-Heptadecanecarboxylic acid|Octadecanoic acid|Isooctadecanoic acid|Octadecansaeure|Cetylacetic acid|Stearate|Isostearic acid|Fatty acids C16-18|N-octadecanoic acidd|Stearinsaeure	for sope|obeo baby bubble|dr.g	DRUGBANK	DB03193	C18H36O2	small molecule	-	57-11-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QIQXTHQIDYTFRH-UHFFFAOYSA-N
20844	111443	5447	-	POR	CPR|CYPOR|P450R	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3115	Riboflavin Monophosphate	-	-	DRUGBANK	DB03247	C17H21N4O9P	small molecule	-	146-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FVTCRASFADXXNN-YRGRVCCFSA-N
20851	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3115	Riboflavin Monophosphate	-	-	DRUGBANK	DB03247	C17H21N4O9P	small molecule	-	146-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FVTCRASFADXXNN-YRGRVCCFSA-N
20852	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3115	Riboflavin Monophosphate	-	-	DRUGBANK	DB03247	C17H21N4O9P	small molecule	-	146-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FVTCRASFADXXNN-YRGRVCCFSA-N
20853	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3115	Riboflavin Monophosphate	-	-	DRUGBANK	DB03247	C17H21N4O9P	small molecule	-	146-17-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FVTCRASFADXXNN-YRGRVCCFSA-N
21098	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	3253	Enalkiren	-	-	DRUGBANK	DB03395	C35H56N6O6	small molecule	-	113082-98-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQXVERRYBYGQJZ-WRPDIKACSA-N
21181	110226	4048	-	LTA4H	-	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3281	Ubenimex	Bestatin	-	DRUGBANK	DB03424	C16H24N2O4	small molecule	-	58970-76-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VGGGPCQERPFHOB-RDBSUJKOSA-N
21182	110226	4048	-	LTA4H	-	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3281	Ubenimex	Bestatin	-	DRUGBANK	DB03424	C16H24N2O4	small molecule	-	58970-76-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VGGGPCQERPFHOB-RDBSUJKOSA-N
21253	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3305	N-(4-(2-((3-Chlorophenylmethyl)Amino)Ethyl)Phenyl)-2-Thiophecarboxamidine	-	-	DRUGBANK	DB03449	C20H20ClN3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZZVGLDBDDYESAB-UHFFFAOYSA-N
21269	108012	1645	RP11-69D4.1	AKR1C1	2-ALPHA-HSD|20-ALPHA-HSD|C9|DD1|DD1/DD2|DDH|DDH1|H-37|HAKRC|HBAB|MBAB	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21270	108012	1645	RP11-69D4.1	AKR1C1	2-ALPHA-HSD|20-ALPHA-HSD|C9|DD1|DD1/DD2|DDH|DDH1|H-37|HAKRC|HBAB|MBAB	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21271	108012	1645	RP11-69D4.1	AKR1C1	2-ALPHA-HSD|20-ALPHA-HSD|C9|DD1|DD1/DD2|DDH|DDH1|H-37|HAKRC|HBAB|MBAB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21277	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21278	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21279	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21280	108013	1646	-	AKR1C2	AKR1C-pseudo|BABP|DD|DD-2|DD/BABP|DD2|DDH2|HAKRD|HBAB|MCDR2|SRXY8|TDD	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21281	108013	1646	-	AKR1C2	AKR1C-pseudo|BABP|DD|DD-2|DD/BABP|DD2|DDH2|HAKRD|HBAB|MCDR2|SRXY8|TDD	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21300	116604	22949	RP11-16L21.1	PTGR1	LTB4DH|PGR1|ZADH3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21306	111443	5447	-	POR	CPR|CYPOR|P450R	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21307	111443	5447	-	POR	CPR|CYPOR|P450R	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21308	111443	5447	-	POR	CPR|CYPOR|P450R	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21320	114196	8644	-	AKR1C3	DD3|DDX|HA1753|HAKRB|HAKRe|HSD17B5|PGFS|hluPGFS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21321	114196	8644	-	AKR1C3	DD3|DDX|HA1753|HAKRB|HAKRe|HSD17B5|PGFS|hluPGFS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21322	114196	8644	-	AKR1C3	DD3|DDX|HA1753|HAKRB|HAKRe|HSD17B5|PGFS|hluPGFS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21334	115610	10327	RP4-697E16.2	AKR1A1	ALDR1|ALR|ARM|DD3|HEL-S-6	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21335	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21336	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21337	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3316	2'-Monophosphoadenosine 5'-Diphosphoribose	-	-	DRUGBANK	DB03461	C21H28N7O17P3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJLXINKUBYWONI-XCSFTKGKSA-N
21351	111337	5320	-	PLA2G2A	MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3326	6-Phenyl-4(R)-(7-Phenyl-Heptanoylamino)-Hexanoic Acid	-	-	DRUGBANK	DB03471	C25H33NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SMNHQYPORNSAQH-QHCPKHFHSA-N
21352	111337	5320	-	PLA2G2A	MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3326	6-Phenyl-4(R)-(7-Phenyl-Heptanoylamino)-Hexanoic Acid	-	-	DRUGBANK	DB03471	C25H33NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SMNHQYPORNSAQH-QHCPKHFHSA-N
21356	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3332	1-Phenylsulfonamide-3-Trifluoromethyl-5-Parabromophenylpyrazole	-	-	DRUGBANK	DB03477	C16H11BrF3N3O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OYZKFVIVPRQRQQ-UHFFFAOYSA-N
21417	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3359	9-Butyl-8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-9h-Purin-6-Ylamine	-	-	DRUGBANK	DB03504	C19H24ClN5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IVPCTHKPOPQMSX-UHFFFAOYSA-N
21419	112986	7132	-	TNFRSF1A	CD120a|FPF|MS5|TBP1|TNF-R|TNF-R-I|TNF-R55|TNFAR|TNFR1|TNFR1-d2|TNFR55|TNFR60|p55|p55-R|p60	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3362	6-[3-(4-Morpholinyl)Propyl]-2-(3-Nitrophenyl)-5-Thioxo-5,6,-Dihydro-7h-Thienol[2',3':4,5]Pyrrolo[1,2-C]Imidazol-7-One	-	-	DRUGBANK	DB03507	C21H20N4O4S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UXGUZFZBZPPZGL-UHFFFAOYSA-N
21420	112986	7132	-	TNFRSF1A	CD120a|FPF|MS5|TBP1|TNF-R|TNF-R-I|TNF-R55|TNFAR|TNFR1|TNFR1-d2|TNFR55|TNFR60|p55|p55-R|p60	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3362	6-[3-(4-Morpholinyl)Propyl]-2-(3-Nitrophenyl)-5-Thioxo-5,6,-Dihydro-7h-Thienol[2',3':4,5]Pyrrolo[1,2-C]Imidazol-7-One	-	-	DRUGBANK	DB03507	C21H20N4O4S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UXGUZFZBZPPZGL-UHFFFAOYSA-N
21421	112986	7132	-	TNFRSF1A	CD120a|FPF|MS5|TBP1|TNF-R|TNF-R-I|TNF-R55|TNFAR|TNFR1|TNFR1-d2|TNFR55|TNFR60|p55|p55-R|p60	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3362	6-[3-(4-Morpholinyl)Propyl]-2-(3-Nitrophenyl)-5-Thioxo-5,6,-Dihydro-7h-Thienol[2',3':4,5]Pyrrolo[1,2-C]Imidazol-7-One	-	-	DRUGBANK	DB03507	C21H20N4O4S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UXGUZFZBZPPZGL-UHFFFAOYSA-N
21507	111336	5319	-	PLA2G1B	PLA2|PLA2A|PPLA2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3414	1-O-Octyl-2-Heptylphosphonyl-Sn-Glycero-3-Phosphoethanolamine	-	-	DRUGBANK	DB03565	C20H45NO8P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RCCNUBYROFOKAU-FQEVSTJZSA-N
21508	111336	5319	-	PLA2G1B	PLA2|PLA2A|PPLA2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3414	1-O-Octyl-2-Heptylphosphonyl-Sn-Glycero-3-Phosphoethanolamine	-	-	DRUGBANK	DB03565	C20H45NO8P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RCCNUBYROFOKAU-FQEVSTJZSA-N
21509	111336	5319	-	PLA2G1B	PLA2|PLA2A|PPLA2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3414	1-O-Octyl-2-Heptylphosphonyl-Sn-Glycero-3-Phosphoethanolamine	-	-	DRUGBANK	DB03565	C20H45NO8P2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RCCNUBYROFOKAU-FQEVSTJZSA-N
21538	119038	30814	-	PLA2G2E	GIIE sPLA2|sPLA2-IIE	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3433	Oxyphenbutazone	Oxyphenbutazonum|Oxiphenbutazone|Oxifenbutazona	oxybutazone tab 100mg|oxyphenb	DRUGBANK	DB03585	C19H20N2O3	small molecule	S01BC02|M01AA03|M02AA04	129-20-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HFHZKZSRXITVMK-UHFFFAOYSA-N
21539	119038	30814	-	PLA2G2E	GIIE sPLA2|sPLA2-IIE	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3433	Oxyphenbutazone	Oxyphenbutazonum|Oxiphenbutazone|Oxifenbutazona	oxybutazone tab 100mg|oxyphenb	DRUGBANK	DB03585	C19H20N2O3	small molecule	S01BC02|M01AA03|M02AA04	129-20-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HFHZKZSRXITVMK-UHFFFAOYSA-N
21540	119038	30814	-	PLA2G2E	GIIE sPLA2|sPLA2-IIE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3433	Oxyphenbutazone	Oxyphenbutazonum|Oxiphenbutazone|Oxifenbutazona	oxybutazone tab 100mg|oxyphenb	DRUGBANK	DB03585	C19H20N2O3	small molecule	S01BC02|M01AA03|M02AA04	129-20-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HFHZKZSRXITVMK-UHFFFAOYSA-N
21543	111336	5319	-	PLA2G1B	PLA2|PLA2A|PPLA2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3435	Pyruvoyl Group	-	-	DRUGBANK	DB03587	C3H4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AIJULSRZWUXGPQ-UHFFFAOYSA-N
21544	111336	5319	-	PLA2G1B	PLA2|PLA2A|PPLA2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3435	Pyruvoyl Group	-	-	DRUGBANK	DB03587	C3H4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AIJULSRZWUXGPQ-UHFFFAOYSA-N
21545	111336	5319	-	PLA2G1B	PLA2|PLA2A|PPLA2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3435	Pyruvoyl Group	-	-	DRUGBANK	DB03587	C3H4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AIJULSRZWUXGPQ-UHFFFAOYSA-N
21627	111336	5319	-	PLA2G1B	PLA2|PLA2A|PPLA2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3480	Lpc-Ether	-	-	DRUGBANK	DB03633	C26H57NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKBJVQHMEXMFDZ-AREMUKBSSA-O
21628	111336	5319	-	PLA2G1B	PLA2|PLA2A|PPLA2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3480	Lpc-Ether	-	-	DRUGBANK	DB03633	C26H57NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKBJVQHMEXMFDZ-AREMUKBSSA-O
21629	111336	5319	-	PLA2G1B	PLA2|PLA2A|PPLA2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3480	Lpc-Ether	-	-	DRUGBANK	DB03633	C26H57NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XKBJVQHMEXMFDZ-AREMUKBSSA-O
21683	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3513	Acetic Acid Salicyloyl-Amino-Ester	-	-	DRUGBANK	DB03667	C9H9NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PCFWLDHLJWUGSU-UHFFFAOYSA-N
21700	108367	2053	-	EPHX2	CEH|SEH	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3523	N-Cyclohexyl-N'-Decylurea	-	-	DRUGBANK	DB03677	C17H34N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LPXYBLIRYGCMPQ-UHFFFAOYSA-N
21766	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3551	S-Ethyl-N-Phenyl-Isothiourea	-	-	DRUGBANK	DB03707	C9H12N2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LAXNJIWNBHHMDO-UHFFFAOYSA-N
21775	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3554	N5-(1-Imino-3-Butenyl)-L-Ornithine	-	-	DRUGBANK	DB03710	C9H20N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRILJVOCVSUPMA-SSDOTTSWSA-O
21776	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3554	N5-(1-Imino-3-Butenyl)-L-Ornithine	-	-	DRUGBANK	DB03710	C9H20N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRILJVOCVSUPMA-SSDOTTSWSA-O
21777	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3554	N5-(1-Imino-3-Butenyl)-L-Ornithine	-	-	DRUGBANK	DB03710	C9H20N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRILJVOCVSUPMA-SSDOTTSWSA-O
21823	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3579	2-Cyclopropylmethylenepropanal	-	-	DRUGBANK	DB03736	C7H12O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NOQCSSAEKDLHCI-ZCFIWIBFSA-N
21824	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3579	2-Cyclopropylmethylenepropanal	-	-	DRUGBANK	DB03736	C7H12O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NOQCSSAEKDLHCI-ZCFIWIBFSA-N
21825	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3579	2-Cyclopropylmethylenepropanal	-	-	DRUGBANK	DB03736	C7H12O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NOQCSSAEKDLHCI-ZCFIWIBFSA-N
21835	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3583	N-acetyl-alpha-D-glucosamine	-GlcNAc|2-(acetylamino)-2-deoxy-A-D-glucopyranose|-D-GlcNAc|N-acetyl--D-glucosamine|2-(acetylamino)-2-deoxy--D-glucopyranose	-	DRUGBANK	DB03740	C8H15NO6	small molecule	-	10036-64-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OVRNDRQMDRJTHS-PVFLNQBWSA-N
21836	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3583	N-acetyl-alpha-D-glucosamine	-GlcNAc|2-(acetylamino)-2-deoxy-A-D-glucopyranose|-D-GlcNAc|N-acetyl--D-glucosamine|2-(acetylamino)-2-deoxy--D-glucopyranose	-	DRUGBANK	DB03740	C8H15NO6	small molecule	-	10036-64-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OVRNDRQMDRJTHS-PVFLNQBWSA-N
21850	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3591	4-(1h-Imidazol-4-Yl)-3-(5-Ethyl-2,4-Dihydroxy-Phenyl)-1h-Pyrazole	-	-	DRUGBANK	DB03749	C14H14N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ATORUNMAUREKMH-UHFFFAOYSA-N
21851	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3591	4-(1h-Imidazol-4-Yl)-3-(5-Ethyl-2,4-Dihydroxy-Phenyl)-1h-Pyrazole	-	-	DRUGBANK	DB03749	C14H14N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ATORUNMAUREKMH-UHFFFAOYSA-N
21852	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3591	4-(1h-Imidazol-4-Yl)-3-(5-Ethyl-2,4-Dihydroxy-Phenyl)-1h-Pyrazole	-	-	DRUGBANK	DB03749	C14H14N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ATORUNMAUREKMH-UHFFFAOYSA-N
21855	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3594	P-(2'-Iodo-5'-Thenoyl)Hydrotropic Acid	-	-	DRUGBANK	DB03752	C14H11IO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UIZPHGUBGPJBAR-QMMMGPOBSA-N
21856	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3595	Flurbiprofen Methyl Ester	-	-	DRUGBANK	DB03753	C16H15FO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CPJBKHZROFMSQM-NSHDSACASA-N
21857	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3595	Flurbiprofen Methyl Ester	-	-	DRUGBANK	DB03753	C16H15FO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CPJBKHZROFMSQM-NSHDSACASA-N
21858	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3595	Flurbiprofen Methyl Ester	-	-	DRUGBANK	DB03753	C16H15FO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CPJBKHZROFMSQM-NSHDSACASA-N
21920	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	unknown	target	Chen X (2002)	11752352	171740	3623	Phenacetin	Acetophenetin|Acetphenetidin|Acetophenetidine|Acetophenetidin	-	DRUGBANK	DB03783	C10H13NO2	small molecule	N02BE73|N02BE03|N02BE53	62-44-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CPJSUEIXXCENMM-UHFFFAOYSA-N
21921	111337	5320	-	PLA2G2A	MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3624	Elaidoylamide	-	-	DRUGBANK	DB03784	C18H35NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FATBGEAMYMYZAF-MDZDMXLPSA-N
21922	111337	5320	-	PLA2G2A	MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3624	Elaidoylamide	-	-	DRUGBANK	DB03784	C18H35NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FATBGEAMYMYZAF-MDZDMXLPSA-N
21923	111337	5320	-	PLA2G2A	MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3624	Elaidoylamide	-	-	DRUGBANK	DB03784	C18H35NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FATBGEAMYMYZAF-MDZDMXLPSA-N
21956	107936	1558	-	CYP2C8	CPC8|CYPIIC8|MP-12/MP-20	9606	Homo sapiens	unknown	target	Schoch GA (2004)	14676196	181840	3635	Palmitic Acid	Palmitinic acid|1-Hexyldecanoic Acid|Hexadecylic acid|Hexadecoic acid|Palmitate|FAT|Hexadecanoic acid|1-Pentadecanecarboxylic acid|Hexadecanoate|Hexaectylic acid|Palmitinsaeure	sha-lem|levovist - pws iv (4g 	DRUGBANK	DB03796	C16H32O2	small molecule	-	57-10-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPCSVZSSVZVIGE-UHFFFAOYSA-N
21993	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3647	9-Butyl-8-(3-Methoxybenzyl)-9h-Purin-6-Amine	-	-	DRUGBANK	DB03809	C17H21N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BWLWUGBHOXIUBP-UHFFFAOYSA-N
22090	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3703	Prostaglandin G2	-	-	DRUGBANK	DB03866	C20H32O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SGUKUZOVHSFKPH-YNNPMVKQSA-N
22127	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3729	5-N-Allyl-Arginine	-	-	DRUGBANK	DB03892	C9H19N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPQWZDPOLXVMOU-ZETCQYMHSA-O
22128	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3729	5-N-Allyl-Arginine	-	-	DRUGBANK	DB03892	C9H19N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPQWZDPOLXVMOU-ZETCQYMHSA-O
22129	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3729	5-N-Allyl-Arginine	-	-	DRUGBANK	DB03892	C9H19N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZPQWZDPOLXVMOU-ZETCQYMHSA-O
22137	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3736	9-Butyl-8-(4-Methoxybenzyl)-9h-Purin-6-Amine	-	-	DRUGBANK	DB03899	C17H21N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NVYATAJRTRFKSW-UHFFFAOYSA-N
22288	112952	7097	-	TLR2	CD282|TIL4	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3798	S-(Dimethylarsenic)Cysteine	-	-	DRUGBANK	DB03963	C5H12AsNO2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UKLXSOVDMSQHMM-SCSAIBSYSA-N
22289	112952	7097	-	TLR2	CD282|TIL4	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3798	S-(Dimethylarsenic)Cysteine	-	-	DRUGBANK	DB03963	C5H12AsNO2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UKLXSOVDMSQHMM-SCSAIBSYSA-N
22300	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3802	1-Methyl-2-Oxy-5,5-Dimethyl Pyrrolidine	-	-	DRUGBANK	DB03968	C7H13NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YARDEGUIPATLSG-UHFFFAOYSA-N
22301	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3802	1-Methyl-2-Oxy-5,5-Dimethyl Pyrrolidine	-	-	DRUGBANK	DB03968	C7H13NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YARDEGUIPATLSG-UHFFFAOYSA-N
22302	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3802	1-Methyl-2-Oxy-5,5-Dimethyl Pyrrolidine	-	-	DRUGBANK	DB03968	C7H13NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YARDEGUIPATLSG-UHFFFAOYSA-N
22438	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3886	9-Butyl-8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine	-	-	DRUGBANK	DB04054	C18H22FN5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PASRTKOWXJDFFV-UHFFFAOYSA-N
22458	116604	22949	RP11-16L21.1	PTGR1	LTB4DH|PGR1|ZADH3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3898	Para-Coumaric Acid	-	-	DRUGBANK	DB04066	C9H8O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NGSWKAQJJWESNS-ZZXKWVIFSA-N
22501	118128	27306	-	HPGDS	GSTS|GSTS1-1|PGD2|PGDS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3909	Glycerol	-	-	DRUGBANK	DB04077	C3H8O3	small molecule	A06AG04|A06AX01	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PEDCQBHIVMGVHV-UHFFFAOYSA-N
22502	118128	27306	-	HPGDS	GSTS|GSTS1-1|PGD2|PGDS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3909	Glycerol	-	-	DRUGBANK	DB04077	C3H8O3	small molecule	A06AG04|A06AX01	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PEDCQBHIVMGVHV-UHFFFAOYSA-N
22503	119038	30814	-	PLA2G2E	GIIE sPLA2|sPLA2-IIE	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3909	Glycerol	-	-	DRUGBANK	DB04077	C3H8O3	small molecule	A06AG04|A06AX01	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PEDCQBHIVMGVHV-UHFFFAOYSA-N
22504	119038	30814	-	PLA2G2E	GIIE sPLA2|sPLA2-IIE	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3909	Glycerol	-	-	DRUGBANK	DB04077	C3H8O3	small molecule	A06AG04|A06AX01	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PEDCQBHIVMGVHV-UHFFFAOYSA-N
22505	119038	30814	-	PLA2G2E	GIIE sPLA2|sPLA2-IIE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	3909	Glycerol	-	-	DRUGBANK	DB04077	C3H8O3	small molecule	A06AG04|A06AX01	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PEDCQBHIVMGVHV-UHFFFAOYSA-N
22586	111337	5320	-	PLA2G2A	MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	3944	1-Octadecyl-2-Acetamido-2-Deoxy-Sn-Glycerol-3-Phosphoethylmethyl Sulfide	-	-	DRUGBANK	DB04112	C26H54NO6PS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZULTVWFLRZJENJ-SANMLTNESA-N
22587	111337	5320	-	PLA2G2A	MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	3944	1-Octadecyl-2-Acetamido-2-Deoxy-Sn-Glycerol-3-Phosphoethylmethyl Sulfide	-	-	DRUGBANK	DB04112	C26H54NO6PS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZULTVWFLRZJENJ-SANMLTNESA-N
22813	108367	2053	-	EPHX2	CEH|SEH	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4041	N-Cyclohexyl-N'-(Propyl)Phenyl Urea	-	-	DRUGBANK	DB04213	C16H24N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HBTZVNKXMFGOOJ-UHFFFAOYSA-N
22836	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4051	Nitroarginine	Nitro-l-arginine|N-nitro-l-arginine|NRG|Ngamma-nitro-l-arginine|N(g)-nitroarginine|N(g)-nitro-l-arginine|N5-(Nitroamidino)-L-2,5-diaminopentanoic acid|NG-nitro-l-arginine|L-NNA|N-omega-nitro-l-arginine|Nomega-nitro-l-arginine|NG-NO2-L-Arg	-	DRUGBANK	DB04223	C6H13N5O4	small molecule	-	2149-70-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MRAUNPAHJZDYCK-BYPYZUCNSA-N
22902	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4081	8-Benzo[1,3]Dioxol-,5-Ylmethyl-9-Butyl-2-Fluoro-9h-Purin-6-Ylamine	-	-	DRUGBANK	DB04254	C17H18FN5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ARWHTQLGMWHTAZ-UHFFFAOYSA-N
22926	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4097	(S)-3-(4-(2-Carbazol-9-Yl-Ethoxy)-Phenyl)-2-Ethoxy-Propionic Acid	-	-	DRUGBANK	DB04270	C25H25NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WUZIMDSVRIBNNI-DEOSSOPVSA-N
22930	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4099	Citric Acid	2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure	medique medi seltzer|purg-odan	DRUGBANK	DB04272	C6H8O7	small molecule	A09AB04	77-92-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRKNYBCHXYNGOX-UHFFFAOYSA-N
22931	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4099	Citric Acid	2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure	medique medi seltzer|purg-odan	DRUGBANK	DB04272	C6H8O7	small molecule	A09AB04	77-92-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRKNYBCHXYNGOX-UHFFFAOYSA-N
22950	110428	4282	-	MIF	GIF|GLIF|MMIF	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4099	Citric Acid	2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure	medique medi seltzer|purg-odan	DRUGBANK	DB04272	C6H8O7	small molecule	A09AB04	77-92-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRKNYBCHXYNGOX-UHFFFAOYSA-N
22951	110428	4282	-	MIF	GIF|GLIF|MMIF	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4099	Citric Acid	2-Hydroxytricarballylic acid|3-Carboxy-3-hydroxypentane-1,5-dioic acid|Citronensure	medique medi seltzer|purg-odan	DRUGBANK	DB04272	C6H8O7	small molecule	A09AB04	77-92-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRKNYBCHXYNGOX-UHFFFAOYSA-N
23002	111337	5320	-	PLA2G2A	MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4114	(S)-5-(4-Benzyloxy-Phenyl)-4-(7-Phenyl-Heptanoylamino)-Pentanoic Acid	-	-	DRUGBANK	DB04287	C31H37NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWLUIYFCMHKLKY-MUUNZHRXSA-N
23003	111337	5320	-	PLA2G2A	MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4114	(S)-5-(4-Benzyloxy-Phenyl)-4-(7-Phenyl-Heptanoylamino)-Pentanoic Acid	-	-	DRUGBANK	DB04287	C31H37NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KWLUIYFCMHKLKY-MUUNZHRXSA-N
23235	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4201	N-Methyl-N-(Methylbenzyl)Formamide	-	-	DRUGBANK	DB04379	C10H13NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YYPINKULTUCCJA-VIFPVBQESA-N
23244	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4209	1-Hydroxy-2-Amino-3-Cyclohexylpropane	-	-	DRUGBANK	DB04387	C9H19NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWDRYURVUDZKSG-VIFPVBQESA-N
23245	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4209	1-Hydroxy-2-Amino-3-Cyclohexylpropane	-	-	DRUGBANK	DB04387	C9H19NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWDRYURVUDZKSG-VIFPVBQESA-N
23246	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4209	1-Hydroxy-2-Amino-3-Cyclohexylpropane	-	-	DRUGBANK	DB04387	C9H19NO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWDRYURVUDZKSG-VIFPVBQESA-N
23477	107319	873	-	CBR1	CBR|SDR21C1|hCBR1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4277	3-(4-Amino-1-Tert-Butyl-1h-Pyrazolo[3,4-D]Pyrimidin-3-Yl)Phenol	-	-	DRUGBANK	DB04463	C15H17N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CPLGZXQPPYRNRC-UHFFFAOYSA-N
23570	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4318	8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine	-	-	DRUGBANK	DB04505	C20H22ClN5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WUJFGZAAFADPSF-UHFFFAOYSA-N
23681	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	unknown	target	Talbot S (2011)	21600945	182187	4362	Niflumic Acid	Acidum niflumicum|Acide niflumique|Niflugel|NFA|Acido niflumico	-	DRUGBANK	DB04552	C13H9F3N2O2	small molecule	M02AA17|M01AX02	4394-00-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZFPYUNJRRFVQU-UHFFFAOYSA-N
23683	111338	5321	-	PLA2G4A	PLA2G4|cPLA2-alpha	9606	Homo sapiens	unknown	target	Jabeen T (2005)	16301791	181921	4362	Niflumic Acid	Acidum niflumicum|Acide niflumique|Niflugel|NFA|Acido niflumico	-	DRUGBANK	DB04552	C13H9F3N2O2	small molecule	M02AA17|M01AX02	4394-00-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZFPYUNJRRFVQU-UHFFFAOYSA-N
23684	111336	5319	-	PLA2G1B	PLA2|PLA2A|PPLA2	9606	Homo sapiens	inhibitor	target	Jabeen T (2005)	16301791	181921	4362	Niflumic Acid	Acidum niflumicum|Acide niflumique|Niflugel|NFA|Acido niflumico	-	DRUGBANK	DB04552	C13H9F3N2O2	small molecule	M02AA17|M01AX02	4394-00-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZFPYUNJRRFVQU-UHFFFAOYSA-N
23685	111336	5319	-	PLA2G1B	PLA2|PLA2A|PPLA2	9606	Homo sapiens	inhibitor	target	Berman HM (2000)	10592235	172122	4362	Niflumic Acid	Acidum niflumicum|Acide niflumique|Niflugel|NFA|Acido niflumico	-	DRUGBANK	DB04552	C13H9F3N2O2	small molecule	M02AA17|M01AX02	4394-00-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZFPYUNJRRFVQU-UHFFFAOYSA-N
23687	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Alpert E (2007)	17098211	138173	4362	Niflumic Acid	Acidum niflumicum|Acide niflumique|Niflugel|NFA|Acido niflumico	-	DRUGBANK	DB04552	C13H9F3N2O2	small molecule	M02AA17|M01AX02	4394-00-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZFPYUNJRRFVQU-UHFFFAOYSA-N
23688	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Jabeen T (2005)	16301791	181921	4362	Niflumic Acid	Acidum niflumicum|Acide niflumique|Niflugel|NFA|Acido niflumico	-	DRUGBANK	DB04552	C13H9F3N2O2	small molecule	M02AA17|M01AX02	4394-00-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZFPYUNJRRFVQU-UHFFFAOYSA-N
23689	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Diao HL (2007)	17485303	182008	4362	Niflumic Acid	Acidum niflumicum|Acide niflumique|Niflugel|NFA|Acido niflumico	-	DRUGBANK	DB04552	C13H9F3N2O2	small molecule	M02AA17|M01AX02	4394-00-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JZFPYUNJRRFVQU-UHFFFAOYSA-N
23693	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	unknown	target	Imming P (2006)	17016423	171742	4367	Arachidonic Acid	-	-	DRUGBANK	DB04557	C20H32O2	small molecule	-	506-32-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YZXBAPSDXZZRGB-CGRWFSSPSA-N
23694	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	unknown	target	Overington JP (2006)	17139284	171741	4367	Arachidonic Acid	-	-	DRUGBANK	DB04557	C20H32O2	small molecule	-	506-32-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YZXBAPSDXZZRGB-CGRWFSSPSA-N
23695	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4367	Arachidonic Acid	-	-	DRUGBANK	DB04557	C20H32O2	small molecule	-	506-32-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YZXBAPSDXZZRGB-CGRWFSSPSA-N
23755	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4398	N-[4-(AMINOSULFONYL)BENZYL]-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE	-	-	DRUGBANK	DB04588	C17H15ClN4O5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OOHYJGNSESWEFT-UHFFFAOYSA-N
23758	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	unknown	target	Nakamura K (2001)	11412837	181773	4408	Aniracetam	1-P-ANISOYL-2-PYRROLIDINONE	-	DRUGBANK	DB04599	C12H13NO3	small molecule	N06BX11	72432-10-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZXNRTKGTQJPIJK-UHFFFAOYSA-N
23805	107933	1555	-	CYP2B6	CPB6|CYP2B|CYP2B7|CYP2B7P|CYPIIB6|EFVM|IIB1|P450	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4469	Cyclohexyl-pentyl-maltoside	5-CYCLOHEXYLPENTYL 4-O-ALPHA-D-GLUCOPYRANOSYL-BETA-D-GLUCOPYRANOSIDE|5-CYCLOHEXYL-1-PENTYL-BETA-D-MALTOSIDE|CYMAL-5	-	DRUGBANK	DB04664	C23H42O11	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RVTGFZGNOSKUDA-ZNGNCRBCSA-N
23808	108012	1645	RP11-69D4.1	AKR1C1	2-ALPHA-HSD|20-ALPHA-HSD|C9|DD1|DD1/DD2|DDH|DDH1|H-37|HAKRC|HBAB|MBAB	9606	Homo sapiens	unknown	target	Dhagat U (2007)	18045204	179205	4478	2-HYDROXY-3,5-DIIODOBENZOIC ACID	-	-	DRUGBANK	DB04674	C7H4I2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHZVWQPHNWDCFS-UHFFFAOYSA-N
23809	108231	1909	-	EDNRA	ET-A|ETA|ETA-R|ETAR|ETRA|hET-AR	9606	Homo sapiens	unknown	target	Blandin V (2000)	11093786	181765	4478	2-HYDROXY-3,5-DIIODOBENZOIC ACID	-	-	DRUGBANK	DB04674	C7H4I2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DHZVWQPHNWDCFS-UHFFFAOYSA-N
23846	119038	30814	-	PLA2G2E	GIIE sPLA2|sPLA2-IIE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4529	Licofelone	LCF|ML3000	-	DRUGBANK	DB04725	C23H22ClNO2	small molecule	-	156897-06-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UAWXGRJVZSAUSZ-UHFFFAOYSA-N
23847	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	unknown	target	Vidal C (2007)	17015640	181969	4529	Licofelone	LCF|ML3000	-	DRUGBANK	DB04725	C23H22ClNO2	small molecule	-	156897-06-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UAWXGRJVZSAUSZ-UHFFFAOYSA-N
23848	106741	240	RP11-67C2.3	ALOX5	5-LO|5-LOX|5LPG|LOG5	9606	Homo sapiens	unknown	target	Chen X (2002)	11752352	171740	4529	Licofelone	LCF|ML3000	-	DRUGBANK	DB04725	C23H22ClNO2	small molecule	-	156897-06-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UAWXGRJVZSAUSZ-UHFFFAOYSA-N
23849	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	unknown	target	Vidal C (2007)	17015640	181969	4529	Licofelone	LCF|ML3000	-	DRUGBANK	DB04725	C23H22ClNO2	small molecule	-	156897-06-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UAWXGRJVZSAUSZ-UHFFFAOYSA-N
23860	119038	30814	-	PLA2G2E	GIIE sPLA2|sPLA2-IIE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4546	Nimesulide	-	-	DRUGBANK	DB04743	C13H12N2O5S	small molecule	M01AX17|M02AA26	51803-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYWYRSMBCFDLJT-UHFFFAOYSA-N
23862	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Rainsford KD (2006)	16846549	181954	4546	Nimesulide	-	-	DRUGBANK	DB04743	C13H12N2O5S	small molecule	M01AX17|M02AA26	51803-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYWYRSMBCFDLJT-UHFFFAOYSA-N
23863	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	4546	Nimesulide	-	-	DRUGBANK	DB04743	C13H12N2O5S	small molecule	M01AX17|M02AA26	51803-78-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HYWYRSMBCFDLJT-UHFFFAOYSA-N
23884	111337	5320	-	PLA2G2A	MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2	9606	Homo sapiens	inhibitor	target	Murakami MT (2005)	15961104	181896	4588	Suramin	Belganyl|Suramin|8,8'-[CARBONYLBIS[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bis-1,3,5-naphthalenetrisulfonic acid|Suramine|Naganol|Naphuride	-	DRUGBANK	DB04786	C51H40N6O23S6	small molecule	P01CX02	145-63-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FIAFUQMPZJWCLV-UHFFFAOYSA-N
23885	111337	5320	-	PLA2G2A	MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2	9606	Homo sapiens	inhibitor	target	Berman HM (2000)	10592235	172122	4588	Suramin	Belganyl|Suramin|8,8'-[CARBONYLBIS[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bis-1,3,5-naphthalenetrisulfonic acid|Suramine|Naganol|Naphuride	-	DRUGBANK	DB04786	C51H40N6O23S6	small molecule	P01CX02	145-63-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FIAFUQMPZJWCLV-UHFFFAOYSA-N
23901	107933	1555	-	CYP2B6	CPB6|CYP2B|CYP2B7|CYP2B7P|CYPIIB6|EFVM|IIB1|P450	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	4596	Bifonazole	Mycospor|(+-)1-([1,1'-Biphenyl]-4-ylphenylmethyl)-1H-imidazole|Bay h 4502|Trifonazole|1-(alpha-(4-Biphenylyl)benzyl)imidazole|Bifonazol|Bifonazolum|1-(p,alpha-Diphenylbenzyl)imidazole|1-((4-Biphenylyl)phenylmethyl)-1H-imidazole|(+-)-1-(p,alpha-Diphenylbenzyl)imidazole	-	DRUGBANK	DB04794	C22H18N2	small molecule	D01AC60|D01AC10	60628-96-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OCAPBUJLXMYKEJ-UHFFFAOYSA-N
23923	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	unknown	target	Chen X (2002)	11752352	171740	4619	Metamizole	Dipyrone	-	DRUGBANK	DB04817	C13H16N3NaO4S	small molecule	N02BB72|N02BB52|N02BB02	50567-35-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DJGAAPFSPWAYTJ-UHFFFAOYSA-M
23935	116412	11251	-	PTGDR2	CD294|CRTH2|DL1R|DP2|GPR44	9606	Homo sapiens	unknown	target	Hata AN (2005)	15563582	161179	4630	Zomepirac	Zomepiracum|5-(4-Chlorobenzoyl)-1,4-dimethyl-1H-pyrrole-2-acetic acid	-	DRUGBANK	DB04828	C15H14ClNO3	small molecule	M01AB04	33369-31-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZXVNMYWKKDOREA-UHFFFAOYSA-N
23986	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Imming P (2006)	17016423	171742	4644	Fluspirilene	Fluspirileno|Fluspirilenum|Imap	imap forte inj 10mg/ml|imap in	DRUGBANK	DB04842	C29H31F2N3O	small molecule	N05AG01	1841-19-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QOYHHIBFXOOADH-UHFFFAOYSA-N
23987	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Schotte A (1996)	8935801	181713	4644	Fluspirilene	Fluspirileno|Fluspirilenum|Imap	imap forte inj 10mg/ml|imap in	DRUGBANK	DB04842	C29H31F2N3O	small molecule	N05AG01	1841-19-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QOYHHIBFXOOADH-UHFFFAOYSA-N
23988	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	4644	Fluspirilene	Fluspirileno|Fluspirilenum|Imap	imap forte inj 10mg/ml|imap in	DRUGBANK	DB04842	C29H31F2N3O	small molecule	N05AG01	1841-19-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QOYHHIBFXOOADH-UHFFFAOYSA-N
23989	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Overington JP (2006)	17139284	171741	4644	Fluspirilene	Fluspirileno|Fluspirilenum|Imap	imap forte inj 10mg/ml|imap in	DRUGBANK	DB04842	C29H31F2N3O	small molecule	N05AG01	1841-19-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QOYHHIBFXOOADH-UHFFFAOYSA-N
23990	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Wang SJ (2002)	11842444	181787	4644	Fluspirilene	Fluspirileno|Fluspirilenum|Imap	imap forte inj 10mg/ml|imap in	DRUGBANK	DB04842	C29H31F2N3O	small molecule	N05AG01	1841-19-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QOYHHIBFXOOADH-UHFFFAOYSA-N
24012	110503	4363	-	ABCC1	ABC29|ABCC|GS-X|MRP|MRP1	9606	Homo sapiens	unknown	target	Minderman H (2004)	15014037	181844	4652	Biricodar dicitrate	biricodar	-	DRUGBANK	DB04851	C46H57N3O21	small molecule	-	174254-13-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VDMKJSJJXQDICL-ZXVJYWQYSA-N
24027	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	unknown	target	Zhu M (2008)	17908924	182052	4657	Brasofensine	-	-	DRUGBANK	DB04857	C16H20Cl2N2O	small molecule	-	171655-91-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NRLIFEGHTNUYFL-QJDHNRDASA-N
24048	107247	796	-	CALCA	CALC1|CGRP|CGRP-I|CGRP1|CT|KC	9606	Homo sapiens	unknown	target	Recober A (2007)	17665333	182035	4669	Olcegepant	-	-	DRUGBANK	DB04869	C38H47Br2N9O5	small molecule	-	204697-65-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ITIXDWVDFFXNEG-JHOUSYSJSA-N
24074	108231	1909	-	EDNRA	ET-A|ETA|ETA-R|ETAR|ETRA|hET-AR	9606	Homo sapiens	unknown	target	Xia QG (2006)	17049116	181972	4683	Darusentan	-	-	DRUGBANK	DB04883	C22H22N2O6	small molecule	-	171714-84-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FEJVSJIALLTFRP-LJQANCHMSA-N
24075	108231	1909	-	EDNRA	ET-A|ETA|ETA-R|ETAR|ETRA|hET-AR	9606	Homo sapiens	unknown	target	Orth SR (2007)	17890870	182050	4683	Darusentan	-	-	DRUGBANK	DB04883	C22H22N2O6	small molecule	-	171714-84-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FEJVSJIALLTFRP-LJQANCHMSA-N
24085	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	unknown	target	Auclair AL (2007)	17393144	181998	4688	Bifeprunox	Bifeprunoxum|Bifeprunox mesilate	-	DRUGBANK	DB04888	C24H23N3O2	small molecule	-	350992-10-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CYGODHVAJQTCBG-UHFFFAOYSA-N
24086	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	unknown	target	Newman-Tancredi A (2007)	17659474	182032	4688	Bifeprunox	Bifeprunoxum|Bifeprunox mesilate	-	DRUGBANK	DB04888	C24H23N3O2	small molecule	-	350992-10-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CYGODHVAJQTCBG-UHFFFAOYSA-N
24087	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	unknown	target	Basile AS (2007)	17325229	181989	4689	Bicifadine	-	-	DRUGBANK	DB04889	C12H15N	small molecule	-	71195-57-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OFYVIGTWSQPCLF-UHFFFAOYSA-N
24164	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	unknown	target	Choung RS (2007)	17300287	181987	4721	Itopride	N-(p-(2-(Dimethylamino)ethoxy)benzyl)veratramide	-	DRUGBANK	DB04924	C20H26N2O4	small molecule	A03FA07	122898-67-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QQQIECGTIMUVDS-UHFFFAOYSA-N
24165	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	unknown	target	Holtmann G (2006)	16495395	181932	4721	Itopride	N-(p-(2-(Dimethylamino)ethoxy)benzyl)veratramide	-	DRUGBANK	DB04924	C20H26N2O4	small molecule	A03FA07	122898-67-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QQQIECGTIMUVDS-UHFFFAOYSA-N
24198	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	antagonist	target	Bobo WV (2013)	23272794	182224	4740	Iloperidone	HP 873|Zomaril|Fanapt|Fanapta|Iloperidonum|1-[4-[3-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1- piperidinyl]propoxy]-3-methoxyphenyl]ethanone|Iloperidona|4'-(3-(4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidino)propoxy)-3'-methoxyacetophenone	fanapt	DRUGBANK	DB04946	C24H27FN2O4	small molecule	N05AX14	133454-47-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XMXHEBAFVSFQEX-UHFFFAOYSA-N
24201	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	antagonist	target	George M (2013)	23545936	182239	4740	Iloperidone	HP 873|Zomaril|Fanapt|Fanapta|Iloperidonum|1-[4-[3-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1- piperidinyl]propoxy]-3-methoxyphenyl]ethanone|Iloperidona|4'-(3-(4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidino)propoxy)-3'-methoxyacetophenone	fanapt	DRUGBANK	DB04946	C24H27FN2O4	small molecule	N05AX14	133454-47-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XMXHEBAFVSFQEX-UHFFFAOYSA-N
24202	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Hesselink JM (2002)	12861482	181824	4740	Iloperidone	HP 873|Zomaril|Fanapt|Fanapta|Iloperidonum|1-[4-[3-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1- piperidinyl]propoxy]-3-methoxyphenyl]ethanone|Iloperidona|4'-(3-(4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidino)propoxy)-3'-methoxyacetophenone	fanapt	DRUGBANK	DB04946	C24H27FN2O4	small molecule	N05AX14	133454-47-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XMXHEBAFVSFQEX-UHFFFAOYSA-N
24203	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Kongsamut S (1996)	8997630	181714	4740	Iloperidone	HP 873|Zomaril|Fanapt|Fanapta|Iloperidonum|1-[4-[3-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1- piperidinyl]propoxy]-3-methoxyphenyl]ethanone|Iloperidona|4'-(3-(4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidino)propoxy)-3'-methoxyacetophenone	fanapt	DRUGBANK	DB04946	C24H27FN2O4	small molecule	N05AX14	133454-47-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XMXHEBAFVSFQEX-UHFFFAOYSA-N
24286	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	unknown	target	Almansa C (2004)	15481993	181866	4878	Cimicoxib	-	-	DRUGBANK	DB05095	C16H13ClFN3O3S	small molecule	-	265114-23-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KYXDNECMRLFQMZ-UHFFFAOYSA-N
24289	111711	5739	-	PTGIR	IP|PRIPR	9606	Homo sapiens	unknown	target	Melian EB (2002)	11790158	181785	5009	Beraprost	-	-	DRUGBANK	DB05229	C24H29NaO5	small molecule	B01AC19	88430-50-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YTCZZXIRLARSET-VJRSQJMHSA-M
24303	109769	3553	-	IL1B	IL-1|IL1-BETA|IL1F2	9606	Homo sapiens	antagonist	target	Eby G (2005)	16122880	181906	5038	Gallium nitrate	Gallium nitrate (anhydrous)|Nitric acid, gallium salt, anhydrate	ganite	DRUGBANK	DB05260	GaN3O9	small molecule	-	13494-90-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CHPZKNULDCNCBW-UHFFFAOYSA-N
24320	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	5046	Rotigotine	(6S)-6-(propyl(2-(2-thienyl)ethyl)amino)-5,6,7,8-tetrahydro-1-naphthalenol	neupro	DRUGBANK	DB05271	C19H25NOS	small molecule	N04BC09	99755-59-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KFQYTPMOWPVWEJ-INIZCTEOSA-N
24321	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	5046	Rotigotine	(6S)-6-(propyl(2-(2-thienyl)ethyl)amino)-5,6,7,8-tetrahydro-1-naphthalenol	neupro	DRUGBANK	DB05271	C19H25NOS	small molecule	N04BC09	99755-59-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KFQYTPMOWPVWEJ-INIZCTEOSA-N
24322	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Kvernmo T (2008)	18691132	174662	5046	Rotigotine	(6S)-6-(propyl(2-(2-thienyl)ethyl)amino)-5,6,7,8-tetrahydro-1-naphthalenol	neupro	DRUGBANK	DB05271	C19H25NOS	small molecule	N04BC09	99755-59-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KFQYTPMOWPVWEJ-INIZCTEOSA-N
24334	112778	6916	-	TBXAS1	BDPLT14|CYP5|CYP5A1|GHOSAL|THAS|TS|TXAS|TXS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5264	NM-702	-	-	DRUGBANK	DB05505	-	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24366	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Cincotta SL (2010)	20856607	182166	5514	Sertindole	SerLect|1-[2-[4-[5-chloro-1-(4-Fluorophenyl)-indol-3-yl]-1-piperidyl]ethyl]imidazolidin-2-one|Sertindole|Serdolect|Sertindol|Sertindolum	-	DRUGBANK	DB06144	C24H26ClFN4O	small molecule	N05AE03	106516-24-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GZKLJWGUPQBVJQ-UHFFFAOYSA-N
24367	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Lindstroem E (2006)	16925508	181962	5514	Sertindole	SerLect|1-[2-[4-[5-chloro-1-(4-Fluorophenyl)-indol-3-yl]-1-piperidyl]ethyl]imidazolidin-2-one|Sertindole|Serdolect|Sertindol|Sertindolum	-	DRUGBANK	DB06144	C24H26ClFN4O	small molecule	N05AE03	106516-24-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GZKLJWGUPQBVJQ-UHFFFAOYSA-N
24368	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Mork A (2009)	19506838	182111	5514	Sertindole	SerLect|1-[2-[4-[5-chloro-1-(4-Fluorophenyl)-indol-3-yl]-1-piperidyl]ethyl]imidazolidin-2-one|Sertindole|Serdolect|Sertindol|Sertindolum	-	DRUGBANK	DB06144	C24H26ClFN4O	small molecule	N05AE03	106516-24-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GZKLJWGUPQBVJQ-UHFFFAOYSA-N
24369	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	5514	Sertindole	SerLect|1-[2-[4-[5-chloro-1-(4-Fluorophenyl)-indol-3-yl]-1-piperidyl]ethyl]imidazolidin-2-one|Sertindole|Serdolect|Sertindol|Sertindolum	-	DRUGBANK	DB06144	C24H26ClFN4O	small molecule	N05AE03	106516-24-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GZKLJWGUPQBVJQ-UHFFFAOYSA-N
24370	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Seeman P (2008)	18293356	182066	5514	Sertindole	SerLect|1-[2-[4-[5-chloro-1-(4-Fluorophenyl)-indol-3-yl]-1-piperidyl]ethyl]imidazolidin-2-one|Sertindole|Serdolect|Sertindol|Sertindolum	-	DRUGBANK	DB06144	C24H26ClFN4O	small molecule	N05AE03	106516-24-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GZKLJWGUPQBVJQ-UHFFFAOYSA-N
24392	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Terai M (1989)	2576228	181658	5516	Mianserin	1,2,3,4,10,14b-Hexahydro-2-methyldibenzo(c,F)pyrazino(1,2-a)azepine|Mianserine|Mianseryna|Mianserina|Mianserinum	-	DRUGBANK	DB06148	C18H20N2	small molecule	N06AX03	24219-97-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UEQUQVLFIPOEMF-UHFFFAOYSA-N
24407	109769	3553	-	IL1B	IL-1|IL1-BETA|IL1F2	9606	Homo sapiens	binder	target	Church LD (2009)	19169963	182096	5521	Canakinumab	ACZ-885|ACZ885	ilaris	DRUGBANK	DB06168	C6452H9958N1722O2010S42	biologic	L04AC08	914613-48-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24409	107093	624	-	BDKRB2	B2R|BK-2|BK2|BKR2|BRB2	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	5524	Icatibant	HOE 140	firazyr	DRUGBANK	DB06196	C59H89N19O13S	small molecule	B06AC02	130308-48-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QURWXBZNHXJZBE-MCDGZUPGSA-N
24410	107093	624	-	BDKRB2	B2R|BK-2|BK2|BKR2|BRB2	9606	Homo sapiens	antagonist	target	Privitera PJ (2003)	14514033	181835	5524	Icatibant	HOE 140	firazyr	DRUGBANK	DB06196	C59H89N19O13S	small molecule	B06AC02	130308-48-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QURWXBZNHXJZBE-MCDGZUPGSA-N
24411	106787	290	-	ANPEP	APN|CD13|GP150|LAP1|P150|PEPN	9606	Homo sapiens	inhibitor	target	Bawolak MT (2006)	17026984	181971	5524	Icatibant	HOE 140	firazyr	DRUGBANK	DB06196	C59H89N19O13S	small molecule	B06AC02	130308-48-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QURWXBZNHXJZBE-MCDGZUPGSA-N
24434	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Shahid M (2009)	18308814	175311	5533	Asenapine	Saphris	saphris	DRUGBANK	DB06216	C21H20ClNO5	small molecule	N05AH05	65576-45-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMDCDXMAFMEDAG-BTJKTKAUSA-N
24435	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Tadori Y (2011)	21658377	182191	5533	Asenapine	Saphris	saphris	DRUGBANK	DB06216	C21H20ClNO5	small molecule	N05AH05	65576-45-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMDCDXMAFMEDAG-BTJKTKAUSA-N
24436	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Citrome L (2011)	21655346	182190	5533	Asenapine	Saphris	saphris	DRUGBANK	DB06216	C21H20ClNO5	small molecule	N05AH05	65576-45-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMDCDXMAFMEDAG-BTJKTKAUSA-N
24443	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	antagonist	target	Shahid M (2009)	18308814	175311	5533	Asenapine	Saphris	saphris	DRUGBANK	DB06216	C21H20ClNO5	small molecule	N05AH05	65576-45-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMDCDXMAFMEDAG-BTJKTKAUSA-N
24444	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	antagonist	target	Tadori Y (2011)	21658377	182191	5533	Asenapine	Saphris	saphris	DRUGBANK	DB06216	C21H20ClNO5	small molecule	N05AH05	65576-45-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMDCDXMAFMEDAG-BTJKTKAUSA-N
24445	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	antagonist	target	Citrome L (2011)	21655346	182190	5533	Asenapine	Saphris	saphris	DRUGBANK	DB06216	C21H20ClNO5	small molecule	N05AH05	65576-45-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMDCDXMAFMEDAG-BTJKTKAUSA-N
24462	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	antagonist	target	Shahid M (2009)	18308814	175311	5533	Asenapine	Saphris	saphris	DRUGBANK	DB06216	C21H20ClNO5	small molecule	N05AH05	65576-45-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMDCDXMAFMEDAG-BTJKTKAUSA-N
24463	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	antagonist	target	Berman HM (2000)	10592235	172122	5533	Asenapine	Saphris	saphris	DRUGBANK	DB06216	C21H20ClNO5	small molecule	N05AH05	65576-45-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMDCDXMAFMEDAG-BTJKTKAUSA-N
24464	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	antagonist	target	Citrome L (2011)	21655346	182190	5533	Asenapine	Saphris	saphris	DRUGBANK	DB06216	C21H20ClNO5	small molecule	N05AH05	65576-45-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GMDCDXMAFMEDAG-BTJKTKAUSA-N
24518	108231	1909	-	EDNRA	ET-A|ETA|ETA-R|ETAR|ETRA|hET-AR	9606	Homo sapiens	antagonist	target	Kramp R (2001)	11704565	176862	5540	Sitaxentan	Sitaxsentan	thelin	DRUGBANK	DB06268	C18H15ClN2O6S2	small molecule	C02KX03	184036-34-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHWXUGHIIBDVKD-UHFFFAOYSA-N
24519	108231	1909	-	EDNRA	ET-A|ETA|ETA-R|ETAR|ETRA|hET-AR	9606	Homo sapiens	antagonist	target	Kiowski W (2001)	11447307	176863	5540	Sitaxentan	Sitaxsentan	thelin	DRUGBANK	DB06268	C18H15ClN2O6S2	small molecule	C02KX03	184036-34-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHWXUGHIIBDVKD-UHFFFAOYSA-N
24520	108231	1909	-	EDNRA	ET-A|ETA|ETA-R|ETAR|ETRA|hET-AR	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	5540	Sitaxentan	Sitaxsentan	thelin	DRUGBANK	DB06268	C18H15ClN2O6S2	small molecule	C02KX03	184036-34-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHWXUGHIIBDVKD-UHFFFAOYSA-N
24521	108231	1909	-	EDNRA	ET-A|ETA|ETA-R|ETAR|ETRA|hET-AR	9606	Homo sapiens	antagonist	target	Sihvola RK (2002)	11849873	176861	5540	Sitaxentan	Sitaxsentan	thelin	DRUGBANK	DB06268	C18H15ClN2O6S2	small molecule	C02KX03	184036-34-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHWXUGHIIBDVKD-UHFFFAOYSA-N
24522	108231	1909	-	EDNRA	ET-A|ETA|ETA-R|ETAR|ETRA|hET-AR	9606	Homo sapiens	antagonist	target	Martin C (2000)	10961375	176864	5540	Sitaxentan	Sitaxsentan	thelin	DRUGBANK	DB06268	C18H15ClN2O6S2	small molecule	C02KX03	184036-34-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHWXUGHIIBDVKD-UHFFFAOYSA-N
24523	108231	1909	-	EDNRA	ET-A|ETA|ETA-R|ETAR|ETRA|hET-AR	9606	Homo sapiens	antagonist	target	Albertini M (2001)	11728166	176865	5540	Sitaxentan	Sitaxsentan	thelin	DRUGBANK	DB06268	C18H15ClN2O6S2	small molecule	C02KX03	184036-34-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHWXUGHIIBDVKD-UHFFFAOYSA-N
24524	108231	1909	-	EDNRA	ET-A|ETA|ETA-R|ETAR|ETRA|hET-AR	9606	Homo sapiens	antagonist	target	Girgis RE (2007)	17472992	182007	5540	Sitaxentan	Sitaxsentan	thelin	DRUGBANK	DB06268	C18H15ClN2O6S2	small molecule	C02KX03	184036-34-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHWXUGHIIBDVKD-UHFFFAOYSA-N
24525	108232	1910	RP11-318G21.1	EDNRB	ABCDS|ET-B|ET-BR|ETB|ETBR|ETRB|HSCR|HSCR2|WS4A	9606	Homo sapiens	antagonist	target	Richard V (1994)	7858879	176868	5540	Sitaxentan	Sitaxsentan	thelin	DRUGBANK	DB06268	C18H15ClN2O6S2	small molecule	C02KX03	184036-34-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHWXUGHIIBDVKD-UHFFFAOYSA-N
24526	108232	1910	RP11-318G21.1	EDNRB	ABCDS|ET-B|ET-BR|ETB|ETBR|ETRB|HSCR|HSCR2|WS4A	9606	Homo sapiens	antagonist	target	Marano G (1998)	9806221	176869	5540	Sitaxentan	Sitaxsentan	thelin	DRUGBANK	DB06268	C18H15ClN2O6S2	small molecule	C02KX03	184036-34-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHWXUGHIIBDVKD-UHFFFAOYSA-N
24527	108232	1910	RP11-318G21.1	EDNRB	ABCDS|ET-B|ET-BR|ETB|ETBR|ETRB|HSCR|HSCR2|WS4A	9606	Homo sapiens	antagonist	target	Gardiner SM (1994)	7921608	176870	5540	Sitaxentan	Sitaxsentan	thelin	DRUGBANK	DB06268	C18H15ClN2O6S2	small molecule	C02KX03	184036-34-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHWXUGHIIBDVKD-UHFFFAOYSA-N
24528	108232	1910	RP11-318G21.1	EDNRB	ABCDS|ET-B|ET-BR|ETB|ETBR|ETRB|HSCR|HSCR2|WS4A	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	5540	Sitaxentan	Sitaxsentan	thelin	DRUGBANK	DB06268	C18H15ClN2O6S2	small molecule	C02KX03	184036-34-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHWXUGHIIBDVKD-UHFFFAOYSA-N
24529	108232	1910	RP11-318G21.1	EDNRB	ABCDS|ET-B|ET-BR|ETB|ETBR|ETRB|HSCR|HSCR2|WS4A	9606	Homo sapiens	antagonist	target	Said SA (2005)	15629255	176866	5540	Sitaxentan	Sitaxsentan	thelin	DRUGBANK	DB06268	C18H15ClN2O6S2	small molecule	C02KX03	184036-34-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHWXUGHIIBDVKD-UHFFFAOYSA-N
24530	108232	1910	RP11-318G21.1	EDNRB	ABCDS|ET-B|ET-BR|ETB|ETBR|ETRB|HSCR|HSCR2|WS4A	9606	Homo sapiens	antagonist	target	Gupta SK (2005)	16335785	176867	5540	Sitaxentan	Sitaxsentan	thelin	DRUGBANK	DB06268	C18H15ClN2O6S2	small molecule	C02KX03	184036-34-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHWXUGHIIBDVKD-UHFFFAOYSA-N
24531	108232	1910	RP11-318G21.1	EDNRB	ABCDS|ET-B|ET-BR|ETB|ETBR|ETRB|HSCR|HSCR2|WS4A	9606	Homo sapiens	antagonist	target	Girgis RE (2007)	17472992	182007	5540	Sitaxentan	Sitaxsentan	thelin	DRUGBANK	DB06268	C18H15ClN2O6S2	small molecule	C02KX03	184036-34-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PHWXUGHIIBDVKD-UHFFFAOYSA-N
24552	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Seeman P (2002)	11873706	174626	5546	Amisulpride	4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-O-anisamide|Amisulprida|4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-2-methoxybenzamide|Amisulpridum|Aminosultopride	-	DRUGBANK	DB06288	C17H27N3O4S	small molecule	N05AL05	71675-85-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NTJOBXMMWNYJFB-UHFFFAOYSA-N
24553	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Horacek J (2006)	16696579	181941	5546	Amisulpride	4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-O-anisamide|Amisulprida|4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-2-methoxybenzamide|Amisulpridum|Aminosultopride	-	DRUGBANK	DB06288	C17H27N3O4S	small molecule	N05AL05	71675-85-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NTJOBXMMWNYJFB-UHFFFAOYSA-N
24554	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Rosenzweig P (2002)	12404702	181804	5546	Amisulpride	4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-O-anisamide|Amisulprida|4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-2-methoxybenzamide|Amisulpridum|Aminosultopride	-	DRUGBANK	DB06288	C17H27N3O4S	small molecule	N05AL05	71675-85-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NTJOBXMMWNYJFB-UHFFFAOYSA-N
24555	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	antagonist	target	Seeman P (2002)	11873706	174626	5546	Amisulpride	4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-O-anisamide|Amisulprida|4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-2-methoxybenzamide|Amisulpridum|Aminosultopride	-	DRUGBANK	DB06288	C17H27N3O4S	small molecule	N05AL05	71675-85-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NTJOBXMMWNYJFB-UHFFFAOYSA-N
24556	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	antagonist	target	Horacek J (2006)	16696579	181941	5546	Amisulpride	4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-O-anisamide|Amisulprida|4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-2-methoxybenzamide|Amisulpridum|Aminosultopride	-	DRUGBANK	DB06288	C17H27N3O4S	small molecule	N05AL05	71675-85-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NTJOBXMMWNYJFB-UHFFFAOYSA-N
24557	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	antagonist	target	Rosenzweig P (2002)	12404702	181804	5546	Amisulpride	4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-O-anisamide|Amisulprida|4-Amino-N-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-2-methoxybenzamide|Amisulpridum|Aminosultopride	-	DRUGBANK	DB06288	C17H27N3O4S	small molecule	N05AL05	71675-85-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NTJOBXMMWNYJFB-UHFFFAOYSA-N
24567	109769	3553	-	IL1B	IL-1|IL1-BETA|IL1F2	9606	Homo sapiens	binder	target	Tran TH (2013)	23553601	182241	5551	Rilonacept	Arcalyst|interleukin-1 (IL-1) trap	arcalyst	DRUGBANK	DB06372	C9030H13932N2400O2670S74	biologic	L04AC04	501081-76-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24568	109769	3553	-	IL1B	IL-1|IL1-BETA|IL1F2	9606	Homo sapiens	binder	target	Cronstein BN (2013)	23319019	182226	5551	Rilonacept	Arcalyst|interleukin-1 (IL-1) trap	arcalyst	DRUGBANK	DB06372	C9030H13932N2400O2670S74	biologic	L04AC04	501081-76-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	-
24781	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Renner RM (2010)	20399943	182151	5605	Lornoxicam	Chlortenoxicam|Lornoxicamum	-	DRUGBANK	DB06725	C13H10ClN3O4S2	small molecule	M01AC05	70374-39-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WLHQHAUOOXYABV-UHFFFAOYSA-N
24782	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Rose P (2007)	17516707	182014	5605	Lornoxicam	Chlortenoxicam|Lornoxicamum	-	DRUGBANK	DB06725	C13H10ClN3O4S2	small molecule	M01AC05	70374-39-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WLHQHAUOOXYABV-UHFFFAOYSA-N
24783	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Berg J (1999)	10450786	181738	5605	Lornoxicam	Chlortenoxicam|Lornoxicamum	-	DRUGBANK	DB06725	C13H10ClN3O4S2	small molecule	M01AC05	70374-39-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WLHQHAUOOXYABV-UHFFFAOYSA-N
24784	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Bianchi M (2002)	11846620	181788	5605	Lornoxicam	Chlortenoxicam|Lornoxicamum	-	DRUGBANK	DB06725	C13H10ClN3O4S2	small molecule	M01AC05	70374-39-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WLHQHAUOOXYABV-UHFFFAOYSA-N
24785	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Renner RM (2010)	20399943	182151	5605	Lornoxicam	Chlortenoxicam|Lornoxicamum	-	DRUGBANK	DB06725	C13H10ClN3O4S2	small molecule	M01AC05	70374-39-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WLHQHAUOOXYABV-UHFFFAOYSA-N
24786	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Rose P (2007)	17516707	182014	5605	Lornoxicam	Chlortenoxicam|Lornoxicamum	-	DRUGBANK	DB06725	C13H10ClN3O4S2	small molecule	M01AC05	70374-39-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WLHQHAUOOXYABV-UHFFFAOYSA-N
24787	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Berg J (1999)	10450786	181738	5605	Lornoxicam	Chlortenoxicam|Lornoxicamum	-	DRUGBANK	DB06725	C13H10ClN3O4S2	small molecule	M01AC05	70374-39-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WLHQHAUOOXYABV-UHFFFAOYSA-N
24788	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Bianchi M (2002)	11846620	181788	5605	Lornoxicam	Chlortenoxicam|Lornoxicamum	-	DRUGBANK	DB06725	C13H10ClN3O4S2	small molecule	M01AC05	70374-39-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WLHQHAUOOXYABV-UHFFFAOYSA-N
24838	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	inhibitor	target	Gamache DA (2000)	10850857	181753	5639	Nepafenac	AHR 9434|Amfenac amide|AL-6515|Nepafenaco|2-amino-3-Benzoylbenzeneacetamide|AL 6515|Nepafenacum|AHR-9434|Nevanac	ilevro|nevanac	DRUGBANK	DB06802	C15H14N2O2	small molecule	S01BC10	78281-72-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QEFAQIPZVLVERP-UHFFFAOYSA-N
24839	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Gamache DA (2000)	10850857	181753	5639	Nepafenac	AHR 9434|Amfenac amide|AL-6515|Nepafenaco|2-amino-3-Benzoylbenzeneacetamide|AL 6515|Nepafenacum|AHR-9434|Nevanac	ilevro|nevanac	DRUGBANK	DB06802	C15H14N2O2	small molecule	S01BC10	78281-72-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QEFAQIPZVLVERP-UHFFFAOYSA-N
24849	110226	4048	-	LTA4H	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5649	5-[2-(1H-pyrrol-1-yl)ethoxy]-1H-indole	-	-	DRUGBANK	DB06828	C14H14N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NSZDJRLPCLOQAM-UHFFFAOYSA-N
24857	112717	6850	-	SYK	p72-Syk	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5655	N-(2-hydroxy-1,1-dimethylethyl)-1-methyl-3-(1H-pyrrolo[2,3-b]pyridin-2-yl)-1H-indole-5-carboxamide	-	-	DRUGBANK	DB06834	C21H22N4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XZRYCTLOGNCQDG-UHFFFAOYSA-N
24879	110226	4048	-	LTA4H	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5672	N-(pyridin-3-ylmethyl)aniline	-	-	DRUGBANK	DB06851	C12H12N2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BJXLHKJBRORJJJ-UHFFFAOYSA-N
24925	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5718	N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOTHIAZIN-4-YL]ETHYL}ACETAMIDE	-	-	DRUGBANK	DB06899	C20H26N6O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMEVNJZCKDVVND-UHFFFAOYSA-N
24933	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5727	(2S)-3-(1-{[2-(2-CHLOROPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL}-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID	-	-	DRUGBANK	DB06908	C24H23ClN2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PAWOPJKHTZCKMT-QFIPXVFZSA-N
24940	110226	4048	-	LTA4H	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5736	(4-fluorophenyl)(pyridin-4-yl)methanone	-	-	DRUGBANK	DB06917	C12H8FNO	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WTRWBYGUMQEFFI-UHFFFAOYSA-N
24949	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5745	(9Z,11E,13S)-13-hydroxyoctadeca-9,11-dienoic acid	-	-	DRUGBANK	DB06926	C18H32O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HNICUWMFWZBIFP-IRQZEAMPSA-N
24977	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5775	N-(4-ACETYLPHENYL)-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE	-	-	DRUGBANK	DB06956	C18H14ClN3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BTTFXKUTBNGQTP-UHFFFAOYSA-N
24978	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5776	4-CHLORO-6-(4-{4-[4-(METHYLSULFONYL)BENZYL]PIPERAZIN-1-YL}-1H-PYRAZOL-5-YL)BENZENE-1,3-DIOL	-	-	DRUGBANK	DB06957	C21H23ClN4O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BDFJIEMVNDLSTB-UHFFFAOYSA-N
24979	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5777	5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-PIPERAZIN-1-YL-1H-PYRAZOLE-3-CARBOXAMIDE	-	-	DRUGBANK	DB06958	C16H20ClN5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SORAKBHHTGVZCS-UHFFFAOYSA-N
24982	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5780	5-(5-chloro-2,4-dihydroxyphenyl)-N-ethyl-4-[4-(morpholin-4-ylmethyl)phenyl]isoxazole-3-carboxamide	-	-	DRUGBANK	DB06961	C23H24ClN3O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	APGOABVITLQCKW-UHFFFAOYSA-N
24985	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5783	5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-(4-METHOXYPHENYL)ISOXAZOLE-3-CARBOXAMIDE	-	-	DRUGBANK	DB06964	C19H17ClN2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JXPCDMPJCKNLBY-UHFFFAOYSA-N
24986	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5786	6-ETHYL-5-[9-(3-METHOXYPROPYL)-9H-CARBAZOL-2-YL]PYRIMIDINE-2,4-DIAMINE	-	-	DRUGBANK	DB06967	C22H25N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLSVRCGEBXIIQO-UHFFFAOYSA-N
24987	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5788	2-amino-4-[2,4-dichloro-5-(2-pyrrolidin-1-ylethoxy)phenyl]-N-ethylthieno[2,3-d]pyrimidine-6-carboxamide	-	-	DRUGBANK	DB06969	C21H23Cl2N5O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WJUNQSYQHHIVFX-UHFFFAOYSA-N
25000	119038	30814	-	PLA2G2E	GIIE sPLA2|sPLA2-IIE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5805	2-(4-(2-HYDROXY-3-(ISOPROPYLAMINO)PROPOXY)PHENYL)ETHANAMIDE	-	-	DRUGBANK	DB06987	C14H22N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	METKIMKYRPQLGS-GFCCVEGCSA-N
25033	111587	5601	-	MAPK9	JNK-55|JNK2|JNK2A|JNK2ALPHA|JNK2B|JNK2BETA|PRKM9|SAPK|SAPK1a|p54a|p54aSAPK	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5838	N-{3-[5-(1H-1,2,4-triazol-3-yl)-1H-indazol-3-yl]phenyl}furan-2-carboxamide	-	-	DRUGBANK	DB07020	C20H14N6O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LMDMJDCLPIVGQD-UHFFFAOYSA-N
25041	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5846	(2-{[(4-BROMO-2-FLUOROBENZYL)AMINO]CARBONYL}-5-CHLOROPHENOXY)ACETIC ACID	-	-	DRUGBANK	DB07028	C16H12BrClFNO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZLIGBZRXAQNUFO-UHFFFAOYSA-N
25043	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5848	(5-CHLORO-2-{[(3-NITROBENZYL)AMINO]CARBONYL}PHENOXY)ACETIC ACID	-	-	DRUGBANK	DB07030	C16H13ClN2O6	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VABIMMIJVWNHFI-UHFFFAOYSA-N
25059	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5871	2-{5-[3-(7-PROPYL-3-TRIFLUOROMETHYLBENZO[D]ISOXAZOL-6-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID	-	-	DRUGBANK	DB07053	C24H23F3N2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TWVYNPULGKGJOS-UHFFFAOYSA-N
25064	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5877	N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOXAZIN-4-YL]ETHYL}ACETAMIDE	-	-	DRUGBANK	DB07059	C20H26N6O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GBXSOZDYCSBLQX-UHFFFAOYSA-N
25067	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5881	{3-[(4,5,7-TRIFLUORO-1,3-BENZOTHIAZOL-2-YL)METHYL]-1H-INDOL-1-YL}ACETIC ACID	-	-	DRUGBANK	DB07063	C18H11F3N2O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KYHVTMFADJNSGS-UHFFFAOYSA-N
25104	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5911	{3-[(5-CHLORO-1,3-BENZOTHIAZOL-2-YL)METHYL]-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL}ACETIC ACID	-	-	DRUGBANK	DB07093	C14H10ClN3O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RQWICELTTDJODO-UHFFFAOYSA-N
25105	110226	4048	-	LTA4H	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5912	1-(2,2'-bithiophen-5-yl)methanamine	-	-	DRUGBANK	DB07094	C9H9NS2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FHYTVXBZSXZMGD-UHFFFAOYSA-N
25109	110226	4048	-	LTA4H	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5917	N-[4-(benzyloxy)phenyl]glycinamide	-	-	DRUGBANK	DB07099	C15H16N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YJPUATSIKWOSST-UHFFFAOYSA-N
25110	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5918	4-CHLORO-6-(4-PIPERAZIN-1-YL-1H-PYRAZOL-5-YL)BENZENE-1,3-DIOL	-	-	DRUGBANK	DB07100	C13H15ClN4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RFPHEBUOQYYPDO-UHFFFAOYSA-N
25112	110226	4048	-	LTA4H	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5920	(2S)-2-amino-5-oxo-5-[(4-phenylmethoxyphenyl)amino]pentanoic acid	-	-	DRUGBANK	DB07102	C18H20N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BYSBXIPCDJNEBG-INIZCTEOSA-N
25113	110226	4048	-	LTA4H	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5922	4-amino-N-[4-(benzyloxy)phenyl]butanamide	-	-	DRUGBANK	DB07104	C17H20N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QTWBKNVNGVYTNZ-UHFFFAOYSA-N
25120	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5929	(4S,5E,7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoic acid	-	-	DRUGBANK	DB07111	C22H32O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IFRKCNPQVIJFAQ-HBUOOPIGSA-N
25122	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5931	(2S)-6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2-(3,5-DIFLUOROPHENYL)-4-(3-METHOXYPROPYL)-2H-1,4-BENZOXAZIN-3(4H)-ONE	-	-	DRUGBANK	DB07113	C24H25F2N5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KHZQOXQOUCGGGA-NRFANRHFSA-N
25150	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5957	3-[5-(3-nitrophenyl)thiophen-2-yl]propanoic acid	-	-	DRUGBANK	DB07139	C13H11NO4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IHKCOKRMJRDWAL-UHFFFAOYSA-N
25169	112717	6850	-	SYK	p72-Syk	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5977	6-({5-fluoro-2-[(3,4,5-trimethoxyphenyl)amino]pyrimidin-4-yl}amino)-2,2-dimethyl-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one	-	-	DRUGBANK	DB07159	C22H23FN6O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NHHQJBCNYHBUSI-UHFFFAOYSA-N
25179	108218	1889	RP3-329E20.1	ECE1	ECE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5988	5-(2-hydroxyethyl)nonane-1,9-diol	-	-	DRUGBANK	DB07171	C11H24O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VICIXNZSEUYGFV-UHFFFAOYSA-N
25180	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5989	(5R,6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid	-	-	DRUGBANK	DB07172	C20H30O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FTAGQROYQYQRHF-CBVHGRPESA-N
25182	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5991	6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-4-(3-METHOXYPROPYL)-2,2-DIMETHYL-2H-1,4-BENZOXAZIN-3(4H)-ONE	-	-	DRUGBANK	DB07174	C20H27N5O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WPAPODFGOZXFLG-UHFFFAOYSA-N
25184	116604	22949	RP11-16L21.1	PTGR1	LTB4DH|PGR1|ZADH3	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5994	(5E,13E)-11-HYDROXY-9,15-DIOXOPROSTA-5,13-DIEN-1-OIC ACID	-	-	DRUGBANK	DB07177	C20H30O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YRTJDWROBKPZNV-DYTRGIJQSA-N
25185	126915	145482	-	PTGR2	HEL-S-298|PGR2|ZADH1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	5994	(5E,13E)-11-HYDROXY-9,15-DIOXOPROSTA-5,13-DIEN-1-OIC ACID	-	-	DRUGBANK	DB07177	C20H30O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YRTJDWROBKPZNV-DYTRGIJQSA-N
25193	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6004	6-[(5-CHLORO-3-METHYL-1-BENZOFURAN-2-YL)SULFONYL]PYRIDAZIN-3(2H)-ONE	-	-	DRUGBANK	DB07187	C13H9ClN2O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FXFPQPNUMWQRAO-UHFFFAOYSA-N
25197	112717	6850	-	SYK	p72-Syk	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6011	2-{2-[(3,5-dimethylphenyl)amino]pyrimidin-4-yl}-N-[(1S)-2-hydroxy-1-methylethyl]-4-methyl-1,3-thiazole-5-carboxamide	-	-	DRUGBANK	DB07194	C20H23N5O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PEGXADGTBNRSGV-ZDUSSCGKSA-N
25200	110226	4048	-	LTA4H	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6013	N-methyl-1-(2-thiophen-2-ylphenyl)methanamine	-	-	DRUGBANK	DB07196	C12H13NS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MRKJJEJYTBOUTH-UHFFFAOYSA-N
25213	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6025	(8E,10S,12Z)-10-hydroxy-6-oxooctadeca-8,12-dienoic acid	-	-	DRUGBANK	DB07208	C18H30O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJFOOCZBVPQYRS-PSDPTOBYSA-N
25214	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6026	(8R,9Z,12Z)-8-hydroxy-6-oxooctadeca-9,12-dienoic acid	-	-	DRUGBANK	DB07209	C18H30O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MLHUENSFQCPBQH-ZBKJIUGYSA-N
25245	114683	9261	-	MAPKAPK2	MAPKAP-K2|MK-2|MK2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6050	3-{[(1R)-1-phenylethyl]amino}-4-(pyridin-4-ylamino)cyclobut-3-ene-1,2-dione	-	-	DRUGBANK	DB07234	C17H15N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MCBPNFWHHNJTGN-LLVKDONJSA-N
25249	110226	4048	-	LTA4H	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6053	{4-[(2R)-pyrrolidin-2-ylmethoxy]phenyl}(4-thiophen-3-ylphenyl)methanone	-	-	DRUGBANK	DB07237	C22H21NO2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VUWFJUJWAWMRQN-HXUWFJFHSA-N
25254	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6060	5-{4-[(3,5-DIFLUOROBENZYL)AMINO]PHENYL}-6-ETHYLPYRIMIDINE-2,4-DIAMINE	-	-	DRUGBANK	DB07244	C19H19F2N5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SRRWXMSVQYQCRX-UHFFFAOYSA-N
25270	110226	4048	-	LTA4H	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6074	(R)-pyridin-4-yl[4-(2-pyrrolidin-1-ylethoxy)phenyl]methanol	-	-	DRUGBANK	DB07258	C18H22N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QQRJWLDQBNAQCC-GOSISDBHSA-N
25271	110226	4048	-	LTA4H	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6075	1-(4-thiophen-2-ylphenyl)methanamine	-	-	DRUGBANK	DB07259	C11H11NS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YKNLMMDEWQZCLJ-UHFFFAOYSA-N
25272	110226	4048	-	LTA4H	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6076	N-benzyl-4-[(2R)-pyrrolidin-2-ylmethoxy]aniline	-	-	DRUGBANK	DB07260	C18H22N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HITMFLNAOQIZSN-QGZVFWFLSA-N
25301	110226	4048	-	LTA4H	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6108	4-(2-amino-1,3-thiazol-4-yl)phenol	-	-	DRUGBANK	DB07292	C9H8N2OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QGSJYYIRAFRPIT-UHFFFAOYSA-N
25309	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6118	(9S,10E,12Z)-9-hydroxyoctadeca-10,12-dienoic acid	-	-	DRUGBANK	DB07302	C18H32O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NPDSHTNEKLQQIJ-UINYOVNOSA-N
25324	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6133	(3E)-3-[(phenylamino)methylidene]dihydrofuran-2(3H)-one	-	-	DRUGBANK	DB07317	C11H11NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BKXNPYSVWOVZGX-CMDGGOBGSA-N
25326	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6135	6-(3-BROMO-2-NAPHTHYL)-1,3,5-TRIAZINE-2,4-DIAMINE	-	-	DRUGBANK	DB07319	C13H10BrN5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RXSSKAZHCZWJPP-UHFFFAOYSA-N
25331	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6140	3-({2-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)ETHYNYL]BENZYL}AMINO)-1,3-OXAZOL-2(3H)-ONE	-	-	DRUGBANK	DB07324	C17H15N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZUJWSOPIDUWELP-UHFFFAOYSA-N
25332	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6141	N-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)METHYL]-3-{[(E)-(2-OXODIHYDROFURAN-3(2H)-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE	-	-	DRUGBANK	DB07325	C17H19N5O4S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VCOKUBHAJVTVNG-FMIVXFBMSA-N
25431	114683	9261	-	MAPKAPK2	MAPKAP-K2|MK-2|MK2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6220	(4R)-N-[4-({[2-(DIMETHYLAMINO)ETHYL]AMINO}CARBONYL)-1,3-THIAZOL-2-YL]-4-METHYL-1-OXO-2,3,4,9-TETRAHYDRO-1H-BETA-CARBOLINE-6-CARBOXAMIDE	-	-	DRUGBANK	DB07406	C21H24N6O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QWFFPYQWUWLDBV-NSHDSACASA-N
25451	114683	9261	-	MAPKAPK2	MAPKAP-K2|MK-2|MK2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6243	(10R)-10-methyl-3-(6-methylpyridin-3-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one	-	-	DRUGBANK	DB07430	C21H18N4OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CMWRPDHVGMHLSZ-GFCCVEGCSA-N
25452	114683	9261	-	MAPKAPK2	MAPKAP-K2|MK-2|MK2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6244	(3R)-3-(aminomethyl)-9-methoxy-1,2,3,4-tetrahydro-5H-[1]benzothieno[3,2-e][1,4]diazepin-5-one	-	-	DRUGBANK	DB07431	C13H15N3O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TXYKBKYDFZQOCB-SSDOTTSWSA-N
25468	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6261	2[4-BROMO-2-FLUOROPHENYL)METHYL]-6-FLUOROSPIRO[ISOQUINOLINE-4-(1H),3'-PYRROLIDINE]-1,2',3,5'(2H)-TETRONE	-	-	DRUGBANK	DB07450	C19H11BrF2N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BMHZAHGTGIZZCT-LJQANCHMSA-N
25469	107924	1544	-	CYP1A2	CP12|P3-450|P450(PA)	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6264	2-PHENYL-4H-BENZO[H]CHROMEN-4-ONE	-	-	DRUGBANK	DB07453	C19H12O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VFMMPHCGEFXGIP-UHFFFAOYSA-N
25518	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6306	5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-(4-METHOXYPHENYL)-1H-PYRAZOLE-3-CARBOXAMIDE	-	-	DRUGBANK	DB07495	C19H18ClN3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HUNAOTXNHVALTN-UHFFFAOYSA-N
25521	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6309	4-[3-(3-NITROPHENYL)-1,2,4-OXADIAZOL-5-YL]BUTANOIC ACID	-	-	DRUGBANK	DB07498	C12H11N3O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LQQYZJRCWBRIMW-UHFFFAOYSA-N
25522	119038	30814	-	PLA2G2E	GIIE sPLA2|sPLA2-IIE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6311	(2E)-1-[2-hydroxy-4-methoxy-5-(3-methylbut-2-en-1-yl)phenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one	-	-	DRUGBANK	DB07500	C21H22O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZUGCRBMNFSAUOC-YRNVUSSQSA-N
25524	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6313	4-bromo-6-(6-hydroxy-1,2-benzisoxazol-3-yl)benzene-1,3-diol	-	-	DRUGBANK	DB07502	C13H8BrNO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LZACPHWPRDKUPK-UHFFFAOYSA-N
25530	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6320	difluoro(5-{2-[(5-octyl-1H-pyrrol-2-yl-kappaN)methylidene]-2H-pyrrol-5-yl-kappaN}pentanoato)boron	-	-	DRUGBANK	DB07509	C22H31BF2N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JNKJCLYKBRBEKW-UHFFFAOYSA-N
25604	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6401	4-[4-(2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)-3-METHYL-1H-PYRAZOL-5-YL]-6-ETHYLBENZENE-1,3-DIOL	-	-	DRUGBANK	DB07594	C20H20N2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OWPMENVYXDJDOW-UHFFFAOYSA-N
25609	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6407	4-chloro-6-{5-[(2-morpholin-4-ylethyl)amino]-1,2-benzisoxazol-3-yl}benzene-1,3-diol	-	-	DRUGBANK	DB07601	C19H20ClN3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JLIRVZVVCCIAKG-UHFFFAOYSA-N
25618	118128	27306	-	HPGDS	GSTS|GSTS1-1|PGD2|PGDS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6419	3-phenyl-5-(1H-pyrazol-3-yl)isoxazole	-	-	DRUGBANK	DB07613	C12H9N3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SRSSTOPJERVMRZ-UHFFFAOYSA-N
25619	118128	27306	-	HPGDS	GSTS|GSTS1-1|PGD2|PGDS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6420	PHENYL-5-(1H-PYRAZOL-3-YL)-1,3-THIAZOLE	-	-	DRUGBANK	DB07614	C12H9N3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NRAHRUHGPGBWSI-UHFFFAOYSA-N
25620	118128	27306	-	HPGDS	GSTS|GSTS1-1|PGD2|PGDS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6421	Tranilast	2-{[(2E)-3-(3,4-dimethoxyphenyl)prop-2-enoyl]amino}benzoic acid	-	DRUGBANK	DB07615	C18H17NO5	small molecule	-	53902-12-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NZHGWWWHIYHZNX-CSKARUKUSA-N
25621	118128	27306	-	HPGDS	GSTS|GSTS1-1|PGD2|PGDS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6422	4-{[4-(4-fluoro-3-methylphenyl)-1,3-thiazol-2-yl]amino}-2-hydroxybenzoic acid	-	-	DRUGBANK	DB07616	C17H13FN2O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	LKZZDHKJFDTYCH-UHFFFAOYSA-N
25661	111336	5319	-	PLA2G1B	PLA2|PLA2A|PPLA2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6463	PHOSPHONIC ACID 2-DODECANOYLAMINO-HEXYL ESTER PROPYL ESTER	-	-	DRUGBANK	DB07657	C20H42NO6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SLLQAGCLXXPCKZ-LJQANCHMSA-N
25682	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6481	Ragaglitazar	NN-622|(2S)-2-ETHOXY-3-{4-[2-(10H-PHENOXAZIN-10-YL)ETHOXY]PHENYL}PROPANOIC ACID|2-ETHOXY-3-[4-(2-PHENOXAZIN-10-YL-ETHOXY)-PHENYL]-PROPIONIC ACID(-) DRF 2725|Q27088511|DRF-2725|2-ETHOXY-3-[4-(2-PHENOXAZIN-10-YL-ETHOXY)-PHENYL]-PROPIONIC ACID|NNC-61-0029|(2S)-2-ETHOXY-3-[4-(2-PHENOXAZIN-10-YLETHOXY)PHENYL]PROPANOIC ACID|1NYX|DRF|(-)-DRF-2725|DRF2725|(S)-2-ETHOXY-3-[4-(2-PHENOXAZIN-10-YL-ETHOXY)-PHENYL]-PROPIONIC ACID|DB07675|RAGAGLITAZAR|GTPL2664|BDBM50109551	-	DRUGBANK	DB07675	C25H25NO5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WMUIIGVAWPWQAW-DEOSSOPVSA-N
25706	114196	8644	-	AKR1C3	DD3|DDX|HA1753|HAKRB|HAKRe|HSD17B5|PGFS|hluPGFS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6504	3-CARBOXAMIDO-1,3,5(10)-ESTRATRIEN-17(R)-SPIRO-2'(5',5'-DIMETHYL-6'OXO)TETRAHYDROPYRAN	-	-	DRUGBANK	DB07700	C25H33NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YVAJWBACBRSVPR-NDUHRLLKSA-N
25724	110428	4282	-	MIF	GIF|GLIF|MMIF	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6521	3-(4-HYDROXY-PHENYL)PYRUVIC ACID	-	-	DRUGBANK	DB07718	C9H8O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KKADPXVIOXHVKN-UHFFFAOYSA-N
25728	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6526	3-(5-methoxy-1H-indol-3-yl)propanoic acid	-	-	DRUGBANK	DB07723	C12H13NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZLSZCJIWILJKMR-UHFFFAOYSA-N
25731	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6527	3-{5-methoxy-1-[(4-methoxyphenyl)sulfonyl]-1H-indol-3-yl}propanoic acid	-	-	DRUGBANK	DB07724	C19H19NO6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YMPALHOKRBVHOJ-UHFFFAOYSA-N
25733	114683	9261	-	MAPKAPK2	MAPKAP-K2|MK-2|MK2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6529	2-[2-(2-FLUOROPHENYL)PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE	-	-	DRUGBANK	DB07728	C18H14FN3O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XJJYJNMNYDNXNO-UHFFFAOYSA-N
25784	108012	1645	RP11-69D4.1	AKR1C1	2-ALPHA-HSD|20-ALPHA-HSD|C9|DD1|DD1/DD2|DDH|DDH1|H-37|HAKRC|HBAB|MBAB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6569	(10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE	-	-	DRUGBANK	DB07768	C19H28O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MUMGGOZAMZWBJJ-KZYORJDKSA-N
25785	108013	1646	-	AKR1C2	AKR1C-pseudo|BABP|DD|DD-2|DD/BABP|DD2|DDH2|HAKRD|HBAB|MCDR2|SRXY8|TDD	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6569	(10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE	-	-	DRUGBANK	DB07768	C19H28O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MUMGGOZAMZWBJJ-KZYORJDKSA-N
25854	111336	5319	-	PLA2G1B	PLA2|PLA2A|PPLA2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6633	1-DECYL-3-TRIFLUORO ETHYL-SN-GLYCERO-2-PHOSPHOMETHANOL	-	-	DRUGBANK	DB07836	C16H32F3O6P	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YBCDZAGHRGXDRX-HNNXBMFYSA-N
25866	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6639	(2S)-2-(4-ethylphenoxy)-3-phenylpropanoic acid	-	-	DRUGBANK	DB07842	C17H18O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CJMVTSLLWMPEKQ-INIZCTEOSA-N
25900	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6660	2-chloro-5-nitro-N-phenylbenzamide	-	-	DRUGBANK	DB07863	C13H9ClN2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DNTSIBUQMRRYIU-UHFFFAOYSA-N
25911	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6674	8-(6-BROMO-BENZO[1,3]DIOXOL-5-YLSULFANYL)-9-(3-ISOPROPYLAMINO-PROPYL)-ADENINE	-	-	DRUGBANK	DB07877	C18H21BrN6O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MWGWLDJLENCVRQ-UHFFFAOYSA-N
25918	110428	4282	-	MIF	GIF|GLIF|MMIF	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6685	3-(4-HYDROXYPHENYL)-4,5-DIHYDRO-5-ISOXAZOLE-ACETIC ACID METHYL ESTER	-	-	DRUGBANK	DB07888	C12H13NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AIXMJTYHQHQJLU-SNVBAGLBSA-N
25938	118128	27306	-	HPGDS	GSTS|GSTS1-1|PGD2|PGDS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6713	4-(BENZHYDRYLOXY)-1-[3-(1H-TETRAAZOL-5-YL)PROPYL]PIPERIDINE	-	-	DRUGBANK	DB07917	C22H27N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TZQGXAHOROZEKN-UHFFFAOYSA-N
25958	108012	1645	RP11-69D4.1	AKR1C1	2-ALPHA-HSD|20-ALPHA-HSD|C9|DD1|DD1/DD2|DDH|DDH1|H-37|HAKRC|HBAB|MBAB	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6727	Hexestrol	Hexoestrolum|4,4'-(1,2-diethylethylene)diphenol|Mesohexestrol|Hexanoestrol|Synoestrolum|Erythrohexestrol|Meso-3,4-di(p-hydroxyphenyl)-n-hexane|Meso-hexestrol	-	DRUGBANK	DB07931	C18H22O2	small molecule	-	84-16-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PBBGSZCBWVPOOL-HDICACEKSA-N
25976	119038	30814	-	PLA2G2E	GIIE sPLA2|sPLA2-IIE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6745	1H-INDOL-3-YLACETIC ACID	-	-	DRUGBANK	DB07950	C10H9NO2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SEOVTRFCIGRIMH-UHFFFAOYSA-N
25990	119038	30814	-	PLA2G2E	GIIE sPLA2|sPLA2-IIE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6753	(2-CARBAMOYLMETHYL-5-PROPYL-OCTAHYDRO-INDOL-7-YL)ACETIC ACID	-	-	DRUGBANK	DB07958	C15H18N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OMLOGGCSARAIGZ-UHFFFAOYSA-N
26008	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6776	2-[1-(4-CHLOROBENZOYL)-5-METHOXY-2-METHYL-1H-INDOL-3-YL]-N-[(1R)-1-(HYDROXYMETHYL)PROPYL]ACETAMIDE	-	-	DRUGBANK	DB07981	C23H25ClN2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GKJWXEORYGBJFS-QGZVFWFLSA-N
26010	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6778	1-(4-IODOBENZOYL)-5-METHOXY-2-METHYL INDOLE-3-ACETIC ACID	-	-	DRUGBANK	DB07983	C19H16INO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CXBFZYKAVCAPSV-UHFFFAOYSA-N
26011	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6779	2-[1-(4-CHLOROBENZOYL)-5-METHOXY-2-METHYL-1H-INDOL-3-YL]-N-[(1S)-1-(HYDROXYMETHYL)PROPYL]ACETAMIDE	-	-	DRUGBANK	DB07984	C23H25ClN2O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GKJWXEORYGBJFS-KRWDZBQOSA-N
26026	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6793	{4-[(CARBOXYMETHOXY)CARBONYL]-3,3-DIOXIDO-1-OXONAPHTHO[1,2-D]ISOTHIAZOL-2(1H)-YL}ACETIC ACID	-	-	DRUGBANK	DB07999	C16H11NO9S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IXLBOIRSEDMRPI-UHFFFAOYSA-N
26027	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6794	2-(CARBOXYMETHYL)-1-OXO-1,2-DIHYDRONAPHTHO[1,2-D]ISOTHIAZOLE-4-CARBOXYLIC ACID 3,3-DIOXIDE	-	-	DRUGBANK	DB08000	C14H9NO7S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZTJGXDGAXGWOGR-UHFFFAOYSA-N
26039	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6811	N-{(3S,4S)-4-[(6-AMINO-4-METHYLPYRIDIN-2-YL)METHYL]PYRROLIDIN-3-YL}-N'-(4-CHLOROBENZYL)ETHANE-1,2-DIAMINE	-	-	DRUGBANK	DB08018	C20H28ClN5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JDRSQGJWTVRNGM-QFBILLFUSA-N
26041	110905	4842	-	NOS1	IHPS1|N-NOS|NC-NOS|NOS|bNOS|nNOS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6812	N-{(3R,4S)-4-[(6-amino-4-methylpyridin-2-yl)methyl]pyrrolidin-3-yl}-N'-(3-chlorobenzyl)ethane-1,2-diamine	-	-	DRUGBANK	DB08019	C20H28ClN5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VWCMAGONQJHIJZ-LPHOPBHVSA-N
26061	110226	4048	-	LTA4H	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6833	N-[(2R)-2-benzyl-4-(hydroxyamino)-4-oxobutanoyl]-L-alanine	-	-	DRUGBANK	DB08040	C14H18N2O5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OJCFZTVYDSKXNM-GXSJLCMTSA-N
26114	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6877	IDD594	-	-	DRUGBANK	DB08084	C16H12BrF2NO3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JCZUIWYXULSXSW-UHFFFAOYSA-N
26126	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6891	[5-(5-nitro-2-furyl)-1,3,4-oxadiazol-2-yl]thio}acetic acid	-	-	DRUGBANK	DB08098	C8H5N3O6S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ITBNJCVIFHSKRL-UHFFFAOYSA-N
26127	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6892	6-ethyl-5-[(2S)-1-(3-methoxypropyl)-2-phenyl-1,2,3,4-tetrahydroquinolin-7-yl]pyrimidine-2,4-diamine	-	-	DRUGBANK	DB08099	C25H31N5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UOYVKYJWAXJTTE-NRFANRHFSA-N
26140	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6913	(2S)-2-(biphenyl-4-yloxy)-3-phenylpropanoic acid	-	-	DRUGBANK	DB08121	C21H18O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TZTPJJNNACUQQR-FQEVSTJZSA-N
26220	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6985	4-methyl-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidin-2-amine	-	-	DRUGBANK	DB08194	C8H11N3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ONZWAEXRMZGFAN-UHFFFAOYSA-N
26222	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	6988	(5E,7S)-2-amino-7-(4-fluoro-2-pyridin-3-ylphenyl)-4-methyl-7,8-dihydroquinazolin-5(6H)-one oxime	-	-	DRUGBANK	DB08197	C20H18FN5O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KYIXUSLGFINPTC-WVFAEZDRSA-N
26307	108367	2053	-	EPHX2	CEH|SEH	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7045	N-[(CYCLOHEXYLAMINO)CARBONYL]GLYCINE	-	-	DRUGBANK	DB08256	C9H16N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NVORCMBCUHQRDL-UHFFFAOYSA-N
26308	108367	2053	-	EPHX2	CEH|SEH	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7046	4-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}BUTANOIC ACID	-	-	DRUGBANK	DB08257	C11H20N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WSVFRGGLURJIMG-UHFFFAOYSA-N
26309	108367	2053	-	EPHX2	CEH|SEH	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7047	6-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}HEXANOIC ACID	-	-	DRUGBANK	DB08258	C13H24N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KFTVEPYSUSWBRD-UHFFFAOYSA-N
26310	108367	2053	-	EPHX2	CEH|SEH	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7048	7-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}HEPTANOIC ACID	-	-	DRUGBANK	DB08259	C14H26N2O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GYTIWWDVOFXKPF-UHFFFAOYSA-N
26341	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7089	3-[5-(2-nitropent-1-en-1-yl)furan-2-yl]benzoic acid	-	-	DRUGBANK	DB08302	C16H15NO5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IRHZCQDCMUWUKV-RAXLEYEMSA-N
26349	118128	27306	-	HPGDS	GSTS|GSTS1-1|PGD2|PGDS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7099	nocodazole	-	-	DRUGBANK	DB08313	C14H11N3O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KYRVNWMVYQXFEU-UHFFFAOYSA-N
26375	110428	4282	-	MIF	GIF|GLIF|MMIF	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7119	4-HYDROXYBENZALDEHYDE O-(CYCLOHEXYLCARBONYL)OXIME	-	-	DRUGBANK	DB08333	C14H17NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YWZBYSBZDQWXGQ-XNTDXEJSSA-N
26376	110428	4282	-	MIF	GIF|GLIF|MMIF	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7120	3-FLUORO-4-HYDROXYBENZALDEHYDE O-(CYCLOHEXYLCARBONYL)OXIME	-	-	DRUGBANK	DB08334	C14H16FNO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NPVNUGQNVVMJJP-CXUHLZMHSA-N
26377	110428	4282	-	MIF	GIF|GLIF|MMIF	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7121	4-HYDROXYBENZALDEHYDE O-(3,3-DIMETHYLBUTANOYL)OXIME	-	-	DRUGBANK	DB08335	C13H17NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IRHAIEVALGHVLW-NTEUORMPSA-N
26407	114683	9261	-	MAPKAPK2	MAPKAP-K2|MK-2|MK2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7143	2-(2-QUINOLIN-3-YLPYRIDIN-4-YL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE	-	-	DRUGBANK	DB08358	C21H16N4O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OWFLADWRSCINST-UHFFFAOYSA-N
26411	112717	6850	-	SYK	p72-Syk	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7146	2-{[(1R,2S)-2-aminocyclohexyl]amino}-4-[(3-methylphenyl)amino]pyrimidine-5-carboxamide	-	-	DRUGBANK	DB08361	C18H24N6O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NZNTWOVDIXCHHS-LSDHHAIUSA-N
26417	107933	1555	-	CYP2B6	CPB6|CYP2B|CYP2B7|CYP2B7P|CYPIIB6|EFVM|IIB1|P450	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7154	1-(biphenyl-4-ylmethyl)-1H-imidazole	-	-	DRUGBANK	DB08369	C16H14N2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DLYMRVCQTVOYEW-UHFFFAOYSA-N
26450	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7186	2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID	-	-	DRUGBANK	DB08402	C18H11Cl2N3O4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VNDRRWBKNSHALL-UHFFFAOYSA-N
26475	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7217	(5E,14E)-11-oxoprosta-5,9,12,14-tetraen-1-oic acid	-	-	DRUGBANK	DB08435	C20H28O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VHRUMKCAEVRUBK-XOVNXQNQSA-N
26476	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7218	8-BENZO[1,3]DIOXOL-,5-YLMETHYL-9-BUTYL-9H-	-	-	DRUGBANK	DB08436	C17H19N5O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JCDXXNIRWRRGBX-UHFFFAOYSA-N
26493	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7224	4-{[(2R)-2-(2-methylphenyl)pyrrolidin-1-yl]carbonyl}benzene-1,3-diol	-	-	DRUGBANK	DB08442	C18H19NO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TWODFUZHWYZBHZ-MRXNPFEDSA-N
26494	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7225	2-(1H-pyrrol-1-ylcarbonyl)benzene-1,3,5-triol	-	-	DRUGBANK	DB08443	C11H9NO4	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RYGSNHBTZDYVSS-UHFFFAOYSA-N
26496	119038	30814	-	PLA2G2E	GIIE sPLA2|sPLA2-IIE	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7229	3-{3-[(DIMETHYLAMINO)METHYL]-1H-INDOL-7-YL}PROPAN-1-OL	-	-	DRUGBANK	DB08447	C14H20N2O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KKQDXWHOFSMCSA-UHFFFAOYSA-N
26498	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7231	2-(3-((4,5,7-trifluorobenzo[d]thiazol-2-yl)methyl)-1H-pyrrolo[2,3-b]pyridin-1-yl)acetic acid	-	-	DRUGBANK	DB08449	C17H10F3N3O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IEVFQDJUDLCOQY-UHFFFAOYSA-N
26520	110226	4048	-	LTA4H	-	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7247	5-[2-(4-hydroxyphenyl)ethyl]benzene-1,3-diol	-	-	DRUGBANK	DB08466	C14H14O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	HITJFUSPLYBJPE-UHFFFAOYSA-N
26538	106747	246	-	ALOX15	12-LOX|15-LOX-1|15LOX-1	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7272	(2E)-3-(2-OCT-1-YN-1-YLPHENYL)ACRYLIC ACID	-	-	DRUGBANK	DB08492	C17H20O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KRDSGPLHVQJFLM-BUHFOSPRSA-N
26598	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7335	2-[(2-methoxyethyl)amino]-4-(4-oxo-1,2,3,4-tetrahydro-9H-carbazol-9-yl)benzamide	-	-	DRUGBANK	DB08557	C22H23N3O3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XQKFKSJUBJPOLY-UHFFFAOYSA-N
26601	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7338	3-FLUORO-N-[1-(4-FLUOROPHENYL)-3-(2-THIENYL)-1H-PYRAZOL-5-YL]BENZENESULFONAMIDE	-	-	DRUGBANK	DB08560	C19H13F2N3O2S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GULUFDCOGAXLEP-UHFFFAOYSA-N
26639	107936	1558	-	CYP2C8	CPC8|CYPIIC8|MP-12/MP-20	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7384	(5R)-5-(4-{[(2R)-6-HYDROXY-2,5,7,8-TETRAMETHYL-3,4-DIHYDRO-2H-CHROMEN-2-YL]METHOXY}BENZYL)-1,3-THIAZOLIDINE-2,4-DIONE	-	-	DRUGBANK	DB08607	C24H27NO5S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GXPHKUHSUJUWKP-NTKDMRAZSA-N
26687	111712	5740	-	PTGIS	CYP8|CYP8A1|PGIS|PTGI	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7449	(6E)-7-{6-[(1E)-OCT-1-ENYL]-2,3-DIAZABICYCLO[2.2.1]HEPT-2-EN-5-YL}HEPT-6-ENOIC ACID	-	-	DRUGBANK	DB08675	C20H32N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	SRTCYJVIMJMLJO-ZPOCGUEASA-N
26695	120958	55856	HT012	ACOT13	PNAS-27|THEM2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7462	undecan-2-one	-	-	DRUGBANK	DB08688	C11H22O	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KYWIYKKSMDLRDC-UHFFFAOYSA-N
26723	118128	27306	-	HPGDS	GSTS|GSTS1-1|PGD2|PGDS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7469	3-(4-nitrophenyl)-1H-pyrazole	-	-	DRUGBANK	DB08695	C9H7N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IPIYADCDDIUVPS-UHFFFAOYSA-N
26761	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7533	(2S)-2-(4-chlorophenoxy)-3-phenylpropanoic acid	-	-	DRUGBANK	DB08760	C15H13ClO3	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	CPBLTMSKPQDJPW-AWEZNQCLSA-N
26765	110428	4282	-	MIF	GIF|GLIF|MMIF	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7538	6-HYDROXY-1,3-BENZOTHIAZOLE-2-SULFONAMIDE	-	-	DRUGBANK	DB08765	C7H6N2O3S2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	NOOBQTYVTDBXTL-UHFFFAOYSA-N
26771	106732	231	-	AKR1B1	ADR|ALDR1|ALR2|AR	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7544	3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL-2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID	-	-	DRUGBANK	DB08772	C19H12F3N3O3S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	BCSVCWVQNOXFGL-UHFFFAOYSA-N
26786	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7558	4-(2-methoxyethoxy)-6-methylpyrimidin-2-amine	-	-	DRUGBANK	DB08786	C8H13N3O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VCJHOFUOIQHNBC-UHFFFAOYSA-N
26787	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7559	4-(2,4-dichlorophenyl)-5-phenyldiazenyl-pyrimidin-2-amine	-	-	DRUGBANK	DB08787	C16H11Cl2N5	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UNJMNJFPEVJCQK-GHVJWSGMSA-N
26788	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7560	3,6-DIAMINO-5-CYANO-4-(4-ETHOXYPHENYL)THIENO[2,3-B]PYRIDINE-2-CARBOXAMIDE	-	-	DRUGBANK	DB08788	C17H15N5O2S	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UOPQHPBCVYHSFF-UHFFFAOYSA-N
26789	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7561	2-AMINO-4-(2,4-DICHLOROPHENYL)-N-ETHYLTHIENO[2,3-D]PYRIMIDINE-6-CARBOXAMIDE	-	-	DRUGBANK	DB08789	C15H12Cl2N4OS	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YPEOXUOUTBMBCX-UHFFFAOYSA-N
26790	118128	27306	-	HPGDS	GSTS|GSTS1-1|PGD2|PGDS	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	7562	1-PHENYL-1H-PYRAZOLE-4-CARBOXYLIC ACID	-	-	DRUGBANK	DB08790	C10H8N2O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZROILLPDIUNLSE-UHFFFAOYSA-N
26848	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	antagonist	target	Dominguez MJ (1985)	3838919	181670	7584	Triflusal	Triflusal	-	DRUGBANK	DB08814	C10H7F3O4	small molecule	B01AC18	322-79-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMWVZGDJPAKBDE-UHFFFAOYSA-N
26849	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	antagonist	target	Anninos H (2009)	19465361	182109	7584	Triflusal	Triflusal	-	DRUGBANK	DB08814	C10H7F3O4	small molecule	B01AC18	322-79-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMWVZGDJPAKBDE-UHFFFAOYSA-N
26860	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	George M (2013)	23545936	182239	7585	Lurasidone	Lurasidona|Lurasidonum	latuda	DRUGBANK	DB08815	C28H36N4O2S	small molecule	N05AE05	367514-87-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PQXKDMSYBGKCJA-CVTJIBDQSA-N
26887	111709	5737	RP5-944H6.1	PTGFR	FP	9606	Homo sapiens	agonist	target	Pantcheva MB (2011)	21858491	182193	7588	Tafluprost	AFP-168|Zioptan	saflutan|zioptan	DRUGBANK	DB08819	C25H34F2O5	small molecule	S01EE05	209860-87-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	WSNODXPBBALQOF-VEJSHDCNSA-N
26889	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Chen X (2002)	11752352	171740	7590	Azilsartan medoxomil	Azilsartan medoxomilo|Azilsartan|Azilsartan kamedoxomil|Edarbi|Azilsartanum medoxomilum	edarbi|edarbyclor	DRUGBANK	DB08822	C30H24N4O8	small molecule	C09CA09|C09DA09	863031-21-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QJFSABGVXDWMIW-UHFFFAOYSA-N
26890	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Miura S (2014)	23563275	182242	7590	Azilsartan medoxomil	Azilsartan medoxomilo|Azilsartan|Azilsartan kamedoxomil|Edarbi|Azilsartanum medoxomilum	edarbi|edarbyclor	DRUGBANK	DB08822	C30H24N4O8	small molecule	C09CA09|C09DA09	863031-21-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QJFSABGVXDWMIW-UHFFFAOYSA-N
26892	108004	1636	-	ACE	ACE1|CD143|DCP|DCP1|ICH|MVCD3	9606	Homo sapiens	inhibitor	target	Furuta S (1993)	8513851	181700	7600	Temocapril	Temocaprilum	-	DRUGBANK	DB08836	C23H28N2O5S2	small molecule	C09AA14	111902-57-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FIQOFIRCTOWDOW-BJLQDIEVSA-N
26918	112717	6850	-	SYK	p72-Syk	9606	Homo sapiens	inhibitor	target	Cozza G (2006)	16610779	181936	7605	Ellagic Acid	2,3,7,8-tetrahydroxychromeno[5,4,3-cde]chromene-5,10-dione|Benzoaric acid|Elagostasine|Lagistase|476-66-4|Alizarine Yellow	-	DRUGBANK	DB08846	C14H6O8	small molecule	-	476-66-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AFSDNFLWKVMVRB-UHFFFAOYSA-N
26988	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Ferguson GD (2007)	17308870	159982	7654	Pomalidomide	-	pomalyst	DRUGBANK	DB08910	C13H11N3O4	small molecule	L04AX06	19171-19-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UVSMNLNDYGZFPF-UHFFFAOYNA-N
26995	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Berman HM (2000)	10592235	172122	7659	Aleglitazar	-	-	DRUGBANK	DB08915	C24H23NO5S	small molecule	-	475479-34-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DAYKLWSKQJBGCS-NRFANRHFSA-N
26996	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	agonist	target	Cavender MA (2010)	20653327	182161	7659	Aleglitazar	-	-	DRUGBANK	DB08915	C24H23NO5S	small molecule	-	475479-34-6	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DAYKLWSKQJBGCS-NRFANRHFSA-N
27002	108231	1909	-	EDNRA	ET-A|ETA|ETA-R|ETAR|ETRA|hET-AR	9606	Homo sapiens	antagonist	target	Bolli MH (2012)	22862294	182209	7671	Macitentan	Macitentanum	opsumit	DRUGBANK	DB08932	C19H20Br2N6O4S	small molecule	C02KX04	441798-33-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JGCMEBMXRHSZKX-UHFFFAOYSA-N
27003	108231	1909	-	EDNRA	ET-A|ETA|ETA-R|ETAR|ETRA|hET-AR	9606	Homo sapiens	antagonist	target	Bruderer S (2012)	22458347	182200	7671	Macitentan	Macitentanum	opsumit	DRUGBANK	DB08932	C19H20Br2N6O4S	small molecule	C02KX04	441798-33-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JGCMEBMXRHSZKX-UHFFFAOYSA-N
27004	108231	1909	-	EDNRA	ET-A|ETA|ETA-R|ETAR|ETRA|hET-AR	9606	Homo sapiens	antagonist	target	Dingemanse J (2014)	24261583	182254	7671	Macitentan	Macitentanum	opsumit	DRUGBANK	DB08932	C19H20Br2N6O4S	small molecule	C02KX04	441798-33-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JGCMEBMXRHSZKX-UHFFFAOYSA-N
27005	108232	1910	RP11-318G21.1	EDNRB	ABCDS|ET-B|ET-BR|ETB|ETBR|ETRB|HSCR|HSCR2|WS4A	9606	Homo sapiens	antagonist	target	Bolli MH (2012)	22862294	182209	7671	Macitentan	Macitentanum	opsumit	DRUGBANK	DB08932	C19H20Br2N6O4S	small molecule	C02KX04	441798-33-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JGCMEBMXRHSZKX-UHFFFAOYSA-N
27006	108232	1910	RP11-318G21.1	EDNRB	ABCDS|ET-B|ET-BR|ETB|ETBR|ETRB|HSCR|HSCR2|WS4A	9606	Homo sapiens	antagonist	target	Bruderer S (2012)	22458347	182200	7671	Macitentan	Macitentanum	opsumit	DRUGBANK	DB08932	C19H20Br2N6O4S	small molecule	C02KX04	441798-33-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JGCMEBMXRHSZKX-UHFFFAOYSA-N
27007	108232	1910	RP11-318G21.1	EDNRB	ABCDS|ET-B|ET-BR|ETB|ETBR|ETRB|HSCR|HSCR2|WS4A	9606	Homo sapiens	antagonist	target	Dingemanse J (2014)	24261583	182254	7671	Macitentan	Macitentanum	opsumit	DRUGBANK	DB08932	C19H20Br2N6O4S	small molecule	C02KX04	441798-33-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JGCMEBMXRHSZKX-UHFFFAOYSA-N
27015	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	agonist	target	Ring RM (2013)	23863923	182253	7747	Captodiame	Captodiame|2-[(4-butylsulfanylphenyl)-phenyl-methyl]sulfanyl-N,N-dimethylethanamine	-	DRUGBANK	DB09014	C21H29NS2	small molecule	N05BB02	486-17-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	IZLPZXSZLLELBJ-UHFFFAOYNA-N
27029	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Tonini M (2004)	14871277	181842	7751	Bromopride	Bromopridum|4-amino-5-bromo-N-[2-(diethylamino)ethyl]-2-methoxybenzamide|Bromoprid|Bromoprida|Bromopride	-	DRUGBANK	DB09018	C14H22BrN3O2	small molecule	A03FA04	4093-35-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	GIYAQDDTCWHPPL-UHFFFAOYSA-N
27066	107948	1576	-	CYP3A4	CP33|CP34|CYP3A|CYP3A3|CYPIIIA3|CYPIIIA4|HLP|NF-25|P450C3|P450PCN1	9606	Homo sapiens	unknown	target	Schwab D (2003)	12699389	137014	192	Erythromycin	Erythromycine|(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione|Erythromycin C|3''-O-demethylerythromycin|Erythromycin A|Eritromicina|Erythromycin|rythromycine|Abomacetin|Erythromycinum	erythro-base tab 250mg usp|ery	DRUGBANK	DB00199	C37H67NO13	small molecule	J01FA01|S01AA17|D10AF52|D10AF02	114-07-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ULGZDMOVFRHVEP-RWJQBGPGSA-N
27073	107948	1576	-	CYP3A4	CP33|CP34|CYP3A|CYP3A3|CYPIIIA3|CYPIIIA4|HLP|NF-25|P450C3|P450PCN1	9606	Homo sapiens	unknown	target	Bosnar M (2012)	22697905	188477	200	Azithromycin	Azithromycinum|Azitromicina|Azithromycine	azithromycin for injection|riv	DRUGBANK	DB00207	C38H72N2O12	small molecule	J01FA10|J01RA07|S01AA26	83905-01-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	MQTOSJVFKKJCRP-BICOPXKESA-N
27189	107948	1576	-	CYP3A4	CP33|CP34|CYP3A|CYP3A3|CYPIIIA3|CYPIIIA4|HLP|NF-25|P450C3|P450PCN1	9606	Homo sapiens	unknown	target	Fontana E (2005)	16248836	188492	941	Isoniazid	Pyridine-4-carboxylic acid hydrazide|Isonicotinsaeurehydrazid|Isoniazid|Isonicotinohydrazide|Isonicotinic acid hydrazide|Isonicotinoylhydrazide|INH|Isonicotinylhydrazine|4-pyridinecarbohydrazide|Isonicotinic hydrazide	isotamine syr pediatric 50mg/5	DRUGBANK	DB00951	C6H7N3O	small molecule	J04AC01|J04AM03|J04AM02|J04AM01|J04AC51|J04AM06|J04AM05|J04AM04	54-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QRXWMOHMRWLFEY-UHFFFAOYSA-N
27190	107924	1544	-	CYP1A2	CP12|P3-450|P450(PA)	9606	Homo sapiens	unknown	target	Fontana E (2005)	16248836	188492	941	Isoniazid	Pyridine-4-carboxylic acid hydrazide|Isonicotinsaeurehydrazid|Isoniazid|Isonicotinohydrazide|Isonicotinic acid hydrazide|Isonicotinoylhydrazide|INH|Isonicotinylhydrazine|4-pyridinecarbohydrazide|Isonicotinic hydrazide	isotamine syr pediatric 50mg/5	DRUGBANK	DB00951	C6H7N3O	small molecule	J04AC01|J04AM03|J04AM02|J04AM01|J04AC51|J04AM06|J04AM05|J04AM04	54-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QRXWMOHMRWLFEY-UHFFFAOYSA-N
27191	107935	1557	RP11-400G3.4	CYP2C19	CPCJ|CYP2C|CYPIIC17|CYPIIC19|P450C2C|P450IIC19	9606	Homo sapiens	unknown	target	Fontana E (2005)	16248836	188492	941	Isoniazid	Pyridine-4-carboxylic acid hydrazide|Isonicotinsaeurehydrazid|Isoniazid|Isonicotinohydrazide|Isonicotinic acid hydrazide|Isonicotinoylhydrazide|INH|Isonicotinylhydrazine|4-pyridinecarbohydrazide|Isonicotinic hydrazide	isotamine syr pediatric 50mg/5	DRUGBANK	DB00951	C6H7N3O	small molecule	J04AC01|J04AM03|J04AM02|J04AM01|J04AC51|J04AM06|J04AM05|J04AM04	54-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QRXWMOHMRWLFEY-UHFFFAOYSA-N
27192	107936	1558	-	CYP2C8	CPC8|CYPIIC8|MP-12/MP-20	9606	Homo sapiens	unknown	target	Fontana E (2005)	16248836	188492	941	Isoniazid	Pyridine-4-carboxylic acid hydrazide|Isonicotinsaeurehydrazid|Isoniazid|Isonicotinohydrazide|Isonicotinic acid hydrazide|Isonicotinoylhydrazide|INH|Isonicotinylhydrazine|4-pyridinecarbohydrazide|Isonicotinic hydrazide	isotamine syr pediatric 50mg/5	DRUGBANK	DB00951	C6H7N3O	small molecule	J04AC01|J04AM03|J04AM02|J04AM01|J04AC51|J04AM06|J04AM05|J04AM04	54-85-3	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QRXWMOHMRWLFEY-UHFFFAOYSA-N
27220	116442	11309	-	SLCO2B1	OATP-B|OATP2B1|OATPB|SLC21A9	9606	Homo sapiens	unknown	target	Karlgren M (2012)	22541068	188500	1034	Rifampicin	Rifampicinum|Rifampin|RFP|Rifampicina|3-(((4-Methyl-1-piperazinyl)imino)methyl)rifamycin SV	rifadin cap 300mg|rifadin iv|r	DRUGBANK	DB01045	C43H58N4O12	small molecule	J04AM02|J04AM06|J04AB02|J04AM05	13292-46-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	JQXXHWHPUNPDRT-WLSIYKJHSA-N
27245	107948	1576	-	CYP3A4	CP33|CP34|CYP3A|CYP3A3|CYPIIIA3|CYPIIIA4|HLP|NF-25|P450C3|P450PCN1	9606	Homo sapiens	unknown	target	Fontana E (2005)	16248836	188492	1199	Clarithromycin	Clarithromycine|Clarithromycina|6-O-Methylerythromycin a|6-O-Methylerythromycin|CLA|CLARITHROMYCIN|6-O-methyl erythromycin|Clarithromycinum	clarithromycin 500 mg|mylan-cl	DRUGBANK	DB01211	C38H69NO13	small molecule	J01FA09|A02BD11|A02BD07|A02BD04|A02BD05|A02BD06|A02BD09	81103-11-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	AGOYDEPGAOXOCK-KCBOHYOISA-N
27371	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	partial agonist	target	Citrome L (2013)	23320989	188516	7764	Cariprazine	trans-N-{4-[2-[4-(2,3-dichlorophenyl)piperazine-1-yl]ethyl]cyclohexyl}-N,N-dimethylurea hydrochloride	vraylar	DRUGBANK	DB06016	C21H32Cl2N4O	small molecule	N05AX15	839712-12-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KPWSJANDNDDRMB-QAQDUYKDSA-N
27372	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Citrome L (2013)	23320989	188516	7764	Cariprazine	trans-N-{4-[2-[4-(2,3-dichlorophenyl)piperazine-1-yl]ethyl]cyclohexyl}-N,N-dimethylurea hydrochloride	vraylar	DRUGBANK	DB06016	C21H32Cl2N4O	small molecule	N05AX15	839712-12-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KPWSJANDNDDRMB-QAQDUYKDSA-N
27373	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	partial agonist	target	Citrome L (2013)	23320989	188516	7764	Cariprazine	trans-N-{4-[2-[4-(2,3-dichlorophenyl)piperazine-1-yl]ethyl]cyclohexyl}-N,N-dimethylurea hydrochloride	vraylar	DRUGBANK	DB06016	C21H32Cl2N4O	small molecule	N05AX15	839712-12-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KPWSJANDNDDRMB-QAQDUYKDSA-N
27374	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	agonist	target	Citrome L (2013)	23320989	188516	7764	Cariprazine	trans-N-{4-[2-[4-(2,3-dichlorophenyl)piperazine-1-yl]ethyl]cyclohexyl}-N,N-dimethylurea hydrochloride	vraylar	DRUGBANK	DB06016	C21H32Cl2N4O	small molecule	N05AX15	839712-12-8	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KPWSJANDNDDRMB-QAQDUYKDSA-N
27422	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Talley JJ (2000)	10794682	188524	7221	Parecoxib	-	-	DRUGBANK	DB08439	C19H18N2O4S	small molecule	M01AH04	198470-84-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	TZRHLKRLEZJVIJ-UHFFFAOYSA-N
27445	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	inhibitor	target	Wood JM (2003)	12927775	188528	7758	Aliskiren	-	rasilez hct|tekturna hct|amtur	DRUGBANK	DB09026	C30H53N3O6	small molecule	C09XA53|C09XA52|C09DX02|C09XA02|C09XA54	173334-57-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UXOWGYHJODZGMF-QORCZRPOSA-N
27446	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	inhibitor	target	Gradman AH (2006)	16965731	188529	7758	Aliskiren	-	rasilez hct|tekturna hct|amtur	DRUGBANK	DB09026	C30H53N3O6	small molecule	C09XA53|C09XA52|C09DX02|C09XA02|C09XA54	173334-57-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UXOWGYHJODZGMF-QORCZRPOSA-N
27447	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	inhibitor	target	Nussberger J (2002)	11799102	188526	7758	Aliskiren	-	rasilez hct|tekturna hct|amtur	DRUGBANK	DB09026	C30H53N3O6	small molecule	C09XA53|C09XA52|C09DX02|C09XA02|C09XA54	173334-57-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UXOWGYHJODZGMF-QORCZRPOSA-N
27448	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	inhibitor	target	Menard J (2006)	16467656	188527	7758	Aliskiren	-	rasilez hct|tekturna hct|amtur	DRUGBANK	DB09026	C30H53N3O6	small molecule	C09XA53|C09XA52|C09DX02|C09XA02|C09XA54	173334-57-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UXOWGYHJODZGMF-QORCZRPOSA-N
27449	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	inhibitor	target	Chen X (2002)	11752352	171740	7758	Aliskiren	-	rasilez hct|tekturna hct|amtur	DRUGBANK	DB09026	C30H53N3O6	small molecule	C09XA53|C09XA52|C09DX02|C09XA02|C09XA54	173334-57-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UXOWGYHJODZGMF-QORCZRPOSA-N
27450	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	inhibitor	target	Azizi M (2006)	16508564	188525	7758	Aliskiren	-	rasilez hct|tekturna hct|amtur	DRUGBANK	DB09026	C30H53N3O6	small molecule	C09XA53|C09XA52|C09DX02|C09XA02|C09XA54	173334-57-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	UXOWGYHJODZGMF-QORCZRPOSA-N
27519	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	antagonist	target	Yoshikawa T (2001)	11350861	188558	7951	AS-8112	-	-	DRUGBANK	DB09207	C17H27BrN4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DALSFUWTAOKVTF-GFCCVEGCSA-N
27520	108148	1814	-	DRD3	D3DR|ETM1|FET1	9606	Homo sapiens	antagonist	target	Yoshikawa T (2001)	11350861	188558	7951	AS-8112	-	-	DRUGBANK	DB09207	C17H27BrN4O2	small molecule	-	-	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	DALSFUWTAOKVTF-GFCCVEGCSA-N
27521	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	unknown	target	McCann ME (2004)	15077695	188559	7961	Firocoxib	-	-	DRUGBANK	DB09217	C17H20O5S	small molecule	-	189954-96-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	FULAPETWGIGNMT-UHFFFAOYSA-N
27585	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	inhibitor	target	Zheng L (2007)	17259377	181291	926	Salicylic acid	2-Carboxyphenol|2-Hydroxybenzoic acid|O-hydroxybenzoic acid|O-carboxyphenol	md cell scalp|neutrogena oil f	DRUGBANK	DB00936	C7H6O3	small molecule	N02BA04|D01AE12|S01BC08	69-72-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	YGSDEFSMJLZEOE-UHFFFAOYSA-N
27586	106691	185	-	AGTR1	AG2S|AGTR1B|AT1|AT1AR|AT1B|AT1BR|AT1R|AT2R1|HAT1R	9606	Homo sapiens	antagonist	target	Tagami T (2009)	19147680	171006	956	Telmisartan	4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid|4'-[(1,7'-Dimethyl-2'-propyl-1H,3'h-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid|Telmisartan|4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid|Micardis|BIBR 277|4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid	telmisartan/hctz|telmisartan|t	DRUGBANK	DB00966	C33H30N4O2	small molecule	C09DA07|C09CA07|C09DB04	144701-48-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	RMMXLENWKUUMAY-UHFFFAOYSA-N
27637	111337	5320	-	PLA2G2A	MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	8061	Isopropyl Alcohol	-	labsco sterile alcohol prep pa	DRUGBANK	DB02325	C3H8O	small molecule	-	67-63-0	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KFZMGEQAYNKOFK-UHFFFAOYSA-N
27659	111337	5320	-	PLA2G2A	MOM1|PLA2|PLA2B|PLA2L|PLA2S|PLAS1|sPLA2	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	8062	Lauric Acid	Dodecanoic acid|N-dodecanoic acid|DAO|Coconut oil fatty acids|Undecane-1-carboxylic acid|Duodecylic acid|Dodecylic acid|C12:0|Dodecanoate|C12 fatty acid|ABL|Dodecylcarboxylate|Laurinsaeure|1-Undecanecarboxylic acid|N-dodecanoate|Laurostearic acid|Dodecoic acid|Vulvic acid|Duodecyclic acid	vitafol plus	DRUGBANK	DB03017	C12H24O2	small molecule	-	143-07-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	POULHZVOKOAJMA-UHFFFAOYSA-N
27672	117662	26279	UNQ768	PLA2G2D	PLA2IID|SPLASH|sPLA2-IID|sPLA2S	9606	Homo sapiens	unknown	target	Berman HM (2000)	10592235	172122	8062	Lauric Acid	Dodecanoic acid|N-dodecanoic acid|DAO|Coconut oil fatty acids|Undecane-1-carboxylic acid|Duodecylic acid|Dodecylic acid|C12:0|Dodecanoate|C12 fatty acid|ABL|Dodecylcarboxylate|Laurinsaeure|1-Undecanecarboxylic acid|N-dodecanoate|Laurostearic acid|Dodecoic acid|Vulvic acid|Duodecyclic acid	vitafol plus	DRUGBANK	DB03017	C12H24O2	small molecule	-	143-07-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	POULHZVOKOAJMA-UHFFFAOYSA-N
27684	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	antagonist	target	Borsini F (2002)	12177684	181800	4708	Flibanserin	BIMT-17-BS|BIMT-17	addyi	DRUGBANK	DB04908	C20H21F3N4O	small molecule	G02CX02	167933-07-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PPRRDFIXUUSXRA-UHFFFAOYSA-N
27685	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	antagonist	target	Invernizzi RW (2003)	12890707	181826	4708	Flibanserin	BIMT-17-BS|BIMT-17	addyi	DRUGBANK	DB04908	C20H21F3N4O	small molecule	G02CX02	167933-07-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PPRRDFIXUUSXRA-UHFFFAOYSA-N
27774	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	agonist	target	Sanner MA (1998)	9871530	196049	704	Apomorphine	(-)-10,11-Dihydroxyaporphine|R-()-apomorphine|(6AR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|()-10,11-dihydroxyaporphine|R-(-)-Apomorphine|(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|Apomorphin	movapo|apokyn	DRUGBANK	DB00714	C17H17NO2	small molecule	G04BE07|N04BC07	58-00-4	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	VMWNQDUVQKEIOC-CYBMUJFWSA-N
27802	111904	5972	-	REN	HNFJ2	9606	Homo sapiens	inhibitor	target	Glassman HN (1990)	1705633	195971	3253	Enalkiren	-	-	DRUGBANK	DB03395	C35H56N6O6	small molecule	-	113082-98-7	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	KQXVERRYBYGQJZ-WRPDIKACSA-N
27807	108149	1815	-	DRD4	D4DR	9606	Homo sapiens	antagonist	target	Deeks ED (2015)	26412054	196031	4708	Flibanserin	BIMT-17-BS|BIMT-17	addyi	DRUGBANK	DB04908	C20H21F3N4O	small molecule	G02CX02	167933-07-5	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	PPRRDFIXUUSXRA-UHFFFAOYSA-N
27809	107093	624	-	BDKRB2	B2R|BK-2|BK2|BKR2|BRB2	9606	Homo sapiens	antagonist	target	Pruneau D (1999)	10596852	195948	4825	Anatibant	-	-	DRUGBANK	DB05038	C34H36Cl2N6O5S	small molecule	-	209733-45-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	XUHBBTKJWIBQMY-MHZLTWQESA-N
27842	108231	1909	-	EDNRA	ET-A|ETA|ETA-R|ETAR|ETRA|hET-AR	9606	Homo sapiens	antagonist	target	Casserly B (2009)	19920913	195995	8074	Ambrisentan	(2S)-2-[(4,6-dimethylpyrimidin-2-yl)oxy]-3-methoxy- 3,3-diphenylpropanoic acid	letairis|volibris	DRUGBANK	DB06403	C22H22N2O4	small molecule	C02KX02	177036-94-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OUJTZYPIHDYQMC-LJQANCHMSA-N
27843	108231	1909	-	EDNRA	ET-A|ETA|ETA-R|ETAR|ETRA|hET-AR	9606	Homo sapiens	antagonist	target	Spence R (2010)	20811346	195998	8074	Ambrisentan	(2S)-2-[(4,6-dimethylpyrimidin-2-yl)oxy]-3-methoxy- 3,3-diphenylpropanoic acid	letairis|volibris	DRUGBANK	DB06403	C22H22N2O4	small molecule	C02KX02	177036-94-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OUJTZYPIHDYQMC-LJQANCHMSA-N
27844	108231	1909	-	EDNRA	ET-A|ETA|ETA-R|ETAR|ETRA|hET-AR	9606	Homo sapiens	antagonist	target	Kingman M (2009)	19601701	195993	8074	Ambrisentan	(2S)-2-[(4,6-dimethylpyrimidin-2-yl)oxy]-3-methoxy- 3,3-diphenylpropanoic acid	letairis|volibris	DRUGBANK	DB06403	C22H22N2O4	small molecule	C02KX02	177036-94-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OUJTZYPIHDYQMC-LJQANCHMSA-N
27845	108231	1909	-	EDNRA	ET-A|ETA|ETA-R|ETAR|ETRA|hET-AR	9606	Homo sapiens	antagonist	target	Richards DB (2009)	19389876	195988	8074	Ambrisentan	(2S)-2-[(4,6-dimethylpyrimidin-2-yl)oxy]-3-methoxy- 3,3-diphenylpropanoic acid	letairis|volibris	DRUGBANK	DB06403	C22H22N2O4	small molecule	C02KX02	177036-94-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OUJTZYPIHDYQMC-LJQANCHMSA-N
27846	108232	1910	RP11-318G21.1	EDNRB	ABCDS|ET-B|ET-BR|ETB|ETBR|ETRB|HSCR|HSCR2|WS4A	9606	Homo sapiens	antagonist	target	Casserly B (2009)	19920913	195995	8074	Ambrisentan	(2S)-2-[(4,6-dimethylpyrimidin-2-yl)oxy]-3-methoxy- 3,3-diphenylpropanoic acid	letairis|volibris	DRUGBANK	DB06403	C22H22N2O4	small molecule	C02KX02	177036-94-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OUJTZYPIHDYQMC-LJQANCHMSA-N
27847	108232	1910	RP11-318G21.1	EDNRB	ABCDS|ET-B|ET-BR|ETB|ETBR|ETRB|HSCR|HSCR2|WS4A	9606	Homo sapiens	antagonist	target	Kingman M (2009)	19601701	195993	8074	Ambrisentan	(2S)-2-[(4,6-dimethylpyrimidin-2-yl)oxy]-3-methoxy- 3,3-diphenylpropanoic acid	letairis|volibris	DRUGBANK	DB06403	C22H22N2O4	small molecule	C02KX02	177036-94-1	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	OUJTZYPIHDYQMC-LJQANCHMSA-N
27915	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	partial agonist	target	Maeda K (2014)	24947465	196021	7873	Brexpiprazole	-	rexulti	DRUGBANK	DB09128	C25H27N3O2S	small molecule	N05AX16	913611-97-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKIAIYBUSXZPLP-UHFFFAOYSA-N
27916	108147	1813	-	DRD2	D2DR|D2R	9606	Homo sapiens	agonist	target	Maeda K (2014)	24947465	196021	7873	Brexpiprazole	-	rexulti	DRUGBANK	DB09128	C25H27N3O2S	small molecule	N05AX16	913611-97-9	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	ZKIAIYBUSXZPLP-UHFFFAOYSA-N
27934	111711	5739	-	PTGIR	IP|PRIPR	9606	Homo sapiens	agonist	target	Kaufmann P (2015)	25850750	196024	8235	Selexipag	-	uptravi titration pack|uptravi	DRUGBANK	DB11362	C26H32N4O4S	small molecule	B01AC27	475086-01-2	DRUGBANK	-	-	-	-	-	-	-	-	-	-	-	QXWZQTURMXZVHJ-UHFFFAOYSA-N
28197	114683	9261	-	MAPKAPK2	MAPKAP-K2|MK-2|MK2	9606	Homo sapiens	degradation	target	Bondeson DP (2018)	29129718	208144	8433	Bivalent ligand 63	Bivalent_ligand_63|PROTAC 1	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited E3 ligase	Standardized BVL Name: PROTAC1(VHL:VHL ligand --- MAPKAPK2:foretinib)	-
29292	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Shi Q (2007)	18029178	224793	9310	3-[4-[3-[(1R)-1-[(5-Chloro-3-methyl-1-benzothiophene-2-carbonyl)amino]ethyl]-5-fluorophenoxy]-2-ethylphenyl]propanoic acid	(R)-3-(4-(3-(1-(5-CHLORO-3-METHYLBENZO[B]THIOPHENE-2-CARBOXAMIDO)ETHYL)-5-FLUOROPHENOXY)-2-ETHYLPHENYL)PROPANOIC ACID|BDBM50227754	-	PUBCHEM	44434362	C29H27ClFNO4S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WQCJKMGDGUHOFD-QGZVFWFLSA-N
29293	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Shi Q (2007)	18029178	224793	404	Rosiglitazone	(RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion|Rosiglitazon|Rosiglitazonum|Rosiglitazone|()-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione|Rosiglitazona|BDBM50030474	phl-rosiglitazone|avandaryl|av	DRUGBANK	DB00412	C18H19N3O3S	small molecule	A10BD03|A10BG02|A10BD04	122320-73-4	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	YASAKCUCGLMORW-UHFFFAOYNA-N
29299	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Dropinski JF (2005)	16153845	224795	9316	1-(4-Tert-butylphenyl)-3-[3-(trifluoromethyl)phenoxy]indole-2-carboxylic acid	1-(4-TERT-BUTYL-PHENYL)-3-(3-TRIFLUOROMETHYL-PHENOXY)-1H-INDOLE-2-CARBOXYLIC ACID|BDBM50173359	-	PUBCHEM	11546956	C26H22F3NO3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	QEDIKMQCSOVILD-UHFFFAOYSA-N
29322	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Flick AC (2016)	27020685	224806	9333	Lobeglitazone sulfate	CKD 501|LOBEGLITAZONE SULFATE|CKD-501|2,4-THIAZOLIDINEDIONE, 5-((4-(2-((6-(4-METHOXYPHENOXY)-4- PYRIMIDINYL)METHYLAMINO)ETHOXY)PHENYL)METHYL)-, SULFATE (1:1)|SB16870|Q27271778|BDBM50152829	-	PUBCHEM	15951505	C24H26N4O9S2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	IFBYQAMJTBOBHB-UHFFFAOYSA-N
29323	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Waszkielewicz AM (2016)	26988801	224807	404	Rosiglitazone	(RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion|Rosiglitazon|Rosiglitazonum|Rosiglitazone|()-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione|Rosiglitazona|BDBM50030474	phl-rosiglitazone|avandaryl|av	DRUGBANK	DB00412	C18H19N3O3S	small molecule	A10BD03|A10BG02|A10BD04	122320-73-4	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	YASAKCUCGLMORW-UHFFFAOYNA-N
29368	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Dixit VA (2016)	26708109	224818	9373	5-{[4-(Benzyloxy)phenyl]methylene}-2,4,6(1H,3H,5H)-pyrimidinetrione	5-{[4-(PHENYLMETHOXY)PHENYL]METHYLENE}-1,3-DIHYDROPYRIMIDINE-2,4,6-TRIONE|242473-63-8|5-[4-(BENZYLOXY)BENZYLIDENE]PYRIMIDINE-2,4,6(1H,3H,5H)-TRIONE|AKOS000514744|5-{[4-(BENZYLOXY)PHENYL]METHYLENE}-2,4,6(1H,3H,5H)-PYRIMIDINETRIONE|KS-00001T0W|ZINC3139774|5-[(4-PHENYLMETHOXYPHENYL)METHYLIDENE]-1,3-DIAZINANE-2,4,6-TRIONE|ST50170955|MCULE-1677643513|12P-135|STK804651|5-[4-(BENZYLOXY)BENZYLIDENE]BARBITURIC ACID|5-{[4-(BENZYLOXY)PHENYL]METHYLIDENE}-1,3-DIAZINANE-2,4,6-TRIONE|BDBM50137109	-	PUBCHEM	2851123	C18H14N2O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	RPNLKHSBSLHOSQ-UHFFFAOYSA-N
29369	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Dixit VA (2016)	26708109	224818	404	Rosiglitazone	(RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion|Rosiglitazon|Rosiglitazonum|Rosiglitazone|()-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione|Rosiglitazona|BDBM50030474	phl-rosiglitazone|avandaryl|av	DRUGBANK	DB00412	C18H19N3O3S	small molecule	A10BD03|A10BG02|A10BD04	122320-73-4	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	YASAKCUCGLMORW-UHFFFAOYNA-N
29451	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Du G (2015)	25978962	224841	404	Rosiglitazone	(RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion|Rosiglitazon|Rosiglitazonum|Rosiglitazone|()-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione|Rosiglitazona|BDBM50030474	phl-rosiglitazone|avandaryl|av	DRUGBANK	DB00412	C18H19N3O3S	small molecule	A10BD03|A10BG02|A10BD04	122320-73-4	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	YASAKCUCGLMORW-UHFFFAOYNA-N
29497	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Zhang H (2015)	25686852	224852	9475	(3R,4S)-4-[[4-[2-(5-Methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]methyl]-1-[4-(trifluoromethyl)pyrimidin-2-yl]pyrrolidine-3-carboxylic acid	BDBM50377302	-	PUBCHEM	10347566	C29H27F3N4O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ABIFPJDABNXEMK-GGAORHGYSA-N
29498	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Zhang H (2015)	25686852	224852	9476	(3R,4S)-4-[[3-[2-(5-Methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]methyl]-1-[4-(trifluoromethyl)pyrimidin-2-yl]pyrrolidine-3-carboxylic acid	BDBM50063315	-	PUBCHEM	58977541	C29H27F3N4O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	CIUUZBXRQNCUIL-GGAORHGYSA-N
29499	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Zhang H (2015)	25686852	224852	9477	(3R,4S)-4-[[4-[2-(5-Methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]methyl]-1-[4-(trifluoromethyl)-1,3-oxazol-2-yl]pyrrolidine-3-carboxylic acid	BDBM50063313	-	PUBCHEM	58977463	C28H26F3N3O5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	JMYUDUHXSWKCSZ-IRLDBZIGSA-N
29500	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Zhang H (2015)	25686852	224852	9478	(3R,4S)-4-[[3-[2-(5-Methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]methyl]-1-phenylpyrrolidine-3-carboxylic acid	BDBM50063311	-	PUBCHEM	58977846	C30H30N2O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WWXVNRULVDGHSD-SQHAQQRYSA-N
29501	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Zhang H (2015)	25686852	224852	9479	(3R,4S)-4-[2-[4-[2-(5-Methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]ethyl]-1-phenoxycarbonylpyrrolidine-3-carboxylic acid	BDBM50063099	-	PUBCHEM	10370056	C32H32N2O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	JHPSLFHGWGTITM-NAKRPHOHSA-N
29502	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Zhang H (2015)	25686852	224852	9480	(3R,4S)-4-[[4-[2-(5-Methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]methyl]-1-phenoxycarbonylpyrrolidine-3-carboxylic acid	BDBM50063089	-	PUBCHEM	10346786	C31H30N2O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	IAXWLNXPJOTFTP-SQHAQQRYSA-N
29566	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Tanaka Y (2014)	25017035	224863	9536	(2r)-2-Benzyl-3-[3-({[4-(Piperidin-1-Yl)benzoyl]amino}methyl)-4-Propoxyphenyl]propanoic Acid	Q27459965|(2R)-2-BENZYL-3-[3-({[4-(PIPERIDIN-1-YL)BENZOYL]AMINO}METHYL)-4-PROPOXYPHENYL]PROPANOIC ACID|(2R)-2-BENZYL-3-[3-[[(4-PIPERIDIN-1-YLBENZOYL)AMINO]METHYL]-4-PROPOXYPHENYL]PROPANOIC ACID|MEKT-28|EK8|BDBM50050557	-	PUBCHEM	56929502	C32H38N2O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ISYAJDFASPMBOB-HHHXNRCGSA-N
29567	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Tanaka Y (2014)	25017035	224863	9537	(2R)-2-[[3-[[[4-(Azocan-1-yl)benzoyl]amino]methyl]-4-propoxyphenyl]methyl]-3-phenylpropanoic acid	(R)-2-[3-[[[4-(OCTAHYDROAZOCINE-1-YL)BENZOYL]AMINO]METHYL]-4-(PROPYLOXY)BENZYL]-3-PHENYLPROPANOIC ACID|BDBM50050556	-	PUBCHEM	102313443	C34H42N2O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	NLXAFEDDAOLUIF-GDLZYMKVSA-N
29568	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Tanaka Y (2014)	25017035	224863	9538	(2R)-2-[[3-[[[4-(Azonan-1-yl)benzoyl]amino]methyl]-4-propoxyphenyl]methyl]-3-phenylpropanoic acid	BDBM50050555	-	PUBCHEM	118708437	C35H44N2O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	LEXLSPDBTSINAM-SSEXGKCCSA-N
29569	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Tanaka Y (2014)	25017035	224863	9539	(2R)-2-Benzyl-3-[4-propoxy-3-[[[4-(3,3,5,5-tetramethylpiperidin-1-yl)benzoyl]amino]methyl]phenyl]propanoic acid	BDBM50050554	-	PUBCHEM	118708440	C36H46N2O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	CTTGJGHAKDHCCV-GDLZYMKVSA-N
29570	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Tanaka Y (2014)	25017035	224863	9540	(2R)-2-[[3-[[[4-(8-Azabicyclo[3.2.1]octan-8-yl)benzoyl]amino]methyl]-4-propoxyphenyl]methyl]-3-phenylpropanoic acid	(R)-2-[3-[[[4-(8-AZABICYCLO[3.2.1]OCTANE-8-YL)BENZOYL]AMINO]METHYL]-4-(PROPYLOXY)BENZYL]-3-PHENYLPROPANOIC ACID|BDBM50050553	-	PUBCHEM	102313442	C34H40N2O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	JRGNQRQWJGAPES-WWUHRCHBSA-N
29571	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Tanaka Y (2014)	25017035	224863	9541	(2R)-2-[[3-[[[4-(9-Azabicyclo[3.3.1]nonan-9-yl)benzoyl]amino]methyl]-4-propoxyphenyl]methyl]-3-phenylpropanoic acid	BDBM50050552	-	PUBCHEM	118708441	C35H42N2O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	HTWMBKHFCRGFJX-WHIWCKBPSA-N
29572	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Tanaka Y (2014)	25017035	224863	9542	(2R)-2-[[3-[[[4-(3-Azabicyclo[3.2.1]octan-3-yl)benzoyl]amino]methyl]-4-propoxyphenyl]methyl]-3-phenylpropanoic acid	BDBM50050551	-	PUBCHEM	118708442	C34H40N2O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	SOCVTCXYXPQYPF-VMJMFXBVSA-N
29573	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Tanaka Y (2014)	25017035	224863	9543	(2R)-2-[[3-[[[4-(2-Azatricyclo[3.3.1.13,7]decan-2-yl)benzoyl]amino]methyl]-4-propoxyphenyl]methyl]-3-phenylpropanoic acid	BDBM50050550	-	PUBCHEM	118708443	C36H42N2O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	GRIHSHBOOIEZBN-YQNGJPPUSA-N
29620	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Casimiro-Garcia A (2008)	18394907	224881	9572	(S)-3-{4-[2-(5-Methyl-2-phenyl-oxazol-4-yl)-ethoxy]-phenyl}-2-pyrrol-1-yl-propionic acid	(S)-3-{4-[2-(5-METHYL-2-PHENYL-OXAZOL-4-YL)-ETHOXY]-PHENYL}-2-PYRROL-1-YL-PROPIONIC ACID|(S)-3-[4-[2-(5-METHYL-2-PHENYLOXAZOL-4-YL)ETHOXY]PHENYL]-2-PYRROL-1-YL-PROPIONIC ACID|(2S)-3-[4-[2-(5-METHYL-2-PHENYL-1,3-OXAZOL-4-YL)ETHOXY]PHENYL]-2-PYRROL-1-YLPROPANOIC ACID|(ALPHAS)-ALPHA-(1H-PYRROLE-1-YL)-4-[2-(2-PHENYL-5-METHYL-4-OXAZOLYL)ETHOXY]BENZENEPROPIONIC ACID|PHENYLPROPANOIC ACID DERIVATIVE, 7|BDBM34017	-	PUBCHEM	9866595	C25H24N2O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	OCWDFPOKWYMLGH-QHCPKHFHSA-N
29628	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Wang W (2008)	18291645	224885	9577	(2S,3S)-1-(4-Tert-butylphenyl)-3-[[3-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]methyl]-4-oxoazetidine-2-carboxylic acid	BDBM50372118	-	PUBCHEM	10369999	C33H34N2O5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	XRVNSFDHOMAYDC-YTMVLYRLSA-N
29629	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Wang W (2008)	18291645	224885	9578	(2S,3S)-1-(4-Methoxyphenyl)-3-[[3-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]methyl]-4-oxoazetidine-2-carboxylic acid	Q27465016|(2S,3S)-1-(4-METHOXYPHENYL)-3-(3-(2-(5-METHYL-2-PHENYLOXAZOL-4-YL)ETHOXY)BENZYL)-4-OXOAZETIDINE-2-CARBOXYLIC ACID|REW|(2S,3S)-1-(4-METHOXYPHENYL)-3-{3-[2-(5-METHYL-2-PHENYL-1,3-OXAZOL-4-YL)ETHOXY]BENZYL}-4-OXOAZETIDINE-2-CARBOXYLIC ACID|BDBM50372107	-	PUBCHEM	10391684	C30H28N2O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	DKIUFVFEAUCDLY-BDYUSTAISA-N
29630	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Wang W (2008)	18291645	224885	9579	(2S,3S)-1-(4-Methoxyphenyl)-3-[[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]methyl]-4-oxoazetidine-2-carboxylic acid	BDBM50372105	-	PUBCHEM	9983904	C30H28N2O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WTRWFOXPPRLKFP-BDYUSTAISA-N
29631	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Wang W (2008)	18291645	224885	404	Rosiglitazone	(RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion|Rosiglitazon|Rosiglitazonum|Rosiglitazone|()-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione|Rosiglitazona|BDBM50030474	phl-rosiglitazone|avandaryl|av	DRUGBANK	DB00412	C18H19N3O3S	small molecule	A10BD03|A10BG02|A10BD04	122320-73-4	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	YASAKCUCGLMORW-UHFFFAOYNA-N
29637	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Potterat O (2007)	18044841	224887	9583	Chlorocyclinone B	METHYL 9-[1-(ACETYLOXYETHYL)]-2-CHLORO-6,8-DIHYDROXY-1-METHOXY-3-METHYL-7,12-DIOXO-7,12-DIHYDROTETRAPHENE-10-CARBOXYLATE|CHLOROCYCLINONE B|BDBM50228360	-	PUBCHEM	24762580	C26H21ClO9	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	MFLXCCWOEBQIHW-UHFFFAOYSA-N
29638	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Potterat O (2007)	18044841	224887	9584	Chlorocyclinone C	METHYL 2-CHLORO-6,8-DIHYDROXY-9-{1-[(HYDROXYACETYL)OXY]ETHYL}-1-METHOXY-3-METHYL-7,12-DIOXO-7,12-DIHYDROTETRAPHENE-10-CARBOXYLATE|CHLOROCYCLINONE C|BDBM50228359	-	PUBCHEM	24180661	C26H21ClO10	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	LMNHPKWXMIGBEL-UHFFFAOYSA-N
29653	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Pochetti G (2007)	17403688	224891	404	Rosiglitazone	(RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion|Rosiglitazon|Rosiglitazonum|Rosiglitazone|()-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione|Rosiglitazona|BDBM50030474	phl-rosiglitazone|avandaryl|av	DRUGBANK	DB00412	C18H19N3O3S	small molecule	A10BD03|A10BG02|A10BD04	122320-73-4	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	YASAKCUCGLMORW-UHFFFAOYNA-N
29655	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Devasthale PV (2007)	17292606	224893	9596	2-((3-(2-(5-Methyl-2-phenyloxazol-4-yl)ethoxy)benzyl)(naphthalen-1-ylmethyl)amino)acetic acid	2-((3-(2-(5-METHYL-2-PHENYLOXAZOL-4-YL)ETHOXY)BENZYL)(NAPHTHALEN-1-YLMETHYL)AMINO)ACETIC ACID|BDBM50205086	-	PUBCHEM	22087541	C32H30N2O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	NICLRQUMPVQLFM-UHFFFAOYSA-N
29671	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Gonzalez IC (2007)	17129725	224896	9612	3-[4-[(3R)-3-(4-Ethyl-2-pyridin-3-ylphenoxy)butoxy]-2-methylphenyl]propanoic acid	3-(4-((R)-3-(4-ETHYL-2-(PYRIDIN-3-YL)PHENOXY)BUTOXY)-2-METHYLPHENYL)PROPANOIC ACID|BDBM50199783	-	PUBCHEM	44439626	C27H31NO4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	QNTSQSFJMIOVQR-HXUWFJFHSA-N
29672	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Gonzalez IC (2007)	17129725	224896	9613	3-[2-Ethyl-4-[(3R)-3-[2-pyridin-2-yl-4-(trifluoromethyl)phenoxy]butoxy]phenyl]propanoic acid	3-(2-ETHYL-4-((R)-3-(2-(PYRIDIN-2-YL)-4-(TRIFLUOROMETHYL)PHENOXY)BUTOXY)PHENYL)PROPANOIC ACID|BDBM50199781	-	PUBCHEM	11409173	C27H28F3NO4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	JUWZDSPINIDMLW-GOSISDBHSA-N
29673	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Gonzalez IC (2007)	17129725	224896	9614	3-[4-[(3R)-3-(4-Ethyl-2-pyridin-2-ylphenoxy)butoxy]-2-methylphenyl]propanoic acid	3-(4-((R)-3-(4-ETHYL-2-(PYRIDIN-2-YL)PHENOXY)BUTOXY)-2-METHYLPHENYL)PROPANOIC ACID|BDBM50199779	-	PUBCHEM	11178006	C27H31NO4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	KZAXXZUCCUNGNL-HXUWFJFHSA-N
29674	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Gonzalez IC (2007)	17129725	224896	9615	3-[2-Methyl-4-[(3R)-3-[2-pyridin-2-yl-4-(trifluoromethyl)phenoxy]butoxy]phenyl]propanoic acid	3-(2-METHYL-4-((R)-3-(2-(PYRIDIN-2-YL)-4-(TRIFLUOROMETHYL)PHENOXY)BUTOXY)PHENYL)PROPANOIC ACID|BDBM50199777	-	PUBCHEM	44439633	C26H26F3NO4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	AIUXBXGPPYWHFP-GOSISDBHSA-N
29675	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Gonzalez IC (2007)	17129725	224896	9616	3-[2-Ethyl-4-[(3R)-3-(4-ethyl-2-pyridin-2-ylphenoxy)butoxy]phenyl]propanoic acid	3-(2-ETHYL-4-((R)-3-(4-ETHYL-2-(PYRIDIN-2-YL)PHENOXY)BUTOXY)PHENYL)PROPANOIC ACID|BDBM50199776	-	PUBCHEM	11155087	C28H33NO4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	GYZNATQOXOBZSD-HXUWFJFHSA-N
29676	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Gonzalez IC (2007)	17129725	224896	9617	3-[4-[(3R)-3-(4-Chloro-2-pyridin-2-ylphenoxy)butoxy]-2-methylphenyl]propanoic acid	3-(4-((R)-3-(4-CHLORO-2-(PYRIDIN-2-YL)PHENOXY)BUTOXY)-2-METHYLPHENYL)PROPANOIC ACID|BDBM50199773	-	PUBCHEM	11247654	C25H26ClNO4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	PHVHNSMKCROBSA-GOSISDBHSA-N
29677	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Gonzalez IC (2007)	17129725	224896	9618	(R)-3-(4-(3-(2-Benzoyl-4-ethylphenoxy)butoxy)-2-methylphenyl)propanoic acid	(R)-3-{4-[3-(2-BENZOYL-4-ETHYL-PHENOXY)-BUTOXY]2-METHYL-PHENYL}PROPIONIC ACID|(R)-3-(4-(3-(2-BENZOYL-4-ETHYLPHENOXY)BUTOXY)-2-METHYLPHENYL)PROPANOIC ACID|BDBM50194627	-	PUBCHEM	11431103	C29H32O5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ONHBOWNRMGRYNP-OAQYLSRUSA-N
29678	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Gonzalez IC (2007)	17129725	224896	404	Rosiglitazone	(RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion|Rosiglitazon|Rosiglitazonum|Rosiglitazone|()-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione|Rosiglitazona|BDBM50030474	phl-rosiglitazone|avandaryl|av	DRUGBANK	DB00412	C18H19N3O3S	small molecule	A10BD03|A10BG02|A10BD04	122320-73-4	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	YASAKCUCGLMORW-UHFFFAOYNA-N
29682	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Warshawsky AM (2006)	17005394	224899	9622	3-[4-[2-[5-Methyl-2-(4-phenylphenyl)-1,3-oxazol-4-yl]ethoxy]-2-[(pyrazin-2-yloxycarbonylamino)methyl]phenyl]propanoic acid	3-{4-[2-(2-BIPHENYL-4-YL-5-METHYL-OXAZOL-4-YL)-ETHOXY]-2-[(PYRAZIN-2-YLOXYCARBONYLAMINO)-METHYL]-PHENYL}-PROPIONIC ACID|BDBM50195716	-	PUBCHEM	44420485	C33H30N4O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	VATCVNIKAWMLQK-UHFFFAOYSA-N
29683	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Warshawsky AM (2006)	17005394	224899	9623	3-[4-[2-[5-Methyl-2-(4-phenoxyphenyl)-1,3-oxazol-4-yl]ethoxy]-2-[(propan-2-yloxycarbonylamino)methyl]phenyl]propanoic acid	3-[4-[2-[5-METHYL-2-(4-PHENOXYPHENYL)-1,3-OXAZOL-4-YL]ETHOXY]-2-[(PROPAN-2-YLOXYCARBONYLAMINO)METHYL]PHENYL]PROPANOIC ACID|3-(2-((ISOPROPOXYCARBONYL)METHYL)-4-(2-(5-METHYL-2-(4-PHENOXYPHENYL)OXAZOL-4-YL)ETHOXY)PHENYL)PROPANOIC ACID|BDBM50195715	-	PUBCHEM	10144243	C32H34N2O7	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	MAINKGNWZLMMRF-UHFFFAOYSA-N
29684	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Warshawsky AM (2006)	17005394	224899	9624	3-(2-((Isopropoxycarbonyl)methyl)-4-(2-(5-methyl-2-phenyloxazol-4-yl)ethoxy)phenyl)propanoic acid	3-(2-((ISOPROPOXYCARBONYL)METHYL)-4-(2-(5-METHYL-2-PHENYLOXAZOL-4-YL)ETHOXY)PHENYL)PROPANOIC ACID|3-[4-[2-(5-METHYL-2-PHENYL-1,3-OXAZOL-4-YL)ETHOXY]-2-[(PROPAN-2-YLOXYCARBONYLAMINO)METHYL]PHENYL]PROPANOIC ACID|BDBM50195714	-	PUBCHEM	10205220	C26H30N2O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	QDTHAXJGRDPCSZ-UHFFFAOYSA-N
29685	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Warshawsky AM (2006)	17005394	224899	9625	3-[4-[2-[5-Methyl-2-(4-pyrimidin-2-ylphenyl)-1,3-oxazol-4-yl]ethoxy]-2-[(propan-2-yloxycarbonylamino)methyl]phenyl]propanoic acid	3-(2-((ISOPROPOXYCARBONYL)METHYL)-4-(2-(5-METHYL-2-(4-(PYRIMIDIN-2-YL)PHENYL)OXAZOL-4-YL)ETHOXY)PHENYL)PROPANOIC ACID|3-[4-[2-[5-METHYL-2-(4-PYRIMIDIN-2-YLPHENYL)-1,3-OXAZOL-4-YL]ETHOXY]-2-[(PROPAN-2-YLOXYCARBONYLAMINO)METHYL]PHENYL]PROPANOIC ACID|BDBM50195713	-	PUBCHEM	10119824	C30H32N4O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	NTXHMSZOGJFPTJ-UHFFFAOYSA-N
29686	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Warshawsky AM (2006)	17005394	224899	9626	3-[4-[2-(5-Methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-2-[(pyrazin-2-yloxycarbonylamino)methyl]phenyl]propanoic acid	3-(4-(2-(5-METHYL-2-PHENYLOXAZOL-4-YL)ETHOXY)-2-(((PYRAZIN-2-YLOXY)CARBONYL)METHYL)PHENYL)PROPANOIC ACID|BDBM50195711	-	PUBCHEM	44420506	C27H26N4O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	CASKZOPCCIBBBW-UHFFFAOYSA-N
29687	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Warshawsky AM (2006)	17005394	224899	9627	3-(2-((Benzyloxycarbonyl)methyl)-4-(2-(5-methyl-2-phenyloxazol-4-yl)ethoxy)phenyl)propanoic acid	3-(2-((BENZYLOXYCARBONYL)METHYL)-4-(2-(5-METHYL-2-PHENYLOXAZOL-4-YL)ETHOXY)PHENYL)PROPANOIC ACID|3-[4-[2-(5-METHYL-2-PHENYL-1,3-OXAZOL-4-YL)ETHOXY]-2-(PHENYLMETHOXYCARBONYLAMINOMETHYL)PHENYL]PROPANOIC ACID|BDBM50195710	-	PUBCHEM	17984540	C30H30N2O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	FUTRFISBYXLQDO-UHFFFAOYSA-N
29688	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Warshawsky AM (2006)	17005394	224899	9628	3-[4-[2-(5-Methyl-2-morpholin-4-yl-1,3-thiazol-4-yl)ethoxy]-2-[(propan-2-yloxycarbonylamino)methyl]phenyl]propanoic acid	3-(2-((ISOPROPOXYCARBONYL)METHYL)-4-(2-(5-METHYL-2-MORPHOLINOTHIAZOL-4-YL)ETHOXY)PHENYL)PROPANOIC ACID|3-[4-[2-(5-METHYL-2-MORPHOLIN-4-YL-1,3-THIAZOL-4-YL)ETHOXY]-2-[(PROPAN-2-YLOXYCARBONYLAMINO)METHYL]PHENYL]PROPANOIC ACID|3-{2-(ISOPROPOXYCARBONYLAMINOMETHYL)-4-[2-(5-METHYL-2-MORPHOLIN-4-YL-THIAZOL-4-YL)ETHOXY]-PHENYL}PROPIONIC ACID|BDBM50195708	-	PUBCHEM	9805639	C24H33N3O6S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	IACIAFCVQNZHDL-UHFFFAOYSA-N
29689	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Warshawsky AM (2006)	17005394	224899	9629	3-[2-[(Benzylsulfonylamino)methyl]-4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]propanoic acid	3-(4-(2-(5-METHYL-2-PHENYLOXAZOL-4-YL)ETHOXY)-2-((PHENYLMETHYLSULFONAMIDO)METHYL)PHENYL)PROPANOIC ACID|BDBM50195707	-	PUBCHEM	44420484	C29H30N2O6S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	AFMUUVLVLJLAEP-UHFFFAOYSA-N
29690	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Warshawsky AM (2006)	17005394	224899	9630	3-[4-[2-[5-Methyl-2-(4-phenylphenyl)-1,3-oxazol-4-yl]ethoxy]-2-[(propan-2-yloxycarbonylamino)methyl]phenyl]propanoic acid	3-[4-[2-[5-METHYL-2-(4-PHENYLPHENYL)-1,3-OXAZOL-4-YL]ETHOXY]-2-[(PROPAN-2-YLOXYCARBONYLAMINO)METHYL]PHENYL]PROPANOIC ACID|3-[4-[2-(2-BIPHENYL-4-YL-5-METHYL-OXAZOL-4-YL)-ETHOXY]-2-(ISOPROPOXYCARBONYLAMINO-METHYL)-PHENYL]-PROPIONIC ACID|BDBM50195702	-	PUBCHEM	10143678	C32H34N2O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	QLZAMMQCUXFOTM-UHFFFAOYSA-N
29691	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Warshawsky AM (2006)	17005394	224899	404	Rosiglitazone	(RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion|Rosiglitazon|Rosiglitazonum|Rosiglitazone|()-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione|Rosiglitazona|BDBM50030474	phl-rosiglitazone|avandaryl|av	DRUGBANK	DB00412	C18H19N3O3S	small molecule	A10BD03|A10BG02|A10BD04	122320-73-4	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	YASAKCUCGLMORW-UHFFFAOYNA-N
29692	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Henry JR (2006)	17005393	224900	9631	3-[5-[2-(5-Methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-2-propoxycarbonyl-3,4-dihydro-1H-isoquinolin-8-yl]propanoic acid	3-[5-[2-(5-METHYL-2-PHENYL-1,3-OXAZOL-4-YL)ETHOXY]-2-PROPOXYCARBONYL-3,4-DIHYDRO-1H-ISOQUINOLIN-8-YL]PROPANOIC ACID|3-(5-(2-(5-METHYL-2-PHENYLOXAZOL-4-YL)ETHOXY)-2-(PROPOXYCARBONYL)-1,2,3,4-TETRAHYDROISOQUINOLIN-8-YL)PROPANOIC ACID|BDBM50195706	-	PUBCHEM	11317867	C28H32N2O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WVKGGZXCUUYLIT-UHFFFAOYSA-N
29693	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Henry JR (2006)	17005393	224900	9632	3-[2-(2,2-Dimethylpropoxycarbonyl)-5-[2-[5-methyl-2-(4-phenylphenyl)-1,3-oxazol-4-yl]ethoxy]-3,4-dihydro-1H-isoquinolin-8-yl]propanoic acid	3-[2-(2,2-DIMETHYLPROPOXYCARBONYL)-5-[2-[5-METHYL-2-(4-PHENYLPHENYL)-1,3-OXAZOL-4-YL]ETHOXY]-3,4-DIHYDRO-1H-ISOQUINOLIN-8-YL]PROPANOIC ACID|5-[2-(2-BIPHENYL-4-YL-5-METHYL-OXAZOL-4-YL)-ETHOXY]-8-(2-CARBOXY-ETHYL)-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID 2,2-DIMETHYL-PROPYL ESTER|BDBM50195705	-	PUBCHEM	44420402	C36H40N2O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	JYMSZNJYYIGFPC-UHFFFAOYSA-N
29694	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Henry JR (2006)	17005393	224900	9633	3-[5-[2-(5-Methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-2-(2-methylpropoxycarbonyl)-3,4-dihydro-1H-isoquinolin-8-yl]propanoic acid	3-(2-(ISOBUTOXYCARBONYL)-5-(2-(5-METHYL-2-PHENYLOXAZOL-4-YL)ETHOXY)-1,2,3,4-TETRAHYDROISOQUINOLIN-8-YL)PROPANOIC ACID|3-[5-[2-(5-METHYL-2-PHENYL-1,3-OXAZOL-4-YL)ETHOXY]-2-(2-METHYLPROPOXYCARBONYL)-3,4-DIHYDRO-1H-ISOQUINOLIN-8-YL]PROPANOIC ACID|BDBM50195704	-	PUBCHEM	44420566	C29H34N2O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ZGYKSGFEFIEJCW-UHFFFAOYSA-N
29695	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Henry JR (2006)	17005393	224900	9634	3-[5-[2-(5-Methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-2-prop-2-ynoxycarbonyl-3,4-dihydro-1H-isoquinolin-8-yl]propanoic acid	3-(5-(2-(5-METHYL-2-PHENYLOXAZOL-4-YL)ETHOXY)-2-((PROP-2-YNYLOXY)CARBONYL)-1,2,3,4-TETRAHYDROISOQUINOLIN-8-YL)PROPANOIC ACID|3-[5-[2-(5-METHYL-2-PHENYL-1,3-OXAZOL-4-YL)ETHOXY]-2-PROP-2-YNOXYCARBONYL-3,4-DIHYDRO-1H-ISOQUINOLIN-8-YL]PROPANOIC ACID|BDBM50195703	-	PUBCHEM	44420565	C28H28N2O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	KZTWWKBUXGHLOG-UHFFFAOYSA-N
29696	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Henry JR (2006)	17005393	224900	9630	3-[4-[2-[5-Methyl-2-(4-phenylphenyl)-1,3-oxazol-4-yl]ethoxy]-2-[(propan-2-yloxycarbonylamino)methyl]phenyl]propanoic acid	3-[4-[2-[5-METHYL-2-(4-PHENYLPHENYL)-1,3-OXAZOL-4-YL]ETHOXY]-2-[(PROPAN-2-YLOXYCARBONYLAMINO)METHYL]PHENYL]PROPANOIC ACID|3-[4-[2-(2-BIPHENYL-4-YL-5-METHYL-OXAZOL-4-YL)-ETHOXY]-2-(ISOPROPOXYCARBONYLAMINO-METHYL)-PHENYL]-PROPIONIC ACID|BDBM50195702	-	PUBCHEM	10143678	C32H34N2O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	QLZAMMQCUXFOTM-UHFFFAOYSA-N
29697	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Henry JR (2006)	17005393	224900	9635	3-[5-[2-[5-Methyl-2-(4-phenylphenyl)-1,3-oxazol-4-yl]ethoxy]-2-propoxycarbonyl-3,4-dihydro-1H-isoquinolin-8-yl]propanoic acid	5-[2-(2-BIPHENYL-4-YL-5-METHYL-OXAZOL-4-YL)-ETHOXY]-8-(2-CARBOXY-ETHYL)-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID PROPYL ESTER|3-[5-[2-[5-METHYL-2-(4-PHENYLPHENYL)-1,3-OXAZOL-4-YL]ETHOXY]-2-PROPOXYCARBONYL-3,4-DIHYDRO-1H-ISOQUINOLIN-8-YL]PROPANOIC ACID|BDBM50195699	-	PUBCHEM	11421714	C34H36N2O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	LLUZQFNWHGWRKI-UHFFFAOYSA-N
29698	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Henry JR (2006)	17005393	224900	9636	Farglitazar	GTPL2672|O-[2-(5-METHYL-2-PHENYL-1,3-OXAZOL-4-YL)ETHYL]-N-[2-(PHENYLCARBONYL)PHENYL]-L-TYROSINE|2-(2-BENZOYL-PHENYLAMINO)-3-{4-[2-(5-METHYL-2-PHENYL-OXAZOL-4-YL)-ETHOXY]-PHENYL}-PROPIONIC ACID(GI 262570)|(S)-2-(2-BENZOYLPHENYLAMINO)-3-(4-(2-(5-METHYL-2-PHENYLOXAZOL-4-YL)ETHOXY)PHENYL)PROPANOIC ACID|GI262570; FARGLITAZAR|FARGLITAZAR (USAN/INN)|KBIOSS_002350|L-TYROSINE, N-(2-BENZOYLPHENYL)-O-(2-(5-METHYL-2-PHENYL-4-OXAZOLYL)ETHYL)|KBIOGR_002347|3433GY7132|DSSTOX_CID_27310|L-TYROSINE, N-(2-BENZOYLPHENYL)-O-(2-(5-METHYL-2-PHENYL-4-OXAZOLYL)ETHYL)-|D04132|KBIO2_007483|1FM9|DTXSID1047310|UNII-3433GY7132|NCGC00254050-01|FARGLITAZAR [USAN]|DSSTOX_GSID_47310|TOX21_300218|NCGC00247940-01|(S)-2-((2-BENZOYLPHENYL)AMINO)-3-(4-(2-(5-METHYL-2-PHENYLOXAZOL-4-YL)ETHOXY)PHENYL)PROPANOIC ACID|LS-184758|2-(2-BENZOYL-PHENYLAMINO)-3-{4-[2-(5-METHYL-2-PHENYL-OXAZOL-4-YL)-ETHOXY]-PHENYL}-PROPIONIC ACID|GI262570X|GI-262570|FARGLITAZAR|GI-262570X|FARGLITAZAR [USAN:INN]|196808-45-4|DSSTOX_RID_82260|CMAP_000025|2(S)-(2-BENZOYLPHENYLAMINO)-3-[4-[2-(5-METHYL-2-PHENYLOXAZOL-4-YL)ETHOXY]PHENYL]PROPIONIC ACID|(2S)-2-[[2-(BENZOYL)PHENYL]AMINO]-3-[4-[2-(5-METHYL-2-PHENYL-1,3-OXAZOL-4-YL)ETHOXY]PHENYL]PROPANOIC ACID|Q5435087|G1-262570|L-TYROSINE, N-(2-BENZOYLPHENYL)-O-[2-(5-METHYL-2-PHENYL-4-OXAZOLYL)ETHYL]- (9CI)|GI262570|GI 262570|KBIO2_002347|(S)-2-(2-BENZOYL-PHENYLAMINO)-3-{4-[2-(5-METHYL-2-PHENYL-OXAZOL-4-YL)-ETHOXY]-PHENYL}-PROPIONIC ACID|L-TYROSINE, N-(2-BENZOYLPHENYL)-O-[2-(5-METHYL-2-PHENYL-4-OXAZOLYL)ETHYL]-|GI 262570X|ZINC49639808|N-(O-BENZOYLPHENYL)-O-(2-(5-METHYL-2-PHENYL-4-OXAZOLYL)ETHYL)-L-TYROSINE|KBIO2_004915|BDBM50085044	-	PUBCHEM	170364	C34H30N2O5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ZZCHHVUQYRMYLW-HKBQPEDESA-N
29699	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Henry JR (2006)	17005393	224900	404	Rosiglitazone	(RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion|Rosiglitazon|Rosiglitazonum|Rosiglitazone|()-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione|Rosiglitazona|BDBM50030474	phl-rosiglitazone|avandaryl|av	DRUGBANK	DB00412	C18H19N3O3S	small molecule	A10BD03|A10BG02|A10BD04	122320-73-4	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	YASAKCUCGLMORW-UHFFFAOYNA-N
29702	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Xu Y (2006)	16970391	224902	9639	3-{4-[3-(2-Benzoyl-4-ethyl-phenoxy)-pentyloxy]-2-methyl-phenyl}-propionic acid	3-{4-[3-(2-BENZOYL-4-ETHYL-PHENOXY)-PENTYLOXY]-2-METHYL-PHENYL}-PROPIONIC ACID|3-[4-[3-(2-BENZOYL-4-ETHYLPHENOXY)PENTOXY]-2-METHYLPHENYL]PROPANOIC ACID|BDBM50194638	-	PUBCHEM	16085984	C30H34O5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	KEUWMDZMXVQKJB-UHFFFAOYSA-N
29703	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Xu Y (2006)	16970391	224902	9640	(r)-3-{4-[3-(4-Chloro-2-phenoxy-phenoxy)-butoxy]-2-fluoro-phenyl}-propionic acid	3-[4-[(3R)-3-(4-CHLORO-2-PHENOXYPHENOXY)BUTOXY]-2-FLUOROPHENYL]PROPANOIC ACID|(R)-3-{4-[3-(4-CHLORO-2-PHENOXY-PHENOXY)-BUTOXY]-2-FLUORO-PHENYL}-PROPIONIC ACID|BDBM50194637	-	PUBCHEM	16085987	C25H24ClFO5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WXCQOBJBCVSXBR-QGZVFWFLSA-N
29704	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Xu Y (2006)	16970391	224902	9641	(R)-3-{4-[3-(4-Chloro-2-phenoxy-phenoxy)-butoxy]-2-methyl-phenyl}-propionic acid	(R)-3-{4-[3-(4-CHLORO-2-PHENOXY-PHENOXY)-BUTOXY]-2-METHYL-PHENYL}-PROPIONIC ACID|3-[4-[(3R)-3-(4-CHLORO-2-PHENOXYPHENOXY)BUTOXY]-2-METHYLPHENYL]PROPANOIC ACID|BDBM50194635	-	PUBCHEM	16085985	C26H27ClO5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ZARBOTMPCCXOHE-LJQANCHMSA-N
29705	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Xu Y (2006)	16970391	224902	9642	3-{4-[3-(2-Benzoyl-4-ethyl-phenoxy)-butoxy]-2-methyl-phenyl}-propionic acid	LS-193043|3-[4-[3-(2-BENZOYL-4-ETHYLPHENOXY)BUTOXY]-2-METHYLPHENYL]PROPANOIC ACID|3-{4-[3-(2-BENZOYL-4-ETHYL-PHENOXY)-BUTOXY]-2-METHYL-PHENYL}-PROPIONIC ACID|3-{4-[3-(2-BENZOYL-4-ETHYL-PHENOXY)-BUTOXY]2-METHYL-PHENYL}PROPIONIC ACID|BDBM50194634	-	PUBCHEM	11305717	C29H32O5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ONHBOWNRMGRYNP-UHFFFAOYSA-N
29706	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Xu Y (2006)	16970391	224902	9643	(R)-3-{4-[3-(4-Chloro-2-phenoxy-phenoxy)-butoxy]-2-trifluoromethyl-phenyl}-propionic acid	3-[4-[(3R)-3-(4-CHLORO-2-PHENOXYPHENOXY)BUTOXY]-2-(TRIFLUOROMETHYL)PHENYL]PROPANOIC ACID|(R)-3-{4-[3-(4-CHLORO-2-PHENOXY-PHENOXY)-BUTOXY]-2-TRIFLUOROMETHYL-PHENYL}-PROPIONIC ACID|BDBM50194633	-	PUBCHEM	16085982	C26H24ClF3O5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	HIOGFQCBUGMDNX-QGZVFWFLSA-N
29707	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Xu Y (2006)	16970391	224902	9644	(R)-3-{4-[3-(4-Ethyl-2-phenoxy-phenoxy)-butoxy]-2-methyl-phenyl}-propionic acid	3-[4-[(3R)-3-(4-ETHYL-2-PHENOXYPHENOXY)BUTOXY]-2-METHYLPHENYL]PROPANOIC ACID|(R)-3-{4-[3-(4-ETHYL-2-PHENOXY-PHENOXY)-BUTOXY]-2-METHYL-PHENYL}-PROPIONIC ACID|BDBM50194631	-	PUBCHEM	16085980	C28H32O5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	VWGFBGMULZAECR-OAQYLSRUSA-N
29708	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Xu Y (2006)	16970391	224902	9645	(R)-3-{4-[3-(4-Chloro-2-phenoxy-phenoxy)-butoxy]-2-ethyl-phenyl}-propionic acid	LS-193041|3-[4-[(3R)-3-(4-CHLORO-2-PHENOXYPHENOXY)BUTOXY]-2-ETHYLPHENYL]PROPANOIC ACID|(R)-3-{4-[3-(4-CHLORO-2-PHENOXY-PHENOXY)-BUTOXY]-2-ETHYL-PHENYL}-PROPIONIC ACID|BDBM50194630	-	PUBCHEM	16085988	C27H29ClO5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	CIPGEDLLCCHFDI-LJQANCHMSA-N
29709	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Xu Y (2006)	16970391	224902	9646	2-{4-[3-(2-Benzoyl-4-ethyl-phenoxy)-butoxy]-phenoxy}-2-methyl-propionic acid	2-[4-[3-(2-BENZOYL-4-ETHYLPHENOXY)BUTOXY]PHENOXY]-2-METHYLPROPANOIC ACID|2-{4-[3-(2-BENZOYL-4-ETHYL-PHENOXY)-BUTOXY]-PHENOXY}-2-METHYL-PROPIONIC ACID|BDBM50194629	-	PUBCHEM	11340513	C29H32O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ILHLGCBMPLPUEJ-UHFFFAOYSA-N
29710	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Xu Y (2006)	16970391	224902	9647	(R)-3-{2-Methyl-4-[3-(2-phenoxy-4-trifluoromethyl-phenoxy)-butoxy]-phenyl}-propionic acid	3-[2-METHYL-4-[(3R)-3-[2-PHENOXY-4-(TRIFLUOROMETHYL)PHENOXY]BUTOXY]PHENYL]PROPANOIC ACID|(R)-3-{2-METHYL-4-[3-(2-PHENOXY-4-TRIFLUOROMETHYL-PHENOXY)-BUTOXY]-PHENYL}-PROPIONIC ACID|BDBM50194628	-	PUBCHEM	16085986	C27H27F3O5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	CDXOSGNAXOTFBO-LJQANCHMSA-N
29711	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Xu Y (2006)	16970391	224902	9618	(R)-3-(4-(3-(2-Benzoyl-4-ethylphenoxy)butoxy)-2-methylphenyl)propanoic acid	(R)-3-{4-[3-(2-BENZOYL-4-ETHYL-PHENOXY)-BUTOXY]2-METHYL-PHENYL}PROPIONIC ACID|(R)-3-(4-(3-(2-BENZOYL-4-ETHYLPHENOXY)BUTOXY)-2-METHYLPHENYL)PROPANOIC ACID|BDBM50194627	-	PUBCHEM	11431103	C29H32O5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ONHBOWNRMGRYNP-OAQYLSRUSA-N
29712	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Xu Y (2006)	16970391	224902	9648	2-(4-(3-(2-Benzoyl-4-ethylphenoxy)propoxy)phenoxy)-2-methylpropanoic acid	2-(4-(3-(2-BENZOYL-4-ETHYLPHENOXY)PROPOXY)PHENOXY)-2-METHYLPROPANOIC ACID|BDBM50194626	-	PUBCHEM	16085983	C28H30O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	AFQIAKAIRKBLKC-UHFFFAOYSA-N
29713	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Xu Y (2006)	16970391	224902	9649	(R)-3-{2-Methyl-4-[3-(2-phenoxy-4-trifluoromethoxy-phenoxy)-butoxy]-phenyl}-propionic acid	(R)-3-{2-METHYL-4-[3-(2-PHENOXY-4-TRIFLUOROMETHOXY-PHENOXY)-BUTOXY]-PHENYL}-PROPIONIC ACID|3-[2-METHYL-4-[(3R)-3-[2-PHENOXY-4-(TRIFLUOROMETHOXY)PHENOXY]BUTOXY]PHENYL]PROPANOIC ACID|BDBM50194625	-	PUBCHEM	16085981	C27H27F3O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	CQHWVRVOKKOIJC-LJQANCHMSA-N
29714	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Xu Y (2006)	16970391	224902	9650	3-{4-[3-(2-Benzyl-4-ethyl-phenoxy)-butoxy]-2-methyl-phenyl}-propionic acid	3-[4-[3-(2-BENZYL-4-ETHYLPHENOXY)BUTOXY]-2-METHYLPHENYL]PROPANOIC ACID|3-{4-[3-(2-BENZYL-4-ETHYL-PHENOXY)-BUTOXY]-2-METHYL-PHENYL}-PROPIONIC ACID|BDBM50194624	-	PUBCHEM	11316788	C29H34O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	QRUJOOQWHBDHME-UHFFFAOYSA-N
29715	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Xu Y (2006)	16970391	224902	404	Rosiglitazone	(RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion|Rosiglitazon|Rosiglitazonum|Rosiglitazone|()-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione|Rosiglitazona|BDBM50030474	phl-rosiglitazone|avandaryl|av	DRUGBANK	DB00412	C18H19N3O3S	small molecule	A10BD03|A10BG02|A10BD04	122320-73-4	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	YASAKCUCGLMORW-UHFFFAOYNA-N
29721	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Hopkins CR (2006)	16919947	170617	9656	1-(3-(Trifluoromethyl)benzyl)-N-(naphthalen-2-ylsulfonyl)-1H-indole-2-carboxamide	1-(3-(TRIFLUOROMETHYL)BENZYL)-N-(NAPHTHALEN-2-YLSULFONYL)-1H-INDOLE-2-CARBOXAMIDE|BDBM50193752	-	PUBCHEM	44419355	C27H19F3N2O3S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	RSDUQVSYQVYCFK-UHFFFAOYSA-N
29722	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Hopkins CR (2006)	16919947	170617	9657	3-(4-Methoxyphenyl)-N-(2-methylphenyl)sulfonyl-1-[[3-(trifluoromethyl)phenyl]methyl]indole-2-carboxamide	1-(3-(TRIFLUOROMETHYL)BENZYL)-3-(4-METHOXYPHENYL)-N-(O-TOLYLSULFONYL)-1H-INDOLE-2-CARBOXAMIDE|BDBM50193751	-	PUBCHEM	44419391	C31H25F3N2O4S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	GIJPWVGTDPKGSQ-UHFFFAOYSA-N
29723	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Hopkins CR (2006)	16919947	170617	9658	1-(3-(Trifluoromethyl)benzyl)-N-(3-(trifluoromethyl)phenylsulfonyl)-1H-indole-2-carboxamide	1-(3-(TRIFLUOROMETHYL)BENZYL)-N-(3-(TRIFLUOROMETHYL)PHENYLSULFONYL)-1H-INDOLE-2-CARBOXAMIDE|BDBM50193750	-	PUBCHEM	44419352	C24H16F6N2O3S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	BNRJBWWXERRJDS-UHFFFAOYSA-N
29724	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Hopkins CR (2006)	16919947	170617	9659	3-(4-Methoxyphenyl)-N-(Phenylsulfonyl)-1-[3-(Trifluoromethyl)benzyl]-1h-Indole-2-Carboxamide	76023-EP2308860A1|3-(4-METHOXYPHENYL)-N-(PHENYLSULFONYL)-1-[3-(TRIFLUOROMETHYL)BENZYL]-1H-INDOLE-2-CARBOXAMIDE|N-(BENZENESULFONYL)-3-(4-METHOXYPHENYL)-1-[[3-(TRIFLUOROMETHYL)PHENYL]METHYL]INDOLE-2-CARBOXAMIDE|2HFP|1-(3-(TRIFLUOROMETHYL)BENZYL)-3-(4-METHOXYPHENYL)-N-(PHENYLSULFONYL)-1H-INDOLE-2-CARBOXAMIDE|Q27463924|(3-(4-METHOXYPHENYL)-1-{[3-(TRIFLUOROMETHYL)PHENYL]METHYL}INDOL-2-YL)-N-(PHENYLSULFONYL) CARBOXAMIDE|NSI|BDBM50193748	-	PUBCHEM	9549238	C30H23F3N2O4S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	BCPFCXDCWUXOGT-UHFFFAOYSA-N
29725	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Hopkins CR (2006)	16919947	170617	9660	N-(4-Fluorophenyl)sulfonyl-3-(4-methoxyphenyl)-1-[[3-(trifluoromethyl)phenyl]methyl]indole-2-carboxamide	1-(3-(TRIFLUOROMETHYL)BENZYL)-N-(4-FLUOROPHENYLSULFONYL)-3-(4-METHOXYPHENYL)-1H-INDOLE-2-CARBOXAMIDE|BDBM50193744	-	PUBCHEM	44419390	C30H22F4N2O4S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	AOVDRHLXGSLJQB-UHFFFAOYSA-N
29726	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Hopkins CR (2006)	16919947	170617	9661	1-(3-(Trifluoromethyl)benzyl)-N-(2-(trifluoromethyl)phenylsulfonyl)-1H-indole-2-carboxamide	1-(3-(TRIFLUOROMETHYL)BENZYL)-N-(2-(TRIFLUOROMETHYL)PHENYLSULFONYL)-1H-INDOLE-2-CARBOXAMIDE|BDBM50193742	-	PUBCHEM	44419356	C24H16F6N2O3S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	RYZBTWSMNGDKFD-UHFFFAOYSA-N
29727	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Hopkins CR (2006)	16919947	170617	9662	1-(3-(Trifluoromethoxy)benzyl)-N-(3-(trifluoromethyl)phenylsulfonyl)-1H-indole-2-carboxamide	1-(3-(TRIFLUOROMETHOXY)BENZYL)-N-(3-(TRIFLUOROMETHYL)PHENYLSULFONYL)-1H-INDOLE-2-CARBOXAMIDE|BDBM50193741	-	PUBCHEM	44419366	C24H16F6N2O4S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	MVMATXNFISADDB-UHFFFAOYSA-N
29728	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Hopkins CR (2006)	16919947	170617	9663	N-(5-Chlorothiophen-2-yl)sulfonyl-1-[[3-(trifluoromethyl)phenyl]methyl]indole-2-carboxamide	1-(3-(TRIFLUOROMETHYL)BENZYL)-N-(5-CHLOROTHIOPHEN-2-YLSULFONYL)-1H-INDOLE-2-CARBOXAMIDE|BDBM50193739	-	PUBCHEM	44419357	C21H14ClF3N2O3S2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ZRPUUOXOGLOCQT-UHFFFAOYSA-N
29729	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Hopkins CR (2006)	16919947	170617	9664	3-(4-Methoxyphenyl)-N-methylsulfonyl-1-[[3-(trifluoromethyl)phenyl]methyl]indole-2-carboxamide	1-(3-(TRIFLUOROMETHYL)BENZYL)-3-(4-METHOXYPHENYL)-N-(METHYLSULFONYL)-1H-INDOLE-2-CARBOXAMIDE|BDBM50193736	-	PUBCHEM	44419392	C25H21F3N2O4S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	RUSDVKUNFXBCHZ-UHFFFAOYSA-N
29730	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Hopkins CR (2006)	16919947	170617	9665	Methyl 2-[[3-(4-methoxyphenyl)-1-[[3-(trifluoromethyl)phenyl]methyl]indole-2-carbonyl]sulfamoyl]benzoate	2-{[3-(4-METHOXY-PHENYL)-1-(3-TRIFLUOROMETHYL-BENZYL)-1H-INDOLE-2-CARBONYL]-SULFAMOYL}-BENZOIC ACID METHYL ESTER|BDBM50193734	-	PUBCHEM	44419255	C32H25F3N2O6S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	RRLTYQDNNRNQPH-UHFFFAOYSA-N
29731	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Hopkins CR (2006)	16919947	170617	9666	1-(3-(Benzyloxy)benzyl)-N-(3-(trifluoromethyl)phenylsulfonyl)-1H-indole-2-carboxamide	1-(3-(BENZYLOXY)BENZYL)-N-(3-(TRIFLUOROMETHYL)PHENYLSULFONYL)-1H-INDOLE-2-CARBOXAMIDE|BDBM50193733	-	PUBCHEM	44419381	C30H23F3N2O4S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	NZNRDAXVBYSQEB-UHFFFAOYSA-N
29732	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Hopkins CR (2006)	16919947	170617	9667	3-(4-Methoxyphenyl)-1-[[3-(trifluoromethyl)phenyl]methyl]-N-[3-(trifluoromethyl)phenyl]sulfonylindole-2-carboxamide	1-(3-(TRIFLUOROMETHYL)BENZYL)-3-(4-METHOXYPHENYL)-N-(3-(TRIFLUOROMETHYL)PHENYLSULFONYL)-1H-INDOLE-2-CARBOXAMIDE|BDBM50193729	-	PUBCHEM	44419253	C31H22F6N2O4S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	LINUGMFIDAUGBH-UHFFFAOYSA-N
29733	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Hopkins CR (2006)	16919947	170617	404	Rosiglitazone	(RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion|Rosiglitazon|Rosiglitazonum|Rosiglitazone|()-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione|Rosiglitazona|BDBM50030474	phl-rosiglitazone|avandaryl|av	DRUGBANK	DB00412	C18H19N3O3S	small molecule	A10BD03|A10BG02|A10BD04	122320-73-4	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	YASAKCUCGLMORW-UHFFFAOYNA-N
29738	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Kuhn B (2006)	16737814	224906	9671	3-(1-((2-(3,5-Dimethylphenyl)-5-methyloxazol-4-yl)methyl)-1H-indol-5-yl)-2-ethoxypropanoic acid	3-[1-[[2-(3,5-DIMETHYLPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL]INDOL-5-YL]-2-ETHOXYPROPANOIC ACID|RAC-3-{1-[2-(3,5-DIMETHYL-PHENYL)-5-METHYL-OXAZOL-4-YLMETHYL]-1H-INDOL-5-YL}-2-ETHOXY-PROPIONIC ACID|3-(1-((2-(3,5-DIMETHYLPHENYL)-5-METHYLOXAZOL-4-YL)METHYL)-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID|BDBM50188038	-	PUBCHEM	10455511	C26H28N2O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	DSKLBNZCCNQVBC-UHFFFAOYSA-N
29739	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Kuhn B (2006)	16737814	224906	9672	3-(1-((2-(3,5-Dichlorophenyl)-5-methyloxazol-4-yl)methyl)-1H-indol-5-yl)-2-ethoxypropanoic acid	3-[1-[[2-(3,5-DICHLOROPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL]INDOL-5-YL]-2-ETHOXYPROPANOIC ACID|RAC-3-{1-[2-(3,5-DICHLORO-PHENYL)-5-METHYL-OXAZOL-4-YLMETHYL]-1H-INDOL-5-YL}-2-ETHOXY-PROPIONIC ACID|3-(1-((2-(3,5-DICHLOROPHENYL)-5-METHYLOXAZOL-4-YL)METHYL)-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID|BDBM50188037	-	PUBCHEM	10344769	C24H22Cl2N2O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	RQMKNZHMAWCBJL-UHFFFAOYSA-N
29740	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Kuhn B (2006)	16737814	224906	9673	3-(1-((2-(3-Chlorophenyl)-5-methyloxazol-4-yl)methyl)-1H-indol-5-yl)-2-ethoxypropanoic acid	3-(1-((2-(3-CHLOROPHENYL)-5-METHYLOXAZOL-4-YL)METHYL)-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID|3-[1-[[2-(3-CHLOROPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL]INDOL-5-YL]-2-ETHOXYPROPANOIC ACID|RAC-3-{1-[2-(3-CHLORO-PHENYL)-5-METHYL-OXAZOL-4-YLMETHYL]-1H-INDOL-5-YL}-2-ETHOXY-PROPIONIC ACID|BDBM50188035	-	PUBCHEM	9980586	C24H23ClN2O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	HMMQETYZLNQVSF-UHFFFAOYSA-N
29741	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Kuhn B (2006)	16737814	224906	9674	3-(1-((2-(3,5-Dimethoxyphenyl)-5-methyloxazol-4-yl)methyl)-1H-indol-5-yl)-2-ethoxypropanoic acid	3-[1-[[2-(3,5-DIMETHOXYPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL]INDOL-5-YL]-2-ETHOXYPROPANOIC ACID|RAC-3-{1-[2-(3,5-DIMETHOXY-PHENYL)-5-METHYL-OXAZOL-4-YLMETHYL]-1H-INDOL-5-YL}-2-ETHOXY-PROPIONIC ACID|3-(1-((2-(3,5-DIMETHOXYPHENYL)-5-METHYLOXAZOL-4-YL)METHYL)-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID|BDBM50188025	-	PUBCHEM	10412116	C26H28N2O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	PMZZWDLQGMUYFU-UHFFFAOYSA-N
29742	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Kuhn B (2006)	16737814	224906	9675	3-(1-((2-(4-Tert-butylphenyl)-5-methyloxazol-4-yl)methyl)-1H-indol-5-yl)-2-ethoxypropanoic acid	3-(1-((2-(4-TERT-BUTYLPHENYL)-5-METHYLOXAZOL-4-YL)METHYL)-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID|3-[1-[[2-(4-TERT-BUTYLPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL]INDOL-5-YL]-2-ETHOXYPROPANOIC ACID|BDBM50188024	-	PUBCHEM	10072967	C28H32N2O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	FVPCEABQEUPZJE-UHFFFAOYSA-N
29743	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Kuhn B (2006)	16737814	224906	9676	2-Ethoxy-3-(1-((2-(4-isopropylphenyl)-5-methyloxazol-4-yl)methyl)-1H-indol-5-yl)propanoic acid	2-ETHOXY-3-[1-[[5-METHYL-2-(4-PROPAN-2-YLPHENYL)-1,3-OXAZOL-4-YL]METHYL]INDOL-5-YL]PROPANOIC ACID|2-ETHOXY-3-(1-((2-(4-ISOPROPYLPHENYL)-5-METHYLOXAZOL-4-YL)METHYL)-1H-INDOL-5-YL)PROPANOIC ACID|BDBM50188023	-	PUBCHEM	10343538	C27H30N2O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	UDXHXODNGSKQKU-UHFFFAOYSA-N
29744	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Kuhn B (2006)	16737814	224906	9677	2-Ethoxy-3-(1-((2-(4-ethylphenyl)-5-methyloxazol-4-yl)methyl)-1H-indol-5-yl)propanoic acid	RAC-2-ETHOXY-3-{1-[2-(4-ETHYL-PHENYL)-5-METHYL-OXAZOL-4-YLMETHYL]-1H-INDOL-5-YL}-PROPIONIC ACID|2-ETHOXY-3-[1-[[2-(4-ETHYLPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL]INDOL-5-YL]PROPANOIC ACID|2-ETHOXY-3-(1-((2-(4-ETHYLPHENYL)-5-METHYLOXAZOL-4-YL)METHYL)-1H-INDOL-5-YL)PROPANOIC ACID|BDBM50188022	-	PUBCHEM	10342769	C26H28N2O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	RTXIDZKNOYTSIW-UHFFFAOYSA-N
29745	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Lu IL (2006)	16640330	171129	9678	N-[1-(4-Fluorophenyl)-3-(2-thienyl)-1H-pyrazol-5-YL]-3,5-bis(trifluoromethyl)benzenesulfonamide	N-(1-(4-FLUOROPHENYL)-3-(THIOPHEN-2-YL)-1H-PYRAZOL-5-YL)-3,5-BIS(TRIFLUOROMETHYL)BENZENESULFONAMIDE|MCULE-9080417768|Q27465446|N-[1-(4-FLUOROPHENYL)-3-(2-THIENYL)-1H-PYRAZOL-5-YL]-3,5-BIS(TRIFLUOROMETHYL)BENZENESULFONAMIDE|N-[1-(4-FLUOROPHENYL)-3-THIOPHEN-2-YL-1H-PYRAZOL-5-YL]-3,5-BIS(TRIFLUOROMETHYL)BENZENESULFONAMIDE|ZINC24800189|2G0H|BDBM50185944	-	PUBCHEM	2742759	C21H12F7N3O2S2	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	BQSKQGGQDUBLNS-UHFFFAOYSA-N
29750	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Mahindroo N (2006)	16451087	171122	4493	2-{5-[3-(6-BENZOYL-1-PROPYLNAPHTHALEN-2-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID	CAY10573|(5-{3-[(6-BENZOYL-1-PROPYL-2-NAPHTHYL)OXY]PROPOXY}-1H-INDOL-1-YL)ACETIC ACID|5-[3-(6-BENZOYL-1-PROPYL-2-NAPHTHYLOXY)PROPOXY]-1H-INDOLE-1-ACETIC ACID|Q27095435|1444AH|853652-40-1|5-[3-[(6-BENZOYL-1-PROPYL-2-NAPHTHALENYL)OXY]PROPOXY]-1H-INDOLE-1-ACETIC ACID|2F4B|2-(5-{3-[(6-BENZOYL-1-PROPYLNAPHTHALEN-2-YL)OXY]PROPOXY}-1H-INDOL-1-YL)ACETIC ACID|ZINC12504466|2-{5-[3-(6-BENZOYL-1-PROPYLNAPHTHALEN-2-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID|DB04689|2-(5-(3-(6-BENZOYL-1-PROPYLNAPHTHALEN-2-YLOXY)PROPOXY)-1H-INDOL-1-YL)ACETIC ACID|[5-(3-{[6-(PHENYLCARBONYL)-1-PROPYLNAPHTHALEN-2-YL]OXY}PROPOXY)-1H-INDOL-1-YL]ACETIC ACID|NS00070789|BDBM50181911	-	DRUGBANK	DB04689	C33H31NO5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ZXWVCCFKIRBLDP-UHFFFAOYSA-N
29751	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Mahindroo N (2006)	16451087	171122	404	Rosiglitazone	(RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion|Rosiglitazon|Rosiglitazonum|Rosiglitazone|()-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione|Rosiglitazona|BDBM50030474	phl-rosiglitazone|avandaryl|av	DRUGBANK	DB00412	C18H19N3O3S	small molecule	A10BD03|A10BG02|A10BD04	122320-73-4	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	YASAKCUCGLMORW-UHFFFAOYNA-N
29752	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Mahindroo N (2005)	16366601	224907	404	Rosiglitazone	(RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion|Rosiglitazon|Rosiglitazonum|Rosiglitazone|()-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione|Rosiglitazona|BDBM50030474	phl-rosiglitazone|avandaryl|av	DRUGBANK	DB00412	C18H19N3O3S	small molecule	A10BD03|A10BG02|A10BD04	122320-73-4	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	YASAKCUCGLMORW-UHFFFAOYNA-N
29754	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Morphy R (2005)	16220969	224908	9684	2-Methyl-3-{4-[2-(5-methyl-2-phenyl-oxazol-4-yl)-ethoxy]-phenyl}-2-phenoxy-propionic acid	2-METHYL-3-{4-[2-(5-METHYL-2-PHENYL-OXAZOL-4-YL)-ETHOXY]-PHENYL}-2-PHENOXY-PROPIONIC ACID|2-METHYL-3-[4-[2-(5-METHYL-2-PHENYL-1,3-OXAZOL-4-YL)ETHOXY]PHENYL]-2-PHENOXYPROPANOIC ACID|BDBM50145712	-	PUBCHEM	10139247	C28H27NO5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	JSTSZHVRXHMZQK-UHFFFAOYSA-N
29756	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Shi GQ (2005)	15974597	170490	9685	(2S)-2-[(2-Oxo-3,5,7-tripropyl-1,3-benzoxazol-6-yl)oxy]-2-(4-propan-2-ylphenyl)acetic acid	I(S)-(4-ISOPROPYL-PHENYL)-(2-OXO-3,5,7-TRIPROPYL-2,3-DIHYDRO-BENZOOXAZOL-6-YLOXY)-ACETIC ACID|BDBM50169254	-	PUBCHEM	11247998	C27H35NO5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	VGNJRUSCVGOQDZ-DEOSSOPVSA-N
29757	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Shi GQ (2005)	15974597	170490	9686	(S)-(4-Isopropyl-phenyl)-(4-propionyl-2,6-dipropyl-phenoxy)-acetic acid	(S)-(4-ISOPROPYL-PHENYL)-(4-PROPIONYL-2,6-DIPROPYL-PHENOXY)-ACETIC ACID|BDBM50169253	-	PUBCHEM	11223613	C26H34O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	BLBKQSCECDPYAW-VWLOTQADSA-N
29758	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Shi GQ (2005)	15974597	170490	9687	(2S)-2-[(2-Oxo-3-propan-2-yl-5,7-dipropyl-1,3-benzoxazol-6-yl)oxy]-2-(4-propan-2-ylphenyl)acetic acid	(S)-(3-ISOPROPYL-2-OXO-5,7-DIPROPYL-2,3-DIHYDRO-BENZOOXAZOL-6-YLOXY)-(4-ISOPROPYL-PHENYL)-ACETIC ACID|BDBM50169245	-	PUBCHEM	11339979	C27H35NO5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	CMBADTBQKXKEOM-DEOSSOPVSA-N
29759	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Shi GQ (2005)	15974597	170490	9688	(2S)-2-[(3-Methyl-2-oxo-5,7-dipropyl-1,3-benzoxazol-6-yl)oxy]-2-(4-propan-2-ylphenyl)acetic acid	(S)-(4-ISOPROPYL-PHENYL)-(3-METHYL-2-OXO-5,7-DIPROPYL-2,3-DIHYDRO-BENZOOXAZOL-6-YLOXY)-ACETIC ACID|BDBM50169233	-	PUBCHEM	11189474	C25H31NO5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	VSBAWOCZJWUIIT-QFIPXVFZSA-N
29760	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Shi GQ (2005)	15974597	170490	9689	(S)-(3-Ethyl-2-oxo-5,7-dipropyl-2,3-dihydro-benzooxazol-6-yloxy)-(4-isopropyl-phenyl)-acetic acid	(S)-(3-ETHYL-2-OXO-5,7-DIPROPYL-2,3-DIHYDRO-BENZOOXAZOL-6-YLOXY)-(4-ISOPROPYL-PHENYL)-ACETIC ACID|BDBM50169227	-	PUBCHEM	11178156	C26H33NO5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WEQANHSKIULRFP-QHCPKHFHSA-N
29761	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Liu K (2005)	15863293	224910	9690	2-[3-[[1-(4-Methoxybenzoyl)-2-methyl-5-(trifluoromethoxy)indol-3-yl]methyl]phenoxy]acetonitrile	{3-[1-(4-METHOXY-BENZOYL)-2-METHYL-5-TRIFLUOROMETHOXY-1H-INDOL-3-YLMETHYL]-PHENOXY}-ACETONITRILE|BDBM50166303	-	PUBCHEM	44400131	C27H21F3N2O4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	XZAJIYHJMAFTGB-UHFFFAOYSA-N
29762	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Liu K (2005)	15863293	224910	9691	(2S)-2-[5-[1-(6-Chloro-1,2-benzoxazol-3-yl)-2-methyl-5-(trifluoromethoxy)indol-3-yl]oxy-2-propylphenoxy]propanoic acid	(S)-2-{5-[1-(6-CHLORO-BENZO[D]ISOXAZOL-3-YL)-2-METHYL-5-TRIFLUOROMETHOXY-1H-INDOL-3-YLMETHYL]-2-PROPYL-PHENOXY}-PROPIONIC ACID|BDBM50166302	-	PUBCHEM	44399972	C29H24ClF3N2O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	NKVXQMXXQRJUBJ-INIZCTEOSA-N
29763	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Liu K (2005)	15863293	224910	9692	(4-Methoxyphenyl)-[2-methyl-3-[(3-prop-2-ynoxyphenyl)methyl]-5-(trifluoromethoxy)indol-1-yl]methanone	(4-METHOXY-PHENYL)-[2-METHYL-3-(3-PROP-2-YNYLOXY-BENZYL)-5-TRIFLUOROMETHOXY-INDOL-1-YL]-METHANONE|BDBM50166301	-	PUBCHEM	44399967	C28H22F3NO4	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	HEMWJRLDDQKGLA-UHFFFAOYSA-N
29764	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Liu K (2005)	15863293	224910	9693	(2S)-2-[2-Chloro-5-[1-(6-chloro-1,2-benzoxazol-3-yl)-2-methyl-5-(trifluoromethoxy)indol-3-yl]oxyphenoxy]propanoic acid	(2S)-2-[2-CHLORO-5-[1-(6-CHLORO-1,2-BENZOXAZOL-3-YL)-2-METHYL-5-(TRIFLUOROMETHOXY)INDOL-3-YL]OXYPHENOXY]PROPANOIC ACID|(S)-2-{2-CHLORO-5-[1-(6-CHLORO-BENZO[D]ISOXAZOL-3-YL)-2-METHYL-5-TRIFLUOROMETHOXY-1H-INDOL-3-YLMETHYL]-PHENOXY}-PROPIONIC ACID|BDBM50166300	-	PUBCHEM	10371027	C26H17Cl2F3N2O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	PESUMSRASMUYKX-ZDUSSCGKSA-N
29765	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Liu K (2005)	15863293	224910	9694	(2S)-2-[4-Chloro-3-[1-(6-chloro-1,2-benzoxazol-3-yl)-2-methyl-5-(trifluoromethoxy)indol-3-yl]oxyphenoxy]propanoic acid	(S)-2-{4-CHLORO-3-[1-(6-CHLORO-BENZO[D]ISOXAZOL-3-YL)-2-METHYL-5-TRIFLUOROMETHOXY-1H-INDOL-3-YLMETHYL]-PHENOXY}-PROPIONIC ACID|(2S)-2-(4-CHLORO-3-(1-(6-CHLOROBENZO[D]ISOXAZOL-3-YL)-2-METHYL-5-(TRIFLUOROMETHOXY)-1H-INDOL-3-YLOXY)PHENOXY)PROPANOIC ACID|(2S)-2-[4-CHLORO-3-[1-(6-CHLORO-1,2-BENZOXAZOL-3-YL)-2-METHYL-5-(TRIFLUOROMETHOXY)INDOL-3-YL]OXYPHENOXY]PROPANOIC ACID|BDBM50166298	-	PUBCHEM	10438226	C26H17Cl2F3N2O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	NOWYXMPKECMLMR-ZDUSSCGKSA-N
29766	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Liu K (2005)	15863293	224910	9695	(2S)-2-[3-[[1-(6-Methoxyquinolin-3-yl)-2-methyl-5-(trifluoromethoxy)indol-3-yl]methyl]phenoxy]propanoic acid	(S)-2-{3-[1-(6-METHOXY-QUINOLIN-3-YL)-2-METHYL-5-TRIFLUOROMETHOXY-1H-INDOL-3-YLMETHYL]-PHENOXY}-PROPIONIC ACID|BDBM50166296	-	PUBCHEM	44399773	C30H25F3N2O5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	VBLJJBHFZCXXCW-SFHVURJKSA-N
29767	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Liu K (2005)	15863293	224910	9696	(2R)-2-[4-Chloro-3-[[1-(6-methoxy-1,2-benzoxazol-3-yl)-2-methyl-5-(trifluoromethoxy)indol-3-yl]methyl]phenoxy]propanoic acid	(R)-2-{4-CHLORO-3-[1-(6-METHOXY-BENZO[D]ISOXAZOL-3-YL)-2-METHYL-5-TRIFLUOROMETHOXY-1H-INDOL-3-YLMETHYL]-PHENOXY}-PROPIONIC ACID|BDBM50166295	-	PUBCHEM	44399983	C28H22ClF3N2O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	QRGIUBNDZNAVAU-OAHLLOKOSA-N
29768	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Liu K (2005)	15863293	224910	9697	(2S)-2-[3-[1-(6-Chloro-1,2-benzoxazol-3-yl)-2-methyl-5-(trifluoromethoxy)indol-3-yl]oxyphenoxy]propanoic acid	(2S)-2-[3-[1-(6-CHLORO-1,2-BENZOXAZOL-3-YL)-2-METHYL-5-(TRIFLUOROMETHOXY)INDOL-3-YL]OXYPHENOXY]PROPANOIC ACID|(S)-2-{3-[1-(6-CHLORO-BENZO[D]ISOXAZOL-3-YL)-2-METHYL-5-TRIFLUOROMETHOXY-1H-INDOL-3-YLMETHYL]-PHENOXY}-PROPIONIC ACID|BDBM50166293	-	PUBCHEM	10437965	C26H18ClF3N2O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	VGORCQXXKHIAFG-AWEZNQCLSA-N
29769	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Liu K (2005)	15863293	224910	9698	(2S)-2-[3-[[1-(4-Methoxyphenyl)-2-methyl-5-(trifluoromethoxy)indol-3-yl]methyl]phenoxy]propanoic acid	(S)-2-{3-[1-(4-METHOXY-PHENYL)-2-METHYL-5-TRIFLUOROMETHOXY-1H-INDOL-3-YLMETHYL]-PHENOXY}-PROPIONIC ACID|BDBM50166292	-	PUBCHEM	44399778	C27H24F3NO5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WASROFIOUZGJFW-KRWDZBQOSA-N
29770	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Liu K (2005)	15863293	224910	9699	(2S)-2-[3-[[1-(4-Methoxybenzoyl)-2-methyl-5-(trifluoromethoxy)indol-3-yl]methyl]phenoxy]propanoic acid	(2S)-2-[3-[[1-(4-METHOXYBENZOYL)-2-METHYL-5-(TRIFLUOROMETHOXY)INDOL-3- YL]METHYL]PHENOXY]PROPANOIC ACID|Q27087738|(S)-2-{3-[1-(4-METHOXY-BENZOYL)-2-METHYL-5-TRIFLUOROMETHOXY-1H-INDOL-3-YLMETHYL]-PHENOXY}-PROPIONIC ACID|(2S)-2-[3-[[1-(4-METHOXYBENZOYL)-2-METHYL-5-(TRIFLUOROMETHOXY)INDOL-3-YL]METHYL]PHENOXY]PROPANOIC ACID|MRL24|(2S)-2-[3-({1-[(4-METHOXYPHENYL)CARBONYL]-2-METHYL-5-(TRIFLUOROMETHOXY)-1H-INDOL-3-YL}METHYL)PHENOXY]PROPANOIC ACID|GTPL6743|(S)-2-(3-((1-(4-METHOXYBENZOYL)-2-METHYL-5-(TRIFLUOROMETHOXY)-1H-INDOL-3-YL)METHYL)PHENOXY)PROPANOIC ACID|NCGC00390369-01|(2S)-2-(3-{[1-(4-METHOXYBENZOYL)-2-METHYL-5-(TRIFLUOROMETHOXY)-1H-INDOL-3-YL]METHYL}PHENOXY)PROPANOIC ACID|MRL 24|BDBM50157917	-	PUBCHEM	9958543	C28H24F3NO6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	OFCWBJAYEIROGZ-KRWDZBQOSA-N
29773	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Acton JJ (2005)	15603954	224912	9700	{4-[1-(4-Chloro-benzoyl)-5-methoxy-2-methyl-1H-indol-3-ylmethyl]-phenoxy}-acetic acid	2-[4-[[1-(4-CHLOROBENZOYL)-5-METHOXY-2-METHYLINDOL-3-YL]METHYL]PHENOXY]ACETIC ACID|{4-[1-(4-CHLORO-BENZOYL)-5-METHOXY-2-METHYL-1H-INDOL-3-YLMETHYL]-PHENOXY}-ACETIC ACID|BDBM50157938	-	PUBCHEM	10226701	C26H22ClNO5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	YAGQPGVXBAGTLQ-UHFFFAOYSA-N
29774	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Acton JJ (2005)	15603954	224912	9701	CID 10143056	Q27087737|(2S)-2-(2-{[1-(4-METHOXYBENZOYL)-2-METHYL-5-(TRIFLUOROMETHOXY)-1H-INDOL-3-YL]METHYL}PHENOXY)PROPANOIC ACID|MRL20|(2S)-2-[2-[[1-(4-METHOXYBENZOYL)-2-METHYL-5-(TRIFLUOROMETHOXY)INDOL-3-YL]METHYL]PHENOXY]PROPANOIC ACID|GTPL6742|(2S)-2-[2-({1-[(4-METHOXYPHENYL)CARBONYL]-2-METHYL-5-(TRIFLUOROMETHOXY)-1H-INDOL-3-YL}METHYL)PHENOXY]PROPANOIC ACID|(S)-2-{2-[1-(4-METHOXY-BENZOYL)-2-METHYL-5-TRIFLUOROMETHOXY-1H-INDOL-3-YLMETHYL]-PHENOXY}-PROPIONIC ACID|BDBM50157936	-	PUBCHEM	10143056	C28H24F3NO6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	BWTOBMCYVACNJZ-KRWDZBQOSA-N
29775	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Acton JJ (2005)	15603954	224912	9702	2-{3-[1-(4-Chloro-benzoyl)-5-methoxy-2-methyl-1H-indol-3-ylmethyl]-phenoxy}-propionic acid	2-{3-[1-(4-CHLORO-BENZOYL)-5-METHOXY-2-METHYL-1H-INDOL-3-YLMETHYL]-PHENOXY}-PROPIONIC ACID|2-[3-[[1-(4-CHLOROBENZOYL)-5-METHOXY-2-METHYLINDOL-3-YL]METHYL]PHENOXY]PROPANOIC ACID|BDBM50157934	-	PUBCHEM	10184159	C27H24ClNO5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	UZJIHIMYKLEBBQ-UHFFFAOYSA-N
29776	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Acton JJ (2005)	15603954	224912	9703	2-{2-[1-(4-Methoxy-benzoyl)-2-methyl-5-trifluoromethoxy-1H-indol-3-ylmethyl]-phenoxy}-propionic acid	2-{2-[1-(4-METHOXY-BENZOYL)-2-METHYL-5-TRIFLUOROMETHOXY-1H-INDOL-3-YLMETHYL]-PHENOXY}-PROPIONIC ACID|2-[2-[[1-(4-METHOXYBENZOYL)-2-METHYL-5-(TRIFLUOROMETHOXY)INDOL-3-YL]METHYL]PHENOXY]PROPANOIC ACID|BDBM50157933	-	PUBCHEM	10208548	C28H24F3NO6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	BWTOBMCYVACNJZ-UHFFFAOYSA-N
29777	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Acton JJ (2005)	15603954	224912	9704	(2R)-2-[2-[[1-(4-Methoxybenzoyl)-2-methyl-5-(trifluoromethoxy)indol-3-yl]methyl]phenoxy]propanoic acid	(2R)-2-[2-[[1-(4-METHOXYBENZOYL)-2-METHYL-5-(TRIFLUOROMETHOXY)INDOL-3-YL]METHYL]PHENOXY]PROPANOIC ACID|(R)-2-{2-[1-(4-METHOXY-BENZOYL)-2-METHYL-5-TRIFLUOROMETHOXY-1H-INDOL-3-YLMETHYL]-PHENOXY}-PROPIONIC ACID|BDBM50157932	-	PUBCHEM	10119125	C28H24F3NO6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	BWTOBMCYVACNJZ-QGZVFWFLSA-N
29778	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Acton JJ (2005)	15603954	224912	9705	2-[2-[[1-(4-Methoxybenzoyl)-2-methyl-5-(trifluoromethoxy)indol-3-yl]methyl]phenoxy]-2-methylpropanoic acid	2-[2-[[1-(4-METHOXYBENZOYL)-2-METHYL-5-(TRIFLUOROMETHOXY)INDOL-3-YL]METHYL]PHENOXY]-2-METHYLPROPANOIC ACID|2-{2-[1-(4-METHOXY-BENZOYL)-2-METHYL-5-TRIFLUOROMETHOXY-1H-INDOL-3-YLMETHYL]-PHENOXY}-2-METHYL-PROPIONIC ACID|BDBM50157931	-	PUBCHEM	10230642	C29H26F3NO6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	SGUDWIZALUVLKT-UHFFFAOYSA-N
29779	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Acton JJ (2005)	15603954	224912	9706	2-{2-[1-(4-Chloro-benzoyl)-5-methoxy-2-methyl-1H-indol-3-ylmethyl]-phenoxy}-propionic acid	2-[2-[[1-(4-CHLOROBENZOYL)-5-METHOXY-2-METHYLINDOL-3-YL]METHYL]PHENOXY]PROPANOIC ACID|2-{2-[1-(4-CHLORO-BENZOYL)-5-METHOXY-2-METHYL-1H-INDOL-3-YLMETHYL]-PHENOXY}-PROPIONIC ACID|BDBM50157930	-	PUBCHEM	10277333	C27H24ClNO5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	XICCHOADKSBRIM-UHFFFAOYSA-N
29780	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Acton JJ (2005)	15603954	224912	9707	(2R)-2-[3-[[1-(4-Methoxybenzoyl)-2-methyl-5-(trifluoromethoxy)indol-3-yl]methyl]phenoxy]propanoic acid	(2R)-2-[3-[[1-(4-METHOXYBENZOYL)-2-METHYL-5-(TRIFLUOROMETHOXY)INDOL-3-YL]METHYL]PHENOXY]PROPANOIC ACID|(R)-2-{3-[1-(4-METHOXY-BENZOYL)-2-METHYL-5-TRIFLUOROMETHOXY-1H-INDOL-3-YLMETHYL]-PHENOXY}-PROPIONIC ACID|BDBM50157927	-	PUBCHEM	44388966	C28H24F3NO6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	OFCWBJAYEIROGZ-QGZVFWFLSA-N
29781	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Acton JJ (2005)	15603954	224912	9708	2-{3-[1-(4-Methoxy-benzoyl)-2-methyl-5-trifluoromethoxy-1H-indol-3-ylmethyl]-phenoxy}-propionic acid	2-{3-[1-(4-METHOXY-BENZOYL)-2-METHYL-5-TRIFLUOROMETHOXY-1H-INDOL-3-YLMETHYL]-PHENOXY}-PROPIONIC ACID|2-[3-[[1-(4-METHOXYBENZOYL)-2-METHYL-5-(TRIFLUOROMETHOXY)INDOL-3-YL]METHYL]PHENOXY]PROPANOIC ACID|BDBM50157926	-	PUBCHEM	10279905	C28H24F3NO6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	OFCWBJAYEIROGZ-UHFFFAOYSA-N
29782	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Acton JJ (2005)	15603954	224912	9709	2-[3-[[1-(4-Methoxybenzoyl)-2-methyl-5-(trifluoromethoxy)indol-3-yl]methyl]phenoxy]butanoic acid	2-{3-[1-(4-METHOXY-BENZOYL)-2-METHYL-5-TRIFLUOROMETHOXY-1H-INDOL-3-YLMETHYL]-PHENOXY}-BUTYRIC ACID|BDBM50157925	-	PUBCHEM	44389085	C29H26F3NO6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	XTHHGKZVXMNJNA-UHFFFAOYSA-N
29783	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Acton JJ (2005)	15603954	224912	9710	2-[3-[[1-(4-Methoxybenzoyl)-2-methyl-5-(trifluoromethoxy)indol-3-yl]methyl]phenoxy]pentanoic acid	2-{3-[1-(4-METHOXY-BENZOYL)-2-METHYL-5-TRIFLUOROMETHOXY-1H-INDOL-3-YLMETHYL]-PHENOXY}-PENTANOIC ACID|BDBM50157921	-	PUBCHEM	44389098	C30H28F3NO6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	UNNWWBCMUJHNAH-UHFFFAOYSA-N
29784	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Acton JJ (2005)	15603954	224912	9711	2-[3-[[1-(4-Methoxybenzoyl)-2-methyl-5-(trifluoromethoxy)indol-3-yl]methyl]phenoxy]-2-methylpropanoic acid	2-[3-[[1-(4-METHOXYBENZOYL)-2-METHYL-5-(TRIFLUOROMETHOXY)INDOL-3-YL]METHYL]PHENOXY]-2-METHYLPROPANOIC ACID|2-{3-[1-(4-METHOXY-BENZOYL)-2-METHYL-5-TRIFLUOROMETHOXY-1H-INDOL-3-YLMETHYL]-PHENOXY}-2-METHYL-PROPIONIC ACID|BDBM50157920	-	PUBCHEM	10280496	C29H26F3NO6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WTIUDROYDYCRCV-UHFFFAOYSA-N
29785	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Acton JJ (2005)	15603954	224912	9712	2-[2-[[1-(4-Methoxybenzoyl)-2-methyl-5-(trifluoromethoxy)indol-3-yl]methyl]phenoxy]butanoic acid	2-{2-[1-(4-METHOXY-BENZOYL)-2-METHYL-5-TRIFLUOROMETHOXY-1H-INDOL-3-YLMETHYL]-PHENOXY}-BUTYRIC ACID|BDBM50157919	-	PUBCHEM	44388998	C29H26F3NO6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	CHGUIFODGMMMKV-UHFFFAOYSA-N
29786	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Acton JJ (2005)	15603954	224912	9713	2-[2-[[1-(4-Chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]methyl]phenoxy]-2-methylpropanoic acid	2-{2-[1-(4-CHLORO-BENZOYL)-5-METHOXY-2-METHYL-1H-INDOL-3-YLMETHYL]-PHENOXY}-2-METHYL-PROPIONIC ACID|2-[2-[[1-(4-CHLOROBENZOYL)-5-METHOXY-2-METHYLINDOL-3-YL]METHYL]PHENOXY]-2-METHYLPROPANOIC ACID|BDBM50157918	-	PUBCHEM	10184971	C28H26ClNO5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	HIPJZUFYVANNKA-UHFFFAOYSA-N
29787	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Acton JJ (2005)	15603954	224912	9699	(2S)-2-[3-[[1-(4-Methoxybenzoyl)-2-methyl-5-(trifluoromethoxy)indol-3-yl]methyl]phenoxy]propanoic acid	(2S)-2-[3-[[1-(4-METHOXYBENZOYL)-2-METHYL-5-(TRIFLUOROMETHOXY)INDOL-3- YL]METHYL]PHENOXY]PROPANOIC ACID|Q27087738|(S)-2-{3-[1-(4-METHOXY-BENZOYL)-2-METHYL-5-TRIFLUOROMETHOXY-1H-INDOL-3-YLMETHYL]-PHENOXY}-PROPIONIC ACID|(2S)-2-[3-[[1-(4-METHOXYBENZOYL)-2-METHYL-5-(TRIFLUOROMETHOXY)INDOL-3-YL]METHYL]PHENOXY]PROPANOIC ACID|MRL24|(2S)-2-[3-({1-[(4-METHOXYPHENYL)CARBONYL]-2-METHYL-5-(TRIFLUOROMETHOXY)-1H-INDOL-3-YL}METHYL)PHENOXY]PROPANOIC ACID|GTPL6743|(S)-2-(3-((1-(4-METHOXYBENZOYL)-2-METHYL-5-(TRIFLUOROMETHOXY)-1H-INDOL-3-YL)METHYL)PHENOXY)PROPANOIC ACID|NCGC00390369-01|(2S)-2-(3-{[1-(4-METHOXYBENZOYL)-2-METHYL-5-(TRIFLUOROMETHOXY)-1H-INDOL-3-YL]METHYL}PHENOXY)PROPANOIC ACID|MRL 24|BDBM50157917	-	PUBCHEM	9958543	C28H24F3NO6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	OFCWBJAYEIROGZ-KRWDZBQOSA-N
29788	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Acton JJ (2005)	15603954	224912	9714	2-[3-[[1-(4-Chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]methyl]phenoxy]-2-methylpropanoic acid	2-{3-[1-(4-CHLORO-BENZOYL)-5-METHOXY-2-METHYL-1H-INDOL-3-YLMETHYL]-PHENOXY}-2-METHYL-PROPIONIC ACID|2-[3-[[1-(4-CHLOROBENZOYL)-5-METHOXY-2-METHYLINDOL-3-YL]METHYL]PHENOXY]-2-METHYLPROPANOIC ACID|BDBM50157916	-	PUBCHEM	10228304	C28H26ClNO5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	NJQKVYQTUIWJEQ-UHFFFAOYSA-N
29789	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Martin JA (2005)	15582409	224913	9715	(S)-3-{4-[3-(Biphenyl-4-yloxy)-propoxy]-phenyl}-2-methoxy-propionic acid	(2S)-2-METHOXY-3-[4-[3-(4-PHENYLPHENOXY)PROPOXY]PHENYL]PROPANOIC ACID|(S)-3-{4-[3-(BIPHENYL-4-YLOXY)-PROPOXY]-PHENYL}-2-METHOXY-PROPIONIC ACID|BDBM50157061	-	PUBCHEM	10223023	C25H26O5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	CFJFKSKRLAYDHM-DEOSSOPVSA-N
29790	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Martin JA (2005)	15582409	224913	9716	(S)-2-Methoxy-3-{4-[4-(4-phenoxy-phenoxy)-but-1-ynyl]-phenyl}-propionic acid	(S)-2-METHOXY-3-{4-[4-(4-PHENOXY-PHENOXY)-BUT-1-YNYL]-PHENYL}-PROPIONIC ACID|(2S)-2-METHOXY-3-[4-[4-(4-PHENOXYPHENOXY)BUT-1-YNYL]PHENYL]PROPANOIC ACID|(2S)-2-METHOXY-3-{4-[4-(4-PHENOXY-PHENOXY)-BUT-1-YNYL]-PHENYL}-PROPIONIC ACID|BDBM50157060	-	PUBCHEM	10136660	C26H24O5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	PXPYSVWYMMGIEN-VWLOTQADSA-N
29791	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Martin JA (2005)	15582409	224913	9717	(S)-3-{4-[3-(4-Benzoyl-phenoxy)-propoxy]-phenyl}-2-methoxy-propionic acid	(2S)-3-[4-[3-(4-BENZOYLPHENOXY)PROPOXY]PHENYL]-2-METHOXYPROPANOIC ACID|(S)-3-{4-[3-(4-BENZOYL-PHENOXY)-PROPOXY]-PHENYL}-2-METHOXY-PROPIONIC ACID|BDBM50157059	-	PUBCHEM	10226233	C26H26O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ONPSUOOPYWPISK-DEOSSOPVSA-N
29792	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Martin JA (2005)	15582409	224913	9718	(S)-2-Methoxy-3-{3-methoxy-4-[3-(4-phenoxy-phenoxy)-propoxy]-phenyl}-propionic acid	(2S)-2-METHOXY-3-[3-METHOXY-4-[3-(4-PHENOXYPHENOXY)PROPOXY]PHENYL]PROPANOIC ACID|(S)-2-METHOXY-3-{3-METHOXY-4-[3-(4-PHENOXY-PHENOXY)-PROPOXY]-PHENYL}-PROPIONIC ACID|BDBM50157058	-	PUBCHEM	10297760	C26H28O7	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	IUORCUOWVWRBDQ-VWLOTQADSA-N
29793	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Martin JA (2005)	15582409	224913	9719	(S)-2-Methoxy-3-{4-[5-(4-phenoxy-phenoxy)-pent-1-ynyl]-phenyl}-propionic acid	(2S)-2-METHOXY-3-[4-[5-(4-PHENOXYPHENOXY)PENT-1-YNYL]PHENYL]PROPANOIC ACID|(S)-2-METHOXY-3-{4-[5-(4-PHENOXY-PHENOXY)-PENT-1-YNYL]-PHENYL}-PROPIONIC ACID|(2S)-2-METHOXY-3-{4-[5-(4-PHENOXY-PHENOXY)-PENT-1-YNYL]-PHENYL}-PROPIONIC ACID|BDBM50157057	-	PUBCHEM	10113515	C27H26O5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	KNNHPJKYTMZLEP-SANMLTNESA-N
29794	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Martin JA (2005)	15582409	224913	9720	Naveglitazar	UNII-Y995M7GM0G|LY 519818|476436-68-7|LY-519818|HY-U00036A|(2S)-2-METHOXY-3-(4-(3-(4-PHENOXYPHENOXY)PROPOXY)PHENYL)PROPANOIC ACID|D08949|BENZENEPROPANOIC ACID, ALPHA-METHOXY-4-(3-(4-PHENOXYPHENOXY)PROPOXY)-, (ALPHAS)-|LY-818|ZINC3950327|CCRIS 9448|LY519818|(S)-2-METHOXY-3-{4-[3-(4-PHENOXY-PHENOXY)-PROPOXY]-PHENYL}-PROPIONIC ACID|Q27294403|NAVEGLITAZAR (USAN/INN)|(2S)-2-METHOXY-3-[4-[3-(4-PHENOXYPHENOXY)PROPOXY]PHENYL]PROPANOIC ACID|NAVEGLITAZAR [USAN:INN]|LY-9818|LY9818|LY 9818|CS-0021934|DB12662|NAVEGLITAZAR|Y995M7GM0G|BDBM50157056	-	PUBCHEM	9888484	C25H26O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	OKJHGOPITGTTIM-DEOSSOPVSA-N
29795	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Martin JA (2005)	15582409	224913	9721	(S)-3-{4-[3-(4-Benzoyl-phenoxy)-propoxy]-3-chloro-phenyl}-2-methoxy-propionic acid	(2S)-3-[4-[3-(4-BENZOYLPHENOXY)PROPOXY]-3-CHLOROPHENYL]-2-METHOXYPROPANOIC ACID|(S)-3-{4-[3-(4-BENZOYL-PHENOXY)-PROPOXY]-3-CHLORO-PHENYL}-2-METHOXY-PROPIONIC ACID|BDBM50157055	-	PUBCHEM	44392315	C26H25ClO6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	XCVUGMYZFJHTQE-DEOSSOPVSA-N
29796	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Martin JA (2005)	15582409	224913	9722	(S)-2-Ethoxy-3-{4-[3-(4-phenoxy-phenoxy)-propoxy]-phenyl}-propionic acid	NAVAGLITAZAR|(S)-2-ETHOXY-3-{4-[3-(4-PHENOXY-PHENOXY)-PROPOXY]-PHENYL}-PROPIONIC ACID|BDBM50157054	-	PUBCHEM	10115344	C26H28O6	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	QTVFGQWILVTOFS-VWLOTQADSA-N
29797	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Martin JA (2005)	15582409	224913	404	Rosiglitazone	(RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion|Rosiglitazon|Rosiglitazonum|Rosiglitazone|()-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione|Rosiglitazona|BDBM50030474	phl-rosiglitazone|avandaryl|av	DRUGBANK	DB00412	C18H19N3O3S	small molecule	A10BD03|A10BG02|A10BD04	122320-73-4	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	YASAKCUCGLMORW-UHFFFAOYNA-N
29799	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Xu Y (2004)	15115385	224915	9723	3-{4-[2-(2-Biphenyl-3-yl-5-methyl-oxazol-4-yl)ethoxy]-phenyl}-2-methyl-2-phenoxypropionic acid	3-{4-[2-(2-BIPHENYL-3-YL-5-METHYL-OXAZOL-4-YL)ETHOXY]-PHENYL}-2-METHYL-2-PHENOXYPROPIONIC ACID|3-{4-[2-(2-BIPHENYL-3-YL-5-METHYL-OXAZOL-4-YL)-ETHOXY]-PHENYL}-2-METHYL-2-PHENOXY-PROPIONIC ACID|2-METHYL-3-[4-[2-[5-METHYL-2-(3-PHENYLPHENYL)-1,3-OXAZOL-4-YL]ETHOXY]PHENYL]-2-PHENOXYPROPANOIC ACID|BDBM50145723	-	PUBCHEM	10119393	C34H31NO5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	QUFDAJDYOPXGGD-UHFFFAOYSA-N
29800	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Xu Y (2004)	15115385	224915	9724	(2S)-2-Methyl-3-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]-2-phenoxypropanoic acid	(2S)-2-METHYL-3-[4-[2-(5-METHYL-2-PHENYL-1,3-OXAZOL-4-YL)ETHOXY]PHENYL]-2-PHENOXYPROPANOIC ACID|(S)-2-METHYL-3-{4-[2-(5-METHYL-2-PHENYL-OXAZOL-4-YL)-ETHOXY]-PHENYL}-2-PHENOXY-PROPIONIC ACID|BDBM50145722	-	PUBCHEM	10004270	C28H27NO5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	JSTSZHVRXHMZQK-NDEPHWFRSA-N
29801	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Xu Y (2004)	15115385	224915	9725	(2S)-2-Methyl-3-[4-[2-(5-methyl-2-thiophen-2-yl-1,3-oxazol-4-yl)ethoxy]phenyl]-2-phenoxypropanoic acid	Q27083197|(S)-2-METHYL-3-{4-[2-(5-METHYL-2-THIOPHEN-2-YL-OXAZOL-4-YL)-ETHOXY]-PHENYL}-2-PHENOXY-PROPIONIC ACID|LY-510929|(2S)-2-METHYL-3-[4-[2-(5-METHYL-2-THIOPHEN-2-YL-1,3-OXAZOL-4-YL)ETHOXY]PHENYL]-2-PHENOXYPROPANOIC ACID|LY-929|(2S)-2-METHYL-3-[4-[2-(5-METHYL-2-THIOPHEN-2-YL-1,3-OXAZOL-4-YL)ETHOXY]PHENYL]-2-(PHENOXY)PROPANOIC ACID|LY 510929|GTPL2657|BDBM50145721	-	PUBCHEM	9890585	C26H25NO5S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	KWSPYUOBNIMILB-SANMLTNESA-N
29802	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Xu Y (2004)	15115385	224915	9726	(2S)-3-[4-[2-(2-Cyclohexyl-5-methyl-1,3-oxazol-4-yl)ethoxy]phenyl]-2-methyl-2-phenoxypropanoic acid	(S)-3-{4-[2-(2-CYCLOHEXYL-5-METHYL-OXAZOL-4-YL)-ETHOXY]-PHENYL}-2-METHYL-2-PHENOXY-PROPIONIC ACID|BDBM50145719	-	PUBCHEM	11178750	C28H33NO5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	OYRNUVYEOVJEPD-NDEPHWFRSA-N
29803	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Xu Y (2004)	15115385	224915	9727	3-{4-[2-(2-Cyclohexyl-5-methyl-oxazol-4-yl)-ethoxy]-phenyl}-2-methyl-2-phenoxy-propionic acid	3-{4-[2-(2-CYCLOHEXYL-5-METHYL-OXAZOL-4-YL)-ETHOXY]-PHENYL}-2-METHYL-2-PHENOXY-PROPIONIC ACID|3-[4-[2-(2-CYCLOHEXYL-5-METHYL-1,3-OXAZOL-4-YL)ETHOXY]PHENYL]-2-METHYL-2-PHENOXYPROPANOIC ACID|BDBM50145718	-	PUBCHEM	11374677	C28H33NO5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	OYRNUVYEOVJEPD-UHFFFAOYSA-N
29804	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Xu Y (2004)	15115385	224915	9684	2-Methyl-3-{4-[2-(5-methyl-2-phenyl-oxazol-4-yl)-ethoxy]-phenyl}-2-phenoxy-propionic acid	2-METHYL-3-{4-[2-(5-METHYL-2-PHENYL-OXAZOL-4-YL)-ETHOXY]-PHENYL}-2-PHENOXY-PROPIONIC ACID|2-METHYL-3-[4-[2-(5-METHYL-2-PHENYL-1,3-OXAZOL-4-YL)ETHOXY]PHENYL]-2-PHENOXYPROPANOIC ACID|BDBM50145712	-	PUBCHEM	10139247	C28H27NO5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	JSTSZHVRXHMZQK-UHFFFAOYSA-N
29805	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Xu Y (2004)	15115385	224915	9728	2-Methyl-3-[4-[2-(5-methyl-2-thiophen-2-yl-1,3-oxazol-4-yl)ethoxy]phenyl]-2-phenoxypropanoic acid	2-METHYL-3-[4-[2-(5-METHYL-2-THIOPHEN-2-YL-1,3-OXAZOL-4-YL)ETHOXY]PHENYL]-2-PHENOXYPROPANOIC ACID|2-METHYL-3-{4-[2-(5-METHYL-2-THIOPHEN-2-YL-OXAZOL-4-YL)-ETHOXY]-PHENYL}-2-PHENOXY-PROPIONIC ACID|BDBM50145710	-	PUBCHEM	10276539	C26H25NO5S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	KWSPYUOBNIMILB-UHFFFAOYSA-N
29808	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Desai RC (2003)	14505666	224918	9730	5-[3-[3-(4-Cycloheptyloxy-2-propylphenoxy)propoxy]phenyl]-1,3-thiazolidine-2,4-dione	BDBM50133669	-	PUBCHEM	44345278	C28H35NO5S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	VSCDIBRPSQPEET-UHFFFAOYSA-N
29809	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Desai RC (2003)	14505666	224918	9731	5-[3-[3-(4-Cyclopentyloxy-2-propylphenoxy)propoxy]phenyl]-1,3-thiazolidine-2,4-dione	BDBM50133667	-	PUBCHEM	44345252	C26H31NO5S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	BZLTUCWBZRKZHF-UHFFFAOYSA-N
29810	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Desai RC (2003)	14505666	224918	9732	5-[3-[3-[2-Propyl-4-(cyclohexylmethyl)phenoxy]propoxy]phenyl]thiazolidine-2,4-dione	5-[3-[3-[2-PROPYL-4-(CYCLOHEXYLMETHYL)PHENOXY]PROPOXY]PHENYL]THIAZOLIDINE-2,4-DIONE|BDBM50133666	-	PUBCHEM	44345031	C28H35NO4S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	UJHOOSFHNXHHKX-UHFFFAOYSA-N
29811	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Desai RC (2003)	14505666	224918	9733	(5S)-5-[3-[3-(4-Benzoyl-2-propylphenoxy)propoxy]phenyl]-1,3-thiazolidine-2,4-dione	BDBM50133663	-	PUBCHEM	70694429	C28H27NO5S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	OZZBRLWUSGYQBE-SANMLTNESA-N
29812	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Desai RC (2003)	14505666	224918	9734	(5R)-5-[3-[3-[4-(1,2-Benzoxazol-3-yl)-2-propylphenoxy]propoxy]phenyl]-1,3-thiazolidine-2,4-dione	BDBM50133661	-	PUBCHEM	54583265	C28H26N2O5S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	JLAXJZRUAXLLMT-AREMUKBSSA-N
29813	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Desai RC (2003)	14505666	224918	9735	5-[3-[3-(4-Cyclohexyloxy-2-propylphenoxy)propoxy]phenyl]-1,3-thiazolidine-2,4-dione	BDBM50133658	-	PUBCHEM	44345458	C27H33NO5S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	GYMUSJRQCDBZCQ-UHFFFAOYSA-N
29814	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Desai RC (2003)	14505666	224918	9736	5-[3-[3-[2-Propyl-4-(cyclohexylcarbonyl)phenoxy]propoxy]phenyl]thiazolidine-2,4-dione	5-[3-[3-[2-PROPYL-4-(CYCLOHEXYLCARBONYL)PHENOXY]PROPOXY]PHENYL]THIAZOLIDINE-2,4-DIONE|BDBM50133654	-	PUBCHEM	44344982	C28H33NO5S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	DSILKMLNLQMKEG-UHFFFAOYSA-N
29815	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Desai RC (2003)	14505666	224918	9737	(5S)-5-[3-[3-(4-Phenoxy-2-propylphenoxy)propoxy]phenyl]-1,3-thiazolidine-2,4-dione	BDBM50131503	-	PUBCHEM	54583268	C27H27NO5S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ZNLPWBJCSSSCCR-VWLOTQADSA-N
29817	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Desai RC (2003)	12873517	224920	9739	(5R)-5-[3-[3-[4-(4-Hydroxyphenoxy)-2-propylphenoxy]propoxy]phenyl]-1,3-thiazolidine-2,4-dione	BDBM50131514	-	PUBCHEM	54587161	C27H27NO6S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	UMCOHKMLPVPQBF-RUZDIDTESA-N
29818	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Desai RC (2003)	12873517	224920	9740	(5S)-5-[3-[3-[4-(4-Chloro-3-methylphenoxy)-2-propylphenoxy]propoxy]phenyl]-1,3-thiazolidine-2,4-dione	BDBM50131512	-	PUBCHEM	54580272	C28H28ClNO5S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	RHXBMPROSWDTQC-SANMLTNESA-N
29819	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Desai RC (2003)	12873517	224920	9741	5-[3-[3-[2-Propyl-4-(3,4-dichlorophenoxy)phenoxy]propoxy]phenyl]thiazolidine-2,4-dione	5-[3-[3-[2-PROPYL-4-(3,4-DICHLOROPHENOXY)PHENOXY]PROPOXY]PHENYL]THIAZOLIDINE-2,4-DIONE|BDBM50131511	-	PUBCHEM	44327417	C27H25Cl2NO5S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	SXOUCNMFIUAZNE-UHFFFAOYSA-N
29820	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Desai RC (2003)	12873517	224920	9742	(5S)-5-[3-[3-[4-(4-Fluorophenoxy)-2-propylphenoxy]propoxy]phenyl]-1,3-thiazolidine-2,4-dione	BDBM50131506	-	PUBCHEM	54584231	C27H26FNO5S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	BEESZPXMMFEPAP-VWLOTQADSA-N
29821	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Desai RC (2003)	12873517	224920	9743	(5R)-5-[3-[3-[4-(4-Fluoro-3-methylphenoxy)-2-propylphenoxy]propoxy]phenyl]-1,3-thiazolidine-2,4-dione	BDBM50131505	-	PUBCHEM	54585196	C28H28FNO5S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	TVEAXARFLUXLEB-AREMUKBSSA-N
29822	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Desai RC (2003)	12873517	224920	9744	(5R)-5-[3-[3-[4-(4-Chlorophenoxy)-2-propylphenoxy]propoxy]phenyl]-1,3-thiazolidine-2,4-dione	BDBM50131504	-	PUBCHEM	54585195	C27H26ClNO5S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	BSYLKYWBLKSLBJ-RUZDIDTESA-N
29823	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Desai RC (2003)	12873517	224920	9737	(5S)-5-[3-[3-(4-Phenoxy-2-propylphenoxy)propoxy]phenyl]-1,3-thiazolidine-2,4-dione	BDBM50131503	-	PUBCHEM	54583268	C27H27NO5S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	ZNLPWBJCSSSCCR-VWLOTQADSA-N
29824	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Desai RC (2003)	12873517	224920	9745	(5S)-5-[3-[3-(4-Phenoxyphenoxy)propoxy]phenyl]-1,3-thiazolidine-2,4-dione	BDBM50131502	-	PUBCHEM	54581270	C24H21NO5S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	BTMVNTBNPIYHBM-QFIPXVFZSA-N
29825	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Ebdrup S (2003)	12672231	170525	6481	Ragaglitazar	NN-622|(2S)-2-ETHOXY-3-{4-[2-(10H-PHENOXAZIN-10-YL)ETHOXY]PHENYL}PROPANOIC ACID|2-ETHOXY-3-[4-(2-PHENOXAZIN-10-YL-ETHOXY)-PHENYL]-PROPIONIC ACID(-) DRF 2725|Q27088511|DRF-2725|2-ETHOXY-3-[4-(2-PHENOXAZIN-10-YL-ETHOXY)-PHENYL]-PROPIONIC ACID|NNC-61-0029|(2S)-2-ETHOXY-3-[4-(2-PHENOXAZIN-10-YLETHOXY)PHENYL]PROPANOIC ACID|1NYX|DRF|(-)-DRF-2725|DRF2725|(S)-2-ETHOXY-3-[4-(2-PHENOXAZIN-10-YL-ETHOXY)-PHENYL]-PROPIONIC ACID|DB07675|RAGAGLITAZAR|GTPL2664|BDBM50109551	-	DRUGBANK	DB07675	C25H25NO5	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	WMUIIGVAWPWQAW-DEOSSOPVSA-N
29826	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Santini C (2003)	12657263	224921	9746	2-[3-Chloro-4-[3-[4-[(Z)-C-ethyl-N-hydroxycarbonimidoyl]-3-hydroxy-2-propylphenoxy]propylsulfanyl]phenyl]acetic acid	3-CHLORO-4-[3-[2-PROPYL-3-HYDROXY-4-[1-(HYDROXYIMINO)PROPYL]PHENOXY]PROPYLTHIO]BENZENEACETIC ACID|BDBM50126019	-	PUBCHEM	136088972	C23H28ClNO5S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	JLVVAYSKHQLKES-PLRJNAJWSA-N
29827	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Santini C (2003)	12657263	224921	9747	Benzeneacetic acid, 3-chloro-4-((3-((3-phenyl-7-propyl-6-benzofuranyl)oxy)propyl)thio)-	UNII-O937X0Z5EM|{3-CHLORO-4-[3-(3-PHENYL-7-PROPYL-BENZOFURAN-6-YLOXY)-PROPYLSULFANYL]-PHENYL}-ACETIC ACID|BENZENEACETIC ACID, 3-CHLORO-4-((3-((3-PHENYL-7-PROPYL-6-BENZOFURANYL)OXY)PROPYL)THIO)-|3-CHLORO-4-(3-(3-PHENYL-7-PROPYLBENZOFURAN-6-YLOXY)PROPYLTHIO)-PHENYLACETIC ACID|L-796,449|L796449|O937X0Z5EM|2-[3-CHLORO-4-[3-[(3-PHENYL-7-PROPYL-1-BENZOFURAN-6-YL)OXY]PROPYLSULFANYL]PHENYL]ACETIC ACID|L-796449|L 796449|Q27078434|{3-CHLORO-4-[3-(3-PHENYL-7-PROPYL-BENZOFURAN-6-YLOXY)-PROPYLSULFANYL]-PHENYL}-ACETIC ACID(L-796449)|GTPL2689|194608-80-5|BDBM50085040	-	PUBCHEM	9891946	C28H27ClO4S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	KAPDPGZDHUCILF-UHFFFAOYSA-N
29828	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Brooks DA (2001)	11405642	224922	9748	5-[[4-[2-(5-Methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione	AD 5061|AD-5061|BM-131246|AD 7057|AD5061|5-{4-[2-(5-METHYL-2-PHENYL-4-OXAZOLYL)ETHOXY]BENZYL}-2,4-THIAZOLIDINEDIONE|GTPL2663|5-({4-[2-(5-METHYL-2-PHENYL-1,3-OXAZOL-4-YL)ETHOXY]PHENYL}METHYL)-1,3-THIAZOLIDINE-2,4-DIONE|Q27074311|HY-101758|AD-7057|CS-6704|5-[[4-[2-(5-METHYL-2-PHENYL-1,3-OXAZOL-4-YL)ETHOXY]PHENYL]METHYL]-1,3-THIAZOLIDINE-2,4-DIONE|AD7057|BDBM50064451	-	PUBCHEM	9953271	C22H20N2O4S	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	GUTCYOKMCPFRGH-UHFFFAOYSA-N
29829	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Brooks DA (2001)	11405642	224922	404	Rosiglitazone	(RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion|Rosiglitazon|Rosiglitazonum|Rosiglitazone|()-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione|Rosiglitazona|BDBM50030474	phl-rosiglitazone|avandaryl|av	DRUGBANK	DB00412	C18H19N3O3S	small molecule	A10BD03|A10BG02|A10BD04	122320-73-4	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	YASAKCUCGLMORW-UHFFFAOYNA-N
29832	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Henke BR (1999)	10612594	224924	9750	2-Phenyl-3-(4-methoxyphenethyl)-1H-indole-5-acetic acid	{3-[2-(4-METHOXY-PHENYL)-ETHYL]-2-PHENYL-1H-INDOL-5-YL}-ACETIC ACID(GW 0207)|2-PHENYL-3-(4-METHOXYPHENETHYL)-1H-INDOLE-5-ACETIC ACID|258345-12-9|2-(3-(4-METHOXYPHENETHYL)-2-PHENYL-1H-INDOL-5-YL)ACETIC ACID|2-[3-[2-(4-METHOXYPHENYL)ETHYL]-2-PHENYL-1H-INDOL-5-YL]ACETIC ACID|{3-[2-(4-METHOXY-PHENYL)-ETHYL]-2-PHENYL-1H-INDOL-5-YL}-ACETIC ACID|GW0207|BDBM50083625	-	PUBCHEM	10068664	C25H23NO3	small molecule	-	-	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	YZLHLVJLTOPOHC-UHFFFAOYSA-N
29833	111464	5468	-	PPARG	CIMT1|GLM1|NR1C3|PPARG1|PPARG2|PPARgamma	9606	Homo sapiens	unknown	target	Parks DJ (1998)	9934490	224925	404	Rosiglitazone	(RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion|Rosiglitazon|Rosiglitazonum|Rosiglitazone|()-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione|Rosiglitazona|BDBM50030474	phl-rosiglitazone|avandaryl|av	DRUGBANK	DB00412	C18H19N3O3S	small molecule	A10BD03|A10BG02|A10BD04	122320-73-4	BINDINGDB	-	-	-	-	-	-	-	-	-	-	-	YASAKCUCGLMORW-UHFFFAOYNA-N
30123	107925	1545	-	CYP1B1	CP1B|CYPIB1|GLC3A|P4501B1	9606	Homo sapiens	degradation	target	Zhou L (2020)	31945665	228714	9783	Bivalent ligand 204	6C|Bivalent_ligand_204	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: 6C (CRBN:thalidomide --- CYP1B1:-naphthoflavone derivative 5)	-
30898	111587	5601	-	MAPK9	JNK-55|JNK2|JNK2A|JNK2ALPHA|JNK2B|JNK2BETA|PRKM9|SAPK|SAPK1a|p54a|p54aSAPK	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10011	Bivalent Ligand 267	DB0646|Bivalent_Ligand_267	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB0646 (CRBN:Thalidomide--- MAPK9:GNF-7)	-
30900	114683	9261	-	MAPKAPK2	MAPKAP-K2|MK-2|MK2	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10011	Bivalent Ligand 267	DB0646|Bivalent_Ligand_267	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB0646 (CRBN:Thalidomide--- MAPKAPK2:GNF-7)	-
31056	111587	5601	-	MAPK9	JNK-55|JNK2|JNK2A|JNK2ALPHA|JNK2B|JNK2BETA|PRKM9|SAPK|SAPK1a|p54a|p54aSAPK	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10005	Bivalent Ligand 269	TMX-02-174|Bivalent_Ligand_269	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TMX-02-174 (CRBN:pomalidomide--- MAPK9:Ceritinib)	-
31134	111587	5601	-	MAPK9	JNK-55|JNK2|JNK2A|JNK2ALPHA|JNK2B|JNK2BETA|PRKM9|SAPK|SAPK1a|p54a|p54aSAPK	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10035	Bivalent Ligand 270	DB0662|Bivalent_Ligand_270	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB0662 (CRBN:thalidomide--- MAPK9:GNF-7)	-
31136	114683	9261	-	MAPKAPK2	MAPKAP-K2|MK-2|MK2	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10035	Bivalent Ligand 270	DB0662|Bivalent_Ligand_270	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB0662 (CRBN:thalidomide--- MAPKAPK2:GNF-7)	-
31326	111587	5601	-	MAPK9	JNK-55|JNK2|JNK2A|JNK2ALPHA|JNK2B|JNK2BETA|PRKM9|SAPK|SAPK1a|p54a|p54aSAPK	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10034	Bivalent Ligand 273	DB1114|Bivalent_Ligand_273	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB1114 (VHL:VHL-1--- MAPK9:GNF-7)	-
31328	114683	9261	-	MAPKAPK2	MAPKAP-K2|MK-2|MK2	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10034	Bivalent Ligand 273	DB1114|Bivalent_Ligand_273	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB1114 (VHL:VHL-1--- MAPKAPK2:GNF-7)	-
31386	111587	5601	-	MAPK9	JNK-55|JNK2|JNK2A|JNK2ALPHA|JNK2B|JNK2BETA|PRKM9|SAPK|SAPK1a|p54a|p54aSAPK	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10039	Bivalent Ligand 274	DB1113|Bivalent_Ligand_274	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB1113 (VHL:VHL-1--- MAPK9:GNF-7)	-
31388	114683	9261	-	MAPKAPK2	MAPKAP-K2|MK-2|MK2	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10039	Bivalent Ligand 274	DB1113|Bivalent_Ligand_274	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB1113 (VHL:VHL-1--- MAPKAPK2:GNF-7)	-
31450	111587	5601	-	MAPK9	JNK-55|JNK2|JNK2A|JNK2ALPHA|JNK2B|JNK2BETA|PRKM9|SAPK|SAPK1a|p54a|p54aSAPK	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10040	Bivalent Ligand 275	TMX-02-138|Bivalent_Ligand_275	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TMX-02-138 (CRBN:pomalidomide--- MAPK9:Ceritinib)	-
31646	111587	5601	-	MAPK9	JNK-55|JNK2|JNK2A|JNK2ALPHA|JNK2B|JNK2BETA|PRKM9|SAPK|SAPK1a|p54a|p54aSAPK	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10042	Bivalent Ligand 279	DB0614|Bivalent_Ligand_279	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB0614 (CRBN:Thalidomide--- MAPK9:Thienopyrimidines)	-
31856	111587	5601	-	MAPK9	JNK-55|JNK2|JNK2A|JNK2ALPHA|JNK2B|JNK2BETA|PRKM9|SAPK|SAPK1a|p54a|p54aSAPK	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10063	Bivalent Ligand 287	DB0663|Bivalent_Ligand_287	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB0663 (CRBN:Thalidomide---a MAPK9:GNF-7)	-
31882	111587	5601	-	MAPK9	JNK-55|JNK2|JNK2A|JNK2ALPHA|JNK2B|JNK2BETA|PRKM9|SAPK|SAPK1a|p54a|p54aSAPK	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10062	Bivalent Ligand 288	DB0661|Bivalent_Ligand_288	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DB0661 (CRBN:Thalidomide--- MAPK9:GNF-7)	-
31958	111587	5601	-	MAPK9	JNK-55|JNK2|JNK2A|JNK2ALPHA|JNK2B|JNK2BETA|PRKM9|SAPK|SAPK1a|p54a|p54aSAPK	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10089	Bivalent Ligand 290	TMX-01-160-1|Bivalent_Ligand_290	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TMX-01-160-1 (CRBN:Thalidomide--- MAPK9:Ceritinib)	-
32142	111587	5601	-	MAPK9	JNK-55|JNK2|JNK2A|JNK2ALPHA|JNK2B|JNK2BETA|PRKM9|SAPK|SAPK1a|p54a|p54aSAPK	9606	Homo sapiens	degradation	target	Donovan KA (2020)	33275901	231643	10088	Bivalent Ligand 297	TMX-02-172|Bivalent_Ligand_297	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: TMX-02-172 (CRBN:pomalidomide--- MAPK9:Ceritinib)	-
32580	111714	5742	RP11-542K23.6	PTGS1	COX1|COX3|PCOX1|PES-1|PGG/HS|PGHS-1|PGHS1|PHS1|PTGHS	9606	Homo sapiens	degradation	target	Zhang C (2021)	34927316	232727	10096	Bivalent Ligand 342	SPNCOX|Bivalent_Ligand_342	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	nano-PROTAC	A nano-particle containing a Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety, which is activatable in the presence of a specific stimulus; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SPNCOX (VHL:GSGSALAPYIP---PTGS1:indomethacin)	-
32582	111715	5743	-	PTGS2	COX-2|COX2|GRIPGHS|PGG/HS|PGHS-2|PHS-2|hCox-2	9606	Homo sapiens	degradation	target	Zhang C (2021)	34927316	232727	10096	Bivalent Ligand 342	SPNCOX|Bivalent_Ligand_342	-	BIOGRID	-	-	polypeptidic	-	-	BIOGRID	nano-PROTAC	A nano-particle containing a Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety, which is activatable in the presence of a specific stimulus; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: SPNCOX (VHL:GSGSALAPYIP---PTGS2:indomethacin)	-
32670	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	degradation	target	Liu Q (2022)	34864330	235159	10030	Bivalent Ligand 376	BP3|Bivalent_Ligand_376	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: BP3 (CRBN:pomalidomide---HSP90AA1:BIIB021)	-
32935	107925	1545	-	CYP1B1	CP1B|CYPIB1|GLC3A|P4501B1	9606	Homo sapiens	degradation	target	Chen P (2021)	34455300	243005	10365	Bivalent ligand 453	4f|Bivalent_ligand_453	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: 4f (CRBN:thalidomide --- CYP1B1:-naphthoflavone)	-
33053	123135	80142	RP11-395P17.2	PTGES2	C9orf15|GBF-1|GBF1|PGES2|mPGES-2	9606	Homo sapiens	antiviral	target	Desantis J (2021)	34534839	232373	10393	Bivalent ligand 486	PROTAC 3 anti-viral|Bivalent_ligand_486	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: PROTAC 3 anti-viral (VHL: HIF-1alpha hydroxyproline derived small molecule---PTGES2:indomethacin; Coronavirus Project)	-
33055	123135	80142	RP11-395P17.2	PTGES2	C9orf15|GBF-1|GBF1|PGES2|mPGES-2	9606	Homo sapiens	antiviral	target	Desantis J (2021)	34534839	232373	10392	Bivalent ligand 487	PROTAC 5 anti-viral|Bivalent_ligand_487	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: PROTAC 5 anti-viral (VHL: HIF-1alpha hydroxyproline derived small molecule---PTGES2:indomethacin; Coronavirus Project)	-
33429	112717	6850	-	SYK	p72-Syk	9606	Homo sapiens	inhibitor/sars-cov-2 inhibitor	target	Liu Q (2022)	35858407	244644	10248	Fostamatinib	2H-Pyrido[3,2-b]-1,4-oxazin-3(4H)-one, 6-[[5-fluoro-2-[(3,4,5-trimethoxyphenyl)amino]-4-pyrimidinyl]amino]-2,2-dimethyl-4-[(phosphonooxy)methyl]-|Fostamatinib|SQ8A3S5101|TAVALISSE|[6-({5-Fluoro-2-[(3,4,5-trimethoxyphenyl)amino]-4-pyrimidinyl}amino)-2,2-dimethyl-3-oxo-2,3-dihydro-4H-pyrido[3,2-b][1,4]oxazin-4-yl]methyl dihydrogen phosphate	-	CHEMSPIDER	9846198	C23H26FN6O9P	small molecule	-	901119-35-5	BIOGRID	-	-	-	-	-	-	-	-	-	-	Coronavirus Project SARS-CoV-2 indirect chemical interaction: SYK inhibitor; SIRT5 activator; antiviral activity against SARS-CoV-2 in Caco-2 cells	GKDRMWXFWHEQQT-UHFFFAOYSA-N
33564	109137	2879	-	GPX4	GPx-4|GSHPx-4|MCSP|PHGPx|snGPx|snPHGPx	9606	Homo sapiens	degradation	target	Song H (2024)	38194774	256616	10757	Bivalent ligand 528	18a|bivalent_ligand_528	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	106826	329	-	BIRC2	API1|HIAP2|Hiap-2|MIHB|RNF48|c-IAP1|cIAP1	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: 18a (BIRC2:bestatin --- GPX4:RSL3)	-
33722	108367	2053	-	EPHX2	CEH|SEH	9606	Homo sapiens	degradation	target	Peyman M (2023)	37826940	254528	10819	Bivalent ligand 590	ALT-PG2|bivalent_ligand_590	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: ALT-PG2 (CRBN:Thalidomide --- sEH:t-TUCB)	-
33724	108367	2053	-	EPHX2	CEH|SEH	9606	Homo sapiens	degradation	target	Wang Y (2023)	36947831	254529	10820	Bivalent ligand 591	compound 1a|bivalent_ligand_591	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: compound 1a (CRBN:Thalidomide --- sEH:t-TUCB)	-
33780	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	degradation	target	Jiang Q (2023)	37619298	254609	10847	Bivalent ligand 626	X10g|bivalent_ligand_626	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: X10g (CRBN:pomalidomide --- HSP90AA1:AT13387 analogue X1)	-
33840	109552	3320	-	HSP90AA1	EL52|HSP86|HSP89A|HSP90A|HSP90N|HSPC1|HSPCA|HSPCAL1|HSPCAL4|HSPN|Hsp89|Hsp90|LAP-2|LAP2	9606	Homo sapiens	degradation	target	Wurnig S (2023)	37448856	254811	10871	Bivalent ligand 650	3a|bivalent_ligand_650	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: 3a (CRBN:pomalidomide --- HSP90AA1:geldanamycin)	-
33942	110428	4282	-	MIF	GIF|GLIF|MMIF	9606	Homo sapiens	degradation	target	Xiao Z (2021)	34018657	255460	10917	Bivalent ligand 696	MD13|bivalent_ligand_696	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: MD13 (CRBN:pomalidomide --- MIF:Compound 3 (MIF tautomerase inhibitor))	-
34086	118128	27306	-	HPGDS	GSTS|GSTS1-1|PGD2|PGDS	9606	Homo sapiens	degradation	target	Yokoo H (2021)	33603969	256668	10971	Bivalent ligand 750	PROTAC(H-PGDS)-1|bivalent_ligand_750	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: PROTAC(H-PGDS)-1 (CRBN:pomalidomide --- HPGDS:TFC-007)	-
34144	109137	2879	-	GPX4	GPx-4|GSHPx-4|MCSP|PHGPx|snGPx|snPHGPx	9606	Homo sapiens	degradation	target	Cai M (2023)	37257255	256438	10986	Bivalent ligand 765	GDC-22|bivalent_ligand_765	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	113269	7428	-	VHL	HRCA1|RCA1|VHL1|pVHL	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: GDC-22 (VHL:VHL Ligand --- GPX4:ML162-1)	-
34190	109137	2879	-	GPX4	GPx-4|GSHPx-4|MCSP|PHGPx|snGPx|snPHGPx	9606	Homo sapiens	degradation	target	Zheng C (2023)	37098297	256452	11004	Bivalent ligand 783	R17|bivalent_ligand_783	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: R17 (CRBN:lenalidomide --- GPX4:RSL3 analogue)	-
34192	109137	2879	-	GPX4	GPx-4|GSHPx-4|MCSP|PHGPx|snGPx|snPHGPx	9606	Homo sapiens	degradation	target	Zheng C (2023)	37098297	256452	11005	Bivalent ligand 784	NC-R17|bivalent_ligand_784	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: NC-R17 (CRBN:lenalidomide --- GPX4:RSL3 analogue)	-
34198	109137	2879	-	GPX4	GPx-4|GSHPx-4|MCSP|PHGPx|snGPx|snPHGPx	9606	Homo sapiens	degradation	target	Wang H (2023)	37087895	256454	11007	Bivalent ligand 786	DC-2|bivalent_ligand_786	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: DC-2 (CRBN:pomalidomide --- GPX4:ML210)	-
34234	109137	2879	-	GPX4	GPx-4|GSHPx-4|MCSP|PHGPx|snGPx|snPHGPx	9606	Homo sapiens	degradation	target	Zhu L (2023)	36924654	256499	11020	Bivalent ligand 799	PD-4|bivalent_ligand_799	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: PD-4 (CRBN:pomalidomide --- GPX4:ML-162)	-
34236	109137	2879	-	GPX4	GPx-4|GSHPx-4|MCSP|PHGPx|snGPx|snPHGPx	9606	Homo sapiens	degradation	target	Zhu L (2023)	36924654	256499	11021	Bivalent ligand 819	PD-P2|bivalent_ligand_819	-	BIOGRID	-	-	small molecule	-	-	BIOGRID	PROTAC	Proteolysis Targeting Chimera; structured as E3 binding moiety--linker--target binding moiety; target degraded via UPS	119360	51185	AD-006	CRBN	MRT2|MRT2A	9606	Homo sapiens	recruited e3 ligase	Standardized BVL Name: PD-P2 (CRBN:pomalidomide --- GPX4:ML-162)	-
